data_1krx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1krx _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.131 0 N-CA-C 112.658 -0.177 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.421 HD11 ' HB ' ' A' ' 29' ' ' THR . 4.2 mm -116.74 112.51 39.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.597 0.237 . . . . 0.0 111.393 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 4.8 p -107.27 117.31 52.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.46 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.634 ' CH2' ' HG2' ' A' ' 46' ' ' LYS . 34.3 m0 -108.03 137.96 45.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 0.0 111.109 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.5 t -124.2 141.92 42.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.944 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -128.03 114.1 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.743 177.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.578 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.2 t0 -171.63 -152.02 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.55 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -66.33 -2.44 4.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.6 OUTLIER 59.01 -148.04 0.48 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 121.201 -0.2 . . . . 0.0 111.299 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 t 34.58 -89.41 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 12' ' ' ASP . 61.6 m -55.65 -55.16 35.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.873 0.368 . . . . 0.0 110.971 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.5 mm -63.58 -34.73 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.112 0.482 . . . . 0.0 111.073 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.439 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 0.7 OUTLIER -69.39 -53.79 17.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.944 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.425 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 85.6 t90 -52.52 -45.11 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.542 ' CG1' HD13 ' A' ' 108' ' ' ILE . 1.4 t -67.94 -57.96 7.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.219 0.533 . . . . 0.0 111.424 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.647 ' HA ' HD12 ' A' ' 108' ' ' ILE . 3.6 mm? -67.04 -27.71 67.62 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 15.8 pt-20 -67.55 -59.89 3.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.533 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.5 mmt180 -75.66 -52.38 10.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.525 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -54.15 -54.04 45.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.811 0.339 . . . . 0.0 111.853 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.683 HD12 ' CD1' ' A' ' 28' ' ' LEU . 5.2 tp -64.3 -25.93 68.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.198 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.32 -33.31 74.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.99 -22.77 74.26 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.385 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.99 -15.59 59.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 110.84 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.73 21.99 8.33 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.64 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.683 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.85 170.84 11.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.397 0.599 . . . . 0.0 111.35 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.442 ' O ' HG13 ' A' ' 6' ' ' VAL . 52.1 m -105.11 106.51 17.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.917 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 8.5 t -105.83 114.47 28.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.391 0.615 . . . . 0.0 112.188 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.532 HG22 ' CE1' ' A' ' 33' ' ' PHE . 2.8 t -122.66 156.78 33.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.576 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 33.9 p -127.81 156.63 42.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.451 0.643 . . . . 0.0 112.234 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.944 ' HB2' HG12 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -128.47 174.12 9.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.242 -179.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.475 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -57.61 -52.33 65.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -160.21 -37.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.586 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 178.43 -55.82 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.498 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.609 ' HA ' HD12 ' A' ' 40' ' ' LEU . 17.2 m120 -56.97 -26.9 60.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 110.689 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -63.91 -48.51 76.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.527 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.604 HG22 HG21 ' A' ' 9' ' ' VAL . 13.5 t -58.99 -32.78 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.447 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.609 HD12 ' HA ' ' A' ' 37' ' ' ASN . 32.7 mt -56.21 -47.56 78.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.335 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.99 -47.95 76.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.339 0.59 . . . . 0.0 110.258 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.15 -32.67 72.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.698 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.501 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 15.6 mt -67.47 -27.65 67.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.054 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.34 -15.87 40.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.492 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 m -123.22 -5.51 8.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.799 ' HG3' ' N ' ' A' ' 47' ' ' THR . 1.3 tttt -155.55 166.57 33.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.309 0.576 . . . . 0.0 111.615 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.799 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 96.7 m -138.29 112.75 8.7 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.796 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.412 ' HD2' HD13 ' A' ' 76' ' ' LEU . 56.5 Cg_endo -71.44 158.1 54.9 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.465 2.11 . . . . 0.0 111.657 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.94 -30.59 50.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.78 0.324 . . . . 0.0 111.037 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.417 ' CG2' HD11 ' A' ' 79' ' ' ILE . 5.9 p -145.26 94.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.446 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HG ' HG12 ' A' ' 78' ' ' VAL . 38.2 tp -83.21 141.26 32.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.432 0.634 . . . . 0.0 112.209 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.745 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -124.33 119.62 29.81 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.588 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.827 ' HA ' HG22 ' A' ' 9' ' ' VAL . 1.4 m -115.28 148.08 39.63 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.578 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 28.1 t0 -82.87 -178.0 6.95 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.348 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.671 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.1 tt -160.0 74.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 121.137 0.494 . . . . 0.0 112.095 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 177.05 58.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.646 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.513 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.33 -63.03 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.908 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.513 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 23.0 Cg_endo -60.22 -165.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.669 2.246 . . . . 0.0 113.356 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.03 -65.06 3.32 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.69 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.579 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -85.19 53.18 2.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.995 0.426 . . . . 0.0 110.94 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.441 ' HB3' HG13 ' A' ' 55' ' ' ILE . 1.2 m-20 55.74 -68.45 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.681 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.671 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -152.16 -35.62 0.03 OUTLIER Glycine 0 CA--C 1.507 -0.44 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.271 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 90' ' ' ALA . 1.0 OUTLIER -53.64 -28.24 31.75 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.2 -34.42 75.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.528 HD11 ' HA3' ' A' ' 36' ' ' GLY . 74.1 mt -59.98 -35.99 76.19 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.672 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.742 HD21 ' HB ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -61.83 -51.06 69.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.433 178.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.668 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 11.9 tttp -47.36 -44.93 24.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.082 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.569 ' CB ' HD13 ' A' ' 40' ' ' LEU . 2.5 mt-30 -60.76 -43.18 98.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.202 0.525 . . . . 0.0 110.174 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.6 mt -64.98 -37.94 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.06 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.668 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -77.21 -23.48 51.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.541 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -67.17 -43.41 82.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.126 0.488 . . . . 0.0 111.233 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.83 -26.55 13.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.176 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.501 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 59.3 m-70 -130.25 76.23 78.11 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.751 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 73.5 Cg_endo -75.21 40.22 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.616 2.21 . . . . 0.0 112.236 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 59.1 mtt -153.97 -39.19 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.435 ' CD2' HD21 ' A' ' 43' ' ' LEU . 16.8 tp -55.01 112.31 3.96 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.916 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.585 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 59.4 Cg_endo -73.41 141.21 31.38 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.934 1.756 . . . . 0.0 111.985 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.742 ' HB ' HD21 ' A' ' 66' ' ' LEU . 2.3 t -128.93 151.58 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.335 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.521 HG12 ' CD2' ' A' ' 99' ' ' PHE . 1.5 mt -120.93 118.54 56.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.991 0.424 . . . . 0.0 111.135 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.544 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 16.3 mm -95.01 142.68 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.509 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.456 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -82.31 -16.83 47.94 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.513 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.6 m -148.14 144.54 27.86 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.906 -0.717 . . . . 0.0 111.989 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.68 40.44 3.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.839 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.469 ' CE1' HG22 ' A' ' 82' ' ' THR . 1.1 p-80 -89.51 -12.07 41.08 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.425 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -92.98 -164.14 1.14 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.641 0.258 . . . . 0.0 110.613 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.412 ' O ' ' CD2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -53.84 93.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.758 0.314 . . . . 0.0 111.334 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.472 ' HA ' HD21 ' A' ' 63' ' ' LEU . 1.7 mt -59.52 -21.89 60.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.741 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.0 -43.47 29.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.333 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . . . -68.95 -23.15 64.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.688 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.576 ' HB2' HD22 ' A' ' 63' ' ' LEU . . . -67.86 -23.01 65.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.754 0.311 . . . . 0.0 110.273 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.635 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.4 t -69.03 -41.95 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.464 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.589 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 91.3 p -60.45 -18.2 49.6 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.742 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.72 -53.91 7.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.431 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.635 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.2 m-85 -58.75 -31.43 68.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.064 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.589 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -75.88 -34.62 60.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.816 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.742 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 3.1 pp0? -80.75 -18.26 48.31 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.607 0.241 . . . . 0.0 110.82 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 77' ' ' PRO . . . 112.27 32.56 2.33 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.207 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . . . -65.01 169.82 4.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.238 0.519 . . . . 0.0 110.998 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.587 ' CZ ' ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -85.55 -55.24 4.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.727 0.298 . . . . 0.0 110.941 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 99' ' ' PHE . 0.1 OUTLIER 164.77 -162.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.884 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.544 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.1 m-85 -132.86 112.49 11.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.127 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.64 HD23 ' CE1' ' A' ' 106' ' ' PHE . 4.8 tp -102.96 142.97 25.66 Favored Pre-proline 0 C--O 1.226 -0.169 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.275 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.733 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 19.3 Cg_endo -56.66 170.6 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.344 2.029 . . . . 0.0 111.196 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.487 ' O ' ' HE3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -44.5 -47.24 26.47 Favored Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.733 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 75.1 Cg_exo -47.99 162.01 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.376 1.384 . . . . 0.0 110.288 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.652 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -176.65 -83.98 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.291 -178.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.4 p30 41.93 -168.56 0.0 OUTLIER 'General case' 0 C--O 1.231 0.113 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.647 HD12 ' HA ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -67.66 -51.5 50.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 121.243 0.544 . . . . 0.0 111.421 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.658 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 2.9 t70 -48.96 -57.42 6.52 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.433 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.652 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.3 mm-40 -77.02 -31.19 56.21 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -84.34 -53.7 5.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.175 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.552 HG22 HG23 ' A' ' 108' ' ' ILE . 42.0 t -56.53 -32.41 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.428 0.632 . . . . 0.0 110.158 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -58.63 -52.72 64.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.821 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.445 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 5.9 tp -71.81 -25.69 62.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.816 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.547 HG11 ' O ' ' A' ' 112' ' ' VAL . 10.0 p -79.24 -54.18 12.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.417 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 1.8 mt-10 -57.57 -62.47 1.77 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.735 0.303 . . . . 0.0 111.515 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.32 -28.65 29.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.287 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.587 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.91 -49.28 20.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.871 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.483 HD12 HG21 ' A' ' 115' ' ' VAL . 5.6 mt -64.58 -31.42 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.125 0.488 . . . . 0.0 110.482 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.8 t -64.95 -33.9 77.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.748 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.7 m80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.762 179.696 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 2.8 mm -114.18 112.54 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 111.28 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 8.4 p -113.66 125.48 70.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.325 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.58 ' NE1' HG21 ' A' ' 31' ' ' THR . 35.5 m0 -115.38 139.08 50.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.626 0.251 . . . . 0.0 110.823 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -132.31 138.29 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.844 HG21 ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -128.11 107.22 15.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.668 178.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 48.6 t0 166.85 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.239 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 0.3 OUTLIER 71.06 -41.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.484 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 16' ' ' ARG . 38.8 t70 74.62 -106.3 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.971 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 12' ' ' ASP . 52.2 p -23.57 -84.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 m -53.46 -45.42 69.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.456 ' O ' HG21 ' A' ' 15' ' ' ILE . 27.1 mm -67.94 -20.48 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.822 0.344 . . . . 0.0 111.741 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.541 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 2.7 ttt180 -79.2 -54.92 5.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 111.689 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.424 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 65.0 t90 -52.37 -42.75 64.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.489 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.514 ' C ' HD11 ' A' ' 108' ' ' ILE . 1.7 t -71.38 -51.18 35.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.038 0.447 . . . . 0.0 111.92 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.519 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 4.4 mm? -70.82 -28.66 64.78 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.466 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.568 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . 23.6 pt-20 -67.59 -58.96 3.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.474 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.4 mmt180 -63.15 -58.01 8.65 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.07 -55.43 27.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.987 0.423 . . . . 0.0 111.474 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.604 ' HG ' HD13 ' A' ' 28' ' ' LEU . 14.3 tp -66.62 -19.71 65.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.467 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -70.6 -33.34 70.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.53 -26.6 68.45 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.235 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.459 ' HB3' HD11 ' A' ' 28' ' ' LEU . . . -76.87 -15.63 59.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.629 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.77 25.65 9.66 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.781 -0.723 . . . . 0.0 114.795 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.604 HD13 ' HG ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -120.0 164.74 15.65 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.61 1.205 . . . . 0.0 112.313 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.502 ' O ' HG13 ' A' ' 6' ' ' VAL . 21.0 m -94.57 111.26 23.02 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.257 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 1.1 m -102.35 118.95 37.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.293 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.615 HG22 ' CE1' ' A' ' 33' ' ' PHE . 3.1 t -128.88 136.1 49.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 55.2 p -113.99 157.62 22.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.748 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.8 m-85 -134.8 173.8 11.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.904 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.9 pp20? -61.3 -58.06 9.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.609 ' C ' HG13 ' A' ' 9' ' ' VAL . 1.9 t30 -156.3 -23.05 0.1 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.477 ' N ' HG13 ' A' ' 9' ' ' VAL . . . 165.12 -59.32 0.25 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.717 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.621 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -47.37 -32.91 5.31 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.148 0.499 . . . . 0.0 110.704 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -60.95 -60.89 3.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.613 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.764 HG21 HG22 ' A' ' 9' ' ' VAL . 1.9 t -53.86 -34.65 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.329 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.621 HD12 ' HA ' ' A' ' 37' ' ' ASN . 32.0 mt -48.81 -52.34 24.59 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.054 0.454 . . . . 0.0 110.406 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -47.97 83.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.108 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.59 -35.16 80.09 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.771 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.642 HD12 HG11 ' A' ' 39' ' ' VAL . 23.2 mt -68.32 -19.93 64.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.612 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.18 -11.98 58.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.296 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.29 -3.79 7.4 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -155.49 161.45 40.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.986 0.422 . . . . 0.0 111.31 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.417 HG21 ' CG ' ' A' ' 76' ' ' LEU . 21.1 m -138.47 112.37 8.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.952 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.64 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 73.9 Cg_endo -74.6 164.91 32.78 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.12 1.88 . . . . 0.0 111.822 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.43 -24.03 34.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.997 0.427 . . . . 0.0 110.472 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.48 ' CG2' HD12 ' A' ' 79' ' ' ILE . 7.5 p -149.97 91.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.491 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.489 ' HG ' HG11 ' A' ' 78' ' ' VAL . 57.9 tp -84.25 149.73 25.91 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.242 0.544 . . . . 0.0 111.906 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.844 ' O ' HG21 ' A' ' 9' ' ' VAL . 5.3 mt -133.73 114.06 13.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.052 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -109.18 144.02 37.83 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 9.7 t0 -73.34 -171.9 1.05 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.756 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.691 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 8.6 tt -169.96 84.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 120.878 0.371 . . . . 0.0 111.703 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.583 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 167.9 59.87 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.171 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -161.0 -63.06 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.095 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.438 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 22.5 Cg_endo -59.47 -173.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.765 2.31 . . . . 0.0 113.471 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.98 -66.67 2.67 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.58 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.47 ' O ' ' N ' ' A' ' 62' ' ' GLY . 2.3 ttm -72.15 57.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.038 0.447 . . . . 0.0 110.367 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.91 -79.09 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.186 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.691 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -146.53 -28.69 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.866 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.636 ' HA ' HD13 ' A' ' 66' ' ' LEU . 3.7 mp -63.16 -19.19 64.25 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.916 0.358 . . . . 0.0 110.703 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.57 -22.76 9.04 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.083 0.468 . . . . 0.0 110.863 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.487 HD21 ' N ' ' A' ' 37' ' ' ASN . 5.8 mt -69.62 -40.79 76.38 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.317 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.636 HD13 ' HA ' ' A' ' 63' ' ' LEU . 6.6 mp -56.61 -41.23 76.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.419 0.628 . . . . 0.0 109.938 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -53.75 -53.13 56.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.07 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.435 ' HB2' HD11 ' A' ' 40' ' ' LEU . 10.8 mm-40 -69.18 -29.34 67.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.182 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.695 HG23 ' CE1' ' A' ' 73' ' ' HIS . 1.5 mm -52.87 -52.75 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.136 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.461 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -68.68 -31.03 69.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.283 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.48 ' NE2' ' HG2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.99 -23.34 44.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.692 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.48 ' HG2' ' NE2' ' A' ' 71' ' ' GLN . 10.4 mmt180 -85.95 -73.27 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.07 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.695 ' CE1' HG23 ' A' ' 69' ' ' ILE . 11.2 p80 -89.35 167.26 18.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.211 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.595 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 89.0 Cg_endo -78.29 72.27 6.36 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.782 2.322 . . . . 0.0 112.912 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.612 ' HB2' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER 54.09 34.37 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.403 179.114 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.64 ' HG ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -63.1 121.04 66.71 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.494 ' HD2' HD22 ' A' ' 76' ' ' LEU . 10.7 Cg_endo -53.58 132.31 48.28 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.846 2.364 . . . . 0.0 113.19 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.55 HG21 HG22 ' A' ' 69' ' ' ILE . 2.9 t -123.41 154.29 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.541 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.524 HD11 ' HG ' ' A' ' 52' ' ' LEU . 3.6 mt -131.56 117.17 34.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.212 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 53' ' ' SER . 11.5 mm -93.57 150.45 3.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.624 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.539 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -87.02 -19.43 28.68 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.618 ' O ' HD11 ' A' ' 55' ' ' ILE . 2.7 m -147.03 171.0 15.95 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.656 0.265 . . . . 0.0 110.996 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.443 ' HB1' ' CD2' ' A' ' 87' ' ' LEU . . . -122.34 -20.99 5.95 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.729 0.3 . . . . 0.0 111.459 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' A' ' 85' ' ' SER . 4.2 m-70 45.07 29.71 0.52 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 73.3 m 67.92 -3.99 1.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.507 ' O ' HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -92.5 39.19 1.02 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.045 0.45 . . . . 0.0 110.301 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.443 ' CD2' ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -48.44 -21.05 0.48 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.292 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -47.49 -57.65 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.535 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . . . -65.64 -24.52 67.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.567 0.222 . . . . 0.0 111.537 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.474 ' HB3' HD22 ' A' ' 63' ' ' LEU . . . -68.69 -33.21 73.58 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.657 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.1 t -62.99 -45.37 99.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.607 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 91.7 p -60.3 -34.1 73.3 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.426 0.632 . . . . 0.0 109.89 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.538 ' HA ' ' CD ' ' A' ' 96' ' ' GLN . . . -59.72 -41.39 90.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.48 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.657 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.8 m-85 -61.91 -21.57 64.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.065 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.612 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.78 -43.41 72.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.503 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.612 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 6.8 pm0 -82.13 -19.12 40.69 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.12 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.63 38.95 0.64 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.662 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.432 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . . . -63.57 154.25 33.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.145 0.472 . . . . 0.0 110.237 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 118' ' ' ALA . 2.2 t80 -79.79 -53.58 6.65 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.71 -162.68 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.769 0.319 . . . . 0.0 111.065 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.556 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.0 m-85 -142.63 139.36 31.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.172 0.511 . . . . 0.0 111.132 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.584 HD23 ' O ' ' A' ' 105' ' ' PRO . 2.1 tp -101.92 140.8 21.5 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.442 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 35.4 Cg_exo -61.42 -34.54 86.28 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.077 1.851 . . . . 0.0 111.962 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.665 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER 167.54 -50.63 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.245 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.7 Cg_endo -47.85 163.79 0.19 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.008 1.805 . . . . 0.0 109.94 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.688 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 26.7 t80 -168.46 -92.13 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.329 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.488 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.7 p30 41.78 -171.24 0.0 OUTLIER 'General case' 0 C--N 1.335 -0.063 0 CA-C-O 120.961 0.41 . . . . 0.0 111.117 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.514 HD11 ' C ' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -68.11 -49.98 62.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.603 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 7.9 m-20 -51.11 -57.11 9.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.819 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.688 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -76.31 -30.54 57.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.498 ' HB3' ' CD1' ' A' ' 106' ' ' PHE . . . -83.61 -56.97 3.43 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.021 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 115' ' ' VAL . 43.3 t -54.43 -30.38 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.459 0.647 . . . . 0.0 109.987 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -60.07 -54.6 44.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.574 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.407 HD22 HG22 ' A' ' 79' ' ' ILE . 6.7 tp -71.4 -22.37 61.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.522 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 112' ' ' VAL . 4.3 p -79.45 -50.34 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.936 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.427 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 23.0 mt-10 -62.73 -46.7 86.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.01 0.433 . . . . 0.0 109.908 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -64.91 -25.71 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.176 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -69.67 -53.41 18.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.093 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.5 mt -66.13 -31.38 53.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.096 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.5 p -70.26 -43.69 69.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.13 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.3 m80 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 -179.848 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.211 -0.355 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.78 112.33 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.686 0.279 . . . . 0.0 111.355 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.585 HG11 ' O ' ' A' ' 29' ' ' THR . 7.1 p -107.2 125.65 63.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.79 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.913 ' CD1' HG21 ' A' ' 31' ' ' THR . 33.1 m0 -112.82 145.24 40.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.038 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -139.09 137.21 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.138 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.823 HG23 ' HA ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -126.35 105.14 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.483 178.099 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 60.8 t0 166.81 118.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.887 0.375 . . . . 0.0 111.243 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.44 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.6 OUTLIER 72.26 -21.59 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.118 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 10' ' ' ASP . 8.5 t0 70.47 -135.31 0.05 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.579 -0.076 . . . . 0.0 110.849 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.4 m -33.55 -45.41 0.17 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.3 m -53.38 -67.57 0.24 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.948 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 25.1 mm -65.84 -20.6 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.453 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.662 ' HG3' HG23 ' A' ' 32' ' ' THR . 12.5 ttt-85 -72.39 -61.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.401 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.473 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 71.4 t90 -48.31 -44.28 33.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.175 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.59 ' C ' HD13 ' A' ' 108' ' ' ILE . 1.9 t -64.82 -62.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.919 0.39 . . . . 0.0 111.859 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 7.4 tp -71.51 -19.45 62.18 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.545 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 13.8 pt-20 -67.96 -57.71 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.687 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.545 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.28 -56.62 11.69 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.993 -179.022 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.8 -56.34 16.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 0.0 111.441 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.713 HD12 ' CD1' ' A' ' 28' ' ' LEU . 13.5 tp -64.42 -19.75 65.72 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.33 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -70.12 -37.66 75.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.6 -25.01 62.7 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.197 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.39 -15.9 59.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.74 0.305 . . . . 0.0 110.768 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.75 26.18 9.28 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.748 -0.739 . . . . 0.0 114.714 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.713 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -122.41 166.14 15.21 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.478 1.139 . . . . 0.0 112.121 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.585 ' O ' HG11 ' A' ' 6' ' ' VAL . 53.5 m -94.98 114.96 26.84 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.34 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -105.17 109.17 21.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.985 -178.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.913 HG21 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -121.8 137.58 54.71 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 74.5 p -117.34 160.83 20.5 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.825 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 7.6 m-85 -136.03 174.52 10.52 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.077 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.632 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.5 pp20? -60.88 -63.29 1.35 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.608 ' N ' HG11 ' A' ' 9' ' ' VAL . 68.3 m-80 -153.89 -22.74 0.14 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.504 ' HA3' ' CD1' ' A' ' 65' ' ' LEU . . . 172.41 -63.42 0.14 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.862 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.492 ' HA ' HD11 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -48.31 -29.38 3.83 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.875 0.369 . . . . 0.0 111.043 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.825 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -63.25 -58.1 8.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.127 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.637 HG22 ' CG ' ' A' ' 33' ' ' PHE . 20.4 t -49.08 -46.27 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.195 0.521 . . . . 0.0 110.899 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.546 HD12 ' HB2' ' A' ' 68' ' ' GLN . 2.1 mt -49.9 -44.86 50.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.003 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.41 81.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.309 0.576 . . . . 0.0 110.937 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.56 -31.55 67.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.217 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.562 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 9.6 mt -65.67 -27.51 68.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.93 -20.08 21.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.608 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.9 t -126.76 1.92 6.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.818 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.492 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -153.99 159.79 41.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 111.049 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.455 HG22 ' CD2' ' A' ' 76' ' ' LEU . 96.3 m -138.67 112.75 8.43 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.238 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.612 ' HD2' HD22 ' A' ' 76' ' ' LEU . 93.9 Cg_endo -77.12 152.52 31.33 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.04 1.827 . . . . 0.0 111.751 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -74.57 -29.12 61.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.816 0.341 . . . . 0.0 110.692 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.434 HG22 HG23 ' A' ' 115' ' ' VAL . 7.5 p -145.32 94.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.484 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 77' ' ' PRO . 63.2 tp -86.95 150.92 23.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.473 0.654 . . . . 0.0 112.282 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.768 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.5 mt -131.76 124.98 30.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.778 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.823 ' HA ' HG23 ' A' ' 9' ' ' VAL . 3.8 m -127.91 150.62 49.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 25.2 t0 -82.7 170.69 14.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.363 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.851 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 3.7 tt -147.15 82.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.842 0.353 . . . . 0.0 111.524 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 174.0 61.12 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.892 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.436 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.55 -62.79 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.65 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 22.5 Cg_endo -58.39 -170.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.249 2.633 . . . . 0.0 113.29 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.68 -71.41 0.75 Allowed Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.327 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.55 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -73.03 59.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.0 110.343 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.81 -74.8 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.46 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.851 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -150.26 -32.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.46 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' O ' ' A' ' 86' ' ' ASP . 3.2 mp -59.08 -20.33 52.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.864 0.364 . . . . 0.0 110.366 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 60' ' ' MET . . . -58.14 -31.37 67.13 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.466 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.65 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 5.9 mt -65.08 -39.61 93.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.409 . . . . 0.0 110.583 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 63' ' ' LEU . 6.0 mp -60.08 -43.36 95.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.74 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.414 ' HE2' ' HB1' ' A' ' 89' ' ' ALA . 22.9 mttm -54.07 -42.51 69.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.235 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.546 ' HB2' HD12 ' A' ' 40' ' ' LEU . 41.1 mm-40 -61.3 -34.14 74.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.236 0.541 . . . . 0.0 110.053 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.566 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 49.7 mm -59.69 -41.68 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.114 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 96' ' ' GLN . 11.9 pttp -74.72 -27.78 60.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.249 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.412 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 1.3 mt-30 -63.73 -42.48 97.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.04 0.447 . . . . 0.0 111.267 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 72' ' ' ARG . 12.4 mtt85 -103.7 -49.99 3.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.276 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.562 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 4.1 m-70 -88.58 135.26 32.67 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.615 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.11 -76.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.849 2.366 . . . . 0.0 112.664 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 21.4 mtm -140.92 52.75 1.59 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.456 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.612 HD22 ' HD2' ' A' ' 48' ' ' PRO . 2.2 tm? -56.49 111.6 3.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.214 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 26.7 Cg_exo -62.35 115.36 2.82 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.27 1.98 . . . . 0.0 112.158 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.885 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -121.82 153.3 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.805 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.52 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 3.2 mt -130.64 117.78 40.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.308 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.6 ' HA ' ' O ' ' A' ' 53' ' ' SER . 19.3 mm -93.86 149.28 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.262 0.553 . . . . 0.0 112.407 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.54 ' N ' ' HE1' ' A' ' 81' ' ' MET . 0.0 OUTLIER -84.7 -18.63 34.66 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.501 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.499 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 3.3 m -147.44 160.98 41.96 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.722 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.422 ' CB ' ' HG ' ' A' ' 87' ' ' LEU . . . -111.09 -24.76 10.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.091 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 47.03 -171.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.344 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.35 53.0 2.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.873 0.368 . . . . 0.0 111.165 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.515 ' O ' HD21 ' A' ' 63' ' ' LEU . 5.6 m-20 -158.98 28.38 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.422 ' HG ' ' CB ' ' A' ' 83' ' ' ALA . 2.0 mt -46.38 -21.39 0.16 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.79 -56.13 8.09 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.414 ' HB1' ' HE2' ' A' ' 67' ' ' LYS . . . -64.65 -19.94 66.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.639 0.257 . . . . 0.0 111.467 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.467 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . . . -65.14 -50.99 63.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.342 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.631 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.7 t -65.35 -48.92 81.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.94 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -58.96 -25.04 63.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.956 0.408 . . . . 0.0 110.218 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.638 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -61.56 -51.86 66.81 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.443 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.647 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 2.7 m-85 -55.83 -30.57 61.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.01 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -37.62 56.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.461 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.529 ' HB2' ' CB ' ' A' ' 70' ' ' LYS . 1.7 pt20 -100.07 4.71 44.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 123.08 81.9 0.56 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.026 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.885 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.7 126.96 1.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 0.0 111.241 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 78.6 t80 -64.77 -53.41 47.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.379 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.647 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.6 OUTLIER 178.2 -169.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.881 0.372 . . . . 0.0 111.086 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.507 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.2 m-85 -123.84 118.72 27.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.471 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.635 HD23 ' CE2' ' A' ' 106' ' ' PHE . 5.7 tp -102.45 134.11 20.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.534 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 8.1 Cg_endo -49.4 166.66 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.697 2.265 . . . . 0.0 112.036 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.626 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -41.13 -50.08 8.17 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.547 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.7 Cg_endo -47.69 162.6 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.768 1.646 . . . . 0.0 110.441 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.664 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -171.58 -87.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.87 -178.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.723 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 43.25 -170.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.59 0.233 . . . . 0.0 110.396 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.59 HD13 ' C ' ' A' ' 18' ' ' VAL . 1.2 mp -68.04 -45.98 82.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.225 0.536 . . . . 0.0 111.336 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.765 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 7.4 t0 -51.72 -58.17 7.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.695 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.664 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 1.4 mm-40 -78.29 -27.69 47.37 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.24 -57.02 3.34 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.722 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.599 ' O ' HG11 ' A' ' 115' ' ' VAL . 41.3 t -54.23 -31.82 22.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.557 0.694 . . . . 0.0 110.158 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -61.84 -52.48 63.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.745 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.418 ' CD2' HG23 ' A' ' 79' ' ' ILE . 13.6 tp -74.3 -20.66 60.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.625 -1.171 . . . . 0.0 112.791 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.599 HG11 ' O ' ' A' ' 112' ' ' VAL . 9.8 p -79.32 -50.12 18.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.934 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.426 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 43.8 mt-10 -64.22 -41.57 96.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.001 0.429 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -67.56 -25.01 65.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.872 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.99 -54.11 8.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.047 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.4 mt -62.61 -31.34 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.084 0.468 . . . . 0.0 110.508 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.1 m -68.55 -38.11 80.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.741 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.676 HD11 ' HB ' ' A' ' 29' ' ' THR . 16.9 mm -130.46 112.86 23.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.772 0.32 . . . . 0.0 111.32 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.689 HG11 ' HG ' ' A' ' 23' ' ' LEU . 7.8 p -107.69 136.01 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.727 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.606 ' NE1' HG21 ' A' ' 31' ' ' THR . 38.5 m0 -122.17 127.37 49.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -118.08 132.23 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -177.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.757 HG22 HG21 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -116.79 105.11 17.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.12 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 37.4 t0 173.87 100.66 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 t0 65.44 -15.03 0.11 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.474 ' H ' ' C ' ' A' ' 10' ' ' ASP . 3.7 p-10 45.27 -152.56 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.55 0.159 . . . . 0.0 110.893 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.423 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.8 t 32.53 -91.73 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.423 ' H ' ' HB3' ' A' ' 13' ' ' SER . 48.3 t -56.25 -57.49 11.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.625 0.25 . . . . 0.0 110.766 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 15' ' ' ILE . 27.1 mm -60.17 -20.78 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.443 . . . . 0.0 110.36 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.575 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 2.4 ttm180 -78.78 -58.8 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.601 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 75.1 t90 -49.16 -41.35 36.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.157 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.529 ' C ' HD12 ' A' ' 108' ' ' ILE . 1.3 t -68.15 -57.84 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.487 HD12 ' HB1' ' A' ' 111' ' ' ALA . 4.2 tp -69.95 -25.4 63.63 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.625 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 23.0 pt-20 -67.69 -57.62 6.06 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.84 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.491 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 6.4 mmt180 -58.49 -53.1 62.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.017 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.43 77.52 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.689 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.3 tm? -76.67 -28.95 56.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.246 0.546 . . . . 0.0 110.474 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.67 -32.25 73.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.424 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.28 -24.64 70.74 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.385 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.06 -14.9 59.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.87 0.367 . . . . 0.0 110.879 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.41 23.33 10.4 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.516 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.499 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -130.96 170.72 14.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 117.471 0.635 . . . . 0.0 111.524 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.676 ' HB ' HD11 ' A' ' 5' ' ' ILE . 31.0 m -96.93 141.74 29.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.236 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.625 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -127.54 119.35 25.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.815 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.606 HG21 ' NE1' ' A' ' 7' ' ' TRP . 2.9 t -131.71 135.63 47.01 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 38.9 p -108.62 163.17 13.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.732 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 39.5 m-85 -137.47 174.03 11.03 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.79 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.726 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.0 pp20? -62.83 -60.4 3.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.748 ' C ' HG12 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -155.38 -32.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.316 0.507 . . . . 0.0 112.19 -179.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.539 ' N ' HG12 ' A' ' 9' ' ' VAL . . . -179.14 -65.71 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.484 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.414 ' HA ' HD12 ' A' ' 40' ' ' LEU . 13.9 m120 -47.72 -27.6 2.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 111.221 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.732 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -57.23 -60.83 3.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.757 HG21 HG22 ' A' ' 9' ' ' VAL . 65.4 t -50.71 -45.9 27.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 68' ' ' GLN . 8.6 mt -46.24 -41.52 13.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.287 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.99 -47.81 67.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.926 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.16 -31.28 67.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.32 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.621 HD13 ' CD2' ' A' ' 73' ' ' HIS . 10.9 mt -61.36 -29.06 69.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.088 0.47 . . . . 0.0 111.042 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.56 -20.04 29.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.483 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 m -118.89 -8.49 10.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.863 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -156.3 157.99 36.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.784 0.326 . . . . 0.0 110.988 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.4 HG23 ' CD2' ' A' ' 76' ' ' LEU . 78.6 m -138.62 112.85 8.48 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.279 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.427 ' HD2' HD22 ' A' ' 76' ' ' LEU . 72.3 Cg_endo -76.94 162.35 32.22 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 121.874 1.716 . . . . 0.0 111.388 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 0.9 OUTLIER -73.76 -21.03 60.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.876 0.37 . . . . 0.0 110.925 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.633 ' CG2' HD11 ' A' ' 79' ' ' ILE . 4.4 p -148.6 163.67 5.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.816 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 7' ' ' TRP . 23.5 tp -152.83 154.18 34.61 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.314 0.578 . . . . 0.0 112.307 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.67 ' HB2' HG13 ' A' ' 8' ' ' VAL . 4.8 mt -137.79 122.05 18.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.513 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.464 ' HA ' HG23 ' A' ' 9' ' ' VAL . 1.3 m -106.55 144.76 32.76 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.576 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 46.0 t0 -79.05 -11.7 60.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.7 ' HB ' ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER 51.53 154.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.684 0.754 . . . . 0.0 111.589 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.603 ' H ' ' C ' ' A' ' 61' ' ' ASP . 5.1 ttt180 84.38 72.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.767 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.474 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.44 -67.07 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 51.8 Cg_endo -66.25 -160.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.154 2.569 . . . . 0.0 113.028 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.17 13.4 50.32 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.392 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.439 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -152.05 47.65 0.77 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.622 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 1.0 OUTLIER 45.77 -86.14 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.569 -178.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.7 ' HA3' ' HB ' ' A' ' 55' ' ' ILE . . . -124.03 -30.5 1.02 Allowed Glycine 0 CA--C 1.508 -0.392 0 C-N-CA 119.863 -1.161 . . . . 0.0 112.901 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.846 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -63.74 -19.48 64.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.31 -34.16 77.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.453 ' CD2' ' HA3' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -57.51 -45.4 85.01 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.352 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.846 HD11 ' HA ' ' A' ' 63' ' ' LEU . 4.9 mt -53.96 -47.0 71.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.53 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.713 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 9.4 tttt -51.98 -43.91 63.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.316 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.575 ' HB2' HD13 ' A' ' 40' ' ' LEU . 9.3 mm100 -65.84 -38.64 89.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.123 0.487 . . . . 0.0 110.279 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.494 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 30.3 mm -61.94 -42.07 93.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.913 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.713 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -70.6 -27.23 63.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.834 -179.08 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -68.76 -39.37 80.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.247 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.99 -54.79 2.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.029 0.443 . . . . 0.0 111.945 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.621 ' CD2' HD13 ' A' ' 43' ' ' LEU . 2.1 m-70 -83.21 145.2 48.36 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.193 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.33 -79.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.724 2.283 . . . . 0.0 113.214 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.723 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 11.5 mtt -127.13 45.68 2.66 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.84 0.352 . . . . 0.0 111.689 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.494 ' HB3' ' CG2' ' A' ' 69' ' ' ILE . 1.4 tm? -58.64 106.97 0.8 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.505 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.446 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 48.3 Cg_exo -58.14 116.38 3.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.453 2.102 . . . . 0.0 112.249 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.702 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -112.88 152.17 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.041 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.633 HD11 ' CG2' ' A' ' 50' ' ' VAL . 5.9 mt -142.73 114.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.593 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.651 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 3.8 mm -94.29 131.38 41.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.315 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.596 ' HE2' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -75.38 -6.39 49.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.429 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.475 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.9 m -145.68 158.04 43.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.602 0.239 . . . . 0.0 110.381 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.57 47.1 1.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.339 . . . . 0.0 110.705 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.402 ' CE1' ' CG2' ' A' ' 82' ' ' THR . 6.6 m-70 -76.13 108.97 9.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.824 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 m 51.94 178.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.717 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.654 ' O ' HD23 ' A' ' 63' ' ' LEU . 1.1 m-20 62.28 14.41 6.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.438 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.88 -23.71 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -48.33 -45.6 35.47 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -73.78 -19.85 60.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.406 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . . . -58.82 -36.87 75.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 0.0 110.219 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.55 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.6 t -65.75 -37.26 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.491 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 m -66.9 -25.12 66.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.181 0.515 . . . . 0.0 109.693 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.627 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -64.33 -47.96 77.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.768 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.55 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.3 m-85 -61.61 -26.98 68.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.48 0.657 . . . . 0.0 109.399 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -41.62 41.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.544 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.723 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.6 pp0? -75.94 -16.95 59.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.806 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.13 -2.39 8.38 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.152 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.702 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -55.94 156.67 5.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.857 0.328 . . . . 0.0 110.875 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.501 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 52.7 t80 -86.79 -53.52 4.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.777 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.49 -161.63 0.02 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.842 0.353 . . . . 0.0 111.677 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.651 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.2 m-85 -127.86 124.4 37.42 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.259 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.605 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 5.8 tp -106.65 137.42 19.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.289 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.715 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 12.3 Cg_endo -53.48 165.75 1.49 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.273 1.982 . . . . 0.0 111.115 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.432 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -41.62 -45.41 7.99 Favored Pre-proline 0 N--CA 1.468 0.461 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.715 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 80.6 Cg_exo -47.07 162.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 121.774 1.649 . . . . 0.0 110.531 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 3.8 t80 -164.21 -95.54 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.237 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.732 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 3.3 p30 43.14 -173.25 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 120.814 0.34 . . . . 0.0 110.597 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.529 HD12 ' C ' ' A' ' 18' ' ' VAL . 1.2 mp -67.47 -48.87 75.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.799 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 11.6 m-20 -52.18 -55.47 20.8 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.847 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.704 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.6 mm-40 -78.0 -30.69 50.24 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.732 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -82.51 -59.6 2.47 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.77 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.578 ' O ' HG13 ' A' ' 115' ' ' VAL . 39.8 t -51.72 -33.87 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.505 0.669 . . . . 0.0 110.5 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.799 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -59.76 -51.43 69.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.76 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.611 HD12 ' HD2' ' A' ' 117' ' ' ARG . 19.8 tp -76.04 -21.17 57.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.959 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 112' ' ' VAL . 5.9 p -79.42 -48.95 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.655 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 70.4 mt-10 -61.58 -52.2 65.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.73 0.3 . . . . 0.0 111.1 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.611 ' HD2' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -61.19 -24.57 66.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.77 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.56 -53.6 9.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 111.303 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.1 -31.32 51.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.481 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.0 p -66.06 -44.48 84.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.52 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 6.7 m80 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.746 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.803 -0.119 . . . . 0.0 112.803 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.678 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 2.5 mp -116.36 118.94 60.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.516 0.198 . . . . 0.0 110.651 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 7.1 p -116.35 123.96 72.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.681 0.277 . . . . 0.0 110.8 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.477 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 43.9 m0 -115.49 131.3 56.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.85 0.357 . . . . 0.0 110.642 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.713 HG12 ' HB2' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -121.47 139.79 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.781 -178.259 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.78 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -126.47 105.81 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.07 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' A' ' 12' ' ' ASP . 43.0 t0 174.52 105.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.705 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.59 -15.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 10' ' ' ASP . 2.6 p30 44.44 -155.22 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.46 0.118 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 1.5 t 30.68 -89.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 12' ' ' ASP . 23.3 m -54.37 -57.49 11.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.37 . . . . 0.0 110.481 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 15' ' ' ILE . 35.5 mm -60.48 -20.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.167 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.536 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 5.8 ttt-85 -77.37 -61.09 2.1 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.808 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.4 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 70.3 t90 -45.58 -42.75 11.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.586 ' C ' HD11 ' A' ' 108' ' ' ILE . 1.8 t -66.95 -62.65 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.04 0.448 . . . . 0.0 112.058 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.452 HD21 ' HB1' ' A' ' 111' ' ' ALA . 12.3 mt -67.12 -26.43 66.69 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.569 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 23.2 pt-20 -65.34 -56.45 12.54 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.104 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.5 mmm180 -62.97 -58.64 6.63 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.094 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.05 -44.1 67.17 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.645 HD11 ' CD1' ' A' ' 28' ' ' LEU . 2.5 tp -73.35 -24.79 60.4 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.431 . . . . 0.0 110.47 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -67.74 -34.99 77.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.24 -24.22 68.77 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.31 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.04 -15.78 58.62 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.64 0.257 . . . . 0.0 111.034 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.07 26.2 8.52 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.957 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.645 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.74 170.28 12.31 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 117.987 0.894 . . . . 0.0 111.61 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.412 ' O ' HG13 ' A' ' 6' ' ' VAL . 55.2 m -99.56 105.68 17.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.644 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 40.9 t -101.07 111.98 24.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.238 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.553 HG22 ' CE1' ' A' ' 33' ' ' PHE . 2.5 t -121.36 151.81 39.71 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.702 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 68.7 p -125.09 160.15 29.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.82 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 5.6 m-85 -135.94 173.86 11.25 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.491 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.8 pp20? -60.57 -59.23 5.73 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.655 ' C ' HG11 ' A' ' 9' ' ' VAL . 5.6 t30 -150.46 -30.2 0.2 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.581 0.628 . . . . 0.0 112.49 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.499 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 168.24 -56.37 0.22 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.435 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.503 ' HA ' HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -45.88 -34.22 3.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.942 0.401 . . . . 0.0 110.89 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.82 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.2 tp10 -60.97 -56.8 16.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.363 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.575 HG22 HG23 ' A' ' 9' ' ' VAL . 3.6 t -49.54 -40.94 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.951 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 37' ' ' ASN . 14.0 mt -55.56 -43.51 75.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.828 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.35 -49.56 59.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.001 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.28 -26.31 66.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.82 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 8.1 mt -71.28 -24.61 62.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.482 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.0 -16.42 43.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.643 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 m -120.26 -6.82 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.591 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -158.72 156.2 29.43 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.674 0.273 . . . . 0.0 110.85 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.5 m -139.42 113.0 7.94 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.506 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.678 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 96.8 Cg_endo -76.42 166.06 28.11 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.22 1.947 . . . . 0.0 111.433 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.422 ' O ' ' HD2' ' A' ' 77' ' ' PRO . 28.8 m-20 -73.91 -63.09 1.29 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.508 HG21 ' N ' ' A' ' 51' ' ' LEU . 4.9 p -95.12 156.25 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.508 ' N ' HG21 ' A' ' 50' ' ' VAL . 50.1 tp -152.85 133.31 13.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.383 0.611 . . . . 0.0 111.856 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.722 ' O ' HG22 ' A' ' 9' ' ' VAL . 2.6 mt -119.67 116.1 25.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.037 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.557 ' HA ' HG22 ' A' ' 9' ' ' VAL . 1.3 t -107.57 146.77 31.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.502 0.668 . . . . 0.0 112.489 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 7.2 t0 -74.43 -178.66 3.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.924 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.574 ' CG2' ' HB ' ' A' ' 82' ' ' THR . 3.3 tt -157.08 86.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.267 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 163.91 58.73 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.711 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.6 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 6.2 tpt -162.76 -63.79 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.6 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 12.1 Cg_endo -53.26 -164.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.065 2.51 . . . . 0.0 113.112 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.56 6.6 72.49 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.801 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.567 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -152.1 51.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.456 ' OD2' HD12 ' A' ' 55' ' ' ILE . 1.3 p-10 48.71 -71.44 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.147 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -141.95 -36.48 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.999 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.697 ' HA ' HD23 ' A' ' 66' ' ' LEU . 1.3 mp -56.76 -18.69 13.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.284 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.407 ' HB1' ' CB ' ' A' ' 60' ' ' MET . . . -63.24 -45.61 90.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.562 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 12.0 mt -56.49 -33.76 66.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.601 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.7 mm? -60.42 -43.81 96.38 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.668 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 14.4 ttmt -56.35 -41.07 75.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.277 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.499 ' HB3' HD12 ' A' ' 40' ' ' LEU . 70.5 mm-40 -70.07 -34.59 73.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.7 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.53 HG23 ' OE1' ' A' ' 96' ' ' GLN . 21.7 mt -67.05 -38.59 81.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.392 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.668 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.57 -24.14 61.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.998 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -78.9 -34.59 44.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.043 0.449 . . . . 0.0 110.935 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -94.04 -69.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.546 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.531 ' NE2' HD11 ' A' ' 43' ' ' LEU . 2.2 p80 -117.66 75.01 9.39 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.071 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.547 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 61.6 Cg_endo -74.96 57.11 4.44 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.299 1.999 . . . . 0.0 112.733 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.414 ' HG3' ' C ' ' A' ' 74' ' ' PRO . 51.3 mtp -154.37 -41.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.101 0.477 . . . . 0.0 111.008 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.542 ' CD1' ' HD2' ' A' ' 48' ' ' PRO . 2.6 tt -58.12 122.29 57.49 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.911 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.428 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 18.7 Cg_endo -59.46 118.61 5.52 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.819 2.346 . . . . 0.0 112.513 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.643 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -99.36 148.07 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.849 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 2.7 mt -140.2 113.69 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.181 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.62 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 24.9 mm -93.42 149.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.131 0.491 . . . . 0.0 112.198 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.485 ' HE3' ' N ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -85.39 -13.48 49.26 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.869 -178.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.574 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.6 m -147.78 160.47 42.7 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.046 -0.409 . . . . 0.0 110.682 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -154.84 65.51 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 0.0 111.17 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.404 ' CD2' ' H ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -78.43 -93.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.824 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.404 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -98.63 -176.57 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.305 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.549 ' O ' HD21 ' A' ' 63' ' ' LEU . 85.2 m-20 58.88 14.42 3.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.583 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.429 ' O ' HD11 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -44.47 -25.33 0.25 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -48.02 -42.65 28.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.032 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.04 -21.37 63.19 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.554 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.475 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -62.56 -41.62 99.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.98 0.419 . . . . 0.0 110.069 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.586 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.8 t -58.35 -39.64 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.437 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.8 p -61.45 -37.73 84.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.41 0.624 . . . . 0.0 110.146 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.64 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -54.83 -43.58 73.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.42 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.586 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 34.0 m-85 -59.16 -22.71 61.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.984 0.421 . . . . 0.0 110.503 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.634 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -71.99 -42.94 65.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.585 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -75.78 -18.1 59.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.99 15.95 4.59 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.433 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.643 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -56.59 148.48 19.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.143 0.471 . . . . 0.0 110.539 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 61.0 t80 -79.81 -53.89 6.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.199 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.91 -158.9 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.002 0.429 . . . . 0.0 111.579 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.62 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.3 m-85 -131.87 125.77 32.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.633 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 6.0 tp -103.01 140.63 21.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.063 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.698 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 18.7 Cg_endo -56.28 165.15 4.49 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.031 1.821 . . . . 0.0 110.448 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.42 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -42.53 -43.87 8.76 Favored Pre-proline 0 N--CA 1.467 0.397 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.698 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 82.0 Cg_exo -47.12 163.88 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.672 1.581 . . . . 0.0 110.818 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.694 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 1.2 t80 -162.49 -92.08 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.528 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.559 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p-10 42.35 -177.12 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.898 0.38 . . . . 0.0 110.889 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.586 HD11 ' C ' ' A' ' 18' ' ' VAL . 1.1 mp -67.9 -44.79 84.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.355 0.598 . . . . 0.0 111.174 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.729 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 3.1 t70 -53.84 -57.28 11.48 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.787 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.6 mm-40 -78.53 -28.43 46.14 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -84.09 -54.24 4.97 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.184 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 115' ' ' VAL . 43.8 t -57.49 -32.4 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.558 0.694 . . . . 0.0 109.956 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.729 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -59.44 -51.93 67.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.769 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.633 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 19.4 tp -76.66 -20.67 56.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.82 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 112' ' ' VAL . 4.4 p -79.13 -48.62 21.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.723 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.431 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 71.8 mt-10 -65.25 -45.49 84.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.949 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 20.4 mtp-105 -63.6 -24.01 67.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.905 0.383 . . . . 0.0 110.803 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.504 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -75.04 -51.15 14.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.133 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -65.61 -31.22 52.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.134 0.492 . . . . 0.0 110.975 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.6 t -70.96 -43.77 67.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.129 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.1 m80 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.097 -179.814 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.722 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.749 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 7' ' ' TRP . 3.1 mp -111.55 119.35 59.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.871 0.367 . . . . 0.0 111.364 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.745 HG11 ' HG ' ' A' ' 23' ' ' LEU . 11.5 p -105.09 127.86 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.076 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.533 ' NE1' HG23 ' A' ' 31' ' ' THR . 29.5 m0 -115.29 143.7 44.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -136.85 143.66 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -133.38 104.73 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.068 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.601 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 43.0 t0 166.47 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.9 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.432 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 71.19 -23.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.94 0.496 . . . . 0.0 112.146 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 10' ' ' ASP . 10.6 t0 69.33 -131.51 0.08 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 122.53 -0.106 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 t -34.08 -45.05 0.19 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -54.67 -67.31 0.28 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 15' ' ' ILE . 27.8 mm -64.38 -20.45 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.714 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.699 ' HA ' HG21 ' A' ' 32' ' ' THR . 53.3 ttt180 -70.3 -61.37 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.849 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.45 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 70.5 t90 -50.36 -43.6 54.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.954 0.407 . . . . 0.0 111.715 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.568 ' CG1' HD12 ' A' ' 108' ' ' ILE . 1.4 t -65.82 -61.11 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.002 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.497 HD23 ' CG2' ' A' ' 8' ' ' VAL . 9.8 tp -71.66 -20.71 61.91 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.644 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 21.2 pt-20 -67.47 -56.94 7.57 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.152 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.521 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 8.7 mmm180 -65.62 -59.42 3.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.215 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.34 -42.73 61.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.745 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.4 tm? -70.43 -26.6 63.74 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.007 0.432 . . . . 0.0 110.516 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.3 76.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.67 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.44 -26.15 69.3 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.27 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.74 -16.32 59.52 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.743 0.306 . . . . 0.0 111.068 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.41 25.81 8.55 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.455 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.722 ' HB3' ' O ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -136.58 175.2 9.83 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 117.382 0.591 . . . . 0.0 111.355 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.454 ' O ' HG13 ' A' ' 6' ' ' VAL . 3.0 m -106.03 134.61 48.89 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.087 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.644 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 12.2 t -124.3 110.54 14.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.456 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.533 HG23 ' NE1' ' A' ' 7' ' ' TRP . 2.5 t -110.66 155.42 22.43 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.699 HG21 ' HA ' ' A' ' 16' ' ' ARG . 81.2 p -131.69 159.34 38.66 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.728 ' HB2' HG11 ' A' ' 9' ' ' VAL . 5.8 m-85 -135.8 173.49 11.65 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.927 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.569 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 1.6 pp20? -61.95 -60.81 3.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.574 ' C ' HG12 ' A' ' 9' ' ' VAL . 29.2 m120 -150.69 -52.47 0.14 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 118.318 0.508 . . . . 0.0 111.581 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.563 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -159.11 -62.03 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.944 -1.122 . . . . 0.0 114.0 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.663 ' HA ' HD12 ' A' ' 40' ' ' LEU . 12.4 m120 -52.42 -27.67 16.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.979 0.389 . . . . 0.0 111.617 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.71 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -62.48 -56.98 12.98 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.482 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.578 HG21 HG21 ' A' ' 9' ' ' VAL . 3.0 t -56.61 -40.64 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.151 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.663 HD12 ' HA ' ' A' ' 37' ' ' ASN . 20.2 mt -50.3 -42.57 52.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.008 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.36 81.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.245 0.545 . . . . 0.0 110.875 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.76 78.96 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.653 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 17.4 mt -59.0 -26.65 64.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.964 0.411 . . . . 0.0 111.132 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.95 -20.84 25.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.64 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.72 1.35 8.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.7 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.44 ' HB3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -156.37 159.43 38.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 111.438 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.9 m -139.41 113.08 7.96 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.189 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.422 ' HD3' HD22 ' A' ' 43' ' ' LEU . 78.0 Cg_endo -77.39 153.75 31.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.023 1.815 . . . . 0.0 111.624 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -73.81 -26.1 60.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.434 HG21 ' CD1' ' A' ' 79' ' ' ILE . 6.2 p -146.14 94.93 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.618 ' HB3' ' O ' ' A' ' 77' ' ' PRO . 56.6 tp -86.53 151.18 23.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.353 0.597 . . . . 0.0 112.151 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.786 ' O ' HG23 ' A' ' 9' ' ' VAL . 7.3 mt -132.99 114.13 13.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.899 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.701 ' HA ' HG23 ' A' ' 9' ' ' VAL . 1.5 m -114.15 149.91 34.97 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 29.2 t0 -78.14 173.47 12.21 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.636 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.718 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -145.09 74.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 120.993 0.425 . . . . 0.0 111.16 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 17.6 ttt-85 176.23 61.08 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.543 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.29 -62.8 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.543 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 20.1 Cg_endo -59.4 -174.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.532 2.154 . . . . 0.0 113.101 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.01 -72.39 0.54 Allowed Glycine 0 C--N 1.335 0.493 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.58 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.541 ' O ' ' N ' ' A' ' 62' ' ' GLY . 1.0 OUTLIER -71.99 56.26 0.31 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.398 179.458 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.63 -77.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.839 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.718 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -136.33 -39.01 0.16 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.466 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.649 HD21 ' O ' ' A' ' 86' ' ' ASP . 1.2 mp -51.7 -25.42 7.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.837 0.351 . . . . 0.0 110.496 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 58' ' ' PRO . . . -58.73 -33.43 70.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.644 ' HA ' ' OE1' ' A' ' 68' ' ' GLN . 0.4 OUTLIER -50.32 -44.64 54.33 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.898 178.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.522 ' HG ' ' HB2' ' A' ' 93' ' ' ALA . 3.1 mm? -60.67 -42.15 96.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.483 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -44.73 -60.68 1.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.404 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.644 ' OE1' ' HA ' ' A' ' 65' ' ' LEU . 9.4 mp0 -59.21 -37.01 76.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.839 0.352 . . . . 0.0 110.185 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.502 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 4.3 mm -64.13 -42.77 96.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.084 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 1.9 ptpp? -76.64 -24.28 53.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.609 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.26 -39.42 16.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.428 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.72 -62.92 1.38 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.278 0.561 . . . . 0.0 111.772 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.509 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 2.1 m-70 -81.42 136.93 48.69 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.979 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.44 -69.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.622 2.215 . . . . 0.0 113.106 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -144.66 37.28 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 111.601 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.418 ' CD2' ' HD2' ' A' ' 48' ' ' PRO . 1.1 tm? -59.94 105.65 0.6 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.407 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.618 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 10.9 Cg_endo -54.07 136.17 66.46 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.468 2.112 . . . . 0.0 112.195 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.655 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.1 t -132.89 152.37 35.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.909 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.489 HD11 ' HG ' ' A' ' 52' ' ' LEU . 3.6 mt -132.18 118.6 37.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.403 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 53' ' ' SER . 21.7 mm -93.86 142.98 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.019 0.438 . . . . 0.0 111.887 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.56 ' HE1' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -75.46 -20.84 58.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.568 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.506 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.4 m -147.59 161.22 41.57 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.365 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.49 57.75 1.79 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.909 0.385 . . . . 0.0 111.705 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -98.47 -179.81 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.999 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER 63.92 -155.59 0.31 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.059 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.649 ' O ' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -60.23 78.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.271 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.472 ' HA ' ' CD2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -52.8 -22.0 4.82 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -48.25 -50.76 28.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 63' ' ' LEU . . . -56.24 -19.89 15.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.012 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.519 ' N ' HD23 ' A' ' 63' ' ' LEU . . . -70.27 -35.88 74.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.64 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.6 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.8 t -67.06 -38.26 80.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.865 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.56 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 4.2 m -61.5 -18.62 59.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.325 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.76 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.82 -57.03 4.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.324 0.583 . . . . 0.0 111.542 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.6 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -54.22 -33.64 58.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.078 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -76.58 -35.31 58.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.244 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.76 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -77.78 -18.5 56.35 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.218 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.41 -11.71 3.25 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.926 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.655 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -54.96 156.2 3.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.307 0.554 . . . . 0.0 111.323 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.466 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 49.9 t80 -79.72 -53.58 6.67 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.252 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.53 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.5 OUTLIER 171.96 -163.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.033 0.444 . . . . 0.0 111.532 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.47 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 2.8 m-85 -125.69 122.32 36.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.259 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' MET . 3.6 tp -102.24 140.66 21.35 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.195 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.743 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 12.7 Cg_endo -54.58 163.68 3.61 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.637 2.225 . . . . 0.0 111.437 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.436 ' HZ2' ' HB2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -41.08 -45.8 6.65 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -178.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.743 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 88.7 Cg_exo -47.39 163.49 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.624 1.549 . . . . 0.0 110.671 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.745 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 12.0 t80 -165.77 -92.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.732 -178.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.717 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 0.1 OUTLIER 40.11 -174.09 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.772 0.32 . . . . 0.0 111.189 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.568 HD12 ' CG1' ' A' ' 18' ' ' VAL . 1.1 mp -68.08 -51.74 45.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.056 0.455 . . . . 0.0 111.835 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.762 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 3.2 p-10 -49.2 -56.05 10.51 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.942 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.745 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.7 mm-40 -76.59 -30.88 57.15 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -81.25 -58.5 3.02 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.903 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 115' ' ' VAL . 40.0 t -53.03 -31.29 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 121.699 0.762 . . . . 0.0 110.212 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.762 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -60.53 -50.74 72.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.921 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.643 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 5.8 tp -76.95 -20.73 55.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.925 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 6' ' ' VAL . 9.7 p -77.76 -48.73 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.954 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.416 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 40.4 mt-10 -62.7 -44.07 97.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.032 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.643 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 7.8 ptm180 -68.14 -23.7 64.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 111.07 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.97 -50.91 17.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.812 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.3 mt -70.19 -32.18 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.6 t -69.63 -42.11 74.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.033 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.2 m80 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.917 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mp -131.88 112.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 111.598 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.737 HG11 ' HG ' ' A' ' 23' ' ' LEU . 12.2 p -107.24 130.24 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.753 ' CH2' ' HG2' ' A' ' 46' ' ' LYS . 23.5 m0 -119.14 135.3 54.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -129.06 136.81 58.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -176.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.901 HG22 ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -122.49 105.79 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.538 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 55.8 t0 170.28 118.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.458 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 2.2 t70 71.05 -43.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.419 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 13' ' ' SER . 49.6 t0 75.59 -107.09 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.947 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 12' ' ' ASP . 31.3 p -23.73 -83.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.421 ' O ' HG21 ' A' ' 18' ' ' VAL . 3.0 m -52.93 -47.56 67.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.455 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.519 HG21 HD13 ' A' ' 19' ' ' LEU . 19.6 mm -64.64 -20.31 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.761 0.315 . . . . 0.0 111.628 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.47 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 7.1 ttp180 -70.75 -60.94 1.96 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.752 0.31 . . . . 0.0 111.586 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.495 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 37.9 t90 -52.08 -44.32 64.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.619 ' CG1' HD11 ' A' ' 108' ' ' ILE . 1.2 t -64.04 -49.91 79.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.728 ' HA ' HD13 ' A' ' 108' ' ' ILE . 43.3 mt -84.07 -22.1 31.31 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 1.2 pp20? -66.42 -59.02 4.06 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.511 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.43 ' HG2' ' CD ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -64.58 -62.85 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.01 -53.98 7.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.944 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.737 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.5 tm? -62.76 -29.21 70.52 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.729 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.91 76.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.516 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.37 -25.24 69.79 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.396 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.97 -15.08 59.76 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.678 0.275 . . . . 0.0 111.053 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.58 23.46 10.14 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.63 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.488 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -133.52 174.64 10.2 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.532 0.666 . . . . 0.0 111.722 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 m -102.81 117.33 34.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.281 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.667 ' HA ' HG12 ' A' ' 6' ' ' VAL . 8.8 t -113.93 113.23 24.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.513 0.673 . . . . 0.0 111.533 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.576 HG21 ' CE1' ' A' ' 33' ' ' PHE . 3.1 t -118.87 156.55 29.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.405 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 31.1 p -135.04 152.11 51.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.426 0.631 . . . . 0.0 112.348 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.869 ' HB2' HG11 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -129.64 174.31 9.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.054 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.605 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -58.34 -106.33 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.461 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -86.14 -71.8 0.52 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.542 ' HA2' HG13 ' A' ' 9' ' ' VAL . . . -161.16 -39.21 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.411 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.443 ' ND2' HD11 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -59.52 -31.63 69.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.901 0.35 . . . . 0.0 110.683 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.741 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -51.84 -57.31 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.634 178.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.691 HG21 ' CD1' ' A' ' 33' ' ' PHE . 2.9 t -56.85 -47.89 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.964 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 68' ' ' GLN . 38.1 mt -46.18 -42.75 14.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.868 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.42 -50.07 69.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.799 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.49 -28.73 67.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.104 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.892 HD12 ' CE1' ' A' ' 73' ' ' HIS . 7.3 mt -71.04 -20.95 62.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.455 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.85 -18.15 20.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.074 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 m -126.35 9.43 7.25 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.806 ' HG3' ' N ' ' A' ' 47' ' ' THR . 3.4 tttt -158.15 163.53 37.48 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.439 0.638 . . . . 0.0 112.153 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.806 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 97.8 m -138.83 111.46 8.1 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.192 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD3' HD22 ' A' ' 43' ' ' LEU . 61.2 Cg_endo -74.41 165.52 31.57 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.447 2.098 . . . . 0.0 111.284 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -82.43 -27.97 31.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.867 0.365 . . . . 0.0 110.818 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.648 HG13 HG22 ' A' ' 6' ' ' VAL . 3.4 p -149.61 99.45 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.41 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.681 HD12 HG13 ' A' ' 39' ' ' VAL . 47.4 tp -86.96 141.93 28.34 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.633 ' CD2' ' HB ' ' A' ' 79' ' ' ILE . 6.2 mt -124.42 115.03 20.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.042 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.901 ' HA ' HG22 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -109.69 141.79 41.78 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.092 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 8.3 t0 -71.38 -171.82 0.66 Allowed 'General case' 0 C--O 1.23 0.055 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.931 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.778 HG13 ' HA3' ' A' ' 62' ' ' GLY . 2.7 tt -170.13 79.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.218 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.8 78.91 1.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.52 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 2.4 ptt? 43.21 49.92 5.38 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.552 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 50.6 Cg_endo -83.14 -74.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.305 2.003 . . . . 0.0 111.663 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.25 -21.34 3.43 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.528 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 4.3 ttm -163.74 68.28 0.19 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 110.225 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.66 -25.1 0.15 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.167 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.778 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 137.68 -27.68 2.81 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.586 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.511 ' CD2' ' HB1' ' A' ' 90' ' ' ALA . 4.3 mp -75.17 -17.98 60.28 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.528 ' HB1' ' N ' ' A' ' 60' ' ' MET . . . -53.43 -24.5 12.82 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.844 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.609 ' O ' HG13 ' A' ' 69' ' ' ILE . 7.4 mp -62.13 -42.36 99.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.598 ' HA ' HD12 ' A' ' 69' ' ' ILE . 85.9 mt -64.19 -42.72 96.54 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.304 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.442 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 9.9 tptm -48.39 -56.37 8.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.736 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.459 ' HB2' HD12 ' A' ' 40' ' ' LEU . 24.8 mm-40 -59.61 -32.45 70.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.862 HG12 ' CE1' ' A' ' 73' ' ' HIS . 97.1 mt -59.98 -46.01 94.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.969 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -67.0 -27.61 67.58 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -86.03 -37.02 19.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.85 -61.97 1.57 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.866 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.892 ' CE1' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -84.96 147.29 47.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.063 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -95.17 103.68 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.227 2.618 . . . . 0.0 112.437 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 18.3 mtm 54.35 24.58 5.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.086 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 48' ' ' PRO . 10.6 tp -69.15 114.36 22.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.99 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.54 120.63 8.64 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.309 2.006 . . . . 0.0 111.991 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.571 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 1.8 t -117.46 151.47 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.293 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.633 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 2.3 mp -131.15 120.39 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.895 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 53' ' ' SER . 18.0 mm -95.49 147.2 6.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.989 0.423 . . . . 0.0 111.375 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.521 ' HE2' ' CB ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -81.18 -18.42 46.31 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.214 -179.02 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.466 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.9 m -147.77 153.53 39.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.374 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 84' ' ' HIS . . . -134.58 -2.02 2.75 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.744 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.472 ' CE1' ' CD1' ' A' ' 55' ' ' ILE . 0.1 OUTLIER 23.43 -95.66 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.205 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 m -141.15 -12.78 0.93 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.454 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 3.7 t70 -78.86 44.49 0.55 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.941 0.401 . . . . 0.0 111.361 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -52.12 -21.06 2.9 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.074 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -47.69 -56.51 7.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.662 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 63' ' ' LEU . . . -68.68 -19.78 64.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.768 0.318 . . . . 0.0 111.247 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.511 ' HB1' ' CD2' ' A' ' 63' ' ' LEU . . . -70.76 -37.73 73.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.88 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.584 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.8 t -63.9 -41.92 94.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.287 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.59 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 23.8 m -61.39 -18.91 60.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 109.991 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.732 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.84 -52.49 10.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.097 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.584 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.0 m-85 -58.24 -33.85 69.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.164 0.507 . . . . 0.0 110.517 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.8 pp0? -76.39 -38.63 55.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.601 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.732 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.2 pp0? -73.12 -18.29 61.31 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.064 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.07 1.44 4.91 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.861 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.571 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -56.82 159.52 3.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.283 0.542 . . . . 0.0 111.537 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.495 ' HB3' HG13 ' A' ' 79' ' ' ILE . 84.0 t80 -85.08 -53.97 4.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.425 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 2.2 t70 173.11 -165.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 111.117 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.574 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.1 m-85 -127.55 122.55 33.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.582 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 tp -102.58 141.04 21.69 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.837 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.715 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 15.8 Cg_endo -55.52 166.31 2.72 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.363 2.042 . . . . 0.0 111.398 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -42.02 -46.64 10.29 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.411 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.715 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 83.0 Cg_exo -47.23 163.75 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 121.805 1.67 . . . . 0.0 110.727 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.694 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 4.1 t80 -165.75 -93.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.36 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.525 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 4.5 p-10 43.92 -175.78 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.706 0.288 . . . . 0.0 110.506 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.728 HD13 ' HA ' ' A' ' 19' ' ' LEU . 1.1 mp -67.96 -45.4 83.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.365 0.602 . . . . 0.0 111.381 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.717 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 30.9 t0 -52.14 -58.08 7.68 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.662 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.4 mm-40 -77.82 -30.06 50.93 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -82.99 -53.62 5.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.256 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.609 ' HA ' HG12 ' A' ' 115' ' ' VAL . 47.7 t -57.79 -32.75 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.431 0.634 . . . . 0.0 110.097 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.717 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -59.57 -52.91 63.51 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.227 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.457 HD23 ' CG2' ' A' ' 79' ' ' ILE . 6.9 tp -75.07 -20.51 59.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.042 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 112' ' ' VAL . 6.0 p -79.18 -43.67 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.601 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.421 ' N ' HG11 ' A' ' 115' ' ' VAL . 16.5 mt-10 -59.89 -51.81 68.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.69 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -23.82 63.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 110.853 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.459 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.66 -52.59 11.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.445 HD12 HD21 ' A' ' 28' ' ' LEU . 4.4 mt -71.57 -32.46 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.117 0.484 . . . . 0.0 111.244 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 t -66.06 -33.65 76.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.506 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.761 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.3 mp -108.97 112.41 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.841 0.353 . . . . 0.0 111.039 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.467 HG22 HD21 ' A' ' 23' ' ' LEU . 6.5 p -109.24 118.46 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.591 ' CD1' HG22 ' A' ' 31' ' ' THR . 37.5 m0 -109.62 140.21 43.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.188 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.784 HG22 HD23 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -125.09 144.85 33.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.194 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.761 HG13 ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -133.14 106.79 10.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.053 0.454 . . . . 0.0 110.957 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 34' ' ' GLU . 8.5 t0 -162.05 -154.46 0.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.746 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.2 -1.56 3.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 62.47 -151.59 0.36 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.474 -0.141 . . . . 0.0 111.013 179.067 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 t 36.32 -90.34 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 18' ' ' VAL . 1.3 t -55.06 -56.5 19.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.672 0.273 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.9 mm -64.3 -30.88 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.299 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.491 ' HG3' HG23 ' A' ' 32' ' ' THR . 8.5 ttm-85 -71.78 -53.3 13.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.628 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.418 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 72.9 t90 -54.07 -40.73 67.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.529 ' C ' HD13 ' A' ' 108' ' ' ILE . 2.8 t -69.04 -56.65 11.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.784 HD23 HG22 ' A' ' 8' ' ' VAL . 7.0 tp -72.38 -23.13 61.07 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.647 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . 14.6 pt-20 -67.31 -59.23 3.58 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.492 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.521 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 11.4 mmm-85 -74.62 -53.84 8.58 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.79 -56.15 17.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 111.786 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.699 HD11 ' CD1' ' A' ' 28' ' ' LEU . 11.4 tp -66.02 -21.36 66.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.639 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 20' ' ' GLU . . . -70.33 -34.83 73.14 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.34 -26.52 68.04 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.349 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.2 -15.95 59.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.649 0.261 . . . . 0.0 110.676 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.2 24.83 8.19 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.699 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -121.37 165.2 15.88 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.75 1.275 . . . . 0.0 112.438 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' HG12 ' A' ' 6' ' ' VAL . 91.8 m -88.74 109.08 19.85 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.16 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.647 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -101.9 115.62 30.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.414 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.591 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -133.62 132.19 40.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.491 HG23 ' HG3' ' A' ' 16' ' ' ARG . 59.2 p -105.87 164.14 12.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.489 0.661 . . . . 0.0 112.523 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.823 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 4.2 m-85 -135.79 173.42 11.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.071 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.561 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 2.0 pp20? -61.53 -49.52 76.38 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.714 ' C ' HG13 ' A' ' 9' ' ' VAL . 19.6 m-20 -165.96 -35.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.761 ' N ' HG13 ' A' ' 9' ' ' VAL . . . -172.79 -64.83 0.05 OUTLIER Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.992 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.14 -30.57 49.6 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.823 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 11.1 tt0 -56.14 -48.03 77.03 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.129 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.686 ' CG2' HG11 ' A' ' 9' ' ' VAL . 4.1 t -52.8 -40.65 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.313 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.9 mt -54.16 -42.12 69.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.727 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.0 -52.48 65.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.848 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.54 -27.94 64.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.812 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.636 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 11.9 mt -67.67 -28.53 67.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.579 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.17 -17.74 4.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.877 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.55 -0.02 8.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.82 164.38 23.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 111.363 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.9 m -138.97 113.35 8.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.562 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.597 ' HD2' HD21 ' A' ' 43' ' ' LEU . 46.3 Cg_endo -68.82 158.44 57.85 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.271 1.981 . . . . 0.0 111.54 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -80.53 -25.94 38.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.47 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.519 HG22 ' CG2' ' A' ' 115' ' ' VAL . 7.6 p -147.93 97.88 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.684 0.278 . . . . 0.0 111.111 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.455 HD22 HG23 ' A' ' 78' ' ' VAL . 18.6 tp -86.83 152.87 22.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.999 0.428 . . . . 0.0 111.989 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.548 ' CD2' ' CZ ' ' A' ' 106' ' ' PHE . 1.1 tt -134.87 114.41 12.54 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.074 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.508 ' HA ' HG21 ' A' ' 9' ' ' VAL . 10.5 t -114.9 136.98 52.51 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 111.919 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -82.75 4.43 25.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.546 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.673 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 7.4 tt 41.84 82.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 12.2 ttp85 175.09 62.23 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.382 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.65 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 10.9 tpt -163.43 -61.13 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.513 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 17.9 Cg_endo -58.02 178.8 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.405 2.07 . . . . 0.0 112.616 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.77 -64.76 3.66 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.177 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.439 ' O ' ' N ' ' A' ' 62' ' ' GLY . 3.8 tpt -72.4 57.24 0.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.005 0.431 . . . . 0.0 110.099 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 0.4 OUTLIER 59.52 -81.8 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.237 -179.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.673 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.39 -31.29 0.15 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.566 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -60.27 -25.34 65.63 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.113 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 68' ' ' GLN . . . -54.32 -34.17 60.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.926 0.393 . . . . 0.0 109.942 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.485 ' O ' HG13 ' A' ' 69' ' ' ILE . 30.7 tp -56.82 -36.99 70.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.825 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 3.7 mm? -64.32 -44.53 91.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.848 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.747 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -57.21 -42.13 80.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.857 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.445 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 8.5 mm100 -65.18 -36.67 84.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.126 0.488 . . . . 0.0 110.487 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 65' ' ' LEU . 59.2 mt -61.51 -39.75 84.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.083 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.747 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.64 -28.01 62.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.258 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -79.42 -39.36 32.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.567 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -96.66 -61.54 1.4 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.876 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.636 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 2.6 m-70 -82.25 157.88 67.51 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.495 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -68.3 -76.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.612 2.208 . . . . 0.0 112.966 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.645 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 31.1 mtm -145.26 56.1 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.027 0.441 . . . . 0.0 111.124 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.516 HD12 ' HD2' ' A' ' 48' ' ' PRO . 17.6 tp -67.05 112.66 10.43 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.145 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 42.1 Cg_endo -67.28 118.75 5.81 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.462 2.108 . . . . 0.0 111.632 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.455 HG23 HD22 ' A' ' 51' ' ' LEU . 11.5 t -120.63 148.93 23.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 111.651 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.533 HG21 ' OD1' ' A' ' 100' ' ' ASP . 2.7 mt -117.2 113.66 43.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.121 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.563 ' HB ' ' CD2' ' A' ' 101' ' ' TYR . 18.3 mm -93.5 135.54 27.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.111 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.753 ' HE1' ' OG1' ' A' ' 82' ' ' THR . 0.1 OUTLIER -73.09 -55.52 6.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.215 0.531 . . . . 0.0 110.7 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.753 ' OG1' ' HE1' ' A' ' 81' ' ' MET . 2.5 m -106.39 157.62 17.49 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.218 -0.301 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.428 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -121.49 37.4 4.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.884 0.373 . . . . 0.0 110.695 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.525 ' CE1' HG12 ' A' ' 55' ' ' ILE . 7.7 p80 -81.17 -172.81 3.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 74.91 -75.93 0.07 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.241 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.417 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -160.03 98.96 1.35 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.796 0.331 . . . . 0.0 111.45 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.692 HD11 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -47.81 -24.52 1.0 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.265 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.04 -42.11 27.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.889 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -72.25 -26.31 61.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.321 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.692 ' HB3' HD11 ' A' ' 87' ' ' LEU . . . -68.03 -45.79 72.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.45 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.582 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 15.0 t -67.6 -47.45 80.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.7 p -63.34 -30.69 71.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.111 0.481 . . . . 0.0 110.16 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.704 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -59.04 -37.38 76.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.682 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.582 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 23.5 m-85 -59.04 -22.11 60.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.077 0.465 . . . . 0.0 110.014 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.616 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.3 -42.15 46.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.075 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.704 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp0? -76.13 -18.11 59.28 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.057 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 128.87 9.21 3.53 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.716 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . . . -54.39 147.52 13.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 117.37 0.585 . . . . 0.0 111.433 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 100' ' ' ASP . 56.2 t80 -86.68 -54.17 4.53 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.533 ' OD1' HG21 ' A' ' 79' ' ' ILE . 19.2 p30 171.51 -168.71 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.811 0.338 . . . . 0.0 111.273 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 90' ' ' ALA . 11.3 m-85 -130.45 134.98 47.52 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.538 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.697 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -137.4 117.57 10.47 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.594 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 102' ' ' LEU . 58.8 Cg_exo -38.68 173.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.604 2.869 . . . . 0.0 114.501 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.626 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -36.91 -49.51 2.04 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.111 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.9 Cg_endo -47.8 123.81 8.94 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 N-CA-C 108.71 -1.304 . . . . 0.0 108.71 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.656 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -156.89 -85.68 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.997 -177.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.847 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.9 p30 37.32 -162.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.857 0.361 . . . . 0.0 110.854 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.602 HD13 ' N ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.9 -52.52 38.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.755 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 32.1 m-20 -50.53 -56.63 10.76 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.549 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.656 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.6 mm-40 -78.27 -30.97 48.84 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.847 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.37 -54.31 4.87 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.755 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.628 ' O ' HG11 ' A' ' 115' ' ' VAL . 32.2 t -55.07 -32.02 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.491 0.663 . . . . 0.0 110.156 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -60.34 -51.87 67.65 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.501 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.444 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 5.9 tp -75.3 -20.59 59.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.697 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 112' ' ' VAL . 6.6 p -79.41 -50.0 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.092 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.425 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 17.9 mt-10 -58.33 -43.97 88.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.666 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -24.33 67.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.96 0.409 . . . . 0.0 110.474 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 99' ' ' PHE . . . -73.71 -59.05 2.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.979 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -64.95 -30.98 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.075 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 t -64.45 -37.18 86.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.076 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.8 m80 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 -179.863 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.458 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 4.0 mm -107.03 112.4 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.678 0.275 . . . . 0.0 111.09 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 5.9 p -109.95 119.2 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.808 0.337 . . . . 0.0 110.563 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.505 ' NE1' HG21 ' A' ' 31' ' ' THR . 34.8 m0 -112.55 131.77 55.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.802 0.334 . . . . 0.0 110.566 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.744 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -122.77 145.6 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.167 0.508 . . . . 0.0 112.283 -177.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.697 ' CG1' ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -131.26 107.91 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.15 178.343 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.567 ' CB ' ' HE1' ' A' ' 81' ' ' MET . 31.6 t0 170.76 107.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.869 0.366 . . . . 0.0 111.674 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.56 -40.59 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.7 OUTLIER 69.23 -159.3 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.416 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.9 t 30.96 -87.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 12' ' ' ASP . 9.6 t -56.09 -57.49 11.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 0.0 110.518 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 15' ' ' ILE . 28.4 mm -61.38 -22.46 27.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.098 0.475 . . . . 0.0 110.186 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.512 ' HG3' HG22 ' A' ' 32' ' ' THR . 5.2 ttp180 -77.42 -59.24 2.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.398 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -46.35 -38.86 9.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.522 ' C ' HD11 ' A' ' 108' ' ' ILE . 1.6 t -72.2 -62.51 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.011 0.434 . . . . 0.0 111.911 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.557 ' CD1' HD13 ' A' ' 108' ' ' ILE . 3.6 mm? -65.37 -25.75 67.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.142 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.611 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 8.9 pt-20 -67.77 -59.3 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.589 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 6.6 mmm180 -71.75 -48.16 48.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.931 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -57.78 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.049 0.452 . . . . 0.0 111.345 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.717 HD12 ' CD1' ' A' ' 28' ' ' LEU . 4.8 tp -63.96 -22.98 67.16 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.348 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.32 -33.95 72.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.24 -22.33 74.45 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.282 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.72 -16.0 58.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.658 0.266 . . . . 0.0 110.997 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.7 25.54 6.52 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.218 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.717 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -130.68 168.72 16.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.897 0.849 . . . . 0.0 111.725 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.435 ' O ' HG13 ' A' ' 6' ' ' VAL . 61.8 m -98.79 105.85 18.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.874 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 33.6 t -104.38 112.87 26.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.556 HG22 ' CE1' ' A' ' 33' ' ' PHE . 3.0 t -120.53 154.63 35.07 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.744 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 16.2 p -125.26 164.87 19.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.543 0.687 . . . . 0.0 112.794 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.764 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 47.4 m-85 -135.97 173.78 11.34 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.517 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.713 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -61.94 -60.94 2.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.693 ' C ' HG11 ' A' ' 9' ' ' VAL . 7.4 t-20 -151.36 -24.73 0.2 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.59 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 167.91 -58.78 0.21 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.922 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.455 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -52.62 -26.95 15.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.853 0.358 . . . . 0.0 110.685 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.764 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -59.38 -60.31 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.802 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.68 HG21 ' CD1' ' A' ' 33' ' ' PHE . 39.4 t -48.58 -34.48 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.834 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.455 ' CD1' ' HA ' ' A' ' 37' ' ' ASN . 19.2 mt -57.48 -43.52 84.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.59 -53.78 51.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.16 0.505 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.24 71.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.905 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.674 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 12.2 mt -59.85 -29.84 68.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.9 -19.59 4.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.101 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 t -127.79 0.2 6.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -156.02 157.76 36.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.78 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.8 m -138.82 114.79 8.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.223 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.508 ' HD2' HD21 ' A' ' 43' ' ' LEU . 61.1 Cg_endo -74.39 154.94 45.95 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.083 1.855 . . . . 0.0 111.716 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.21 -23.99 40.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.749 0.309 . . . . 0.0 111.08 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.498 ' CG2' ' CD1' ' A' ' 79' ' ' ILE . 3.3 p -145.8 92.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.56 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.448 HD21 HG11 ' A' ' 39' ' ' VAL . 63.2 tp -86.61 152.45 22.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.233 0.539 . . . . 0.0 111.929 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.675 ' HB2' HG13 ' A' ' 8' ' ' VAL . 4.8 mt -138.2 123.26 19.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.557 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.544 ' HA ' HG22 ' A' ' 9' ' ' VAL . 7.3 t -111.05 144.76 39.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 50.0 t0 -75.47 -11.06 59.96 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.761 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.675 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.7 tt 44.35 78.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 9.2 tpt180 172.05 76.08 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.679 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.589 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.24 -61.78 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 73.7 Cg_endo -74.13 -170.08 0.66 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.134 1.889 . . . . 0.0 113.504 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.3 -59.68 10.27 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.845 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.545 ' O ' ' N ' ' A' ' 62' ' ' GLY . 10.4 tpp -72.92 52.91 0.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.911 0.386 . . . . 0.0 110.602 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.81 -76.75 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.287 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.675 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.75 -32.04 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.189 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.597 ' HG ' HD11 ' A' ' 55' ' ' ILE . 4.0 mp -51.79 -29.56 19.57 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HA ' ' HG3' ' A' ' 67' ' ' LYS . . . -55.66 -32.49 63.25 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.929 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.59 HD13 ' HA3' ' A' ' 36' ' ' GLY . 13.5 mt -56.2 -44.39 79.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.544 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.43 ' CD2' ' CG1' ' A' ' 78' ' ' VAL . 30.5 mt -60.57 -44.36 96.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.122 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.605 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 9.8 mttt -49.75 -40.8 42.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.212 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -70.37 -35.64 73.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.203 0.525 . . . . 0.0 110.321 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.424 HG21 HD22 ' A' ' 76' ' ' LEU . 69.9 mt -62.42 -40.62 88.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.09 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -76.23 -25.01 54.61 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.705 -179.487 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -36.21 25.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.649 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.0 mtp85 -92.77 -25.74 18.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.739 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.674 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 40.0 m-70 -124.25 152.72 68.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 120.862 0.363 . . . . 0.0 111.533 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.08 -83.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.083 2.522 . . . . 0.0 113.063 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.97 51.31 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.663 0.268 . . . . 0.0 111.073 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.48 ' CD2' HD21 ' A' ' 43' ' ' LEU . 55.3 tp -60.81 110.54 3.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.704 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.84 115.7 3.4 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.103 1.868 . . . . 0.0 111.527 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.43 ' CG1' ' CD2' ' A' ' 66' ' ' LEU . 3.5 t -108.01 154.25 9.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.58 0.705 . . . . 0.0 111.525 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.586 HD11 ' HG ' ' A' ' 52' ' ' LEU . 3.5 mt -131.22 117.32 36.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.177 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.712 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 33.0 mm -93.42 143.51 11.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.997 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.567 ' HE1' ' CB ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -94.3 -7.87 40.62 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.714 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.56 ' O ' HG22 ' A' ' 55' ' ' ILE . 3.0 m -147.52 129.11 15.05 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.93 0.395 . . . . 0.0 111.352 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.6 86.42 2.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.422 ' CE1' HG22 ' A' ' 82' ' ' THR . 52.3 m-70 -66.78 -159.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.935 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.7 34.15 0.53 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.673 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.526 ' HB2' HD13 ' A' ' 63' ' ' LEU . 1.3 m-20 -125.35 26.73 6.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.04 0.448 . . . . 0.0 110.333 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -44.54 -21.58 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.447 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -47.82 -47.26 31.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.521 0.2 . . . . 0.0 111.386 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.452 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -72.58 -22.45 60.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.856 0.36 . . . . 0.0 110.926 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.515 ' HB1' ' CE1' ' A' ' 101' ' ' TYR . . . -67.58 -49.02 65.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.374 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.583 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.4 t -57.71 -49.05 82.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.05 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -29.81 68.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.411 0.624 . . . . 0.0 109.901 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 96' ' ' GLN . . . -58.53 -39.81 81.2 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.14 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.583 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 25.6 m-85 -61.31 -21.18 63.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.43 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.602 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.15 -42.59 55.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.706 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.602 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 1.2 pt20 -77.0 -15.1 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.817 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.32 13.44 4.81 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.626 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.52 143.77 28.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.146 0.473 . . . . 0.0 110.982 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.553 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 69.5 t80 -76.39 -53.96 7.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.222 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.4 t0 172.98 -166.1 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.947 0.403 . . . . 0.0 111.555 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.712 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.4 m-85 -129.05 118.97 23.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.347 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.9 tp -102.56 131.1 22.76 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.664 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.582 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 83.5 Cg_exo -47.48 168.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.551 2.168 . . . . 0.0 111.98 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.436 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -43.32 -46.36 15.7 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.582 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 88.1 Cg_exo -46.56 163.34 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 121.705 1.603 . . . . 0.0 110.763 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.682 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 5.0 t80 -169.39 -91.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.389 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.499 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.8 p-10 43.46 -174.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.73 0.3 . . . . 0.0 110.912 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.564 HG23 HG23 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -67.98 -48.14 76.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.225 0.536 . . . . 0.0 110.819 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.729 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 5.1 t70 -50.32 -57.18 8.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.082 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.682 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.5 mm-40 -79.25 -27.2 42.37 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -84.15 -53.43 5.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.603 ' O ' HG11 ' A' ' 115' ' ' VAL . 42.3 t -59.17 -32.16 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.507 0.67 . . . . 0.0 110.17 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.729 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -60.89 -52.62 64.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.752 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.51 ' CD2' HG22 ' A' ' 79' ' ' ILE . 11.4 tp -75.67 -20.36 58.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.545 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.603 HG11 ' O ' ' A' ' 112' ' ' VAL . 3.6 p -78.28 -46.35 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.017 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.408 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 43.6 mt-10 -61.95 -45.35 94.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.808 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.464 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 5.0 ptm180 -62.76 -25.7 68.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.671 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.553 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.93 -52.17 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.238 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.423 HD12 ' CD2' ' A' ' 28' ' ' LEU . 5.1 mt -68.31 -30.7 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.148 0.499 . . . . 0.0 110.738 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 m -65.28 -41.8 93.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.796 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.5 m80 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.734 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.676 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 1.5 mm -107.8 112.29 39.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.764 0.316 . . . . 0.0 110.763 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.794 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 7.1 p -113.91 124.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.526 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.624 ' HH2' ' CG ' ' A' ' 46' ' ' LYS . 53.2 m0 -116.71 133.35 56.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.702 0.287 . . . . 0.0 110.394 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -119.13 128.99 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.89 ' CG2' ' HA ' ' A' ' 53' ' ' SER . 2.7 m -117.65 118.77 59.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 110.419 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.463 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 17.2 t0 -173.45 -146.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.872 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -65.24 -4.46 5.25 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.6 t0 58.56 -147.5 0.5 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 122.543 -0.098 . . . . 0.0 111.234 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t 34.31 -87.87 0.01 OUTLIER 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 12' ' ' ASP . 39.2 m -58.1 -57.31 13.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.76 0.314 . . . . 0.0 110.988 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.58 -31.39 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.304 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.438 ' HG3' HG23 ' A' ' 32' ' ' THR . 15.4 ttp180 -72.37 -57.39 4.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.831 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.417 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 66.0 t90 -50.83 -42.4 58.45 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.467 ' O ' ' HB1' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -70.49 -58.77 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.184 0.516 . . . . 0.0 111.598 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.59 HD11 HD13 ' A' ' 108' ' ' ILE . 3.9 mm? -66.63 -26.99 67.34 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.67 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.564 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 12.2 pt-20 -66.87 -60.14 2.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.564 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.0 OUTLIER -72.35 -55.3 7.33 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 18' ' ' VAL . . . -50.37 -57.25 8.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.0 111.815 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.686 HD11 ' CD1' ' A' ' 28' ' ' LEU . 4.6 tp -60.68 -25.24 66.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.438 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.76 -37.14 79.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.76 -23.69 70.91 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.513 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.69 -15.72 59.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.582 0.229 . . . . 0.0 110.977 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.14 25.04 6.58 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.39 -0.91 . . . . 0.0 114.29 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.686 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.24 170.06 15.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.78 0.79 . . . . 0.0 111.436 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.428 ' O ' HG11 ' A' ' 6' ' ' VAL . 57.3 m -101.41 105.82 16.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.215 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.794 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 16.0 t -105.99 111.46 24.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.155 0.502 . . . . 0.0 111.952 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.517 ' CG2' ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -121.26 155.64 34.2 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 32.6 p -126.02 159.99 31.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.559 0.695 . . . . 0.0 112.543 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.887 ' HB2' HG11 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -136.44 174.32 10.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.267 -179.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.626 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -63.04 -33.43 75.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.035 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.626 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 2.2 t30 -176.34 171.76 2.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.019 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.503 ' HA3' ' HG ' ' A' ' 65' ' ' LEU . . . -50.26 -25.27 7.93 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.144 -1.027 . . . . 0.0 111.907 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.43 ' HA ' HD11 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -58.58 -52.21 66.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.673 0.273 . . . . 0.0 110.63 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.6 tt0 -51.95 -51.54 56.44 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.669 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.475 HG11 ' HG ' ' A' ' 43' ' ' LEU . 52.2 t -50.72 -35.1 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.133 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.478 HD12 ' CB ' ' A' ' 68' ' ' GLN . 20.2 mt -54.98 -43.1 73.21 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.04 -47.79 64.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.879 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.99 80.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 14.7 mt -67.19 -25.0 65.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.239 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.23 -15.3 23.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.766 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.2 -4.97 8.39 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -167.07 165.96 15.41 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.932 0.396 . . . . 0.0 110.844 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.47 ' HA ' HD23 ' A' ' 43' ' ' LEU . 89.0 m -138.79 120.85 10.35 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.452 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.523 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 93.0 Cg_endo -80.61 162.11 21.8 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.087 1.858 . . . . 0.0 111.638 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -74.01 -27.9 61.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 0.0 110.849 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.462 HG13 ' CG2' ' A' ' 6' ' ' VAL . 3.3 p -145.14 154.95 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 9.5 tp -152.98 136.75 16.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 111.342 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.575 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -111.45 122.59 48.25 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.89 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -106.83 137.95 43.91 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 29.1 t0 -73.02 171.33 13.06 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.342 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.663 HG13 ' O ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -157.97 93.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.383 -178.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.83 44.12 2.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.561 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 8.1 ttp 59.89 46.14 1.26 Allowed Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 55.2 Cg_endo -71.1 -73.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.296 1.997 . . . . 0.0 112.188 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.447 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -112.15 -27.73 3.85 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.233 -0.508 . . . . 0.0 111.851 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.586 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 16.0 ttm -155.63 64.39 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.361 . . . . 0.0 110.456 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.663 ' O ' HG13 ' A' ' 55' ' ' ILE . 2.4 t70 71.87 -23.54 0.19 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.172 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.595 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 136.44 -29.55 2.78 Favored Glycine 0 CA--C 1.506 -0.505 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.631 ' HA ' HD23 ' A' ' 66' ' ' LEU . 2.2 mp -70.11 -19.85 63.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.891 -0.655 . . . . 0.0 110.296 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.586 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.64 -30.75 44.43 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.128 0.49 . . . . 0.0 109.819 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.503 ' HG ' ' HA3' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -59.63 -48.39 81.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.537 178.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.631 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.5 mm? -48.74 -41.72 33.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.018 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.695 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 16.9 tttp -58.78 -43.73 90.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.351 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.478 ' CB ' HD12 ' A' ' 40' ' ' LEU . 40.8 mm-40 -62.73 -38.83 92.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.221 0.534 . . . . 0.0 110.648 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.489 HD13 HG21 ' A' ' 78' ' ' VAL . 73.5 mt -57.41 -40.22 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.814 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.695 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.34 -22.56 47.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.15 -43.5 86.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.862 0.363 . . . . 0.0 111.85 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -99.3 -31.97 11.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.037 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.522 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 1.9 m-70 -112.68 138.2 21.99 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.764 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.37 -68.15 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.261 1.974 . . . . 0.0 112.554 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mpp? -148.45 53.67 1.01 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 110.736 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.563 ' O ' HG22 ' A' ' 78' ' ' VAL . 3.1 tm? -55.26 115.06 8.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.419 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.482 ' HD2' HD21 ' A' ' 76' ' ' LEU . 10.0 Cg_endo -53.5 121.51 9.62 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.615 2.21 . . . . 0.0 112.213 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.714 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.2 t -127.99 149.36 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.22 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.575 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.6 mp -137.4 116.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.586 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.661 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 25.3 mm -92.65 142.98 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.276 0.56 . . . . 0.0 111.944 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.496 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.87 -9.7 59.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.984 -178.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.487 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.4 m -147.6 152.45 37.94 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.611 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.66 73.51 0.43 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -96.62 -21.12 17.83 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.3 m -159.84 175.76 12.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.049 0.452 . . . . 0.0 111.451 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.56 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.2 OUTLIER 54.42 29.25 10.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.411 -179.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.56 -21.06 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.546 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -47.81 -52.68 17.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.678 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.5 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . . . -68.56 -19.77 64.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.315 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.609 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . . . -66.75 -54.43 22.87 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.833 0.349 . . . . 0.0 111.011 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.628 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 4.1 t -62.23 -45.06 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.5 p -60.7 -27.05 67.58 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.628 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -59.09 -50.18 75.04 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.483 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.628 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -59.68 -33.63 71.82 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.901 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -39.72 69.48 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.449 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.576 ' HB2' ' CB ' ' A' ' 70' ' ' LYS . 7.6 pt20 -93.3 -7.42 44.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 132.02 82.36 0.22 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.766 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.714 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.46 139.18 2.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.559 0.218 . . . . 0.0 110.552 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.549 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 38.1 t80 -74.94 -53.76 8.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.347 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.678 ' OD2' HD11 ' A' ' 114' ' ' LEU . 38.5 p-10 177.71 -168.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.0 111.256 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.661 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 7.6 m-85 -123.1 152.76 40.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.802 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.532 HD11 ' O ' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -143.02 142.79 22.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.759 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.424 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 56.1 Cg_exo -51.68 165.44 0.73 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.382 2.054 . . . . 0.0 111.889 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.596 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -41.16 -51.05 8.07 Favored Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 3.9 Cg_endo -47.62 164.1 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.868 1.712 . . . . 0.0 110.353 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.831 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 174.98 -85.59 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.174 -0.211 . . . . 0.0 111.089 -179.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 48.4 -174.16 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.654 HG23 HG22 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -57.7 -49.95 79.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.191 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.684 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 2.2 t70 -50.99 -58.89 4.91 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.154 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.831 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 7.6 mm-40 -81.18 -28.67 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.73 -47.74 10.86 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.951 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.654 HG22 HG23 ' A' ' 108' ' ' ILE . 59.5 t -62.09 -32.68 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.591 0.71 . . . . 0.0 109.733 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -59.64 -50.36 74.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.913 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.678 HD11 ' OD2' ' A' ' 100' ' ' ASP . 15.4 tp -75.69 -21.15 57.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.747 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 112' ' ' VAL . 4.1 p -79.52 -48.14 21.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.836 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.408 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 49.8 mt-10 -65.72 -39.95 91.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.918 0.389 . . . . 0.0 110.326 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.8 mtp85 -65.38 -23.88 67.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.763 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.549 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -75.01 -49.1 20.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.221 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.8 mt -68.0 -30.69 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.714 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.5 m -73.32 -40.0 64.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.877 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 27.6 m80 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.009 179.9 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.47 HD13 ' HB ' ' A' ' 29' ' ' THR . 2.8 mm -124.42 118.85 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.507 HG13 ' HG ' ' A' ' 23' ' ' LEU . 9.0 p -105.68 122.85 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.952 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.567 ' NE1' HG21 ' A' ' 31' ' ' THR . 27.2 m0 -107.87 137.41 45.93 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.674 -0.41 . . . . 0.0 109.975 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -131.06 144.45 37.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.331 -177.257 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.782 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -133.95 105.29 6.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.142 178.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 64.2 t0 166.9 118.3 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.415 ' CB ' HG12 ' A' ' 15' ' ' ILE . 2.4 t0 71.02 -16.36 0.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.1 t0 67.81 -139.63 0.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.253 -0.279 . . . . 0.0 110.985 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 t -32.82 -43.17 0.09 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.405 ' O ' HG22 ' A' ' 18' ' ' VAL . 36.1 t -53.15 -69.65 0.11 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 25.9 mm -63.94 -20.79 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.525 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 7.1 ttp180 -68.03 -58.48 4.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.469 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 77.3 t90 -51.13 -44.87 61.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.735 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.591 ' C ' HD11 ' A' ' 108' ' ' ILE . 2.4 t -62.92 -61.04 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.13 0.49 . . . . 0.0 111.975 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.539 ' N ' HD11 ' A' ' 108' ' ' ILE . 14.2 tp -72.28 -21.69 61.32 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 14.6 pt-20 -66.93 -56.06 11.86 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.408 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.516 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -62.78 -56.93 13.09 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.459 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.82 -49.5 70.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 111.929 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.507 ' HG ' HG13 ' A' ' 6' ' ' VAL . 1.5 tm? -69.78 -24.07 63.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.181 0.515 . . . . 0.0 110.339 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.07 -32.74 70.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.4 -27.11 67.25 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.231 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.31 -15.38 59.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 110.513 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.71 24.5 13.42 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.873 -0.68 . . . . 0.0 114.214 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.473 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -124.14 164.15 20.04 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 118.32 1.06 . . . . 0.0 112.438 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.479 ' O ' HG12 ' A' ' 6' ' ' VAL . 99.7 m -84.66 136.79 33.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.926 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -127.57 111.53 13.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.715 -179.007 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.567 HG21 ' NE1' ' A' ' 7' ' ' TRP . 2.8 t -123.55 147.33 47.38 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.692 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 71.7 p -126.25 159.49 32.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.469 0.652 . . . . 0.0 112.658 -178.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.817 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 2.2 m-85 -136.13 174.12 10.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.987 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.555 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -54.52 -51.17 65.97 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -177.002 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.606 ' N ' HG13 ' A' ' 9' ' ' VAL . 11.3 m-20 -171.24 -20.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.648 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . 169.46 -45.61 0.21 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.732 -1.223 . . . . 0.0 114.13 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.822 ' HA ' HD11 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -61.04 -39.17 88.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.447 0.624 . . . . 0.0 111.415 -178.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.817 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -57.86 -54.17 49.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.493 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.564 HG23 HG22 ' A' ' 9' ' ' VAL . 2.6 t -51.53 -47.19 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.322 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.822 HD11 ' HA ' ' A' ' 37' ' ' ASN . 15.0 mt -48.01 -43.58 30.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.91 -48.67 65.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.903 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.91 -27.68 67.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.28 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.614 HD12 ' NE2' ' A' ' 73' ' ' HIS . 17.6 mt -73.01 -23.96 60.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.946 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.83 -19.62 6.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.475 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.19 3.16 5.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -153.99 154.52 33.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.897 0.38 . . . . 0.0 111.518 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.9 m -138.86 113.18 8.36 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.426 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.531 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 72.7 Cg_endo -74.17 165.58 31.59 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.324 2.016 . . . . 0.0 111.266 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.424 ' OD2' ' HA2' ' A' ' 4' ' ' GLY . 93.5 m-20 -77.53 -30.67 52.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.855 0.359 . . . . 0.0 110.894 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.478 HG12 ' CG2' ' A' ' 6' ' ' VAL . 7.6 p -146.52 102.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.486 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.46 ' CB ' HD21 ' A' ' 76' ' ' LEU . 61.3 tp -87.26 137.19 32.56 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.694 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.6 mt -119.14 122.46 42.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.31 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.765 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -119.16 148.35 43.18 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 7.0 t0 -76.66 -167.0 0.74 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.558 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.769 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -165.4 72.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.832 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 29.2 ttt180 177.18 63.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.954 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.466 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 1.1 tmm? -163.27 -61.85 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.86 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.466 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 33.0 Cg_endo -61.82 -171.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.394 2.063 . . . . 0.0 112.689 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.11 -78.61 0.1 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.437 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.644 ' O ' ' N ' ' A' ' 62' ' ' GLY . 2.7 mtt -69.91 64.52 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.394 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD2' HD11 ' A' ' 63' ' ' LEU . 6.0 p-10 48.73 -66.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.543 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.769 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -143.51 -39.63 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.82 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 86' ' ' ASP . 1.8 mp -51.65 -25.18 6.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.414 . . . . 0.0 110.291 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 58' ' ' PRO . . . -55.55 -33.62 64.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.373 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.62 HD12 HD13 ' A' ' 69' ' ' ILE . 3.5 pp -65.17 -25.68 67.84 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 6.2 mp -66.1 -41.55 90.45 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 22.1 mmtm -53.06 -50.93 63.35 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.784 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.489 ' OE1' HD12 ' A' ' 40' ' ' LEU . 1.8 mt-30 -53.36 -43.89 68.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.76 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.634 HG12 ' CE1' ' A' ' 73' ' ' HIS . 61.6 mt -55.68 -45.53 79.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.003 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.504 ' CB ' ' HG3' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -63.71 -28.21 69.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.121 0.486 . . . . 0.0 110.67 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.447 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 4.3 mt-30 -77.07 -41.14 43.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.236 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -93.57 -73.2 0.57 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.372 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.634 ' CE1' HG12 ' A' ' 69' ' ' ILE . 7.6 p80 -110.55 76.97 1.2 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.75 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HB2' ' OE1' ' A' ' 96' ' ' GLN . 72.7 Cg_endo -77.25 29.44 0.42 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.963 2.442 . . . . 0.0 114.011 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.0 mtp -134.19 -32.07 1.08 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.855 0.36 . . . . 0.0 111.564 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.547 ' HB3' ' HD1' ' A' ' 73' ' ' HIS . 5.6 tp -66.34 141.87 97.47 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.306 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.436 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 78.7 Cg_endo -76.87 131.43 12.18 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.819 2.346 . . . . 0.0 112.304 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.41 141.52 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.058 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.542 HD11 ' HG ' ' A' ' 52' ' ' LEU . 2.6 mt -130.28 115.93 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.434 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.593 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 32.2 mm -93.64 145.82 7.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.042 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.526 ' O ' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -80.83 -24.64 38.32 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.347 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.538 ' O ' HG21 ' A' ' 80' ' ' ILE . 3.0 m -148.03 149.44 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.755 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -126.93 68.23 1.26 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.754 0.311 . . . . 0.0 111.304 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 61' ' ' ASP . 9.0 p80 -98.08 111.2 23.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.026 0.441 . . . . 0.0 111.569 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 t 54.39 168.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.022 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.568 ' O ' HD23 ' A' ' 63' ' ' LEU . 0.8 OUTLIER 62.19 14.71 6.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.518 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.463 HD22 ' HB1' ' A' ' 90' ' ' ALA . 1.4 mt -46.38 -25.14 0.6 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -48.61 -41.12 29.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.865 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.509 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . . . -70.93 -22.08 62.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.463 ' HB1' HD22 ' A' ' 87' ' ' LEU . . . -69.76 -34.51 73.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.942 0.401 . . . . 0.0 110.588 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.693 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.2 t -61.19 -45.15 99.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.141 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.591 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 20.6 m -57.99 -48.78 78.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.561 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.506 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -47.21 -43.67 21.75 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.154 0.502 . . . . 0.0 110.943 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.693 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 11.2 m-85 -54.89 -26.31 34.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.044 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.632 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.5 -48.07 61.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.341 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.632 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 26.7 mm-40 -72.5 -18.8 61.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.721 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.38 27.83 1.42 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.845 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.506 ' HB3' ' C ' ' A' ' 93' ' ' ALA . . . -62.21 146.78 49.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.349 0.574 . . . . 0.0 110.295 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.545 ' O ' ' HB2' ' A' ' 100' ' ' ASP . 45.4 t80 -74.18 -54.14 8.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.109 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 0.9 OUTLIER 166.99 -162.69 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.157 0.503 . . . . 0.0 111.445 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.593 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.4 m-85 -131.31 153.21 49.81 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.355 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 1.018 HD22 ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -141.53 149.89 55.66 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.963 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.462 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 29.0 Cg_endo -64.42 161.21 35.71 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.493 2.129 . . . . 0.0 111.426 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.576 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -33.58 -51.25 0.79 Allowed Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.1 Cg_endo -47.47 162.41 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.729 1.619 . . . . 0.0 110.345 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 1.018 ' CD1' HD22 ' A' ' 102' ' ' LEU . 0.1 OUTLIER 177.85 -79.45 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.064 -178.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.632 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 3.0 p30 42.54 -168.27 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.591 HD11 ' C ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.98 -47.19 79.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.825 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.71 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -51.95 -57.98 7.85 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.773 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.668 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 13.5 mm-40 -77.45 -31.88 54.12 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.758 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . . . -83.32 -49.93 8.88 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.537 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.574 ' O ' HG12 ' A' ' 115' ' ' VAL . 44.4 t -59.47 -31.54 46.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.526 0.679 . . . . 0.0 109.758 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.71 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -59.84 -51.34 70.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.964 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.551 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 6.9 tp -75.86 -21.59 57.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.641 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.2 p -79.44 -48.15 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.023 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.406 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 40.7 mt-10 -65.09 -40.52 94.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.699 0.285 . . . . 0.0 110.769 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.551 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 2.4 ptm85 -62.6 -25.07 67.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 0.0 110.394 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.431 ' HB1' ' CE1' ' A' ' 99' ' ' PHE . . . -70.61 -49.81 43.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.077 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.6 mt -66.38 -31.87 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -31.98 70.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.715 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.956 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.356 -0.297 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 1.4 mp -114.96 120.96 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.798 0.333 . . . . 0.0 111.211 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 7.5 p -114.23 120.77 64.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.321 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.506 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.8 m0 -111.04 136.46 50.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.744 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -122.12 137.89 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.888 -178.167 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.965 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -121.43 115.25 46.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.157 0.503 . . . . 0.0 110.068 178.138 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.583 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 7.5 t70 -168.35 -154.45 0.14 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.597 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -66.32 -3.17 5.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 65.56 -154.08 0.26 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.263 -0.273 . . . . 0.0 111.107 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 t 34.56 -89.12 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.422 ' N ' ' O ' ' A' ' 12' ' ' ASP . 17.1 m -54.22 -58.81 5.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.724 0.297 . . . . 0.0 111.395 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 26.4 mm -62.96 -30.53 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.937 0.398 . . . . 0.0 110.937 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.485 ' HG3' HG21 ' A' ' 32' ' ' THR . 22.5 ttt85 -72.36 -47.46 49.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.947 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.4 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 52.6 t90 -60.4 -40.92 92.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.483 ' C ' HD12 ' A' ' 108' ' ' ILE . 1.7 t -74.24 -43.09 50.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.97 0.414 . . . . 0.0 111.557 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.519 ' HA ' HD12 ' A' ' 108' ' ' ILE . 3.9 mm? -77.02 -27.57 54.63 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.1 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.643 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 16.7 pt-20 -67.89 -59.77 3.03 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.925 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.492 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -68.58 -55.96 9.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.09 -51.39 58.0 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.661 HD13 ' CD1' ' A' ' 28' ' ' LEU . 2.5 tp -67.35 -23.3 65.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.413 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -68.22 -36.64 79.84 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.36 -24.44 65.63 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.203 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.422 ' CB ' HD12 ' A' ' 28' ' ' LEU . . . -78.43 -15.6 58.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.741 0.305 . . . . 0.0 110.91 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.61 26.14 9.41 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.988 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.661 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.66 170.37 11.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.759 0.78 . . . . 0.0 111.808 179.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.405 ' O ' HG12 ' A' ' 6' ' ' VAL . 24.3 m -101.4 105.88 16.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.343 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.643 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 4.9 t -102.25 114.57 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.992 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.506 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -123.79 150.38 44.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 70.8 p -122.06 163.78 18.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.965 ' HB2' HG12 ' A' ' 9' ' ' VAL . 1.2 m-85 -136.4 175.43 9.62 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.755 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.589 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.9 pp20? -60.35 -55.69 30.52 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -177.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 5.6 m-80 -150.81 -43.89 0.12 Allowed 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.547 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 177.51 -46.03 0.1 OUTLIER Glycine 0 C--N 1.318 -0.454 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.353 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.422 ' ND2' HD11 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -63.25 -27.73 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.796 0.332 . . . . 0.0 110.6 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -58.59 -55.45 34.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.712 179.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.613 HG21 HG11 ' A' ' 9' ' ' VAL . 3.4 t -50.53 -38.92 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.965 0.412 . . . . 0.0 111.123 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 68' ' ' GLN . 13.3 mt -59.38 -44.07 92.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.52 -49.93 55.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.065 0.459 . . . . 0.0 111.108 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.09 -33.02 74.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.824 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.501 HD21 ' HD2' ' A' ' 48' ' ' PRO . 15.6 mt -62.15 -23.83 66.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.05 -20.42 16.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.791 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -116.56 -6.15 11.66 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -159.27 158.2 32.03 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.929 0.395 . . . . 0.0 111.012 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.9 m -138.71 114.93 8.76 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.954 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.533 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 91.0 Cg_endo -81.73 165.05 18.1 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.117 1.878 . . . . 0.0 111.53 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 5' ' ' ILE . 3.9 p30 -74.25 -59.81 2.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.123 0.487 . . . . 0.0 110.086 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.585 HG23 HG23 ' A' ' 115' ' ' VAL . 12.0 p -99.48 160.58 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.201 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 79' ' ' ILE . 32.1 tp -153.07 153.12 32.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.138 0.494 . . . . 0.0 111.676 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.763 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.2 mt -137.24 120.78 17.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.042 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.652 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -105.31 134.44 48.42 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.583 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.594 ' O ' HG21 ' A' ' 55' ' ' ILE . 9.2 t70 -61.71 -28.43 69.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.636 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.792 HG13 ' HA3' ' A' ' 62' ' ' GLY . 0.3 OUTLIER 41.8 92.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.772 -179.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.529 ' O ' ' HG3' ' A' ' 57' ' ' MET . 0.0 OUTLIER -175.3 104.86 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.193 0.52 . . . . 0.0 112.124 179.237 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER 40.03 47.91 1.96 Allowed Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 178.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.601 ' HG3' ' HA2' ' A' ' 62' ' ' GLY . 98.6 Cg_endo -90.76 -53.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.511 2.141 . . . . 0.0 111.693 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.01 -21.9 0.12 Allowed Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.66 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.581 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 3.6 tpt -163.98 67.21 0.17 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.658 0.383 . . . . 0.0 110.071 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 71.95 -22.56 0.2 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.616 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.792 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 136.65 -27.68 2.93 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.683 HD13 ' HB3' ' A' ' 86' ' ' ASP . 5.1 mp -77.1 -19.97 56.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.581 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.77 -32.65 53.19 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.003 0.43 . . . . 0.0 110.455 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.432 ' O ' HG13 ' A' ' 69' ' ' ILE . 14.7 mt -57.23 -44.42 83.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.538 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 63' ' ' LEU . 3.5 mm? -55.02 -44.79 74.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.93 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.638 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -52.71 -45.06 66.76 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.17 179.591 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.497 ' HB2' HD13 ' A' ' 40' ' ' LEU . 25.8 mm100 -67.45 -31.1 71.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.037 0.446 . . . . 0.0 110.601 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.538 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 94.5 mt -63.08 -41.06 91.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.755 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 3.4 pttp -74.76 -22.78 58.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.347 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.452 ' NE2' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -81.75 -31.95 31.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.395 -179.468 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.452 ' HG3' ' NE2' ' A' ' 71' ' ' GLN . 41.1 mtt180 -106.81 -59.48 1.8 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 112.191 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.538 ' CD2' ' HA ' ' A' ' 69' ' ' ILE . 2.2 m-70 -81.4 145.13 54.76 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.302 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -95.75 102.71 0.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.219 2.613 . . . . 0.0 113.14 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.576 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.6 mtt 54.26 35.97 24.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.809 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.443 ' O ' HG21 ' A' ' 78' ' ' VAL . 1.1 tt -64.68 110.34 3.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.632 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 49' ' ' ASP . 51.1 Cg_exo -54.02 116.87 3.33 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.164 1.91 . . . . 0.0 111.713 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 76' ' ' LEU . 2.4 t -122.1 146.07 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.321 0.581 . . . . 0.0 112.056 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 3.2 mt -122.07 116.94 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.957 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.607 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 9.3 mm -93.42 120.82 43.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.23 0.538 . . . . 0.0 112.315 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.487 ' HE3' ' CE ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -74.35 -8.86 57.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.286 -179.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 80' ' ' ILE . 3.0 m -147.52 136.01 21.74 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.09 0.472 . . . . 0.0 111.948 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.03 84.41 2.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.137 0.494 . . . . 0.0 110.562 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.434 ' CE1' HG21 ' A' ' 82' ' ' THR . 56.8 m-70 -66.78 -157.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.016 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -86.07 40.53 0.87 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.683 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -129.26 36.07 4.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.075 0.464 . . . . 0.0 109.98 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -45.42 -21.57 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.917 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.67 -55.12 10.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.492 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.434 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -69.42 -22.99 63.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.358 . . . . 0.0 110.654 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.444 ' CB ' ' CE1' ' A' ' 101' ' ' TYR . . . -68.69 -44.41 74.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.577 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.609 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 10.8 t -65.11 -42.66 94.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.804 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 77.6 p -67.12 -23.56 65.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.977 0.418 . . . . 0.0 109.932 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.673 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -65.99 -37.5 86.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.285 0.564 . . . . 0.0 109.835 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.609 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.9 m-85 -68.29 -23.9 64.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.282 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.404 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.1 OUTLIER -74.87 -29.55 61.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.272 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.673 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -92.19 -17.19 25.22 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.06 24.75 1.44 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.944 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 93' ' ' ALA . . . -68.92 145.94 53.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.118 0.459 . . . . 0.0 110.584 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.526 ' HE2' HD11 ' A' ' 114' ' ' LEU . 22.9 t80 -79.45 -53.39 6.94 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.45 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t0 179.42 -164.99 0.05 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.945 0.403 . . . . 0.0 111.932 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.607 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 7.8 m-85 -137.56 122.52 18.96 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.537 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.505 ' CD1' ' O ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -123.0 142.87 39.24 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.898 -179.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.55 175.39 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.874 2.383 . . . . 0.0 113.07 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -43.5 -53.1 12.38 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 6.3 Cg_endo -48.73 163.42 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.832 1.688 . . . . 0.0 110.442 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.847 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 172.87 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.739 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 45.65 -171.28 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.538 ' CA ' HG22 ' A' ' 112' ' ' VAL . 1.1 mp -60.13 -49.94 82.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.512 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.695 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 15.6 t0 -52.31 -58.57 6.25 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.847 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -80.35 -28.12 38.15 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.96 -52.16 6.56 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.589 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.573 ' O ' HG11 ' A' ' 115' ' ' VAL . 40.1 t -57.75 -33.54 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.49 0.662 . . . . 0.0 110.082 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.695 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -59.0 -51.62 69.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.626 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.526 HD11 ' HE2' ' A' ' 99' ' ' PHE . 9.6 tp -75.53 -21.89 57.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.045 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.585 HG23 HG23 ' A' ' 50' ' ' VAL . 3.0 p -79.46 -52.16 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.45 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 32.3 mt-10 -58.75 -40.14 82.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.648 0.261 . . . . 0.0 111.544 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.491 ' HD2' HD11 ' A' ' 114' ' ' LEU . 9.8 ptp180 -65.91 -23.73 66.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 0.0 110.774 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.482 ' HB1' ' CE2' ' A' ' 99' ' ' PHE . . . -71.71 -49.41 39.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.776 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.5 mt -71.05 -31.75 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.7 t -66.08 -34.64 78.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.721 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.09 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.562 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.9 mm -125.92 120.04 56.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.656 HG11 ' HG ' ' A' ' 23' ' ' LEU . 7.4 p -110.77 132.17 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.59 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.606 ' NE1' HG22 ' A' ' 31' ' ' THR . 35.0 m0 -119.58 127.44 52.97 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -124.2 122.05 63.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.891 HG21 ' HA ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -111.07 113.63 44.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.201 178.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.417 ' O ' HG13 ' A' ' 15' ' ' ILE . 15.8 t0 -177.36 68.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.195 0.521 . . . . 0.0 111.464 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.8 t70 69.13 -2.14 1.9 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 14' ' ' SER . 6.6 p-10 43.25 -126.8 0.81 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.481 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.586 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 1.7 t 34.94 -82.59 0.0 OUTLIER 'General case' 0 C--N 1.343 0.304 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.567 ' N ' ' O ' ' A' ' 12' ' ' ASP . 15.2 t -82.46 -48.4 11.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.655 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 10' ' ' ASP . 46.6 mm -63.73 -22.4 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.723 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 0.0 OUTLIER -81.58 -55.54 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.358 . . . . 0.0 111.552 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.571 ' H ' ' HG3' ' A' ' 16' ' ' ARG . 85.1 t90 -48.78 -41.69 33.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.535 ' C ' HD12 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -70.44 -61.43 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.432 . . . . 0.0 112.058 -178.63 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 8.3 tp -66.3 -27.36 67.86 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.659 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . 12.4 pt-20 -67.7 -58.35 4.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.134 0.492 . . . . 0.0 111.446 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.474 ' N ' ' CG ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -54.39 -64.68 0.75 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.086 -179.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.34 -27.39 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.656 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.7 tm? -82.14 -29.85 31.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.383 0.611 . . . . 0.0 110.467 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.44 73.51 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.55 -26.79 70.04 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.393 -0.908 . . . . 0.0 110.95 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.431 ' CB ' HD11 ' A' ' 28' ' ' LEU . . . -78.27 -15.52 58.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.97 24.54 11.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.051 0.78 . . . . 0.0 115.051 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.571 ' HB2' HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -126.18 164.15 21.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.611 1.205 . . . . 0.0 112.372 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 6' ' ' VAL . 79.0 m -79.75 129.09 34.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.038 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 1.8 p -121.67 111.2 16.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.976 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.606 HG22 ' NE1' ' A' ' 7' ' ' TRP . 2.6 t -135.85 134.03 38.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.723 ' OG1' ' HB3' ' A' ' 16' ' ' ARG . 43.6 p -115.61 155.09 28.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -136.58 174.1 10.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.226 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.518 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -58.42 -108.9 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.473 ' O ' HG13 ' A' ' 9' ' ' VAL . 24.3 m-80 -85.86 -179.92 6.91 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.547 ' CA ' ' HG ' ' A' ' 65' ' ' LEU . . . -68.71 0.25 14.83 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.391 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.438 ' ND2' HD12 ' A' ' 40' ' ' LEU . 1.8 t-20 -81.28 -41.69 21.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.668 0.734 . . . . 0.0 109.507 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.518 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -51.92 -55.31 21.04 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.992 179.102 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.534 HG21 HG13 ' A' ' 9' ' ' VAL . 33.2 t -44.15 -35.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.151 0.501 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.438 HD12 ' ND2' ' A' ' 37' ' ' ASN . 14.1 mt -61.84 -50.12 73.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.485 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.99 -48.26 82.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.324 0.583 . . . . 0.0 110.864 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.32 73.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.38 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 10.9 mt -66.62 -24.07 66.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.156 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.94 -18.4 60.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.669 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.55 -8.15 11.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -159.69 159.37 32.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.586 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.3 m -138.8 113.49 8.45 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.688 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.562 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 89.1 Cg_endo -80.0 165.34 21.89 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.215 1.944 . . . . 0.0 111.26 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.673 ' O ' ' HD2' ' A' ' 77' ' ' PRO . 3.3 p30 -74.38 -59.03 2.91 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.544 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.464 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 7.6 p -101.72 162.11 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.393 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.432 ' CD1' ' HB2' ' A' ' 7' ' ' TRP . 42.4 tp -152.86 152.25 31.33 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.013 0.435 . . . . 0.0 111.705 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.639 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -137.31 120.91 17.25 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.936 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.891 ' HA ' HG21 ' A' ' 9' ' ' VAL . 49.1 m -109.07 137.15 47.42 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 55' ' ' ILE . 39.6 t0 -65.9 -20.59 66.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.694 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER 47.22 79.71 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 112.106 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 171.36 85.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.487 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.606 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -163.3 -66.89 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 87.1 Cg_endo -77.4 -165.7 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.451 2.1 . . . . 0.0 113.677 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 61' ' ' ASP . . . -58.98 -51.01 61.76 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.844 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.499 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -74.28 45.41 0.22 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 110.563 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 59' ' ' GLY . 0.3 OUTLIER 55.81 -82.15 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.658 -179.034 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -143.12 -31.92 0.1 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.926 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.643 HD13 ' HB2' ' A' ' 86' ' ' ASP . 1.4 mp -49.92 -26.85 4.53 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.33 -30.98 61.3 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.997 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.547 ' HG ' ' CA ' ' A' ' 36' ' ' GLY . 2.3 mm? -60.94 -50.21 74.34 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.983 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.454 HD12 HG13 ' A' ' 80' ' ' ILE . 51.7 mt -49.65 -46.48 49.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.092 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.44 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -50.28 -46.59 55.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.211 0.529 . . . . 0.0 110.176 179.404 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -63.38 -38.63 91.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.525 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.421 HG23 HD22 ' A' ' 76' ' ' LEU . 75.2 mt -61.35 -40.85 87.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.521 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 44.5 pttt -72.24 -21.35 61.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.19 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -31.8 62.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.586 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -106.25 -24.0 12.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.031 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.54 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 40.8 m-70 -141.97 86.16 10.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.71 15.57 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.01 2.473 . . . . 0.0 113.127 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.554 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 11.9 mtt -145.36 4.83 1.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.447 ' CD1' ' O ' ' A' ' 48' ' ' PRO . 15.9 tp -76.39 107.44 4.59 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 49' ' ' ASP . 39.3 Cg_exo -58.99 121.14 9.45 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.578 2.185 . . . . 0.0 111.732 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.613 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.3 t -120.64 150.52 23.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.488 0.661 . . . . 0.0 111.922 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.639 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 3.7 mt -131.79 116.32 30.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.634 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.755 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 13.4 mm -93.43 137.92 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.62 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -85.41 -15.19 43.88 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.512 -179.199 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.513 ' H ' HG23 ' A' ' 80' ' ' ILE . 2.7 m -147.27 163.66 35.69 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.06 -47.62 3.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 110.973 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 44.56 59.37 3.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.978 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 52.37 -170.5 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.782 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.643 ' HB2' HD13 ' A' ' 63' ' ' LEU . 54.1 m-20 59.94 31.88 20.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.52 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -46.48 -24.25 0.49 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.723 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.81 -45.56 29.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.24 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.411 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . . . -70.78 -23.07 62.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.675 0.274 . . . . 0.0 111.411 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.551 ' HB1' ' CE1' ' A' ' 101' ' ' TYR . . . -66.81 -46.39 75.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.742 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.608 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.7 t -61.3 -36.85 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.8 m -60.93 -41.23 95.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.213 0.53 . . . . 0.0 110.237 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 96' ' ' GLN . . . -54.76 -49.06 71.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.117 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.608 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 8.7 m-85 -51.39 -27.76 10.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.596 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.561 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -70.4 -39.75 74.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.315 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.561 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 7.2 pt20 -77.97 -18.18 56.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.028 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.0 4.99 5.41 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.378 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.613 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -53.1 132.71 38.56 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.269 0.535 . . . . 0.0 110.751 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.449 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 8.6 t80 -64.14 -53.44 49.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.488 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 0.4 OUTLIER 175.75 -161.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.041 0.448 . . . . 0.0 111.904 -179.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.755 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.7 m-85 -132.57 135.86 46.2 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.136 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.62 ' HG ' ' HA ' ' A' ' 81' ' ' MET . 1.3 pp -126.59 136.49 28.77 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.842 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.68 172.13 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.271 1.98 . . . . 0.0 111.908 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.602 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -41.86 -49.8 10.52 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.649 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.9 Cg_endo -47.91 164.4 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 121.94 1.76 . . . . 0.0 110.704 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.792 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 173.86 -90.16 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.287 -0.165 . . . . 0.0 111.064 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.594 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.4 p30 50.98 -178.85 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.581 HG23 HG21 ' A' ' 112' ' ' VAL . 1.2 mp -54.46 -49.49 65.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.442 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.739 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 9.6 t0 -51.89 -58.79 5.45 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.792 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 4.8 mm-40 -82.41 -27.83 31.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.1 -47.27 11.08 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.873 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.606 ' O ' HG11 ' A' ' 115' ' ' VAL . 53.4 t -62.73 -32.03 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.493 0.663 . . . . 0.0 109.505 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -61.32 -49.89 75.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.144 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.476 ' CD2' ' HB3' ' A' ' 102' ' ' LEU . 8.3 tp -75.64 -20.94 58.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.433 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.606 HG11 ' O ' ' A' ' 112' ' ' VAL . 4.1 p -79.26 -49.41 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.441 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 34.7 mt-10 -65.35 -44.24 88.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.631 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 117' ' ' ARG . 6.4 mmt180 -63.02 -23.88 67.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.408 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 114' ' ' LEU . . . -73.18 -49.45 27.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.053 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.451 HG12 ' OD1' ' A' ' 49' ' ' ASP . 3.7 mt -67.02 -31.11 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.817 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 t -66.74 -43.11 85.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.752 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.7 m80 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.984 179.899 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.854 -0.098 . . . . 0.0 112.854 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 48' ' ' PRO . 3.4 mp -117.41 115.8 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 0.0 111.512 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.748 HG13 ' HG ' ' A' ' 23' ' ' LEU . 8.3 p -107.11 122.44 61.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.596 ' CD2' ' HG3' ' A' ' 48' ' ' PRO . 35.2 m0 -112.42 137.92 49.91 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.587 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -126.55 147.92 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.095 -178.112 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.766 HG22 ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -134.65 121.14 34.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.084 178.075 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 14.6 t0 -177.33 -147.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.905 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.53 -2.18 4.44 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 14' ' ' SER . 2.3 t70 55.49 -143.03 0.75 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.407 ' HB3' ' H ' ' A' ' 14' ' ' SER . 4.0 t 33.2 -90.22 0.01 OUTLIER 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.436 ' O ' HG21 ' A' ' 18' ' ' VAL . 3.8 m -57.8 -52.84 63.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.704 0.288 . . . . 0.0 111.357 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 14.6 mm -62.62 -36.28 74.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.943 0.401 . . . . 0.0 111.556 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -68.84 -41.92 77.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.313 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.472 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . 33.3 t90 -65.12 -58.7 5.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.306 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.515 ' CG1' HD11 ' A' ' 108' ' ' ILE . 1.4 t -57.35 -43.61 82.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.106 -178.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.66 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 4.4 mm? -76.85 -31.72 57.04 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.708 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 17.0 pt-20 -64.73 -61.92 1.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.687 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.672 ' HD2' ' H ' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -52.69 -63.87 1.0 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 0.0 112.095 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.16 -35.99 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.374 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.748 ' HG ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -73.87 -30.26 62.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.886 0.374 . . . . 0.0 110.331 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.08 -35.03 79.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.76 69.28 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.129 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.39 -15.34 58.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.65 0.262 . . . . 0.0 111.03 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.64 26.03 10.25 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.73 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.489 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -137.44 176.0 9.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.46 0.63 . . . . 0.0 111.316 179.7 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.505 ' O ' HG12 ' A' ' 6' ' ' VAL . 22.2 m -105.87 131.51 53.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.432 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.708 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 2.0 t -119.71 114.31 21.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.86 0.362 . . . . 0.0 111.767 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.508 HG22 ' NE1' ' A' ' 7' ' ' TRP . 2.7 t -123.08 155.27 37.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 37.8 p -129.92 157.75 41.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.148 0.499 . . . . 0.0 112.167 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.703 ' HB2' HG12 ' A' ' 9' ' ' VAL . 1.5 m-85 -133.18 173.25 11.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.614 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.678 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -63.25 -47.21 83.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.199 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.487 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 42.9 t30 -161.64 168.47 23.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.928 0.394 . . . . 0.0 110.666 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.676 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -49.75 -11.45 0.33 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.573 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -81.91 -45.36 15.56 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.603 0.701 . . . . 0.0 109.913 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.678 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 2.0 tt0 -55.28 -51.69 65.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.019 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.677 HG22 HG11 ' A' ' 9' ' ' VAL . 17.9 t -51.55 -33.13 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.035 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.385 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.487 HD12 ' HB3' ' A' ' 68' ' ' GLN . 17.3 mt -57.66 -51.68 68.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.011 0.434 . . . . 0.0 110.13 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.29 -47.45 85.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.746 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.74 -34.54 78.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.096 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.652 ' HG ' HG12 ' A' ' 39' ' ' VAL . 31.5 mt -68.24 -23.87 64.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.865 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.88 -15.33 29.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.329 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.24 -7.81 11.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -164.53 160.73 20.67 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 120.988 0.423 . . . . 0.0 111.46 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.3 m -138.8 112.76 8.34 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.262 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.596 ' HG3' ' CD2' ' A' ' 7' ' ' TRP . 6.5 Cg_exo -74.83 165.84 30.57 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.638 2.225 . . . . 0.0 111.487 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.11 -25.71 59.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.553 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.717 HG12 HG23 ' A' ' 6' ' ' VAL . 4.2 p -145.02 161.71 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.534 HD13 ' HB2' ' A' ' 7' ' ' TRP . 33.1 tp -153.03 150.28 29.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.432 0.634 . . . . 0.0 112.362 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.723 ' O ' HG22 ' A' ' 9' ' ' VAL . 6.2 mt -128.28 115.91 19.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.971 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.766 ' HA ' HG22 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -107.95 135.45 49.31 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 24.0 t0 -75.89 170.96 15.22 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.599 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.658 HG13 ' HA3' ' A' ' 62' ' ' GLY . 1.3 tt -158.56 92.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.349 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.411 ' O ' ' CG ' ' A' ' 57' ' ' MET . 0.1 OUTLIER -124.65 56.91 1.28 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.954 0.407 . . . . 0.0 111.446 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.481 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 5.7 ptt? 47.97 41.75 1.02 Allowed Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 57' ' ' MET . 38.0 Cg_endo -65.44 -81.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.966 1.777 . . . . 0.0 111.319 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.39 -84.61 1.8 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.538 ' C ' ' H ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -87.77 61.18 6.31 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.6 OUTLIER 67.11 -21.9 0.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.345 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.658 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 135.79 -33.02 2.45 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.517 HD22 ' O ' ' A' ' 86' ' ' ASP . 4.8 mp -65.19 -21.67 66.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.508 ' HB3' ' CB ' ' A' ' 60' ' ' MET . . . -53.39 -36.4 61.41 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.929 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.676 ' HB3' ' HA3' ' A' ' 36' ' ' GLY . 14.1 mt -56.58 -45.91 81.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.527 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.424 HD22 ' HB1' ' A' ' 93' ' ' ALA . 0.3 OUTLIER -58.43 -49.02 78.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.209 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.488 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 7.5 tttp -53.61 -42.3 67.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.217 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.487 ' HB3' HD12 ' A' ' 40' ' ' LEU . 21.8 mm100 -62.33 -40.04 95.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.696 0.284 . . . . 0.0 111.049 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.574 ' CG2' ' HD2' ' A' ' 73' ' ' HIS . 28.0 mt -56.41 -51.09 68.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.219 0.533 . . . . 0.0 111.187 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.68 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -59.07 -29.63 67.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.225 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.425 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 2.2 mt-30 -69.93 -23.71 63.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.992 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -114.14 -15.05 12.29 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.68 ' CD2' ' HA ' ' A' ' 70' ' ' LYS . 1.7 p80 -106.73 166.34 11.31 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -87.12 -55.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.082 2.521 . . . . 0.0 112.278 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.491 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 19.6 mtp -157.38 43.3 0.34 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.619 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.632 ' H ' ' ND1' ' A' ' 73' ' ' HIS . 0.9 OUTLIER -72.0 113.32 19.29 Favored Pre-proline 0 N--CA 1.455 -0.188 0 C-N-CA 122.206 0.202 . . . . 0.0 111.407 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 39.9 Cg_endo -68.55 115.54 3.96 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 121.89 1.726 . . . . 0.0 111.945 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.601 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 6.1 t -98.82 150.36 5.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.082 0.467 . . . . 0.0 111.393 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.57 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 2.1 mt -134.11 115.0 20.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.96 178.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.608 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 27.6 mm -93.59 150.02 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.478 ' HE2' ' N ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -86.24 -20.05 29.05 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.432 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.565 ' O ' HG23 ' A' ' 55' ' ' ILE . 3.1 m -141.17 142.25 34.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.215 0.531 . . . . 0.0 111.388 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.39 31.75 3.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.433 ' CE1' HG23 ' A' ' 82' ' ' THR . 1.1 p-80 -88.79 31.57 0.84 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.477 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.497 ' HB2' HD13 ' A' ' 63' ' ' LEU . 61.6 m -133.96 -161.94 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.713 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.517 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -56.34 86.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.589 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.759 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -51.2 -23.24 3.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 111.459 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.76 -44.9 39.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.958 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.503 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -66.92 -25.31 66.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.951 0.405 . . . . 0.0 111.21 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.759 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -72.57 -22.46 60.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.995 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.514 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 14.5 t -70.89 -41.39 77.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.059 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.405 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 32.8 m -65.79 -19.58 65.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.113 0.483 . . . . 0.0 109.935 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.555 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -64.52 -46.84 81.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.008 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.514 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.4 m-85 -63.93 -29.45 70.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.803 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.563 HE22 ' HD2' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -63.65 -45.52 89.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.897 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.658 ' HG2' ' HB3' ' A' ' 70' ' ' LYS . 1.4 pp0? -75.03 -18.51 60.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.628 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.64 21.16 4.39 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.533 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.601 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -59.18 157.04 11.13 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 117.082 0.441 . . . . 0.0 110.99 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 21.2 t80 -82.19 -53.38 6.12 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.543 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 169.86 -165.4 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.092 0.472 . . . . 0.0 111.531 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.608 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.2 m-85 -124.17 119.33 29.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.608 HD22 ' CE2' ' A' ' 106' ' ' PHE . 6.0 tp -102.51 134.95 19.65 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.752 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 11.3 Cg_endo -52.66 170.79 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.462 2.108 . . . . 0.0 111.674 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.443 ' HD2' ' HA ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -43.63 -46.83 18.91 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.437 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.752 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 73.4 Cg_exo -48.11 163.36 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.682 1.588 . . . . 0.0 110.416 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.666 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -174.65 -86.66 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.694 -178.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.741 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 43.42 -170.97 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.621 0.248 . . . . 0.0 110.445 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.626 HD13 ' HA ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.91 -45.39 84.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.36 0.6 . . . . 0.0 111.429 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.782 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 12.9 t70 -52.8 -55.86 19.9 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.868 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.666 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -79.85 -27.98 40.1 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.28 -54.26 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.85 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.545 ' O ' HG11 ' A' ' 115' ' ' VAL . 36.5 t -58.09 -33.58 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.439 0.637 . . . . 0.0 110.3 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -60.19 -51.61 68.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.9 0.857 . . . . 0.0 109.512 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.551 HD22 HG22 ' A' ' 79' ' ' ILE . 6.6 tp -76.24 -21.01 56.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.76 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.545 HG11 ' O ' ' A' ' 112' ' ' VAL . 4.1 p -79.45 -50.28 18.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.164 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.429 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 82.9 mt-10 -65.07 -45.13 86.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.649 0.262 . . . . 0.0 110.538 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -62.01 -26.31 68.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 0.0 110.419 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.45 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -72.48 -57.45 4.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.17 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.6 mt -68.43 -30.79 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.132 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.2 m -67.52 -45.12 76.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.026 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 4.6 m80 . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 -179.824 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.517 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.1 mp -104.23 113.28 40.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.729 0.3 . . . . 0.0 111.163 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 2.8 p -106.06 129.64 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.665 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.603 ' HB2' HD13 ' A' ' 51' ' ' LEU . 39.8 m0 -117.76 141.99 47.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.655 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.718 HG11 ' HB2' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -134.32 133.5 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.297 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.791 HG23 ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -117.66 108.85 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.996 178.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 37.0 t0 166.84 120.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t0 69.75 -45.2 0.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.133 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 16' ' ' ARG . 40.9 t0 75.15 -98.74 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.367 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' ASP . 5.7 p -26.67 -87.73 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.673 ' O ' HG21 ' A' ' 18' ' ' VAL . 35.3 m -54.98 -39.14 68.68 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 10' ' ' ASP . 21.4 mm -68.47 -20.49 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.624 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.44 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 0.1 OUTLIER -74.79 -58.54 3.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 111.236 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.415 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 49.9 t90 -49.96 -41.94 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.498 . . . . 0.0 112.237 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 14' ' ' SER . 1.6 t -70.44 -62.26 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.026 0.441 . . . . 0.0 111.734 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.817 HD13 HD11 ' A' ' 108' ' ' ILE . 3.8 mm? -63.7 -27.36 69.16 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.536 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.635 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 15.1 pt-20 -67.18 -61.06 2.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.486 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.1 mmm180 -67.51 -56.88 7.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.25 -59.58 3.55 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.931 0.396 . . . . 0.0 111.718 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' A' ' 28' ' ' LEU . 4.0 tp -61.4 -20.98 63.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.068 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -66.55 -38.5 87.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.97 -24.61 65.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.585 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.82 -15.59 58.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.664 0.269 . . . . 0.0 111.013 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.25 25.74 7.71 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.833 -0.698 . . . . 0.0 113.767 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.739 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.72 170.64 13.58 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 117.5 0.65 . . . . 0.0 111.609 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.42 ' O ' HG11 ' A' ' 6' ' ' VAL . 58.0 m -107.26 105.47 15.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.086 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.729 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 2.1 t -98.94 118.1 34.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.177 0.513 . . . . 0.0 112.133 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.553 HG21 ' CE1' ' A' ' 33' ' ' PHE . 2.7 t -119.7 156.59 30.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.3 p -132.76 152.32 51.8 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.727 ' HB2' HG12 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -129.08 174.31 9.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.713 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -57.92 -108.46 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.501 -178.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.435 ' C ' HG13 ' A' ' 9' ' ' VAL . 41.2 m-20 -78.79 -68.44 0.65 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.115 0.484 . . . . 0.0 111.938 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.517 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . -171.91 -33.67 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.046 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.471 ' HA ' HD11 ' A' ' 40' ' ' LEU . 6.0 m120 -62.14 -30.75 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.692 0.282 . . . . 0.0 110.733 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -54.22 -52.65 60.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.853 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.727 HG21 ' CD1' ' A' ' 33' ' ' PHE . 63.1 t -54.74 -47.14 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.048 0.451 . . . . 0.0 110.62 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.582 HD23 HG13 ' A' ' 69' ' ' ILE . 22.5 mt -50.9 -43.15 59.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.112 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.96 -47.71 67.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.274 0.559 . . . . 0.0 110.715 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.34 -31.81 73.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.5 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.613 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 10.6 mt -61.45 -26.3 67.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.111 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.73 -17.47 60.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.305 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.43 -6.21 11.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.72 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -161.88 162.21 29.16 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.828 0.347 . . . . 0.0 111.075 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.0 m -138.97 112.66 8.2 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.154 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.517 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 73.5 Cg_endo -76.58 164.31 30.65 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.899 1.733 . . . . 0.0 111.539 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.49 -23.54 58.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.809 0.338 . . . . 0.0 110.761 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.713 HG23 HG22 ' A' ' 115' ' ' VAL . 6.3 p -145.17 161.58 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.653 ' N ' HG22 ' A' ' 50' ' ' VAL . 22.9 tp -151.45 148.42 28.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.524 0.678 . . . . 0.0 112.073 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.718 ' HB2' HG11 ' A' ' 8' ' ' VAL . 3.1 mt -135.72 126.01 26.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.792 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.791 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -111.13 145.25 38.93 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -178.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 49.6 t0 -74.16 -19.4 60.57 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.27 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.622 HG13 ' C ' ' A' ' 62' ' ' GLY . 7.0 tt 44.96 86.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.63 99.44 0.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.54 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 55.39 44.85 1.76 Allowed Pre-proline 0 N--CA 1.47 0.575 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 177.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.586 ' CD ' ' HA2' ' A' ' 62' ' ' GLY . 26.8 Cg_endo -91.9 -35.87 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.958 2.439 . . . . 0.0 112.422 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.429 ' H ' ' CD ' ' A' ' 58' ' ' PRO . . . -176.06 -24.91 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.302 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.609 ' N ' ' HB2' ' A' ' 64' ' ' ALA . 23.3 ttt -152.43 71.43 0.94 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.69 -35.45 0.24 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.1 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.622 ' C ' HG13 ' A' ' 55' ' ' ILE . . . 157.82 -34.54 0.53 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.472 ' CD1' ' HB2' ' A' ' 85' ' ' SER . 5.3 mp -66.85 -25.05 66.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.768 0.318 . . . . 0.0 110.485 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.609 ' HB2' ' N ' ' A' ' 60' ' ' MET . . . -53.98 -26.02 23.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.656 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.553 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 76.2 mt -55.96 -40.27 73.0 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.151 0.5 . . . . 0.0 110.061 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.572 HD11 HG13 ' A' ' 80' ' ' ILE . 4.8 mp -70.33 -39.43 74.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.049 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.695 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.0 tmtt? -55.2 -42.99 74.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.299 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.492 ' HB3' ' NH1' ' A' ' 72' ' ' ARG . 12.1 mm100 -69.05 -37.5 78.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.735 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.582 HG13 HD23 ' A' ' 40' ' ' LEU . 13.2 mt -62.83 -23.1 32.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.803 0.335 . . . . 0.0 110.849 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.695 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 2.5 mtmp? -75.18 -50.72 15.33 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.105 0.955 . . . . 0.0 109.291 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -62.13 -33.21 74.04 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.337 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.492 ' NH1' ' HB3' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -94.13 -28.7 15.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.665 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.613 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 40.5 m-70 -153.54 82.4 4.69 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.653 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.635 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 55.5 Cg_endo -71.28 31.76 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.738 2.292 . . . . 0.0 113.172 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.434 ' H ' ' C ' ' A' ' 73' ' ' HIS . 0.1 OUTLIER -143.78 -37.21 0.34 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.1 0.476 . . . . 0.0 111.238 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.405 ' CD2' HD23 ' A' ' 51' ' ' LEU . 6.7 tp -50.77 129.8 28.02 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.512 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.685 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 51.9 Cg_endo -73.24 122.98 8.44 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.729 2.286 . . . . 0.0 112.181 179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.684 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.3 t -110.28 142.78 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.125 0.488 . . . . 0.0 111.253 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 3.1 mt -133.89 113.52 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.383 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.609 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 18.9 mm -93.42 137.28 22.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.102 0.477 . . . . 0.0 112.127 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.566 ' HE1' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.84 -4.04 59.06 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.349 -179.168 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.601 ' O ' HG22 ' A' ' 80' ' ' ILE . 2.5 m -148.03 144.19 27.75 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.584 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.78 61.41 1.37 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.336 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -98.93 -22.78 15.6 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.472 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -84.33 -166.49 1.46 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.169 0.509 . . . . 0.0 111.996 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.471 ' O ' HD22 ' A' ' 63' ' ' LEU . 4.7 m-20 -54.76 97.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.777 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.429 ' CD1' ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -51.24 -21.68 2.24 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.3 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -48.59 -45.04 37.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.277 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.416 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -65.69 -20.61 66.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.804 0.335 . . . . 0.0 110.89 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.452 ' HB1' ' CE1' ' A' ' 101' ' ' TYR . . . -72.98 -32.2 65.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.711 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.555 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.9 t -65.71 -42.73 93.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 19.7 m -63.49 -19.91 65.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.382 . . . . 0.0 110.012 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.702 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -66.37 -44.95 81.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.451 0.643 . . . . 0.0 109.842 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.555 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 5.0 m-85 -65.88 -23.88 66.74 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.868 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.427 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -69.1 -36.39 77.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.307 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.702 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 3.9 pp0? -86.68 -18.27 31.67 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.706 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.13 21.27 3.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.304 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.684 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -65.04 152.79 42.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.212 0.506 . . . . 0.0 110.182 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.536 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 38.6 t80 -81.96 -54.0 5.68 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.441 ' OD2' ' CD2' ' A' ' 99' ' ' PHE . 14.7 p30 174.77 -170.76 0.05 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.993 0.425 . . . . 0.0 111.685 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.609 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.1 m-85 -119.72 125.67 49.22 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.771 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.682 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 11.0 tp -102.87 139.33 20.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.458 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.705 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 20.9 Cg_endo -58.88 171.83 1.91 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.092 1.861 . . . . 0.0 111.096 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.488 ' O ' ' HE3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -43.18 -45.88 13.98 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.705 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 87.3 Cg_exo -47.44 163.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.676 1.584 . . . . 0.0 110.843 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.669 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 3.2 t80 -167.56 -92.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.995 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 106' ' ' PHE . 5.3 p-10 44.12 -173.79 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.654 0.264 . . . . 0.0 110.586 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.817 HD11 HD13 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -67.66 -47.14 81.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.386 0.612 . . . . 0.0 110.849 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.809 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 1.1 t70 -51.01 -58.12 6.88 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.212 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.669 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.7 mm-40 -79.13 -26.77 42.8 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -84.15 -53.16 5.71 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.138 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.64 HG22 HG23 ' A' ' 108' ' ' ILE . 43.9 t -59.97 -31.45 47.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.507 0.67 . . . . 0.0 110.084 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.809 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -61.23 -50.96 70.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.626 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.682 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 23.8 tp -75.46 -20.46 58.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.517 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.713 HG22 HG23 ' A' ' 50' ' ' VAL . 4.2 p -79.27 -48.03 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.055 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.411 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 4.1 mt-10 -61.12 -45.66 93.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.726 0.298 . . . . 0.0 110.838 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.467 ' HD2' HD13 ' A' ' 114' ' ' LEU . 4.1 ptp180 -64.2 -23.73 67.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.897 0.379 . . . . 0.0 110.687 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.536 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.22 -49.46 35.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.938 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.1 mt -66.2 -30.89 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.6 m -68.37 -44.01 76.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.3 m80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 -179.761 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.414 ' C ' HD11 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.232 0 N-CA-C 112.034 -0.426 . . . . 0.0 112.034 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.618 HD12 ' HB ' ' A' ' 29' ' ' THR . 6.3 mm -129.39 113.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 6' ' ' VAL . 9.2 p -105.56 127.69 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.799 ' CD1' HG23 ' A' ' 31' ' ' THR . 24.6 m0 -114.67 132.81 56.27 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -127.99 139.8 50.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.861 HG23 ' CG2' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -128.38 105.37 13.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.187 179.029 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 58.1 t0 166.72 119.45 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.424 0.453 . . . . 0.0 110.682 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 72.79 -28.11 0.19 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 10' ' ' ASP . 7.9 t0 73.02 -133.38 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.978 -0.101 . . . . 0.0 110.943 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.1 t -30.71 -48.47 0.11 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 t -53.95 -68.18 0.2 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.654 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 15' ' ' ILE . 24.8 mm -62.31 -20.76 25.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.55 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.499 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 6.0 ttt180 -70.53 -60.57 2.19 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.651 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.495 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 57.1 t90 -49.98 -44.52 50.92 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 111.912 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.602 ' C ' HD12 ' A' ' 108' ' ' ILE . 1.3 t -64.97 -59.14 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.477 ' CD2' HD11 ' A' ' 108' ' ' ILE . 56.4 mt -70.75 -26.33 63.31 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 17' ' ' TRP . 12.8 pt-20 -63.81 -57.88 8.54 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.769 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.476 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 2.4 mmp_? -63.75 -60.04 3.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.905 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.88 -56.17 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.977 0.417 . . . . 0.0 111.85 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.492 ' CD1' HG13 ' A' ' 6' ' ' VAL . 1.5 tm? -64.95 -23.75 67.32 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.015 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -71.28 -32.6 68.87 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.56 -26.49 66.65 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.385 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.31 -15.65 59.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.812 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.01 23.09 11.86 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.798 -0.715 . . . . 0.0 114.326 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.462 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -123.45 163.62 20.52 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.418 1.109 . . . . 0.0 112.167 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.618 ' HB ' HD12 ' A' ' 5' ' ' ILE . 89.9 m -84.53 136.35 33.84 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.626 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.479 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -127.97 108.51 10.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.645 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.799 HG23 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -121.68 147.59 45.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.9 p -125.59 161.44 27.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.63 0.728 . . . . 0.0 112.958 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.842 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.3 m-85 -136.12 173.86 11.25 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.108 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.434 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.6 pp20? -61.56 -60.51 3.58 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.645 ' C ' HG13 ' A' ' 9' ' ' VAL . 67.8 m-80 -152.97 -23.79 0.15 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.53 ' HA3' ' HG ' ' A' ' 65' ' ' LEU . . . 166.44 -56.83 0.24 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.067 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.408 ' HA ' HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -47.89 -37.5 14.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.014 -179.363 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.842 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 8.3 tt0 -58.42 -55.44 34.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.742 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.861 ' CG2' HG23 ' A' ' 9' ' ' VAL . 2.9 t -51.18 -46.48 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.107 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' A' ' 68' ' ' GLN . 31.7 mt -46.55 -45.57 18.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.21 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.07 -48.75 69.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.113 0.482 . . . . 0.0 111.326 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.79 -35.35 79.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.45 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.567 HD13 ' NE2' ' A' ' 73' ' ' HIS . 16.6 mt -63.38 -25.37 68.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.27 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -16.95 22.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.218 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.5 t -121.11 -5.39 9.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.472 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -156.53 160.04 39.13 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.91 0.386 . . . . 0.0 111.665 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.5 m -139.2 112.0 7.94 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.625 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.518 ' O ' HD13 ' A' ' 76' ' ' LEU . 58.8 Cg_endo -69.47 166.43 27.28 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.717 2.278 . . . . 0.0 111.839 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.86 -27.01 33.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.449 HG11 ' CG2' ' A' ' 115' ' ' VAL . 4.8 p -147.95 101.17 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.425 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.489 HD22 HD23 ' A' ' 76' ' ' LEU . 62.7 tp -87.15 141.74 28.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.409 0.623 . . . . 0.0 112.491 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.699 ' O ' HG22 ' A' ' 9' ' ' VAL . 5.3 mt -124.35 117.51 24.65 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -112.5 146.71 37.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.021 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.735 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 20.4 t0 -77.2 179.4 6.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.95 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.727 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.1 tt -156.23 78.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.798 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 50.7 ttp85 176.71 69.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.564 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.467 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -160.9 -67.09 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.879 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 57' ' ' MET . 35.6 Cg_endo -64.86 -176.06 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.536 2.158 . . . . 0.0 113.033 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.8 -54.34 38.14 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.486 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.587 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -78.14 49.23 0.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.733 0.301 . . . . 0.0 110.75 179.675 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.61 -72.13 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.727 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -149.47 -35.51 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.261 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.603 ' HA ' HD21 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -54.61 -21.42 10.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.11 179.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.517 ' HB1' ' CB ' ' A' ' 60' ' ' MET . . . -53.75 -36.23 62.1 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.53 ' HG ' ' HA3' ' A' ' 36' ' ' GLY . 1.1 tm? -59.97 -40.92 90.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.154 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.603 HD21 ' HA ' ' A' ' 63' ' ' LEU . 4.3 mm? -54.39 -43.94 71.87 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.17 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 53.9 tttm -56.9 -43.46 81.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.319 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.456 ' HB3' HD12 ' A' ' 40' ' ' LEU . 21.0 mm100 -60.93 -34.7 75.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.233 0.54 . . . . 0.0 110.147 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.537 ' CG2' ' CE1' ' A' ' 73' ' ' HIS . 92.5 mt -58.92 -39.84 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.527 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -69.61 -29.03 66.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.036 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.436 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -70.89 -35.36 72.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.986 -179.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.63 -71.64 0.71 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.527 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.749 ' HD1' ' HB3' ' A' ' 76' ' ' LEU . 4.6 p80 -112.22 71.96 1.15 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.458 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 75' ' ' MET . 62.4 Cg_endo -73.62 50.67 2.08 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.595 2.197 . . . . 0.0 113.675 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.521 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 8.8 mtm -156.64 -39.51 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.749 ' HB3' ' HD1' ' A' ' 73' ' ' HIS . 8.7 tp -59.57 130.33 87.8 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-O 120.945 0.403 . . . . 0.0 112.041 -178.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.55 115.29 3.83 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.307 2.671 . . . . 0.0 113.871 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.765 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.2 t -98.38 151.79 4.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.407 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.424 HG23 ' CD2' ' A' ' 114' ' ' LEU . 2.0 mt -136.57 114.56 14.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.064 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 53' ' ' SER . 17.9 mm -93.7 146.03 7.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.505 ' O ' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -81.45 -14.53 56.94 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.521 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 3.8 m -148.43 161.96 40.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.1 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.24 64.04 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.856 0.36 . . . . 0.0 111.246 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.89 111.86 24.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.987 0.422 . . . . 0.0 111.558 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.8 t 60.59 161.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.647 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.495 ' HB2' HD13 ' A' ' 63' ' ' LEU . 24.9 m-20 61.91 18.99 10.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.475 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.409 HD13 ' HB1' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -46.44 -22.68 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -48.06 -50.17 28.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 63' ' ' LEU . . . -67.34 -20.01 65.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.689 0.281 . . . . 0.0 111.503 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.529 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . . . -63.95 -57.17 10.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.809 0.338 . . . . 0.0 111.008 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.601 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.3 t -62.93 -43.47 99.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.5 m -58.8 -31.68 68.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.183 0.516 . . . . 0.0 110.458 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.434 ' HB1' ' CB ' ' A' ' 98' ' ' ALA . . . -63.65 -43.68 96.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.36 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.601 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 2.6 m-85 -59.59 -22.19 61.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.545 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.565 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.77 -37.99 54.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.099 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.565 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 2.1 pp0? -100.04 -13.34 19.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.59 82.88 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.615 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.765 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.53 111.24 0.56 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.293 0.568 . . . . 0.0 111.611 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 118' ' ' ALA . 18.1 t80 -55.22 -49.81 71.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.919 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.508 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER 173.92 -161.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.067 0.46 . . . . 0.0 111.918 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.553 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.9 m-85 -127.16 130.21 49.32 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.377 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.585 ' HB2' HD23 ' A' ' 114' ' ' LEU . 4.2 tp -108.27 142.43 25.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.11 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.666 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 17.8 Cg_endo -58.99 163.69 11.23 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.261 1.974 . . . . 0.0 111.372 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.408 ' HE2' ' OG1' ' A' ' 82' ' ' THR . 0.5 OUTLIER -36.25 -47.69 1.52 Allowed Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.613 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.666 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 84.2 Cg_exo -47.03 163.22 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.818 1.679 . . . . 0.0 110.756 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.669 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 3.6 t80 -165.55 -92.19 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.167 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.4 p-10 42.48 -173.69 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.874 0.369 . . . . 0.0 110.628 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.83 -47.49 79.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.285 0.564 . . . . 0.0 111.487 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.677 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 12.2 t70 -51.75 -57.58 8.86 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.713 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.669 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.5 mm-40 -78.45 -29.09 46.73 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -83.34 -54.55 4.91 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.061 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.565 ' O ' HG11 ' A' ' 115' ' ' VAL . 39.6 t -57.2 -32.4 40.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.476 0.655 . . . . 0.0 110.162 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -58.84 -53.15 61.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.064 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.585 HD23 ' HB2' ' A' ' 102' ' ' LEU . 33.4 tp -74.62 -21.39 59.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.98 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.565 HG11 ' O ' ' A' ' 112' ' ' VAL . 5.1 p -79.57 -50.16 18.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.161 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.408 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 94.7 mt-10 -65.47 -40.07 92.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.78 0.324 . . . . 0.0 111.026 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.506 ' HD2' HD13 ' A' ' 114' ' ' LEU . 5.6 ptp180 -65.96 -27.52 68.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.461 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.462 ' HB3' ' CE2' ' A' ' 99' ' ' PHE . . . -70.19 -51.99 26.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.004 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.1 mt -65.29 -31.86 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.161 0.505 . . . . 0.0 111.033 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -43.58 76.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 2.2 mp -124.2 113.49 36.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.478 0.656 . . . . 0.0 111.022 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.76 HG11 ' HG ' ' A' ' 23' ' ' LEU . 10.4 p -107.21 120.36 58.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.502 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.675 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 31.0 m0 -112.26 145.8 39.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.069 0.461 . . . . 0.0 110.222 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.788 ' CG2' HG21 ' A' ' 32' ' ' THR . 0.2 OUTLIER -137.29 149.67 25.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -176.145 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.727 HG13 ' C ' ' A' ' 35' ' ' ASN . 1.4 t -133.28 105.17 7.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.787 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.571 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 44.1 t0 166.85 122.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.687 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 72.04 -40.92 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.821 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 10' ' ' ASP . 37.6 t0 75.28 -121.92 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.849 -0.159 . . . . 0.0 110.729 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.4 t -31.33 -47.54 0.11 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 18' ' ' VAL . 47.5 t -63.8 -63.32 1.2 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.342 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.566 HG21 HG21 ' A' ' 8' ' ' VAL . 20.1 mm -63.21 -25.16 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.418 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 7.3 ttt180 -61.58 -58.05 9.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.02 0.438 . . . . 0.0 111.445 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.454 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 53.5 t90 -56.69 -46.28 81.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.649 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.501 ' C ' HD13 ' A' ' 108' ' ' ILE . 2.0 t -65.47 -44.41 94.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.571 HD23 HG13 ' A' ' 8' ' ' VAL . 5.6 tp -83.06 -23.97 32.93 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.689 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 26.5 pt-20 -66.78 -56.19 11.56 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.729 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.483 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.3 mmm180 -65.51 -56.33 12.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.122 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.62 -45.65 73.73 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.76 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.3 tm? -69.21 -26.71 64.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.531 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.22 -32.44 73.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.14 -29.02 71.64 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.21 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.76 -15.37 59.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 110.982 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.45 26.06 11.43 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.695 -0.765 . . . . 0.0 113.863 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.472 HD12 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -133.74 171.2 14.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.75 0.775 . . . . 0.0 111.903 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.458 ' O ' HG13 ' A' ' 6' ' ' VAL . 25.8 m -94.27 128.82 40.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.225 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.689 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 1.8 t -122.97 120.94 34.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.264 0.554 . . . . 0.0 111.865 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.577 HG23 ' CE1' ' A' ' 33' ' ' PHE . 2.8 t -134.3 132.32 39.43 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.788 HG21 ' CG2' ' A' ' 8' ' ' VAL . 76.5 p -107.97 159.28 16.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.484 0.659 . . . . 0.0 112.27 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.698 ' CG ' HG22 ' A' ' 39' ' ' VAL . 1.7 m-85 -131.96 174.2 10.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.12 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -63.36 -106.78 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.92 -178.425 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.727 ' C ' HG13 ' A' ' 9' ' ' VAL . 10.9 p30 -88.85 -49.56 6.74 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.583 ' HA3' ' CD2' ' A' ' 65' ' ' LEU . . . 173.83 -43.37 0.15 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.066 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.847 ' HA ' HD11 ' A' ' 40' ' ' LEU . 25.5 m120 -53.08 -24.72 10.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 111.2 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -57.2 -60.02 4.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.43 179.419 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 9' ' ' VAL . 72.7 t -58.65 -35.94 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.722 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.847 HD11 ' HA ' ' A' ' 37' ' ' ASN . 40.3 mt -47.17 -46.14 23.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 0.0 110.489 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.63 -45.95 34.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.972 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.56 -29.81 66.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.865 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.597 ' HG ' HG11 ' A' ' 39' ' ' VAL . 12.2 mt -72.05 -23.54 61.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.664 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.32 -17.71 13.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.606 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.55 -7.25 9.69 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -159.67 159.14 32.64 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.74 0.305 . . . . 0.0 111.397 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.5 m -138.75 114.33 8.63 Favored Pre-proline 0 N--CA 1.454 -0.263 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.713 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.533 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 72.9 Cg_endo -78.69 165.04 25.21 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.371 2.047 . . . . 0.0 111.331 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.03 -26.68 60.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.929 0.395 . . . . 0.0 110.451 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.539 HG22 ' H ' ' A' ' 51' ' ' LEU . 10.0 p -145.11 161.09 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.675 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 13.5 tp -152.92 140.08 19.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.222 0.534 . . . . 0.0 112.3 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -104.55 137.6 42.16 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.489 179.436 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 26.2 t -127.72 133.98 49.55 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.644 ' O ' HD23 ' A' ' 65' ' ' LEU . 32.0 t0 -83.08 172.87 12.26 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.242 0.544 . . . . 0.0 111.499 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.618 ' HB ' ' HA3' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -140.24 84.05 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.956 -179.551 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -111.49 36.28 3.3 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.744 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.683 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 52.87 53.28 11.81 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 178.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.416 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 43.5 Cg_endo -75.02 -65.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.322 2.015 . . . . 0.0 111.831 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.44 -27.25 1.21 Allowed Glycine 0 CA--C 1.518 0.239 0 N-CA-C 111.824 -0.511 . . . . 0.0 111.824 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.444 ' N ' ' HB2' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -155.09 63.09 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.683 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 4.3 p-10 54.12 -82.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.026 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.618 ' HA3' ' HB ' ' A' ' 55' ' ' ILE . . . -137.46 -24.24 0.43 Allowed Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.691 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -77.51 -19.11 56.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.735 0.268 . . . . 0.0 111.106 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.444 ' HB2' ' N ' ' A' ' 60' ' ' MET . . . -55.14 -31.26 61.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.336 0.588 . . . . 0.0 109.897 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 54' ' ' ASP . 6.6 mp -67.5 -36.27 80.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.425 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.425 HD11 ' CB ' ' A' ' 93' ' ' ALA . 14.1 mt -63.22 -42.64 99.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.912 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 50.4 tttm -55.01 -54.2 45.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.882 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.707 ' CB ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -54.75 -43.13 72.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.154 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.507 HD13 HG11 ' A' ' 78' ' ' VAL . 21.0 mt -59.17 -40.55 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.131 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -74.2 -23.07 59.15 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.981 -179.245 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -68.41 -51.21 46.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -93.48 -35.58 12.88 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.513 ' CD2' HD12 ' A' ' 43' ' ' LEU . 2.3 m-70 -99.65 144.04 27.57 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.603 -178.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.58 -70.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.623 2.215 . . . . 0.0 112.711 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.606 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 60.7 mtt -147.77 52.96 1.04 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.936 0.398 . . . . 0.0 111.516 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.438 HD12 ' HG2' ' A' ' 48' ' ' PRO . 5.5 tp -72.34 113.8 24.03 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.639 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -53.49 132.73 50.2 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.191 1.928 . . . . 0.0 111.793 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.507 HG11 HD13 ' A' ' 69' ' ' ILE . 2.5 t -126.67 146.64 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.566 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.455 HG21 HD21 ' A' ' 114' ' ' LEU . 3.3 mt -126.88 116.39 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.955 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.504 ' HB ' ' CD2' ' A' ' 101' ' ' TYR . 1.4 mp -94.16 145.44 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.889 0.376 . . . . 0.0 111.306 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.51 ' HE2' ' N ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -87.68 -22.21 24.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.248 -178.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.537 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.4 m -147.68 145.65 28.98 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.371 -0.206 . . . . 0.0 110.453 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.408 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -103.32 -29.28 11.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.73 0.3 . . . . 0.0 111.606 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.422 ' CE1' HG22 ' A' ' 82' ' ' THR . 3.3 m-70 44.75 -92.67 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.26 -172.84 3.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.942 0.401 . . . . 0.0 111.479 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.516 ' O ' HD23 ' A' ' 63' ' ' LEU . 63.5 m-20 58.15 33.29 23.01 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.007 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mt -48.82 -21.17 0.59 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.409 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -47.82 -44.55 28.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.636 0.255 . . . . 0.0 111.45 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -69.68 -21.61 63.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.577 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.479 ' CB ' HD22 ' A' ' 63' ' ' LEU . . . -68.11 -32.94 73.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.65 0.262 . . . . 0.0 111.026 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.518 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 9.8 t -71.27 -39.05 72.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.552 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 95.0 p -69.46 -20.23 63.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.805 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.663 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -66.84 -42.47 85.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.365 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.518 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 7.6 m-85 -64.6 -25.83 68.14 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.2 -38.51 51.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.62 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.663 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.7 pp0? -77.42 -18.45 57.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.295 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.11 -10.53 5.64 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.453 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.456 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -48.37 155.79 0.48 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.068 0.434 . . . . 0.0 111.329 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.446 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 18.7 t80 -86.41 -53.89 4.74 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.477 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER 169.23 -166.06 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.855 0.36 . . . . 0.0 111.337 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.504 ' CD2' ' HB ' ' A' ' 80' ' ' ILE . 3.4 m-85 -121.46 133.83 55.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.287 0.565 . . . . 0.0 111.292 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.465 ' CD1' ' HD2' ' A' ' 103' ' ' PRO . 3.9 tp -120.76 141.63 32.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.905 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.465 ' HD2' ' CD1' ' A' ' 102' ' ' LEU . 19.5 Cg_endo -56.66 168.24 2.41 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.418 2.079 . . . . 0.0 111.815 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -43.09 -54.0 9.79 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.886 -0.143 . . . . 0.0 111.179 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 7.2 Cg_endo -48.43 163.88 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.878 1.719 . . . . 0.0 110.384 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.819 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 173.81 -86.89 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 2.4 p30 50.12 -178.58 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.508 HG21 HG21 ' A' ' 112' ' ' VAL . 1.1 mp -55.83 -47.55 79.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.718 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 4.4 t70 -54.57 -58.63 6.72 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.822 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.819 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 5.5 mm-40 -81.93 -25.59 34.78 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 107' ' ' ASP . . . -83.19 -51.16 7.73 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.518 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.599 ' O ' HG11 ' A' ' 115' ' ' VAL . 46.5 t -61.24 -32.75 53.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.486 0.66 . . . . 0.0 110.099 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.718 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -58.98 -50.62 73.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.218 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.455 HD21 HG21 ' A' ' 79' ' ' ILE . 7.5 tp -77.1 -21.03 54.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.42 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.599 HG11 ' O ' ' A' ' 112' ' ' VAL . 3.0 p -78.18 -47.49 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.751 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 52.9 mt-10 -62.73 -42.4 99.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.83 0.348 . . . . 0.0 110.571 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -66.53 -24.48 66.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.612 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.23 -54.15 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.936 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -61.13 -31.44 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.981 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.0 t -70.06 -41.07 74.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.009 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.053 0.454 . . . . 0.0 111.024 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.4 mp -107.91 115.54 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.853 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 3.0 p -107.01 126.69 63.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.937 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.881 ' CD1' HG21 ' A' ' 31' ' ' THR . 32.8 m0 -114.48 147.26 39.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.886 0.374 . . . . 0.0 110.643 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.681 HG12 HD11 ' A' ' 52' ' ' LEU . 0.6 OUTLIER -137.28 145.75 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.924 0.392 . . . . 0.0 111.669 -178.526 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.886 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -129.28 112.14 24.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.231 178.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.707 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 7.5 t70 -165.21 -154.29 0.21 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.142 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.412 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -67.05 8.77 0.25 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.422 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 10' ' ' ASP . 2.9 p30 45.39 -143.84 0.21 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.412 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.9 t 34.97 -91.78 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.432 ' O ' HG21 ' A' ' 18' ' ' VAL . 12.2 m -58.62 -52.33 66.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.703 0.287 . . . . 0.0 111.192 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.3 mm -62.69 -29.13 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.217 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.507 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 0.2 OUTLIER -72.79 -57.66 3.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.806 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 77.1 t90 -50.2 -40.33 46.79 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 108' ' ' ILE . 1.8 t -71.42 -56.41 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.749 HD12 HD12 ' A' ' 108' ' ' ILE . 6.0 tp -71.59 -23.02 61.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.668 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.79 -60.08 2.81 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.535 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.547 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.0 mmm180 -72.64 -52.86 13.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.866 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.441 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -50.62 -60.01 3.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.975 0.416 . . . . 0.0 111.598 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.743 HD13 ' CD1' ' A' ' 28' ' ' LEU . 4.5 tp -61.82 -22.7 65.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.288 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -67.56 -37.49 82.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.8 -24.31 68.12 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.571 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.11 -15.61 59.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.664 0.269 . . . . 0.0 110.924 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.57 24.06 7.61 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.963 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.743 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -130.37 172.14 12.18 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 117.686 0.743 . . . . 0.0 111.376 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 m -105.7 105.77 15.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.465 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.668 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 5.7 t -100.57 115.64 30.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.136 0.493 . . . . 0.0 112.235 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.881 HG21 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -117.82 156.33 28.54 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 29.8 p -130.12 161.05 31.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.229 0.537 . . . . 0.0 111.439 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.886 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.5 m-85 -133.57 174.46 10.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.42 -178.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.501 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.4 pp20? -59.04 -49.57 77.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -154.52 -51.43 0.09 Allowed 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.99 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.731 ' HA2' HG12 ' A' ' 9' ' ' VAL . . . -175.92 -44.38 0.06 OUTLIER Glycine 0 C--N 1.315 -0.597 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.967 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.542 ' HA ' HD13 ' A' ' 40' ' ' LEU . 4.2 m120 -62.49 -27.38 69.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.018 0.437 . . . . 0.0 110.648 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.649 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -59.65 -47.6 84.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.012 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.581 HG23 ' CG1' ' A' ' 9' ' ' VAL . 21.4 t -62.38 -42.07 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.977 0.418 . . . . 0.0 111.063 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.542 HD13 ' HA ' ' A' ' 37' ' ' ASN . 25.8 mt -52.07 -42.28 63.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.731 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.79 -48.35 38.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.199 0.523 . . . . 0.0 110.947 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.92 -32.15 72.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.009 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 12.9 mt -68.89 -21.32 64.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.609 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.19 -19.99 37.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.706 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.88 -1.15 6.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -153.69 153.27 31.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.942 0.401 . . . . 0.0 111.007 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 95.5 m -139.02 112.55 8.15 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.247 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.471 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.7 Cg_endo -77.42 164.2 28.96 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.944 1.763 . . . . 0.0 111.325 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.37 -25.6 59.6 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.693 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.656 ' CG2' HD12 ' A' ' 79' ' ' ILE . 4.8 p -145.07 159.68 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.005 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.493 ' HG ' ' N ' ' A' ' 52' ' ' LEU . 14.9 tp -152.94 155.81 37.71 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.235 0.541 . . . . 0.0 112.179 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.681 HD11 HG12 ' A' ' 8' ' ' VAL . 1.7 mt -136.52 127.55 27.76 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.373 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.603 ' HA ' HG21 ' A' ' 9' ' ' VAL . 42.4 t -106.68 140.27 39.81 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.707 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 10.0 t0 -65.8 -35.87 81.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.697 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.564 ' CG2' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER 45.12 90.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.971 0.415 . . . . 0.0 110.632 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.91 90.31 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.574 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 53.6 44.99 2.14 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.457 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.611 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 90.0 Cg_endo -89.3 -54.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.574 2.183 . . . . 0.0 112.139 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.43 -19.42 0.09 OUTLIER Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.633 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.631 ' N ' ' HB2' ' A' ' 64' ' ' ALA . 3.0 tpt -163.59 69.85 0.21 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.146 0.498 . . . . 0.0 110.132 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.54 -22.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.303 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.611 ' HA2' ' CG ' ' A' ' 58' ' ' PRO . . . 139.83 -34.86 1.98 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.236 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.479 ' CD2' ' HB1' ' A' ' 90' ' ' ALA . 4.9 mp -72.67 -16.32 61.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.509 -0.345 . . . . 0.0 111.047 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.631 ' HB2' ' N ' ' A' ' 60' ' ' MET . . . -53.68 -33.34 55.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.216 0.532 . . . . 0.0 110.191 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.573 HD23 ' HA3' ' A' ' 36' ' ' GLY . 49.6 mt -60.98 -35.62 77.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.561 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.592 ' HA ' HD13 ' A' ' 69' ' ' ILE . 3.6 mm? -61.28 -45.04 96.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.164 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.546 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 61.2 tttt -54.44 -41.48 69.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.62 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.532 ' HB2' HD11 ' A' ' 40' ' ' LEU . 11.6 mm100 -67.46 -33.41 75.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.627 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.592 HD13 ' HA ' ' A' ' 66' ' ' LEU . 92.8 mt -63.96 -38.37 82.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.829 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.36 -24.47 46.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.758 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.405 ' NE2' ' HG2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -86.09 -34.25 20.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.825 -178.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.405 ' HG2' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -94.86 -25.57 16.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.558 ' CD2' ' HA ' ' A' ' 69' ' ' ILE . 1.1 m-70 -126.36 163.4 40.55 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.795 0.331 . . . . 0.0 111.265 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.07 -81.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.571 2.181 . . . . 0.0 112.857 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.615 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.0 mpt? -138.95 48.09 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 111.152 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.442 HD13 ' HD2' ' A' ' 48' ' ' PRO . 4.7 tp -63.72 118.01 40.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.793 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.24 119.04 5.88 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.146 1.897 . . . . 0.0 111.87 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.485 HG21 HG21 ' A' ' 69' ' ' ILE . 2.3 t -117.11 139.71 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.271 0.558 . . . . 0.0 111.554 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.656 HD12 ' CG2' ' A' ' 50' ' ' VAL . 3.9 mt -123.7 115.47 45.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.445 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.705 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 4.8 mm -93.53 127.47 45.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.614 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 1.1 ptp -80.26 -2.09 43.6 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.625 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.555 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.7 m -147.87 142.87 26.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.73 0.3 . . . . 0.0 110.715 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.471 ' HB1' ' CD2' ' A' ' 101' ' ' TYR . . . -162.93 65.22 0.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.908 0.385 . . . . 0.0 111.004 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -98.26 -45.57 6.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.186 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.39 165.74 17.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 111.293 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.467 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.4 OUTLIER 59.91 24.08 13.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.429 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 4.7 mt -48.73 -21.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -48.01 -55.23 10.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.662 0.268 . . . . 0.0 111.58 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.419 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -60.0 -20.56 58.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.748 0.309 . . . . 0.0 111.095 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.583 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . . . -66.96 -39.07 87.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.44 . . . . 0.0 110.419 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.593 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 16.2 t -64.99 -45.27 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.362 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 p -61.34 -32.39 72.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 110.403 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.661 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -58.83 -39.03 80.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.115 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.593 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 20.3 m-85 -61.76 -20.9 64.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.99 0.424 . . . . 0.0 110.164 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.628 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.49 -42.51 52.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.444 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.661 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -75.66 -16.56 60.17 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.029 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.23 24.43 2.22 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.297 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.5 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . . . -65.85 140.13 58.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.819 0.31 . . . . 0.0 110.5 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 47.9 t80 -72.52 -53.67 11.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.198 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.622 ' OD2' HD11 ' A' ' 114' ' ' LEU . 47.4 p-10 178.26 -160.69 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.709 0.29 . . . . 0.0 111.38 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.705 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 8.1 m-85 -141.87 113.36 7.71 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.726 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.674 HD11 ' O ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -105.33 142.8 25.47 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.593 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.646 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 9.4 Cg_endo -51.01 166.97 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.002 2.468 . . . . 0.0 112.212 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.686 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -40.89 -42.94 4.04 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 3.6 Cg_endo -45.99 163.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.02 1.814 . . . . 0.0 110.328 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.687 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 43.6 t80 -169.93 -95.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.947 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.647 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 3.6 p30 44.27 -172.39 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.691 0.281 . . . . 0.0 110.551 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.749 HD12 HD12 ' A' ' 19' ' ' LEU . 1.1 mp -67.71 -47.79 78.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.14 0.495 . . . . 0.0 112.069 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.878 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 37.3 m-20 -52.29 -54.53 30.28 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.716 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.687 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.4 mm-40 -80.24 -30.11 38.47 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 107' ' ' ASP . . . -83.5 -51.0 7.72 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.2 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.554 ' HA ' ' CG1' ' A' ' 115' ' ' VAL . 40.6 t -61.47 -32.91 54.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.498 0.666 . . . . 0.0 110.241 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.878 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -60.34 -50.55 73.16 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.818 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.622 HD11 ' OD2' ' A' ' 100' ' ' ASP . 13.6 tp -77.65 -21.17 52.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.443 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.554 ' CG1' ' HA ' ' A' ' 112' ' ' VAL . 4.5 p -79.44 -50.74 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.441 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 25.5 mt-10 -62.75 -42.45 99.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 110.843 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -63.28 -23.71 67.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.436 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.498 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -73.1 -55.98 5.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.067 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.9 mt -65.47 -31.6 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.13 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.5 t -66.77 -40.18 88.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.956 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 9.2 m80 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.176 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 mp -122.19 113.48 38.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.787 0.327 . . . . 0.0 111.357 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.676 HG22 HG23 ' A' ' 115' ' ' VAL . 11.8 p -105.45 131.51 54.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.365 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.53 ' NE1' HG21 ' A' ' 31' ' ' THR . 32.1 m0 -118.1 135.99 53.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.797 0.332 . . . . 0.0 110.764 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -127.19 138.21 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.9 -178.307 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.94 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -125.64 115.73 44.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.66 178.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.624 ' HB2' ' HE3' ' A' ' 81' ' ' MET . 12.5 t0 -170.95 -149.05 0.06 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.802 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -66.05 -3.04 4.69 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.42 ' OD1' ' HD3' ' A' ' 16' ' ' ARG . 2.4 t70 55.15 -141.24 0.87 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.304 0.113 . . . . 0.0 111.304 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 t 36.12 -92.25 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.416 ' O ' HG21 ' A' ' 18' ' ' VAL . 1.2 t -60.47 -50.11 74.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.765 0.317 . . . . 0.0 111.044 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.86 -32.43 55.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 111.3 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.462 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 11.8 ttt180 -70.98 -59.48 2.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.213 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.412 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 64.7 t90 -47.88 -44.47 29.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.542 ' C ' HD12 ' A' ' 108' ' ' ILE . 1.9 t -67.59 -61.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.048 0.452 . . . . 0.0 111.932 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.55 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 37.1 mt -66.72 -25.63 66.62 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.59 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 19.8 pt-20 -66.05 -59.13 4.1 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.56 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.59 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.5 mmt180 -74.54 -59.94 2.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.133 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.01 -51.84 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.581 ' HG ' HG13 ' A' ' 6' ' ' VAL . 2.1 tm? -62.71 -31.99 73.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.173 0.511 . . . . 0.0 110.789 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 28' ' ' LEU . . . -65.32 -34.89 79.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.651 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.22 -24.49 67.34 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.452 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.91 -15.6 59.63 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 111.153 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.79 14.0 16.76 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.809 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.518 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -127.12 172.51 10.47 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.85 0.825 . . . . 0.0 111.449 179.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 6' ' ' VAL . 57.2 m -105.56 113.95 27.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.309 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 35.8 t -107.62 114.43 28.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.172 0.51 . . . . 0.0 111.935 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.53 HG21 ' NE1' ' A' ' 7' ' ' TRP . 2.9 t -118.12 154.23 32.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.7 p -126.35 159.52 32.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.214 0.53 . . . . 0.0 112.12 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.94 ' HB2' HG12 ' A' ' 9' ' ' VAL . 2.8 m-85 -134.18 174.05 10.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.921 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -60.4 -53.55 56.23 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -176.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.66 ' C ' HG13 ' A' ' 9' ' ' VAL . 25.6 p30 -156.88 -32.09 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.885 0.766 . . . . 0.0 112.844 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.716 ' HA3' ' HG ' ' A' ' 65' ' ' LEU . . . 167.79 -51.41 0.23 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.012 -1.089 . . . . 0.0 113.383 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.535 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -56.18 -29.87 61.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.864 0.364 . . . . 0.0 110.837 -179.206 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -62.46 -53.9 48.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.664 HG23 HG22 ' A' ' 9' ' ' VAL . 4.8 t -53.81 -37.59 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.382 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 37' ' ' ASN . 17.7 mt -54.21 -43.05 70.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.04 0.448 . . . . 0.0 110.441 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 44' ' ' ALA . . . -68.87 -47.15 66.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.993 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.02 -35.02 79.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.197 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.52 ' CB ' ' CE1' ' A' ' 73' ' ' HIS . 17.3 mt -66.52 -24.5 66.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.883 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 41' ' ' ALA . . . -57.08 -19.06 17.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.961 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.13 -8.95 9.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -149.49 157.34 43.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.396 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.0 m -139.2 112.66 8.05 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.361 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.433 ' HD3' HD22 ' A' ' 43' ' ' LEU . 73.9 Cg_endo -75.56 165.43 30.5 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.143 1.896 . . . . 0.0 111.298 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.85 -25.09 59.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.019 0.437 . . . . 0.0 110.334 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.519 HG12 HG23 ' A' ' 6' ' ' VAL . 6.4 p -145.84 161.99 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.514 ' H ' HG23 ' A' ' 50' ' ' VAL . 19.3 tp -152.83 144.88 23.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.504 0.668 . . . . 0.0 111.623 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.672 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.2 mt -127.92 115.26 18.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.687 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.609 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -106.87 143.68 34.61 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.55 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 15.6 t0 -73.5 176.84 5.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.734 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.848 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 6.6 tt -153.07 81.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.69 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 172.96 54.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.341 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.413 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.23 -62.5 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.454 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.564 ' HG2' ' HA2' ' A' ' 62' ' ' GLY . 18.9 Cg_endo -56.4 -177.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.672 2.248 . . . . 0.0 112.833 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -50.44 -75.53 0.21 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.59 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.561 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -71.26 59.88 0.28 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 110.462 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.29 -73.57 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.312 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.848 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.77 -35.82 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.083 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.606 ' HA ' HD22 ' A' ' 66' ' ' LEU . 2.8 mp -55.24 -24.11 26.02 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.605 0.241 . . . . 0.0 111.032 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -55.4 -35.86 65.78 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.254 0.549 . . . . 0.0 109.996 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.716 ' HG ' ' HA3' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -58.46 -40.6 83.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.009 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' ' 63' ' ' LEU . 3.4 mm? -57.92 -43.23 86.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -55.25 -45.16 76.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.51 178.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.49 ' HB2' HD13 ' A' ' 40' ' ' LEU . 2.0 mm-40 -66.22 -34.27 77.65 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.932 0.396 . . . . 0.0 110.423 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.448 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 55.9 mt -60.18 -44.67 95.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.597 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -74.72 -21.4 59.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.601 -179.279 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 -35.02 26.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.625 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -100.45 -39.82 7.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.52 ' CE1' ' CB ' ' A' ' 43' ' ' LEU . 3.2 m-70 -102.12 151.79 38.12 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.696 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -96.37 102.3 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.252 2.635 . . . . 0.0 113.027 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.622 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 22.8 mtm 57.0 30.66 18.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.024 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.411 HD11 HD23 ' A' ' 51' ' ' LEU . 2.2 tm? -64.99 111.4 5.8 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.527 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -57.91 116.31 3.14 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.605 2.203 . . . . 0.0 112.531 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.807 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 1.6 t -116.4 151.01 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.646 0.736 . . . . 0.0 111.994 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.571 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 1.9 mp -139.67 119.26 13.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.759 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.612 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 21.8 mm -93.67 150.38 3.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.242 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.624 ' HE3' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -82.35 -27.98 31.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.387 -177.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.618 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 18.0 m -133.98 157.35 46.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.567 0.222 . . . . 0.0 110.588 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.428 ' N ' HG23 ' A' ' 82' ' ' THR . . . -148.94 62.2 1.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.962 0.411 . . . . 0.0 111.326 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.512 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -90.57 -93.98 0.12 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.706 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.46 160.35 22.71 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.078 0.466 . . . . 0.0 112.0 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.577 ' O ' HD23 ' A' ' 63' ' ' LEU . 3.7 m-20 62.26 15.87 7.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.603 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.424 ' HA ' ' CD2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -47.28 -23.46 0.56 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.31 -48.17 36.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.43 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . . . -64.68 -20.52 66.35 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.508 ' N ' HD22 ' A' ' 63' ' ' LEU . . . -58.72 -33.72 70.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.528 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.6 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.2 t -67.44 -36.92 77.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.582 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.519 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 16.5 m -63.31 -20.12 65.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.241 0.544 . . . . 0.0 109.706 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.728 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.65 -53.75 8.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.751 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.6 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.3 m-85 -59.31 -33.87 71.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.142 0.496 . . . . 0.0 110.675 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.2 pp0? -74.65 -38.02 62.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.051 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.728 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 2.9 pp0? -74.59 -18.31 60.59 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.897 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.0 -6.57 3.44 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.574 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.807 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -58.98 148.93 28.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.067 0.434 . . . . 0.0 111.62 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.501 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 40.8 t80 -78.07 -53.06 7.82 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.717 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.412 ' OD1' HG22 ' A' ' 79' ' ' ILE . 13.4 p30 -179.96 -166.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.328 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.583 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.0 m-85 -127.68 141.33 51.64 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.165 0.507 . . . . 0.0 111.402 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 4.5 tp -102.41 145.91 31.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.533 ' HG2' ' HD2' ' A' ' 105' ' ' PRO . 29.2 Cg_endo -68.89 -39.81 7.74 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.032 1.821 . . . . 0.0 112.36 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.674 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER 173.85 -48.77 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.773 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.4 Cg_endo -47.62 163.99 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.887 1.725 . . . . 0.0 109.78 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.711 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 2.5 t80 -166.09 -91.74 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.972 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.539 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 4.9 p-10 41.76 -174.94 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.997 0.427 . . . . 0.0 110.979 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.542 HD12 ' C ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.97 -49.55 67.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.392 0.615 . . . . 0.0 111.396 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.784 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -49.68 -57.77 6.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.974 -179.526 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.711 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.1 mm-40 -76.44 -29.97 57.18 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.539 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -83.19 -60.38 2.17 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.771 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.577 ' O ' HG13 ' A' ' 115' ' ' VAL . 32.6 t -50.93 -33.74 12.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.45 0.643 . . . . 0.0 110.416 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.784 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.72 -51.05 71.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.379 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.549 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 9.3 tp -76.82 -20.31 56.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.814 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.676 HG23 HG22 ' A' ' 6' ' ' VAL . 3.7 p -79.34 -48.77 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.151 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.433 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 22.8 mt-10 -61.97 -46.75 87.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.853 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.549 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 4.5 ptm180 -64.0 -23.44 67.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.823 0.344 . . . . 0.0 110.701 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.501 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.65 -50.98 21.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.47 -30.93 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.262 0.553 . . . . 0.0 110.783 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.7 m -70.15 -40.85 74.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.838 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.6 m170 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.845 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.242 -0.343 . . . . 0.0 112.242 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.3 mm -123.63 112.44 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.061 0.457 . . . . 0.0 111.578 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.636 HG13 ' HA ' ' A' ' 30' ' ' CYS . 2.8 p -115.78 120.89 66.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.86 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.526 ' NE1' HG21 ' A' ' 31' ' ' THR . 29.8 m0 -112.85 142.86 45.02 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.144 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -132.69 144.77 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.261 -178.409 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.891 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -132.08 121.57 46.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.225 178.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.5 t0 -176.42 -148.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.284 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.27 -1.77 3.7 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.1 -146.72 0.5 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 121.288 -0.165 . . . . 0.0 110.843 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 14' ' ' SER . 85.5 p 34.06 -93.1 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.427 ' O ' HG23 ' A' ' 18' ' ' VAL . 49.7 p -52.88 -58.07 8.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.257 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.6 mm -60.61 -31.41 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.01 0.433 . . . . 0.0 111.253 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.42 ' HG3' HG23 ' A' ' 32' ' ' THR . 13.5 ttt85 -72.86 -59.51 2.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.82 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.444 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 16.9 t90 -46.99 -43.76 19.63 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.591 ' CG1' HD12 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -68.39 -62.85 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.806 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.624 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 6.1 tp -67.89 -21.77 65.13 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.714 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.0 pt-20 -67.54 -60.06 2.86 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.672 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.535 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -75.02 -47.3 29.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 18' ' ' VAL . . . -54.89 -58.52 7.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.748 0.309 . . . . 0.0 111.772 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.624 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 2.8 mt -59.01 -28.24 66.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -61.77 -36.89 82.36 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.5 -24.99 71.25 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.457 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.67 -15.57 59.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 110.957 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.76 25.95 7.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.486 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.512 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.44 172.26 11.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.374 0.587 . . . . 0.0 111.401 179.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.2 m -104.1 109.46 21.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.22 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.714 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 7.6 t -106.65 110.51 22.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.198 0.523 . . . . 0.0 111.898 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.526 HG21 ' NE1' ' A' ' 7' ' ' TRP . 3.3 t -121.26 151.79 39.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.917 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.683 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.8 p -124.75 161.09 27.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.288 0.566 . . . . 0.0 112.108 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.891 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.3 m-85 -133.07 174.37 10.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.742 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.561 ' HG2' ' HG3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.66 -51.85 68.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -176.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.687 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -162.62 -24.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.7 0.682 . . . . 0.0 112.744 -179.256 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.574 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 163.79 -52.25 0.29 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.387 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.597 ' HA ' HD12 ' A' ' 40' ' ' LEU . 29.0 m120 -52.68 -33.69 48.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.724 0.297 . . . . 0.0 111.012 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -61.91 -54.32 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.731 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.637 HG21 ' CG ' ' A' ' 33' ' ' PHE . 2.9 t -54.58 -38.86 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.562 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.597 HD12 ' HA ' ' A' ' 37' ' ' ASN . 24.6 mt -52.26 -44.75 65.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.914 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.2 66.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.177 0.513 . . . . 0.0 111.048 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.46 94.18 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.547 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.55 HD11 ' CD2' ' A' ' 73' ' ' HIS . 21.7 mt -59.13 -26.48 64.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.473 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.48 -14.8 8.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.293 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.41 -9.51 10.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.98 165.16 32.54 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.087 0.47 . . . . 0.0 111.829 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.435 ' CG2' HD23 ' A' ' 76' ' ' LEU . 91.0 m -138.3 118.31 9.92 Favored Pre-proline 0 N--CA 1.452 -0.353 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.898 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.472 ' O ' HD23 ' A' ' 76' ' ' LEU . 73.6 Cg_endo -75.63 157.03 40.29 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.526 2.151 . . . . 0.0 111.991 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -73.76 -28.16 61.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 0.0 110.725 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.512 HG21 ' CD1' ' A' ' 79' ' ' ILE . 7.3 p -145.23 99.61 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.524 ' HB3' ' O ' ' A' ' 77' ' ' PRO . 63.7 tp -87.15 145.61 26.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.48 0.657 . . . . 0.0 112.184 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 9' ' ' VAL . 5.1 mt -132.85 114.43 14.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.801 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.676 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -111.3 149.95 30.36 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.287 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 18.5 t0 -80.14 -178.18 6.42 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.695 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.777 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 2.6 tt -159.92 73.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.588 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 177.56 63.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.94 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.462 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 3.1 tpp -163.5 -62.36 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.571 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 19.6 Cg_endo -59.49 -178.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.544 2.162 . . . . 0.0 113.03 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.81 -66.25 2.89 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.54 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.3 OUTLIER -72.97 54.62 0.38 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.52 -75.8 0.01 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.838 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.777 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -145.12 -32.74 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.761 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 1.4 mp -61.98 -16.46 51.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.503 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.425 ' HB3' ' CB ' ' A' ' 60' ' ' MET . . . -54.59 -35.26 63.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.316 0.579 . . . . 0.0 109.72 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.571 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 7.7 mt -63.6 -38.78 92.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.745 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 7.4 mp -52.35 -47.47 66.07 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 1.5 ttmp? -51.79 -43.39 63.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.701 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.513 ' HB2' HD13 ' A' ' 40' ' ' LEU . 12.1 mm-40 -65.62 -35.75 81.72 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.613 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.512 ' CG2' ' CE1' ' A' ' 73' ' ' HIS . 82.3 mt -63.06 -44.95 99.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.188 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 3.9 pttt -65.8 -23.67 66.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.187 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -28.32 41.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.297 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -112.31 -71.73 0.74 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.796 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.561 ' HD1' ' HB3' ' A' ' 76' ' ' LEU . 6.1 p80 -112.38 66.3 0.83 Allowed Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.494 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.574 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 25.8 Cg_endo -63.33 -31.99 72.88 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 113.576 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.498 ' HA ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -88.89 -19.81 25.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.51 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.561 ' HB3' ' HD1' ' A' ' 73' ' ' HIS . 3.1 tm? -62.83 118.44 42.0 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.619 0.247 . . . . 0.0 111.42 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 52.7 Cg_exo -54.15 115.88 2.67 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.722 2.281 . . . . 0.0 113.087 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.758 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -113.98 142.39 26.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.015 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.603 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 3.1 mt -130.12 115.85 34.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.943 0.402 . . . . 0.0 110.55 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.626 ' HA ' ' O ' ' A' ' 53' ' ' SER . 25.1 mm -93.85 145.74 7.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.439 ' O ' ' C ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -78.72 -19.92 51.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.028 -179.11 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.625 ' H ' HG21 ' A' ' 80' ' ' ILE . 6.0 m -147.65 157.54 43.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.432 ' CB ' ' CD2' ' A' ' 101' ' ' TYR . . . -133.48 50.69 2.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.996 0.427 . . . . 0.0 111.166 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.56 -176.14 3.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.956 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.1 t 71.25 -76.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.423 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.435 ' O ' HD23 ' A' ' 63' ' ' LEU . 7.6 m-20 -139.08 77.52 1.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.841 0.353 . . . . 0.0 111.121 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.523 ' O ' ' HB2' ' A' ' 90' ' ' ALA . 3.4 tm? -52.19 -21.8 3.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.62 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.06 -56.63 8.46 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.34 -24.26 67.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 87' ' ' LEU . . . -57.84 -63.07 1.37 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.82 0.343 . . . . 0.0 111.825 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.424 HG23 HD12 ' A' ' 87' ' ' LEU . 11.6 t -56.57 -38.45 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.921 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.406 ' HA ' ' HB3' ' A' ' 95' ' ' GLN . 1.4 m -60.48 -33.53 72.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.744 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 96' ' ' GLN . . . -68.12 -46.66 70.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.202 0.525 . . . . 0.0 111.118 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.638 ' HA ' ' HB2' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -75.83 -23.74 55.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.873 178.676 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.406 ' HB3' ' HA ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -74.48 -33.67 62.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.939 178.802 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 93' ' ' ALA . 15.2 pt20 -82.56 -18.47 41.29 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.442 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 75' ' ' MET . . . 161.94 -25.39 0.24 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.292 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.758 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -60.42 162.67 5.96 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.679 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 100' ' ' ASP . 28.4 t80 -74.57 -54.04 8.25 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.4 t0 170.5 -157.48 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.506 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.0 m-85 -129.14 123.01 31.05 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 81' ' ' MET . 3.8 tp -104.45 137.79 19.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.144 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.443 ' C ' ' HD2' ' A' ' 105' ' ' PRO . 69.5 Cg_exo -50.81 168.57 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.293 1.995 . . . . 0.0 111.847 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.65 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -44.07 -44.11 16.44 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 4.4 Cg_endo -47.4 163.48 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.645 1.563 . . . . 0.0 110.466 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.69 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 9.4 t80 -166.66 -94.36 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.679 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 43.01 -174.07 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.591 HD12 ' CG1' ' A' ' 18' ' ' VAL . 1.1 mp -67.55 -47.32 80.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.289 0.566 . . . . 0.0 111.557 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.684 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -51.98 -56.02 16.85 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.966 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.69 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.7 mm-40 -79.49 -28.35 41.47 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 107' ' ' ASP . . . -84.24 -53.8 5.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.018 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.56 ' HA ' ' CG1' ' A' ' 115' ' ' VAL . 42.8 t -58.63 -31.92 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 121.417 0.627 . . . . 0.0 110.221 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.17 -53.54 56.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.461 178.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.549 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 8.5 tp -75.19 -20.5 59.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.095 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.56 ' CG1' ' HA ' ' A' ' 112' ' ' VAL . 5.3 p -79.23 -49.76 19.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.443 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 16.2 mt-10 -68.59 -38.87 81.0 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.944 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 113' ' ' ALA . 4.4 ptp85 -66.15 -26.13 67.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.063 0.459 . . . . 0.0 110.649 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.449 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.49 -51.44 23.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.025 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -64.9 -31.48 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.146 0.498 . . . . 0.0 110.787 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.7 m -71.59 -42.56 67.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.746 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.788 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.192 0 N-CA-C 112.818 -0.113 . . . . 0.0 112.818 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.694 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.4 mp -111.51 114.46 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.698 0.285 . . . . 0.0 110.985 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.745 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 7.7 p -105.53 116.11 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.248 179.314 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.531 ' NE1' HG21 ' A' ' 31' ' ' THR . 33.2 m0 -109.05 149.63 29.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.801 0.334 . . . . 0.0 111.35 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.761 HG23 HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -139.5 148.51 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.548 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.835 HG21 ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -134.18 118.37 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.139 177.435 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.479 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.3 t0 -173.64 -151.97 0.05 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.123 -179.356 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.34 -2.63 4.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 58.19 -137.73 0.88 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.009 178.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.9 p 34.74 -104.86 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.418 ' O ' HG21 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -54.12 -42.73 69.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.567 0.223 . . . . 0.0 111.468 -179.178 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.8 mm -65.24 -36.26 77.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.063 0.458 . . . . 0.0 111.252 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.474 ' HG3' HG22 ' A' ' 32' ' ' THR . 26.4 ttt-85 -70.72 -56.31 6.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.829 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.439 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 69.9 t90 -48.81 -43.87 38.65 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.567 ' CG1' HD12 ' A' ' 108' ' ' ILE . 1.6 t -67.2 -59.83 3.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.843 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.761 HD21 HG23 ' A' ' 8' ' ' VAL . 7.1 tp -70.93 -22.58 62.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.6 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 11.1 pt-20 -66.59 -60.12 3.0 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.435 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.563 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.6 mmt180 -74.9 -51.0 14.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.052 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.467 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -51.01 -58.7 5.39 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.625 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 1.8 mt -59.7 -28.93 67.74 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.4 83.14 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.52 -24.91 69.77 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.672 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.473 ' CB ' HD11 ' A' ' 28' ' ' LEU . . . -76.79 -15.52 59.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.693 0.282 . . . . 0.0 111.0 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.1 24.02 7.83 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.503 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.489 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.29 169.77 13.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 111.371 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.2 m -104.52 105.68 15.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.086 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.745 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 18.0 t -101.69 112.75 25.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.198 0.523 . . . . 0.0 111.992 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.551 HG22 ' CE1' ' A' ' 33' ' ' PHE . 3.1 t -122.13 152.95 39.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.18 178.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 38.1 p -126.74 152.5 46.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.267 0.556 . . . . 0.0 112.259 -179.084 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.781 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -129.21 174.04 9.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.54 -179.903 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.58 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -58.87 -104.65 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.025 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 13.8 m-20 -85.23 -70.76 0.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.415 ' HA2' HG12 ' A' ' 9' ' ' VAL . . . -167.26 -31.2 0.02 OUTLIER Glycine 0 C--N 1.318 -0.423 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.203 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -67.06 -31.3 71.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.506 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.626 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.7 tm-20 -52.99 -57.64 9.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.424 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.718 HG21 ' CD1' ' A' ' 33' ' ' PHE . 14.4 t -50.99 -42.71 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.297 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' A' ' 68' ' ' GLN . 26.1 mt -51.74 -44.58 63.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.96 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.07 -50.37 70.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.913 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.25 70.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.924 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.616 HD12 ' CG1' ' A' ' 39' ' ' VAL . 3.3 mt -67.61 -24.28 65.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.433 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.74 -17.12 3.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.34 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.71 -3.96 7.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -154.89 157.38 37.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.998 0.428 . . . . 0.0 111.372 -179.82 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.453 HG22 HD12 ' A' ' 76' ' ' LEU . 90.7 m -139.33 110.87 7.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.788 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.694 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 59.3 Cg_endo -71.73 156.76 56.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.429 2.086 . . . . 0.0 112.011 178.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -75.34 -24.27 57.32 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.304 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.435 HG12 ' CG2' ' A' ' 6' ' ' VAL . 6.7 p -145.02 95.3 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.441 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.46 HD12 ' HB2' ' A' ' 7' ' ' TRP . 28.0 tp -86.86 138.29 31.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.264 0.554 . . . . 0.0 111.884 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.528 ' CD2' ' HB ' ' A' ' 79' ' ' ILE . 4.4 mt -122.89 131.19 53.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.06 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.835 ' HA ' HG21 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -131.27 148.03 52.65 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.931 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 24.0 t0 -76.35 -164.47 0.4 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.315 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.75 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -170.66 77.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.276 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 179.38 56.41 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.86 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.606 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 12.7 tpt -157.7 -66.27 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.643 ' HG3' HD13 ' A' ' 65' ' ' LEU . 18.2 Cg_endo -58.06 -166.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.279 1.986 . . . . 0.0 112.877 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.84 -57.66 13.49 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.578 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.475 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -86.12 48.86 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.596 0.236 . . . . 0.0 110.831 179.808 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.492 ' HB3' HG13 ' A' ' 55' ' ' ILE . 0.3 OUTLIER 53.76 -83.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.991 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.75 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.84 -17.17 0.56 Allowed Glycine 0 CA--C 1.511 -0.161 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.032 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.688 ' HG ' ' HB3' ' A' ' 89' ' ' ALA . 1.8 tp -75.15 -12.89 60.4 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.192 0.52 . . . . 0.0 109.997 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.57 -64.87 0.76 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.5 178.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.643 HD13 ' HG3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -53.16 -22.94 7.18 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.856 179.834 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.552 ' O ' ' HB ' ' A' ' 69' ' ' ILE . 2.6 tp -62.19 -46.48 88.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 10.8 mtpp -55.62 -39.85 71.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.448 177.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.545 ' HB2' HD12 ' A' ' 40' ' ' LEU . 6.0 mm-40 -60.77 -33.23 72.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.038 178.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 66' ' ' LEU . 96.3 mt -59.32 -48.09 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.873 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.625 ' HB3' ' HG3' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -64.25 -29.69 70.78 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.97 0.414 . . . . 0.0 110.749 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.474 ' HG3' ' HD2' ' A' ' 70' ' ' LYS . 7.8 mt-30 -80.87 -31.02 35.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.684 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.7 -56.82 3.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.619 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -91.04 157.3 43.25 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.385 -179.624 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.8 -59.14 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.446 2.097 . . . . 0.0 112.44 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.7 mtt -156.8 28.98 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.128 0.489 . . . . 0.0 110.428 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.641 HD12 ' HD2' ' A' ' 48' ' ' PRO . 1.8 tt -55.85 112.24 4.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.411 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 31.7 Cg_exo -62.63 114.54 2.43 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 121.836 1.691 . . . . 0.0 112.277 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.926 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -99.54 150.9 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.605 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.528 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 1.9 mp -133.74 115.44 21.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.82 0.343 . . . . 0.0 110.594 179.65 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.614 ' HA ' ' O ' ' A' ' 53' ' ' SER . 45.3 mm -97.25 149.32 5.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.223 0.535 . . . . 0.0 112.408 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.535 ' HE1' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -82.07 -21.81 36.65 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.9 -178.746 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.672 ' O ' HG22 ' A' ' 55' ' ' ILE . 2.7 m -148.1 139.54 23.6 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.808 -0.558 . . . . 0.0 111.291 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.499 ' CB ' ' CD2' ' A' ' 101' ' ' TYR . . . -115.7 41.46 2.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.717 0.294 . . . . 0.0 111.583 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.411 ' ND1' HG22 ' A' ' 82' ' ' THR . 0.8 OUTLIER -81.18 54.47 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 0.0 110.831 179.687 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.9 p -159.19 -166.59 1.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.421 ' O ' ' CD2' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -61.35 85.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.414 HD23 ' HB1' ' A' ' 90' ' ' ALA . 4.7 mt -49.13 -22.53 0.98 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.137 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -47.89 -45.93 31.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.688 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . . . -72.05 -19.43 61.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.477 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.428 ' HB2' HD21 ' A' ' 63' ' ' LEU . . . -75.64 -46.18 32.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.341 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.746 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 12.1 t -68.19 -38.36 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.501 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.5 p -69.93 -23.4 63.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.977 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' GLY . . . -63.86 -42.82 97.46 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.235 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.746 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 1.1 m-85 -63.75 -27.65 69.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.456 178.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.86 -34.85 62.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.381 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.625 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 1.1 pt20 -98.67 -5.22 32.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.608 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 130.89 80.24 0.21 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.135 -179.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.926 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.56 134.87 1.86 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.188 0.518 . . . . 0.0 111.384 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 32.7 t80 -75.79 -54.2 7.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.709 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER 171.99 -164.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 0.0 111.449 -179.134 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.499 ' CD2' ' CB ' ' A' ' 83' ' ' ALA . 2.9 m-85 -125.89 119.92 29.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.989 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.632 HD23 ' CE1' ' A' ' 106' ' ' PHE . 4.3 tp -102.56 136.71 19.3 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.735 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 10.0 Cg_endo -49.22 167.88 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.664 2.243 . . . . 0.0 111.641 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -41.45 -49.93 9.2 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 111.369 0.137 . . . . 0.0 111.369 -178.747 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.735 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 71.0 Cg_exo -47.36 162.94 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.574 1.516 . . . . 0.0 110.028 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.654 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -175.3 -85.54 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.39 -178.419 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.802 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 4.3 p30 42.66 -168.41 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.618 HD11 ' HA ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.78 -47.24 80.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.268 0.556 . . . . 0.0 111.489 -179.887 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.701 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 5.0 t0 -51.75 -57.55 8.94 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.911 -179.321 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.654 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 17.8 mm-40 -78.98 -27.77 43.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.016 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.802 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -84.34 -54.76 4.56 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.826 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.589 ' O ' HG12 ' A' ' 115' ' ' VAL . 39.2 t -56.49 -32.17 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.523 0.677 . . . . 0.0 110.023 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -60.55 -52.42 65.24 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.499 178.293 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.47 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 5.4 tp -74.51 -21.49 59.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.789 -178.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.589 HG12 ' O ' ' A' ' 112' ' ' VAL . 7.2 p -79.27 -51.86 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 120.376 -0.529 . . . . 0.0 112.019 -179.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.452 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 20.2 mt-10 -64.53 -46.34 83.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.527 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -62.56 -27.65 69.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -71.47 -54.66 9.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.219 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.62 -32.12 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.216 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 116' ' ' GLU . 0.4 OUTLIER -69.13 -40.52 78.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.829 179.861 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.967 -179.97 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.415 ' HA2' ' OD2' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.562 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 2.2 mm -114.54 117.84 56.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.078 0.466 . . . . 0.0 112.133 -178.341 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.736 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 2.6 p -106.11 123.94 61.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.698 177.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.478 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 38.1 m0 -115.62 141.54 47.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -128.72 135.24 62.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.384 0.611 . . . . 0.0 111.934 -178.416 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.828 HG23 ' HB2' ' A' ' 33' ' ' PHE . 1.5 t -123.53 108.17 20.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.06 179.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.558 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 14.0 t70 -161.66 -149.92 0.18 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.408 -179.071 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.486 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 2.8 m-20 -66.32 -3.08 5.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.574 0.226 . . . . 0.0 111.595 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.8 t70 61.29 -144.8 0.45 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.392 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 14' ' ' SER . 2.4 t 32.74 -90.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.435 ' H ' ' HB3' ' A' ' 13' ' ' SER . 2.0 m -55.87 -52.36 64.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.749 0.309 . . . . 0.0 111.21 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.1 mm -63.79 -31.65 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 111.173 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.467 ' HD3' ' OE1' ' A' ' 20' ' ' GLU . 2.6 ttm180 -73.09 -54.59 8.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.677 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.516 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 44.4 t90 -51.3 -42.87 61.47 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.499 ' C ' HD13 ' A' ' 108' ' ' ILE . 2.1 t -68.17 -63.11 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.058 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.643 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 9.1 mt -65.86 -22.05 66.51 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.634 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.51 -56.91 7.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.219 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.513 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -77.87 -47.18 19.36 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.612 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 18' ' ' VAL . . . -56.84 -58.07 9.72 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.752 0.311 . . . . 0.0 111.725 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 2.0 mt -61.29 -29.43 69.86 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.98 -34.15 74.32 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.59 -24.95 74.0 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.442 178.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.424 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -76.88 -15.56 59.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.726 179.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.82 25.15 7.73 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.817 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.48 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.21 170.4 11.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.267 0.534 . . . . 0.0 111.455 179.611 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.438 ' O ' HG11 ' A' ' 6' ' ' VAL . 52.7 m -103.74 106.14 16.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.49 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.736 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.2 t -104.23 112.46 25.49 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.478 ' CG2' ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -122.83 156.67 34.09 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.307 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.692 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 36.3 p -127.21 157.88 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.305 -178.392 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.828 ' HB2' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -135.92 171.49 14.38 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.81 -179.683 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.788 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -64.28 -49.68 70.87 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.017 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.788 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 2.1 t30 -162.79 167.06 23.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -178.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -42.85 -27.79 0.61 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.382 -0.914 . . . . 0.0 112.735 -178.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.471 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -64.09 -47.8 78.62 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.708 0.289 . . . . 0.0 110.753 179.371 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -51.82 -52.19 51.04 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.046 179.527 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.706 HG22 HG21 ' A' ' 9' ' ' VAL . 32.0 t -48.69 -40.97 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.025 0.44 . . . . 0.0 110.935 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 68' ' ' GLN . 17.7 mt -50.17 -48.22 54.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.61 -48.95 75.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.487 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.52 -41.08 96.61 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.906 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.654 ' HG ' HG11 ' A' ' 39' ' ' VAL . 29.4 mt -61.2 -20.82 63.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.02 -14.45 3.7 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.63 -179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.69 -6.89 6.82 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.547 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.19 166.89 20.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.883 0.373 . . . . 0.0 111.801 -179.46 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.503 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 57.6 m -139.02 122.1 10.73 Favored Pre-proline 0 N--CA 1.454 -0.228 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.436 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.562 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 98.4 Cg_endo -79.46 155.35 24.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.304 2.003 . . . . 0.0 111.491 178.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.415 ' OD2' ' HA2' ' A' ' 4' ' ' GLY . 77.3 m-20 -75.34 -25.76 58.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.716 -179.32 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.527 HG23 ' CG2' ' A' ' 115' ' ' VAL . 3.8 p -145.69 91.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.415 HD11 HG21 ' A' ' 39' ' ' VAL . 32.5 tp -87.12 144.49 26.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.228 -179.376 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.559 HD22 ' CZ ' ' A' ' 106' ' ' PHE . 2.1 mt -125.95 137.5 53.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.934 178.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.699 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -133.57 135.61 44.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -178.197 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.596 ' H ' HG12 ' A' ' 9' ' ' VAL . 15.5 t0 -66.88 174.89 2.71 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.937 178.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.741 HG13 ' N ' ' A' ' 62' ' ' GLY . 6.8 tt -152.47 77.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.495 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER 176.67 65.7 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.188 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.593 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 1.6 ttt -158.46 -67.73 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.74 ' HG3' HD22 ' A' ' 65' ' ' LEU . 59.3 Cg_endo -70.18 -163.07 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.554 2.169 . . . . 0.0 113.035 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.62 -60.6 7.54 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.211 -179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.568 ' O ' ' N ' ' A' ' 62' ' ' GLY . 1.8 mtp -84.39 45.36 1.11 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.839 0.32 . . . . 0.0 111.594 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.548 ' HB3' HG13 ' A' ' 55' ' ' ILE . 1.2 m-20 50.98 -75.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.366 179.154 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.741 ' N ' HG13 ' A' ' 55' ' ' ILE . . . -139.09 -33.17 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.386 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.607 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -56.75 -22.82 38.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.737 0.303 . . . . 0.0 110.324 -179.862 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.546 ' CB ' ' HB2' ' A' ' 60' ' ' MET . . . -63.19 -39.25 94.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.217 0.532 . . . . 0.0 110.291 178.203 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.74 HD22 ' HG3' ' A' ' 58' ' ' PRO . 2.3 mm? -59.52 -37.44 78.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.39 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.0 mm? -59.75 -42.85 94.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.81 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.584 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 2.5 tttt -56.3 -44.45 79.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.655 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.52 ' HB3' HD13 ' A' ' 40' ' ' LEU . 3.0 mt-30 -63.52 -39.46 94.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.161 0.505 . . . . 0.0 111.142 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 58.4 mt -57.43 -51.43 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.679 -178.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.74 -23.6 67.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.401 -179.829 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -49.72 70.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.191 -178.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -99.35 -20.54 16.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.401 -178.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.484 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 4.2 m-70 -116.5 146.7 38.08 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.856 0.36 . . . . 0.0 111.152 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.85 -75.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.48 2.12 . . . . 0.0 112.74 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 38.3 mtp -149.54 57.69 1.0 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.058 0.456 . . . . 0.0 111.072 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.531 ' O ' HG22 ' A' ' 78' ' ' VAL . 2.0 tt -66.88 118.49 55.55 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.717 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.507 ' HD2' HD23 ' A' ' 76' ' ' LEU . 32.3 Cg_exo -58.61 115.34 2.47 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.552 1.501 . . . . 0.0 111.929 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.933 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -111.27 150.09 13.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.143 179.522 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.554 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 2.8 mt -136.83 115.39 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.997 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 53' ' ' SER . 14.2 mm -93.09 150.91 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 111.693 -178.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.619 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -78.98 -27.01 43.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.195 -178.348 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 2.8 m -143.29 170.7 15.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.415 ' CB ' HD21 ' A' ' 87' ' ' LEU . . . -127.61 45.57 2.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.456 ' CE1' HG22 ' A' ' 82' ' ' THR . 47.3 m-70 -69.34 -174.77 0.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 111.135 179.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 86' ' ' ASP . 48.1 t 50.67 -165.34 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.879 179.241 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.432 ' N ' ' OG ' ' A' ' 85' ' ' SER . 19.3 p-10 -59.49 101.26 0.1 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.798 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.5 HD11 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -55.9 -21.87 22.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.082 178.971 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -48.14 -45.9 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.28 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.607 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.69 -19.27 65.15 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.461 -179.349 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.547 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . . . -65.45 -53.99 34.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.086 0.469 . . . . 0.0 110.329 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.55 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.7 t -62.27 -39.83 85.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.561 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.624 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 83.5 p -63.55 -15.03 56.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.941 178.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.453 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -75.77 -57.76 3.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.187 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.592 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 3.3 m-85 -52.48 -34.15 47.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.134 -179.276 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -75.61 -33.5 60.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.012 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.493 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 10.0 pt20 -99.01 3.13 46.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.38 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 125.08 81.9 0.48 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.575 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.933 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.54 132.85 1.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.153 0.501 . . . . 0.0 111.723 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 74.8 t80 -75.08 -53.52 8.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.531 -179.165 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.592 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -178.49 -166.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.143 0.497 . . . . 0.0 111.821 -179.556 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.547 ' CE1' ' HB2' ' A' ' 90' ' ' ALA . 2.4 m-85 -125.79 140.4 52.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.322 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.597 ' HB3' ' HA ' ' A' ' 81' ' ' MET . 5.3 tp -101.89 150.43 37.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 16.5 Cg_exo -69.08 -43.15 3.42 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.302 2.001 . . . . 0.0 111.533 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.479 ' HE2' ' HB2' ' A' ' 81' ' ' MET . 0.0 OUTLIER 172.81 -46.96 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.479 178.963 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.516 ' O ' HD21 ' A' ' 102' ' ' LEU . 75.9 Cg_exo -47.72 164.59 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.905 1.737 . . . . 0.0 109.614 178.081 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.69 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 6.0 t80 -166.18 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.133 -177.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.497 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 3.7 p30 44.26 -172.08 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.881 0.372 . . . . 0.0 110.611 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.548 HG22 HG23 ' A' ' 112' ' ' VAL . 1.1 mp -68.1 -50.63 56.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.155 0.502 . . . . 0.0 111.994 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.745 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -50.4 -54.35 22.47 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.943 -178.504 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.69 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.2 mm-40 -80.02 -30.62 39.56 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.228 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -83.85 -51.47 7.16 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.962 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.648 ' O ' HG11 ' A' ' 115' ' ' VAL . 41.5 t -60.3 -31.97 49.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.388 0.613 . . . . 0.0 110.379 179.231 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.745 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -59.75 -51.82 68.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.742 0.782 . . . . 0.0 109.409 178.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.437 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 6.5 tp -75.26 -20.78 59.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.873 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.648 HG11 ' O ' ' A' ' 112' ' ' VAL . 6.0 p -78.78 -51.64 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.217 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.466 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 40.5 mt-10 -68.53 -40.88 80.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.783 0.325 . . . . 0.0 110.537 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -66.56 -26.83 67.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.528 179.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -71.62 -55.04 8.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.956 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -66.43 -31.37 53.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.054 0.454 . . . . 0.0 110.79 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.3 t -67.78 -44.03 78.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.969 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 CA-C-O 120.78 0.1 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.1 mp -121.85 112.72 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.031 0.443 . . . . 0.0 110.898 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 29' ' ' THR . 8.9 p -113.73 126.05 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.886 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.64 ' HH2' ' CG ' ' A' ' 46' ' ' LYS . 54.4 m0 -118.13 138.03 52.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.823 0.344 . . . . 0.0 110.801 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.603 HG13 ' HB2' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -123.61 119.21 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.895 -178.302 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.694 ' CG1' ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -104.46 104.53 16.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.615 0.245 . . . . 0.0 110.357 179.212 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.501 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 63.9 t0 166.78 119.18 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.905 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 73.84 -22.24 0.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 178.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 73.3 -140.97 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.532 -0.105 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.0 t -31.69 -44.15 0.07 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.16 -69.56 0.11 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.695 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 24.0 mm -60.4 -20.3 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.718 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.463 ' HG3' HG22 ' A' ' 32' ' ' THR . 35.0 ttp180 -73.27 -61.81 1.69 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.781 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.555 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 80.5 t90 -47.64 -48.03 28.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.111 -178.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.491 ' C ' HD12 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -64.6 -61.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.113 0.482 . . . . 0.0 111.971 -179.023 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.604 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 31.8 mt -68.65 -22.09 64.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.957 -177.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.585 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 17.8 pt-20 -66.57 -57.75 6.62 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.495 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.499 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -59.11 -51.15 71.28 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.664 -179.587 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.29 -51.96 67.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 0.0 111.796 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.804 ' CD2' HD11 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -67.24 -22.64 65.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.388 179.79 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -66.93 -34.84 78.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.027 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.65 -28.23 65.06 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.002 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.448 ' CB ' HD12 ' A' ' 28' ' ' LEU . . . -76.69 -15.48 59.78 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.895 0.378 . . . . 0.0 110.503 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.16 24.21 17.48 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.973 -0.632 . . . . 0.0 114.316 178.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.804 HD11 ' CD2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -121.95 159.89 25.98 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 117.961 0.88 . . . . 0.0 112.751 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.573 ' O ' HG12 ' A' ' 6' ' ' VAL . 55.2 m -81.0 126.77 31.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.431 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.585 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -116.75 108.03 15.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.154 -178.482 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.553 ' CG2' ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -130.29 141.84 50.58 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 65.0 p -115.86 162.53 17.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.574 0.702 . . . . 0.0 112.823 -178.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.815 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 2.6 m-85 -135.85 173.51 11.63 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.491 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.647 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -62.91 -59.45 4.83 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -177.004 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.477 ' CA ' HG13 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -151.22 -60.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.08 -178.729 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -152.44 -55.75 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.579 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.502 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -54.35 -29.59 48.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.991 0.395 . . . . 0.0 111.009 -179.216 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.815 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -62.19 -60.74 3.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.668 179.348 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.588 HG23 HG22 ' A' ' 9' ' ' VAL . 22.0 t -48.8 -42.65 13.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.272 179.311 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.683 HD13 ' HB3' ' A' ' 68' ' ' GLN . 38.6 mt -45.64 -46.58 14.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.033 0.444 . . . . 0.0 110.455 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.95 -47.39 80.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.537 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.83 -41.26 83.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.991 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 19.4 mt -66.32 -29.29 69.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.19 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.04 -19.99 55.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.201 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 t -123.42 0.62 8.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.64 ' CG ' ' HH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -164.65 165.62 20.81 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.116 0.484 . . . . 0.0 111.062 -179.916 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.404 HG21 ' CD2' ' A' ' 76' ' ' LEU . 54.1 m -138.5 114.52 8.85 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.498 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.5 ' HD3' ' CZ3' ' A' ' 7' ' ' TRP . 91.0 Cg_endo -77.58 164.54 28.22 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.1 1.866 . . . . 0.0 111.978 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -78.01 -31.15 50.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 110.401 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.478 HG22 ' N ' ' A' ' 51' ' ' LEU . 3.4 p -145.22 149.05 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.503 ' CD1' ' HB2' ' A' ' 7' ' ' TRP . 0.6 OUTLIER -152.97 145.59 24.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.321 0.582 . . . . 0.0 112.31 -178.18 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.685 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.2 mt -123.87 122.07 37.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.285 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -111.55 150.45 29.99 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.776 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' HA ' ' SD ' ' A' ' 81' ' ' MET . 15.8 t0 -77.48 169.72 17.82 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.465 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.614 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.5 tt -144.02 165.94 13.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.369 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 65.21 65.08 0.59 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.674 0.75 . . . . 0.0 111.297 -179.366 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.612 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -158.01 -63.02 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.685 179.293 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 68.7 Cg_endo -69.29 -157.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.505 2.136 . . . . 0.0 112.33 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.5 -72.94 0.6 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.069 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.532 ' O ' ' N ' ' A' ' 62' ' ' GLY . 1.5 ttt -71.22 57.51 0.23 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.916 0.388 . . . . 0.0 111.16 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.546 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 56.45 -77.58 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.537 -179.592 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.46 -31.27 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.389 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' A' ' 66' ' ' LEU . 1.7 mp -62.29 -17.1 57.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.745 0.307 . . . . 0.0 110.613 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.409 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -59.71 -37.98 80.38 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.014 0.435 . . . . 0.0 110.13 178.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.497 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 30.3 mt -61.26 -39.08 89.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 63' ' ' LEU . 4.0 mm? -55.47 -43.51 75.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.142 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.634 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 23.6 ttmm -57.97 -42.51 85.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.768 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.683 ' HB3' HD13 ' A' ' 40' ' ' LEU . 3.2 mt-30 -65.51 -41.37 93.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.059 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.595 HG21 ' CD2' ' A' ' 73' ' ' HIS . 36.6 mt -57.25 -50.36 76.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.634 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.634 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.27 -24.01 67.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.254 -179.532 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -23.13 66.08 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.861 -0.335 . . . . 0.0 111.053 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -108.35 -20.18 13.22 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.595 ' CD2' HG21 ' A' ' 69' ' ' ILE . 6.2 p80 -113.64 166.99 10.11 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 112.106 -179.093 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 94.0 Cg_endo -88.27 -47.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.216 2.611 . . . . 0.0 111.837 178.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.2 mtt -157.45 54.37 0.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.579 ' H ' ' ND1' ' A' ' 73' ' ' HIS . 0.7 OUTLIER -76.61 112.6 22.83 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-O 120.62 0.247 . . . . 0.0 110.861 179.819 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 37.6 Cg_endo -66.81 115.47 3.6 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.158 1.906 . . . . 0.0 111.86 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.57 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.4 t -109.11 152.34 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.595 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 3.2 mt -136.09 118.07 20.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.096 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.559 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 15.4 mm -93.61 144.25 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.387 0.613 . . . . 0.0 112.167 -179.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.721 ' HE2' ' CZ ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -77.21 -15.99 59.25 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.014 -179.369 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.544 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.5 m -147.79 169.32 20.01 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.213 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.94 41.83 1.42 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.771 0.319 . . . . 0.0 111.488 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -68.62 113.74 6.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.963 0.411 . . . . 0.0 112.071 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 m 48.58 -177.52 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.925 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.422 ' O ' HD22 ' A' ' 63' ' ' LEU . 6.5 m-20 52.24 26.22 3.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.155 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.418 HD12 ' CB ' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -56.14 -22.11 26.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.556 -179.919 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.32 -43.62 43.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.711 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.19 -23.42 62.96 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.474 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . . . -64.7 -39.73 94.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.946 0.403 . . . . 0.0 110.492 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.586 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.1 t -69.88 -45.03 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.185 179.47 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.9 m -62.52 -28.89 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.539 ' O ' ' HG2' ' A' ' 96' ' ' GLN . . . -62.13 -41.85 98.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.492 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.586 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.4 m-85 -61.43 -21.7 64.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.145 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.59 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -72.81 -42.18 64.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.772 -179.907 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.602 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.1 pt20 -77.55 -18.15 57.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.505 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 129.82 5.07 4.54 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.149 -1.024 . . . . 0.0 114.139 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.57 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -54.65 152.79 6.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.477 0.638 . . . . 0.0 111.311 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 39.3 t80 -85.7 -53.58 5.06 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.335 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.81 -163.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.18 0.514 . . . . 0.0 111.799 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.559 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.9 m-85 -131.66 122.11 25.42 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.624 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.462 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 5.8 tp -103.69 141.03 21.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.728 -179.567 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.588 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 19.6 Cg_endo -57.87 169.89 2.37 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.334 2.023 . . . . 0.0 111.591 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.646 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -44.22 -46.5 23.04 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -179.17 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 2.8 Cg_endo -46.49 163.62 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.826 1.684 . . . . 0.0 110.539 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.746 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 1.0 OUTLIER -166.41 -88.47 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.434 -177.812 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.546 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p-10 42.23 -175.48 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.959 0.409 . . . . 0.0 110.613 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.491 HD12 ' C ' ' A' ' 18' ' ' VAL . 1.1 mp -68.01 -47.44 78.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.3 0.571 . . . . 0.0 111.652 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.559 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 68.1 m-20 -54.05 -54.96 32.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.831 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.746 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.9 mm-40 -77.65 -29.43 51.63 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 107' ' ' ASP . . . -84.22 -57.34 3.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.015 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.558 ' O ' HG11 ' A' ' 115' ' ' VAL . 43.9 t -54.67 -32.17 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.456 0.646 . . . . 0.0 110.142 179.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -59.85 -54.76 42.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.055 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.462 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 32.5 tp -73.33 -20.66 60.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.66 -179.138 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.558 HG11 ' O ' ' A' ' 112' ' ' VAL . 2.4 p -79.06 -47.54 22.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.278 -178.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.08 -38.0 84.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.79 0.328 . . . . 0.0 110.462 179.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.2 mtt85 -65.04 -24.32 67.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.542 179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.65 -52.55 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.066 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.7 mt -60.75 -31.49 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.107 0.479 . . . . 0.0 110.659 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.5 m -70.56 -43.5 69.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.704 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 32.2 m80 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.859 179.852 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.463 ' C ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 2.2 mp -133.34 113.07 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.715 HG13 ' HG ' ' A' ' 23' ' ' LEU . 7.9 p -111.69 125.54 69.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.868 0.366 . . . . 0.0 111.433 179.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.724 ' CD1' HG23 ' A' ' 31' ' ' THR . 19.7 m0 -114.88 129.03 56.62 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.433 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.6 OUTLIER -123.42 144.76 31.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.454 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.646 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 0.1 OUTLIER -135.32 105.81 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.582 178.31 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 51.4 t0 167.49 120.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.637 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.404 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 70.86 -32.15 0.24 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.216 179.567 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 10' ' ' ASP . 5.0 t70 73.75 -134.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 12' ' ' ASP . 47.6 t -21.0 -58.17 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.441 ' O ' HG21 ' A' ' 18' ' ' VAL . 19.4 m -53.04 -69.52 0.11 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.259 -179.088 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 26.7 mm -60.46 -20.38 20.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.51 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 47.8 ttt180 -72.35 -61.45 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.861 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 75.9 t90 -47.46 -42.85 23.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.533 ' C ' HD13 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -67.52 -62.16 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.736 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 8.6 tp -70.79 -21.6 62.47 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.553 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 22.7 pt-20 -67.47 -56.68 8.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.47 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.553 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 9.5 mmm-85 -68.51 -56.34 8.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.479 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.54 -36.94 64.82 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.715 ' HG ' HG13 ' A' ' 6' ' ' VAL . 1.1 tm? -73.7 -27.45 61.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.997 0.427 . . . . 0.0 110.687 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.42 -32.64 72.82 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.59 -25.71 71.66 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.432 178.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.77 -15.48 59.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.728 0.299 . . . . 0.0 111.135 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.64 25.34 8.69 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.487 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.463 ' HB3' ' C ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -134.98 178.27 7.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.632 0.716 . . . . 0.0 111.726 179.849 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.521 ' O ' HG12 ' A' ' 6' ' ' VAL . 7.9 m -105.64 128.01 53.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.069 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.485 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 42.6 t -123.11 113.01 18.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.134 0.492 . . . . 0.0 111.953 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.724 HG23 ' CD1' ' A' ' 7' ' ' TRP . 3.0 t -119.08 156.03 30.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.253 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.9 p -133.91 160.19 38.43 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.092 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.678 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.3 m-85 -135.86 174.16 10.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.421 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.529 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.89 -105.05 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.025 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.569 ' C ' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -84.57 -61.52 1.77 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.033 0.444 . . . . 0.0 111.978 -178.154 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.714 ' HA3' ' HG ' ' A' ' 65' ' ' LEU . . . -176.64 -37.01 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.074 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.701 ' HA ' HD12 ' A' ' 40' ' ' LEU . 3.0 m120 -60.18 -29.64 68.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.678 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -54.53 -54.8 36.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.424 179.791 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.588 HG13 HD12 ' A' ' 43' ' ' LEU . 6.6 t -49.39 -46.01 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.262 0.553 . . . . 0.0 110.907 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.701 HD12 ' HA ' ' A' ' 37' ' ' ASN . 30.3 mt -47.2 -43.46 21.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.306 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.87 82.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.31 0.576 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.22 77.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.1 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.656 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.3 mt -59.89 -24.46 64.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.201 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.84 -22.31 5.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.698 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.94 8.32 5.22 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.05 163.21 37.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.98 0.419 . . . . 0.0 111.198 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.7 m -138.39 118.56 9.91 Favored Pre-proline 0 N--CA 1.453 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.009 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.566 ' HB3' ' CG ' ' A' ' 7' ' ' TRP . 56.0 Cg_endo -69.69 154.96 67.36 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.165 1.91 . . . . 0.0 112.292 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.559 ' HB3' ' O ' ' A' ' 5' ' ' ILE . 26.8 t0 -79.38 -32.66 43.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.611 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.596 HG11 HD12 ' A' ' 119' ' ' ILE . 7.3 p -150.47 94.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.625 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.486 HD13 HG13 ' A' ' 39' ' ' VAL . 28.5 tp -84.48 153.84 23.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.664 ' CD2' ' HB ' ' A' ' 79' ' ' ILE . 2.7 mt -136.74 114.76 11.45 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.802 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.577 ' HA ' HG21 ' A' ' 9' ' ' VAL . 4.9 t -108.95 149.4 29.25 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.646 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 25.9 t0 -82.99 166.84 18.49 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.381 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.663 ' CG2' ' HB ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -155.5 108.95 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.994 -179.914 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.47 40.22 0.76 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.375 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER 66.94 51.06 0.62 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.434 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 62.6 Cg_endo -78.96 -77.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.812 2.341 . . . . 0.0 112.159 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.424 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -109.27 -29.78 3.85 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.815 179.526 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.553 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -152.47 65.78 0.82 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.095 0.474 . . . . 0.0 110.279 179.362 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 55' ' ' ILE . 0.5 OUTLIER 68.74 -22.99 0.14 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.872 179.824 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.599 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 135.24 -31.49 2.68 Favored Glycine 0 CA--C 1.502 -0.757 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 4.7 mp -70.16 -15.47 62.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.89 -37.98 64.31 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.061 0.458 . . . . 0.0 110.447 178.448 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.714 ' HG ' ' HA3' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -58.15 -36.61 73.25 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.926 179.511 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.569 ' HB3' ' CB ' ' A' ' 93' ' ' ALA . 4.0 mm? -59.34 -43.61 92.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.494 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.561 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 14.0 mttt -52.59 -47.25 67.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.09 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.528 ' CB ' HD13 ' A' ' 40' ' ' LEU . 2.0 mt-30 -61.09 -32.19 71.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.059 179.162 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.469 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 10.7 mt -67.97 -41.6 84.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.166 -178.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 9.9 pttt -77.63 -24.88 49.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.955 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -74.25 -43.43 57.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.883 0.373 . . . . 0.0 111.888 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -89.45 -54.59 4.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.132 -179.06 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.656 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -89.96 135.49 30.17 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.261 -178.858 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -56.74 -64.84 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.512 2.142 . . . . 0.0 112.667 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.8 mtm -142.01 44.7 1.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.787 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.463 HD23 ' HD2' ' A' ' 48' ' ' PRO . 2.9 tm? -63.01 111.17 4.39 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.037 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HD2' HD22 ' A' ' 76' ' ' LEU . 38.7 Cg_exo -58.94 116.29 3.15 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.639 2.226 . . . . 0.0 113.013 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.927 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -118.55 153.29 20.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.68 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.664 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 3.6 mt -134.14 117.6 25.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.017 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.586 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 26.6 mm -93.57 141.76 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.219 0.533 . . . . 0.0 112.06 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.541 ' HE2' ' CB ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -84.72 -11.73 55.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.558 -179.147 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.663 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 15.3 m -147.47 133.0 18.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.576 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.63 -1.53 7.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -69.32 67.48 0.19 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 0.0 110.256 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.5 m -155.98 -79.09 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.35 -179.34 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.463 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -145.62 79.39 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.68 -179.609 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.437 ' HA ' ' HB1' ' A' ' 90' ' ' ALA . 4.5 mt -46.12 -21.46 0.15 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.281 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.76 -57.44 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.572 0.225 . . . . 0.0 110.96 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.45 -20.87 62.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 110.87 179.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.521 ' CB ' ' CE1' ' A' ' 101' ' ' TYR . . . -69.65 -60.88 2.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.505 ' HA ' ' HD2' ' A' ' 94' ' ' TYR . 21.6 t -60.75 -46.12 96.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.486 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.7 m -56.81 -49.12 76.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.003 0.43 . . . . 0.0 111.246 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.569 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -62.93 -40.3 97.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.143 -179.403 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.763 ' HA ' ' CB ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -71.17 -20.71 62.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.218 179.918 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.56 -38.68 62.63 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.465 179.174 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.572 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 2.6 pt20 -100.23 -17.43 17.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.75 66.79 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.496 -1.335 . . . . 0.0 114.081 -179.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.927 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -170.48 132.91 1.0 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.592 0.234 . . . . 0.0 110.553 178.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.427 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 45.2 t80 -62.92 -53.14 58.7 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.504 -178.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 178.23 -161.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 0.0 111.408 -179.306 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.586 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.2 m-85 -127.59 126.82 42.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.489 ' HB2' HD23 ' A' ' 114' ' ' LEU . 6.3 tp -108.03 135.38 19.88 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.81 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.419 ' C ' ' HD2' ' A' ' 105' ' ' PRO . 77.3 Cg_exo -50.03 170.02 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.2 1.933 . . . . 0.0 111.453 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.647 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -44.6 -44.5 20.83 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.296 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 4.8 Cg_endo -47.58 163.4 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.739 1.626 . . . . 0.0 110.942 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.685 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 9.8 t80 -165.68 -95.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.717 -178.4 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 4.2 p-10 44.18 -174.03 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.126 -0.359 . . . . 0.0 110.896 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.533 HD13 ' C ' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -68.02 -47.72 77.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.197 0.523 . . . . 0.0 111.633 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.772 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 23.3 t70 -51.15 -57.47 8.65 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.714 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.685 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.3 mm-40 -78.22 -29.44 48.27 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.206 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -82.16 -57.71 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.772 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 115' ' ' VAL . 38.5 t -54.06 -32.46 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.467 0.651 . . . . 0.0 110.159 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -59.46 -51.65 68.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.885 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.514 HD21 HG22 ' A' ' 79' ' ' ILE . 19.3 tp -77.42 -20.55 54.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.791 -178.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 112' ' ' VAL . 4.2 p -76.43 -46.84 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.496 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.401 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 29.1 mt-10 -63.62 -52.46 60.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.738 0.304 . . . . 0.0 110.537 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 -57.58 -25.89 60.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.05 0.452 . . . . 0.0 110.508 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.427 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.77 -53.87 8.37 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.488 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.596 HD12 HG11 ' A' ' 50' ' ' VAL . 3.4 mt -68.83 -32.92 56.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.029 0.442 . . . . 0.0 111.112 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.59 -48.53 47.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.32 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.1 m170 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.369 . . . . 0.0 111.124 -179.81 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.418 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.5 mm -119.41 112.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.655 0.264 . . . . 0.0 111.56 -179.205 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.85 HG11 ' HG ' ' A' ' 23' ' ' LEU . 8.6 p -106.31 118.04 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.291 178.438 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.785 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.4 m0 -111.92 123.8 51.02 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -117.27 136.19 55.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.301 -177.255 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.913 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -121.55 115.65 47.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.855 178.338 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.642 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 5.0 t70 -169.8 -152.62 0.1 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.113 -178.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.36 6.22 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 14' ' ' SER . 3.9 p30 47.05 -146.5 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t 35.49 -88.58 0.01 OUTLIER 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 12' ' ' ASP . 2.7 m -59.93 -54.48 45.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.68 0.276 . . . . 0.0 111.116 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.9 mm -62.75 -31.75 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.486 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.457 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 5.9 ttp180 -69.11 -48.96 61.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.564 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.638 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 14.9 t90 -61.63 -58.37 8.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.02 -179.24 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.529 ' CG1' HD11 ' A' ' 108' ' ' ILE . 1.4 t -55.62 -40.47 59.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.185 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.567 ' HA ' HD13 ' A' ' 108' ' ' ILE . 5.1 tp -84.32 -24.8 29.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -177.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.638 ' HG2' ' O ' ' A' ' 17' ' ' TRP . 19.7 pt-20 -67.63 -59.63 3.19 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.605 -178.702 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.758 ' H ' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -59.35 -65.28 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.138 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.47 -30.64 5.35 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.956 -179.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.85 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.8 tm? -78.89 -32.44 45.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.25 0.548 . . . . 0.0 110.276 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.22 73.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.198 178.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.16 -26.67 71.65 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.85 -15.39 59.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.865 0.364 . . . . 0.0 110.684 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.38 25.69 10.78 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.827 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -131.09 169.07 16.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.621 0.71 . . . . 0.0 111.697 179.771 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.6 m -96.93 116.24 28.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.658 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.591 ' HA ' HG12 ' A' ' 6' ' ' VAL . 51.5 t -110.24 114.61 28.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.395 0.616 . . . . 0.0 111.883 -179.428 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.785 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.0 t -125.26 155.61 39.86 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 66.9 p -129.08 164.86 22.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.259 0.552 . . . . 0.0 112.116 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.913 ' HB2' HG11 ' A' ' 9' ' ' VAL . 3.3 m-85 -136.43 174.57 10.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.799 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.575 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.1 pp20? -59.3 -55.68 31.73 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -177.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.692 ' C ' HG12 ' A' ' 9' ' ' VAL . 10.6 t-20 -153.15 -39.58 0.1 Allowed 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.451 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.573 ' N ' HG12 ' A' ' 9' ' ' VAL . . . 175.82 -51.06 0.12 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.4 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.555 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -56.65 -27.5 58.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.729 0.3 . . . . 0.0 110.768 -179.513 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.735 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -61.16 -55.28 34.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.692 179.031 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.613 HG21 ' CD1' ' A' ' 33' ' ' PHE . 67.3 t -52.46 -43.16 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.971 0.415 . . . . 0.0 111.138 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.637 HD13 ' CB ' ' A' ' 68' ' ' GLN . 14.2 mt -52.76 -43.22 65.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.401 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.59 -49.4 68.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.201 0.524 . . . . 0.0 110.621 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.67 -30.36 71.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.571 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.512 ' HG ' HG11 ' A' ' 39' ' ' VAL . 10.0 mt -61.91 -22.15 65.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.362 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.18 -15.1 59.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.35 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 t -120.77 -5.2 9.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.51 165.54 28.44 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.907 0.384 . . . . 0.0 111.517 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.7 m -138.27 115.75 9.28 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.331 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.51 ' HD2' HD21 ' A' ' 43' ' ' LEU . 59.7 Cg_endo -72.73 147.23 44.57 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.495 2.13 . . . . 0.0 111.914 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.71 -20.26 53.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.343 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.491 HG12 ' CG2' ' A' ' 6' ' ' VAL . 3.2 p -148.63 95.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.965 0.412 . . . . 0.0 110.168 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 7' ' ' TRP . 12.7 tp -86.74 151.75 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.293 -178.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.649 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 15.5 mt -135.97 116.17 13.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.596 179.04 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.736 ' HA ' HG22 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -105.77 141.01 37.93 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -177.226 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.642 ' OD2' ' HA ' ' A' ' 10' ' ' ASP . 9.8 t70 -70.85 -28.36 64.53 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.957 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.664 HG13 ' C ' ' A' ' 62' ' ' GLY . 2.7 tt 45.98 83.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.556 0.217 . . . . 0.0 111.459 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.04 96.4 0.27 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.604 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.6 OUTLIER 58.04 46.37 1.78 Allowed Pre-proline 0 N--CA 1.466 0.352 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 178.352 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.604 ' HD3' ' N ' ' A' ' 57' ' ' MET . 87.9 Cg_endo -90.36 -55.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.987 2.458 . . . . 0.0 111.927 178.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.93 -18.59 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.422 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.612 ' N ' ' HB3' ' A' ' 64' ' ' ALA . 10.2 tpt -158.75 71.54 0.55 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.18 0.514 . . . . 0.0 109.802 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.77 -31.27 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.9 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.664 ' C ' HG13 ' A' ' 55' ' ' ILE . . . 155.17 -34.07 0.66 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.823 -179.005 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 86' ' ' ASP . 5.4 mp -72.47 -25.87 61.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.89 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.612 ' HB3' ' N ' ' A' ' 60' ' ' MET . . . -53.78 -30.34 44.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.283 0.563 . . . . 0.0 109.72 178.495 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.54 HD12 ' HA3' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -47.94 -52.8 18.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.931 178.816 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.466 ' HG ' ' CB ' ' A' ' 93' ' ' ALA . 0.3 OUTLIER -58.27 -53.07 62.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.245 179.127 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.719 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -43.24 -38.34 2.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.383 179.728 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.637 ' CB ' HD13 ' A' ' 40' ' ' LEU . 18.9 mm100 -71.39 -38.07 71.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.166 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.6 mt -64.33 -36.35 76.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.962 -179.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.719 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -73.44 -29.85 62.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.979 -179.907 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.66 -41.32 99.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.835 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -97.3 -23.09 16.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.782 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.452 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 56.2 m-70 -146.33 85.24 7.47 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.844 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 73.3 Cg_endo -75.53 13.11 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.948 2.432 . . . . 0.0 113.018 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.7 mtt -134.33 -0.62 2.96 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.61 0.243 . . . . 0.0 111.172 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 tt -76.54 113.16 26.54 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.487 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -67.72 116.69 4.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.366 2.044 . . . . 0.0 111.81 178.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.549 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.1 t -115.47 151.22 17.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.539 0.685 . . . . 0.0 112.347 -178.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.649 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 1.1 mp -129.23 117.29 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.696 178.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.745 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 5.8 mm -93.52 133.15 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.594 -178.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.553 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.87 -1.88 49.19 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.488 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.517 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.4 m -148.0 158.92 44.31 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.091 -0.381 . . . . 0.0 110.069 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -163.19 57.59 0.19 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.866 0.365 . . . . 0.0 111.813 179.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.404 ' HD2' HG23 ' A' ' 82' ' ' THR . 33.3 p80 -98.99 -20.39 16.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.695 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.421 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -84.48 -168.46 2.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.175 0.512 . . . . 0.0 112.339 -178.76 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.487 ' O ' HD22 ' A' ' 63' ' ' LEU . 4.5 m-20 -52.56 89.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.93 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.722 HD11 ' HB1' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -46.64 -22.96 0.34 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.555 179.042 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.98 -44.91 30.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.415 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.82 -19.93 66.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.886 0.374 . . . . 0.0 111.363 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.722 ' HB1' HD11 ' A' ' 87' ' ' LEU . . . -75.78 -28.59 58.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.634 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.533 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.5 t -59.19 -38.84 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.536 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.6 m -65.35 -21.75 66.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.644 178.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.562 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -66.65 -47.65 71.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.857 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.533 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.4 m-85 -62.4 -24.32 67.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.076 179.34 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -42.17 59.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.261 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.562 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 2.3 pp0? -77.73 -11.02 59.84 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.068 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.85 15.34 10.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.93 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.549 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -56.84 138.87 52.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.75 0.275 . . . . 0.0 110.499 179.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.427 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 17.1 t80 -69.14 -52.78 24.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.688 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.5 -161.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.745 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 6.6 m-85 -132.09 118.92 20.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.452 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.632 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 5.1 tp -102.44 140.89 21.53 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.332 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.689 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 22.1 Cg_endo -59.06 168.7 4.28 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.098 1.865 . . . . 0.0 111.047 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.592 ' O ' ' HE3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -41.79 -43.35 6.34 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.329 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.689 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 80.4 Cg_exo -47.05 163.02 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.345 1.363 . . . . 0.0 110.317 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.705 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 2.9 t80 -166.44 -91.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.461 -177.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.543 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.7 p-10 43.42 -176.31 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 120.854 0.359 . . . . 0.0 110.442 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.567 HD13 ' HA ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.96 -45.23 84.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.303 0.573 . . . . 0.0 111.072 -179.837 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.741 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.6 t0 -52.15 -57.25 10.17 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.879 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.705 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.2 mm-40 -78.84 -29.34 44.57 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.2 -51.87 6.69 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.124 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 115' ' ' VAL . 42.0 t -59.58 -32.3 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 121.589 0.709 . . . . 0.0 110.085 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.27 -50.94 71.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.362 178.386 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.632 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 12.5 tp -79.01 -20.5 48.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.56 -178.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 112' ' ' VAL . 5.4 p -74.94 -51.8 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.012 -179.182 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.462 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 84.3 mt-10 -68.31 -37.87 81.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.877 0.37 . . . . 0.0 110.901 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -63.1 -23.99 67.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.457 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.427 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.94 -54.82 8.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.24 -30.71 50.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.111 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 m -66.96 -46.75 73.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 7.3 m80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.163 -179.719 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.1 mp -111.08 112.99 42.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.962 0.41 . . . . 0.0 111.113 -179.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 5.8 p -108.15 128.94 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.715 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.941 ' CD1' HG21 ' A' ' 31' ' ' THR . 36.0 m0 -115.93 144.38 44.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.573 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.4 t -134.9 147.82 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.109 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -134.55 105.1 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.608 177.679 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.585 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 57.1 t0 166.85 123.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.804 0.335 . . . . 0.0 111.336 179.144 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.452 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER 69.49 -21.78 0.16 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 178.849 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 10' ' ' ASP . 14.7 t70 70.56 -130.44 0.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 O-C-N 122.41 -0.181 . . . . 0.0 111.19 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 t -37.27 -45.36 0.65 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.044 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.94 -64.19 0.91 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.168 -179.639 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 32.1 mm -68.31 -20.63 25.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.556 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 0.0 OUTLIER -68.84 -55.46 11.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.427 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -54.58 -43.96 72.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.795 0.331 . . . . 0.0 111.651 -179.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.629 ' CG1' HD12 ' A' ' 108' ' ' ILE . 1.4 t -68.46 -46.88 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.679 ' HA ' HD11 ' A' ' 108' ' ' ILE . 3.9 mm? -81.67 -23.85 36.64 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.637 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 14.0 pt-20 -67.66 -60.36 2.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.814 -179.151 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.6 mmt180 -63.92 -59.34 4.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.137 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.09 -54.24 21.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 111.932 -179.15 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.716 HD12 ' CD1' ' A' ' 28' ' ' LEU . 2.7 tp -65.26 -22.7 66.89 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.282 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -68.21 -36.79 80.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.25 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.26 -26.34 63.74 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.338 178.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.429 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -77.69 -15.47 59.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.703 0.287 . . . . 0.0 111.111 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.96 26.15 9.9 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.673 178.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.716 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -124.51 169.45 11.87 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.442 0.621 . . . . 0.0 111.224 179.53 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.2 m -104.17 106.46 16.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.166 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 11.4 t -101.76 115.06 29.69 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.058 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.941 HG21 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -118.94 156.63 29.22 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 18.3 p -129.84 162.79 27.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.658 0.742 . . . . 0.0 112.761 -179.283 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.809 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 20.0 m-85 -135.95 173.55 11.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.966 -179.078 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.632 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.5 pp20? -57.63 -59.52 5.07 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -177.319 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.61 ' C ' HG11 ' A' ' 9' ' ' VAL . 71.6 m-20 -152.54 -29.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.399 0.545 . . . . 0.0 112.466 -179.274 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.445 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 172.27 -59.19 0.16 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.892 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.514 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -48.1 -31.35 5.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.852 0.358 . . . . 0.0 110.662 -179.701 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.809 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -60.87 -56.41 21.48 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.491 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.621 HG21 HG21 ' A' ' 9' ' ' VAL . 5.0 t -53.86 -42.67 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.754 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 37' ' ' ASN . 14.3 mt -53.95 -43.71 70.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.72 -50.67 68.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.55 68.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.51 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 9.0 mt -65.85 -25.15 67.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.062 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.45 -19.28 61.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.337 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 t -119.32 -1.78 10.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.903 -179.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -163.16 158.71 22.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.997 0.427 . . . . 0.0 111.1 -179.849 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.5 m -139.09 112.26 8.05 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.406 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.512 ' HD2' HD13 ' A' ' 76' ' ' LEU . 57.9 Cg_endo -71.36 164.35 36.03 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.921 1.747 . . . . 0.0 111.281 179.209 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.64 -24.1 58.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.907 0.384 . . . . 0.0 110.581 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.585 ' CG2' HD12 ' A' ' 79' ' ' ILE . 7.3 p -145.22 161.88 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.626 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 51' ' ' LEU . 30.8 tp -152.83 155.88 37.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.214 0.53 . . . . 0.0 112.251 -178.605 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.82 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -138.01 121.08 16.73 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.831 -179.801 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.585 ' HA ' HG22 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -105.73 138.96 41.04 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.873 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 53.0 t0 -69.76 -19.3 63.53 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.995 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.579 ' HB ' ' CG2' ' A' ' 80' ' ' ILE . 5.2 tt 46.16 73.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.224 0.535 . . . . 0.0 111.604 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.17 75.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.489 179.754 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.463 ' HG3' ' HB2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -163.13 -61.16 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.623 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.701 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 59.7 Cg_endo -70.38 -169.32 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.524 2.149 . . . . 0.0 113.656 -178.549 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.71 -58.29 15.36 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.51 179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.495 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -73.72 51.79 0.38 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.145 0.497 . . . . 0.0 110.274 179.475 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.19 -80.11 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.329 -179.297 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.522 ' HA3' ' CA ' ' A' ' 55' ' ' ILE . . . -143.54 -31.98 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.368 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.554 HD13 ' H ' ' A' ' 63' ' ' LEU . 3.8 mp -53.76 -24.11 14.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.29 -33.93 74.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.263 178.621 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.701 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 16.0 mt -60.41 -32.53 71.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.74 179.463 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.6 ' HA ' HD13 ' A' ' 69' ' ' ILE . 5.8 mp -67.22 -42.55 83.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.379 179.558 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.588 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 5.2 mttt -54.21 -41.47 68.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.657 178.742 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.422 ' CB ' HD11 ' A' ' 40' ' ' LEU . 80.2 mm-40 -63.28 -43.16 98.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.6 HD13 ' HA ' ' A' ' 66' ' ' LEU . 5.6 mt -66.47 -36.26 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.701 -178.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.588 ' HG2' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -73.66 -28.46 61.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.934 0.397 . . . . 0.0 110.92 179.853 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.431 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -72.94 -34.78 66.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.987 -179.823 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -93.48 -59.25 2.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.261 179.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.411 ' C ' ' H ' ' A' ' 75' ' ' MET . 68.4 m-70 -111.83 85.15 6.03 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.355 179.463 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 56.2 Cg_endo -71.17 20.18 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.725 2.283 . . . . 0.0 113.282 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 29.1 mtm -144.15 0.93 1.08 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.512 HD13 ' HD2' ' A' ' 48' ' ' PRO . 15.1 tp -76.17 114.87 41.72 Favored Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 179.8 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.31 120.64 8.16 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.471 2.114 . . . . 0.0 111.882 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.49 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -115.47 149.29 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.255 0.55 . . . . 0.0 111.885 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 3.6 mt -132.73 114.51 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.534 178.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.654 HG21 ' O ' ' A' ' 82' ' ' THR . 11.4 mm -93.78 138.28 20.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.19 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.594 ' HB3' ' HD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.15 -9.34 57.98 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.25 -179.338 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.654 ' O ' HG21 ' A' ' 80' ' ' ILE . 3.7 m -147.44 168.6 21.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.714 0.292 . . . . 0.0 110.671 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 84' ' ' HIS . . . -143.22 -18.89 0.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 179.646 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.525 ' CE1' ' CD1' ' A' ' 55' ' ' ILE . 0.2 OUTLIER 23.14 -98.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.247 0.619 . . . . 0.0 112.372 -179.677 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 m -129.29 -176.91 4.03 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.92 0.391 . . . . 0.0 111.245 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.45 ' O ' HD21 ' A' ' 63' ' ' LEU . 5.6 t70 61.64 31.49 18.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.113 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' A' ' 90' ' ' ALA . 4.5 mt -49.61 -21.64 1.07 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.768 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.92 -38.73 17.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.129 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.538 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -74.3 -20.39 60.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.123 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.556 ' HB1' ' CE1' ' A' ' 101' ' ' TYR . . . -71.08 -27.53 63.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.962 0.41 . . . . 0.0 110.109 178.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.564 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.4 t -69.08 -41.53 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.09 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.2 m -61.93 -26.46 68.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.054 0.454 . . . . 0.0 110.026 179.134 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.475 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -63.9 -46.01 86.75 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.929 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.564 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 10.2 m-85 -59.96 -23.78 63.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.555 179.199 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -36.97 65.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.984 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -82.87 -3.5 56.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.733 -179.901 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.85 18.02 13.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.129 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.49 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -61.21 145.1 52.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.965 0.383 . . . . 0.0 110.164 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.529 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 36.9 t80 -72.87 -53.69 10.72 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.776 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.444 ' OD2' ' CD2' ' A' ' 99' ' ' PHE . 12.9 p30 172.61 -167.45 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.821 0.344 . . . . 0.0 111.287 -179.283 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.617 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.3 m-85 -125.6 117.44 23.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.064 0.459 . . . . 0.0 110.736 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.449 ' O ' ' C ' ' A' ' 81' ' ' MET . 7.3 tp -103.01 134.16 19.94 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.577 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.514 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 19.3 Cg_endo -57.71 177.51 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.385 2.057 . . . . 0.0 111.562 179.264 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -40.02 -51.41 5.76 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.182 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 7.1 Cg_endo -48.13 163.88 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.304 2.003 . . . . 0.0 111.532 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.622 ' HA ' ' CG ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 173.92 -88.7 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.132 -179.609 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.622 ' O ' ' CB ' ' A' ' 111' ' ' ALA . 2.7 p30 47.77 -177.21 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.679 HD11 ' HA ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -64.67 -49.03 82.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 C-N-CA 119.714 -0.795 . . . . 0.0 112.344 -178.727 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.411 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 0.9 OUTLIER -53.89 -55.25 28.57 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.175 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.622 ' CG ' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.72 -28.16 24.82 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.704 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.622 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -82.81 -47.41 11.92 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.612 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.636 HG23 HG21 ' A' ' 108' ' ' ILE . 45.3 t -64.3 -32.9 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.474 0.654 . . . . 0.0 109.507 178.262 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.97 -47.95 81.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.172 178.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.475 ' CD2' HG22 ' A' ' 79' ' ' ILE . 6.3 tp -78.91 -22.39 45.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.981 -179.313 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 112' ' ' VAL . 2.3 p -79.37 -49.92 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.822 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.445 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 24.8 mt-10 -55.88 -48.46 75.54 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.626 0.25 . . . . 0.0 111.373 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -61.42 -23.25 65.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.867 0.365 . . . . 0.0 110.82 179.729 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.529 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.53 -48.2 42.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.92 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.2 mt -72.43 -30.76 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.198 0.523 . . . . 0.0 110.523 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 t -69.77 -45.12 68.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.013 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.949 0.404 . . . . 0.0 111.416 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.15 151.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.195 0.521 . . . . 0.0 111.27 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.501 ' HG2' ' CD1' ' A' ' 5' ' ' ILE . 6.1 tpt180 -74.13 -75.05 0.17 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.712 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.24 91.9 1.73 Allowed Glycine 0 C--N 1.323 -0.162 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.658 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.501 ' CD1' ' HG2' ' A' ' 3' ' ' ARG . 4.2 mm -116.74 112.51 39.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.597 0.237 . . . . 0.0 111.393 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 4.8 p -107.27 117.31 52.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.46 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.634 ' CH2' ' HG2' ' A' ' 46' ' ' LYS . 34.3 m0 -108.03 137.96 45.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 0.0 111.109 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.5 t -124.2 141.92 42.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.944 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -128.03 114.1 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.743 177.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.578 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.2 t0 -171.63 -152.02 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.55 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -66.33 -2.44 4.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.6 OUTLIER 59.01 -148.04 0.48 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 121.201 -0.2 . . . . 0.0 111.299 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 t 34.58 -89.41 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 12' ' ' ASP . 61.6 m -55.65 -55.16 35.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.873 0.368 . . . . 0.0 110.971 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.5 mm -63.58 -34.73 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.112 0.482 . . . . 0.0 111.073 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.439 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 0.7 OUTLIER -69.39 -53.79 17.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.944 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.425 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 85.6 t90 -52.52 -45.11 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.542 ' CG1' HD13 ' A' ' 108' ' ' ILE . 1.4 t -67.94 -57.96 7.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.219 0.533 . . . . 0.0 111.424 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.647 ' HA ' HD12 ' A' ' 108' ' ' ILE . 3.6 mm? -67.04 -27.71 67.62 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 15.8 pt-20 -67.55 -59.89 3.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.533 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.5 mmt180 -75.66 -52.38 10.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.525 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -54.15 -54.04 45.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.811 0.339 . . . . 0.0 111.853 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.683 HD12 ' CD1' ' A' ' 28' ' ' LEU . 5.2 tp -64.3 -25.93 68.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.198 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.32 -33.31 74.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.99 -22.77 74.26 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.385 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.99 -15.59 59.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 110.84 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.73 21.99 8.33 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.64 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.683 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.85 170.84 11.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.397 0.599 . . . . 0.0 111.35 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.442 ' O ' HG13 ' A' ' 6' ' ' VAL . 52.1 m -105.11 106.51 17.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.917 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 8.5 t -105.83 114.47 28.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.391 0.615 . . . . 0.0 112.188 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.532 HG22 ' CE1' ' A' ' 33' ' ' PHE . 2.8 t -122.66 156.78 33.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.576 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 33.9 p -127.81 156.63 42.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.451 0.643 . . . . 0.0 112.234 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.944 ' HB2' HG12 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -128.47 174.12 9.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.242 -179.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.475 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -57.61 -52.33 65.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -160.21 -37.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.586 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 178.43 -55.82 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.498 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.609 ' HA ' HD12 ' A' ' 40' ' ' LEU . 17.2 m120 -56.97 -26.9 60.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 110.689 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -63.91 -48.51 76.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.527 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.604 HG22 HG21 ' A' ' 9' ' ' VAL . 13.5 t -58.99 -32.78 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.447 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.609 HD12 ' HA ' ' A' ' 37' ' ' ASN . 32.7 mt -56.21 -47.56 78.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.335 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.99 -47.95 76.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.339 0.59 . . . . 0.0 110.258 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.15 -32.67 72.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.698 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.501 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 15.6 mt -67.47 -27.65 67.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.054 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.34 -15.87 40.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.492 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 m -123.22 -5.51 8.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.799 ' HG3' ' N ' ' A' ' 47' ' ' THR . 1.3 tttt -155.55 166.57 33.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.309 0.576 . . . . 0.0 111.615 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.799 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 96.7 m -138.29 112.75 8.7 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.796 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.412 ' HD2' HD13 ' A' ' 76' ' ' LEU . 56.5 Cg_endo -71.44 158.1 54.9 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.465 2.11 . . . . 0.0 111.657 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.94 -30.59 50.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.78 0.324 . . . . 0.0 111.037 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.417 ' CG2' HD11 ' A' ' 79' ' ' ILE . 5.9 p -145.26 94.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.446 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HG ' HG12 ' A' ' 78' ' ' VAL . 38.2 tp -83.21 141.26 32.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.432 0.634 . . . . 0.0 112.209 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.745 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -124.33 119.62 29.81 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.588 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.827 ' HA ' HG22 ' A' ' 9' ' ' VAL . 1.4 m -115.28 148.08 39.63 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.578 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 28.1 t0 -82.87 -178.0 6.95 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.348 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.671 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.1 tt -160.0 74.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 121.137 0.494 . . . . 0.0 112.095 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 177.05 58.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.646 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.513 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.33 -63.03 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.908 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.513 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 23.0 Cg_endo -60.22 -165.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.669 2.246 . . . . 0.0 113.356 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.03 -65.06 3.32 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.69 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.579 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -85.19 53.18 2.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.995 0.426 . . . . 0.0 110.94 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.441 ' HB3' HG13 ' A' ' 55' ' ' ILE . 1.2 m-20 55.74 -68.45 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.681 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.671 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -152.16 -35.62 0.03 OUTLIER Glycine 0 CA--C 1.507 -0.44 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.271 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 90' ' ' ALA . 1.0 OUTLIER -53.64 -28.24 31.75 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.2 -34.42 75.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.528 HD11 ' HA3' ' A' ' 36' ' ' GLY . 74.1 mt -59.98 -35.99 76.19 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.672 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.742 HD21 ' HB ' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -61.83 -51.06 69.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.433 178.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.668 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 11.9 tttp -47.36 -44.93 24.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.082 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.569 ' CB ' HD13 ' A' ' 40' ' ' LEU . 2.5 mt-30 -60.76 -43.18 98.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.202 0.525 . . . . 0.0 110.174 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.6 mt -64.98 -37.94 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.06 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.668 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -77.21 -23.48 51.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.541 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -67.17 -43.41 82.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.126 0.488 . . . . 0.0 111.233 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.83 -26.55 13.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.176 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.501 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 59.3 m-70 -130.25 76.23 78.11 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.751 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 73.5 Cg_endo -75.21 40.22 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.616 2.21 . . . . 0.0 112.236 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 59.1 mtt -153.97 -39.19 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.435 ' CD2' HD21 ' A' ' 43' ' ' LEU . 16.8 tp -55.01 112.31 3.96 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.916 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.585 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 59.4 Cg_endo -73.41 141.21 31.38 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.934 1.756 . . . . 0.0 111.985 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.742 ' HB ' HD21 ' A' ' 66' ' ' LEU . 2.3 t -128.93 151.58 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.335 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.521 HG12 ' CD2' ' A' ' 99' ' ' PHE . 1.5 mt -120.93 118.54 56.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.991 0.424 . . . . 0.0 111.135 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.544 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 16.3 mm -95.01 142.68 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.509 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.456 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -82.31 -16.83 47.94 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.513 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.6 m -148.14 144.54 27.86 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.906 -0.717 . . . . 0.0 111.989 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.68 40.44 3.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.839 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.469 ' CE1' HG22 ' A' ' 82' ' ' THR . 1.1 p-80 -89.51 -12.07 41.08 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.425 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -92.98 -164.14 1.14 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.641 0.258 . . . . 0.0 110.613 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.412 ' O ' ' CD2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -53.84 93.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.758 0.314 . . . . 0.0 111.334 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.472 ' HA ' HD21 ' A' ' 63' ' ' LEU . 1.7 mt -59.52 -21.89 60.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.741 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.0 -43.47 29.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.333 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . . . -68.95 -23.15 64.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.688 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.576 ' HB2' HD22 ' A' ' 63' ' ' LEU . . . -67.86 -23.01 65.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.754 0.311 . . . . 0.0 110.273 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.635 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.4 t -69.03 -41.95 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.464 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.589 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 91.3 p -60.45 -18.2 49.6 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.742 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.72 -53.91 7.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.431 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.635 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.2 m-85 -58.75 -31.43 68.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.064 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.589 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -75.88 -34.62 60.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.816 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.742 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 3.1 pp0? -80.75 -18.26 48.31 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.607 0.241 . . . . 0.0 110.82 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 77' ' ' PRO . . . 112.27 32.56 2.33 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.207 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . . . -65.01 169.82 4.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.238 0.519 . . . . 0.0 110.998 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.587 ' CZ ' ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -85.55 -55.24 4.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.727 0.298 . . . . 0.0 110.941 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 99' ' ' PHE . 0.1 OUTLIER 164.77 -162.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.884 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.544 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.1 m-85 -132.86 112.49 11.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.127 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.64 HD23 ' CE1' ' A' ' 106' ' ' PHE . 4.8 tp -102.96 142.97 25.66 Favored Pre-proline 0 C--O 1.226 -0.169 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.275 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.733 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 19.3 Cg_endo -56.66 170.6 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.344 2.029 . . . . 0.0 111.196 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.487 ' O ' ' HE3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -44.5 -47.24 26.47 Favored Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.733 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 75.1 Cg_exo -47.99 162.01 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.376 1.384 . . . . 0.0 110.288 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.652 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -176.65 -83.98 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.291 -178.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.4 p30 41.93 -168.56 0.0 OUTLIER 'General case' 0 C--O 1.231 0.113 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.647 HD12 ' HA ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -67.66 -51.5 50.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 121.243 0.544 . . . . 0.0 111.421 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.658 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 2.9 t70 -48.96 -57.42 6.52 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.433 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.652 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.3 mm-40 -77.02 -31.19 56.21 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -84.34 -53.7 5.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.175 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.552 HG22 HG23 ' A' ' 108' ' ' ILE . 42.0 t -56.53 -32.41 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.428 0.632 . . . . 0.0 110.158 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -58.63 -52.72 64.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.821 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.445 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 5.9 tp -71.81 -25.69 62.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.816 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.547 HG11 ' O ' ' A' ' 112' ' ' VAL . 10.0 p -79.24 -54.18 12.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.417 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 1.8 mt-10 -57.57 -62.47 1.77 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.735 0.303 . . . . 0.0 111.515 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.32 -28.65 29.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.287 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.587 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.91 -49.28 20.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.871 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.483 HD12 HG21 ' A' ' 115' ' ' VAL . 5.6 mt -64.58 -31.42 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.125 0.488 . . . . 0.0 110.482 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.8 t -64.95 -33.9 77.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.748 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -73.76 -27.99 61.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.762 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -78.88 -55.93 4.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.87 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 59.51 174.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.052 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -179.923 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.866 0.365 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.66 155.11 22.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.43 -33.52 23.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.061 0.458 . . . . 0.0 110.817 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.61 94.51 0.34 Allowed Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.42 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 2.8 mm -114.18 112.54 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 111.28 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 8.4 p -113.66 125.48 70.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.325 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.58 ' NE1' HG21 ' A' ' 31' ' ' THR . 35.5 m0 -115.38 139.08 50.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.626 0.251 . . . . 0.0 110.823 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -132.31 138.29 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.844 HG21 ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -128.11 107.22 15.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.668 178.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 48.6 t0 166.85 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.239 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 0.3 OUTLIER 71.06 -41.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.484 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 16' ' ' ARG . 38.8 t70 74.62 -106.3 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.971 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 12' ' ' ASP . 52.2 p -23.57 -84.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 m -53.46 -45.42 69.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.456 ' O ' HG21 ' A' ' 15' ' ' ILE . 27.1 mm -67.94 -20.48 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.822 0.344 . . . . 0.0 111.741 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.541 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 2.7 ttt180 -79.2 -54.92 5.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 111.689 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.424 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 65.0 t90 -52.37 -42.75 64.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.489 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.514 ' C ' HD11 ' A' ' 108' ' ' ILE . 1.7 t -71.38 -51.18 35.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.038 0.447 . . . . 0.0 111.92 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.519 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 4.4 mm? -70.82 -28.66 64.78 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.466 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.568 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . 23.6 pt-20 -67.59 -58.96 3.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.474 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.4 mmt180 -63.15 -58.01 8.65 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.07 -55.43 27.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.987 0.423 . . . . 0.0 111.474 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.604 ' HG ' HD13 ' A' ' 28' ' ' LEU . 14.3 tp -66.62 -19.71 65.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.467 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -70.6 -33.34 70.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.53 -26.6 68.45 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.235 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.459 ' HB3' HD11 ' A' ' 28' ' ' LEU . . . -76.87 -15.63 59.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.629 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.77 25.65 9.66 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.781 -0.723 . . . . 0.0 114.795 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.604 HD13 ' HG ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -120.0 164.74 15.65 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.61 1.205 . . . . 0.0 112.313 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.502 ' O ' HG13 ' A' ' 6' ' ' VAL . 21.0 m -94.57 111.26 23.02 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.257 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 1.1 m -102.35 118.95 37.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.293 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.615 HG22 ' CE1' ' A' ' 33' ' ' PHE . 3.1 t -128.88 136.1 49.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 55.2 p -113.99 157.62 22.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.748 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.8 m-85 -134.8 173.8 11.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.904 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.9 pp20? -61.3 -58.06 9.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.609 ' C ' HG13 ' A' ' 9' ' ' VAL . 1.9 t30 -156.3 -23.05 0.1 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.477 ' N ' HG13 ' A' ' 9' ' ' VAL . . . 165.12 -59.32 0.25 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.717 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.621 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -47.37 -32.91 5.31 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.148 0.499 . . . . 0.0 110.704 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -60.95 -60.89 3.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.613 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.764 HG21 HG22 ' A' ' 9' ' ' VAL . 1.9 t -53.86 -34.65 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.329 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.621 HD12 ' HA ' ' A' ' 37' ' ' ASN . 32.0 mt -48.81 -52.34 24.59 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.054 0.454 . . . . 0.0 110.406 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -47.97 83.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.108 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.59 -35.16 80.09 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.771 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.642 HD12 HG11 ' A' ' 39' ' ' VAL . 23.2 mt -68.32 -19.93 64.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.612 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.18 -11.98 58.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.296 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.29 -3.79 7.4 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -155.49 161.45 40.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.986 0.422 . . . . 0.0 111.31 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.417 HG21 ' CG ' ' A' ' 76' ' ' LEU . 21.1 m -138.47 112.37 8.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.952 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.64 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 73.9 Cg_endo -74.6 164.91 32.78 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.12 1.88 . . . . 0.0 111.822 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.43 -24.03 34.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.997 0.427 . . . . 0.0 110.472 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.48 ' CG2' HD12 ' A' ' 79' ' ' ILE . 7.5 p -149.97 91.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.491 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.489 ' HG ' HG11 ' A' ' 78' ' ' VAL . 57.9 tp -84.25 149.73 25.91 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.242 0.544 . . . . 0.0 111.906 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.844 ' O ' HG21 ' A' ' 9' ' ' VAL . 5.3 mt -133.73 114.06 13.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.052 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -109.18 144.02 37.83 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 9.7 t0 -73.34 -171.9 1.05 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.756 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.691 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 8.6 tt -169.96 84.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 120.878 0.371 . . . . 0.0 111.703 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.583 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 167.9 59.87 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.171 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -161.0 -63.06 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.095 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.438 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 22.5 Cg_endo -59.47 -173.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.765 2.31 . . . . 0.0 113.471 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.98 -66.67 2.67 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.58 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.47 ' O ' ' N ' ' A' ' 62' ' ' GLY . 2.3 ttm -72.15 57.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.038 0.447 . . . . 0.0 110.367 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.91 -79.09 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.186 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.691 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -146.53 -28.69 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.866 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.636 ' HA ' HD13 ' A' ' 66' ' ' LEU . 3.7 mp -63.16 -19.19 64.25 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.916 0.358 . . . . 0.0 110.703 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.57 -22.76 9.04 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.083 0.468 . . . . 0.0 110.863 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.487 HD21 ' N ' ' A' ' 37' ' ' ASN . 5.8 mt -69.62 -40.79 76.38 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.317 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.636 HD13 ' HA ' ' A' ' 63' ' ' LEU . 6.6 mp -56.61 -41.23 76.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.419 0.628 . . . . 0.0 109.938 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -53.75 -53.13 56.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.07 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.435 ' HB2' HD11 ' A' ' 40' ' ' LEU . 10.8 mm-40 -69.18 -29.34 67.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.182 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.695 HG23 ' CE1' ' A' ' 73' ' ' HIS . 1.5 mm -52.87 -52.75 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.136 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.461 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -68.68 -31.03 69.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.283 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.48 ' NE2' ' HG2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.99 -23.34 44.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.692 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.48 ' HG2' ' NE2' ' A' ' 71' ' ' GLN . 10.4 mmt180 -85.95 -73.27 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.07 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.695 ' CE1' HG23 ' A' ' 69' ' ' ILE . 11.2 p80 -89.35 167.26 18.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.211 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.595 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 89.0 Cg_endo -78.29 72.27 6.36 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.782 2.322 . . . . 0.0 112.912 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.612 ' HB2' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER 54.09 34.37 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.403 179.114 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.64 ' HG ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -63.1 121.04 66.71 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.494 ' HD2' HD22 ' A' ' 76' ' ' LEU . 10.7 Cg_endo -53.58 132.31 48.28 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.846 2.364 . . . . 0.0 113.19 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.55 HG21 HG22 ' A' ' 69' ' ' ILE . 2.9 t -123.41 154.29 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.541 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.524 HD11 ' HG ' ' A' ' 52' ' ' LEU . 3.6 mt -131.56 117.17 34.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.212 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 53' ' ' SER . 11.5 mm -93.57 150.45 3.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.624 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.539 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -87.02 -19.43 28.68 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.618 ' O ' HD11 ' A' ' 55' ' ' ILE . 2.7 m -147.03 171.0 15.95 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.656 0.265 . . . . 0.0 110.996 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.443 ' HB1' ' CD2' ' A' ' 87' ' ' LEU . . . -122.34 -20.99 5.95 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.729 0.3 . . . . 0.0 111.459 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' A' ' 85' ' ' SER . 4.2 m-70 45.07 29.71 0.52 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 73.3 m 67.92 -3.99 1.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.507 ' O ' HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -92.5 39.19 1.02 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.045 0.45 . . . . 0.0 110.301 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.443 ' CD2' ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -48.44 -21.05 0.48 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.292 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -47.49 -57.65 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.535 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . . . -65.64 -24.52 67.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.567 0.222 . . . . 0.0 111.537 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.474 ' HB3' HD22 ' A' ' 63' ' ' LEU . . . -68.69 -33.21 73.58 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.657 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.1 t -62.99 -45.37 99.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.607 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 91.7 p -60.3 -34.1 73.3 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.426 0.632 . . . . 0.0 109.89 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.538 ' HA ' ' CD ' ' A' ' 96' ' ' GLN . . . -59.72 -41.39 90.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.48 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.657 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.8 m-85 -61.91 -21.57 64.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.065 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.612 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.78 -43.41 72.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.503 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.612 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 6.8 pm0 -82.13 -19.12 40.69 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.12 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.63 38.95 0.64 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.662 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.432 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . . . -63.57 154.25 33.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.145 0.472 . . . . 0.0 110.237 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 118' ' ' ALA . 2.2 t80 -79.79 -53.58 6.65 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.71 -162.68 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.769 0.319 . . . . 0.0 111.065 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.556 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.0 m-85 -142.63 139.36 31.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.172 0.511 . . . . 0.0 111.132 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.584 HD23 ' O ' ' A' ' 105' ' ' PRO . 2.1 tp -101.92 140.8 21.5 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.442 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 35.4 Cg_exo -61.42 -34.54 86.28 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.077 1.851 . . . . 0.0 111.962 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.665 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER 167.54 -50.63 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.245 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.7 Cg_endo -47.85 163.79 0.19 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.008 1.805 . . . . 0.0 109.94 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.688 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 26.7 t80 -168.46 -92.13 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.329 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.488 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.7 p30 41.78 -171.24 0.0 OUTLIER 'General case' 0 C--N 1.335 -0.063 0 CA-C-O 120.961 0.41 . . . . 0.0 111.117 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.514 HD11 ' C ' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -68.11 -49.98 62.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.603 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 7.9 m-20 -51.11 -57.11 9.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.819 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.688 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -76.31 -30.54 57.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.498 ' HB3' ' CD1' ' A' ' 106' ' ' PHE . . . -83.61 -56.97 3.43 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.021 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 115' ' ' VAL . 43.3 t -54.43 -30.38 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.459 0.647 . . . . 0.0 109.987 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -60.07 -54.6 44.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.574 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.407 HD22 HG22 ' A' ' 79' ' ' ILE . 6.7 tp -71.4 -22.37 61.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.522 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 112' ' ' VAL . 4.3 p -79.45 -50.34 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.936 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.427 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 23.0 mt-10 -62.73 -46.7 86.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.01 0.433 . . . . 0.0 109.908 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -64.91 -25.71 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.176 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . . . -69.67 -53.41 18.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.093 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.5 mt -66.13 -31.38 53.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.096 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.5 p -70.26 -43.69 69.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.13 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -64.66 -30.66 71.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.41 -55.36 6.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.173 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 56.48 173.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.834 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.016 0.436 . . . . 0.0 110.96 -179.823 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mmt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.732 0.301 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 60.22 160.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.724 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -61.74 -17.58 56.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.057 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.13 92.99 0.23 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.211 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.78 112.33 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.686 0.279 . . . . 0.0 111.355 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.585 HG11 ' O ' ' A' ' 29' ' ' THR . 7.1 p -107.2 125.65 63.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.79 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.913 ' CD1' HG21 ' A' ' 31' ' ' THR . 33.1 m0 -112.82 145.24 40.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.038 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -139.09 137.21 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.138 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.823 HG23 ' HA ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -126.35 105.14 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.483 178.099 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 60.8 t0 166.81 118.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.887 0.375 . . . . 0.0 111.243 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.44 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.6 OUTLIER 72.26 -21.59 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.118 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 10' ' ' ASP . 8.5 t0 70.47 -135.31 0.05 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.579 -0.076 . . . . 0.0 110.849 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.4 m -33.55 -45.41 0.17 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.3 m -53.38 -67.57 0.24 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.948 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 25.1 mm -65.84 -20.6 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.453 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.662 ' HG3' HG23 ' A' ' 32' ' ' THR . 12.5 ttt-85 -72.39 -61.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.401 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.473 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 71.4 t90 -48.31 -44.28 33.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.175 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.59 ' C ' HD13 ' A' ' 108' ' ' ILE . 1.9 t -64.82 -62.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.919 0.39 . . . . 0.0 111.859 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 7.4 tp -71.51 -19.45 62.18 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.545 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 13.8 pt-20 -67.96 -57.71 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.687 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.545 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.28 -56.62 11.69 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.993 -179.022 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.8 -56.34 16.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 0.0 111.441 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.713 HD12 ' CD1' ' A' ' 28' ' ' LEU . 13.5 tp -64.42 -19.75 65.72 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.33 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -70.12 -37.66 75.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.6 -25.01 62.7 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.197 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.39 -15.9 59.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.74 0.305 . . . . 0.0 110.768 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.75 26.18 9.28 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.748 -0.739 . . . . 0.0 114.714 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.713 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -122.41 166.14 15.21 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.478 1.139 . . . . 0.0 112.121 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.585 ' O ' HG11 ' A' ' 6' ' ' VAL . 53.5 m -94.98 114.96 26.84 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.34 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -105.17 109.17 21.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.985 -178.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.913 HG21 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -121.8 137.58 54.71 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 74.5 p -117.34 160.83 20.5 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.825 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 7.6 m-85 -136.03 174.52 10.52 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.077 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.632 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.5 pp20? -60.88 -63.29 1.35 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.608 ' N ' HG11 ' A' ' 9' ' ' VAL . 68.3 m-80 -153.89 -22.74 0.14 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.504 ' HA3' ' CD1' ' A' ' 65' ' ' LEU . . . 172.41 -63.42 0.14 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.862 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.492 ' HA ' HD11 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -48.31 -29.38 3.83 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.875 0.369 . . . . 0.0 111.043 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.825 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -63.25 -58.1 8.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.127 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.637 HG22 ' CG ' ' A' ' 33' ' ' PHE . 20.4 t -49.08 -46.27 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.195 0.521 . . . . 0.0 110.899 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.546 HD12 ' HB2' ' A' ' 68' ' ' GLN . 2.1 mt -49.9 -44.86 50.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.003 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.41 81.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.309 0.576 . . . . 0.0 110.937 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.56 -31.55 67.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.217 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.562 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 9.6 mt -65.67 -27.51 68.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.93 -20.08 21.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.608 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.9 t -126.76 1.92 6.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.818 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.492 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -153.99 159.79 41.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 111.049 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.455 HG22 ' CD2' ' A' ' 76' ' ' LEU . 96.3 m -138.67 112.75 8.43 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.238 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.612 ' HD2' HD22 ' A' ' 76' ' ' LEU . 93.9 Cg_endo -77.12 152.52 31.33 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.04 1.827 . . . . 0.0 111.751 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -74.57 -29.12 61.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.816 0.341 . . . . 0.0 110.692 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.434 HG22 HG23 ' A' ' 115' ' ' VAL . 7.5 p -145.32 94.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.484 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 77' ' ' PRO . 63.2 tp -86.95 150.92 23.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.473 0.654 . . . . 0.0 112.282 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.768 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.5 mt -131.76 124.98 30.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.778 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.823 ' HA ' HG23 ' A' ' 9' ' ' VAL . 3.8 m -127.91 150.62 49.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 25.2 t0 -82.7 170.69 14.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.363 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.851 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 3.7 tt -147.15 82.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.842 0.353 . . . . 0.0 111.524 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 174.0 61.12 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.892 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.436 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.55 -62.79 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.65 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 22.5 Cg_endo -58.39 -170.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.249 2.633 . . . . 0.0 113.29 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.68 -71.41 0.75 Allowed Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.327 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.55 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -73.03 59.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.0 110.343 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.81 -74.8 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.46 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.851 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -150.26 -32.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.46 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' O ' ' A' ' 86' ' ' ASP . 3.2 mp -59.08 -20.33 52.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.864 0.364 . . . . 0.0 110.366 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 60' ' ' MET . . . -58.14 -31.37 67.13 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.466 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.65 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 5.9 mt -65.08 -39.61 93.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.409 . . . . 0.0 110.583 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 63' ' ' LEU . 6.0 mp -60.08 -43.36 95.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.74 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.414 ' HE2' ' HB1' ' A' ' 89' ' ' ALA . 22.9 mttm -54.07 -42.51 69.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.235 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.546 ' HB2' HD12 ' A' ' 40' ' ' LEU . 41.1 mm-40 -61.3 -34.14 74.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.236 0.541 . . . . 0.0 110.053 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.566 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 49.7 mm -59.69 -41.68 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.114 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 96' ' ' GLN . 11.9 pttp -74.72 -27.78 60.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.249 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.412 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 1.3 mt-30 -63.73 -42.48 97.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.04 0.447 . . . . 0.0 111.267 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 72' ' ' ARG . 12.4 mtt85 -103.7 -49.99 3.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.276 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.562 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 4.1 m-70 -88.58 135.26 32.67 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.615 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.11 -76.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.849 2.366 . . . . 0.0 112.664 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 21.4 mtm -140.92 52.75 1.59 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.456 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.612 HD22 ' HD2' ' A' ' 48' ' ' PRO . 2.2 tm? -56.49 111.6 3.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.214 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 26.7 Cg_exo -62.35 115.36 2.82 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.27 1.98 . . . . 0.0 112.158 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.885 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -121.82 153.3 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.805 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.52 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 3.2 mt -130.64 117.78 40.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.308 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.6 ' HA ' ' O ' ' A' ' 53' ' ' SER . 19.3 mm -93.86 149.28 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.262 0.553 . . . . 0.0 112.407 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.54 ' N ' ' HE1' ' A' ' 81' ' ' MET . 0.0 OUTLIER -84.7 -18.63 34.66 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.501 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.499 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 3.3 m -147.44 160.98 41.96 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.722 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.422 ' CB ' ' HG ' ' A' ' 87' ' ' LEU . . . -111.09 -24.76 10.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.091 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 47.03 -171.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.344 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.35 53.0 2.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.873 0.368 . . . . 0.0 111.165 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.515 ' O ' HD21 ' A' ' 63' ' ' LEU . 5.6 m-20 -158.98 28.38 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.422 ' HG ' ' CB ' ' A' ' 83' ' ' ALA . 2.0 mt -46.38 -21.39 0.16 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.79 -56.13 8.09 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.414 ' HB1' ' HE2' ' A' ' 67' ' ' LYS . . . -64.65 -19.94 66.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.639 0.257 . . . . 0.0 111.467 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.467 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . . . -65.14 -50.99 63.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.342 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.631 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.7 t -65.35 -48.92 81.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.94 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -58.96 -25.04 63.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.956 0.408 . . . . 0.0 110.218 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.638 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -61.56 -51.86 66.81 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.443 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.647 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 2.7 m-85 -55.83 -30.57 61.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.01 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -37.62 56.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.461 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.529 ' HB2' ' CB ' ' A' ' 70' ' ' LYS . 1.7 pt20 -100.07 4.71 44.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 123.08 81.9 0.56 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.026 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.885 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.7 126.96 1.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 0.0 111.241 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 78.6 t80 -64.77 -53.41 47.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.379 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.647 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.6 OUTLIER 178.2 -169.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.881 0.372 . . . . 0.0 111.086 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.507 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.2 m-85 -123.84 118.72 27.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.471 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.635 HD23 ' CE2' ' A' ' 106' ' ' PHE . 5.7 tp -102.45 134.11 20.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.534 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 8.1 Cg_endo -49.4 166.66 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.697 2.265 . . . . 0.0 112.036 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.626 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -41.13 -50.08 8.17 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.547 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.7 Cg_endo -47.69 162.6 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.768 1.646 . . . . 0.0 110.441 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.664 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -171.58 -87.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.87 -178.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.723 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 43.25 -170.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.59 0.233 . . . . 0.0 110.396 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.59 HD13 ' C ' ' A' ' 18' ' ' VAL . 1.2 mp -68.04 -45.98 82.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.225 0.536 . . . . 0.0 111.336 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.765 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 7.4 t0 -51.72 -58.17 7.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.695 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.664 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 1.4 mm-40 -78.29 -27.69 47.37 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.24 -57.02 3.34 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.722 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.599 ' O ' HG11 ' A' ' 115' ' ' VAL . 41.3 t -54.23 -31.82 22.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.557 0.694 . . . . 0.0 110.158 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -61.84 -52.48 63.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.745 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.418 ' CD2' HG23 ' A' ' 79' ' ' ILE . 13.6 tp -74.3 -20.66 60.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.625 -1.171 . . . . 0.0 112.791 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.599 HG11 ' O ' ' A' ' 112' ' ' VAL . 9.8 p -79.32 -50.12 18.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.934 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.426 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 43.8 mt-10 -64.22 -41.57 96.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.001 0.429 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -67.56 -25.01 65.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.872 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.99 -54.11 8.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.047 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.4 mt -62.61 -31.34 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.084 0.468 . . . . 0.0 110.508 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.1 m -68.55 -38.11 80.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.741 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -29.59 70.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.88 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -69.23 -37.75 78.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.993 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -75.3 -170.15 1.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.902 179.925 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.812 0.339 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.483 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -88.54 159.92 17.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.953 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.417 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -64.72 -62.45 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.222 0.534 . . . . 0.0 111.736 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.417 ' H ' ' CG ' ' A' ' 3' ' ' ARG . . . 153.45 103.45 0.23 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.367 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.676 HD11 ' HB ' ' A' ' 29' ' ' THR . 16.9 mm -130.46 112.86 23.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.772 0.32 . . . . 0.0 111.32 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.689 HG11 ' HG ' ' A' ' 23' ' ' LEU . 7.8 p -107.69 136.01 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.727 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.606 ' NE1' HG21 ' A' ' 31' ' ' THR . 38.5 m0 -122.17 127.37 49.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -118.08 132.23 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -177.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.757 HG22 HG21 ' A' ' 39' ' ' VAL . 0.1 OUTLIER -116.79 105.11 17.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.12 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 37.4 t0 173.87 100.66 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 t0 65.44 -15.03 0.11 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.474 ' H ' ' C ' ' A' ' 10' ' ' ASP . 3.7 p-10 45.27 -152.56 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.55 0.159 . . . . 0.0 110.893 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.423 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.8 t 32.53 -91.73 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.423 ' H ' ' HB3' ' A' ' 13' ' ' SER . 48.3 t -56.25 -57.49 11.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.625 0.25 . . . . 0.0 110.766 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 15' ' ' ILE . 27.1 mm -60.17 -20.78 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.443 . . . . 0.0 110.36 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.575 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 2.4 ttm180 -78.78 -58.8 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.601 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 75.1 t90 -49.16 -41.35 36.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.157 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.529 ' C ' HD12 ' A' ' 108' ' ' ILE . 1.3 t -68.15 -57.84 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.487 HD12 ' HB1' ' A' ' 111' ' ' ALA . 4.2 tp -69.95 -25.4 63.63 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.625 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 23.0 pt-20 -67.69 -57.62 6.06 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.84 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.491 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 6.4 mmt180 -58.49 -53.1 62.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.017 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.43 77.52 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.689 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.3 tm? -76.67 -28.95 56.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.246 0.546 . . . . 0.0 110.474 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.67 -32.25 73.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.424 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.28 -24.64 70.74 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.385 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.06 -14.9 59.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.87 0.367 . . . . 0.0 110.879 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.41 23.33 10.4 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.516 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.499 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -130.96 170.72 14.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 117.471 0.635 . . . . 0.0 111.524 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.676 ' HB ' HD11 ' A' ' 5' ' ' ILE . 31.0 m -96.93 141.74 29.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.236 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.625 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -127.54 119.35 25.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.815 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.606 HG21 ' NE1' ' A' ' 7' ' ' TRP . 2.9 t -131.71 135.63 47.01 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 38.9 p -108.62 163.17 13.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.732 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 39.5 m-85 -137.47 174.03 11.03 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.79 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.726 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.0 pp20? -62.83 -60.4 3.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.748 ' C ' HG12 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -155.38 -32.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.316 0.507 . . . . 0.0 112.19 -179.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.539 ' N ' HG12 ' A' ' 9' ' ' VAL . . . -179.14 -65.71 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.484 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.414 ' HA ' HD12 ' A' ' 40' ' ' LEU . 13.9 m120 -47.72 -27.6 2.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 111.221 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.732 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -57.23 -60.83 3.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.757 HG21 HG22 ' A' ' 9' ' ' VAL . 65.4 t -50.71 -45.9 27.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 68' ' ' GLN . 8.6 mt -46.24 -41.52 13.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.287 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.99 -47.81 67.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.926 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.16 -31.28 67.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.32 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.621 HD13 ' CD2' ' A' ' 73' ' ' HIS . 10.9 mt -61.36 -29.06 69.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.088 0.47 . . . . 0.0 111.042 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.56 -20.04 29.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.483 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 m -118.89 -8.49 10.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.863 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -156.3 157.99 36.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.784 0.326 . . . . 0.0 110.988 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.4 HG23 ' CD2' ' A' ' 76' ' ' LEU . 78.6 m -138.62 112.85 8.48 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.279 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.427 ' HD2' HD22 ' A' ' 76' ' ' LEU . 72.3 Cg_endo -76.94 162.35 32.22 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 121.874 1.716 . . . . 0.0 111.388 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.483 ' OD2' ' HB3' ' A' ' 2' ' ' GLN . 0.9 OUTLIER -73.76 -21.03 60.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.876 0.37 . . . . 0.0 110.925 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.633 ' CG2' HD11 ' A' ' 79' ' ' ILE . 4.4 p -148.6 163.67 5.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.816 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 7' ' ' TRP . 23.5 tp -152.83 154.18 34.61 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.314 0.578 . . . . 0.0 112.307 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.67 ' HB2' HG13 ' A' ' 8' ' ' VAL . 4.8 mt -137.79 122.05 18.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.513 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.464 ' HA ' HG23 ' A' ' 9' ' ' VAL . 1.3 m -106.55 144.76 32.76 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.576 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 46.0 t0 -79.05 -11.7 60.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.7 ' HB ' ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER 51.53 154.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.684 0.754 . . . . 0.0 111.589 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.603 ' H ' ' C ' ' A' ' 61' ' ' ASP . 5.1 ttt180 84.38 72.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.767 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.474 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.44 -67.07 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 51.8 Cg_endo -66.25 -160.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.154 2.569 . . . . 0.0 113.028 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.17 13.4 50.32 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.392 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.439 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -152.05 47.65 0.77 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.622 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 1.0 OUTLIER 45.77 -86.14 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.569 -178.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.7 ' HA3' ' HB ' ' A' ' 55' ' ' ILE . . . -124.03 -30.5 1.02 Allowed Glycine 0 CA--C 1.508 -0.392 0 C-N-CA 119.863 -1.161 . . . . 0.0 112.901 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.846 ' HA ' HD11 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -63.74 -19.48 64.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.31 -34.16 77.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.453 ' CD2' ' HA3' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -57.51 -45.4 85.01 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.352 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.846 HD11 ' HA ' ' A' ' 63' ' ' LEU . 4.9 mt -53.96 -47.0 71.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.53 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.713 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 9.4 tttt -51.98 -43.91 63.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.316 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.575 ' HB2' HD13 ' A' ' 40' ' ' LEU . 9.3 mm100 -65.84 -38.64 89.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.123 0.487 . . . . 0.0 110.279 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.494 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 30.3 mm -61.94 -42.07 93.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.913 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.713 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -70.6 -27.23 63.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.834 -179.08 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -68.76 -39.37 80.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.247 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.99 -54.79 2.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.029 0.443 . . . . 0.0 111.945 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.621 ' CD2' HD13 ' A' ' 43' ' ' LEU . 2.1 m-70 -83.21 145.2 48.36 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.193 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.33 -79.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.724 2.283 . . . . 0.0 113.214 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.723 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 11.5 mtt -127.13 45.68 2.66 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.84 0.352 . . . . 0.0 111.689 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.494 ' HB3' ' CG2' ' A' ' 69' ' ' ILE . 1.4 tm? -58.64 106.97 0.8 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.505 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.446 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 48.3 Cg_exo -58.14 116.38 3.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.453 2.102 . . . . 0.0 112.249 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.702 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -112.88 152.17 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.041 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.633 HD11 ' CG2' ' A' ' 50' ' ' VAL . 5.9 mt -142.73 114.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.593 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.651 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 3.8 mm -94.29 131.38 41.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.315 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.596 ' HE2' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -75.38 -6.39 49.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.429 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.475 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.9 m -145.68 158.04 43.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.602 0.239 . . . . 0.0 110.381 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.57 47.1 1.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.339 . . . . 0.0 110.705 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.402 ' CE1' ' CG2' ' A' ' 82' ' ' THR . 6.6 m-70 -76.13 108.97 9.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.824 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 m 51.94 178.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.717 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.654 ' O ' HD23 ' A' ' 63' ' ' LEU . 1.1 m-20 62.28 14.41 6.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.438 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.88 -23.71 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -48.33 -45.6 35.47 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -73.78 -19.85 60.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.406 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . . . -58.82 -36.87 75.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 0.0 110.219 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.55 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.6 t -65.75 -37.26 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.491 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 m -66.9 -25.12 66.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.181 0.515 . . . . 0.0 109.693 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.627 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -64.33 -47.96 77.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.768 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.55 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.3 m-85 -61.61 -26.98 68.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.48 0.657 . . . . 0.0 109.399 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -41.62 41.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.544 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.723 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.6 pp0? -75.94 -16.95 59.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.806 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.13 -2.39 8.38 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.152 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.702 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -55.94 156.67 5.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.857 0.328 . . . . 0.0 110.875 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.501 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 52.7 t80 -86.79 -53.52 4.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.777 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.49 -161.63 0.02 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.842 0.353 . . . . 0.0 111.677 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.651 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.2 m-85 -127.86 124.4 37.42 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.259 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.605 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 5.8 tp -106.65 137.42 19.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.289 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.715 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 12.3 Cg_endo -53.48 165.75 1.49 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.273 1.982 . . . . 0.0 111.115 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.432 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -41.62 -45.41 7.99 Favored Pre-proline 0 N--CA 1.468 0.461 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.715 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 80.6 Cg_exo -47.07 162.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 121.774 1.649 . . . . 0.0 110.531 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 3.8 t80 -164.21 -95.54 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.237 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.732 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 3.3 p30 43.14 -173.25 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 120.814 0.34 . . . . 0.0 110.597 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.529 HD12 ' C ' ' A' ' 18' ' ' VAL . 1.2 mp -67.47 -48.87 75.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.799 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 11.6 m-20 -52.18 -55.47 20.8 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.847 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.704 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.6 mm-40 -78.0 -30.69 50.24 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.732 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -82.51 -59.6 2.47 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.77 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.578 ' O ' HG13 ' A' ' 115' ' ' VAL . 39.8 t -51.72 -33.87 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.505 0.669 . . . . 0.0 110.5 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.799 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -59.76 -51.43 69.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.76 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.611 HD12 ' HD2' ' A' ' 117' ' ' ARG . 19.8 tp -76.04 -21.17 57.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.959 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 112' ' ' VAL . 5.9 p -79.42 -48.95 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.655 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 70.4 mt-10 -61.58 -52.2 65.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.73 0.3 . . . . 0.0 111.1 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.611 ' HD2' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -61.19 -24.57 66.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.77 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.56 -53.6 9.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 111.303 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.1 -31.32 51.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.481 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.0 p -66.06 -44.48 84.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.52 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -74.6 -28.83 61.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.746 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -78.02 -57.34 3.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.577 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.4 172.43 13.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.828 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.888 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.726 0.298 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.64 133.64 55.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.108 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.425 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 1.7 ttt180 -56.54 -23.21 38.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.916 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 56.31 77.99 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.803 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.678 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 2.5 mp -116.36 118.94 60.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.516 0.198 . . . . 0.0 110.651 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 7.1 p -116.35 123.96 72.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.681 0.277 . . . . 0.0 110.8 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.477 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 43.9 m0 -115.49 131.3 56.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.85 0.357 . . . . 0.0 110.642 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.713 HG12 ' HB2' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -121.47 139.79 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.781 -178.259 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.78 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -126.47 105.81 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.07 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.488 ' C ' ' H ' ' A' ' 12' ' ' ASP . 43.0 t0 174.52 105.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.705 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.59 -15.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 10' ' ' ASP . 2.6 p30 44.44 -155.22 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.46 0.118 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 1.5 t 30.68 -89.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 12' ' ' ASP . 23.3 m -54.37 -57.49 11.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.37 . . . . 0.0 110.481 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 15' ' ' ILE . 35.5 mm -60.48 -20.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.167 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.536 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 5.8 ttt-85 -77.37 -61.09 2.1 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.808 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.4 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 70.3 t90 -45.58 -42.75 11.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.586 ' C ' HD11 ' A' ' 108' ' ' ILE . 1.8 t -66.95 -62.65 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.04 0.448 . . . . 0.0 112.058 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.452 HD21 ' HB1' ' A' ' 111' ' ' ALA . 12.3 mt -67.12 -26.43 66.69 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.569 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 23.2 pt-20 -65.34 -56.45 12.54 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.104 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.5 mmm180 -62.97 -58.64 6.63 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.094 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.05 -44.1 67.17 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.645 HD11 ' CD1' ' A' ' 28' ' ' LEU . 2.5 tp -73.35 -24.79 60.4 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.431 . . . . 0.0 110.47 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -67.74 -34.99 77.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.24 -24.22 68.77 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.31 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.04 -15.78 58.62 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.64 0.257 . . . . 0.0 111.034 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.07 26.2 8.52 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.957 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.645 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.74 170.28 12.31 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 117.987 0.894 . . . . 0.0 111.61 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.412 ' O ' HG13 ' A' ' 6' ' ' VAL . 55.2 m -99.56 105.68 17.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.644 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 40.9 t -101.07 111.98 24.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.238 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.553 HG22 ' CE1' ' A' ' 33' ' ' PHE . 2.5 t -121.36 151.81 39.71 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.702 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 68.7 p -125.09 160.15 29.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.82 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 5.6 m-85 -135.94 173.86 11.25 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.491 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.8 pp20? -60.57 -59.23 5.73 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.655 ' C ' HG11 ' A' ' 9' ' ' VAL . 5.6 t30 -150.46 -30.2 0.2 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.581 0.628 . . . . 0.0 112.49 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.499 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 168.24 -56.37 0.22 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.435 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.503 ' HA ' HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -45.88 -34.22 3.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.942 0.401 . . . . 0.0 110.89 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.82 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.2 tp10 -60.97 -56.8 16.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.363 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.575 HG22 HG23 ' A' ' 9' ' ' VAL . 3.6 t -49.54 -40.94 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.951 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 37' ' ' ASN . 14.0 mt -55.56 -43.51 75.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.828 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.35 -49.56 59.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.001 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.28 -26.31 66.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.82 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 8.1 mt -71.28 -24.61 62.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.482 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.0 -16.42 43.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.643 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 m -120.26 -6.82 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.591 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -158.72 156.2 29.43 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.674 0.273 . . . . 0.0 110.85 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.5 m -139.42 113.0 7.94 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.506 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.678 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 96.8 Cg_endo -76.42 166.06 28.11 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.22 1.947 . . . . 0.0 111.433 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.422 ' O ' ' HD2' ' A' ' 77' ' ' PRO . 28.8 m-20 -73.91 -63.09 1.29 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.508 HG21 ' N ' ' A' ' 51' ' ' LEU . 4.9 p -95.12 156.25 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.508 ' N ' HG21 ' A' ' 50' ' ' VAL . 50.1 tp -152.85 133.31 13.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.383 0.611 . . . . 0.0 111.856 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.722 ' O ' HG22 ' A' ' 9' ' ' VAL . 2.6 mt -119.67 116.1 25.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.037 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.557 ' HA ' HG22 ' A' ' 9' ' ' VAL . 1.3 t -107.57 146.77 31.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.502 0.668 . . . . 0.0 112.489 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 7.2 t0 -74.43 -178.66 3.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.924 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.574 ' CG2' ' HB ' ' A' ' 82' ' ' THR . 3.3 tt -157.08 86.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.267 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 163.91 58.73 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.711 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.6 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 6.2 tpt -162.76 -63.79 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.6 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 12.1 Cg_endo -53.26 -164.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.065 2.51 . . . . 0.0 113.112 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.56 6.6 72.49 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.801 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.567 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -152.1 51.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.456 ' OD2' HD12 ' A' ' 55' ' ' ILE . 1.3 p-10 48.71 -71.44 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.147 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -141.95 -36.48 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.999 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.697 ' HA ' HD23 ' A' ' 66' ' ' LEU . 1.3 mp -56.76 -18.69 13.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.284 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.407 ' HB1' ' CB ' ' A' ' 60' ' ' MET . . . -63.24 -45.61 90.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.562 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 12.0 mt -56.49 -33.76 66.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.601 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.7 mm? -60.42 -43.81 96.38 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.668 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 14.4 ttmt -56.35 -41.07 75.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.277 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.499 ' HB3' HD12 ' A' ' 40' ' ' LEU . 70.5 mm-40 -70.07 -34.59 73.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.7 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.53 HG23 ' OE1' ' A' ' 96' ' ' GLN . 21.7 mt -67.05 -38.59 81.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.392 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.668 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.57 -24.14 61.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.998 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -78.9 -34.59 44.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.043 0.449 . . . . 0.0 110.935 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -94.04 -69.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.546 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.531 ' NE2' HD11 ' A' ' 43' ' ' LEU . 2.2 p80 -117.66 75.01 9.39 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.071 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.547 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 61.6 Cg_endo -74.96 57.11 4.44 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.299 1.999 . . . . 0.0 112.733 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.414 ' HG3' ' C ' ' A' ' 74' ' ' PRO . 51.3 mtp -154.37 -41.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.101 0.477 . . . . 0.0 111.008 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.542 ' CD1' ' HD2' ' A' ' 48' ' ' PRO . 2.6 tt -58.12 122.29 57.49 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.911 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.523 ' HD3' ' CE2' ' A' ' 122' ' ' TYR . 18.7 Cg_endo -59.46 118.61 5.52 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.819 2.346 . . . . 0.0 112.513 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.643 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -99.36 148.07 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.849 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 2.7 mt -140.2 113.69 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.181 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.62 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 24.9 mm -93.42 149.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.131 0.491 . . . . 0.0 112.198 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.485 ' HE3' ' N ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -85.39 -13.48 49.26 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.869 -178.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.574 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.6 m -147.78 160.47 42.7 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.046 -0.409 . . . . 0.0 110.682 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -154.84 65.51 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 0.0 111.17 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.404 ' CD2' ' H ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -78.43 -93.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.824 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.404 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -98.63 -176.57 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.305 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.549 ' O ' HD21 ' A' ' 63' ' ' LEU . 85.2 m-20 58.88 14.42 3.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.583 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.429 ' O ' HD11 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -44.47 -25.33 0.25 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -48.02 -42.65 28.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.032 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.04 -21.37 63.19 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.554 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.475 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -62.56 -41.62 99.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.98 0.419 . . . . 0.0 110.069 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.586 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.8 t -58.35 -39.64 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.437 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.8 p -61.45 -37.73 84.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.41 0.624 . . . . 0.0 110.146 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.64 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -54.83 -43.58 73.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.42 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.586 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 34.0 m-85 -59.16 -22.71 61.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.984 0.421 . . . . 0.0 110.503 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.634 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -71.99 -42.94 65.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.585 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -75.78 -18.1 59.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.99 15.95 4.59 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.433 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.643 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -56.59 148.48 19.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.143 0.471 . . . . 0.0 110.539 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 61.0 t80 -79.81 -53.89 6.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.199 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.91 -158.9 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.002 0.429 . . . . 0.0 111.579 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.62 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.3 m-85 -131.87 125.77 32.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.633 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 6.0 tp -103.01 140.63 21.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.063 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.698 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 18.7 Cg_endo -56.28 165.15 4.49 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.031 1.821 . . . . 0.0 110.448 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.42 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -42.53 -43.87 8.76 Favored Pre-proline 0 N--CA 1.467 0.397 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.698 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 82.0 Cg_exo -47.12 163.88 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.672 1.581 . . . . 0.0 110.818 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.694 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 1.2 t80 -162.49 -92.08 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.528 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.559 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p-10 42.35 -177.12 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.898 0.38 . . . . 0.0 110.889 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.586 HD11 ' C ' ' A' ' 18' ' ' VAL . 1.1 mp -67.9 -44.79 84.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.355 0.598 . . . . 0.0 111.174 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.729 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 3.1 t70 -53.84 -57.28 11.48 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.787 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.6 mm-40 -78.53 -28.43 46.14 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -84.09 -54.24 4.97 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.184 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 115' ' ' VAL . 43.8 t -57.49 -32.4 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.558 0.694 . . . . 0.0 109.956 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.729 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -59.44 -51.93 67.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.769 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.633 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 19.4 tp -76.66 -20.67 56.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.82 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 112' ' ' VAL . 4.4 p -79.13 -48.62 21.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.723 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.431 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 71.8 mt-10 -65.25 -45.49 84.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.949 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 20.4 mtp-105 -63.6 -24.01 67.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.905 0.383 . . . . 0.0 110.803 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.504 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -75.04 -51.15 14.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.133 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -65.61 -31.22 52.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.134 0.492 . . . . 0.0 110.975 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.6 t -70.96 -43.77 67.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.129 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -76.89 -27.57 55.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.097 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.523 ' CE2' ' HD3' ' A' ' 77' ' ' PRO . 6.2 t80 -79.55 -56.47 4.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.038 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 58.5 170.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.953 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.817 0.342 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -74.87 146.17 42.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.323 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.68 9.25 1.9 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.816 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.722 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 71.06 89.11 0.1 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.575 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 7' ' ' TRP . 3.1 mp -111.55 119.35 59.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.871 0.367 . . . . 0.0 111.364 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.745 HG11 ' HG ' ' A' ' 23' ' ' LEU . 11.5 p -105.09 127.86 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.076 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.533 ' NE1' HG23 ' A' ' 31' ' ' THR . 29.5 m0 -115.29 143.7 44.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -136.85 143.66 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -133.38 104.73 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.068 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.601 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 43.0 t0 166.47 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.9 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.432 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 71.19 -23.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.94 0.496 . . . . 0.0 112.146 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 10' ' ' ASP . 10.6 t0 69.33 -131.51 0.08 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 122.53 -0.106 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 t -34.08 -45.05 0.19 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -54.67 -67.31 0.28 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 15' ' ' ILE . 27.8 mm -64.38 -20.45 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.714 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.699 ' HA ' HG21 ' A' ' 32' ' ' THR . 53.3 ttt180 -70.3 -61.37 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.849 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.45 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 70.5 t90 -50.36 -43.6 54.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.954 0.407 . . . . 0.0 111.715 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.568 ' CG1' HD12 ' A' ' 108' ' ' ILE . 1.4 t -65.82 -61.11 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.002 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.497 HD23 ' CG2' ' A' ' 8' ' ' VAL . 9.8 tp -71.66 -20.71 61.91 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.644 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 21.2 pt-20 -67.47 -56.94 7.57 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.152 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.521 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 8.7 mmm180 -65.62 -59.42 3.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.215 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.34 -42.73 61.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.745 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.4 tm? -70.43 -26.6 63.74 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.007 0.432 . . . . 0.0 110.516 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.3 76.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.67 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.44 -26.15 69.3 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.27 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.74 -16.32 59.52 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.743 0.306 . . . . 0.0 111.068 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.41 25.81 8.55 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.455 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.722 ' HB3' ' O ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -136.58 175.2 9.83 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 117.382 0.591 . . . . 0.0 111.355 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.454 ' O ' HG13 ' A' ' 6' ' ' VAL . 3.0 m -106.03 134.61 48.89 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.087 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.644 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 12.2 t -124.3 110.54 14.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.456 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.533 HG23 ' NE1' ' A' ' 7' ' ' TRP . 2.5 t -110.66 155.42 22.43 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.699 HG21 ' HA ' ' A' ' 16' ' ' ARG . 81.2 p -131.69 159.34 38.66 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.728 ' HB2' HG11 ' A' ' 9' ' ' VAL . 5.8 m-85 -135.8 173.49 11.65 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.927 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.569 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 1.6 pp20? -61.95 -60.81 3.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.574 ' C ' HG12 ' A' ' 9' ' ' VAL . 29.2 m120 -150.69 -52.47 0.14 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 118.318 0.508 . . . . 0.0 111.581 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.563 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -159.11 -62.03 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.944 -1.122 . . . . 0.0 114.0 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.663 ' HA ' HD12 ' A' ' 40' ' ' LEU . 12.4 m120 -52.42 -27.67 16.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.979 0.389 . . . . 0.0 111.617 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.71 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -62.48 -56.98 12.98 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.482 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.578 HG21 HG21 ' A' ' 9' ' ' VAL . 3.0 t -56.61 -40.64 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.151 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.663 HD12 ' HA ' ' A' ' 37' ' ' ASN . 20.2 mt -50.3 -42.57 52.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.008 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.36 81.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.245 0.545 . . . . 0.0 110.875 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.76 78.96 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.653 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 17.4 mt -59.0 -26.65 64.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.964 0.411 . . . . 0.0 111.132 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.95 -20.84 25.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.64 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.72 1.35 8.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.7 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.44 ' HB3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -156.37 159.43 38.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 111.438 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.9 m -139.41 113.08 7.96 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.189 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.422 ' HD3' HD22 ' A' ' 43' ' ' LEU . 78.0 Cg_endo -77.39 153.75 31.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.023 1.815 . . . . 0.0 111.624 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -73.81 -26.1 60.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.434 HG21 ' CD1' ' A' ' 79' ' ' ILE . 6.2 p -146.14 94.93 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.618 ' HB3' ' O ' ' A' ' 77' ' ' PRO . 56.6 tp -86.53 151.18 23.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.353 0.597 . . . . 0.0 112.151 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.786 ' O ' HG23 ' A' ' 9' ' ' VAL . 7.3 mt -132.99 114.13 13.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.899 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.701 ' HA ' HG23 ' A' ' 9' ' ' VAL . 1.5 m -114.15 149.91 34.97 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 29.2 t0 -78.14 173.47 12.21 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.636 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.718 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -145.09 74.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 120.993 0.425 . . . . 0.0 111.16 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 17.6 ttt-85 176.23 61.08 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.543 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.29 -62.8 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.543 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 20.1 Cg_endo -59.4 -174.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.532 2.154 . . . . 0.0 113.101 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.01 -72.39 0.54 Allowed Glycine 0 C--N 1.335 0.493 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.58 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.541 ' O ' ' N ' ' A' ' 62' ' ' GLY . 1.0 OUTLIER -71.99 56.26 0.31 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.398 179.458 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.63 -77.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.839 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.718 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -136.33 -39.01 0.16 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.466 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.649 HD21 ' O ' ' A' ' 86' ' ' ASP . 1.2 mp -51.7 -25.42 7.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.837 0.351 . . . . 0.0 110.496 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 58' ' ' PRO . . . -58.73 -33.43 70.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.644 ' HA ' ' OE1' ' A' ' 68' ' ' GLN . 0.4 OUTLIER -50.32 -44.64 54.33 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.898 178.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.522 ' HG ' ' HB2' ' A' ' 93' ' ' ALA . 3.1 mm? -60.67 -42.15 96.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.483 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -44.73 -60.68 1.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.404 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.644 ' OE1' ' HA ' ' A' ' 65' ' ' LEU . 9.4 mp0 -59.21 -37.01 76.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.839 0.352 . . . . 0.0 110.185 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.502 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 4.3 mm -64.13 -42.77 96.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.084 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 1.9 ptpp? -76.64 -24.28 53.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.609 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.26 -39.42 16.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.428 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.72 -62.92 1.38 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.278 0.561 . . . . 0.0 111.772 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.509 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 2.1 m-70 -81.42 136.93 48.69 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.979 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.44 -69.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.622 2.215 . . . . 0.0 113.106 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -144.66 37.28 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 111.601 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.418 ' CD2' ' HD2' ' A' ' 48' ' ' PRO . 1.1 tm? -59.94 105.65 0.6 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.407 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.618 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 10.9 Cg_endo -54.07 136.17 66.46 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.468 2.112 . . . . 0.0 112.195 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.655 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.1 t -132.89 152.37 35.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.909 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.489 HD11 ' HG ' ' A' ' 52' ' ' LEU . 3.6 mt -132.18 118.6 37.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.403 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 53' ' ' SER . 21.7 mm -93.86 142.98 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.019 0.438 . . . . 0.0 111.887 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.56 ' HE1' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -75.46 -20.84 58.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.568 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.506 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.4 m -147.59 161.22 41.57 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.365 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.49 57.75 1.79 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.909 0.385 . . . . 0.0 111.705 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -98.47 -179.81 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.999 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER 63.92 -155.59 0.31 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.059 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.649 ' O ' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -60.23 78.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.271 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.472 ' HA ' ' CD2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -52.8 -22.0 4.82 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -48.25 -50.76 28.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 63' ' ' LEU . . . -56.24 -19.89 15.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.012 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.519 ' N ' HD23 ' A' ' 63' ' ' LEU . . . -70.27 -35.88 74.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.64 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.6 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.8 t -67.06 -38.26 80.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.865 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.56 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 4.2 m -61.5 -18.62 59.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.325 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.76 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.82 -57.03 4.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.324 0.583 . . . . 0.0 111.542 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.6 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -54.22 -33.64 58.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.078 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -76.58 -35.31 58.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.244 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.76 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -77.78 -18.5 56.35 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.218 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.41 -11.71 3.25 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.926 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.655 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -54.96 156.2 3.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.307 0.554 . . . . 0.0 111.323 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.466 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 49.9 t80 -79.72 -53.58 6.67 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.252 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.53 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.5 OUTLIER 171.96 -163.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.033 0.444 . . . . 0.0 111.532 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.47 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 2.8 m-85 -125.69 122.32 36.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.259 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' MET . 3.6 tp -102.24 140.66 21.35 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.195 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.743 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 12.7 Cg_endo -54.58 163.68 3.61 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.637 2.225 . . . . 0.0 111.437 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.436 ' HZ2' ' HB2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -41.08 -45.8 6.65 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -178.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.743 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 88.7 Cg_exo -47.39 163.49 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.624 1.549 . . . . 0.0 110.671 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.745 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 12.0 t80 -165.77 -92.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.732 -178.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.717 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 0.1 OUTLIER 40.11 -174.09 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.772 0.32 . . . . 0.0 111.189 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.568 HD12 ' CG1' ' A' ' 18' ' ' VAL . 1.1 mp -68.08 -51.74 45.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.056 0.455 . . . . 0.0 111.835 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.762 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 3.2 p-10 -49.2 -56.05 10.51 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.942 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.745 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.7 mm-40 -76.59 -30.88 57.15 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -81.25 -58.5 3.02 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.903 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 115' ' ' VAL . 40.0 t -53.03 -31.29 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 121.699 0.762 . . . . 0.0 110.212 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.762 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -60.53 -50.74 72.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.921 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.643 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 5.8 tp -76.95 -20.73 55.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.925 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 6' ' ' VAL . 9.7 p -77.76 -48.73 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.954 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.416 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 40.4 mt-10 -62.7 -44.07 97.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.032 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.643 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 7.8 ptm180 -68.14 -23.7 64.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 111.07 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.97 -50.91 17.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.812 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.3 mt -70.19 -32.18 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.6 t -69.63 -42.11 74.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.033 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -70.59 -28.02 64.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.16 -54.41 5.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.844 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.97 169.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.059 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.792 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -150.26 163.01 39.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.879 0.371 . . . . 0.0 111.05 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.09 -20.15 17.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.031 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.06 100.95 1.23 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.518 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mp -131.88 112.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 111.598 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.737 HG11 ' HG ' ' A' ' 23' ' ' LEU . 12.2 p -107.24 130.24 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.753 ' CH2' ' HG2' ' A' ' 46' ' ' LYS . 23.5 m0 -119.14 135.3 54.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -129.06 136.81 58.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -176.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.901 HG22 ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -122.49 105.79 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.538 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 55.8 t0 170.28 118.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.458 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 2.2 t70 71.05 -43.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.419 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 13' ' ' SER . 49.6 t0 75.59 -107.09 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.947 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 12' ' ' ASP . 31.3 p -23.73 -83.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.421 ' O ' HG21 ' A' ' 18' ' ' VAL . 3.0 m -52.93 -47.56 67.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.455 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.519 HG21 HD13 ' A' ' 19' ' ' LEU . 19.6 mm -64.64 -20.31 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.761 0.315 . . . . 0.0 111.628 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.47 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 7.1 ttp180 -70.75 -60.94 1.96 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.752 0.31 . . . . 0.0 111.586 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.495 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 37.9 t90 -52.08 -44.32 64.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.619 ' CG1' HD11 ' A' ' 108' ' ' ILE . 1.2 t -64.04 -49.91 79.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.728 ' HA ' HD13 ' A' ' 108' ' ' ILE . 43.3 mt -84.07 -22.1 31.31 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 1.2 pp20? -66.42 -59.02 4.06 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.511 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.43 ' HG2' ' CD ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -64.58 -62.85 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.01 -53.98 7.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.944 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.737 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.5 tm? -62.76 -29.21 70.52 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.729 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.91 76.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.516 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.37 -25.24 69.79 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.396 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.97 -15.08 59.76 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.678 0.275 . . . . 0.0 111.053 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.58 23.46 10.14 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.63 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.488 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -133.52 174.64 10.2 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.532 0.666 . . . . 0.0 111.722 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 m -102.81 117.33 34.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.281 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.667 ' HA ' HG12 ' A' ' 6' ' ' VAL . 8.8 t -113.93 113.23 24.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.513 0.673 . . . . 0.0 111.533 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.576 HG21 ' CE1' ' A' ' 33' ' ' PHE . 3.1 t -118.87 156.55 29.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.405 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 31.1 p -135.04 152.11 51.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.426 0.631 . . . . 0.0 112.348 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.869 ' HB2' HG11 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -129.64 174.31 9.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.054 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.605 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -58.34 -106.33 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.461 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -86.14 -71.8 0.52 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.542 ' HA2' HG13 ' A' ' 9' ' ' VAL . . . -161.16 -39.21 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.411 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.443 ' ND2' HD11 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -59.52 -31.63 69.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.901 0.35 . . . . 0.0 110.683 -179.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.741 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -51.84 -57.31 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.634 178.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.691 HG21 ' CD1' ' A' ' 33' ' ' PHE . 2.9 t -56.85 -47.89 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.964 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 68' ' ' GLN . 38.1 mt -46.18 -42.75 14.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.868 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.42 -50.07 69.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.799 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.49 -28.73 67.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.104 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.892 HD12 ' CE1' ' A' ' 73' ' ' HIS . 7.3 mt -71.04 -20.95 62.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.455 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.85 -18.15 20.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.074 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 m -126.35 9.43 7.25 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.806 ' HG3' ' N ' ' A' ' 47' ' ' THR . 3.4 tttt -158.15 163.53 37.48 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.439 0.638 . . . . 0.0 112.153 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.806 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 97.8 m -138.83 111.46 8.1 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.192 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD3' HD22 ' A' ' 43' ' ' LEU . 61.2 Cg_endo -74.41 165.52 31.57 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.447 2.098 . . . . 0.0 111.284 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -82.43 -27.97 31.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.867 0.365 . . . . 0.0 110.818 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.648 HG13 HG22 ' A' ' 6' ' ' VAL . 3.4 p -149.61 99.45 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.41 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.681 HD12 HG13 ' A' ' 39' ' ' VAL . 47.4 tp -86.96 141.93 28.34 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.633 ' CD2' ' HB ' ' A' ' 79' ' ' ILE . 6.2 mt -124.42 115.03 20.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.042 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.901 ' HA ' HG22 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -109.69 141.79 41.78 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.092 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 8.3 t0 -71.38 -171.82 0.66 Allowed 'General case' 0 C--O 1.23 0.055 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.931 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.778 HG13 ' HA3' ' A' ' 62' ' ' GLY . 2.7 tt -170.13 79.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.218 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.8 78.91 1.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.52 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 2.4 ptt? 43.21 49.92 5.38 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.552 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 50.6 Cg_endo -83.14 -74.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.305 2.003 . . . . 0.0 111.663 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.25 -21.34 3.43 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.528 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 4.3 ttm -163.74 68.28 0.19 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 110.225 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.66 -25.1 0.15 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.167 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.778 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 137.68 -27.68 2.81 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.586 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.511 ' CD2' ' HB1' ' A' ' 90' ' ' ALA . 4.3 mp -75.17 -17.98 60.28 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.528 ' HB1' ' N ' ' A' ' 60' ' ' MET . . . -53.43 -24.5 12.82 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.844 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.609 ' O ' HG13 ' A' ' 69' ' ' ILE . 7.4 mp -62.13 -42.36 99.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.598 ' HA ' HD12 ' A' ' 69' ' ' ILE . 85.9 mt -64.19 -42.72 96.54 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.304 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.442 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 9.9 tptm -48.39 -56.37 8.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.736 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.459 ' HB2' HD12 ' A' ' 40' ' ' LEU . 24.8 mm-40 -59.61 -32.45 70.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.862 HG12 ' CE1' ' A' ' 73' ' ' HIS . 97.1 mt -59.98 -46.01 94.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.969 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -67.0 -27.61 67.58 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -86.03 -37.02 19.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.85 -61.97 1.57 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.866 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.892 ' CE1' HD12 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -84.96 147.29 47.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.063 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -95.17 103.68 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.227 2.618 . . . . 0.0 112.437 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 18.3 mtm 54.35 24.58 5.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.086 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 48' ' ' PRO . 10.6 tp -69.15 114.36 22.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.99 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.54 120.63 8.64 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.309 2.006 . . . . 0.0 111.991 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.571 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 1.8 t -117.46 151.47 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.293 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.633 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 2.3 mp -131.15 120.39 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.895 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 53' ' ' SER . 18.0 mm -95.49 147.2 6.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.989 0.423 . . . . 0.0 111.375 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.521 ' HE2' ' CB ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -81.18 -18.42 46.31 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.214 -179.02 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.466 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.9 m -147.77 153.53 39.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.374 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 84' ' ' HIS . . . -134.58 -2.02 2.75 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.744 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.472 ' CE1' ' CD1' ' A' ' 55' ' ' ILE . 0.1 OUTLIER 23.43 -95.66 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.205 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 m -141.15 -12.78 0.93 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.454 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 3.7 t70 -78.86 44.49 0.55 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.941 0.401 . . . . 0.0 111.361 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -52.12 -21.06 2.9 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.074 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -47.69 -56.51 7.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.662 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 63' ' ' LEU . . . -68.68 -19.78 64.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.768 0.318 . . . . 0.0 111.247 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.511 ' HB1' ' CD2' ' A' ' 63' ' ' LEU . . . -70.76 -37.73 73.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.88 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.584 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.8 t -63.9 -41.92 94.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.287 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.59 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 23.8 m -61.39 -18.91 60.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 109.991 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.732 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.84 -52.49 10.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.097 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.584 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.0 m-85 -58.24 -33.85 69.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.164 0.507 . . . . 0.0 110.517 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.8 pp0? -76.39 -38.63 55.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.601 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.732 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.2 pp0? -73.12 -18.29 61.31 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.064 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.07 1.44 4.91 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.861 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.571 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -56.82 159.52 3.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.283 0.542 . . . . 0.0 111.537 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.495 ' HB3' HG13 ' A' ' 79' ' ' ILE . 84.0 t80 -85.08 -53.97 4.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.425 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 2.2 t70 173.11 -165.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 111.117 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.574 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.1 m-85 -127.55 122.55 33.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.582 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 tp -102.58 141.04 21.69 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.837 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.715 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 15.8 Cg_endo -55.52 166.31 2.72 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.363 2.042 . . . . 0.0 111.398 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -42.02 -46.64 10.29 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.411 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.715 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 83.0 Cg_exo -47.23 163.75 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 121.805 1.67 . . . . 0.0 110.727 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.694 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 4.1 t80 -165.75 -93.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.36 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.525 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 4.5 p-10 43.92 -175.78 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.706 0.288 . . . . 0.0 110.506 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.728 HD13 ' HA ' ' A' ' 19' ' ' LEU . 1.1 mp -67.96 -45.4 83.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.365 0.602 . . . . 0.0 111.381 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.717 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 30.9 t0 -52.14 -58.08 7.68 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.662 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.4 mm-40 -77.82 -30.06 50.93 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -82.99 -53.62 5.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.256 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.609 ' HA ' HG12 ' A' ' 115' ' ' VAL . 47.7 t -57.79 -32.75 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.431 0.634 . . . . 0.0 110.097 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.717 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -59.57 -52.91 63.51 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.227 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.457 HD23 ' CG2' ' A' ' 79' ' ' ILE . 6.9 tp -75.07 -20.51 59.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.042 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 112' ' ' VAL . 6.0 p -79.18 -43.67 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.601 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.421 ' N ' HG11 ' A' ' 115' ' ' VAL . 16.5 mt-10 -59.89 -51.81 68.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.69 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -23.82 63.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 110.853 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.459 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.66 -52.59 11.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.445 HD12 HD21 ' A' ' 28' ' ' LEU . 4.4 mt -71.57 -32.46 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.117 0.484 . . . . 0.0 111.244 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 t -66.06 -33.65 76.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.506 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -69.32 -26.63 64.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.761 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.37 -57.41 3.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.829 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -177.7 4.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.961 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.948 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.635 0.255 . . . . 0.0 111.555 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.08 178.61 8.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.653 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.421 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -174.2 -33.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.903 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.45 72.65 0.93 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.553 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.3 mp -108.97 112.41 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.841 0.353 . . . . 0.0 111.039 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.467 HG22 HD21 ' A' ' 23' ' ' LEU . 6.5 p -109.24 118.46 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.591 ' CD1' HG22 ' A' ' 31' ' ' THR . 37.5 m0 -109.62 140.21 43.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.188 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.784 HG22 HD23 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -125.09 144.85 33.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.194 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.761 HG13 ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -133.14 106.79 10.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.053 0.454 . . . . 0.0 110.957 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 34' ' ' GLU . 8.5 t0 -162.05 -154.46 0.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.746 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.2 -1.56 3.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 62.47 -151.59 0.36 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.474 -0.141 . . . . 0.0 111.013 179.067 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 t 36.32 -90.34 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 18' ' ' VAL . 1.3 t -55.06 -56.5 19.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.672 0.273 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.9 mm -64.3 -30.88 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.299 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.491 ' HG3' HG23 ' A' ' 32' ' ' THR . 8.5 ttm-85 -71.78 -53.3 13.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.628 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.418 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 72.9 t90 -54.07 -40.73 67.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.529 ' C ' HD13 ' A' ' 108' ' ' ILE . 2.8 t -69.04 -56.65 11.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.784 HD23 HG22 ' A' ' 8' ' ' VAL . 7.0 tp -72.38 -23.13 61.07 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.647 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . 14.6 pt-20 -67.31 -59.23 3.58 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.492 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.521 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 11.4 mmm-85 -74.62 -53.84 8.58 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.79 -56.15 17.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 111.786 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.699 HD11 ' CD1' ' A' ' 28' ' ' LEU . 11.4 tp -66.02 -21.36 66.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.639 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 20' ' ' GLU . . . -70.33 -34.83 73.14 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.34 -26.52 68.04 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.349 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.2 -15.95 59.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.649 0.261 . . . . 0.0 110.676 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.2 24.83 8.19 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.699 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -121.37 165.2 15.88 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.75 1.275 . . . . 0.0 112.438 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' HG12 ' A' ' 6' ' ' VAL . 91.8 m -88.74 109.08 19.85 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.16 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.647 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -101.9 115.62 30.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.414 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.591 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -133.62 132.19 40.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.491 HG23 ' HG3' ' A' ' 16' ' ' ARG . 59.2 p -105.87 164.14 12.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.489 0.661 . . . . 0.0 112.523 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.823 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 4.2 m-85 -135.79 173.42 11.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.071 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.561 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 2.0 pp20? -61.53 -49.52 76.38 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.714 ' C ' HG13 ' A' ' 9' ' ' VAL . 19.6 m-20 -165.96 -35.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.761 ' N ' HG13 ' A' ' 9' ' ' VAL . . . -172.79 -64.83 0.05 OUTLIER Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.992 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.14 -30.57 49.6 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.823 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 11.1 tt0 -56.14 -48.03 77.03 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.129 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.686 ' CG2' HG11 ' A' ' 9' ' ' VAL . 4.1 t -52.8 -40.65 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.313 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.9 mt -54.16 -42.12 69.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.727 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.0 -52.48 65.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.848 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.54 -27.94 64.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.812 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.636 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 11.9 mt -67.67 -28.53 67.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.579 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.17 -17.74 4.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.877 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.55 -0.02 8.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.82 164.38 23.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 111.363 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.9 m -138.97 113.35 8.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.562 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.597 ' HD2' HD21 ' A' ' 43' ' ' LEU . 46.3 Cg_endo -68.82 158.44 57.85 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.271 1.981 . . . . 0.0 111.54 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -80.53 -25.94 38.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.47 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.519 HG22 ' CG2' ' A' ' 115' ' ' VAL . 7.6 p -147.93 97.88 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.684 0.278 . . . . 0.0 111.111 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.455 HD22 HG23 ' A' ' 78' ' ' VAL . 18.6 tp -86.83 152.87 22.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.999 0.428 . . . . 0.0 111.989 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.548 ' CD2' ' CZ ' ' A' ' 106' ' ' PHE . 1.1 tt -134.87 114.41 12.54 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.074 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.508 ' HA ' HG21 ' A' ' 9' ' ' VAL . 10.5 t -114.9 136.98 52.51 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 111.919 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -82.75 4.43 25.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.546 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.673 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 7.4 tt 41.84 82.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 12.2 ttp85 175.09 62.23 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.382 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.65 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 10.9 tpt -163.43 -61.13 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.513 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 17.9 Cg_endo -58.02 178.8 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.405 2.07 . . . . 0.0 112.616 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.77 -64.76 3.66 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.177 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.439 ' O ' ' N ' ' A' ' 62' ' ' GLY . 3.8 tpt -72.4 57.24 0.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.005 0.431 . . . . 0.0 110.099 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 0.4 OUTLIER 59.52 -81.8 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.237 -179.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.673 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.39 -31.29 0.15 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.566 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -60.27 -25.34 65.63 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.113 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 68' ' ' GLN . . . -54.32 -34.17 60.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.926 0.393 . . . . 0.0 109.942 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.485 ' O ' HG13 ' A' ' 69' ' ' ILE . 30.7 tp -56.82 -36.99 70.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.825 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 3.7 mm? -64.32 -44.53 91.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.848 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.747 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -57.21 -42.13 80.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.857 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.445 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 8.5 mm100 -65.18 -36.67 84.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.126 0.488 . . . . 0.0 110.487 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 65' ' ' LEU . 59.2 mt -61.51 -39.75 84.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.083 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.747 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.64 -28.01 62.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.258 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -79.42 -39.36 32.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.567 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -96.66 -61.54 1.4 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.876 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.636 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 2.6 m-70 -82.25 157.88 67.51 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.495 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -68.3 -76.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.612 2.208 . . . . 0.0 112.966 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.645 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 31.1 mtm -145.26 56.1 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.027 0.441 . . . . 0.0 111.124 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.516 HD12 ' HD2' ' A' ' 48' ' ' PRO . 17.6 tp -67.05 112.66 10.43 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.145 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 42.1 Cg_endo -67.28 118.75 5.81 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.462 2.108 . . . . 0.0 111.632 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.455 HG23 HD22 ' A' ' 51' ' ' LEU . 11.5 t -120.63 148.93 23.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 111.651 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.533 HG21 ' OD1' ' A' ' 100' ' ' ASP . 2.7 mt -117.2 113.66 43.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.121 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.563 ' HB ' ' CD2' ' A' ' 101' ' ' TYR . 18.3 mm -93.5 135.54 27.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.111 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.753 ' HE1' ' OG1' ' A' ' 82' ' ' THR . 0.1 OUTLIER -73.09 -55.52 6.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.215 0.531 . . . . 0.0 110.7 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.753 ' OG1' ' HE1' ' A' ' 81' ' ' MET . 2.5 m -106.39 157.62 17.49 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.218 -0.301 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.428 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -121.49 37.4 4.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.884 0.373 . . . . 0.0 110.695 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.525 ' CE1' HG12 ' A' ' 55' ' ' ILE . 7.7 p80 -81.17 -172.81 3.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 74.91 -75.93 0.07 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.241 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.417 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -160.03 98.96 1.35 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.796 0.331 . . . . 0.0 111.45 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.692 HD11 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -47.81 -24.52 1.0 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.265 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.04 -42.11 27.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.889 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -72.25 -26.31 61.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.321 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.692 ' HB3' HD11 ' A' ' 87' ' ' LEU . . . -68.03 -45.79 72.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.45 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.582 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 15.0 t -67.6 -47.45 80.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.7 p -63.34 -30.69 71.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.111 0.481 . . . . 0.0 110.16 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.704 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -59.04 -37.38 76.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.682 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.582 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 23.5 m-85 -59.04 -22.11 60.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.077 0.465 . . . . 0.0 110.014 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.616 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.3 -42.15 46.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.075 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.704 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp0? -76.13 -18.11 59.28 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.057 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 128.87 9.21 3.53 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.716 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 93' ' ' ALA . . . -54.39 147.52 13.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 117.37 0.585 . . . . 0.0 111.433 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 100' ' ' ASP . 56.2 t80 -86.68 -54.17 4.53 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.533 ' OD1' HG21 ' A' ' 79' ' ' ILE . 19.2 p30 171.51 -168.71 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.811 0.338 . . . . 0.0 111.273 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 90' ' ' ALA . 11.3 m-85 -130.45 134.98 47.52 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.538 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.697 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -137.4 117.57 10.47 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.594 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 102' ' ' LEU . 58.8 Cg_exo -38.68 173.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.604 2.869 . . . . 0.0 114.501 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.626 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -36.91 -49.51 2.04 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.111 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.9 Cg_endo -47.8 123.81 8.94 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 N-CA-C 108.71 -1.304 . . . . 0.0 108.71 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.656 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -156.89 -85.68 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.997 -177.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.847 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.9 p30 37.32 -162.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.857 0.361 . . . . 0.0 110.854 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.602 HD13 ' N ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.9 -52.52 38.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.755 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 32.1 m-20 -50.53 -56.63 10.76 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.549 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.656 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.6 mm-40 -78.27 -30.97 48.84 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.847 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.37 -54.31 4.87 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.755 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.628 ' O ' HG11 ' A' ' 115' ' ' VAL . 32.2 t -55.07 -32.02 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.491 0.663 . . . . 0.0 110.156 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -60.34 -51.87 67.65 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.501 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.444 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 5.9 tp -75.3 -20.59 59.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.697 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 112' ' ' VAL . 6.6 p -79.41 -50.0 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.092 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.425 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 17.9 mt-10 -58.33 -43.97 88.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.666 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -24.33 67.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.96 0.409 . . . . 0.0 110.474 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 99' ' ' PHE . . . -73.71 -59.05 2.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.979 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -64.95 -30.98 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.075 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 t -64.45 -37.18 86.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.076 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -78.7 -25.8 44.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.29 -52.2 29.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.01 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.23 176.36 7.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.93 179.893 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . 0.45 ' F2 ' ' HD3' ' A' ' 56' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.853 0.358 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 61.22 155.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.704 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.08 70.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.021 0.439 . . . . 0.0 111.198 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . -98.52 84.29 0.67 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.409 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.458 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 4.0 mm -107.03 112.4 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.678 0.275 . . . . 0.0 111.09 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 5.9 p -109.95 119.2 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.808 0.337 . . . . 0.0 110.563 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.505 ' NE1' HG21 ' A' ' 31' ' ' THR . 34.8 m0 -112.55 131.77 55.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.802 0.334 . . . . 0.0 110.566 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.744 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -122.77 145.6 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.167 0.508 . . . . 0.0 112.283 -177.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.697 ' CG1' ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -131.26 107.91 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.15 178.343 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.567 ' CB ' ' HE1' ' A' ' 81' ' ' MET . 31.6 t0 170.76 107.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.869 0.366 . . . . 0.0 111.674 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.56 -40.59 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.7 OUTLIER 69.23 -159.3 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.416 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.9 t 30.96 -87.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 12' ' ' ASP . 9.6 t -56.09 -57.49 11.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 0.0 110.518 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 15' ' ' ILE . 28.4 mm -61.38 -22.46 27.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.098 0.475 . . . . 0.0 110.186 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.512 ' HG3' HG22 ' A' ' 32' ' ' THR . 5.2 ttp180 -77.42 -59.24 2.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.398 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -46.35 -38.86 9.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.522 ' C ' HD11 ' A' ' 108' ' ' ILE . 1.6 t -72.2 -62.51 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.011 0.434 . . . . 0.0 111.911 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.557 ' CD1' HD13 ' A' ' 108' ' ' ILE . 3.6 mm? -65.37 -25.75 67.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.142 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.611 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 8.9 pt-20 -67.77 -59.3 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.589 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 6.6 mmm180 -71.75 -48.16 48.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.931 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -57.78 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.049 0.452 . . . . 0.0 111.345 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.717 HD12 ' CD1' ' A' ' 28' ' ' LEU . 4.8 tp -63.96 -22.98 67.16 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.348 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.32 -33.95 72.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.24 -22.33 74.45 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.282 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.72 -16.0 58.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.658 0.266 . . . . 0.0 110.997 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.7 25.54 6.52 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.218 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.717 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -130.68 168.72 16.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.897 0.849 . . . . 0.0 111.725 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.435 ' O ' HG13 ' A' ' 6' ' ' VAL . 61.8 m -98.79 105.85 18.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.874 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 33.6 t -104.38 112.87 26.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.556 HG22 ' CE1' ' A' ' 33' ' ' PHE . 3.0 t -120.53 154.63 35.07 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.744 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 16.2 p -125.26 164.87 19.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.543 0.687 . . . . 0.0 112.794 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.764 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 47.4 m-85 -135.97 173.78 11.34 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.517 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.713 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -61.94 -60.94 2.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.693 ' C ' HG11 ' A' ' 9' ' ' VAL . 7.4 t-20 -151.36 -24.73 0.2 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.59 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 167.91 -58.78 0.21 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.922 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.455 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -52.62 -26.95 15.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.853 0.358 . . . . 0.0 110.685 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.764 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -59.38 -60.31 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.802 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.68 HG21 ' CD1' ' A' ' 33' ' ' PHE . 39.4 t -48.58 -34.48 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.834 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.455 ' CD1' ' HA ' ' A' ' 37' ' ' ASN . 19.2 mt -57.48 -43.52 84.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.59 -53.78 51.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.16 0.505 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.24 71.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.905 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.674 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 12.2 mt -59.85 -29.84 68.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.9 -19.59 4.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.101 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 t -127.79 0.2 6.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -156.02 157.76 36.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.78 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.8 m -138.82 114.79 8.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.223 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.508 ' HD2' HD21 ' A' ' 43' ' ' LEU . 61.1 Cg_endo -74.39 154.94 45.95 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.083 1.855 . . . . 0.0 111.716 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.21 -23.99 40.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.749 0.309 . . . . 0.0 111.08 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.498 ' CG2' ' CD1' ' A' ' 79' ' ' ILE . 3.3 p -145.8 92.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.56 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.448 HD21 HG11 ' A' ' 39' ' ' VAL . 63.2 tp -86.61 152.45 22.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.233 0.539 . . . . 0.0 111.929 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.675 ' HB2' HG13 ' A' ' 8' ' ' VAL . 4.8 mt -138.2 123.26 19.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.557 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.544 ' HA ' HG22 ' A' ' 9' ' ' VAL . 7.3 t -111.05 144.76 39.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 50.0 t0 -75.47 -11.06 59.96 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.761 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.675 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.7 tt 44.35 78.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 9.2 tpt180 172.05 76.08 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.679 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.589 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.24 -61.78 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 73.7 Cg_endo -74.13 -170.08 0.66 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.134 1.889 . . . . 0.0 113.504 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.3 -59.68 10.27 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.845 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.545 ' O ' ' N ' ' A' ' 62' ' ' GLY . 10.4 tpp -72.92 52.91 0.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.911 0.386 . . . . 0.0 110.602 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.81 -76.75 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.287 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.675 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.75 -32.04 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.189 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.597 ' HG ' HD11 ' A' ' 55' ' ' ILE . 4.0 mp -51.79 -29.56 19.57 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HA ' ' HG3' ' A' ' 67' ' ' LYS . . . -55.66 -32.49 63.25 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.929 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.59 HD13 ' HA3' ' A' ' 36' ' ' GLY . 13.5 mt -56.2 -44.39 79.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.544 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.43 ' CD2' ' CG1' ' A' ' 78' ' ' VAL . 30.5 mt -60.57 -44.36 96.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.122 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.605 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 9.8 mttt -49.75 -40.8 42.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.212 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -70.37 -35.64 73.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.203 0.525 . . . . 0.0 110.321 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.424 HG21 HD22 ' A' ' 76' ' ' LEU . 69.9 mt -62.42 -40.62 88.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.09 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -76.23 -25.01 54.61 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.705 -179.487 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -36.21 25.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.649 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.0 mtp85 -92.77 -25.74 18.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.739 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.674 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 40.0 m-70 -124.25 152.72 68.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 120.862 0.363 . . . . 0.0 111.533 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.08 -83.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.083 2.522 . . . . 0.0 113.063 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.97 51.31 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.663 0.268 . . . . 0.0 111.073 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.48 ' CD2' HD21 ' A' ' 43' ' ' LEU . 55.3 tp -60.81 110.54 3.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.704 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.84 115.7 3.4 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.103 1.868 . . . . 0.0 111.527 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.43 ' CG1' ' CD2' ' A' ' 66' ' ' LEU . 3.5 t -108.01 154.25 9.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.58 0.705 . . . . 0.0 111.525 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.586 HD11 ' HG ' ' A' ' 52' ' ' LEU . 3.5 mt -131.22 117.32 36.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.177 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.712 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 33.0 mm -93.42 143.51 11.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.997 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.567 ' HE1' ' CB ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -94.3 -7.87 40.62 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.714 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.56 ' O ' HG22 ' A' ' 55' ' ' ILE . 3.0 m -147.52 129.11 15.05 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.93 0.395 . . . . 0.0 111.352 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.6 86.42 2.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.422 ' CE1' HG22 ' A' ' 82' ' ' THR . 52.3 m-70 -66.78 -159.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.935 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.7 34.15 0.53 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.673 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.526 ' HB2' HD13 ' A' ' 63' ' ' LEU . 1.3 m-20 -125.35 26.73 6.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.04 0.448 . . . . 0.0 110.333 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -44.54 -21.58 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.447 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -47.82 -47.26 31.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.521 0.2 . . . . 0.0 111.386 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.452 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -72.58 -22.45 60.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.856 0.36 . . . . 0.0 110.926 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.515 ' HB1' ' CE1' ' A' ' 101' ' ' TYR . . . -67.58 -49.02 65.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.374 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.583 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.4 t -57.71 -49.05 82.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.05 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -29.81 68.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.411 0.624 . . . . 0.0 109.901 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 96' ' ' GLN . . . -58.53 -39.81 81.2 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.14 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.583 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 25.6 m-85 -61.31 -21.18 63.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.43 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.602 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.15 -42.59 55.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.706 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.602 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 1.2 pt20 -77.0 -15.1 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.817 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.32 13.44 4.81 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.626 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.52 143.77 28.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.146 0.473 . . . . 0.0 110.982 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.553 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 69.5 t80 -76.39 -53.96 7.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.222 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.4 t0 172.98 -166.1 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.947 0.403 . . . . 0.0 111.555 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.712 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.4 m-85 -129.05 118.97 23.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.347 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.9 tp -102.56 131.1 22.76 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.664 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.582 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 83.5 Cg_exo -47.48 168.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.551 2.168 . . . . 0.0 111.98 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.436 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -43.32 -46.36 15.7 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.582 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 88.1 Cg_exo -46.56 163.34 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 121.705 1.603 . . . . 0.0 110.763 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.682 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 5.0 t80 -169.39 -91.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.389 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.499 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.8 p-10 43.46 -174.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.73 0.3 . . . . 0.0 110.912 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.564 HG23 HG23 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -67.98 -48.14 76.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.225 0.536 . . . . 0.0 110.819 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.729 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 5.1 t70 -50.32 -57.18 8.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.082 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.682 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.5 mm-40 -79.25 -27.2 42.37 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -84.15 -53.43 5.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.603 ' O ' HG11 ' A' ' 115' ' ' VAL . 42.3 t -59.17 -32.16 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.507 0.67 . . . . 0.0 110.17 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.729 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -60.89 -52.62 64.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.752 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.51 ' CD2' HG22 ' A' ' 79' ' ' ILE . 11.4 tp -75.67 -20.36 58.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.545 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.603 HG11 ' O ' ' A' ' 112' ' ' VAL . 3.6 p -78.28 -46.35 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.017 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.408 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 43.6 mt-10 -61.95 -45.35 94.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.808 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.464 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 5.0 ptm180 -62.76 -25.7 68.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.671 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.553 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.93 -52.17 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.238 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.423 HD12 ' CD2' ' A' ' 28' ' ' LEU . 5.1 mt -68.31 -30.7 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.148 0.499 . . . . 0.0 110.738 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 m -65.28 -41.8 93.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.796 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -61.03 -31.26 70.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.734 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -88.13 -50.22 6.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.719 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 58.61 163.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.006 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.457 ' C ' ' H ' ' A' ' 3' ' ' ARG . 5.3 ttt . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 120.729 0.299 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 71.27 -41.78 0.51 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.49 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.457 ' H ' ' C ' ' A' ' 1' ' ' MET . 0.2 OUTLIER 80.94 -55.71 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.361 0.601 . . . . 0.0 110.672 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 76.9 68.52 1.51 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.814 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 1.5 mm -107.8 112.29 39.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.764 0.316 . . . . 0.0 110.763 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.794 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 7.1 p -113.91 124.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.526 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.624 ' HH2' ' CG ' ' A' ' 46' ' ' LYS . 53.2 m0 -116.71 133.35 56.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.702 0.287 . . . . 0.0 110.394 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -119.13 128.99 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.89 ' CG2' ' HA ' ' A' ' 53' ' ' SER . 2.7 m -117.65 118.77 59.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 110.419 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.463 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 17.2 t0 -173.45 -146.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.872 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -65.24 -4.46 5.25 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.6 t0 58.56 -147.5 0.5 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 122.543 -0.098 . . . . 0.0 111.234 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t 34.31 -87.87 0.01 OUTLIER 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 12' ' ' ASP . 39.2 m -58.1 -57.31 13.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.76 0.314 . . . . 0.0 110.988 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.58 -31.39 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.304 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.438 ' HG3' HG23 ' A' ' 32' ' ' THR . 15.4 ttp180 -72.37 -57.39 4.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.831 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.417 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 66.0 t90 -50.83 -42.4 58.45 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.467 ' O ' ' HB1' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -70.49 -58.77 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.184 0.516 . . . . 0.0 111.598 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.59 HD11 HD13 ' A' ' 108' ' ' ILE . 3.9 mm? -66.63 -26.99 67.34 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.67 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.564 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 12.2 pt-20 -66.87 -60.14 2.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.564 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.0 OUTLIER -72.35 -55.3 7.33 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 18' ' ' VAL . . . -50.37 -57.25 8.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.0 111.815 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.686 HD11 ' CD1' ' A' ' 28' ' ' LEU . 4.6 tp -60.68 -25.24 66.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.438 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.76 -37.14 79.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.76 -23.69 70.91 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.513 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.69 -15.72 59.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.582 0.229 . . . . 0.0 110.977 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.14 25.04 6.58 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.39 -0.91 . . . . 0.0 114.29 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.686 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.24 170.06 15.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.78 0.79 . . . . 0.0 111.436 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.428 ' O ' HG11 ' A' ' 6' ' ' VAL . 57.3 m -101.41 105.82 16.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.215 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.794 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 16.0 t -105.99 111.46 24.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.155 0.502 . . . . 0.0 111.952 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.517 ' CG2' ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -121.26 155.64 34.2 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 32.6 p -126.02 159.99 31.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.559 0.695 . . . . 0.0 112.543 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.887 ' HB2' HG11 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -136.44 174.32 10.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.267 -179.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.626 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -63.04 -33.43 75.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.035 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.626 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 2.2 t30 -176.34 171.76 2.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.019 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.503 ' HA3' ' HG ' ' A' ' 65' ' ' LEU . . . -50.26 -25.27 7.93 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.144 -1.027 . . . . 0.0 111.907 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.43 ' HA ' HD11 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -58.58 -52.21 66.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.673 0.273 . . . . 0.0 110.63 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.6 tt0 -51.95 -51.54 56.44 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.669 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.475 HG11 ' HG ' ' A' ' 43' ' ' LEU . 52.2 t -50.72 -35.1 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.133 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.478 HD12 ' CB ' ' A' ' 68' ' ' GLN . 20.2 mt -54.98 -43.1 73.21 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.04 -47.79 64.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.879 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.99 80.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 14.7 mt -67.19 -25.0 65.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.239 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.23 -15.3 23.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.766 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.2 -4.97 8.39 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -167.07 165.96 15.41 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.932 0.396 . . . . 0.0 110.844 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.47 ' HA ' HD23 ' A' ' 43' ' ' LEU . 89.0 m -138.79 120.85 10.35 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.452 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.523 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 93.0 Cg_endo -80.61 162.11 21.8 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.087 1.858 . . . . 0.0 111.638 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -74.01 -27.9 61.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 0.0 110.849 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.462 HG13 ' CG2' ' A' ' 6' ' ' VAL . 3.3 p -145.14 154.95 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 9.5 tp -152.98 136.75 16.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 111.342 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.575 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.4 OUTLIER -111.45 122.59 48.25 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.89 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -106.83 137.95 43.91 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 29.1 t0 -73.02 171.33 13.06 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.342 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.663 HG13 ' O ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -157.97 93.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.383 -178.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.83 44.12 2.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.561 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 8.1 ttp 59.89 46.14 1.26 Allowed Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 55.2 Cg_endo -71.1 -73.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.296 1.997 . . . . 0.0 112.188 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.447 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -112.15 -27.73 3.85 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.233 -0.508 . . . . 0.0 111.851 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.586 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 16.0 ttm -155.63 64.39 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.361 . . . . 0.0 110.456 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.663 ' O ' HG13 ' A' ' 55' ' ' ILE . 2.4 t70 71.87 -23.54 0.19 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.172 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.595 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 136.44 -29.55 2.78 Favored Glycine 0 CA--C 1.506 -0.505 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.631 ' HA ' HD23 ' A' ' 66' ' ' LEU . 2.2 mp -70.11 -19.85 63.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.891 -0.655 . . . . 0.0 110.296 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.586 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.64 -30.75 44.43 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.128 0.49 . . . . 0.0 109.819 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.503 ' HG ' ' HA3' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -59.63 -48.39 81.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.537 178.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.631 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.5 mm? -48.74 -41.72 33.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.018 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.695 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 16.9 tttp -58.78 -43.73 90.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.351 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.478 ' CB ' HD12 ' A' ' 40' ' ' LEU . 40.8 mm-40 -62.73 -38.83 92.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.221 0.534 . . . . 0.0 110.648 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.489 HD13 HG21 ' A' ' 78' ' ' VAL . 73.5 mt -57.41 -40.22 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.814 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.695 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.34 -22.56 47.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.15 -43.5 86.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.862 0.363 . . . . 0.0 111.85 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -99.3 -31.97 11.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.037 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.522 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 1.9 m-70 -112.68 138.2 21.99 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.764 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.37 -68.15 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.261 1.974 . . . . 0.0 112.554 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mpp? -148.45 53.67 1.01 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 110.736 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.563 ' O ' HG22 ' A' ' 78' ' ' VAL . 3.1 tm? -55.26 115.06 8.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.419 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.482 ' HD2' HD21 ' A' ' 76' ' ' LEU . 10.0 Cg_endo -53.5 121.51 9.62 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.615 2.21 . . . . 0.0 112.213 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.714 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.2 t -127.99 149.36 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.22 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.575 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.6 mp -137.4 116.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.586 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.661 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 25.3 mm -92.65 142.98 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.276 0.56 . . . . 0.0 111.944 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.496 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.87 -9.7 59.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.984 -178.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.487 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.4 m -147.6 152.45 37.94 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.611 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.66 73.51 0.43 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -96.62 -21.12 17.83 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.3 m -159.84 175.76 12.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.049 0.452 . . . . 0.0 111.451 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.56 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.2 OUTLIER 54.42 29.25 10.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.411 -179.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.56 -21.06 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.546 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -47.81 -52.68 17.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.678 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.5 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . . . -68.56 -19.77 64.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.315 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.609 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . . . -66.75 -54.43 22.87 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.833 0.349 . . . . 0.0 111.011 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.628 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 4.1 t -62.23 -45.06 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.5 p -60.7 -27.05 67.58 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.628 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -59.09 -50.18 75.04 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.483 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.628 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -59.68 -33.63 71.82 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.901 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -39.72 69.48 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.449 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.576 ' HB2' ' CB ' ' A' ' 70' ' ' LYS . 7.6 pt20 -93.3 -7.42 44.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 132.02 82.36 0.22 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.766 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.714 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.46 139.18 2.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.559 0.218 . . . . 0.0 110.552 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.549 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 38.1 t80 -74.94 -53.76 8.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.347 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.678 ' OD2' HD11 ' A' ' 114' ' ' LEU . 38.5 p-10 177.71 -168.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.0 111.256 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.661 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 7.6 m-85 -123.1 152.76 40.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.802 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.532 HD11 ' O ' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -143.02 142.79 22.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.759 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.424 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 56.1 Cg_exo -51.68 165.44 0.73 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.382 2.054 . . . . 0.0 111.889 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.596 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -41.16 -51.05 8.07 Favored Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 3.9 Cg_endo -47.62 164.1 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.868 1.712 . . . . 0.0 110.353 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.831 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 174.98 -85.59 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.174 -0.211 . . . . 0.0 111.089 -179.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 48.4 -174.16 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.654 HG23 HG22 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -57.7 -49.95 79.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.191 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.684 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 2.2 t70 -50.99 -58.89 4.91 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.154 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.831 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 7.6 mm-40 -81.18 -28.67 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.73 -47.74 10.86 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.951 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.654 HG22 HG23 ' A' ' 108' ' ' ILE . 59.5 t -62.09 -32.68 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.591 0.71 . . . . 0.0 109.733 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -59.64 -50.36 74.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.913 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.678 HD11 ' OD2' ' A' ' 100' ' ' ASP . 15.4 tp -75.69 -21.15 57.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.747 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 112' ' ' VAL . 4.1 p -79.52 -48.14 21.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.836 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.408 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 49.8 mt-10 -65.72 -39.95 91.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.918 0.389 . . . . 0.0 110.326 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.8 mtp85 -65.38 -23.88 67.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.763 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.549 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -75.01 -49.1 20.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.221 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.8 mt -68.0 -30.69 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.714 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.5 m -73.32 -40.0 64.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.877 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -77.9 -29.14 50.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.009 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -71.33 -51.85 22.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.853 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.27 170.9 15.16 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.986 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.885 0.374 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -161.22 -23.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.622 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.489 ' HG3' HG12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -74.39 50.32 0.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.859 0.362 . . . . 0.0 111.021 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . -68.05 89.77 0.21 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.489 HG12 ' HG3' ' A' ' 3' ' ' ARG . 2.8 mm -124.42 118.85 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.507 HG13 ' HG ' ' A' ' 23' ' ' LEU . 9.0 p -105.68 122.85 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.952 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.567 ' NE1' HG21 ' A' ' 31' ' ' THR . 27.2 m0 -107.87 137.41 45.93 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.674 -0.41 . . . . 0.0 109.975 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -131.06 144.45 37.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.331 -177.257 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.782 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -133.95 105.29 6.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.142 178.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 64.2 t0 166.9 118.3 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.415 ' CB ' HG12 ' A' ' 15' ' ' ILE . 2.4 t0 71.02 -16.36 0.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.1 t0 67.81 -139.63 0.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.253 -0.279 . . . . 0.0 110.985 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 t -32.82 -43.17 0.09 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.405 ' O ' HG22 ' A' ' 18' ' ' VAL . 36.1 t -53.15 -69.65 0.11 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 25.9 mm -63.94 -20.79 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.525 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 7.1 ttp180 -68.03 -58.48 4.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.469 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 77.3 t90 -51.13 -44.87 61.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.735 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.591 ' C ' HD11 ' A' ' 108' ' ' ILE . 2.4 t -62.92 -61.04 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.13 0.49 . . . . 0.0 111.975 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.539 ' N ' HD11 ' A' ' 108' ' ' ILE . 14.2 tp -72.28 -21.69 61.32 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 14.6 pt-20 -66.93 -56.06 11.86 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.408 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.516 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -62.78 -56.93 13.09 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.459 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.82 -49.5 70.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 111.929 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.507 ' HG ' HG13 ' A' ' 6' ' ' VAL . 1.5 tm? -69.78 -24.07 63.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.181 0.515 . . . . 0.0 110.339 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.07 -32.74 70.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.4 -27.11 67.25 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.231 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.31 -15.38 59.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 110.513 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.71 24.5 13.42 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.873 -0.68 . . . . 0.0 114.214 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.473 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -124.14 164.15 20.04 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 118.32 1.06 . . . . 0.0 112.438 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.479 ' O ' HG12 ' A' ' 6' ' ' VAL . 99.7 m -84.66 136.79 33.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.926 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -127.57 111.53 13.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.715 -179.007 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.567 HG21 ' NE1' ' A' ' 7' ' ' TRP . 2.8 t -123.55 147.33 47.38 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.692 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 71.7 p -126.25 159.49 32.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.469 0.652 . . . . 0.0 112.658 -178.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.817 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 2.2 m-85 -136.13 174.12 10.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.987 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.555 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -54.52 -51.17 65.97 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -177.002 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.606 ' N ' HG13 ' A' ' 9' ' ' VAL . 11.3 m-20 -171.24 -20.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.648 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . 169.46 -45.61 0.21 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.732 -1.223 . . . . 0.0 114.13 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.822 ' HA ' HD11 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -61.04 -39.17 88.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.447 0.624 . . . . 0.0 111.415 -178.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.817 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -57.86 -54.17 49.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.493 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.564 HG23 HG22 ' A' ' 9' ' ' VAL . 2.6 t -51.53 -47.19 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.322 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.822 HD11 ' HA ' ' A' ' 37' ' ' ASN . 15.0 mt -48.01 -43.58 30.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.91 -48.67 65.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.903 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.91 -27.68 67.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.28 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.614 HD12 ' NE2' ' A' ' 73' ' ' HIS . 17.6 mt -73.01 -23.96 60.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.946 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.83 -19.62 6.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.475 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.19 3.16 5.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -153.99 154.52 33.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.897 0.38 . . . . 0.0 111.518 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.9 m -138.86 113.18 8.36 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.426 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.531 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 72.7 Cg_endo -74.17 165.58 31.59 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.324 2.016 . . . . 0.0 111.266 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' OD2' ' HA2' ' A' ' 4' ' ' GLY . 93.5 m-20 -77.53 -30.67 52.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.855 0.359 . . . . 0.0 110.894 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.478 HG12 ' CG2' ' A' ' 6' ' ' VAL . 7.6 p -146.52 102.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.486 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.46 ' CB ' HD21 ' A' ' 76' ' ' LEU . 61.3 tp -87.26 137.19 32.56 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.694 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.6 mt -119.14 122.46 42.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.31 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.765 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -119.16 148.35 43.18 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 7.0 t0 -76.66 -167.0 0.74 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.558 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.769 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -165.4 72.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.832 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 29.2 ttt180 177.18 63.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.954 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.466 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 1.1 tmm? -163.27 -61.85 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.86 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.466 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 33.0 Cg_endo -61.82 -171.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.394 2.063 . . . . 0.0 112.689 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.11 -78.61 0.1 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.437 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.644 ' O ' ' N ' ' A' ' 62' ' ' GLY . 2.7 mtt -69.91 64.52 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.394 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.482 ' OD2' HD11 ' A' ' 63' ' ' LEU . 6.0 p-10 48.73 -66.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.543 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.769 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -143.51 -39.63 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.82 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 86' ' ' ASP . 1.8 mp -51.65 -25.18 6.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.414 . . . . 0.0 110.291 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 58' ' ' PRO . . . -55.55 -33.62 64.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.373 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.62 HD12 HD13 ' A' ' 69' ' ' ILE . 3.5 pp -65.17 -25.68 67.84 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 6.2 mp -66.1 -41.55 90.45 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 22.1 mmtm -53.06 -50.93 63.35 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.784 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.489 ' OE1' HD12 ' A' ' 40' ' ' LEU . 1.8 mt-30 -53.36 -43.89 68.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.76 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.634 HG12 ' CE1' ' A' ' 73' ' ' HIS . 61.6 mt -55.68 -45.53 79.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.003 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.504 ' CB ' ' HG3' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -63.71 -28.21 69.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.121 0.486 . . . . 0.0 110.67 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.447 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 4.3 mt-30 -77.07 -41.14 43.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.236 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -93.57 -73.2 0.57 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.372 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.634 ' CE1' HG12 ' A' ' 69' ' ' ILE . 7.6 p80 -110.55 76.97 1.2 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.75 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HB2' ' OE1' ' A' ' 96' ' ' GLN . 72.7 Cg_endo -77.25 29.44 0.42 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.963 2.442 . . . . 0.0 114.011 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.0 mtp -134.19 -32.07 1.08 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.855 0.36 . . . . 0.0 111.564 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.547 ' HB3' ' HD1' ' A' ' 73' ' ' HIS . 5.6 tp -66.34 141.87 97.47 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.306 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.436 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 78.7 Cg_endo -76.87 131.43 12.18 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.819 2.346 . . . . 0.0 112.304 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.41 141.52 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.058 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.542 HD11 ' HG ' ' A' ' 52' ' ' LEU . 2.6 mt -130.28 115.93 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.434 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.593 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 32.2 mm -93.64 145.82 7.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.042 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.526 ' O ' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -80.83 -24.64 38.32 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.347 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.538 ' O ' HG21 ' A' ' 80' ' ' ILE . 3.0 m -148.03 149.44 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.755 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -126.93 68.23 1.26 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.754 0.311 . . . . 0.0 111.304 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 61' ' ' ASP . 9.0 p80 -98.08 111.2 23.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.026 0.441 . . . . 0.0 111.569 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 t 54.39 168.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.022 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.568 ' O ' HD23 ' A' ' 63' ' ' LEU . 0.8 OUTLIER 62.19 14.71 6.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.518 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.463 HD22 ' HB1' ' A' ' 90' ' ' ALA . 1.4 mt -46.38 -25.14 0.6 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -48.61 -41.12 29.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.865 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.509 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . . . -70.93 -22.08 62.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.463 ' HB1' HD22 ' A' ' 87' ' ' LEU . . . -69.76 -34.51 73.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.942 0.401 . . . . 0.0 110.588 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.693 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.2 t -61.19 -45.15 99.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.141 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.591 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 20.6 m -57.99 -48.78 78.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.561 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.506 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -47.21 -43.67 21.75 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.154 0.502 . . . . 0.0 110.943 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.693 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 11.2 m-85 -54.89 -26.31 34.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.044 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.632 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.5 -48.07 61.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.341 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.632 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 26.7 mm-40 -72.5 -18.8 61.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.721 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.38 27.83 1.42 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.845 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.506 ' HB3' ' C ' ' A' ' 93' ' ' ALA . . . -62.21 146.78 49.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.349 0.574 . . . . 0.0 110.295 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.545 ' O ' ' HB2' ' A' ' 100' ' ' ASP . 45.4 t80 -74.18 -54.14 8.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.109 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 0.9 OUTLIER 166.99 -162.69 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.157 0.503 . . . . 0.0 111.445 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.593 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.4 m-85 -131.31 153.21 49.81 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.355 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 1.018 HD22 ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -141.53 149.89 55.66 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.963 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.462 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 29.0 Cg_endo -64.42 161.21 35.71 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.493 2.129 . . . . 0.0 111.426 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.576 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -33.58 -51.25 0.79 Allowed Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.1 Cg_endo -47.47 162.41 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.729 1.619 . . . . 0.0 110.345 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 1.018 ' CD1' HD22 ' A' ' 102' ' ' LEU . 0.1 OUTLIER 177.85 -79.45 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.064 -178.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.632 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 3.0 p30 42.54 -168.27 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.591 HD11 ' C ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.98 -47.19 79.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.825 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.71 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -51.95 -57.98 7.85 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.773 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.668 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 13.5 mm-40 -77.45 -31.88 54.12 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.758 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . . . -83.32 -49.93 8.88 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.537 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.574 ' O ' HG12 ' A' ' 115' ' ' VAL . 44.4 t -59.47 -31.54 46.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.526 0.679 . . . . 0.0 109.758 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.71 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -59.84 -51.34 70.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.964 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.551 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 6.9 tp -75.86 -21.59 57.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.641 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.2 p -79.44 -48.15 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.023 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.406 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 40.7 mt-10 -65.09 -40.52 94.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.699 0.285 . . . . 0.0 110.769 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.551 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 2.4 ptm85 -62.6 -25.07 67.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 0.0 110.394 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.431 ' HB1' ' CE1' ' A' ' 99' ' ' PHE . . . -70.61 -49.81 43.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.077 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.6 mt -66.38 -31.87 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -31.98 70.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.715 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.65 -24.98 63.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.956 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -66.32 -46.78 75.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.85 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -78.31 -55.33 5.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.16 0.505 . . . . 0.0 111.337 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 . . . . . 0 C--N 1.32 -0.705 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.085 -179.933 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.877 0.37 . . . . 0.0 111.494 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -87.48 155.93 19.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.097 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 2.9 11.15 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.24 82.36 0.34 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.356 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 1.4 mp -114.96 120.96 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.798 0.333 . . . . 0.0 111.211 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 7.5 p -114.23 120.77 64.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.321 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.506 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.8 m0 -111.04 136.46 50.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.744 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -122.12 137.89 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.888 -178.167 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.965 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -121.43 115.25 46.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.157 0.503 . . . . 0.0 110.068 178.138 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.583 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 7.5 t70 -168.35 -154.45 0.14 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.597 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -66.32 -3.17 5.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 65.56 -154.08 0.26 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.263 -0.273 . . . . 0.0 111.107 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 t 34.56 -89.12 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.422 ' N ' ' O ' ' A' ' 12' ' ' ASP . 17.1 m -54.22 -58.81 5.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.724 0.297 . . . . 0.0 111.395 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 26.4 mm -62.96 -30.53 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.937 0.398 . . . . 0.0 110.937 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.485 ' HG3' HG21 ' A' ' 32' ' ' THR . 22.5 ttt85 -72.36 -47.46 49.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.947 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.4 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 52.6 t90 -60.4 -40.92 92.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.483 ' C ' HD12 ' A' ' 108' ' ' ILE . 1.7 t -74.24 -43.09 50.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.97 0.414 . . . . 0.0 111.557 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.519 ' HA ' HD12 ' A' ' 108' ' ' ILE . 3.9 mm? -77.02 -27.57 54.63 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.1 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.643 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 16.7 pt-20 -67.89 -59.77 3.03 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.925 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.492 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -68.58 -55.96 9.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.09 -51.39 58.0 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.661 HD13 ' CD1' ' A' ' 28' ' ' LEU . 2.5 tp -67.35 -23.3 65.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.413 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -68.22 -36.64 79.84 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.36 -24.44 65.63 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.203 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.422 ' CB ' HD12 ' A' ' 28' ' ' LEU . . . -78.43 -15.6 58.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.741 0.305 . . . . 0.0 110.91 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.61 26.14 9.41 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.988 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.661 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.66 170.37 11.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.759 0.78 . . . . 0.0 111.808 179.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.405 ' O ' HG12 ' A' ' 6' ' ' VAL . 24.3 m -101.4 105.88 16.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.343 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.643 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 4.9 t -102.25 114.57 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.992 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.506 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -123.79 150.38 44.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 70.8 p -122.06 163.78 18.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.965 ' HB2' HG12 ' A' ' 9' ' ' VAL . 1.2 m-85 -136.4 175.43 9.62 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.755 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.589 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.9 pp20? -60.35 -55.69 30.52 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -177.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 5.6 m-80 -150.81 -43.89 0.12 Allowed 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.547 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 177.51 -46.03 0.1 OUTLIER Glycine 0 C--N 1.318 -0.454 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.353 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.422 ' ND2' HD11 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -63.25 -27.73 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.796 0.332 . . . . 0.0 110.6 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -58.59 -55.45 34.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.712 179.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.613 HG21 HG11 ' A' ' 9' ' ' VAL . 3.4 t -50.53 -38.92 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.965 0.412 . . . . 0.0 111.123 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 68' ' ' GLN . 13.3 mt -59.38 -44.07 92.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.52 -49.93 55.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.065 0.459 . . . . 0.0 111.108 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.09 -33.02 74.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.824 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.501 HD21 ' HD2' ' A' ' 48' ' ' PRO . 15.6 mt -62.15 -23.83 66.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.05 -20.42 16.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.791 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -116.56 -6.15 11.66 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -159.27 158.2 32.03 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.929 0.395 . . . . 0.0 111.012 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.9 m -138.71 114.93 8.76 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.954 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.533 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 91.0 Cg_endo -81.73 165.05 18.1 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.117 1.878 . . . . 0.0 111.53 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 5' ' ' ILE . 3.9 p30 -74.25 -59.81 2.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.123 0.487 . . . . 0.0 110.086 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.585 HG23 HG23 ' A' ' 115' ' ' VAL . 12.0 p -99.48 160.58 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.201 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 79' ' ' ILE . 32.1 tp -153.07 153.12 32.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.138 0.494 . . . . 0.0 111.676 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.763 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.2 mt -137.24 120.78 17.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.042 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.652 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -105.31 134.44 48.42 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.583 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.594 ' O ' HG21 ' A' ' 55' ' ' ILE . 9.2 t70 -61.71 -28.43 69.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.636 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.792 HG13 ' HA3' ' A' ' 62' ' ' GLY . 0.3 OUTLIER 41.8 92.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.772 -179.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.529 ' O ' ' HG3' ' A' ' 57' ' ' MET . 0.0 OUTLIER -175.3 104.86 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.193 0.52 . . . . 0.0 112.124 179.237 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER 40.03 47.91 1.96 Allowed Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 178.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.601 ' HG3' ' HA2' ' A' ' 62' ' ' GLY . 98.6 Cg_endo -90.76 -53.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.511 2.141 . . . . 0.0 111.693 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.01 -21.9 0.12 Allowed Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.66 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.581 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 3.6 tpt -163.98 67.21 0.17 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.658 0.383 . . . . 0.0 110.071 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 71.95 -22.56 0.2 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.616 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.792 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 136.65 -27.68 2.93 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.683 HD13 ' HB3' ' A' ' 86' ' ' ASP . 5.1 mp -77.1 -19.97 56.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.581 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.77 -32.65 53.19 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.003 0.43 . . . . 0.0 110.455 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.432 ' O ' HG13 ' A' ' 69' ' ' ILE . 14.7 mt -57.23 -44.42 83.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.538 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 63' ' ' LEU . 3.5 mm? -55.02 -44.79 74.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.93 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.638 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -52.71 -45.06 66.76 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.17 179.591 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.497 ' HB2' HD13 ' A' ' 40' ' ' LEU . 25.8 mm100 -67.45 -31.1 71.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.037 0.446 . . . . 0.0 110.601 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.538 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 94.5 mt -63.08 -41.06 91.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.755 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 3.4 pttp -74.76 -22.78 58.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.347 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.452 ' NE2' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -81.75 -31.95 31.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.395 -179.468 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.452 ' HG3' ' NE2' ' A' ' 71' ' ' GLN . 41.1 mtt180 -106.81 -59.48 1.8 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 112.191 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.538 ' CD2' ' HA ' ' A' ' 69' ' ' ILE . 2.2 m-70 -81.4 145.13 54.76 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.302 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -95.75 102.71 0.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.219 2.613 . . . . 0.0 113.14 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.576 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.6 mtt 54.26 35.97 24.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.809 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.443 ' O ' HG21 ' A' ' 78' ' ' VAL . 1.1 tt -64.68 110.34 3.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.632 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.432 ' HG3' ' CZ ' ' A' ' 122' ' ' TYR . 51.1 Cg_exo -54.02 116.87 3.33 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.164 1.91 . . . . 0.0 111.713 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 76' ' ' LEU . 2.4 t -122.1 146.07 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.321 0.581 . . . . 0.0 112.056 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 3.2 mt -122.07 116.94 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.957 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.607 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 9.3 mm -93.42 120.82 43.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.23 0.538 . . . . 0.0 112.315 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.487 ' HE3' ' CE ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -74.35 -8.86 57.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.286 -179.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 80' ' ' ILE . 3.0 m -147.52 136.01 21.74 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.09 0.472 . . . . 0.0 111.948 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.03 84.41 2.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.137 0.494 . . . . 0.0 110.562 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.434 ' CE1' HG21 ' A' ' 82' ' ' THR . 56.8 m-70 -66.78 -157.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.016 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -86.07 40.53 0.87 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.683 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -129.26 36.07 4.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.075 0.464 . . . . 0.0 109.98 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -45.42 -21.57 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.917 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.67 -55.12 10.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.492 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.434 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -69.42 -22.99 63.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.358 . . . . 0.0 110.654 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.444 ' CB ' ' CE1' ' A' ' 101' ' ' TYR . . . -68.69 -44.41 74.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.577 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.609 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 10.8 t -65.11 -42.66 94.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.804 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 77.6 p -67.12 -23.56 65.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.977 0.418 . . . . 0.0 109.932 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.673 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -65.99 -37.5 86.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.285 0.564 . . . . 0.0 109.835 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.609 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.9 m-85 -68.29 -23.9 64.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.282 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.404 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.1 OUTLIER -74.87 -29.55 61.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.272 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.673 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -92.19 -17.19 25.22 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.06 24.75 1.44 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.944 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 93' ' ' ALA . . . -68.92 145.94 53.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.118 0.459 . . . . 0.0 110.584 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.526 ' HE2' HD11 ' A' ' 114' ' ' LEU . 22.9 t80 -79.45 -53.39 6.94 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.45 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t0 179.42 -164.99 0.05 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.945 0.403 . . . . 0.0 111.932 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.607 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 7.8 m-85 -137.56 122.52 18.96 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.537 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.505 ' CD1' ' O ' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -123.0 142.87 39.24 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.898 -179.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.55 175.39 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.874 2.383 . . . . 0.0 113.07 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.585 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -43.5 -53.1 12.38 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 6.3 Cg_endo -48.73 163.42 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.832 1.688 . . . . 0.0 110.442 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.847 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 172.87 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.739 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 45.65 -171.28 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.538 ' CA ' HG22 ' A' ' 112' ' ' VAL . 1.1 mp -60.13 -49.94 82.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.512 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.695 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 15.6 t0 -52.31 -58.57 6.25 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.847 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -80.35 -28.12 38.15 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.96 -52.16 6.56 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.589 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.573 ' O ' HG11 ' A' ' 115' ' ' VAL . 40.1 t -57.75 -33.54 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.49 0.662 . . . . 0.0 110.082 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.695 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -59.0 -51.62 69.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.626 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.526 HD11 ' HE2' ' A' ' 99' ' ' PHE . 9.6 tp -75.53 -21.89 57.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.045 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.585 HG23 HG23 ' A' ' 50' ' ' VAL . 3.0 p -79.46 -52.16 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.45 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 32.3 mt-10 -58.75 -40.14 82.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.648 0.261 . . . . 0.0 111.544 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.491 ' HD2' HD11 ' A' ' 114' ' ' LEU . 9.8 ptp180 -65.91 -23.73 66.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 0.0 110.774 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.482 ' HB1' ' CE2' ' A' ' 99' ' ' PHE . . . -71.71 -49.41 39.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.776 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.5 mt -71.05 -31.75 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.7 t -66.08 -34.64 78.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.721 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -78.21 -23.73 47.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.09 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.432 ' CZ ' ' HG3' ' A' ' 77' ' ' PRO . 0.3 OUTLIER -71.99 -59.19 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.98 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -76.41 173.05 11.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.85 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 N--CA 1.465 0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.564 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptm . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -96.58 -18.65 19.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 111.138 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -1.06 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.757 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 92.26 89.72 1.48 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.728 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.562 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.9 mm -125.92 120.04 56.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.656 HG11 ' HG ' ' A' ' 23' ' ' LEU . 7.4 p -110.77 132.17 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.59 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.606 ' NE1' HG22 ' A' ' 31' ' ' THR . 35.0 m0 -119.58 127.44 52.97 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -124.2 122.05 63.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.891 HG21 ' HA ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -111.07 113.63 44.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.201 178.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.417 ' O ' HG13 ' A' ' 15' ' ' ILE . 15.8 t0 -177.36 68.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.195 0.521 . . . . 0.0 111.464 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.8 t70 69.13 -2.14 1.9 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 14' ' ' SER . 6.6 p-10 43.25 -126.8 0.81 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.481 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.586 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 1.7 t 34.94 -82.59 0.0 OUTLIER 'General case' 0 C--N 1.343 0.304 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.567 ' N ' ' O ' ' A' ' 12' ' ' ASP . 15.2 t -82.46 -48.4 11.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.655 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 10' ' ' ASP . 46.6 mm -63.73 -22.4 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.723 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 0.0 OUTLIER -81.58 -55.54 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.358 . . . . 0.0 111.552 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.571 ' H ' ' HG3' ' A' ' 16' ' ' ARG . 85.1 t90 -48.78 -41.69 33.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.535 ' C ' HD12 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -70.44 -61.43 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.432 . . . . 0.0 112.058 -178.63 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 8.3 tp -66.3 -27.36 67.86 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.659 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . 12.4 pt-20 -67.7 -58.35 4.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.134 0.492 . . . . 0.0 111.446 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.474 ' N ' ' CG ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -54.39 -64.68 0.75 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.086 -179.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.34 -27.39 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.656 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.7 tm? -82.14 -29.85 31.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.383 0.611 . . . . 0.0 110.467 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.44 73.51 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.55 -26.79 70.04 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.393 -0.908 . . . . 0.0 110.95 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.431 ' CB ' HD11 ' A' ' 28' ' ' LEU . . . -78.27 -15.52 58.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.97 24.54 11.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.051 0.78 . . . . 0.0 115.051 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.571 ' HB2' HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -126.18 164.15 21.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.611 1.205 . . . . 0.0 112.372 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 6' ' ' VAL . 79.0 m -79.75 129.09 34.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.038 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 1.8 p -121.67 111.2 16.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.976 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.606 HG22 ' NE1' ' A' ' 7' ' ' TRP . 2.6 t -135.85 134.03 38.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.723 ' OG1' ' HB3' ' A' ' 16' ' ' ARG . 43.6 p -115.61 155.09 28.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -136.58 174.1 10.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.226 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.518 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -58.42 -108.9 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.473 ' O ' HG13 ' A' ' 9' ' ' VAL . 24.3 m-80 -85.86 -179.92 6.91 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.547 ' CA ' ' HG ' ' A' ' 65' ' ' LEU . . . -68.71 0.25 14.83 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.391 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.438 ' ND2' HD12 ' A' ' 40' ' ' LEU . 1.8 t-20 -81.28 -41.69 21.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.668 0.734 . . . . 0.0 109.507 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.518 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -51.92 -55.31 21.04 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.992 179.102 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.534 HG21 HG13 ' A' ' 9' ' ' VAL . 33.2 t -44.15 -35.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.151 0.501 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.438 HD12 ' ND2' ' A' ' 37' ' ' ASN . 14.1 mt -61.84 -50.12 73.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.485 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.99 -48.26 82.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.324 0.583 . . . . 0.0 110.864 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.32 73.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.38 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 10.9 mt -66.62 -24.07 66.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.156 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.94 -18.4 60.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.669 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.55 -8.15 11.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -159.69 159.37 32.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.586 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.3 m -138.8 113.49 8.45 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.688 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.562 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 89.1 Cg_endo -80.0 165.34 21.89 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.215 1.944 . . . . 0.0 111.26 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.673 ' O ' ' HD2' ' A' ' 77' ' ' PRO . 3.3 p30 -74.38 -59.03 2.91 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.544 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.464 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 7.6 p -101.72 162.11 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.393 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.432 ' CD1' ' HB2' ' A' ' 7' ' ' TRP . 42.4 tp -152.86 152.25 31.33 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.013 0.435 . . . . 0.0 111.705 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.639 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -137.31 120.91 17.25 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.936 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.891 ' HA ' HG21 ' A' ' 9' ' ' VAL . 49.1 m -109.07 137.15 47.42 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 55' ' ' ILE . 39.6 t0 -65.9 -20.59 66.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.694 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER 47.22 79.71 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 112.106 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 171.36 85.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.487 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.606 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -163.3 -66.89 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 87.1 Cg_endo -77.4 -165.7 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.451 2.1 . . . . 0.0 113.677 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 61' ' ' ASP . . . -58.98 -51.01 61.76 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.844 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.499 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -74.28 45.41 0.22 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 110.563 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 59' ' ' GLY . 0.3 OUTLIER 55.81 -82.15 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.658 -179.034 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -143.12 -31.92 0.1 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.926 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.643 HD13 ' HB2' ' A' ' 86' ' ' ASP . 1.4 mp -49.92 -26.85 4.53 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.33 -30.98 61.3 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.997 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.547 ' HG ' ' CA ' ' A' ' 36' ' ' GLY . 2.3 mm? -60.94 -50.21 74.34 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.983 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.454 HD12 HG13 ' A' ' 80' ' ' ILE . 51.7 mt -49.65 -46.48 49.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.092 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.44 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -50.28 -46.59 55.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.211 0.529 . . . . 0.0 110.176 179.404 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -63.38 -38.63 91.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.525 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.421 HG23 HD22 ' A' ' 76' ' ' LEU . 75.2 mt -61.35 -40.85 87.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.521 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 67' ' ' LYS . 44.5 pttt -72.24 -21.35 61.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.19 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -31.8 62.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.586 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -106.25 -24.0 12.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.031 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.54 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 40.8 m-70 -141.97 86.16 10.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.71 15.57 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.01 2.473 . . . . 0.0 113.127 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.554 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 11.9 mtt -145.36 4.83 1.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.447 ' CD1' ' O ' ' A' ' 48' ' ' PRO . 15.9 tp -76.39 107.44 4.59 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 49' ' ' ASP . 39.3 Cg_exo -58.99 121.14 9.45 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.578 2.185 . . . . 0.0 111.732 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.613 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.3 t -120.64 150.52 23.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.488 0.661 . . . . 0.0 111.922 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.639 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 3.7 mt -131.79 116.32 30.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.634 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.755 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 13.4 mm -93.43 137.92 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.62 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -85.41 -15.19 43.88 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.512 -179.199 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.513 ' H ' HG23 ' A' ' 80' ' ' ILE . 2.7 m -147.27 163.66 35.69 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.06 -47.62 3.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 110.973 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 44.56 59.37 3.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.978 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 52.37 -170.5 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.782 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.643 ' HB2' HD13 ' A' ' 63' ' ' LEU . 54.1 m-20 59.94 31.88 20.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.52 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -46.48 -24.25 0.49 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.723 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.81 -45.56 29.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.24 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.411 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . . . -70.78 -23.07 62.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.675 0.274 . . . . 0.0 111.411 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.551 ' HB1' ' CE1' ' A' ' 101' ' ' TYR . . . -66.81 -46.39 75.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.742 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.608 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.7 t -61.3 -36.85 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.8 m -60.93 -41.23 95.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.213 0.53 . . . . 0.0 110.237 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 96' ' ' GLN . . . -54.76 -49.06 71.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.117 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.608 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 8.7 m-85 -51.39 -27.76 10.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.596 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.561 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -70.4 -39.75 74.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.315 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.561 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 7.2 pt20 -77.97 -18.18 56.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.028 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.0 4.99 5.41 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.378 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.613 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -53.1 132.71 38.56 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.269 0.535 . . . . 0.0 110.751 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.449 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 8.6 t80 -64.14 -53.44 49.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.488 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 0.4 OUTLIER 175.75 -161.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.041 0.448 . . . . 0.0 111.904 -179.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.755 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.7 m-85 -132.57 135.86 46.2 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.136 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.62 ' HG ' ' HA ' ' A' ' 81' ' ' MET . 1.3 pp -126.59 136.49 28.77 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.842 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.68 172.13 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.271 1.98 . . . . 0.0 111.908 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.602 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -41.86 -49.8 10.52 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.649 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.9 Cg_endo -47.91 164.4 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 121.94 1.76 . . . . 0.0 110.704 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.792 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 173.86 -90.16 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.287 -0.165 . . . . 0.0 111.064 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.594 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.4 p30 50.98 -178.85 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.581 HG23 HG21 ' A' ' 112' ' ' VAL . 1.2 mp -54.46 -49.49 65.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.442 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.739 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 9.6 t0 -51.89 -58.79 5.45 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.792 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 4.8 mm-40 -82.41 -27.83 31.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.1 -47.27 11.08 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.873 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.606 ' O ' HG11 ' A' ' 115' ' ' VAL . 53.4 t -62.73 -32.03 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.493 0.663 . . . . 0.0 109.505 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -61.32 -49.89 75.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.144 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.476 ' CD2' ' HB3' ' A' ' 102' ' ' LEU . 8.3 tp -75.64 -20.94 58.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.433 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.606 HG11 ' O ' ' A' ' 112' ' ' VAL . 4.1 p -79.26 -49.41 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.441 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 34.7 mt-10 -65.35 -44.24 88.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.631 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 117' ' ' ARG . 6.4 mmt180 -63.02 -23.88 67.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.408 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 114' ' ' LEU . . . -73.18 -49.45 27.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.053 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.451 HG12 ' OD1' ' A' ' 49' ' ' ASP . 3.7 mt -67.02 -31.11 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.817 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 t -66.74 -43.11 85.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.752 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -68.46 -26.89 65.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.984 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -66.77 -53.23 35.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.534 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.35 -176.37 3.1 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.407 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--N 1.331 -0.239 0 CA-C-O 120.912 0.387 . . . . 0.0 110.83 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.891 0.377 . . . . 0.0 111.466 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.78 162.47 13.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.869 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.559 ' HB3' HD11 ' A' ' 5' ' ' ILE . 6.4 ttt180 -68.73 -52.28 32.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.09 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 67.36 85.85 0.09 OUTLIER Glycine 0 C--N 1.32 -0.33 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.854 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.559 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.4 mp -117.41 115.8 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 0.0 111.512 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.748 HG13 ' HG ' ' A' ' 23' ' ' LEU . 8.3 p -107.11 122.44 61.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.596 ' CD2' ' HG3' ' A' ' 48' ' ' PRO . 35.2 m0 -112.42 137.92 49.91 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.587 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -126.55 147.92 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.095 -178.112 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.766 HG22 ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -134.65 121.14 34.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.084 178.075 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 14.6 t0 -177.33 -147.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.905 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.53 -2.18 4.44 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 14' ' ' SER . 2.3 t70 55.49 -143.03 0.75 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.407 ' HB3' ' H ' ' A' ' 14' ' ' SER . 4.0 t 33.2 -90.22 0.01 OUTLIER 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.436 ' O ' HG21 ' A' ' 18' ' ' VAL . 3.8 m -57.8 -52.84 63.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.704 0.288 . . . . 0.0 111.357 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 14.6 mm -62.62 -36.28 74.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.943 0.401 . . . . 0.0 111.556 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -68.84 -41.92 77.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.313 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.472 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . 33.3 t90 -65.12 -58.7 5.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.306 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.515 ' CG1' HD11 ' A' ' 108' ' ' ILE . 1.4 t -57.35 -43.61 82.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.106 -178.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.66 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 4.4 mm? -76.85 -31.72 57.04 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.708 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 17.0 pt-20 -64.73 -61.92 1.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.687 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.672 ' HD2' ' H ' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -52.69 -63.87 1.0 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 0.0 112.095 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.16 -35.99 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.374 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.748 ' HG ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -73.87 -30.26 62.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.886 0.374 . . . . 0.0 110.331 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.08 -35.03 79.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.76 69.28 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.129 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.39 -15.34 58.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.65 0.262 . . . . 0.0 111.03 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.64 26.03 10.25 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.73 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.489 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -137.44 176.0 9.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.46 0.63 . . . . 0.0 111.316 179.7 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.505 ' O ' HG12 ' A' ' 6' ' ' VAL . 22.2 m -105.87 131.51 53.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.432 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.708 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 2.0 t -119.71 114.31 21.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.86 0.362 . . . . 0.0 111.767 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.508 HG22 ' NE1' ' A' ' 7' ' ' TRP . 2.7 t -123.08 155.27 37.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 37.8 p -129.92 157.75 41.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.148 0.499 . . . . 0.0 112.167 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.703 ' HB2' HG12 ' A' ' 9' ' ' VAL . 1.5 m-85 -133.18 173.25 11.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.614 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.678 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -63.25 -47.21 83.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.199 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.487 ' H ' ' HG3' ' A' ' 34' ' ' GLU . 42.9 t30 -161.64 168.47 23.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.928 0.394 . . . . 0.0 110.666 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.676 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -49.75 -11.45 0.33 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.573 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -81.91 -45.36 15.56 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.603 0.701 . . . . 0.0 109.913 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.678 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 2.0 tt0 -55.28 -51.69 65.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.019 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.677 HG22 HG11 ' A' ' 9' ' ' VAL . 17.9 t -51.55 -33.13 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.035 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.385 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.487 HD12 ' HB3' ' A' ' 68' ' ' GLN . 17.3 mt -57.66 -51.68 68.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.011 0.434 . . . . 0.0 110.13 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.29 -47.45 85.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.746 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.74 -34.54 78.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.096 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.652 ' HG ' HG12 ' A' ' 39' ' ' VAL . 31.5 mt -68.24 -23.87 64.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.865 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.88 -15.33 29.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.329 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.24 -7.81 11.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -164.53 160.73 20.67 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 120.988 0.423 . . . . 0.0 111.46 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.3 m -138.8 112.76 8.34 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.262 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.596 ' HG3' ' CD2' ' A' ' 7' ' ' TRP . 6.5 Cg_exo -74.83 165.84 30.57 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.638 2.225 . . . . 0.0 111.487 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.11 -25.71 59.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.553 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.717 HG12 HG23 ' A' ' 6' ' ' VAL . 4.2 p -145.02 161.71 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.534 HD13 ' HB2' ' A' ' 7' ' ' TRP . 33.1 tp -153.03 150.28 29.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.432 0.634 . . . . 0.0 112.362 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.723 ' O ' HG22 ' A' ' 9' ' ' VAL . 6.2 mt -128.28 115.91 19.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.971 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.766 ' HA ' HG22 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -107.95 135.45 49.31 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 24.0 t0 -75.89 170.96 15.22 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.599 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.658 HG13 ' HA3' ' A' ' 62' ' ' GLY . 1.3 tt -158.56 92.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.349 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.411 ' O ' ' CG ' ' A' ' 57' ' ' MET . 0.1 OUTLIER -124.65 56.91 1.28 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.954 0.407 . . . . 0.0 111.446 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.481 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 5.7 ptt? 47.97 41.75 1.02 Allowed Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 57' ' ' MET . 38.0 Cg_endo -65.44 -81.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.966 1.777 . . . . 0.0 111.319 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.39 -84.61 1.8 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.538 ' C ' ' H ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -87.77 61.18 6.31 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.6 OUTLIER 67.11 -21.9 0.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.345 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.658 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 135.79 -33.02 2.45 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.517 HD22 ' O ' ' A' ' 86' ' ' ASP . 4.8 mp -65.19 -21.67 66.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.508 ' HB3' ' CB ' ' A' ' 60' ' ' MET . . . -53.39 -36.4 61.41 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.929 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.676 ' HB3' ' HA3' ' A' ' 36' ' ' GLY . 14.1 mt -56.58 -45.91 81.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.527 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.424 HD22 ' HB1' ' A' ' 93' ' ' ALA . 0.3 OUTLIER -58.43 -49.02 78.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.209 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.488 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 7.5 tttp -53.61 -42.3 67.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.217 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.487 ' HB3' HD12 ' A' ' 40' ' ' LEU . 21.8 mm100 -62.33 -40.04 95.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.696 0.284 . . . . 0.0 111.049 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.574 ' CG2' ' HD2' ' A' ' 73' ' ' HIS . 28.0 mt -56.41 -51.09 68.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.219 0.533 . . . . 0.0 111.187 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.68 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -59.07 -29.63 67.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.225 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.425 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 2.2 mt-30 -69.93 -23.71 63.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.992 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -114.14 -15.05 12.29 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.68 ' CD2' ' HA ' ' A' ' 70' ' ' LYS . 1.7 p80 -106.73 166.34 11.31 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -87.12 -55.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.082 2.521 . . . . 0.0 112.278 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.491 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 19.6 mtp -157.38 43.3 0.34 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.619 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.632 ' H ' ' ND1' ' A' ' 73' ' ' HIS . 0.9 OUTLIER -72.0 113.32 19.29 Favored Pre-proline 0 N--CA 1.455 -0.188 0 C-N-CA 122.206 0.202 . . . . 0.0 111.407 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 39.9 Cg_endo -68.55 115.54 3.96 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 121.89 1.726 . . . . 0.0 111.945 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.601 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 6.1 t -98.82 150.36 5.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.082 0.467 . . . . 0.0 111.393 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.57 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 2.1 mt -134.11 115.0 20.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.96 178.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.608 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 27.6 mm -93.59 150.02 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.478 ' HE2' ' N ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -86.24 -20.05 29.05 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.432 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.565 ' O ' HG23 ' A' ' 55' ' ' ILE . 3.1 m -141.17 142.25 34.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.215 0.531 . . . . 0.0 111.388 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.39 31.75 3.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.433 ' CE1' HG23 ' A' ' 82' ' ' THR . 1.1 p-80 -88.79 31.57 0.84 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.477 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.497 ' HB2' HD13 ' A' ' 63' ' ' LEU . 61.6 m -133.96 -161.94 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.713 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.517 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -56.34 86.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.589 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.759 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -51.2 -23.24 3.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 111.459 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.76 -44.9 39.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.958 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.503 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -66.92 -25.31 66.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.951 0.405 . . . . 0.0 111.21 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.759 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -72.57 -22.46 60.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.995 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.514 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 14.5 t -70.89 -41.39 77.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.059 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.405 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 32.8 m -65.79 -19.58 65.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.113 0.483 . . . . 0.0 109.935 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.555 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -64.52 -46.84 81.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.008 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.514 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.4 m-85 -63.93 -29.45 70.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.803 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.563 HE22 ' HD2' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -63.65 -45.52 89.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.897 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.658 ' HG2' ' HB3' ' A' ' 70' ' ' LYS . 1.4 pp0? -75.03 -18.51 60.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.628 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.64 21.16 4.39 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.533 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.601 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -59.18 157.04 11.13 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 117.082 0.441 . . . . 0.0 110.99 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 21.2 t80 -82.19 -53.38 6.12 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.543 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 169.86 -165.4 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.092 0.472 . . . . 0.0 111.531 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.608 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.2 m-85 -124.17 119.33 29.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.608 HD22 ' CE2' ' A' ' 106' ' ' PHE . 6.0 tp -102.51 134.95 19.65 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.752 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 11.3 Cg_endo -52.66 170.79 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.462 2.108 . . . . 0.0 111.674 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.443 ' HD2' ' HA ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -43.63 -46.83 18.91 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.437 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.752 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 73.4 Cg_exo -48.11 163.36 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.682 1.588 . . . . 0.0 110.416 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.666 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -174.65 -86.66 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.694 -178.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.741 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 43.42 -170.97 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.621 0.248 . . . . 0.0 110.445 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.626 HD13 ' HA ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.91 -45.39 84.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.36 0.6 . . . . 0.0 111.429 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.782 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 12.9 t70 -52.8 -55.86 19.9 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.868 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.666 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -79.85 -27.98 40.1 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.28 -54.26 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.85 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.545 ' O ' HG11 ' A' ' 115' ' ' VAL . 36.5 t -58.09 -33.58 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.439 0.637 . . . . 0.0 110.3 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -60.19 -51.61 68.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.9 0.857 . . . . 0.0 109.512 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.551 HD22 HG22 ' A' ' 79' ' ' ILE . 6.6 tp -76.24 -21.01 56.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.76 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.545 HG11 ' O ' ' A' ' 112' ' ' VAL . 4.1 p -79.45 -50.28 18.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.164 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.429 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 82.9 mt-10 -65.07 -45.13 86.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.649 0.262 . . . . 0.0 110.538 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -62.01 -26.31 68.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 0.0 110.419 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.45 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -72.48 -57.45 4.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.17 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.6 mt -68.43 -30.79 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.132 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.2 m -67.52 -45.12 76.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.026 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -66.7 -27.79 67.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.78 -57.62 3.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.986 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -75.6 179.19 5.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.844 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.894 0.378 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.98 -175.52 5.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.604 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -9.96 38.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.378 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 88.65 84.84 1.25 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.955 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.517 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.1 mp -104.23 113.28 40.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.729 0.3 . . . . 0.0 111.163 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 2.8 p -106.06 129.64 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.665 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.603 ' HB2' HD13 ' A' ' 51' ' ' LEU . 39.8 m0 -117.76 141.99 47.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.655 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.718 HG11 ' HB2' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -134.32 133.5 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.297 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.791 HG23 ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -117.66 108.85 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.996 178.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 37.0 t0 166.84 120.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t0 69.75 -45.2 0.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.133 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 16' ' ' ARG . 40.9 t0 75.15 -98.74 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.367 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' ASP . 5.7 p -26.67 -87.73 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.673 ' O ' HG21 ' A' ' 18' ' ' VAL . 35.3 m -54.98 -39.14 68.68 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 10' ' ' ASP . 21.4 mm -68.47 -20.49 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.624 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.44 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 0.1 OUTLIER -74.79 -58.54 3.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 111.236 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.415 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 49.9 t90 -49.96 -41.94 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.498 . . . . 0.0 112.237 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 14' ' ' SER . 1.6 t -70.44 -62.26 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.026 0.441 . . . . 0.0 111.734 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.817 HD13 HD11 ' A' ' 108' ' ' ILE . 3.8 mm? -63.7 -27.36 69.16 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.536 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.635 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 15.1 pt-20 -67.18 -61.06 2.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.486 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.1 mmm180 -67.51 -56.88 7.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.25 -59.58 3.55 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.931 0.396 . . . . 0.0 111.718 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' A' ' 28' ' ' LEU . 4.0 tp -61.4 -20.98 63.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.068 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -66.55 -38.5 87.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.97 -24.61 65.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.585 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.82 -15.59 58.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.664 0.269 . . . . 0.0 111.013 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.25 25.74 7.71 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.833 -0.698 . . . . 0.0 113.767 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.739 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.72 170.64 13.58 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 117.5 0.65 . . . . 0.0 111.609 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.42 ' O ' HG11 ' A' ' 6' ' ' VAL . 58.0 m -107.26 105.47 15.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.086 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.729 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 2.1 t -98.94 118.1 34.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.177 0.513 . . . . 0.0 112.133 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.553 HG21 ' CE1' ' A' ' 33' ' ' PHE . 2.7 t -119.7 156.59 30.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.3 p -132.76 152.32 51.8 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.727 ' HB2' HG12 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -129.08 174.31 9.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.713 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -57.92 -108.46 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.501 -178.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.435 ' C ' HG13 ' A' ' 9' ' ' VAL . 41.2 m-20 -78.79 -68.44 0.65 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.115 0.484 . . . . 0.0 111.938 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.517 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . -171.91 -33.67 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.046 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.471 ' HA ' HD11 ' A' ' 40' ' ' LEU . 6.0 m120 -62.14 -30.75 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.692 0.282 . . . . 0.0 110.733 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -54.22 -52.65 60.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.853 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.727 HG21 ' CD1' ' A' ' 33' ' ' PHE . 63.1 t -54.74 -47.14 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.048 0.451 . . . . 0.0 110.62 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.582 HD23 HG13 ' A' ' 69' ' ' ILE . 22.5 mt -50.9 -43.15 59.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.112 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.96 -47.71 67.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.274 0.559 . . . . 0.0 110.715 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.34 -31.81 73.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.5 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.613 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 10.6 mt -61.45 -26.3 67.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.111 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.73 -17.47 60.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.305 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.43 -6.21 11.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.72 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -161.88 162.21 29.16 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.828 0.347 . . . . 0.0 111.075 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.0 m -138.97 112.66 8.2 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.154 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.517 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 73.5 Cg_endo -76.58 164.31 30.65 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.899 1.733 . . . . 0.0 111.539 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.49 -23.54 58.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.809 0.338 . . . . 0.0 110.761 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.713 HG23 HG22 ' A' ' 115' ' ' VAL . 6.3 p -145.17 161.58 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.653 ' N ' HG22 ' A' ' 50' ' ' VAL . 22.9 tp -151.45 148.42 28.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.524 0.678 . . . . 0.0 112.073 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.718 ' HB2' HG11 ' A' ' 8' ' ' VAL . 3.1 mt -135.72 126.01 26.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.792 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.791 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -111.13 145.25 38.93 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -178.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 49.6 t0 -74.16 -19.4 60.57 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.27 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.622 HG13 ' C ' ' A' ' 62' ' ' GLY . 7.0 tt 44.96 86.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.63 99.44 0.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.54 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 55.39 44.85 1.76 Allowed Pre-proline 0 N--CA 1.47 0.575 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 177.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.586 ' CD ' ' HA2' ' A' ' 62' ' ' GLY . 26.8 Cg_endo -91.9 -35.87 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.958 2.439 . . . . 0.0 112.422 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.429 ' H ' ' CD ' ' A' ' 58' ' ' PRO . . . -176.06 -24.91 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.302 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.609 ' N ' ' HB2' ' A' ' 64' ' ' ALA . 23.3 ttt -152.43 71.43 0.94 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.69 -35.45 0.24 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.1 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.622 ' C ' HG13 ' A' ' 55' ' ' ILE . . . 157.82 -34.54 0.53 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.472 ' CD1' ' HB2' ' A' ' 85' ' ' SER . 5.3 mp -66.85 -25.05 66.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.768 0.318 . . . . 0.0 110.485 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.609 ' HB2' ' N ' ' A' ' 60' ' ' MET . . . -53.98 -26.02 23.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.656 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.553 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 76.2 mt -55.96 -40.27 73.0 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.151 0.5 . . . . 0.0 110.061 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.572 HD11 HG13 ' A' ' 80' ' ' ILE . 4.8 mp -70.33 -39.43 74.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.049 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.695 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.0 tmtt? -55.2 -42.99 74.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.299 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.492 ' HB3' ' NH1' ' A' ' 72' ' ' ARG . 12.1 mm100 -69.05 -37.5 78.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.735 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.582 HG13 HD23 ' A' ' 40' ' ' LEU . 13.2 mt -62.83 -23.1 32.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.803 0.335 . . . . 0.0 110.849 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.695 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 2.5 mtmp? -75.18 -50.72 15.33 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.105 0.955 . . . . 0.0 109.291 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -62.13 -33.21 74.04 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.337 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.492 ' NH1' ' HB3' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -94.13 -28.7 15.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.665 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.613 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 40.5 m-70 -153.54 82.4 4.69 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.653 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.635 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 55.5 Cg_endo -71.28 31.76 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.738 2.292 . . . . 0.0 113.172 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.434 ' H ' ' C ' ' A' ' 73' ' ' HIS . 0.1 OUTLIER -143.78 -37.21 0.34 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.1 0.476 . . . . 0.0 111.238 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.405 ' CD2' HD23 ' A' ' 51' ' ' LEU . 6.7 tp -50.77 129.8 28.02 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.512 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.685 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 51.9 Cg_endo -73.24 122.98 8.44 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.729 2.286 . . . . 0.0 112.181 179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.684 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.3 t -110.28 142.78 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.125 0.488 . . . . 0.0 111.253 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 3.1 mt -133.89 113.52 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.383 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.609 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 18.9 mm -93.42 137.28 22.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.102 0.477 . . . . 0.0 112.127 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.566 ' HE1' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.84 -4.04 59.06 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.349 -179.168 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.601 ' O ' HG22 ' A' ' 80' ' ' ILE . 2.5 m -148.03 144.19 27.75 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.584 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.78 61.41 1.37 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.336 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -98.93 -22.78 15.6 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.472 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -84.33 -166.49 1.46 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.169 0.509 . . . . 0.0 111.996 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.471 ' O ' HD22 ' A' ' 63' ' ' LEU . 4.7 m-20 -54.76 97.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.777 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.429 ' CD1' ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -51.24 -21.68 2.24 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.3 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -48.59 -45.04 37.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.277 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.416 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -65.69 -20.61 66.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.804 0.335 . . . . 0.0 110.89 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.452 ' HB1' ' CE1' ' A' ' 101' ' ' TYR . . . -72.98 -32.2 65.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.711 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.555 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.9 t -65.71 -42.73 93.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 19.7 m -63.49 -19.91 65.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.382 . . . . 0.0 110.012 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.702 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -66.37 -44.95 81.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.451 0.643 . . . . 0.0 109.842 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.555 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 5.0 m-85 -65.88 -23.88 66.74 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.868 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.427 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -69.1 -36.39 77.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.307 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.702 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 3.9 pp0? -86.68 -18.27 31.67 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.706 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.13 21.27 3.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.304 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.684 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -65.04 152.79 42.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.212 0.506 . . . . 0.0 110.182 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.536 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 38.6 t80 -81.96 -54.0 5.68 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.441 ' OD2' ' CD2' ' A' ' 99' ' ' PHE . 14.7 p30 174.77 -170.76 0.05 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.993 0.425 . . . . 0.0 111.685 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.609 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.1 m-85 -119.72 125.67 49.22 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.771 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.682 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 11.0 tp -102.87 139.33 20.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.458 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.705 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 20.9 Cg_endo -58.88 171.83 1.91 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.092 1.861 . . . . 0.0 111.096 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.488 ' O ' ' HE3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -43.18 -45.88 13.98 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.705 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 87.3 Cg_exo -47.44 163.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.676 1.584 . . . . 0.0 110.843 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.669 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 3.2 t80 -167.56 -92.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.995 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 106' ' ' PHE . 5.3 p-10 44.12 -173.79 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.654 0.264 . . . . 0.0 110.586 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.817 HD11 HD13 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -67.66 -47.14 81.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.386 0.612 . . . . 0.0 110.849 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.809 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 1.1 t70 -51.01 -58.12 6.88 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.212 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.669 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.7 mm-40 -79.13 -26.77 42.8 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -84.15 -53.16 5.71 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.138 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.64 HG22 HG23 ' A' ' 108' ' ' ILE . 43.9 t -59.97 -31.45 47.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.507 0.67 . . . . 0.0 110.084 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.809 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -61.23 -50.96 70.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.626 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.682 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 23.8 tp -75.46 -20.46 58.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.517 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.713 HG22 HG23 ' A' ' 50' ' ' VAL . 4.2 p -79.27 -48.03 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.055 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.411 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 4.1 mt-10 -61.12 -45.66 93.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.726 0.298 . . . . 0.0 110.838 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.467 ' HD2' HD13 ' A' ' 114' ' ' LEU . 4.1 ptp180 -64.2 -23.73 67.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.897 0.379 . . . . 0.0 110.687 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.536 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.22 -49.46 35.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.938 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.1 mt -66.2 -30.89 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.6 m -68.37 -44.01 76.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -62.47 -31.13 71.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 77' ' ' PRO . 0.3 OUTLIER -85.11 -51.12 6.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.897 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 59.39 175.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.985 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mtt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.754 0.311 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.3 154.28 33.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.804 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.616 ' HG3' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -56.86 -34.28 67.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.053 0.454 . . . . 0.0 110.855 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.414 ' C ' HD11 ' A' ' 5' ' ' ILE . . . 93.2 110.54 2.01 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.034 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.618 HD12 ' HB ' ' A' ' 29' ' ' THR . 6.3 mm -129.39 113.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 6' ' ' VAL . 9.2 p -105.56 127.69 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.799 ' CD1' HG23 ' A' ' 31' ' ' THR . 24.6 m0 -114.67 132.81 56.27 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -127.99 139.8 50.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.861 HG23 ' CG2' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -128.38 105.37 13.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.187 179.029 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 58.1 t0 166.72 119.45 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.424 0.453 . . . . 0.0 110.682 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 72.79 -28.11 0.19 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 10' ' ' ASP . 7.9 t0 73.02 -133.38 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.978 -0.101 . . . . 0.0 110.943 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.1 t -30.71 -48.47 0.11 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 t -53.95 -68.18 0.2 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.654 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 15' ' ' ILE . 24.8 mm -62.31 -20.76 25.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.55 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.499 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 6.0 ttt180 -70.53 -60.57 2.19 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.651 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.495 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 57.1 t90 -49.98 -44.52 50.92 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 111.912 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.602 ' C ' HD12 ' A' ' 108' ' ' ILE . 1.3 t -64.97 -59.14 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.477 ' CD2' HD11 ' A' ' 108' ' ' ILE . 56.4 mt -70.75 -26.33 63.31 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 17' ' ' TRP . 12.8 pt-20 -63.81 -57.88 8.54 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.769 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.476 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 2.4 mmp_? -63.75 -60.04 3.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.905 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.88 -56.17 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.977 0.417 . . . . 0.0 111.85 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.492 ' CD1' HG13 ' A' ' 6' ' ' VAL . 1.5 tm? -64.95 -23.75 67.32 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.015 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 20' ' ' GLU . . . -71.28 -32.6 68.87 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.56 -26.49 66.65 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.385 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.31 -15.65 59.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.812 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.01 23.09 11.86 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.798 -0.715 . . . . 0.0 114.326 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.462 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -123.45 163.62 20.52 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.418 1.109 . . . . 0.0 112.167 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.618 ' HB ' HD12 ' A' ' 5' ' ' ILE . 89.9 m -84.53 136.35 33.84 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.626 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.479 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -127.97 108.51 10.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.645 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.799 HG23 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -121.68 147.59 45.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.9 p -125.59 161.44 27.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.63 0.728 . . . . 0.0 112.958 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.842 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.3 m-85 -136.12 173.86 11.25 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.108 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.434 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.6 pp20? -61.56 -60.51 3.58 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.645 ' C ' HG13 ' A' ' 9' ' ' VAL . 67.8 m-80 -152.97 -23.79 0.15 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.53 ' HA3' ' HG ' ' A' ' 65' ' ' LEU . . . 166.44 -56.83 0.24 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.067 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.408 ' HA ' HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -47.89 -37.5 14.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.014 -179.363 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.842 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 8.3 tt0 -58.42 -55.44 34.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.742 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.861 ' CG2' HG23 ' A' ' 9' ' ' VAL . 2.9 t -51.18 -46.48 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.107 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' A' ' 68' ' ' GLN . 31.7 mt -46.55 -45.57 18.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.21 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.07 -48.75 69.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.113 0.482 . . . . 0.0 111.326 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.79 -35.35 79.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.45 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.567 HD13 ' NE2' ' A' ' 73' ' ' HIS . 16.6 mt -63.38 -25.37 68.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.27 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -16.95 22.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.218 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.5 t -121.11 -5.39 9.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.472 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -156.53 160.04 39.13 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.91 0.386 . . . . 0.0 111.665 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.5 m -139.2 112.0 7.94 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.625 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.518 ' O ' HD13 ' A' ' 76' ' ' LEU . 58.8 Cg_endo -69.47 166.43 27.28 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.717 2.278 . . . . 0.0 111.839 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.86 -27.01 33.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.449 HG11 ' CG2' ' A' ' 115' ' ' VAL . 4.8 p -147.95 101.17 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.425 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.489 HD22 HD23 ' A' ' 76' ' ' LEU . 62.7 tp -87.15 141.74 28.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.409 0.623 . . . . 0.0 112.491 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.699 ' O ' HG22 ' A' ' 9' ' ' VAL . 5.3 mt -124.35 117.51 24.65 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -112.5 146.71 37.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.021 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.735 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 20.4 t0 -77.2 179.4 6.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.95 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.727 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.1 tt -156.23 78.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.798 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 50.7 ttp85 176.71 69.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.564 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.467 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -160.9 -67.09 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.879 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 57' ' ' MET . 35.6 Cg_endo -64.86 -176.06 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.536 2.158 . . . . 0.0 113.033 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.8 -54.34 38.14 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.486 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.587 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -78.14 49.23 0.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.733 0.301 . . . . 0.0 110.75 179.675 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.61 -72.13 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.727 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -149.47 -35.51 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.261 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.603 ' HA ' HD21 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -54.61 -21.42 10.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.11 179.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.517 ' HB1' ' CB ' ' A' ' 60' ' ' MET . . . -53.75 -36.23 62.1 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.53 ' HG ' ' HA3' ' A' ' 36' ' ' GLY . 1.1 tm? -59.97 -40.92 90.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.154 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.603 HD21 ' HA ' ' A' ' 63' ' ' LEU . 4.3 mm? -54.39 -43.94 71.87 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.17 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 53.9 tttm -56.9 -43.46 81.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.319 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.456 ' HB3' HD12 ' A' ' 40' ' ' LEU . 21.0 mm100 -60.93 -34.7 75.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.233 0.54 . . . . 0.0 110.147 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.537 ' CG2' ' CE1' ' A' ' 73' ' ' HIS . 92.5 mt -58.92 -39.84 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.527 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -69.61 -29.03 66.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.036 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.436 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -70.89 -35.36 72.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.986 -179.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.63 -71.64 0.71 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.527 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.749 ' HD1' ' HB3' ' A' ' 76' ' ' LEU . 4.6 p80 -112.22 71.96 1.15 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.458 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 75' ' ' MET . 62.4 Cg_endo -73.62 50.67 2.08 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.595 2.197 . . . . 0.0 113.675 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.521 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 8.8 mtm -156.64 -39.51 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.749 ' HB3' ' HD1' ' A' ' 73' ' ' HIS . 8.7 tp -59.57 130.33 87.8 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-O 120.945 0.403 . . . . 0.0 112.041 -178.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.55 115.29 3.83 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.307 2.671 . . . . 0.0 113.871 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.765 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.2 t -98.38 151.79 4.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.407 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.424 HG23 ' CD2' ' A' ' 114' ' ' LEU . 2.0 mt -136.57 114.56 14.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.064 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 53' ' ' SER . 17.9 mm -93.7 146.03 7.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.505 ' O ' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -81.45 -14.53 56.94 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.521 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 3.8 m -148.43 161.96 40.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.1 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.24 64.04 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.856 0.36 . . . . 0.0 111.246 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.89 111.86 24.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.987 0.422 . . . . 0.0 111.558 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.8 t 60.59 161.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.647 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.495 ' HB2' HD13 ' A' ' 63' ' ' LEU . 24.9 m-20 61.91 18.99 10.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.475 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.409 HD13 ' HB1' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -46.44 -22.68 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -48.06 -50.17 28.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 63' ' ' LEU . . . -67.34 -20.01 65.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.689 0.281 . . . . 0.0 111.503 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.529 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . . . -63.95 -57.17 10.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.809 0.338 . . . . 0.0 111.008 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.601 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.3 t -62.93 -43.47 99.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.5 m -58.8 -31.68 68.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.183 0.516 . . . . 0.0 110.458 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.434 ' HB1' ' CB ' ' A' ' 98' ' ' ALA . . . -63.65 -43.68 96.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.36 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.601 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 2.6 m-85 -59.59 -22.19 61.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.545 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.565 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.77 -37.99 54.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.099 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.565 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 2.1 pp0? -100.04 -13.34 19.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.59 82.88 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.615 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.765 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.53 111.24 0.56 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.293 0.568 . . . . 0.0 111.611 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 118' ' ' ALA . 18.1 t80 -55.22 -49.81 71.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.919 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.508 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER 173.92 -161.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.067 0.46 . . . . 0.0 111.918 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.553 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.9 m-85 -127.16 130.21 49.32 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.377 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.585 ' HB2' HD23 ' A' ' 114' ' ' LEU . 4.2 tp -108.27 142.43 25.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.11 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.666 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 17.8 Cg_endo -58.99 163.69 11.23 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.261 1.974 . . . . 0.0 111.372 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.408 ' HE2' ' OG1' ' A' ' 82' ' ' THR . 0.5 OUTLIER -36.25 -47.69 1.52 Allowed Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.613 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.666 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 84.2 Cg_exo -47.03 163.22 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.818 1.679 . . . . 0.0 110.756 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.669 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 3.6 t80 -165.55 -92.19 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.167 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.4 p-10 42.48 -173.69 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.874 0.369 . . . . 0.0 110.628 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.602 HD12 ' C ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.83 -47.49 79.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.285 0.564 . . . . 0.0 111.487 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.677 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 12.2 t70 -51.75 -57.58 8.86 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.713 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.669 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.5 mm-40 -78.45 -29.09 46.73 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -83.34 -54.55 4.91 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.061 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.565 ' O ' HG11 ' A' ' 115' ' ' VAL . 39.6 t -57.2 -32.4 40.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.476 0.655 . . . . 0.0 110.162 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -58.84 -53.15 61.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.064 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.585 HD23 ' HB2' ' A' ' 102' ' ' LEU . 33.4 tp -74.62 -21.39 59.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.98 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.565 HG11 ' O ' ' A' ' 112' ' ' VAL . 5.1 p -79.57 -50.16 18.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.161 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.408 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 94.7 mt-10 -65.47 -40.07 92.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.78 0.324 . . . . 0.0 111.026 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.506 ' HD2' HD13 ' A' ' 114' ' ' LEU . 5.6 ptp180 -65.96 -27.52 68.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.461 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.462 ' HB3' ' CE2' ' A' ' 99' ' ' PHE . . . -70.19 -51.99 26.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.004 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.1 mt -65.29 -31.86 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.161 0.505 . . . . 0.0 111.033 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -43.58 76.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.52 -24.44 66.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -67.47 -43.75 80.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.982 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -75.53 170.25 16.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.986 179.806 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.957 0.408 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -162.78 173.68 13.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.785 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.43 -9.56 19.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.412 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 90.46 99.98 1.16 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.256 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 2.2 mp -124.2 113.49 36.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.478 0.656 . . . . 0.0 111.022 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.76 HG11 ' HG ' ' A' ' 23' ' ' LEU . 10.4 p -107.21 120.36 58.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.502 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.675 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 31.0 m0 -112.26 145.8 39.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.069 0.461 . . . . 0.0 110.222 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.788 ' CG2' HG21 ' A' ' 32' ' ' THR . 0.2 OUTLIER -137.29 149.67 25.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -176.145 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.727 HG13 ' C ' ' A' ' 35' ' ' ASN . 1.4 t -133.28 105.17 7.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.787 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.571 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 44.1 t0 166.85 122.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.687 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 72.04 -40.92 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.821 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 10' ' ' ASP . 37.6 t0 75.28 -121.92 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.849 -0.159 . . . . 0.0 110.729 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.4 t -31.33 -47.54 0.11 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 18' ' ' VAL . 47.5 t -63.8 -63.32 1.2 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.342 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.566 HG21 HG21 ' A' ' 8' ' ' VAL . 20.1 mm -63.21 -25.16 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.418 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 7.3 ttt180 -61.58 -58.05 9.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.02 0.438 . . . . 0.0 111.445 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.454 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 53.5 t90 -56.69 -46.28 81.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.649 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.501 ' C ' HD13 ' A' ' 108' ' ' ILE . 2.0 t -65.47 -44.41 94.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.571 HD23 HG13 ' A' ' 8' ' ' VAL . 5.6 tp -83.06 -23.97 32.93 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.689 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 26.5 pt-20 -66.78 -56.19 11.56 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.729 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.483 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.3 mmm180 -65.51 -56.33 12.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.122 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.62 -45.65 73.73 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.76 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.3 tm? -69.21 -26.71 64.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.531 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.22 -32.44 73.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.14 -29.02 71.64 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.21 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.76 -15.37 59.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 110.982 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.45 26.06 11.43 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.695 -0.765 . . . . 0.0 113.863 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.472 HD12 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -133.74 171.2 14.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.75 0.775 . . . . 0.0 111.903 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.458 ' O ' HG13 ' A' ' 6' ' ' VAL . 25.8 m -94.27 128.82 40.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.225 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.689 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 1.8 t -122.97 120.94 34.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.264 0.554 . . . . 0.0 111.865 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.577 HG23 ' CE1' ' A' ' 33' ' ' PHE . 2.8 t -134.3 132.32 39.43 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.788 HG21 ' CG2' ' A' ' 8' ' ' VAL . 76.5 p -107.97 159.28 16.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.484 0.659 . . . . 0.0 112.27 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.698 ' CG ' HG22 ' A' ' 39' ' ' VAL . 1.7 m-85 -131.96 174.2 10.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.12 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -63.36 -106.78 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.92 -178.425 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.727 ' C ' HG13 ' A' ' 9' ' ' VAL . 10.9 p30 -88.85 -49.56 6.74 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.583 ' HA3' ' CD2' ' A' ' 65' ' ' LEU . . . 173.83 -43.37 0.15 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.066 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.847 ' HA ' HD11 ' A' ' 40' ' ' LEU . 25.5 m120 -53.08 -24.72 10.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 111.2 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -57.2 -60.02 4.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.43 179.419 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 9' ' ' VAL . 72.7 t -58.65 -35.94 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.722 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.847 HD11 ' HA ' ' A' ' 37' ' ' ASN . 40.3 mt -47.17 -46.14 23.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 0.0 110.489 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.63 -45.95 34.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.972 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.56 -29.81 66.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.865 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.597 ' HG ' HG11 ' A' ' 39' ' ' VAL . 12.2 mt -72.05 -23.54 61.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.664 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.32 -17.71 13.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.606 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.55 -7.25 9.69 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -159.67 159.14 32.64 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.74 0.305 . . . . 0.0 111.397 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.5 m -138.75 114.33 8.63 Favored Pre-proline 0 N--CA 1.454 -0.263 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.713 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.533 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 72.9 Cg_endo -78.69 165.04 25.21 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.371 2.047 . . . . 0.0 111.331 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.03 -26.68 60.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.929 0.395 . . . . 0.0 110.451 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.539 HG22 ' H ' ' A' ' 51' ' ' LEU . 10.0 p -145.11 161.09 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.675 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 13.5 tp -152.92 140.08 19.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.222 0.534 . . . . 0.0 112.3 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -104.55 137.6 42.16 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.489 179.436 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 26.2 t -127.72 133.98 49.55 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.644 ' O ' HD23 ' A' ' 65' ' ' LEU . 32.0 t0 -83.08 172.87 12.26 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.242 0.544 . . . . 0.0 111.499 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.618 ' HB ' ' HA3' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -140.24 84.05 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.956 -179.551 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -111.49 36.28 3.3 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.744 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.683 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 52.87 53.28 11.81 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 178.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.416 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 43.5 Cg_endo -75.02 -65.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.322 2.015 . . . . 0.0 111.831 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.44 -27.25 1.21 Allowed Glycine 0 CA--C 1.518 0.239 0 N-CA-C 111.824 -0.511 . . . . 0.0 111.824 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.444 ' N ' ' HB2' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -155.09 63.09 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.683 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 4.3 p-10 54.12 -82.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.026 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.618 ' HA3' ' HB ' ' A' ' 55' ' ' ILE . . . -137.46 -24.24 0.43 Allowed Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.691 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -77.51 -19.11 56.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.735 0.268 . . . . 0.0 111.106 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.444 ' HB2' ' N ' ' A' ' 60' ' ' MET . . . -55.14 -31.26 61.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.336 0.588 . . . . 0.0 109.897 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 54' ' ' ASP . 6.6 mp -67.5 -36.27 80.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.425 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.425 HD11 ' CB ' ' A' ' 93' ' ' ALA . 14.1 mt -63.22 -42.64 99.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.912 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 50.4 tttm -55.01 -54.2 45.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.882 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.707 ' CB ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -54.75 -43.13 72.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.154 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.507 HD13 HG11 ' A' ' 78' ' ' VAL . 21.0 mt -59.17 -40.55 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.131 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -74.2 -23.07 59.15 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.981 -179.245 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -68.41 -51.21 46.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -93.48 -35.58 12.88 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.513 ' CD2' HD12 ' A' ' 43' ' ' LEU . 2.3 m-70 -99.65 144.04 27.57 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.603 -178.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.58 -70.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.623 2.215 . . . . 0.0 112.711 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.606 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 60.7 mtt -147.77 52.96 1.04 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.936 0.398 . . . . 0.0 111.516 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.438 HD12 ' HG2' ' A' ' 48' ' ' PRO . 5.5 tp -72.34 113.8 24.03 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.639 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -53.49 132.73 50.2 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.191 1.928 . . . . 0.0 111.793 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.507 HG11 HD13 ' A' ' 69' ' ' ILE . 2.5 t -126.67 146.64 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.566 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.455 HG21 HD21 ' A' ' 114' ' ' LEU . 3.3 mt -126.88 116.39 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.955 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.504 ' HB ' ' CD2' ' A' ' 101' ' ' TYR . 1.4 mp -94.16 145.44 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.889 0.376 . . . . 0.0 111.306 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.51 ' HE2' ' N ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -87.68 -22.21 24.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.248 -178.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.537 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.4 m -147.68 145.65 28.98 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.371 -0.206 . . . . 0.0 110.453 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.408 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -103.32 -29.28 11.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.73 0.3 . . . . 0.0 111.606 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.422 ' CE1' HG22 ' A' ' 82' ' ' THR . 3.3 m-70 44.75 -92.67 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.26 -172.84 3.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.942 0.401 . . . . 0.0 111.479 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.516 ' O ' HD23 ' A' ' 63' ' ' LEU . 63.5 m-20 58.15 33.29 23.01 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.007 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mt -48.82 -21.17 0.59 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.409 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -47.82 -44.55 28.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.636 0.255 . . . . 0.0 111.45 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -69.68 -21.61 63.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.577 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.479 ' CB ' HD22 ' A' ' 63' ' ' LEU . . . -68.11 -32.94 73.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.65 0.262 . . . . 0.0 111.026 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.518 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 9.8 t -71.27 -39.05 72.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.552 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 95.0 p -69.46 -20.23 63.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.805 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.663 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -66.84 -42.47 85.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.365 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.518 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 7.6 m-85 -64.6 -25.83 68.14 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.2 -38.51 51.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.62 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.663 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.7 pp0? -77.42 -18.45 57.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.295 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.11 -10.53 5.64 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.453 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.456 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -48.37 155.79 0.48 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.068 0.434 . . . . 0.0 111.329 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.446 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 18.7 t80 -86.41 -53.89 4.74 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.477 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER 169.23 -166.06 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.855 0.36 . . . . 0.0 111.337 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.504 ' CD2' ' HB ' ' A' ' 80' ' ' ILE . 3.4 m-85 -121.46 133.83 55.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.287 0.565 . . . . 0.0 111.292 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.465 ' CD1' ' HD2' ' A' ' 103' ' ' PRO . 3.9 tp -120.76 141.63 32.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.905 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.465 ' HD2' ' CD1' ' A' ' 102' ' ' LEU . 19.5 Cg_endo -56.66 168.24 2.41 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.418 2.079 . . . . 0.0 111.815 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -43.09 -54.0 9.79 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.886 -0.143 . . . . 0.0 111.179 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 7.2 Cg_endo -48.43 163.88 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.878 1.719 . . . . 0.0 110.384 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.819 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 173.81 -86.89 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 2.4 p30 50.12 -178.58 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.508 HG21 HG21 ' A' ' 112' ' ' VAL . 1.1 mp -55.83 -47.55 79.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.718 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 4.4 t70 -54.57 -58.63 6.72 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.822 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.819 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 5.5 mm-40 -81.93 -25.59 34.78 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 107' ' ' ASP . . . -83.19 -51.16 7.73 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.518 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.599 ' O ' HG11 ' A' ' 115' ' ' VAL . 46.5 t -61.24 -32.75 53.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.486 0.66 . . . . 0.0 110.099 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.718 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -58.98 -50.62 73.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.218 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.455 HD21 HG21 ' A' ' 79' ' ' ILE . 7.5 tp -77.1 -21.03 54.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.42 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.599 HG11 ' O ' ' A' ' 112' ' ' VAL . 3.0 p -78.18 -47.49 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.751 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 52.9 mt-10 -62.73 -42.4 99.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.83 0.348 . . . . 0.0 110.571 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -66.53 -24.48 66.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.612 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.23 -54.15 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.936 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -61.13 -31.44 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.981 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.0 t -70.06 -41.07 74.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.009 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.55 -42.56 98.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.053 0.454 . . . . 0.0 111.024 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -76.44 -52.76 9.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.023 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 59.51 177.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.809 0.337 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -68.32 143.69 55.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.434 ' HE ' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -61.38 -20.56 63.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.118 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.95 93.37 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.544 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.434 HD12 ' HE ' ' A' ' 3' ' ' ARG . 3.4 mp -107.91 115.54 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.853 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 3.0 p -107.01 126.69 63.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.937 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.881 ' CD1' HG21 ' A' ' 31' ' ' THR . 32.8 m0 -114.48 147.26 39.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.886 0.374 . . . . 0.0 110.643 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.681 HG12 HD11 ' A' ' 52' ' ' LEU . 0.6 OUTLIER -137.28 145.75 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.924 0.392 . . . . 0.0 111.669 -178.526 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.886 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -129.28 112.14 24.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.231 178.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.707 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 7.5 t70 -165.21 -154.29 0.21 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.142 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.412 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -67.05 8.77 0.25 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.422 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 10' ' ' ASP . 2.9 p30 45.39 -143.84 0.21 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.412 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.9 t 34.97 -91.78 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.432 ' O ' HG21 ' A' ' 18' ' ' VAL . 12.2 m -58.62 -52.33 66.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.703 0.287 . . . . 0.0 111.192 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.3 mm -62.69 -29.13 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.217 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.507 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 0.2 OUTLIER -72.79 -57.66 3.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.806 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 77.1 t90 -50.2 -40.33 46.79 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 108' ' ' ILE . 1.8 t -71.42 -56.41 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.749 HD12 HD12 ' A' ' 108' ' ' ILE . 6.0 tp -71.59 -23.02 61.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.668 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.79 -60.08 2.81 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.535 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.547 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.0 mmm180 -72.64 -52.86 13.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.866 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.441 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -50.62 -60.01 3.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.975 0.416 . . . . 0.0 111.598 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.743 HD13 ' CD1' ' A' ' 28' ' ' LEU . 4.5 tp -61.82 -22.7 65.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.288 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -67.56 -37.49 82.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.8 -24.31 68.12 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.571 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.11 -15.61 59.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.664 0.269 . . . . 0.0 110.924 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.57 24.06 7.61 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.963 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.743 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -130.37 172.14 12.18 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 117.686 0.743 . . . . 0.0 111.376 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 m -105.7 105.77 15.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.465 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.668 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 5.7 t -100.57 115.64 30.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.136 0.493 . . . . 0.0 112.235 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.881 HG21 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -117.82 156.33 28.54 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 29.8 p -130.12 161.05 31.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.229 0.537 . . . . 0.0 111.439 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.886 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.5 m-85 -133.57 174.46 10.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.42 -178.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.501 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.4 pp20? -59.04 -49.57 77.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -154.52 -51.43 0.09 Allowed 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.99 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.731 ' HA2' HG12 ' A' ' 9' ' ' VAL . . . -175.92 -44.38 0.06 OUTLIER Glycine 0 C--N 1.315 -0.597 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.967 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.542 ' HA ' HD13 ' A' ' 40' ' ' LEU . 4.2 m120 -62.49 -27.38 69.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.018 0.437 . . . . 0.0 110.648 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.649 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -59.65 -47.6 84.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.012 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.581 HG23 ' CG1' ' A' ' 9' ' ' VAL . 21.4 t -62.38 -42.07 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.977 0.418 . . . . 0.0 111.063 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.542 HD13 ' HA ' ' A' ' 37' ' ' ASN . 25.8 mt -52.07 -42.28 63.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.731 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.79 -48.35 38.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.199 0.523 . . . . 0.0 110.947 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.92 -32.15 72.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.009 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 12.9 mt -68.89 -21.32 64.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.609 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.19 -19.99 37.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.706 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.88 -1.15 6.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -153.69 153.27 31.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.942 0.401 . . . . 0.0 111.007 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 95.5 m -139.02 112.55 8.15 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.247 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.471 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.7 Cg_endo -77.42 164.2 28.96 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.944 1.763 . . . . 0.0 111.325 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.37 -25.6 59.6 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.693 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.656 ' CG2' HD12 ' A' ' 79' ' ' ILE . 4.8 p -145.07 159.68 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.005 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.493 ' HG ' ' N ' ' A' ' 52' ' ' LEU . 14.9 tp -152.94 155.81 37.71 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.235 0.541 . . . . 0.0 112.179 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.681 HD11 HG12 ' A' ' 8' ' ' VAL . 1.7 mt -136.52 127.55 27.76 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.373 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.603 ' HA ' HG21 ' A' ' 9' ' ' VAL . 42.4 t -106.68 140.27 39.81 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.707 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 10.0 t0 -65.8 -35.87 81.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.697 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.564 ' CG2' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER 45.12 90.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.971 0.415 . . . . 0.0 110.632 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.91 90.31 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.574 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 53.6 44.99 2.14 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.457 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.611 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 90.0 Cg_endo -89.3 -54.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.574 2.183 . . . . 0.0 112.139 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.43 -19.42 0.09 OUTLIER Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.633 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.631 ' N ' ' HB2' ' A' ' 64' ' ' ALA . 3.0 tpt -163.59 69.85 0.21 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.146 0.498 . . . . 0.0 110.132 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.54 -22.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.303 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.611 ' HA2' ' CG ' ' A' ' 58' ' ' PRO . . . 139.83 -34.86 1.98 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.236 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.479 ' CD2' ' HB1' ' A' ' 90' ' ' ALA . 4.9 mp -72.67 -16.32 61.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.509 -0.345 . . . . 0.0 111.047 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.631 ' HB2' ' N ' ' A' ' 60' ' ' MET . . . -53.68 -33.34 55.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.216 0.532 . . . . 0.0 110.191 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.573 HD23 ' HA3' ' A' ' 36' ' ' GLY . 49.6 mt -60.98 -35.62 77.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.561 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.592 ' HA ' HD13 ' A' ' 69' ' ' ILE . 3.6 mm? -61.28 -45.04 96.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.164 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.546 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 61.2 tttt -54.44 -41.48 69.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.62 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.532 ' HB2' HD11 ' A' ' 40' ' ' LEU . 11.6 mm100 -67.46 -33.41 75.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.627 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.592 HD13 ' HA ' ' A' ' 66' ' ' LEU . 92.8 mt -63.96 -38.37 82.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.829 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.36 -24.47 46.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.758 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.405 ' NE2' ' HG2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -86.09 -34.25 20.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.825 -178.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.405 ' HG2' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -94.86 -25.57 16.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.558 ' CD2' ' HA ' ' A' ' 69' ' ' ILE . 1.1 m-70 -126.36 163.4 40.55 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.795 0.331 . . . . 0.0 111.265 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.07 -81.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.571 2.181 . . . . 0.0 112.857 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.615 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.0 mpt? -138.95 48.09 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 111.152 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.442 HD13 ' HD2' ' A' ' 48' ' ' PRO . 4.7 tp -63.72 118.01 40.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.793 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.24 119.04 5.88 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.146 1.897 . . . . 0.0 111.87 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.485 HG21 HG21 ' A' ' 69' ' ' ILE . 2.3 t -117.11 139.71 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.271 0.558 . . . . 0.0 111.554 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.656 HD12 ' CG2' ' A' ' 50' ' ' VAL . 3.9 mt -123.7 115.47 45.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.445 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.705 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 4.8 mm -93.53 127.47 45.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.614 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 1.1 ptp -80.26 -2.09 43.6 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.625 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.555 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.7 m -147.87 142.87 26.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.73 0.3 . . . . 0.0 110.715 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.471 ' HB1' ' CD2' ' A' ' 101' ' ' TYR . . . -162.93 65.22 0.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.908 0.385 . . . . 0.0 111.004 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -98.26 -45.57 6.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.186 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.39 165.74 17.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 111.293 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.467 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.4 OUTLIER 59.91 24.08 13.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.429 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 4.7 mt -48.73 -21.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -48.01 -55.23 10.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.662 0.268 . . . . 0.0 111.58 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.419 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -60.0 -20.56 58.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.748 0.309 . . . . 0.0 111.095 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.583 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . . . -66.96 -39.07 87.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.44 . . . . 0.0 110.419 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.593 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 16.2 t -64.99 -45.27 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.362 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 p -61.34 -32.39 72.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 110.403 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.661 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -58.83 -39.03 80.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.115 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.593 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 20.3 m-85 -61.76 -20.9 64.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.99 0.424 . . . . 0.0 110.164 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.628 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.49 -42.51 52.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.444 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.661 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -75.66 -16.56 60.17 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.029 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.23 24.43 2.22 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.297 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.5 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . . . -65.85 140.13 58.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.819 0.31 . . . . 0.0 110.5 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 47.9 t80 -72.52 -53.67 11.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.198 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.622 ' OD2' HD11 ' A' ' 114' ' ' LEU . 47.4 p-10 178.26 -160.69 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.709 0.29 . . . . 0.0 111.38 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.705 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 8.1 m-85 -141.87 113.36 7.71 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.726 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.674 HD11 ' O ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -105.33 142.8 25.47 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.593 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.646 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 9.4 Cg_endo -51.01 166.97 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.002 2.468 . . . . 0.0 112.212 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.686 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -40.89 -42.94 4.04 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 3.6 Cg_endo -45.99 163.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.02 1.814 . . . . 0.0 110.328 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.687 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 43.6 t80 -169.93 -95.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.947 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.647 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 3.6 p30 44.27 -172.39 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.691 0.281 . . . . 0.0 110.551 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.749 HD12 HD12 ' A' ' 19' ' ' LEU . 1.1 mp -67.71 -47.79 78.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.14 0.495 . . . . 0.0 112.069 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.878 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 37.3 m-20 -52.29 -54.53 30.28 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.716 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.687 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.4 mm-40 -80.24 -30.11 38.47 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 107' ' ' ASP . . . -83.5 -51.0 7.72 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.2 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.554 ' HA ' ' CG1' ' A' ' 115' ' ' VAL . 40.6 t -61.47 -32.91 54.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.498 0.666 . . . . 0.0 110.241 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.878 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -60.34 -50.55 73.16 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.818 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.622 HD11 ' OD2' ' A' ' 100' ' ' ASP . 13.6 tp -77.65 -21.17 52.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.443 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.554 ' CG1' ' HA ' ' A' ' 112' ' ' VAL . 4.5 p -79.44 -50.74 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.441 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 25.5 mt-10 -62.75 -42.45 99.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 110.843 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -63.28 -23.71 67.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.436 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.498 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -73.1 -55.98 5.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.067 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.9 mt -65.47 -31.6 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.13 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.5 t -66.77 -40.18 88.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.956 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -68.41 -24.88 64.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.176 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -72.05 -47.85 48.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.974 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -76.5 -55.28 5.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.213 0.53 . . . . 0.0 111.126 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.874 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.7 0.285 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.52 160.84 26.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.343 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.35 0.32 17.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.492 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.69 92.92 0.83 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.866 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 mp -122.19 113.48 38.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.787 0.327 . . . . 0.0 111.357 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.676 HG22 HG23 ' A' ' 115' ' ' VAL . 11.8 p -105.45 131.51 54.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.365 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.53 ' NE1' HG21 ' A' ' 31' ' ' THR . 32.1 m0 -118.1 135.99 53.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.797 0.332 . . . . 0.0 110.764 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -127.19 138.21 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.9 -178.307 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.94 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -125.64 115.73 44.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.66 178.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.624 ' HB2' ' HE3' ' A' ' 81' ' ' MET . 12.5 t0 -170.95 -149.05 0.06 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.802 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -66.05 -3.04 4.69 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.42 ' OD1' ' HD3' ' A' ' 16' ' ' ARG . 2.4 t70 55.15 -141.24 0.87 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.304 0.113 . . . . 0.0 111.304 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 t 36.12 -92.25 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.416 ' O ' HG21 ' A' ' 18' ' ' VAL . 1.2 t -60.47 -50.11 74.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.765 0.317 . . . . 0.0 111.044 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.86 -32.43 55.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 111.3 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.462 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 11.8 ttt180 -70.98 -59.48 2.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.213 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.412 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 64.7 t90 -47.88 -44.47 29.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.542 ' C ' HD12 ' A' ' 108' ' ' ILE . 1.9 t -67.59 -61.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.048 0.452 . . . . 0.0 111.932 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.55 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 37.1 mt -66.72 -25.63 66.62 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.59 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 19.8 pt-20 -66.05 -59.13 4.1 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.56 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.59 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.5 mmt180 -74.54 -59.94 2.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.133 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.01 -51.84 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.581 ' HG ' HG13 ' A' ' 6' ' ' VAL . 2.1 tm? -62.71 -31.99 73.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.173 0.511 . . . . 0.0 110.789 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 28' ' ' LEU . . . -65.32 -34.89 79.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.651 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.22 -24.49 67.34 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.452 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.91 -15.6 59.63 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 111.153 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.79 14.0 16.76 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.809 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.518 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -127.12 172.51 10.47 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.85 0.825 . . . . 0.0 111.449 179.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 6' ' ' VAL . 57.2 m -105.56 113.95 27.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.309 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 35.8 t -107.62 114.43 28.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.172 0.51 . . . . 0.0 111.935 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.53 HG21 ' NE1' ' A' ' 7' ' ' TRP . 2.9 t -118.12 154.23 32.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.7 p -126.35 159.52 32.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.214 0.53 . . . . 0.0 112.12 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.94 ' HB2' HG12 ' A' ' 9' ' ' VAL . 2.8 m-85 -134.18 174.05 10.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.921 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -60.4 -53.55 56.23 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -176.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.66 ' C ' HG13 ' A' ' 9' ' ' VAL . 25.6 p30 -156.88 -32.09 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.885 0.766 . . . . 0.0 112.844 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.716 ' HA3' ' HG ' ' A' ' 65' ' ' LEU . . . 167.79 -51.41 0.23 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.012 -1.089 . . . . 0.0 113.383 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.535 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -56.18 -29.87 61.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.864 0.364 . . . . 0.0 110.837 -179.206 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -62.46 -53.9 48.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.664 HG23 HG22 ' A' ' 9' ' ' VAL . 4.8 t -53.81 -37.59 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.382 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 37' ' ' ASN . 17.7 mt -54.21 -43.05 70.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.04 0.448 . . . . 0.0 110.441 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 44' ' ' ALA . . . -68.87 -47.15 66.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.993 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.02 -35.02 79.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.197 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.52 ' CB ' ' CE1' ' A' ' 73' ' ' HIS . 17.3 mt -66.52 -24.5 66.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.883 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 41' ' ' ALA . . . -57.08 -19.06 17.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.961 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.13 -8.95 9.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -149.49 157.34 43.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.396 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.0 m -139.2 112.66 8.05 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.361 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.433 ' HD3' HD22 ' A' ' 43' ' ' LEU . 73.9 Cg_endo -75.56 165.43 30.5 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.143 1.896 . . . . 0.0 111.298 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.85 -25.09 59.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.019 0.437 . . . . 0.0 110.334 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.519 HG12 HG23 ' A' ' 6' ' ' VAL . 6.4 p -145.84 161.99 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.514 ' H ' HG23 ' A' ' 50' ' ' VAL . 19.3 tp -152.83 144.88 23.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.504 0.668 . . . . 0.0 111.623 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.672 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.2 mt -127.92 115.26 18.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.687 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.609 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -106.87 143.68 34.61 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.55 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 15.6 t0 -73.5 176.84 5.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.734 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.848 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 6.6 tt -153.07 81.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.69 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 172.96 54.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.341 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.413 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.23 -62.5 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.454 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.564 ' HG2' ' HA2' ' A' ' 62' ' ' GLY . 18.9 Cg_endo -56.4 -177.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.672 2.248 . . . . 0.0 112.833 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -50.44 -75.53 0.21 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.59 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.561 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -71.26 59.88 0.28 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 110.462 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.29 -73.57 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.312 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.848 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.77 -35.82 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.083 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.606 ' HA ' HD22 ' A' ' 66' ' ' LEU . 2.8 mp -55.24 -24.11 26.02 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.605 0.241 . . . . 0.0 111.032 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -55.4 -35.86 65.78 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.254 0.549 . . . . 0.0 109.996 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.716 ' HG ' ' HA3' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -58.46 -40.6 83.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.009 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.606 HD22 ' HA ' ' A' ' 63' ' ' LEU . 3.4 mm? -57.92 -43.23 86.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -55.25 -45.16 76.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.51 178.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.49 ' HB2' HD13 ' A' ' 40' ' ' LEU . 2.0 mm-40 -66.22 -34.27 77.65 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.932 0.396 . . . . 0.0 110.423 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.448 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 55.9 mt -60.18 -44.67 95.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.597 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -74.72 -21.4 59.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.601 -179.279 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 -35.02 26.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.625 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -100.45 -39.82 7.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.52 ' CE1' ' CB ' ' A' ' 43' ' ' LEU . 3.2 m-70 -102.12 151.79 38.12 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.696 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -96.37 102.3 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.252 2.635 . . . . 0.0 113.027 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.622 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 22.8 mtm 57.0 30.66 18.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.024 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.411 HD11 HD23 ' A' ' 51' ' ' LEU . 2.2 tm? -64.99 111.4 5.8 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.527 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -57.91 116.31 3.14 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.605 2.203 . . . . 0.0 112.531 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.807 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 1.6 t -116.4 151.01 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.646 0.736 . . . . 0.0 111.994 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.571 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 1.9 mp -139.67 119.26 13.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.759 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.612 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 21.8 mm -93.67 150.38 3.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.242 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.624 ' HE3' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -82.35 -27.98 31.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.387 -177.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.618 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 18.0 m -133.98 157.35 46.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.567 0.222 . . . . 0.0 110.588 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.428 ' N ' HG23 ' A' ' 82' ' ' THR . . . -148.94 62.2 1.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.962 0.411 . . . . 0.0 111.326 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.512 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -90.57 -93.98 0.12 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.706 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.46 160.35 22.71 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.078 0.466 . . . . 0.0 112.0 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.577 ' O ' HD23 ' A' ' 63' ' ' LEU . 3.7 m-20 62.26 15.87 7.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.603 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.424 ' HA ' ' CD2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -47.28 -23.46 0.56 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.31 -48.17 36.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.43 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . . . -64.68 -20.52 66.35 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.508 ' N ' HD22 ' A' ' 63' ' ' LEU . . . -58.72 -33.72 70.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.528 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.6 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.2 t -67.44 -36.92 77.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.582 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.519 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 16.5 m -63.31 -20.12 65.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.241 0.544 . . . . 0.0 109.706 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.728 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.65 -53.75 8.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.751 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.6 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.3 m-85 -59.31 -33.87 71.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.142 0.496 . . . . 0.0 110.675 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.2 pp0? -74.65 -38.02 62.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.051 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.728 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 2.9 pp0? -74.59 -18.31 60.59 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.897 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.0 -6.57 3.44 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.574 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.807 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -58.98 148.93 28.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.067 0.434 . . . . 0.0 111.62 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.501 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 40.8 t80 -78.07 -53.06 7.82 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.717 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.412 ' OD1' HG22 ' A' ' 79' ' ' ILE . 13.4 p30 -179.96 -166.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.328 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.583 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.0 m-85 -127.68 141.33 51.64 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.165 0.507 . . . . 0.0 111.402 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 4.5 tp -102.41 145.91 31.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.533 ' HG2' ' HD2' ' A' ' 105' ' ' PRO . 29.2 Cg_endo -68.89 -39.81 7.74 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.032 1.821 . . . . 0.0 112.36 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.674 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER 173.85 -48.77 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.773 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.4 Cg_endo -47.62 163.99 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.887 1.725 . . . . 0.0 109.78 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.711 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 2.5 t80 -166.09 -91.74 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.972 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.539 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 4.9 p-10 41.76 -174.94 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.997 0.427 . . . . 0.0 110.979 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.542 HD12 ' C ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.97 -49.55 67.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.392 0.615 . . . . 0.0 111.396 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.784 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -49.68 -57.77 6.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.974 -179.526 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.711 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.1 mm-40 -76.44 -29.97 57.18 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.539 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -83.19 -60.38 2.17 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.771 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.577 ' O ' HG13 ' A' ' 115' ' ' VAL . 32.6 t -50.93 -33.74 12.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.45 0.643 . . . . 0.0 110.416 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.784 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.72 -51.05 71.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.379 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.549 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 9.3 tp -76.82 -20.31 56.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.814 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.676 HG23 HG22 ' A' ' 6' ' ' VAL . 3.7 p -79.34 -48.77 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.151 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.433 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 22.8 mt-10 -61.97 -46.75 87.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.853 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.549 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 4.5 ptm180 -64.0 -23.44 67.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.823 0.344 . . . . 0.0 110.701 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.501 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.65 -50.98 21.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.47 -30.93 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.262 0.553 . . . . 0.0 110.783 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.7 m -70.15 -40.85 74.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.838 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -76.77 -25.25 53.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.82 -24.48 24.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.234 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.88 158.95 38.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.971 0.415 . . . . 0.0 110.999 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.905 -179.897 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.6 mtp . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.78 0.324 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.547 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 0.9 OUTLIER -107.64 -40.33 5.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.48 179.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 2' ' ' GLN . 1.6 ptp180 66.54 -25.74 0.11 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.514 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 2' ' ' GLN . . . 101.91 93.29 2.2 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.242 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.513 HD12 ' CG ' ' A' ' 3' ' ' ARG . 5.3 mm -123.63 112.44 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.061 0.457 . . . . 0.0 111.578 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.636 HG13 ' HA ' ' A' ' 30' ' ' CYS . 2.8 p -115.78 120.89 66.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.86 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.526 ' NE1' HG21 ' A' ' 31' ' ' THR . 29.8 m0 -112.85 142.86 45.02 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.144 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -132.69 144.77 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.261 -178.409 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.891 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -132.08 121.57 46.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.225 178.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.5 t0 -176.42 -148.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.284 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.27 -1.77 3.7 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.1 -146.72 0.5 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 121.288 -0.165 . . . . 0.0 110.843 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 14' ' ' SER . 85.5 p 34.06 -93.1 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.427 ' O ' HG23 ' A' ' 18' ' ' VAL . 49.7 p -52.88 -58.07 8.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.257 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.6 mm -60.61 -31.41 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.01 0.433 . . . . 0.0 111.253 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.42 ' HG3' HG23 ' A' ' 32' ' ' THR . 13.5 ttt85 -72.86 -59.51 2.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.82 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.444 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 16.9 t90 -46.99 -43.76 19.63 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.591 ' CG1' HD12 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -68.39 -62.85 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.806 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.624 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 6.1 tp -67.89 -21.77 65.13 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.714 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.0 pt-20 -67.54 -60.06 2.86 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.672 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.535 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -75.02 -47.3 29.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 18' ' ' VAL . . . -54.89 -58.52 7.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.748 0.309 . . . . 0.0 111.772 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.624 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 2.8 mt -59.01 -28.24 66.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -61.77 -36.89 82.36 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.5 -24.99 71.25 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.457 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.67 -15.57 59.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 110.957 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.76 25.95 7.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.486 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.512 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.44 172.26 11.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.374 0.587 . . . . 0.0 111.401 179.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.2 m -104.1 109.46 21.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.22 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.714 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 7.6 t -106.65 110.51 22.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.198 0.523 . . . . 0.0 111.898 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.526 HG21 ' NE1' ' A' ' 7' ' ' TRP . 3.3 t -121.26 151.79 39.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.917 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.683 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.8 p -124.75 161.09 27.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.288 0.566 . . . . 0.0 112.108 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.891 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.3 m-85 -133.07 174.37 10.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.742 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.561 ' HG2' ' HG3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.66 -51.85 68.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -176.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.687 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -162.62 -24.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.7 0.682 . . . . 0.0 112.744 -179.256 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.574 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 163.79 -52.25 0.29 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.387 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.597 ' HA ' HD12 ' A' ' 40' ' ' LEU . 29.0 m120 -52.68 -33.69 48.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.724 0.297 . . . . 0.0 111.012 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -61.91 -54.32 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.731 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.637 HG21 ' CG ' ' A' ' 33' ' ' PHE . 2.9 t -54.58 -38.86 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.562 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.597 HD12 ' HA ' ' A' ' 37' ' ' ASN . 24.6 mt -52.26 -44.75 65.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.914 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.2 66.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.177 0.513 . . . . 0.0 111.048 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.46 94.18 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.547 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.55 HD11 ' CD2' ' A' ' 73' ' ' HIS . 21.7 mt -59.13 -26.48 64.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.473 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.48 -14.8 8.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.293 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.41 -9.51 10.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.98 165.16 32.54 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.087 0.47 . . . . 0.0 111.829 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.435 ' CG2' HD23 ' A' ' 76' ' ' LEU . 91.0 m -138.3 118.31 9.92 Favored Pre-proline 0 N--CA 1.452 -0.353 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.898 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.472 ' O ' HD23 ' A' ' 76' ' ' LEU . 73.6 Cg_endo -75.63 157.03 40.29 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.526 2.151 . . . . 0.0 111.991 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -73.76 -28.16 61.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 0.0 110.725 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.512 HG21 ' CD1' ' A' ' 79' ' ' ILE . 7.3 p -145.23 99.61 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.524 ' HB3' ' O ' ' A' ' 77' ' ' PRO . 63.7 tp -87.15 145.61 26.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.48 0.657 . . . . 0.0 112.184 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 9' ' ' VAL . 5.1 mt -132.85 114.43 14.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.801 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.676 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -111.3 149.95 30.36 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.287 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 18.5 t0 -80.14 -178.18 6.42 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.695 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.777 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 2.6 tt -159.92 73.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.588 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 177.56 63.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.94 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.462 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 3.1 tpp -163.5 -62.36 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.571 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 19.6 Cg_endo -59.49 -178.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.544 2.162 . . . . 0.0 113.03 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.81 -66.25 2.89 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.54 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.3 OUTLIER -72.97 54.62 0.38 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.52 -75.8 0.01 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.838 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.777 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -145.12 -32.74 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.761 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 1.4 mp -61.98 -16.46 51.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.503 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.425 ' HB3' ' CB ' ' A' ' 60' ' ' MET . . . -54.59 -35.26 63.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.316 0.579 . . . . 0.0 109.72 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.571 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 7.7 mt -63.6 -38.78 92.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.745 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 7.4 mp -52.35 -47.47 66.07 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 1.5 ttmp? -51.79 -43.39 63.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.701 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.513 ' HB2' HD13 ' A' ' 40' ' ' LEU . 12.1 mm-40 -65.62 -35.75 81.72 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.613 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.512 ' CG2' ' CE1' ' A' ' 73' ' ' HIS . 82.3 mt -63.06 -44.95 99.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.188 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 3.9 pttt -65.8 -23.67 66.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.187 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -28.32 41.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.297 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -112.31 -71.73 0.74 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.796 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.561 ' HD1' ' HB3' ' A' ' 76' ' ' LEU . 6.1 p80 -112.38 66.3 0.83 Allowed Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.494 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.574 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 25.8 Cg_endo -63.33 -31.99 72.88 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 113.576 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.498 ' HA ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -88.89 -19.81 25.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.51 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.561 ' HB3' ' HD1' ' A' ' 73' ' ' HIS . 3.1 tm? -62.83 118.44 42.0 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.619 0.247 . . . . 0.0 111.42 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 52.7 Cg_exo -54.15 115.88 2.67 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.722 2.281 . . . . 0.0 113.087 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.758 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -113.98 142.39 26.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.015 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.603 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 3.1 mt -130.12 115.85 34.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.943 0.402 . . . . 0.0 110.55 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.626 ' HA ' ' O ' ' A' ' 53' ' ' SER . 25.1 mm -93.85 145.74 7.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.439 ' O ' ' C ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -78.72 -19.92 51.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.028 -179.11 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.625 ' H ' HG21 ' A' ' 80' ' ' ILE . 6.0 m -147.65 157.54 43.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.432 ' CB ' ' CD2' ' A' ' 101' ' ' TYR . . . -133.48 50.69 2.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.996 0.427 . . . . 0.0 111.166 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.56 -176.14 3.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.956 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.1 t 71.25 -76.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.423 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.435 ' O ' HD23 ' A' ' 63' ' ' LEU . 7.6 m-20 -139.08 77.52 1.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.841 0.353 . . . . 0.0 111.121 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.523 ' O ' ' HB2' ' A' ' 90' ' ' ALA . 3.4 tm? -52.19 -21.8 3.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.62 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.06 -56.63 8.46 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.34 -24.26 67.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 87' ' ' LEU . . . -57.84 -63.07 1.37 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.82 0.343 . . . . 0.0 111.825 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.424 HG23 HD12 ' A' ' 87' ' ' LEU . 11.6 t -56.57 -38.45 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.921 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.406 ' HA ' ' HB3' ' A' ' 95' ' ' GLN . 1.4 m -60.48 -33.53 72.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.744 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 96' ' ' GLN . . . -68.12 -46.66 70.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.202 0.525 . . . . 0.0 111.118 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.638 ' HA ' ' HB2' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -75.83 -23.74 55.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.873 178.676 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.406 ' HB3' ' HA ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -74.48 -33.67 62.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.939 178.802 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 93' ' ' ALA . 15.2 pt20 -82.56 -18.47 41.29 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.442 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 75' ' ' MET . . . 161.94 -25.39 0.24 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.292 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.758 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -60.42 162.67 5.96 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.679 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 100' ' ' ASP . 28.4 t80 -74.57 -54.04 8.25 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.4 t0 170.5 -157.48 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.506 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.0 m-85 -129.14 123.01 31.05 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 81' ' ' MET . 3.8 tp -104.45 137.79 19.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.144 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.443 ' C ' ' HD2' ' A' ' 105' ' ' PRO . 69.5 Cg_exo -50.81 168.57 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.293 1.995 . . . . 0.0 111.847 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.65 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -44.07 -44.11 16.44 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 4.4 Cg_endo -47.4 163.48 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.645 1.563 . . . . 0.0 110.466 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.69 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 9.4 t80 -166.66 -94.36 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.679 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 43.01 -174.07 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.591 HD12 ' CG1' ' A' ' 18' ' ' VAL . 1.1 mp -67.55 -47.32 80.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.289 0.566 . . . . 0.0 111.557 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.684 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -51.98 -56.02 16.85 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.966 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.69 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.7 mm-40 -79.49 -28.35 41.47 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 107' ' ' ASP . . . -84.24 -53.8 5.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.018 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.56 ' HA ' ' CG1' ' A' ' 115' ' ' VAL . 42.8 t -58.63 -31.92 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 121.417 0.627 . . . . 0.0 110.221 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.17 -53.54 56.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.461 178.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.549 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 8.5 tp -75.19 -20.5 59.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.095 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.56 ' CG1' ' HA ' ' A' ' 112' ' ' VAL . 5.3 p -79.23 -49.76 19.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.443 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 16.2 mt-10 -68.59 -38.87 81.0 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.944 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 113' ' ' ALA . 4.4 ptp85 -66.15 -26.13 67.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.063 0.459 . . . . 0.0 110.649 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.449 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.49 -51.44 23.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.025 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -64.9 -31.48 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.146 0.498 . . . . 0.0 110.787 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.7 m -71.59 -42.56 67.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.746 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -30.37 69.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.788 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -74.08 -47.76 34.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.553 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -76.57 159.33 30.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.878 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.672 0.272 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 56.99 169.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.96 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.441 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 2.0 tpm_? -63.57 -22.1 66.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.798 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 56.78 76.29 0.21 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.818 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.694 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.4 mp -111.51 114.46 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.698 0.285 . . . . 0.0 110.985 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.745 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 7.7 p -105.53 116.11 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.248 179.314 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.531 ' NE1' HG21 ' A' ' 31' ' ' THR . 33.2 m0 -109.05 149.63 29.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.801 0.334 . . . . 0.0 111.35 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.761 HG23 HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -139.5 148.51 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.548 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.835 HG21 ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -134.18 118.37 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.139 177.435 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.479 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.3 t0 -173.64 -151.97 0.05 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.123 -179.356 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.34 -2.63 4.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 58.19 -137.73 0.88 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.009 178.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.9 p 34.74 -104.86 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.418 ' O ' HG21 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -54.12 -42.73 69.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.567 0.223 . . . . 0.0 111.468 -179.178 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.8 mm -65.24 -36.26 77.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.063 0.458 . . . . 0.0 111.252 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.474 ' HG3' HG22 ' A' ' 32' ' ' THR . 26.4 ttt-85 -70.72 -56.31 6.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.829 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.439 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 69.9 t90 -48.81 -43.87 38.65 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.567 ' CG1' HD12 ' A' ' 108' ' ' ILE . 1.6 t -67.2 -59.83 3.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.843 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.761 HD21 HG23 ' A' ' 8' ' ' VAL . 7.1 tp -70.93 -22.58 62.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.6 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 11.1 pt-20 -66.59 -60.12 3.0 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.435 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.563 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.6 mmt180 -74.9 -51.0 14.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.052 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.467 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -51.01 -58.7 5.39 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.625 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 1.8 mt -59.7 -28.93 67.74 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.4 83.14 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.52 -24.91 69.77 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.672 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.473 ' CB ' HD11 ' A' ' 28' ' ' LEU . . . -76.79 -15.52 59.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.693 0.282 . . . . 0.0 111.0 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.1 24.02 7.83 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.503 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.489 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.29 169.77 13.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 111.371 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.2 m -104.52 105.68 15.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.086 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.745 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 18.0 t -101.69 112.75 25.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.198 0.523 . . . . 0.0 111.992 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.551 HG22 ' CE1' ' A' ' 33' ' ' PHE . 3.1 t -122.13 152.95 39.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.18 178.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 38.1 p -126.74 152.5 46.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.267 0.556 . . . . 0.0 112.259 -179.084 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.781 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -129.21 174.04 9.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.54 -179.903 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.58 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -58.87 -104.65 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.025 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.427 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 13.8 m-20 -85.23 -70.76 0.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' HA2' HG12 ' A' ' 9' ' ' VAL . . . -167.26 -31.2 0.02 OUTLIER Glycine 0 C--N 1.318 -0.423 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.203 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -67.06 -31.3 71.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.506 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.626 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.7 tm-20 -52.99 -57.64 9.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.424 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.718 HG21 ' CD1' ' A' ' 33' ' ' PHE . 14.4 t -50.99 -42.71 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.297 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' A' ' 68' ' ' GLN . 26.1 mt -51.74 -44.58 63.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.96 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.07 -50.37 70.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.913 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.25 70.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.924 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.616 HD12 ' CG1' ' A' ' 39' ' ' VAL . 3.3 mt -67.61 -24.28 65.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.433 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.74 -17.12 3.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.34 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.71 -3.96 7.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -154.89 157.38 37.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.998 0.428 . . . . 0.0 111.372 -179.82 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.453 HG22 HD12 ' A' ' 76' ' ' LEU . 90.7 m -139.33 110.87 7.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.788 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.694 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 59.3 Cg_endo -71.73 156.76 56.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.429 2.086 . . . . 0.0 112.011 178.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -75.34 -24.27 57.32 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.304 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.435 HG12 ' CG2' ' A' ' 6' ' ' VAL . 6.7 p -145.02 95.3 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.441 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.46 HD12 ' HB2' ' A' ' 7' ' ' TRP . 28.0 tp -86.86 138.29 31.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.264 0.554 . . . . 0.0 111.884 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.528 ' CD2' ' HB ' ' A' ' 79' ' ' ILE . 4.4 mt -122.89 131.19 53.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.06 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.835 ' HA ' HG21 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -131.27 148.03 52.65 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.931 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 24.0 t0 -76.35 -164.47 0.4 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.315 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.75 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -170.66 77.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.276 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.409 ' HG2' ' F3 ' ' A' ' 125' ' ' BEF . 4.6 ptm180 179.38 56.41 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.86 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.606 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 12.7 tpt -157.7 -66.27 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.643 ' HG3' HD13 ' A' ' 65' ' ' LEU . 18.2 Cg_endo -58.06 -166.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.279 1.986 . . . . 0.0 112.877 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.84 -57.66 13.49 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.578 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.475 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -86.12 48.86 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.596 0.236 . . . . 0.0 110.831 179.808 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.492 ' HB3' HG13 ' A' ' 55' ' ' ILE . 0.3 OUTLIER 53.76 -83.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.991 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.75 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.84 -17.17 0.56 Allowed Glycine 0 CA--C 1.511 -0.161 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.032 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.688 ' HG ' ' HB3' ' A' ' 89' ' ' ALA . 1.8 tp -75.15 -12.89 60.4 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.192 0.52 . . . . 0.0 109.997 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.57 -64.87 0.76 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.5 178.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.643 HD13 ' HG3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -53.16 -22.94 7.18 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.856 179.834 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.552 ' O ' ' HB ' ' A' ' 69' ' ' ILE . 2.6 tp -62.19 -46.48 88.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 10.8 mtpp -55.62 -39.85 71.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.448 177.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.545 ' HB2' HD12 ' A' ' 40' ' ' LEU . 6.0 mm-40 -60.77 -33.23 72.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.038 178.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 66' ' ' LEU . 96.3 mt -59.32 -48.09 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.873 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.625 ' HB3' ' HG3' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -64.25 -29.69 70.78 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.97 0.414 . . . . 0.0 110.749 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.474 ' HG3' ' HD2' ' A' ' 70' ' ' LYS . 7.8 mt-30 -80.87 -31.02 35.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.684 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.7 -56.82 3.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.619 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.579 ' N ' ' CD2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -91.04 157.3 43.25 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.385 -179.624 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.8 -59.14 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.446 2.097 . . . . 0.0 112.44 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.7 mtt -156.8 28.98 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.128 0.489 . . . . 0.0 110.428 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.641 HD12 ' HD2' ' A' ' 48' ' ' PRO . 1.8 tt -55.85 112.24 4.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.411 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 31.7 Cg_exo -62.63 114.54 2.43 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 121.836 1.691 . . . . 0.0 112.277 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.926 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -99.54 150.9 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.605 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.528 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 1.9 mp -133.74 115.44 21.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.82 0.343 . . . . 0.0 110.594 179.65 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.614 ' HA ' ' O ' ' A' ' 53' ' ' SER . 45.3 mm -97.25 149.32 5.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.223 0.535 . . . . 0.0 112.408 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.535 ' HE1' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -82.07 -21.81 36.65 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.9 -178.746 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.672 ' O ' HG22 ' A' ' 55' ' ' ILE . 2.7 m -148.1 139.54 23.6 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.808 -0.558 . . . . 0.0 111.291 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.499 ' CB ' ' CD2' ' A' ' 101' ' ' TYR . . . -115.7 41.46 2.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.717 0.294 . . . . 0.0 111.583 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.411 ' ND1' HG22 ' A' ' 82' ' ' THR . 0.8 OUTLIER -81.18 54.47 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 0.0 110.831 179.687 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.9 p -159.19 -166.59 1.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.421 ' O ' ' CD2' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -61.35 85.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.414 HD23 ' HB1' ' A' ' 90' ' ' ALA . 4.7 mt -49.13 -22.53 0.98 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.137 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -47.89 -45.93 31.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.688 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . . . -72.05 -19.43 61.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.477 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.428 ' HB2' HD21 ' A' ' 63' ' ' LEU . . . -75.64 -46.18 32.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.341 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.746 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 12.1 t -68.19 -38.36 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.501 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.5 p -69.93 -23.4 63.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.977 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' GLY . . . -63.86 -42.82 97.46 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.235 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.746 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 1.1 m-85 -63.75 -27.65 69.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.456 178.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.86 -34.85 62.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.381 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.625 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 1.1 pt20 -98.67 -5.22 32.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.608 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 130.89 80.24 0.21 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.135 -179.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.926 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.56 134.87 1.86 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.188 0.518 . . . . 0.0 111.384 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 32.7 t80 -75.79 -54.2 7.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.709 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER 171.99 -164.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 0.0 111.449 -179.134 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.499 ' CD2' ' CB ' ' A' ' 83' ' ' ALA . 2.9 m-85 -125.89 119.92 29.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.989 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.632 HD23 ' CE1' ' A' ' 106' ' ' PHE . 4.3 tp -102.56 136.71 19.3 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.735 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 10.0 Cg_endo -49.22 167.88 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.664 2.243 . . . . 0.0 111.641 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -41.45 -49.93 9.2 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 111.369 0.137 . . . . 0.0 111.369 -178.747 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.735 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 71.0 Cg_exo -47.36 162.94 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.574 1.516 . . . . 0.0 110.028 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.654 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -175.3 -85.54 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.39 -178.419 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.802 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 4.3 p30 42.66 -168.41 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.618 HD11 ' HA ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.78 -47.24 80.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.268 0.556 . . . . 0.0 111.489 -179.887 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.701 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 5.0 t0 -51.75 -57.55 8.94 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.911 -179.321 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.654 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 17.8 mm-40 -78.98 -27.77 43.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.016 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.802 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -84.34 -54.76 4.56 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.826 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.589 ' O ' HG12 ' A' ' 115' ' ' VAL . 39.2 t -56.49 -32.17 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.523 0.677 . . . . 0.0 110.023 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.701 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -60.55 -52.42 65.24 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.499 178.293 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.47 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 5.4 tp -74.51 -21.49 59.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.789 -178.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.589 HG12 ' O ' ' A' ' 112' ' ' VAL . 7.2 p -79.27 -51.86 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 120.376 -0.529 . . . . 0.0 112.019 -179.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.452 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 20.2 mt-10 -64.53 -46.34 83.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.527 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -62.56 -27.65 69.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -71.47 -54.66 9.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.219 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.62 -32.12 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.216 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 116' ' ' GLU . 0.4 OUTLIER -69.13 -40.52 78.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.829 179.861 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -57.83 -27.27 63.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.967 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -84.43 -52.7 5.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.736 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -76.57 173.16 11.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.757 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 179.858 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . 0.409 ' F3 ' ' HG2' ' A' ' 56' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.645 0.259 . . . . 0.0 111.492 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -123.65 -18.51 6.09 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.421 ' O ' ' OD2' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -73.37 47.99 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.307 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.415 ' HA2' ' OD2' ' A' ' 49' ' ' ASP . . . -68.62 81.59 0.22 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 178.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.562 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 2.2 mm -114.54 117.84 56.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.078 0.466 . . . . 0.0 112.133 -178.341 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.736 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 2.6 p -106.11 123.94 61.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.698 177.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.478 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 38.1 m0 -115.62 141.54 47.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -128.72 135.24 62.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.384 0.611 . . . . 0.0 111.934 -178.416 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.828 HG23 ' HB2' ' A' ' 33' ' ' PHE . 1.5 t -123.53 108.17 20.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.06 179.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.558 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 14.0 t70 -161.66 -149.92 0.18 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.408 -179.071 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.486 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 2.8 m-20 -66.32 -3.08 5.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.574 0.226 . . . . 0.0 111.595 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.8 t70 61.29 -144.8 0.45 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.392 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 14' ' ' SER . 2.4 t 32.74 -90.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.435 ' H ' ' HB3' ' A' ' 13' ' ' SER . 2.0 m -55.87 -52.36 64.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.749 0.309 . . . . 0.0 111.21 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.1 mm -63.79 -31.65 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 111.173 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.467 ' HD3' ' OE1' ' A' ' 20' ' ' GLU . 2.6 ttm180 -73.09 -54.59 8.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.677 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.516 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 44.4 t90 -51.3 -42.87 61.47 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.499 ' C ' HD13 ' A' ' 108' ' ' ILE . 2.1 t -68.17 -63.11 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.058 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.643 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 9.1 mt -65.86 -22.05 66.51 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.634 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.51 -56.91 7.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.219 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.513 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -77.87 -47.18 19.36 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.612 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 18' ' ' VAL . . . -56.84 -58.07 9.72 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.752 0.311 . . . . 0.0 111.725 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 2.0 mt -61.29 -29.43 69.86 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.98 -34.15 74.32 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.59 -24.95 74.0 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.442 178.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.424 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -76.88 -15.56 59.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.726 179.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.82 25.15 7.73 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.817 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.48 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.21 170.4 11.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.267 0.534 . . . . 0.0 111.455 179.611 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.438 ' O ' HG11 ' A' ' 6' ' ' VAL . 52.7 m -103.74 106.14 16.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.49 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.736 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.2 t -104.23 112.46 25.49 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.478 ' CG2' ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -122.83 156.67 34.09 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.307 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.692 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 36.3 p -127.21 157.88 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.305 -178.392 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.828 ' HB2' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -135.92 171.49 14.38 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.81 -179.683 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.788 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -64.28 -49.68 70.87 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.017 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.788 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 2.1 t30 -162.79 167.06 23.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -178.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -42.85 -27.79 0.61 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.382 -0.914 . . . . 0.0 112.735 -178.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.471 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -64.09 -47.8 78.62 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.708 0.289 . . . . 0.0 110.753 179.371 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -51.82 -52.19 51.04 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.046 179.527 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.706 HG22 HG21 ' A' ' 9' ' ' VAL . 32.0 t -48.69 -40.97 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.025 0.44 . . . . 0.0 110.935 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 68' ' ' GLN . 17.7 mt -50.17 -48.22 54.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.61 -48.95 75.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.487 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.52 -41.08 96.61 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.906 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.654 ' HG ' HG11 ' A' ' 39' ' ' VAL . 29.4 mt -61.2 -20.82 63.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.02 -14.45 3.7 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.63 -179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.69 -6.89 6.82 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.547 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.19 166.89 20.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.883 0.373 . . . . 0.0 111.801 -179.46 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.503 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 57.6 m -139.02 122.1 10.73 Favored Pre-proline 0 N--CA 1.454 -0.228 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.436 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.562 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 98.4 Cg_endo -79.46 155.35 24.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.304 2.003 . . . . 0.0 111.491 178.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 3' ' ' ARG . 77.3 m-20 -75.34 -25.76 58.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.716 -179.32 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.527 HG23 ' CG2' ' A' ' 115' ' ' VAL . 3.8 p -145.69 91.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.415 HD11 HG21 ' A' ' 39' ' ' VAL . 32.5 tp -87.12 144.49 26.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.228 -179.376 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.559 HD22 ' CZ ' ' A' ' 106' ' ' PHE . 2.1 mt -125.95 137.5 53.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.934 178.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.699 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -133.57 135.61 44.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -178.197 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.596 ' H ' HG12 ' A' ' 9' ' ' VAL . 15.5 t0 -66.88 174.89 2.71 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.937 178.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.741 HG13 ' N ' ' A' ' 62' ' ' GLY . 6.8 tt -152.47 77.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.495 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER 176.67 65.7 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.188 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.593 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 1.6 ttt -158.46 -67.73 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.74 ' HG3' HD22 ' A' ' 65' ' ' LEU . 59.3 Cg_endo -70.18 -163.07 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.554 2.169 . . . . 0.0 113.035 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.62 -60.6 7.54 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.211 -179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.568 ' O ' ' N ' ' A' ' 62' ' ' GLY . 1.8 mtp -84.39 45.36 1.11 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.839 0.32 . . . . 0.0 111.594 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.548 ' HB3' HG13 ' A' ' 55' ' ' ILE . 1.2 m-20 50.98 -75.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.366 179.154 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.741 ' N ' HG13 ' A' ' 55' ' ' ILE . . . -139.09 -33.17 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.386 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.607 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -56.75 -22.82 38.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.737 0.303 . . . . 0.0 110.324 -179.862 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.546 ' CB ' ' HB2' ' A' ' 60' ' ' MET . . . -63.19 -39.25 94.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.217 0.532 . . . . 0.0 110.291 178.203 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.74 HD22 ' HG3' ' A' ' 58' ' ' PRO . 2.3 mm? -59.52 -37.44 78.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.39 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.0 mm? -59.75 -42.85 94.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.81 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.584 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 2.5 tttt -56.3 -44.45 79.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.655 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.52 ' HB3' HD13 ' A' ' 40' ' ' LEU . 3.0 mt-30 -63.52 -39.46 94.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.161 0.505 . . . . 0.0 111.142 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 58.4 mt -57.43 -51.43 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.679 -178.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.74 -23.6 67.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.401 -179.829 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -49.72 70.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.191 -178.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -99.35 -20.54 16.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.401 -178.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.484 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 4.2 m-70 -116.5 146.7 38.08 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.856 0.36 . . . . 0.0 111.152 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.85 -75.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.48 2.12 . . . . 0.0 112.74 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 38.3 mtp -149.54 57.69 1.0 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.058 0.456 . . . . 0.0 111.072 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' O ' HG22 ' A' ' 78' ' ' VAL . 2.0 tt -66.88 118.49 55.55 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.717 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.507 ' HD2' HD23 ' A' ' 76' ' ' LEU . 32.3 Cg_exo -58.61 115.34 2.47 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.552 1.501 . . . . 0.0 111.929 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.933 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -111.27 150.09 13.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.143 179.522 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.554 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 2.8 mt -136.83 115.39 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.997 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 53' ' ' SER . 14.2 mm -93.09 150.91 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 111.693 -178.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.619 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -78.98 -27.01 43.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.195 -178.348 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 2.8 m -143.29 170.7 15.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.415 ' CB ' HD21 ' A' ' 87' ' ' LEU . . . -127.61 45.57 2.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.456 ' CE1' HG22 ' A' ' 82' ' ' THR . 47.3 m-70 -69.34 -174.77 0.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 111.135 179.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 86' ' ' ASP . 48.1 t 50.67 -165.34 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.879 179.241 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.432 ' N ' ' OG ' ' A' ' 85' ' ' SER . 19.3 p-10 -59.49 101.26 0.1 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.798 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.5 HD11 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -55.9 -21.87 22.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.082 178.971 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -48.14 -45.9 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.28 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.607 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.69 -19.27 65.15 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.461 -179.349 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.547 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . . . -65.45 -53.99 34.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.086 0.469 . . . . 0.0 110.329 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.55 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.7 t -62.27 -39.83 85.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.561 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.624 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 83.5 p -63.55 -15.03 56.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.941 178.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.453 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -75.77 -57.76 3.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.187 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.592 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 3.3 m-85 -52.48 -34.15 47.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.134 -179.276 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -75.61 -33.5 60.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.012 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.493 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 10.0 pt20 -99.01 3.13 46.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.38 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 125.08 81.9 0.48 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.575 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.933 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.54 132.85 1.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.153 0.501 . . . . 0.0 111.723 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 74.8 t80 -75.08 -53.52 8.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.531 -179.165 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.592 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -178.49 -166.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.143 0.497 . . . . 0.0 111.821 -179.556 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.547 ' CE1' ' HB2' ' A' ' 90' ' ' ALA . 2.4 m-85 -125.79 140.4 52.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.322 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.597 ' HB3' ' HA ' ' A' ' 81' ' ' MET . 5.3 tp -101.89 150.43 37.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 16.5 Cg_exo -69.08 -43.15 3.42 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.302 2.001 . . . . 0.0 111.533 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.479 ' HE2' ' HB2' ' A' ' 81' ' ' MET . 0.0 OUTLIER 172.81 -46.96 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.479 178.963 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.516 ' O ' HD21 ' A' ' 102' ' ' LEU . 75.9 Cg_exo -47.72 164.59 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.905 1.737 . . . . 0.0 109.614 178.081 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.69 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 6.0 t80 -166.18 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.133 -177.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.497 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 3.7 p30 44.26 -172.08 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.881 0.372 . . . . 0.0 110.611 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.548 HG22 HG23 ' A' ' 112' ' ' VAL . 1.1 mp -68.1 -50.63 56.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.155 0.502 . . . . 0.0 111.994 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.745 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -50.4 -54.35 22.47 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.943 -178.504 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.69 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.2 mm-40 -80.02 -30.62 39.56 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.228 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -83.85 -51.47 7.16 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.962 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.648 ' O ' HG11 ' A' ' 115' ' ' VAL . 41.5 t -60.3 -31.97 49.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.388 0.613 . . . . 0.0 110.379 179.231 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.745 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -59.75 -51.82 68.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.742 0.782 . . . . 0.0 109.409 178.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.437 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 6.5 tp -75.26 -20.78 59.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.873 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.648 HG11 ' O ' ' A' ' 112' ' ' VAL . 6.0 p -78.78 -51.64 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.217 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.466 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 40.5 mt-10 -68.53 -40.88 80.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.783 0.325 . . . . 0.0 110.537 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -66.56 -26.83 67.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.528 179.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -71.62 -55.04 8.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.956 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -66.43 -31.37 53.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.054 0.454 . . . . 0.0 110.79 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.3 t -67.78 -44.03 78.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.969 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.04 -24.28 65.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.11 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.48 -40.52 77.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.028 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -75.87 -174.57 2.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.793 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.783 0.325 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 0.3 OUTLIER -126.6 175.84 7.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.866 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 2' ' ' GLN . 1.5 ptt180 72.75 2.85 4.51 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.725 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.01 102.94 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.938 179.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.1 mp -121.85 112.72 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.031 0.443 . . . . 0.0 110.898 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 29' ' ' THR . 8.9 p -113.73 126.05 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.886 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.64 ' HH2' ' CG ' ' A' ' 46' ' ' LYS . 54.4 m0 -118.13 138.03 52.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.823 0.344 . . . . 0.0 110.801 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.603 HG13 ' HB2' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -123.61 119.21 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.895 -178.302 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.694 ' CG1' ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -104.46 104.53 16.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.615 0.245 . . . . 0.0 110.357 179.212 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.501 ' O ' ' HB ' ' A' ' 15' ' ' ILE . 63.9 t0 166.78 119.18 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.905 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 73.84 -22.24 0.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 178.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 73.3 -140.97 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.532 -0.105 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.0 t -31.69 -44.15 0.07 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.16 -69.56 0.11 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.695 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 24.0 mm -60.4 -20.3 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.718 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.463 ' HG3' HG22 ' A' ' 32' ' ' THR . 35.0 ttp180 -73.27 -61.81 1.69 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.781 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.555 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 80.5 t90 -47.64 -48.03 28.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.111 -178.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.491 ' C ' HD12 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -64.6 -61.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.113 0.482 . . . . 0.0 111.971 -179.023 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.604 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 31.8 mt -68.65 -22.09 64.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.957 -177.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.585 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 17.8 pt-20 -66.57 -57.75 6.62 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.495 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.499 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -59.11 -51.15 71.28 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.664 -179.587 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.29 -51.96 67.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 0.0 111.796 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.804 ' CD2' HD11 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -67.24 -22.64 65.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.388 179.79 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -66.93 -34.84 78.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.027 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.65 -28.23 65.06 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.002 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.448 ' CB ' HD12 ' A' ' 28' ' ' LEU . . . -76.69 -15.48 59.78 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.895 0.378 . . . . 0.0 110.503 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.16 24.21 17.48 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.973 -0.632 . . . . 0.0 114.316 178.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.804 HD11 ' CD2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -121.95 159.89 25.98 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 117.961 0.88 . . . . 0.0 112.751 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.573 ' O ' HG12 ' A' ' 6' ' ' VAL . 55.2 m -81.0 126.77 31.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.431 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.585 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -116.75 108.03 15.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.154 -178.482 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.553 ' CG2' ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -130.29 141.84 50.58 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 65.0 p -115.86 162.53 17.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.574 0.702 . . . . 0.0 112.823 -178.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.815 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 2.6 m-85 -135.85 173.51 11.63 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.491 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.647 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -62.91 -59.45 4.83 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -177.004 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.477 ' CA ' HG13 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -151.22 -60.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.08 -178.729 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -152.44 -55.75 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.579 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.502 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -54.35 -29.59 48.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.991 0.395 . . . . 0.0 111.009 -179.216 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.815 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -62.19 -60.74 3.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.668 179.348 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.588 HG23 HG22 ' A' ' 9' ' ' VAL . 22.0 t -48.8 -42.65 13.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.272 179.311 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.683 HD13 ' HB3' ' A' ' 68' ' ' GLN . 38.6 mt -45.64 -46.58 14.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.033 0.444 . . . . 0.0 110.455 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.95 -47.39 80.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.537 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.83 -41.26 83.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.991 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 19.4 mt -66.32 -29.29 69.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.19 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.04 -19.99 55.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.201 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 t -123.42 0.62 8.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.64 ' CG ' ' HH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -164.65 165.62 20.81 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.116 0.484 . . . . 0.0 111.062 -179.916 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.404 HG21 ' CD2' ' A' ' 76' ' ' LEU . 54.1 m -138.5 114.52 8.85 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.498 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.5 ' HD3' ' CZ3' ' A' ' 7' ' ' TRP . 91.0 Cg_endo -77.58 164.54 28.22 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.1 1.866 . . . . 0.0 111.978 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -78.01 -31.15 50.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 110.401 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.478 HG22 ' N ' ' A' ' 51' ' ' LEU . 3.4 p -145.22 149.05 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.503 ' CD1' ' HB2' ' A' ' 7' ' ' TRP . 0.6 OUTLIER -152.97 145.59 24.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.321 0.582 . . . . 0.0 112.31 -178.18 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.685 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.2 mt -123.87 122.07 37.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.285 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -111.55 150.45 29.99 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.776 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' HA ' ' SD ' ' A' ' 81' ' ' MET . 15.8 t0 -77.48 169.72 17.82 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.465 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.614 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.5 tt -144.02 165.94 13.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.369 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.56 ' HG3' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 65.21 65.08 0.59 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.674 0.75 . . . . 0.0 111.297 -179.366 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.612 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -158.01 -63.02 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.685 179.293 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.612 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 68.7 Cg_endo -69.29 -157.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.505 2.136 . . . . 0.0 112.33 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.5 -72.94 0.6 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.069 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.532 ' O ' ' N ' ' A' ' 62' ' ' GLY . 1.5 ttt -71.22 57.51 0.23 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.916 0.388 . . . . 0.0 111.16 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.546 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 56.45 -77.58 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.537 -179.592 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.46 -31.27 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.389 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' A' ' 66' ' ' LEU . 1.7 mp -62.29 -17.1 57.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.745 0.307 . . . . 0.0 110.613 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.409 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -59.71 -37.98 80.38 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.014 0.435 . . . . 0.0 110.13 178.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.497 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 30.3 mt -61.26 -39.08 89.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 63' ' ' LEU . 4.0 mm? -55.47 -43.51 75.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.142 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.634 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 23.6 ttmm -57.97 -42.51 85.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.768 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.683 ' HB3' HD13 ' A' ' 40' ' ' LEU . 3.2 mt-30 -65.51 -41.37 93.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.059 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.595 HG21 ' CD2' ' A' ' 73' ' ' HIS . 36.6 mt -57.25 -50.36 76.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.634 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.634 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.27 -24.01 67.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.254 -179.532 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -23.13 66.08 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.861 -0.335 . . . . 0.0 111.053 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -108.35 -20.18 13.22 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.595 ' CD2' HG21 ' A' ' 69' ' ' ILE . 6.2 p80 -113.64 166.99 10.11 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 112.106 -179.093 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 94.0 Cg_endo -88.27 -47.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.216 2.611 . . . . 0.0 111.837 178.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.2 mtt -157.45 54.37 0.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.579 ' H ' ' ND1' ' A' ' 73' ' ' HIS . 0.7 OUTLIER -76.61 112.6 22.83 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-O 120.62 0.247 . . . . 0.0 110.861 179.819 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 37.6 Cg_endo -66.81 115.47 3.6 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.158 1.906 . . . . 0.0 111.86 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.57 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.4 t -109.11 152.34 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.595 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 3.2 mt -136.09 118.07 20.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.096 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.559 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 15.4 mm -93.61 144.25 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.387 0.613 . . . . 0.0 112.167 -179.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.721 ' HE2' ' CZ ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -77.21 -15.99 59.25 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.014 -179.369 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.544 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.5 m -147.79 169.32 20.01 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.213 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.94 41.83 1.42 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.771 0.319 . . . . 0.0 111.488 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -68.62 113.74 6.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.963 0.411 . . . . 0.0 112.071 -179.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 m 48.58 -177.52 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.925 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.422 ' O ' HD22 ' A' ' 63' ' ' LEU . 6.5 m-20 52.24 26.22 3.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.155 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.418 HD12 ' CB ' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -56.14 -22.11 26.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.556 -179.919 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.32 -43.62 43.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.711 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.19 -23.42 62.96 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.474 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . . . -64.7 -39.73 94.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.946 0.403 . . . . 0.0 110.492 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.586 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.1 t -69.88 -45.03 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.185 179.47 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.9 m -62.52 -28.89 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.539 ' O ' ' HG2' ' A' ' 96' ' ' GLN . . . -62.13 -41.85 98.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.492 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.586 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.4 m-85 -61.43 -21.7 64.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.145 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.59 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -72.81 -42.18 64.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.772 -179.907 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.602 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.1 pt20 -77.55 -18.15 57.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.505 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 129.82 5.07 4.54 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.149 -1.024 . . . . 0.0 114.139 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.57 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -54.65 152.79 6.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.477 0.638 . . . . 0.0 111.311 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 39.3 t80 -85.7 -53.58 5.06 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.335 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.81 -163.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.18 0.514 . . . . 0.0 111.799 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.559 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.9 m-85 -131.66 122.11 25.42 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.624 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.462 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 5.8 tp -103.69 141.03 21.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.728 -179.567 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.588 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 19.6 Cg_endo -57.87 169.89 2.37 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.334 2.023 . . . . 0.0 111.591 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.646 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -44.22 -46.5 23.04 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -179.17 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 2.8 Cg_endo -46.49 163.62 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.826 1.684 . . . . 0.0 110.539 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.746 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 1.0 OUTLIER -166.41 -88.47 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.434 -177.812 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.546 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p-10 42.23 -175.48 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.959 0.409 . . . . 0.0 110.613 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.491 HD12 ' C ' ' A' ' 18' ' ' VAL . 1.1 mp -68.01 -47.44 78.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.3 0.571 . . . . 0.0 111.652 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.559 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 68.1 m-20 -54.05 -54.96 32.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.831 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.746 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.9 mm-40 -77.65 -29.43 51.63 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 107' ' ' ASP . . . -84.22 -57.34 3.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.015 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.558 ' O ' HG11 ' A' ' 115' ' ' VAL . 43.9 t -54.67 -32.17 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.456 0.646 . . . . 0.0 110.142 179.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -59.85 -54.76 42.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.055 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.462 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 32.5 tp -73.33 -20.66 60.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.66 -179.138 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.558 HG11 ' O ' ' A' ' 112' ' ' VAL . 2.4 p -79.06 -47.54 22.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.278 -178.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.08 -38.0 84.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.79 0.328 . . . . 0.0 110.462 179.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.2 mtt85 -65.04 -24.32 67.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.542 179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.65 -52.55 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.066 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.7 mt -60.75 -31.49 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.107 0.479 . . . . 0.0 110.659 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.5 m -70.56 -43.5 69.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.704 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -77.29 -28.92 53.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.859 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -75.64 -56.1 5.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.807 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 58.72 171.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.804 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mmt . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.872 0.368 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -152.31 139.55 19.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -21.05 58.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.045 179.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.463 ' C ' ' HB3' ' A' ' 28' ' ' LEU . . . 81.63 106.41 0.37 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.538 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 2.2 mp -133.34 113.07 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.715 HG13 ' HG ' ' A' ' 23' ' ' LEU . 7.9 p -111.69 125.54 69.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.868 0.366 . . . . 0.0 111.433 179.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.724 ' CD1' HG23 ' A' ' 31' ' ' THR . 19.7 m0 -114.88 129.03 56.62 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.433 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.6 OUTLIER -123.42 144.76 31.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.454 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.646 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 0.1 OUTLIER -135.32 105.81 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.582 178.31 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 51.4 t0 167.49 120.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.637 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.404 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 70.86 -32.15 0.24 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.216 179.567 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 10' ' ' ASP . 5.0 t70 73.75 -134.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 12' ' ' ASP . 47.6 t -21.0 -58.17 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.441 ' O ' HG21 ' A' ' 18' ' ' VAL . 19.4 m -53.04 -69.52 0.11 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.259 -179.088 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 26.7 mm -60.46 -20.38 20.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.51 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 47.8 ttt180 -72.35 -61.45 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.861 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 75.9 t90 -47.46 -42.85 23.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.533 ' C ' HD13 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -67.52 -62.16 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.736 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 8.6 tp -70.79 -21.6 62.47 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.553 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 22.7 pt-20 -67.47 -56.68 8.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.47 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.553 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 9.5 mmm-85 -68.51 -56.34 8.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.479 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.54 -36.94 64.82 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.715 ' HG ' HG13 ' A' ' 6' ' ' VAL . 1.1 tm? -73.7 -27.45 61.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.997 0.427 . . . . 0.0 110.687 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.42 -32.64 72.82 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.59 -25.71 71.66 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.432 178.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.77 -15.48 59.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.728 0.299 . . . . 0.0 111.135 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.64 25.34 8.69 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.487 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.463 ' HB3' ' C ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -134.98 178.27 7.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.632 0.716 . . . . 0.0 111.726 179.849 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.521 ' O ' HG12 ' A' ' 6' ' ' VAL . 7.9 m -105.64 128.01 53.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.069 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.485 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 42.6 t -123.11 113.01 18.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.134 0.492 . . . . 0.0 111.953 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.724 HG23 ' CD1' ' A' ' 7' ' ' TRP . 3.0 t -119.08 156.03 30.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.253 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.9 p -133.91 160.19 38.43 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.092 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.678 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.3 m-85 -135.86 174.16 10.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.421 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.529 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.89 -105.05 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.025 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.569 ' C ' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -84.57 -61.52 1.77 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.033 0.444 . . . . 0.0 111.978 -178.154 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.714 ' HA3' ' HG ' ' A' ' 65' ' ' LEU . . . -176.64 -37.01 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.074 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.701 ' HA ' HD12 ' A' ' 40' ' ' LEU . 3.0 m120 -60.18 -29.64 68.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.678 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -54.53 -54.8 36.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.424 179.791 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.588 HG13 HD12 ' A' ' 43' ' ' LEU . 6.6 t -49.39 -46.01 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.262 0.553 . . . . 0.0 110.907 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.701 HD12 ' HA ' ' A' ' 37' ' ' ASN . 30.3 mt -47.2 -43.46 21.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.306 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.87 82.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.31 0.576 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.22 77.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.1 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.656 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.3 mt -59.89 -24.46 64.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.201 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.84 -22.31 5.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.698 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.94 8.32 5.22 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.05 163.21 37.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.98 0.419 . . . . 0.0 111.198 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.7 m -138.39 118.56 9.91 Favored Pre-proline 0 N--CA 1.453 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.009 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.566 ' HB3' ' CG ' ' A' ' 7' ' ' TRP . 56.0 Cg_endo -69.69 154.96 67.36 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.165 1.91 . . . . 0.0 112.292 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.559 ' HB3' ' O ' ' A' ' 5' ' ' ILE . 26.8 t0 -79.38 -32.66 43.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.611 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.596 HG11 HD12 ' A' ' 119' ' ' ILE . 7.3 p -150.47 94.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.625 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.486 HD13 HG13 ' A' ' 39' ' ' VAL . 28.5 tp -84.48 153.84 23.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.664 ' CD2' ' HB ' ' A' ' 79' ' ' ILE . 2.7 mt -136.74 114.76 11.45 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.802 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.577 ' HA ' HG21 ' A' ' 9' ' ' VAL . 4.9 t -108.95 149.4 29.25 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.646 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 25.9 t0 -82.99 166.84 18.49 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.381 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.663 ' CG2' ' HB ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -155.5 108.95 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.994 -179.914 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.47 40.22 0.76 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.375 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER 66.94 51.06 0.62 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.434 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 62.6 Cg_endo -78.96 -77.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.812 2.341 . . . . 0.0 112.159 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.424 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -109.27 -29.78 3.85 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.815 179.526 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.553 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -152.47 65.78 0.82 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.095 0.474 . . . . 0.0 110.279 179.362 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 55' ' ' ILE . 0.5 OUTLIER 68.74 -22.99 0.14 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.872 179.824 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.599 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 135.24 -31.49 2.68 Favored Glycine 0 CA--C 1.502 -0.757 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 4.7 mp -70.16 -15.47 62.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.89 -37.98 64.31 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.061 0.458 . . . . 0.0 110.447 178.448 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.714 ' HG ' ' HA3' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -58.15 -36.61 73.25 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.926 179.511 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.569 ' HB3' ' CB ' ' A' ' 93' ' ' ALA . 4.0 mm? -59.34 -43.61 92.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.494 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.561 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 14.0 mttt -52.59 -47.25 67.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.09 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.528 ' CB ' HD13 ' A' ' 40' ' ' LEU . 2.0 mt-30 -61.09 -32.19 71.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.059 179.162 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.469 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 10.7 mt -67.97 -41.6 84.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.166 -178.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 9.9 pttt -77.63 -24.88 49.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.955 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -74.25 -43.43 57.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.883 0.373 . . . . 0.0 111.888 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -89.45 -54.59 4.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.132 -179.06 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.656 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -89.96 135.49 30.17 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.261 -178.858 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -56.74 -64.84 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.512 2.142 . . . . 0.0 112.667 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.8 mtm -142.01 44.7 1.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.787 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.463 HD23 ' HD2' ' A' ' 48' ' ' PRO . 2.9 tm? -63.01 111.17 4.39 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.037 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HD2' HD22 ' A' ' 76' ' ' LEU . 38.7 Cg_exo -58.94 116.29 3.15 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.639 2.226 . . . . 0.0 113.013 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.927 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -118.55 153.29 20.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.68 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.664 ' HB ' ' CD2' ' A' ' 52' ' ' LEU . 3.6 mt -134.14 117.6 25.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.017 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.586 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 26.6 mm -93.57 141.76 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.219 0.533 . . . . 0.0 112.06 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.541 ' HE2' ' CB ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -84.72 -11.73 55.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.558 -179.147 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.663 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 15.3 m -147.47 133.0 18.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.576 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.63 -1.53 7.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -69.32 67.48 0.19 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 0.0 110.256 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.5 m -155.98 -79.09 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.35 -179.34 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.463 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -145.62 79.39 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.68 -179.609 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.437 ' HA ' ' HB1' ' A' ' 90' ' ' ALA . 4.5 mt -46.12 -21.46 0.15 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.281 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.76 -57.44 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.572 0.225 . . . . 0.0 110.96 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.45 -20.87 62.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 110.87 179.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.521 ' CB ' ' CE1' ' A' ' 101' ' ' TYR . . . -69.65 -60.88 2.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.505 ' HA ' ' HD2' ' A' ' 94' ' ' TYR . 21.6 t -60.75 -46.12 96.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.486 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.7 m -56.81 -49.12 76.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.003 0.43 . . . . 0.0 111.246 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.569 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -62.93 -40.3 97.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.143 -179.403 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.763 ' HA ' ' CB ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -71.17 -20.71 62.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.218 179.918 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.56 -38.68 62.63 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.465 179.174 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.572 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 2.6 pt20 -100.23 -17.43 17.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.75 66.79 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.496 -1.335 . . . . 0.0 114.081 -179.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.927 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -170.48 132.91 1.0 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.592 0.234 . . . . 0.0 110.553 178.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.427 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 45.2 t80 -62.92 -53.14 58.7 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.504 -178.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 178.23 -161.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 0.0 111.408 -179.306 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.586 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.2 m-85 -127.59 126.82 42.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.489 ' HB2' HD23 ' A' ' 114' ' ' LEU . 6.3 tp -108.03 135.38 19.88 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.81 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' C ' ' HD2' ' A' ' 105' ' ' PRO . 77.3 Cg_exo -50.03 170.02 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.2 1.933 . . . . 0.0 111.453 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.647 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -44.6 -44.5 20.83 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.296 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 4.8 Cg_endo -47.58 163.4 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.739 1.626 . . . . 0.0 110.942 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.685 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 9.8 t80 -165.68 -95.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.717 -178.4 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 4.2 p-10 44.18 -174.03 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.126 -0.359 . . . . 0.0 110.896 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.533 HD13 ' C ' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -68.02 -47.72 77.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.197 0.523 . . . . 0.0 111.633 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.772 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 23.3 t70 -51.15 -57.47 8.65 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.714 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.685 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.3 mm-40 -78.22 -29.44 48.27 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.206 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -82.16 -57.71 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.772 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 115' ' ' VAL . 38.5 t -54.06 -32.46 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.467 0.651 . . . . 0.0 110.159 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -59.46 -51.65 68.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.885 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.514 HD21 HG22 ' A' ' 79' ' ' ILE . 19.3 tp -77.42 -20.55 54.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.791 -178.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 112' ' ' VAL . 4.2 p -76.43 -46.84 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.496 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.401 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 29.1 mt-10 -63.62 -52.46 60.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.738 0.304 . . . . 0.0 110.537 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 -57.58 -25.89 60.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.05 0.452 . . . . 0.0 110.508 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.427 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.77 -53.87 8.37 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.488 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.596 HD12 HG11 ' A' ' 50' ' ' VAL . 3.4 mt -68.83 -32.92 56.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.029 0.442 . . . . 0.0 111.112 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.59 -48.53 47.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.32 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -59.32 -25.24 64.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.369 . . . . 0.0 111.124 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -68.92 -50.3 50.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.678 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -76.36 165.44 24.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.835 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 -179.971 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 mtt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 120.994 0.426 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.94 154.07 23.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.1 -179.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -153.93 72.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.702 179.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.84 99.56 2.08 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.762 179.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.418 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.5 mm -119.41 112.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.655 0.264 . . . . 0.0 111.56 -179.205 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.85 HG11 ' HG ' ' A' ' 23' ' ' LEU . 8.6 p -106.31 118.04 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.291 178.438 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.785 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.4 m0 -111.92 123.8 51.02 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -117.27 136.19 55.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.301 -177.255 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.913 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -121.55 115.65 47.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.855 178.338 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.642 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 5.0 t70 -169.8 -152.62 0.1 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.113 -178.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.36 6.22 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 14' ' ' SER . 3.9 p30 47.05 -146.5 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t 35.49 -88.58 0.01 OUTLIER 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 12' ' ' ASP . 2.7 m -59.93 -54.48 45.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.68 0.276 . . . . 0.0 111.116 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.9 mm -62.75 -31.75 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.486 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.457 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 5.9 ttp180 -69.11 -48.96 61.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.564 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.638 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 14.9 t90 -61.63 -58.37 8.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.02 -179.24 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.529 ' CG1' HD11 ' A' ' 108' ' ' ILE . 1.4 t -55.62 -40.47 59.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.185 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.567 ' HA ' HD13 ' A' ' 108' ' ' ILE . 5.1 tp -84.32 -24.8 29.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -177.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.638 ' HG2' ' O ' ' A' ' 17' ' ' TRP . 19.7 pt-20 -67.63 -59.63 3.19 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.605 -178.702 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.758 ' H ' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -59.35 -65.28 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.138 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.47 -30.64 5.35 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.956 -179.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.85 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.8 tm? -78.89 -32.44 45.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.25 0.548 . . . . 0.0 110.276 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.22 73.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.198 178.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.16 -26.67 71.65 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.85 -15.39 59.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.865 0.364 . . . . 0.0 110.684 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.38 25.69 10.78 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.827 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -131.09 169.07 16.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.621 0.71 . . . . 0.0 111.697 179.771 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.6 m -96.93 116.24 28.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.658 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.591 ' HA ' HG12 ' A' ' 6' ' ' VAL . 51.5 t -110.24 114.61 28.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.395 0.616 . . . . 0.0 111.883 -179.428 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.785 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.0 t -125.26 155.61 39.86 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 66.9 p -129.08 164.86 22.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.259 0.552 . . . . 0.0 112.116 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.913 ' HB2' HG11 ' A' ' 9' ' ' VAL . 3.3 m-85 -136.43 174.57 10.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.799 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.575 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.1 pp20? -59.3 -55.68 31.73 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -177.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.692 ' C ' HG12 ' A' ' 9' ' ' VAL . 10.6 t-20 -153.15 -39.58 0.1 Allowed 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.451 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.573 ' N ' HG12 ' A' ' 9' ' ' VAL . . . 175.82 -51.06 0.12 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.4 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.555 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -56.65 -27.5 58.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.729 0.3 . . . . 0.0 110.768 -179.513 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.735 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -61.16 -55.28 34.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.692 179.031 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.613 HG21 ' CD1' ' A' ' 33' ' ' PHE . 67.3 t -52.46 -43.16 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.971 0.415 . . . . 0.0 111.138 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.637 HD13 ' CB ' ' A' ' 68' ' ' GLN . 14.2 mt -52.76 -43.22 65.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.401 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.59 -49.4 68.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.201 0.524 . . . . 0.0 110.621 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.67 -30.36 71.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.571 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.512 ' HG ' HG11 ' A' ' 39' ' ' VAL . 10.0 mt -61.91 -22.15 65.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.362 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.18 -15.1 59.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.35 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 t -120.77 -5.2 9.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.51 165.54 28.44 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.907 0.384 . . . . 0.0 111.517 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.7 m -138.27 115.75 9.28 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.331 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.51 ' HD2' HD21 ' A' ' 43' ' ' LEU . 59.7 Cg_endo -72.73 147.23 44.57 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.495 2.13 . . . . 0.0 111.914 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.71 -20.26 53.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.343 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.491 HG12 ' CG2' ' A' ' 6' ' ' VAL . 3.2 p -148.63 95.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.965 0.412 . . . . 0.0 110.168 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 7' ' ' TRP . 12.7 tp -86.74 151.75 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.293 -178.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.649 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 15.5 mt -135.97 116.17 13.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.596 179.04 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.736 ' HA ' HG22 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -105.77 141.01 37.93 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -177.226 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.642 ' OD2' ' HA ' ' A' ' 10' ' ' ASP . 9.8 t70 -70.85 -28.36 64.53 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.957 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.664 HG13 ' C ' ' A' ' 62' ' ' GLY . 2.7 tt 45.98 83.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.556 0.217 . . . . 0.0 111.459 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.04 96.4 0.27 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.604 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.6 OUTLIER 58.04 46.37 1.78 Allowed Pre-proline 0 N--CA 1.466 0.352 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 178.352 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.604 ' HD3' ' N ' ' A' ' 57' ' ' MET . 87.9 Cg_endo -90.36 -55.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.987 2.458 . . . . 0.0 111.927 178.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.93 -18.59 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.422 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.612 ' N ' ' HB3' ' A' ' 64' ' ' ALA . 10.2 tpt -158.75 71.54 0.55 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.18 0.514 . . . . 0.0 109.802 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.77 -31.27 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.9 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.664 ' C ' HG13 ' A' ' 55' ' ' ILE . . . 155.17 -34.07 0.66 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.823 -179.005 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 86' ' ' ASP . 5.4 mp -72.47 -25.87 61.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.89 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.612 ' HB3' ' N ' ' A' ' 60' ' ' MET . . . -53.78 -30.34 44.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.283 0.563 . . . . 0.0 109.72 178.495 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.54 HD12 ' HA3' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -47.94 -52.8 18.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.931 178.816 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.466 ' HG ' ' CB ' ' A' ' 93' ' ' ALA . 0.3 OUTLIER -58.27 -53.07 62.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.245 179.127 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.719 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -43.24 -38.34 2.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.383 179.728 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.637 ' CB ' HD13 ' A' ' 40' ' ' LEU . 18.9 mm100 -71.39 -38.07 71.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.166 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.6 mt -64.33 -36.35 76.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.962 -179.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.719 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -73.44 -29.85 62.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.979 -179.907 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.66 -41.32 99.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.835 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -97.3 -23.09 16.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.782 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.452 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 56.2 m-70 -146.33 85.24 7.47 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.844 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 73.3 Cg_endo -75.53 13.11 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.948 2.432 . . . . 0.0 113.018 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.7 mtt -134.33 -0.62 2.96 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.61 0.243 . . . . 0.0 111.172 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.6 tt -76.54 113.16 26.54 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.487 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -67.72 116.69 4.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.366 2.044 . . . . 0.0 111.81 178.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.549 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.1 t -115.47 151.22 17.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.539 0.685 . . . . 0.0 112.347 -178.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.649 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 1.1 mp -129.23 117.29 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.696 178.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.745 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 5.8 mm -93.52 133.15 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.594 -178.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.553 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.87 -1.88 49.19 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.488 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.517 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 2.4 m -148.0 158.92 44.31 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.091 -0.381 . . . . 0.0 110.069 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -163.19 57.59 0.19 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.866 0.365 . . . . 0.0 111.813 179.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.404 ' HD2' HG23 ' A' ' 82' ' ' THR . 33.3 p80 -98.99 -20.39 16.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.695 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.421 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -84.48 -168.46 2.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.175 0.512 . . . . 0.0 112.339 -178.76 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.487 ' O ' HD22 ' A' ' 63' ' ' LEU . 4.5 m-20 -52.56 89.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.93 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.722 HD11 ' HB1' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -46.64 -22.96 0.34 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.555 179.042 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.98 -44.91 30.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.415 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.82 -19.93 66.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.886 0.374 . . . . 0.0 111.363 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.722 ' HB1' HD11 ' A' ' 87' ' ' LEU . . . -75.78 -28.59 58.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.634 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.533 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.5 t -59.19 -38.84 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.536 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.6 m -65.35 -21.75 66.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.644 178.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.562 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -66.65 -47.65 71.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.857 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.533 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.4 m-85 -62.4 -24.32 67.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.076 179.34 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -42.17 59.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.261 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.562 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 2.3 pp0? -77.73 -11.02 59.84 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.068 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.85 15.34 10.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.93 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.549 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -56.84 138.87 52.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.75 0.275 . . . . 0.0 110.499 179.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.427 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 17.1 t80 -69.14 -52.78 24.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.688 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.5 -161.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.745 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 6.6 m-85 -132.09 118.92 20.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.452 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.632 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 5.1 tp -102.44 140.89 21.53 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.332 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.689 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 22.1 Cg_endo -59.06 168.7 4.28 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.098 1.865 . . . . 0.0 111.047 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.592 ' O ' ' HE3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -41.79 -43.35 6.34 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.329 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.689 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 80.4 Cg_exo -47.05 163.02 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.345 1.363 . . . . 0.0 110.317 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.705 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 2.9 t80 -166.44 -91.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.461 -177.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.543 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.7 p-10 43.42 -176.31 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 120.854 0.359 . . . . 0.0 110.442 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.567 HD13 ' HA ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.96 -45.23 84.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.303 0.573 . . . . 0.0 111.072 -179.837 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.741 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.6 t0 -52.15 -57.25 10.17 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.879 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.705 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.2 mm-40 -78.84 -29.34 44.57 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.2 -51.87 6.69 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.124 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 115' ' ' VAL . 42.0 t -59.58 -32.3 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 121.589 0.709 . . . . 0.0 110.085 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.27 -50.94 71.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.362 178.386 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.632 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 12.5 tp -79.01 -20.5 48.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.56 -178.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 112' ' ' VAL . 5.4 p -74.94 -51.8 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.012 -179.182 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.462 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 84.3 mt-10 -68.31 -37.87 81.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.877 0.37 . . . . 0.0 110.901 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -63.1 -23.99 67.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.457 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.427 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.94 -54.82 8.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.24 -30.71 50.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.111 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 m -66.96 -46.75 73.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -57.79 -26.55 62.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.163 -179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -78.47 -57.48 3.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.969 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -75.62 -173.91 2.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.854 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mtp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.827 0.346 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.26 155.93 44.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.666 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -16.68 48.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.12 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.5 92.33 0.67 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.005 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.1 mp -111.08 112.99 42.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.962 0.41 . . . . 0.0 111.113 -179.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 5.8 p -108.15 128.94 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.715 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.941 ' CD1' HG21 ' A' ' 31' ' ' THR . 36.0 m0 -115.93 144.38 44.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.573 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.4 t -134.9 147.82 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.109 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -134.55 105.1 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.608 177.679 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.585 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 57.1 t0 166.85 123.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.804 0.335 . . . . 0.0 111.336 179.144 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.452 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER 69.49 -21.78 0.16 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 178.849 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 10' ' ' ASP . 14.7 t70 70.56 -130.44 0.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 O-C-N 122.41 -0.181 . . . . 0.0 111.19 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 t -37.27 -45.36 0.65 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.044 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.94 -64.19 0.91 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.168 -179.639 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 32.1 mm -68.31 -20.63 25.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.556 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 0.0 OUTLIER -68.84 -55.46 11.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.427 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -54.58 -43.96 72.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.795 0.331 . . . . 0.0 111.651 -179.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.629 ' CG1' HD12 ' A' ' 108' ' ' ILE . 1.4 t -68.46 -46.88 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.679 ' HA ' HD11 ' A' ' 108' ' ' ILE . 3.9 mm? -81.67 -23.85 36.64 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.637 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 14.0 pt-20 -67.66 -60.36 2.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.814 -179.151 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.6 mmt180 -63.92 -59.34 4.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.137 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.09 -54.24 21.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 111.932 -179.15 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.716 HD12 ' CD1' ' A' ' 28' ' ' LEU . 2.7 tp -65.26 -22.7 66.89 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.282 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -68.21 -36.79 80.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.25 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.26 -26.34 63.74 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.338 178.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.429 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -77.69 -15.47 59.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.703 0.287 . . . . 0.0 111.111 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.96 26.15 9.9 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.673 178.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.716 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -124.51 169.45 11.87 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.442 0.621 . . . . 0.0 111.224 179.53 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.2 m -104.17 106.46 16.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.166 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 11.4 t -101.76 115.06 29.69 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.058 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.941 HG21 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -118.94 156.63 29.22 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 18.3 p -129.84 162.79 27.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.658 0.742 . . . . 0.0 112.761 -179.283 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.809 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 20.0 m-85 -135.95 173.55 11.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.966 -179.078 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.632 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.5 pp20? -57.63 -59.52 5.07 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -177.319 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.61 ' C ' HG11 ' A' ' 9' ' ' VAL . 71.6 m-20 -152.54 -29.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.399 0.545 . . . . 0.0 112.466 -179.274 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.445 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 172.27 -59.19 0.16 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.892 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.514 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -48.1 -31.35 5.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.852 0.358 . . . . 0.0 110.662 -179.701 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.809 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -60.87 -56.41 21.48 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.491 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.621 HG21 HG21 ' A' ' 9' ' ' VAL . 5.0 t -53.86 -42.67 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.754 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 37' ' ' ASN . 14.3 mt -53.95 -43.71 70.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.72 -50.67 68.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.55 68.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.51 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 9.0 mt -65.85 -25.15 67.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.062 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.45 -19.28 61.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.337 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 t -119.32 -1.78 10.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.903 -179.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -163.16 158.71 22.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.997 0.427 . . . . 0.0 111.1 -179.849 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.5 m -139.09 112.26 8.05 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.406 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.512 ' HD2' HD13 ' A' ' 76' ' ' LEU . 57.9 Cg_endo -71.36 164.35 36.03 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.921 1.747 . . . . 0.0 111.281 179.209 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.64 -24.1 58.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.907 0.384 . . . . 0.0 110.581 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.585 ' CG2' HD12 ' A' ' 79' ' ' ILE . 7.3 p -145.22 161.88 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.626 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 51' ' ' LEU . 30.8 tp -152.83 155.88 37.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.214 0.53 . . . . 0.0 112.251 -178.605 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.82 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -138.01 121.08 16.73 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.831 -179.801 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.585 ' HA ' HG22 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -105.73 138.96 41.04 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.873 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 53.0 t0 -69.76 -19.3 63.53 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.995 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.579 ' HB ' ' CG2' ' A' ' 80' ' ' ILE . 5.2 tt 46.16 73.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.224 0.535 . . . . 0.0 111.604 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.17 75.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.489 179.754 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.463 ' HG3' ' HB2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -163.13 -61.16 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.623 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.701 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 59.7 Cg_endo -70.38 -169.32 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.524 2.149 . . . . 0.0 113.656 -178.549 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.71 -58.29 15.36 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.51 179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.495 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -73.72 51.79 0.38 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.145 0.497 . . . . 0.0 110.274 179.475 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.19 -80.11 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.329 -179.297 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.522 ' HA3' ' CA ' ' A' ' 55' ' ' ILE . . . -143.54 -31.98 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.368 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.554 HD13 ' H ' ' A' ' 63' ' ' LEU . 3.8 mp -53.76 -24.11 14.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.29 -33.93 74.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.263 178.621 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.701 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 16.0 mt -60.41 -32.53 71.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.74 179.463 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.6 ' HA ' HD13 ' A' ' 69' ' ' ILE . 5.8 mp -67.22 -42.55 83.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.379 179.558 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.588 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 5.2 mttt -54.21 -41.47 68.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.657 178.742 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.422 ' CB ' HD11 ' A' ' 40' ' ' LEU . 80.2 mm-40 -63.28 -43.16 98.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.6 HD13 ' HA ' ' A' ' 66' ' ' LEU . 5.6 mt -66.47 -36.26 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.701 -178.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.588 ' HG2' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -73.66 -28.46 61.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.934 0.397 . . . . 0.0 110.92 179.853 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.431 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -72.94 -34.78 66.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.987 -179.823 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -93.48 -59.25 2.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.261 179.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.411 ' C ' ' H ' ' A' ' 75' ' ' MET . 68.4 m-70 -111.83 85.15 6.03 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.355 179.463 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 56.2 Cg_endo -71.17 20.18 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.725 2.283 . . . . 0.0 113.282 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 29.1 mtm -144.15 0.93 1.08 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.512 HD13 ' HD2' ' A' ' 48' ' ' PRO . 15.1 tp -76.17 114.87 41.72 Favored Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 179.8 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.31 120.64 8.16 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.471 2.114 . . . . 0.0 111.882 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.49 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -115.47 149.29 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.255 0.55 . . . . 0.0 111.885 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 3.6 mt -132.73 114.51 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.534 178.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.654 HG21 ' O ' ' A' ' 82' ' ' THR . 11.4 mm -93.78 138.28 20.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.19 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.594 ' HB3' ' HD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.15 -9.34 57.98 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.25 -179.338 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.654 ' O ' HG21 ' A' ' 80' ' ' ILE . 3.7 m -147.44 168.6 21.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.714 0.292 . . . . 0.0 110.671 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 84' ' ' HIS . . . -143.22 -18.89 0.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 179.646 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.525 ' CE1' ' CD1' ' A' ' 55' ' ' ILE . 0.2 OUTLIER 23.14 -98.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.247 0.619 . . . . 0.0 112.372 -179.677 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 m -129.29 -176.91 4.03 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.92 0.391 . . . . 0.0 111.245 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.45 ' O ' HD21 ' A' ' 63' ' ' LEU . 5.6 t70 61.64 31.49 18.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.113 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' A' ' 90' ' ' ALA . 4.5 mt -49.61 -21.64 1.07 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.768 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.92 -38.73 17.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.129 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.538 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -74.3 -20.39 60.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.123 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.556 ' HB1' ' CE1' ' A' ' 101' ' ' TYR . . . -71.08 -27.53 63.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.962 0.41 . . . . 0.0 110.109 178.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.564 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.4 t -69.08 -41.53 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.09 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.2 m -61.93 -26.46 68.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.054 0.454 . . . . 0.0 110.026 179.134 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.475 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -63.9 -46.01 86.75 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.929 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.564 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 10.2 m-85 -59.96 -23.78 63.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.555 179.199 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -36.97 65.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.984 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -82.87 -3.5 56.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.733 -179.901 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.85 18.02 13.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.129 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.49 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -61.21 145.1 52.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.965 0.383 . . . . 0.0 110.164 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.529 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 36.9 t80 -72.87 -53.69 10.72 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.776 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.444 ' OD2' ' CD2' ' A' ' 99' ' ' PHE . 12.9 p30 172.61 -167.45 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.821 0.344 . . . . 0.0 111.287 -179.283 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.617 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.3 m-85 -125.6 117.44 23.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.064 0.459 . . . . 0.0 110.736 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.449 ' O ' ' C ' ' A' ' 81' ' ' MET . 7.3 tp -103.01 134.16 19.94 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.577 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.514 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 19.3 Cg_endo -57.71 177.51 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.385 2.057 . . . . 0.0 111.562 179.264 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.611 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -40.02 -51.41 5.76 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.182 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 7.1 Cg_endo -48.13 163.88 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.304 2.003 . . . . 0.0 111.532 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.622 ' HA ' ' CG ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 173.92 -88.7 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.132 -179.609 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.622 ' O ' ' CB ' ' A' ' 111' ' ' ALA . 2.7 p30 47.77 -177.21 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.679 HD11 ' HA ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -64.67 -49.03 82.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 C-N-CA 119.714 -0.795 . . . . 0.0 112.344 -178.727 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.411 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 0.9 OUTLIER -53.89 -55.25 28.57 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.175 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.622 ' CG ' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.72 -28.16 24.82 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.704 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.622 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -82.81 -47.41 11.92 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.612 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.636 HG23 HG21 ' A' ' 108' ' ' ILE . 45.3 t -64.3 -32.9 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.474 0.654 . . . . 0.0 109.507 178.262 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.97 -47.95 81.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.172 178.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.475 ' CD2' HG22 ' A' ' 79' ' ' ILE . 6.3 tp -78.91 -22.39 45.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.981 -179.313 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 112' ' ' VAL . 2.3 p -79.37 -49.92 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.822 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.445 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 24.8 mt-10 -55.88 -48.46 75.54 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.626 0.25 . . . . 0.0 111.373 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -61.42 -23.25 65.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.867 0.365 . . . . 0.0 110.82 179.729 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.529 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.53 -48.2 42.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.92 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.2 mt -72.43 -30.76 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.198 0.523 . . . . 0.0 110.523 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 t -69.77 -45.12 68.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.013 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.69 -25.31 68.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -75.3 -56.21 4.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 -179.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -76.52 -173.63 2.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.818 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.711 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.454 -0.131 0 N-CA-C 112.658 -0.177 . . . . 0.0 112.658 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.801 HG21 ' NZ ' ' A' ' 46' ' ' LYS . 4.2 mm -116.74 112.51 39.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.597 0.237 . . . . 0.0 111.393 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.931 HG11 ' CD2' ' A' ' 23' ' ' LEU . 4.8 p -107.27 117.31 52.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.46 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.833 ' CD1' HG22 ' A' ' 31' ' ' THR . 34.3 m0 -108.03 137.96 45.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 0.0 111.109 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.5 t -124.2 141.92 42.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -128.03 114.1 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.743 177.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.594 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.2 t0 -171.63 -152.02 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.55 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -66.33 -2.44 4.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.6 OUTLIER 59.01 -148.04 0.48 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 121.201 -0.2 . . . . 0.0 111.299 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 t 34.58 -89.41 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.807 ' O ' HG23 ' A' ' 18' ' ' VAL . 61.6 m -55.65 -55.16 35.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.873 0.368 . . . . 0.0 110.971 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.5 mm -63.58 -34.73 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.112 0.482 . . . . 0.0 111.073 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.713 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.7 OUTLIER -69.39 -53.79 17.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.944 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.444 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 85.6 t90 -52.52 -45.11 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 14' ' ' SER . 1.4 t -67.94 -57.96 7.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.219 0.533 . . . . 0.0 111.424 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.666 ' HA ' HD11 ' A' ' 108' ' ' ILE . 3.6 mm? -67.04 -27.71 67.62 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 15.8 pt-20 -67.55 -59.89 3.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.558 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.5 mmt180 -75.66 -52.38 10.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.551 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -54.15 -54.04 45.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.811 0.339 . . . . 0.0 111.853 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.931 ' CD2' HG11 ' A' ' 6' ' ' VAL . 5.2 tp -64.3 -25.93 68.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.198 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -68.32 -33.31 74.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.99 -22.77 74.26 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.385 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.602 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.99 -15.59 59.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 110.84 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.73 21.99 8.33 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.64 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.717 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.85 170.84 11.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.397 0.599 . . . . 0.0 111.35 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.1 m -105.11 106.51 17.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.917 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 8.5 t -105.83 114.47 28.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.391 0.615 . . . . 0.0 112.188 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.833 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -122.66 156.78 33.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.576 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.713 HG21 ' HA ' ' A' ' 16' ' ' ARG . 33.9 p -127.81 156.63 42.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.451 0.643 . . . . 0.0 112.234 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.904 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -128.47 174.12 9.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.242 -179.391 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.502 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -57.61 -52.33 65.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -160.21 -37.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.658 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . 178.43 -55.82 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.498 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.421 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 55.5 m-80 -56.97 -26.9 60.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 110.689 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -63.91 -48.51 76.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.527 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.731 HG21 HG22 ' A' ' 9' ' ' VAL . 13.5 t -58.99 -32.78 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.447 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.73 HD11 ' OE1' ' A' ' 68' ' ' GLN . 32.7 mt -56.21 -47.56 78.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.335 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.99 -47.95 76.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.339 0.59 . . . . 0.0 110.258 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.15 -32.67 72.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.698 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.645 ' HG ' HG12 ' A' ' 39' ' ' VAL . 15.6 mt -67.47 -27.65 67.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.054 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.34 -15.87 40.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.492 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 m -123.22 -5.51 8.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.82 ' HG3' ' N ' ' A' ' 47' ' ' THR . 1.3 tttt -155.55 166.57 33.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.309 0.576 . . . . 0.0 111.615 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.82 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 96.7 m -138.29 112.75 8.7 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.796 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.559 ' HG2' HD11 ' A' ' 76' ' ' LEU . 56.5 Cg_endo -71.44 158.1 54.9 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.465 2.11 . . . . 0.0 111.657 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.94 -30.59 50.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.78 0.324 . . . . 0.0 111.037 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.029 HG21 HG23 ' A' ' 115' ' ' VAL . 5.9 p -145.26 94.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.446 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.623 HD22 HD21 ' A' ' 76' ' ' LEU . 38.2 tp -83.21 141.26 32.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.432 0.634 . . . . 0.0 112.209 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.931 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -124.33 119.62 29.81 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.588 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.701 ' HA ' HG23 ' A' ' 9' ' ' VAL . 1.4 m -115.28 148.08 39.63 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 28.1 t0 -82.87 -178.0 6.95 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.348 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.69 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.1 tt -160.0 74.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 121.137 0.494 . . . . 0.0 112.095 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 177.05 58.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.646 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.529 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.33 -63.03 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.908 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.529 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 23.0 Cg_endo -60.22 -165.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.669 2.246 . . . . 0.0 113.356 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.03 -65.06 3.32 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.69 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.941 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -85.19 53.18 2.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.995 0.426 . . . . 0.0 110.94 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.465 ' HB3' HG13 ' A' ' 55' ' ' ILE . 1.2 m-20 55.74 -68.45 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.681 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -152.16 -35.62 0.03 OUTLIER Glycine 0 CA--C 1.507 -0.44 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.271 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.832 HD22 ' O ' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -53.64 -28.24 31.75 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.941 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -61.2 -34.42 75.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.658 HD22 ' HA3' ' A' ' 36' ' ' GLY . 74.1 mt -59.98 -35.99 76.19 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.672 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.756 ' HA ' HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -61.83 -51.06 69.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.433 178.818 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.691 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 11.9 tttp -47.36 -44.93 24.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.082 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.73 ' OE1' HD11 ' A' ' 40' ' ' LEU . 2.5 mt-30 -60.76 -43.18 98.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.202 0.525 . . . . 0.0 110.174 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.832 HD13 HG21 ' A' ' 78' ' ' VAL . 10.6 mt -64.98 -37.94 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.06 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.691 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -77.21 -23.48 51.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.541 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -67.17 -43.41 82.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.126 0.488 . . . . 0.0 111.233 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.83 -26.55 13.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.176 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.524 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 59.3 m-70 -130.25 76.23 78.11 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.751 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.576 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 73.5 Cg_endo -75.21 40.22 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.616 2.21 . . . . 0.0 112.236 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 59.1 mtt -153.97 -39.19 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.722 HD13 HG23 ' A' ' 47' ' ' THR . 16.8 tp -55.01 112.31 3.96 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.916 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.634 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 59.4 Cg_endo -73.41 141.21 31.38 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.934 1.756 . . . . 0.0 111.985 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.832 HG21 HD13 ' A' ' 69' ' ' ILE . 2.3 t -128.93 151.58 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.335 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.574 HD12 ' HG ' ' A' ' 52' ' ' LEU . 1.5 mt -120.93 118.54 56.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.991 0.424 . . . . 0.0 111.135 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.737 HD11 HD23 ' A' ' 66' ' ' LEU . 16.3 mm -95.01 142.68 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.509 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.464 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -82.31 -16.83 47.94 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.104 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.619 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.6 m -148.14 144.54 27.86 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.906 -0.717 . . . . 0.0 111.989 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.826 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -129.68 40.44 3.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.839 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.51 -12.07 41.08 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.44 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -92.98 -164.14 1.14 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.641 0.258 . . . . 0.0 110.613 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.832 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -53.84 93.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.758 0.314 . . . . 0.0 111.334 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.436 ' HA ' ' CD2' ' A' ' 63' ' ' LEU . 1.7 mt -59.52 -21.89 60.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.741 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.0 -43.47 29.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.333 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.625 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -68.95 -23.15 64.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.688 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.757 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -67.86 -23.01 65.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.754 0.311 . . . . 0.0 110.273 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.643 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.4 t -69.03 -41.95 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.464 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.608 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 91.3 p -60.45 -18.2 49.6 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.751 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.72 -53.91 7.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.431 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.643 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.2 m-85 -58.75 -31.43 68.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.064 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.608 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -75.88 -34.62 60.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.816 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.751 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 3.1 pp0? -80.75 -18.26 48.31 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.607 0.241 . . . . 0.0 110.82 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.27 32.56 2.33 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.207 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.661 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -65.01 169.82 4.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.238 0.519 . . . . 0.0 110.998 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.634 ' HD1' ' HB2' ' A' ' 77' ' ' PRO . 0.1 OUTLIER -85.55 -55.24 4.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.727 0.298 . . . . 0.0 110.941 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 99' ' ' PHE . 0.1 OUTLIER 164.77 -162.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.884 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.826 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.1 m-85 -132.86 112.49 11.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.127 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.648 HD22 ' CE1' ' A' ' 106' ' ' PHE . 4.8 tp -102.96 142.97 25.66 Favored Pre-proline 0 C--O 1.226 -0.169 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.275 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.742 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 19.3 Cg_endo -56.66 170.6 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.344 2.029 . . . . 0.0 111.196 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -44.5 -47.24 26.47 Favored Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.624 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.742 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 75.1 Cg_exo -47.99 162.01 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.376 1.384 . . . . 0.0 110.288 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.791 ' HD1' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -176.65 -83.98 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.291 -178.572 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.4 p30 41.93 -168.56 0.0 OUTLIER 'General case' 0 C--O 1.231 0.113 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.691 HD13 HG12 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -67.66 -51.5 50.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 121.243 0.544 . . . . 0.0 111.421 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.613 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.9 t70 -48.96 -57.42 6.52 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.433 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.3 mm-40 -77.02 -31.19 56.21 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.791 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.34 -53.7 5.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.175 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.739 ' HA ' HG12 ' A' ' 115' ' ' VAL . 42.0 t -56.53 -32.41 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.428 0.632 . . . . 0.0 110.158 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -58.63 -52.72 64.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.821 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.505 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.9 tp -71.81 -25.69 62.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.816 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 1.029 HG23 HG21 ' A' ' 50' ' ' VAL . 10.0 p -79.24 -54.18 12.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.538 ' N ' HG13 ' A' ' 115' ' ' VAL . 1.8 mt-10 -57.57 -62.47 1.77 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.735 0.303 . . . . 0.0 111.515 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 117' ' ' ARG . 0.4 OUTLIER -53.32 -28.65 29.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.287 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.597 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.91 -49.28 20.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.871 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.914 HD11 HG22 ' A' ' 115' ' ' VAL . 5.6 mt -64.58 -31.42 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.125 0.488 . . . . 0.0 110.482 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.8 t -64.95 -33.9 77.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.748 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.7 m80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.762 179.696 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.767 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.767 HD13 ' C ' ' A' ' 4' ' ' GLY . 2.8 mm -114.18 112.54 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 111.28 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.949 HG11 ' CD2' ' A' ' 23' ' ' LEU . 8.4 p -113.66 125.48 70.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.325 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.966 ' CD1' HG22 ' A' ' 31' ' ' THR . 35.5 m0 -115.38 139.08 50.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.626 0.251 . . . . 0.0 110.823 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -132.31 138.29 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.043 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -128.11 107.22 15.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.668 178.569 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 48.6 t0 166.85 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.239 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.487 ' HB3' HG12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 71.06 -41.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.484 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 16' ' ' ARG . 38.8 t70 74.62 -106.3 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.971 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 12' ' ' ASP . 52.2 p -23.57 -84.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.734 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.9 m -53.46 -45.42 69.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.487 HG12 ' HB3' ' A' ' 11' ' ' ASP . 27.1 mm -67.94 -20.48 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.822 0.344 . . . . 0.0 111.741 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.638 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.7 ttt180 -79.2 -54.92 5.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 111.689 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.447 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 65.0 t90 -52.37 -42.75 64.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.489 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 14' ' ' SER . 1.7 t -71.38 -51.18 35.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.038 0.447 . . . . 0.0 111.92 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.613 HD22 ' CD1' ' A' ' 108' ' ' ILE . 4.4 mm? -70.82 -28.66 64.78 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.466 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.694 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 23.6 pt-20 -67.59 -58.96 3.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.491 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.4 mmt180 -63.15 -58.01 8.65 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.07 -55.43 27.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.987 0.423 . . . . 0.0 111.474 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.949 ' CD2' HG11 ' A' ' 6' ' ' VAL . 14.3 tp -66.62 -19.71 65.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.467 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.6 -33.34 70.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.53 -26.6 68.45 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.235 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.546 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.87 -15.63 59.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.629 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.77 25.65 9.66 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.781 -0.723 . . . . 0.0 114.795 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.803 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -120.0 164.74 15.65 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.61 1.205 . . . . 0.0 112.313 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.0 m -94.57 111.26 23.02 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.257 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 1.1 m -102.35 118.95 37.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.293 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.966 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -128.88 136.1 49.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.675 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 55.2 p -113.99 157.62 22.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.043 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.8 m-85 -134.8 173.8 11.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.904 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.602 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.9 pp20? -61.3 -58.06 9.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -156.3 -23.05 0.1 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.725 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 165.12 -59.32 0.25 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.717 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.544 ' N ' HD22 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -47.37 -32.91 5.31 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.148 0.499 . . . . 0.0 110.704 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.771 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -60.95 -60.89 3.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.613 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.84 HG21 ' CG2' ' A' ' 9' ' ' VAL . 1.9 t -53.86 -34.65 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.329 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.717 HD13 ' HB2' ' A' ' 68' ' ' GLN . 32.0 mt -48.81 -52.34 24.59 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.054 0.454 . . . . 0.0 110.406 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -47.97 83.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.108 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.59 -35.16 80.09 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.771 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.872 HD13 ' HD2' ' A' ' 73' ' ' HIS . 23.2 mt -68.32 -19.93 64.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.612 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.18 -11.98 58.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.296 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.29 -3.79 7.4 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -155.49 161.45 40.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.986 0.422 . . . . 0.0 111.31 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.43 HG23 ' CG ' ' A' ' 76' ' ' LEU . 21.1 m -138.47 112.37 8.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.952 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.649 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 73.9 Cg_endo -74.6 164.91 32.78 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.12 1.88 . . . . 0.0 111.822 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.43 -24.03 34.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.997 0.427 . . . . 0.0 110.472 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.851 HG11 ' CG2' ' A' ' 115' ' ' VAL . 7.5 p -149.97 91.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.491 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.669 HD23 HG22 ' A' ' 78' ' ' VAL . 57.9 tp -84.25 149.73 25.91 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.242 0.544 . . . . 0.0 111.906 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.873 HD22 ' CE2' ' A' ' 106' ' ' PHE . 5.3 mt -133.73 114.06 13.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.052 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.666 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -109.18 144.02 37.83 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.487 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 9.7 t0 -73.34 -171.9 1.05 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.756 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.727 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 8.6 tt -169.96 84.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 120.878 0.371 . . . . 0.0 111.703 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 167.9 59.87 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.171 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -161.0 -63.06 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.095 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.46 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 22.5 Cg_endo -59.47 -173.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.765 2.31 . . . . 0.0 113.471 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.98 -66.67 2.67 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.58 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.671 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 2.3 ttm -72.15 57.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.038 0.447 . . . . 0.0 110.367 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.91 -79.09 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.186 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.727 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -146.53 -28.69 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.866 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.735 HD13 ' HB3' ' A' ' 86' ' ' ASP . 3.7 mp -63.16 -19.19 64.25 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.916 0.358 . . . . 0.0 110.703 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.671 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -53.57 -22.76 9.04 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.083 0.468 . . . . 0.0 110.863 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.725 HD13 ' HA3' ' A' ' 36' ' ' GLY . 5.8 mt -69.62 -40.79 76.38 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.317 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.729 HD23 ' CB ' ' A' ' 93' ' ' ALA . 6.6 mp -56.61 -41.23 76.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.419 0.628 . . . . 0.0 109.938 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -53.75 -53.13 56.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.07 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.717 ' HB2' HD13 ' A' ' 40' ' ' LEU . 10.8 mm-40 -69.18 -29.34 67.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.182 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.019 HG23 ' NE2' ' A' ' 73' ' ' HIS . 1.5 mm -52.87 -52.75 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.136 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -68.68 -31.03 69.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.283 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -78.99 -23.34 44.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.692 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -85.95 -73.27 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.07 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 1.019 ' NE2' HG23 ' A' ' 69' ' ' ILE . 11.2 p80 -89.35 167.26 18.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.211 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.63 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 89.0 Cg_endo -78.29 72.27 6.36 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.782 2.322 . . . . 0.0 112.912 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.632 ' HB2' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER 54.09 34.37 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.403 179.114 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 77' ' ' PRO . 0.1 OUTLIER -63.1 121.04 66.71 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.712 ' N ' HD22 ' A' ' 76' ' ' LEU . 10.7 Cg_endo -53.58 132.31 48.28 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.846 2.364 . . . . 0.0 113.19 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.669 HG22 HD23 ' A' ' 51' ' ' LEU . 2.9 t -123.41 154.29 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.541 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.794 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.6 mt -131.56 117.17 34.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.212 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 53' ' ' SER . 11.5 mm -93.57 150.45 3.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.624 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.554 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -87.02 -19.43 28.68 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.696 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.67 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.7 m -147.03 171.0 15.95 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.656 0.265 . . . . 0.0 110.996 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.5 ' H ' HG22 ' A' ' 82' ' ' THR . . . -122.34 -20.99 5.95 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.729 0.3 . . . . 0.0 111.459 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.416 ' H ' HG22 ' A' ' 82' ' ' THR . 4.2 m-70 45.07 29.71 0.52 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 73.3 m 67.92 -3.99 1.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.735 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -92.5 39.19 1.02 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.045 0.45 . . . . 0.0 110.301 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.739 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -48.44 -21.05 0.48 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.292 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -47.49 -57.65 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.445 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.64 -24.52 67.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.567 0.222 . . . . 0.0 111.537 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.739 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.69 -33.21 73.58 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.666 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.1 t -62.99 -45.37 99.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.607 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 91.7 p -60.3 -34.1 73.3 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.426 0.632 . . . . 0.0 109.89 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.729 ' CB ' HD23 ' A' ' 66' ' ' LEU . . . -59.72 -41.39 90.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.48 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.666 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.8 m-85 -61.91 -21.57 64.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.065 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.632 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.78 -43.41 72.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.503 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.632 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 6.8 pm0 -82.13 -19.12 40.69 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.12 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.63 38.95 0.64 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.662 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.693 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -63.57 154.25 33.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.145 0.472 . . . . 0.0 110.237 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.718 ' CZ ' ' HB1' ' A' ' 118' ' ' ALA . 2.2 t80 -79.79 -53.58 6.65 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.71 -162.68 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.769 0.319 . . . . 0.0 111.065 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.582 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.0 m-85 -142.63 139.36 31.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.172 0.511 . . . . 0.0 111.132 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 2.1 tp -101.92 140.8 21.5 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.489 ' O ' HG23 ' A' ' 82' ' ' THR . 35.4 Cg_exo -61.42 -34.54 86.28 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.077 1.851 . . . . 0.0 111.962 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.676 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER 167.54 -50.63 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.245 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.7 Cg_endo -47.85 163.79 0.19 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.008 1.805 . . . . 0.0 109.94 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.873 ' CE2' HD22 ' A' ' 52' ' ' LEU . 26.7 t80 -168.46 -92.13 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.329 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 3.7 p30 41.78 -171.24 0.0 OUTLIER 'General case' 0 C--N 1.335 -0.063 0 CA-C-O 120.961 0.41 . . . . 0.0 111.117 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.896 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -68.11 -49.98 62.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 7.9 m-20 -51.11 -57.11 9.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.819 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -76.31 -30.54 57.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.508 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . . . -83.61 -56.97 3.43 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.021 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.896 HG21 HG23 ' A' ' 108' ' ' ILE . 43.3 t -54.43 -30.38 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.459 0.647 . . . . 0.0 109.987 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.07 -54.6 44.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.574 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.794 ' CD2' HG21 ' A' ' 79' ' ' ILE . 6.7 tp -71.4 -22.37 61.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.522 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.851 ' CG2' HG11 ' A' ' 50' ' ' VAL . 4.3 p -79.45 -50.34 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.936 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.471 ' N ' HG13 ' A' ' 115' ' ' VAL . 23.0 mt-10 -62.73 -46.7 86.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.01 0.433 . . . . 0.0 109.908 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -64.91 -25.71 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.176 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.718 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -69.67 -53.41 18.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.093 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.5 mt -66.13 -31.38 53.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.096 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.5 p -70.26 -43.69 69.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.13 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.3 m80 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 -179.848 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.211 -0.355 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.78 112.33 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.686 0.279 . . . . 0.0 111.355 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.975 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.1 p -107.2 125.65 63.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.79 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.91 ' CD1' HG22 ' A' ' 31' ' ' THR . 33.1 m0 -112.82 145.24 40.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.038 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.693 ' HB ' HG22 ' A' ' 32' ' ' THR . 0.5 OUTLIER -139.09 137.21 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.138 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.998 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -126.35 105.14 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.483 178.099 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.581 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 60.8 t0 166.81 118.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.887 0.375 . . . . 0.0 111.243 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.469 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.6 OUTLIER 72.26 -21.59 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.118 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 10' ' ' ASP . 8.5 t0 70.47 -135.31 0.05 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.579 -0.076 . . . . 0.0 110.849 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.4 m -33.55 -45.41 0.17 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.3 m -53.38 -67.57 0.24 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.948 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.542 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 25.1 mm -65.84 -20.6 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.453 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.62 ' HA ' HG21 ' A' ' 32' ' ' THR . 12.5 ttt-85 -72.39 -61.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.401 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.496 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 71.4 t90 -48.31 -44.28 33.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.175 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.945 HG12 HD13 ' A' ' 108' ' ' ILE . 1.9 t -64.82 -62.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.919 0.39 . . . . 0.0 111.859 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.569 ' HA ' HD11 ' A' ' 108' ' ' ILE . 7.4 tp -71.51 -19.45 62.18 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 13.8 pt-20 -67.96 -57.71 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.687 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.564 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.28 -56.62 11.69 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.993 -179.022 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.8 -56.34 16.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 0.0 111.441 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.975 ' CD2' HG11 ' A' ' 6' ' ' VAL . 13.5 tp -64.42 -19.75 65.72 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.33 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.12 -37.66 75.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.6 -25.01 62.7 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.197 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.39 -15.9 59.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.74 0.305 . . . . 0.0 110.768 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.75 26.18 9.28 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.748 -0.739 . . . . 0.0 114.714 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.699 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -122.41 166.14 15.21 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.478 1.139 . . . . 0.0 112.121 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.5 m -94.98 114.96 26.84 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.34 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -105.17 109.17 21.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.985 -178.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.91 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -121.8 137.58 54.71 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.693 HG22 ' HB ' ' A' ' 8' ' ' VAL . 74.5 p -117.34 160.83 20.5 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.998 ' HB2' HG13 ' A' ' 9' ' ' VAL . 7.6 m-85 -136.03 174.52 10.52 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.077 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.659 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.5 pp20? -60.88 -63.29 1.35 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.538 ' N ' HG12 ' A' ' 9' ' ' VAL . 27.1 m120 -153.89 -22.74 0.14 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.856 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 172.41 -63.42 0.14 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.862 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.484 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -48.31 -29.38 3.83 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.875 0.369 . . . . 0.0 111.043 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.86 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -63.25 -58.1 8.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.127 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.749 HG21 ' CG2' ' A' ' 9' ' ' VAL . 20.4 t -49.08 -46.27 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.195 0.521 . . . . 0.0 110.899 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.585 HD22 ' CD1' ' A' ' 69' ' ' ILE . 2.1 mt -49.9 -44.86 50.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.003 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.41 81.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.309 0.576 . . . . 0.0 110.937 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.56 -31.55 67.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.217 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.664 ' CD1' HG12 ' A' ' 39' ' ' VAL . 9.6 mt -65.67 -27.51 68.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.93 -20.08 21.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.608 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.9 t -126.76 1.92 6.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.818 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.497 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -153.99 159.79 41.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 111.049 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 1.051 HG23 HD23 ' A' ' 76' ' ' LEU . 96.3 m -138.67 112.75 8.43 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.238 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.722 ' HD2' HD21 ' A' ' 76' ' ' LEU . 93.9 Cg_endo -77.12 152.52 31.33 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.04 1.827 . . . . 0.0 111.751 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -74.57 -29.12 61.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.816 0.341 . . . . 0.0 110.692 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.68 HG13 HG23 ' A' ' 6' ' ' VAL . 7.5 p -145.32 94.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.484 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.817 HD23 HG22 ' A' ' 78' ' ' VAL . 63.2 tp -86.95 150.92 23.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.473 0.654 . . . . 0.0 112.282 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.878 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.5 mt -131.76 124.98 30.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.778 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.719 ' HA ' HG23 ' A' ' 9' ' ' VAL . 3.8 m -127.91 150.62 49.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 25.2 t0 -82.7 170.69 14.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.363 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.89 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 3.7 tt -147.15 82.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.842 0.353 . . . . 0.0 111.524 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 174.0 61.12 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.892 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.437 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.55 -62.79 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.68 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 22.5 Cg_endo -58.39 -170.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.249 2.633 . . . . 0.0 113.29 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.68 -71.41 0.75 Allowed Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.327 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.916 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -73.03 59.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.0 110.343 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.81 -74.8 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.46 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.89 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -150.26 -32.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.46 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.882 ' HA ' HD13 ' A' ' 66' ' ' LEU . 3.2 mp -59.08 -20.33 52.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.864 0.364 . . . . 0.0 110.366 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.916 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -58.14 -31.37 67.13 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.466 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.856 HD13 ' HA3' ' A' ' 36' ' ' GLY . 5.9 mt -65.08 -39.61 93.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.409 . . . . 0.0 110.583 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.882 HD13 ' HA ' ' A' ' 63' ' ' LEU . 6.0 mp -60.08 -43.36 95.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.74 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -54.07 -42.51 69.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.235 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.548 ' HB2' HD13 ' A' ' 40' ' ' LEU . 41.1 mm-40 -61.3 -34.14 74.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.236 0.541 . . . . 0.0 110.053 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.598 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 49.7 mm -59.69 -41.68 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.114 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.538 ' CB ' ' HB2' ' A' ' 96' ' ' GLN . 11.9 pttp -74.72 -27.78 60.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.249 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.424 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 1.3 mt-30 -63.73 -42.48 97.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.04 0.447 . . . . 0.0 111.267 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 72' ' ' ARG . 12.4 mtt85 -103.7 -49.99 3.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.276 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.586 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 4.1 m-70 -88.58 135.26 32.67 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.615 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.11 -76.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.849 2.366 . . . . 0.0 112.664 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 21.4 mtm -140.92 52.75 1.59 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.456 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.051 HD23 HG23 ' A' ' 47' ' ' THR . 2.2 tm? -56.49 111.6 3.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.214 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.52 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 26.7 Cg_exo -62.35 115.36 2.82 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.27 1.98 . . . . 0.0 112.158 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.953 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -121.82 153.3 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.805 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.773 HG21 ' CD2' ' A' ' 114' ' ' LEU . 3.2 mt -130.64 117.78 40.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.308 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.637 HG22 ' H ' ' A' ' 82' ' ' THR . 19.3 mm -93.86 149.28 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.262 0.553 . . . . 0.0 112.407 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.583 ' N ' ' HE2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -84.7 -18.63 34.66 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.501 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.648 ' O ' HG21 ' A' ' 55' ' ' ILE . 3.3 m -147.44 160.98 41.96 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.722 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.834 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -111.09 -24.76 10.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.091 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 47.03 -171.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.344 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.35 53.0 2.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.873 0.368 . . . . 0.0 111.165 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.524 ' HB2' HD13 ' A' ' 63' ' ' LEU . 5.6 m-20 -158.98 28.38 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.834 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 2.0 mt -46.38 -21.39 0.16 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.79 -56.13 8.09 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -64.65 -19.94 66.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.639 0.257 . . . . 0.0 111.467 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -65.14 -50.99 63.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.342 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.652 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.7 t -65.35 -48.92 81.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.94 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -58.96 -25.04 63.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.956 0.408 . . . . 0.0 110.218 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.561 ' HB1' HD23 ' A' ' 66' ' ' LEU . . . -61.56 -51.86 66.81 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.443 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.665 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 2.7 m-85 -55.83 -30.57 61.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.01 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -37.62 56.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.461 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.538 ' HB2' ' CB ' ' A' ' 70' ' ' LYS . 1.7 pt20 -100.07 4.71 44.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 123.08 81.9 0.56 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.026 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.953 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.7 126.96 1.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 0.0 111.241 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 78.6 t80 -64.77 -53.41 47.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.379 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.665 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.6 OUTLIER 178.2 -169.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.881 0.372 . . . . 0.0 111.086 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.532 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.2 m-85 -123.84 118.72 27.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.471 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.665 HD23 ' CE2' ' A' ' 106' ' ' PHE . 5.7 tp -102.45 134.11 20.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 8.1 Cg_endo -49.4 166.66 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.697 2.265 . . . . 0.0 112.036 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.637 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -41.13 -50.08 8.17 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.547 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.7 Cg_endo -47.69 162.6 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.768 1.646 . . . . 0.0 110.441 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.873 ' HD1' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -171.58 -87.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.87 -178.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.7 p30 43.25 -170.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.59 0.233 . . . . 0.0 110.396 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.945 HD13 HG12 ' A' ' 18' ' ' VAL . 1.2 mp -68.04 -45.98 82.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.225 0.536 . . . . 0.0 111.336 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.564 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 7.4 t0 -51.72 -58.17 7.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.695 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.669 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 1.4 mm-40 -78.29 -27.69 47.37 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.873 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.24 -57.02 3.34 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.722 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.684 HG21 HG23 ' A' ' 108' ' ' ILE . 41.3 t -54.23 -31.82 22.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.557 0.694 . . . . 0.0 110.158 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.84 -52.48 63.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.745 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.773 ' CD2' HG21 ' A' ' 79' ' ' ILE . 13.6 tp -74.3 -20.66 60.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.625 -1.171 . . . . 0.0 112.791 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 112' ' ' VAL . 9.8 p -79.32 -50.12 18.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.934 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.507 ' N ' HG13 ' A' ' 115' ' ' VAL . 43.8 mt-10 -64.22 -41.57 96.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.001 0.429 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -67.56 -25.01 65.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.872 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.99 -54.11 8.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.047 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.4 mt -62.61 -31.34 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.084 0.468 . . . . 0.0 110.508 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.1 m -68.55 -38.11 80.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.741 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.594 ' O ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.594 HD13 ' O ' ' A' ' 4' ' ' GLY . 16.9 mm -130.46 112.86 23.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.772 0.32 . . . . 0.0 111.32 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.861 HG23 HG13 ' A' ' 50' ' ' VAL . 7.8 p -107.69 136.01 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.727 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.99 ' CD1' HG22 ' A' ' 31' ' ' THR . 38.5 m0 -122.17 127.37 49.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -118.08 132.23 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -177.78 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.989 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -116.79 105.11 17.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.12 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.54 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 37.4 t0 173.87 100.66 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.411 ' HB3' ' CG1' ' A' ' 15' ' ' ILE . 3.2 t0 65.44 -15.03 0.11 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 10' ' ' ASP . 3.7 p-10 45.27 -152.56 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.55 0.159 . . . . 0.0 110.893 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 1.8 t 32.53 -91.73 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.75 ' O ' HG23 ' A' ' 18' ' ' VAL . 48.3 t -56.25 -57.49 11.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.625 0.25 . . . . 0.0 110.766 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 10' ' ' ASP . 27.1 mm -60.17 -20.78 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.443 . . . . 0.0 110.36 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.628 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.4 ttm180 -78.78 -58.8 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.601 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.413 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 75.1 t90 -49.16 -41.35 36.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.157 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 14' ' ' SER . 1.3 t -68.15 -57.84 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 111' ' ' ALA . 4.2 tp -69.95 -25.4 63.63 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.644 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 23.0 pt-20 -67.69 -57.62 6.06 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.84 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.509 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 6.4 mmt180 -58.49 -53.1 62.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.017 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.43 77.52 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.794 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.3 tm? -76.67 -28.95 56.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.246 0.546 . . . . 0.0 110.474 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.67 -32.25 73.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.424 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.28 -24.64 70.74 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.385 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.06 -14.9 59.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.87 0.367 . . . . 0.0 110.879 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.41 23.33 10.4 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.516 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.604 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -130.96 170.72 14.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 117.471 0.635 . . . . 0.0 111.524 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.626 ' O ' HG12 ' A' ' 6' ' ' VAL . 31.0 m -96.93 141.74 29.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.236 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.644 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -127.54 119.35 25.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.815 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.99 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -131.71 135.63 47.01 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 38.9 p -108.62 163.17 13.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.989 ' HB2' HG13 ' A' ' 9' ' ' VAL . 39.5 m-85 -137.47 174.03 11.03 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.79 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.763 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.0 pp20? -62.83 -60.4 3.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.563 ' N ' HG12 ' A' ' 9' ' ' VAL . 18.4 t-20 -155.38 -32.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.316 0.507 . . . . 0.0 112.19 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.536 ' HA3' HD21 ' A' ' 65' ' ' LEU . . . -179.14 -65.71 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.484 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -47.72 -27.6 2.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 111.221 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.763 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -57.23 -60.83 3.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.685 HG13 ' HE3' ' A' ' 7' ' ' TRP . 65.4 t -50.71 -45.9 27.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.794 HD21 ' CD1' ' A' ' 65' ' ' LEU . 8.6 mt -46.24 -41.52 13.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.287 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.99 -47.81 67.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.926 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.16 -31.28 67.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.32 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.716 HD21 ' HD2' ' A' ' 48' ' ' PRO . 10.9 mt -61.36 -29.06 69.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.088 0.47 . . . . 0.0 111.042 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.56 -20.04 29.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.483 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 m -118.89 -8.49 10.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.863 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -156.3 157.99 36.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.784 0.326 . . . . 0.0 110.988 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.854 HG23 HD23 ' A' ' 76' ' ' LEU . 78.6 m -138.62 112.85 8.48 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.279 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.716 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.3 Cg_endo -76.94 162.35 32.22 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 121.874 1.716 . . . . 0.0 111.388 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 0.9 OUTLIER -73.76 -21.03 60.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.876 0.37 . . . . 0.0 110.925 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.861 HG13 HG23 ' A' ' 6' ' ' VAL . 4.4 p -148.6 163.67 5.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.816 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.682 HD11 HG21 ' A' ' 39' ' ' VAL . 23.5 tp -152.83 154.18 34.61 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.314 0.578 . . . . 0.0 112.307 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.977 ' O ' HG23 ' A' ' 9' ' ' VAL . 4.8 mt -137.79 122.05 18.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.513 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.73 ' O ' ' HE3' ' A' ' 81' ' ' MET . 1.3 m -106.55 144.76 32.76 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.591 ' O ' HG23 ' A' ' 55' ' ' ILE . 46.0 t0 -79.05 -11.7 60.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.741 HD13 ' HB ' ' A' ' 82' ' ' THR . 0.7 OUTLIER 51.53 154.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.684 0.754 . . . . 0.0 111.589 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.67 ' H ' ' C ' ' A' ' 61' ' ' ASP . 5.1 ttt180 84.38 72.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.767 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.483 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.44 -67.07 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.621 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 51.8 Cg_endo -66.25 -160.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.154 2.569 . . . . 0.0 113.028 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.17 13.4 50.32 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.392 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.847 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -152.05 47.65 0.77 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.67 ' C ' ' H ' ' A' ' 56' ' ' ARG . 1.0 OUTLIER 45.77 -86.14 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.569 -178.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.735 ' HA3' ' HB ' ' A' ' 55' ' ' ILE . . . -124.03 -30.5 1.02 Allowed Glycine 0 CA--C 1.508 -0.392 0 C-N-CA 119.863 -1.161 . . . . 0.0 112.901 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.776 HD23 ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -63.74 -19.48 64.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -65.31 -34.16 77.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.794 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -57.51 -45.4 85.01 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.352 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.037 HD13 ' HB2' ' A' ' 93' ' ' ALA . 4.9 mt -53.96 -47.0 71.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.53 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.743 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 9.4 tttt -51.98 -43.91 63.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.316 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.474 ' CB ' HD13 ' A' ' 40' ' ' LEU . 9.3 mm100 -65.84 -38.64 89.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.123 0.487 . . . . 0.0 110.279 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.525 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 30.3 mm -61.94 -42.07 93.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.913 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.743 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -70.6 -27.23 63.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.834 -179.08 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -68.76 -39.37 80.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.247 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.99 -54.79 2.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.029 0.443 . . . . 0.0 111.945 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.661 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -83.21 145.2 48.36 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.193 -178.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.33 -79.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.724 2.283 . . . . 0.0 113.214 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.736 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 11.5 mtt -127.13 45.68 2.66 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.84 0.352 . . . . 0.0 111.689 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.854 HD23 HG23 ' A' ' 47' ' ' THR . 1.4 tm? -58.64 106.97 0.8 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.505 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.47 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 48.3 Cg_exo -58.14 116.38 3.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.453 2.102 . . . . 0.0 112.249 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.759 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -112.88 152.17 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.041 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.759 ' HB ' HD23 ' A' ' 52' ' ' LEU . 5.9 mt -142.73 114.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.593 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.678 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 3.8 mm -94.29 131.38 41.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.315 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.814 ' HE1' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -75.38 -6.39 49.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.429 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.741 ' HB ' HD13 ' A' ' 55' ' ' ILE . 2.9 m -145.68 158.04 43.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.602 0.239 . . . . 0.0 110.381 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.681 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -143.57 47.1 1.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.339 . . . . 0.0 110.705 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.418 ' CD2' HG21 ' A' ' 82' ' ' THR . 6.6 m-70 -76.13 108.97 9.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.824 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 m 51.94 178.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.717 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.562 ' CB ' HD13 ' A' ' 63' ' ' LEU . 1.1 m-20 62.28 14.41 6.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.438 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -45.88 -23.71 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -48.33 -45.6 35.47 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -73.78 -19.85 60.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.776 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -58.82 -36.87 75.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 0.0 110.219 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.552 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.6 t -65.75 -37.26 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.491 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 m -66.9 -25.12 66.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.181 0.515 . . . . 0.0 109.693 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 1.037 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -64.33 -47.96 77.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.768 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.552 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.3 m-85 -61.61 -26.98 68.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.48 0.657 . . . . 0.0 109.399 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -41.62 41.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.544 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.736 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.6 pp0? -75.94 -16.95 59.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.806 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.13 -2.39 8.38 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.152 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.759 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -55.94 156.67 5.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.857 0.328 . . . . 0.0 110.875 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.501 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 52.7 t80 -86.79 -53.52 4.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.777 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.49 -161.63 0.02 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.842 0.353 . . . . 0.0 111.677 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.681 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 5.2 m-85 -127.86 124.4 37.42 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.259 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 114' ' ' LEU . 5.8 tp -106.65 137.42 19.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.289 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.727 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 12.3 Cg_endo -53.48 165.75 1.49 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.273 1.982 . . . . 0.0 111.115 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.432 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -41.62 -45.41 7.99 Favored Pre-proline 0 N--CA 1.468 0.461 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.315 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.727 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 80.6 Cg_exo -47.07 162.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 121.774 1.649 . . . . 0.0 110.531 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.762 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 3.8 t80 -164.21 -95.54 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.237 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p30 43.14 -173.25 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 120.814 0.34 . . . . 0.0 110.597 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.795 HG23 HG21 ' A' ' 112' ' ' VAL . 1.2 mp -67.47 -48.87 75.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 11.6 m-20 -52.18 -55.47 20.8 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.847 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.706 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.6 mm-40 -78.0 -30.69 50.24 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.664 ' HB3' HD11 ' A' ' 19' ' ' LEU . . . -82.51 -59.6 2.47 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.77 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.795 HG21 HG23 ' A' ' 108' ' ' ILE . 39.8 t -51.72 -33.87 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.505 0.669 . . . . 0.0 110.5 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.76 -51.43 69.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.76 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.626 HD22 HD13 ' A' ' 102' ' ' LEU . 19.8 tp -76.04 -21.17 57.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.959 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 112' ' ' VAL . 5.9 p -79.42 -48.95 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.655 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.477 ' N ' HG13 ' A' ' 115' ' ' VAL . 70.4 mt-10 -61.58 -52.2 65.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.73 0.3 . . . . 0.0 111.1 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.588 ' HD2' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -61.19 -24.57 66.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.77 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.56 -53.6 9.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 111.303 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.606 HD11 HG22 ' A' ' 115' ' ' VAL . 4.9 mt -68.1 -31.32 51.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.481 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.0 p -66.06 -44.48 84.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.52 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 6.7 m80 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.746 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.803 -0.119 . . . . 0.0 112.803 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.683 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 2.5 mp -116.36 118.94 60.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.516 0.198 . . . . 0.0 110.651 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.909 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.1 p -116.35 123.96 72.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.681 0.277 . . . . 0.0 110.8 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.919 ' CD1' HG22 ' A' ' 31' ' ' THR . 43.9 m0 -115.49 131.3 56.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.85 0.357 . . . . 0.0 110.642 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -121.47 139.79 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.781 -178.259 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.026 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -126.47 105.81 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.07 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.484 ' HB2' ' SD ' ' A' ' 81' ' ' MET . 43.0 t0 174.52 105.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.705 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.59 -15.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 10' ' ' ASP . 2.6 p30 44.44 -155.22 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.46 0.118 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 1.5 t 30.68 -89.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.634 ' O ' HG23 ' A' ' 18' ' ' VAL . 23.3 m -54.37 -57.49 11.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.37 . . . . 0.0 110.481 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 10' ' ' ASP . 35.5 mm -60.48 -20.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.167 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.764 ' HA ' HG21 ' A' ' 32' ' ' THR . 5.8 ttt-85 -77.37 -61.09 2.1 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.808 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.422 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 70.3 t90 -45.58 -42.75 11.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.797 HG12 HD13 ' A' ' 108' ' ' ILE . 1.8 t -66.95 -62.65 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.04 0.448 . . . . 0.0 112.058 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.486 ' HA ' HD11 ' A' ' 108' ' ' ILE . 12.3 mt -67.12 -26.43 66.69 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.579 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 23.2 pt-20 -65.34 -56.45 12.54 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.104 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.538 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.5 mmm180 -62.97 -58.64 6.63 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.094 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.05 -44.1 67.17 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.909 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.5 tp -73.35 -24.79 60.4 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.431 . . . . 0.0 110.47 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.74 -34.99 77.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.24 -24.22 68.77 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.31 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.634 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.04 -15.78 58.62 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.64 0.257 . . . . 0.0 111.034 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.07 26.2 8.52 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.957 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.702 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.74 170.28 12.31 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 117.987 0.894 . . . . 0.0 111.61 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.2 m -99.56 105.68 17.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.644 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.677 ' HA ' HG13 ' A' ' 6' ' ' VAL . 40.9 t -101.07 111.98 24.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.238 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.919 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -121.36 151.81 39.71 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.764 HG21 ' HA ' ' A' ' 16' ' ' ARG . 68.7 p -125.09 160.15 29.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.026 ' HB2' HG13 ' A' ' 9' ' ' VAL . 5.6 m-85 -135.94 173.86 11.25 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.491 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.508 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.8 pp20? -60.57 -59.23 5.73 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -150.46 -30.2 0.2 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.581 0.628 . . . . 0.0 112.49 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.625 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . 168.24 -56.37 0.22 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.435 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -45.88 -34.22 3.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.942 0.401 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.854 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.2 tp10 -60.97 -56.8 16.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.363 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.762 HG21 ' CG2' ' A' ' 9' ' ' VAL . 3.6 t -49.54 -40.94 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.951 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 68' ' ' GLN . 14.0 mt -55.56 -43.51 75.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.828 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.35 -49.56 59.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.001 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.28 -26.31 66.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.82 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.749 ' CD1' HG12 ' A' ' 39' ' ' VAL . 8.1 mt -71.28 -24.61 62.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.482 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.0 -16.42 43.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.643 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 m -120.26 -6.82 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.591 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -158.72 156.2 29.43 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.674 0.273 . . . . 0.0 110.85 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 1.006 HG23 HD12 ' A' ' 76' ' ' LEU . 67.5 m -139.42 113.0 7.94 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.506 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.683 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 96.8 Cg_endo -76.42 166.06 28.11 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.22 1.947 . . . . 0.0 111.433 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.407 ' O ' ' HD2' ' A' ' 77' ' ' PRO . 28.8 m-20 -73.91 -63.09 1.29 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.852 HG13 HG23 ' A' ' 6' ' ' VAL . 4.9 p -95.12 156.25 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.672 HD12 ' O ' ' A' ' 7' ' ' TRP . 50.1 tp -152.85 133.31 13.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.383 0.611 . . . . 0.0 111.856 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.743 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.6 mt -119.67 116.1 25.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.037 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.564 ' HA ' HG23 ' A' ' 9' ' ' VAL . 1.3 t -107.57 146.77 31.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.502 0.668 . . . . 0.0 112.489 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 7.2 t0 -74.43 -178.66 3.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.924 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.583 ' CG2' ' HB ' ' A' ' 82' ' ' THR . 3.3 tt -157.08 86.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.267 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 163.91 58.73 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.711 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.609 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 6.2 tpt -162.76 -63.79 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.609 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 12.1 Cg_endo -53.26 -164.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.065 2.51 . . . . 0.0 113.112 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.56 6.6 72.49 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.801 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.602 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -152.1 51.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.326 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.5 ' OD2' HD12 ' A' ' 63' ' ' LEU . 1.3 p-10 48.71 -71.44 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.147 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 55' ' ' ILE . . . -141.95 -36.48 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.999 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.873 ' HA ' HD23 ' A' ' 66' ' ' LEU . 1.3 mp -56.76 -18.69 13.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.284 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -63.24 -45.61 90.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.625 HD22 ' HA3' ' A' ' 36' ' ' GLY . 12.0 mt -56.49 -33.76 66.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.601 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.873 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.7 mm? -60.42 -43.81 96.38 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.692 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 14.4 ttmt -56.35 -41.07 75.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.277 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.599 ' HB3' HD13 ' A' ' 40' ' ' LEU . 70.5 mm-40 -70.07 -34.59 73.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.7 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.922 HG23 ' NE2' ' A' ' 73' ' ' HIS . 21.7 mt -67.05 -38.59 81.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.392 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.692 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.57 -24.14 61.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.998 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -78.9 -34.59 44.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.043 0.449 . . . . 0.0 110.935 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -94.04 -69.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.546 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.922 ' NE2' HG23 ' A' ' 69' ' ' ILE . 2.2 p80 -117.66 75.01 9.39 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.071 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.586 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 61.6 Cg_endo -74.96 57.11 4.44 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.299 1.999 . . . . 0.0 112.733 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.428 ' HG3' ' C ' ' A' ' 74' ' ' PRO . 51.3 mtp -154.37 -41.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.101 0.477 . . . . 0.0 111.008 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.006 HD12 HG23 ' A' ' 47' ' ' THR . 2.6 tt -58.12 122.29 57.49 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.911 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.451 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 18.7 Cg_endo -59.46 118.61 5.52 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.819 2.346 . . . . 0.0 112.513 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.709 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -99.36 148.07 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.849 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.659 ' HB ' HD23 ' A' ' 52' ' ' LEU . 2.7 mt -140.2 113.69 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.181 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.684 HG22 ' H ' ' A' ' 82' ' ' THR . 24.9 mm -93.42 149.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.131 0.491 . . . . 0.0 112.198 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.532 ' HE2' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.39 -13.48 49.26 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.869 -178.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.684 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.6 m -147.78 160.47 42.7 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.046 -0.409 . . . . 0.0 110.682 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.817 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -154.84 65.51 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 0.0 111.17 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.43 -93.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.824 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.63 -176.57 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.305 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.523 ' O ' HD22 ' A' ' 63' ' ' LEU . 85.2 m-20 58.88 14.42 3.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.583 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.804 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -44.47 -25.33 0.25 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -48.02 -42.65 28.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.032 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.603 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.04 -21.37 63.19 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.554 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.687 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -62.56 -41.62 99.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.98 0.419 . . . . 0.0 110.069 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.6 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.8 t -58.35 -39.64 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.437 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.8 p -61.45 -37.73 84.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.41 0.624 . . . . 0.0 110.146 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.67 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -54.83 -43.58 73.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.42 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.6 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 34.0 m-85 -59.16 -22.71 61.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.984 0.421 . . . . 0.0 110.503 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.651 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -71.99 -42.94 65.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.585 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.67 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -75.78 -18.1 59.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.99 15.95 4.59 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.433 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.709 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -56.59 148.48 19.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.143 0.471 . . . . 0.0 110.539 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.511 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 61.0 t80 -79.81 -53.89 6.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.199 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.406 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER 174.91 -158.9 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.002 0.429 . . . . 0.0 111.579 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.817 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.3 m-85 -131.87 125.77 32.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.653 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 6.0 tp -103.01 140.63 21.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.063 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.719 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 18.7 Cg_endo -56.28 165.15 4.49 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.031 1.821 . . . . 0.0 110.448 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -42.53 -43.87 8.76 Favored Pre-proline 0 N--CA 1.467 0.397 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.038 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.719 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 82.0 Cg_exo -47.12 163.88 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.672 1.581 . . . . 0.0 110.818 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.692 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 1.2 t80 -162.49 -92.08 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.528 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.559 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p-10 42.35 -177.12 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.898 0.38 . . . . 0.0 110.889 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.797 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -67.9 -44.79 84.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.355 0.598 . . . . 0.0 111.174 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.1 t70 -53.84 -57.28 11.48 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.787 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.692 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.6 mm-40 -78.53 -28.43 46.14 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.09 -54.24 4.97 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.184 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.753 HG21 HG23 ' A' ' 108' ' ' ILE . 43.8 t -57.49 -32.4 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.558 0.694 . . . . 0.0 109.956 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.44 -51.93 67.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.769 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.653 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 19.4 tp -76.66 -20.67 56.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.82 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.4 p -79.13 -48.62 21.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.723 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.465 ' N ' HG13 ' A' ' 115' ' ' VAL . 71.8 mt-10 -65.25 -45.49 84.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.949 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 20.4 mtp-105 -63.6 -24.01 67.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.905 0.383 . . . . 0.0 110.803 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.511 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -75.04 -51.15 14.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.133 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -65.61 -31.22 52.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.134 0.492 . . . . 0.0 110.975 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.6 t -70.96 -43.77 67.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.129 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.1 m80 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.097 -179.814 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.741 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.749 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.1 mp -111.55 119.35 59.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.871 0.367 . . . . 0.0 111.364 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.826 HG23 HG13 ' A' ' 50' ' ' VAL . 11.5 p -105.09 127.86 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.076 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.881 ' CD1' HG22 ' A' ' 31' ' ' THR . 29.5 m0 -115.29 143.7 44.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.786 HG21 HD23 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -136.85 143.66 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.043 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -133.38 104.73 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.068 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.61 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 43.0 t0 166.47 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.9 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.459 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 71.19 -23.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.94 0.496 . . . . 0.0 112.146 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 10' ' ' ASP . 10.6 t0 69.33 -131.51 0.08 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 122.53 -0.106 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 t -34.08 -45.05 0.19 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.704 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.2 m -54.67 -67.31 0.28 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 27.8 mm -64.38 -20.45 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.714 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.614 ' HA ' HG21 ' A' ' 32' ' ' THR . 53.3 ttt180 -70.3 -61.37 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.849 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.472 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 70.5 t90 -50.36 -43.6 54.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.954 0.407 . . . . 0.0 111.715 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.855 HG12 HD13 ' A' ' 108' ' ' ILE . 1.4 t -65.82 -61.11 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.002 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.786 HD23 HG21 ' A' ' 8' ' ' VAL . 9.8 tp -71.66 -20.71 61.91 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.667 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 21.2 pt-20 -67.47 -56.94 7.57 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.152 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.541 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 8.7 mmm180 -65.62 -59.42 3.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.215 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.34 -42.73 61.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.807 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.4 tm? -70.43 -26.6 63.74 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.007 0.432 . . . . 0.0 110.516 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.3 76.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.67 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.44 -26.15 69.3 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.27 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.543 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.74 -16.32 59.52 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.743 0.306 . . . . 0.0 111.068 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.41 25.81 8.55 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.455 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.741 ' HB3' ' O ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -136.58 175.2 9.83 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 117.382 0.591 . . . . 0.0 111.355 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.599 ' O ' HG12 ' A' ' 6' ' ' VAL . 3.0 m -106.03 134.61 48.89 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.087 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.667 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 12.2 t -124.3 110.54 14.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.456 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.881 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -110.66 155.42 22.43 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 81.2 p -131.69 159.34 38.66 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.043 ' HB2' HG13 ' A' ' 9' ' ' VAL . 5.8 m-85 -135.8 173.49 11.65 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.927 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.602 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 1.6 pp20? -61.95 -60.81 3.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.742 ' O ' HD11 ' A' ' 65' ' ' LEU . 29.2 m120 -150.69 -52.47 0.14 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 118.318 0.508 . . . . 0.0 111.581 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.657 ' CA ' HD11 ' A' ' 65' ' ' LEU . . . -159.11 -62.03 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.944 -1.122 . . . . 0.0 114.0 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.534 ' HA ' HD12 ' A' ' 40' ' ' LEU . 56.1 m-20 -52.42 -27.67 16.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.979 0.389 . . . . 0.0 111.617 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -62.48 -56.98 12.98 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.482 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.789 HG21 ' CG2' ' A' ' 9' ' ' VAL . 3.0 t -56.61 -40.64 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.151 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.612 HD13 ' CB ' ' A' ' 68' ' ' GLN . 20.2 mt -50.3 -42.57 52.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.008 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.36 81.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.245 0.545 . . . . 0.0 110.875 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.76 78.96 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.653 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.534 ' HG ' HG12 ' A' ' 39' ' ' VAL . 17.4 mt -59.0 -26.65 64.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.964 0.411 . . . . 0.0 111.132 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.95 -20.84 25.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.64 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.72 1.35 8.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.7 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.46 ' HB3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -156.37 159.43 38.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 111.438 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.486 HG23 HD23 ' A' ' 76' ' ' LEU . 86.9 m -139.41 113.08 7.96 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.189 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.564 ' HG2' HD21 ' A' ' 76' ' ' LEU . 78.0 Cg_endo -77.39 153.75 31.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.023 1.815 . . . . 0.0 111.624 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -73.81 -26.1 60.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.826 HG13 HG23 ' A' ' 6' ' ' VAL . 6.2 p -146.14 94.93 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.751 ' O ' HD12 ' A' ' 79' ' ' ILE . 56.6 tp -86.53 151.18 23.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.353 0.597 . . . . 0.0 112.151 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.771 ' O ' HG23 ' A' ' 9' ' ' VAL . 7.3 mt -132.99 114.13 13.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.899 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.956 ' HB3' HD13 ' A' ' 65' ' ' LEU . 1.5 m -114.15 149.91 34.97 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.626 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 29.2 t0 -78.14 173.47 12.21 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.636 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.764 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -145.09 74.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 120.993 0.425 . . . . 0.0 111.16 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 17.6 ttt-85 176.23 61.08 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.549 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.29 -62.8 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.549 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 20.1 Cg_endo -59.4 -174.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.532 2.154 . . . . 0.0 113.101 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.01 -72.39 0.54 Allowed Glycine 0 C--N 1.335 0.493 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.58 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.672 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -71.99 56.26 0.31 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.398 179.458 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.63 -77.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.839 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.764 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -136.33 -39.01 0.16 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.466 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.798 HD23 ' HB2' ' A' ' 90' ' ' ALA . 1.2 mp -51.7 -25.42 7.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.837 0.351 . . . . 0.0 110.496 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -58.73 -33.43 70.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.956 HD13 ' HB3' ' A' ' 53' ' ' SER . 0.4 OUTLIER -50.32 -44.64 54.33 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.898 178.723 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.644 ' HG ' ' HB2' ' A' ' 93' ' ' ALA . 3.1 mm? -60.67 -42.15 96.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.483 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.575 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -44.73 -60.68 1.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.404 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.645 ' OE1' ' HA ' ' A' ' 65' ' ' LEU . 9.4 mp0 -59.21 -37.01 76.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.839 0.352 . . . . 0.0 110.185 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.597 HG21 ' CG2' ' A' ' 78' ' ' VAL . 4.3 mm -64.13 -42.77 96.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.084 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 1.9 ptpp? -76.64 -24.28 53.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.609 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -86.26 -39.42 16.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.428 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.72 -62.92 1.38 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.278 0.561 . . . . 0.0 111.772 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.529 ' CE1' HD13 ' A' ' 43' ' ' LEU . 1.1 m80 -81.42 136.93 48.69 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.979 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.44 -69.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.622 2.215 . . . . 0.0 113.106 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.406 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 1.1 mpt? -144.66 37.28 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 111.601 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.671 HD11 HD22 ' A' ' 51' ' ' LEU . 1.1 tm? -59.94 105.65 0.6 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.407 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.639 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 10.9 Cg_endo -54.07 136.17 66.46 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.468 2.112 . . . . 0.0 112.195 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.729 HG13 HD23 ' A' ' 51' ' ' LEU . 2.1 t -132.89 152.37 35.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.909 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.768 HG21 ' CD2' ' A' ' 114' ' ' LEU . 3.6 mt -132.18 118.6 37.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.403 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 53' ' ' SER . 21.7 mm -93.86 142.98 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.019 0.438 . . . . 0.0 111.887 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.662 ' HE3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -75.46 -20.84 58.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.568 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.599 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.4 m -147.59 161.22 41.57 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.365 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.678 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -133.49 57.75 1.79 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.909 0.385 . . . . 0.0 111.705 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -98.47 -179.81 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.999 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER 63.92 -155.59 0.31 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.059 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.525 ' O ' HD22 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -60.23 78.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.271 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.709 ' HA ' HD21 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -52.8 -22.0 4.82 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.346 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -48.25 -50.76 28.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.606 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -56.24 -19.89 15.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.012 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.798 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -70.27 -35.88 74.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.64 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.613 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.8 t -67.06 -38.26 80.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.865 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.578 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 4.2 m -61.5 -18.62 59.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.325 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.782 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.82 -57.03 4.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.324 0.583 . . . . 0.0 111.542 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.613 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -54.22 -33.64 58.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.078 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -76.58 -35.31 58.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.244 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.782 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -77.78 -18.5 56.35 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.218 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.41 -11.71 3.25 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.926 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.692 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -54.96 156.2 3.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.307 0.554 . . . . 0.0 111.323 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.473 ' HD2' HG12 ' A' ' 79' ' ' ILE . 49.9 t80 -79.72 -53.58 6.67 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.252 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.541 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.5 OUTLIER 171.96 -163.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.033 0.444 . . . . 0.0 111.532 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.678 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 2.8 m-85 -125.69 122.32 36.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.259 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' MET . 3.6 tp -102.24 140.66 21.35 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.195 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.753 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 12.7 Cg_endo -54.58 163.68 3.61 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.637 2.225 . . . . 0.0 111.437 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -41.08 -45.8 6.65 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -178.355 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.753 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 88.7 Cg_exo -47.39 163.49 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.624 1.549 . . . . 0.0 110.671 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.749 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 12.0 t80 -165.77 -92.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.732 -178.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.565 ' O ' ' O ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER 40.11 -174.09 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.772 0.32 . . . . 0.0 111.189 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.855 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -68.08 -51.74 45.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.056 0.455 . . . . 0.0 111.835 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.2 p-10 -49.2 -56.05 10.51 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.942 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.749 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.7 mm-40 -76.59 -30.88 57.15 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.25 -58.5 3.02 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.903 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.677 HG21 HG23 ' A' ' 108' ' ' ILE . 40.0 t -53.03 -31.29 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 121.699 0.762 . . . . 0.0 110.212 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.53 -50.74 72.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.921 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.768 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.8 tp -76.95 -20.73 55.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.925 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.646 HG12 ' HA ' ' A' ' 112' ' ' VAL . 9.7 p -77.76 -48.73 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.954 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.504 ' N ' HG13 ' A' ' 115' ' ' VAL . 40.4 mt-10 -62.7 -44.07 97.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.032 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.663 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 7.8 ptm180 -68.14 -23.7 64.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 111.07 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.97 -50.91 17.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.812 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 115' ' ' VAL . 4.3 mt -70.19 -32.18 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.6 t -69.63 -42.11 74.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.033 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.2 m80 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.917 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.469 HG21 ' CE ' ' A' ' 46' ' ' LYS . 2.1 mp -131.88 112.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 111.598 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.765 HG11 ' HG ' ' A' ' 23' ' ' LEU . 12.2 p -107.24 130.24 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.873 ' CD1' HG22 ' A' ' 31' ' ' THR . 23.5 m0 -119.14 135.3 54.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -129.06 136.81 58.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -176.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.88 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -122.49 105.79 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.538 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 55.8 t0 170.28 118.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.458 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 2.2 t70 71.05 -43.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.419 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 49.6 t0 75.59 -107.09 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.947 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 12' ' ' ASP . 31.3 p -23.73 -83.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.714 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.0 m -52.93 -47.56 67.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.455 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.446 ' CG1' ' HB3' ' A' ' 11' ' ' ASP . 19.6 mm -64.64 -20.31 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.761 0.315 . . . . 0.0 111.628 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.481 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 7.1 ttp180 -70.75 -60.94 1.96 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.752 0.31 . . . . 0.0 111.586 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.562 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 37.9 t90 -52.08 -44.32 64.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.735 HG12 HD13 ' A' ' 108' ' ' ILE . 1.2 t -64.04 -49.91 79.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.616 ' HA ' HD11 ' A' ' 108' ' ' ILE . 43.3 mt -84.07 -22.1 31.31 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.618 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 1.2 pp20? -66.42 -59.02 4.06 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.511 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.458 ' HG2' ' CD ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -64.58 -62.85 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.01 -53.98 7.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.944 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.765 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.5 tm? -62.76 -29.21 70.52 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.729 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -66.5 -33.91 76.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.516 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.37 -25.24 69.79 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.396 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.578 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.97 -15.08 59.76 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.678 0.275 . . . . 0.0 111.053 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.58 23.46 10.14 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.63 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.578 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -133.52 174.64 10.2 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.532 0.666 . . . . 0.0 111.722 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 m -102.81 117.33 34.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.281 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.68 ' HB2' HD12 ' A' ' 23' ' ' LEU . 8.8 t -113.93 113.23 24.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.513 0.673 . . . . 0.0 111.533 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.873 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -118.87 156.55 29.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.405 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 31.1 p -135.04 152.11 51.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.426 0.631 . . . . 0.0 112.348 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.88 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -129.64 174.31 9.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.054 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.635 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -58.34 -106.33 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.441 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -86.14 -71.8 0.52 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.359 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.762 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -161.16 -39.21 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.411 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -31.63 69.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.901 0.35 . . . . 0.0 110.683 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.772 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -51.84 -57.31 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.634 178.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.828 HG21 HG22 ' A' ' 9' ' ' VAL . 2.9 t -56.85 -47.89 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.964 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.452 HD13 ' CB ' ' A' ' 68' ' ' GLN . 38.1 mt -46.18 -42.75 14.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.868 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.42 -50.07 69.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.799 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.49 -28.73 67.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.104 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.936 HD13 ' CE1' ' A' ' 73' ' ' HIS . 7.3 mt -71.04 -20.95 62.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.455 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.85 -18.15 20.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.074 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 m -126.35 9.43 7.25 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.823 ' HG3' ' N ' ' A' ' 47' ' ' THR . 3.4 tttt -158.15 163.53 37.48 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.439 0.638 . . . . 0.0 112.153 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.978 HG23 HD13 ' A' ' 76' ' ' LEU . 97.8 m -138.83 111.46 8.1 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.192 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' O ' HD11 ' A' ' 76' ' ' LEU . 61.2 Cg_endo -74.41 165.52 31.57 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.447 2.098 . . . . 0.0 111.284 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -82.43 -27.97 31.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.867 0.365 . . . . 0.0 110.818 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.756 HG13 HG23 ' A' ' 6' ' ' VAL . 3.4 p -149.61 99.45 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.41 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.846 ' O ' HD12 ' A' ' 79' ' ' ILE . 47.4 tp -86.96 141.93 28.34 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.938 HD23 ' HB ' ' A' ' 79' ' ' ILE . 6.2 mt -124.42 115.03 20.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.042 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.699 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -109.69 141.79 41.78 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.092 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 8.3 t0 -71.38 -171.82 0.66 Allowed 'General case' 0 C--O 1.23 0.055 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.931 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.96 HD11 ' CE1' ' A' ' 84' ' ' HIS . 2.7 tt -170.13 79.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.218 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.8 78.91 1.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.541 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 2.4 ptt? 43.21 49.92 5.38 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.56 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 50.6 Cg_endo -83.14 -74.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.305 2.003 . . . . 0.0 111.663 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.25 -21.34 3.43 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.976 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 4.3 ttm -163.74 68.28 0.19 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 110.225 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.66 -25.1 0.15 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.167 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.79 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 137.68 -27.68 2.81 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.586 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 4.3 mp -75.17 -17.98 60.28 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.976 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.43 -24.5 12.82 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.844 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.612 ' O ' HG13 ' A' ' 69' ' ' ILE . 7.4 mp -62.13 -42.36 99.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.842 ' HA ' HD12 ' A' ' 69' ' ' ILE . 85.9 mt -64.19 -42.72 96.54 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.304 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 9.9 tptm -48.39 -56.37 8.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.736 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.452 ' CB ' HD13 ' A' ' 40' ' ' LEU . 24.8 mm-40 -59.61 -32.45 70.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.931 HG23 ' ND1' ' A' ' 73' ' ' HIS . 97.1 mt -59.98 -46.01 94.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.969 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -67.0 -27.61 67.58 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -86.03 -37.02 19.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -89.85 -61.97 1.57 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.866 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.936 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -84.96 147.29 47.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.063 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -95.17 103.68 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.227 2.618 . . . . 0.0 112.437 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 18.3 mtm 54.35 24.58 5.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.086 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.978 HD13 HG23 ' A' ' 47' ' ' THR . 10.6 tp -69.15 114.36 22.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.99 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.54 120.63 8.64 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.309 2.006 . . . . 0.0 111.991 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.921 HG21 HD13 ' A' ' 69' ' ' ILE . 1.8 t -117.46 151.47 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.293 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.938 ' HB ' HD23 ' A' ' 52' ' ' LEU . 2.3 mp -131.15 120.39 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.895 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.639 HG22 ' H ' ' A' ' 82' ' ' THR . 18.0 mm -95.49 147.2 6.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.989 0.423 . . . . 0.0 111.375 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.76 ' HE3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.18 -18.42 46.31 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.214 -179.02 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.927 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.9 m -147.77 153.53 39.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.374 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.71 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -134.58 -2.02 2.75 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.744 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.96 ' CE1' HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 23.43 -95.66 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.205 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 m -141.15 -12.78 0.93 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.462 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 3.7 t70 -78.86 44.49 0.55 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.941 0.401 . . . . 0.0 111.361 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.948 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -52.12 -21.06 2.9 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.074 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -47.69 -56.51 7.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.662 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.699 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -68.68 -19.78 64.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.768 0.318 . . . . 0.0 111.247 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.948 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -70.76 -37.73 73.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.88 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.596 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.8 t -63.9 -41.92 94.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.287 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.604 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 23.8 m -61.39 -18.91 60.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 109.991 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.748 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.84 -52.49 10.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.097 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.596 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.0 m-85 -58.24 -33.85 69.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.164 0.507 . . . . 0.0 110.517 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.8 pp0? -76.39 -38.63 55.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.601 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.748 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.2 pp0? -73.12 -18.29 61.31 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.064 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.07 1.44 4.91 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.861 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.612 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -56.82 159.52 3.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.283 0.542 . . . . 0.0 111.537 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.531 ' HB3' HG13 ' A' ' 79' ' ' ILE . 84.0 t80 -85.08 -53.97 4.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.425 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 2.2 t70 173.11 -165.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 111.117 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.71 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.1 m-85 -127.55 122.55 33.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.582 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.412 ' HB2' HD22 ' A' ' 114' ' ' LEU . 1.8 tp -102.58 141.04 21.69 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.837 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.714 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 15.8 Cg_endo -55.52 166.31 2.72 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.363 2.042 . . . . 0.0 111.398 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.431 ' HE2' ' HA ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -42.02 -46.64 10.29 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.411 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.714 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 83.0 Cg_exo -47.23 163.75 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 121.805 1.67 . . . . 0.0 110.727 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.76 ' CE1' ' HE3' ' A' ' 81' ' ' MET . 4.1 t80 -165.75 -93.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.36 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.5 p-10 43.92 -175.78 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.706 0.288 . . . . 0.0 110.506 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.836 HG23 HG21 ' A' ' 112' ' ' VAL . 1.1 mp -67.96 -45.4 83.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.365 0.602 . . . . 0.0 111.381 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 30.9 t0 -52.14 -58.08 7.68 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.662 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.692 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.4 mm-40 -77.82 -30.06 50.93 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -82.99 -53.62 5.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.256 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.836 HG21 HG23 ' A' ' 108' ' ' ILE . 47.7 t -57.79 -32.75 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.431 0.634 . . . . 0.0 110.097 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.57 -52.91 63.51 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.227 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.792 ' CD2' HG21 ' A' ' 79' ' ' ILE . 6.9 tp -75.07 -20.51 59.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.042 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 112' ' ' VAL . 6.0 p -79.18 -43.67 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.601 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.404 ' N ' HG13 ' A' ' 115' ' ' VAL . 16.5 mt-10 -59.89 -51.81 68.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.69 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.4 ' NE ' HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -59.67 -23.82 63.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 110.853 179.467 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.46 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.66 -52.59 11.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.486 HD13 HD22 ' A' ' 28' ' ' LEU . 4.4 mt -71.57 -32.46 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.117 0.484 . . . . 0.0 111.244 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 t -66.06 -33.65 76.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.506 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.761 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.498 HD12 ' OD2' ' A' ' 49' ' ' ASP . 3.3 mp -108.97 112.41 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.841 0.353 . . . . 0.0 111.039 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.899 HG11 ' CD2' ' A' ' 23' ' ' LEU . 6.5 p -109.24 118.46 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.942 ' CD1' HG22 ' A' ' 31' ' ' THR . 37.5 m0 -109.62 140.21 43.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.188 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.626 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -125.09 144.85 33.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.194 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.104 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -133.14 106.79 10.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.053 0.454 . . . . 0.0 110.957 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 34' ' ' GLU . 8.5 t0 -162.05 -154.46 0.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.746 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.2 -1.56 3.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 62.47 -151.59 0.36 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.474 -0.141 . . . . 0.0 111.013 179.067 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 t 36.32 -90.34 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.772 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.3 t -55.06 -56.5 19.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.672 0.273 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.9 mm -64.3 -30.88 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.299 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.828 ' HA ' HG21 ' A' ' 32' ' ' THR . 8.5 ttm-85 -71.78 -53.3 13.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.628 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.441 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 72.9 t90 -54.07 -40.73 67.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 14' ' ' SER . 2.8 t -69.04 -56.65 11.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.66 HD13 HD12 ' A' ' 108' ' ' ILE . 7.0 tp -72.38 -23.13 61.07 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.679 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . 14.6 pt-20 -67.31 -59.23 3.58 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.492 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.544 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 11.4 mmm-85 -74.62 -53.84 8.58 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.79 -56.15 17.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 111.786 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.899 ' CD2' HG11 ' A' ' 6' ' ' VAL . 11.4 tp -66.02 -21.36 66.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.639 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.33 -34.83 73.14 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.34 -26.52 68.04 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.349 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.433 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.2 -15.95 59.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.649 0.261 . . . . 0.0 110.676 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.2 24.83 8.19 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.679 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -121.37 165.2 15.88 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.75 1.275 . . . . 0.0 112.438 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.8 m -88.74 109.08 19.85 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.16 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.679 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -101.9 115.62 30.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.414 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.942 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -133.62 132.19 40.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.828 HG21 ' HA ' ' A' ' 16' ' ' ARG . 59.2 p -105.87 164.14 12.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.489 0.661 . . . . 0.0 112.523 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.104 ' HB2' HG13 ' A' ' 9' ' ' VAL . 4.2 m-85 -135.79 173.42 11.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.071 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.592 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 2.0 pp20? -61.53 -49.52 76.38 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.704 ' HB3' ' HB2' ' A' ' 57' ' ' MET . 19.6 m-20 -165.96 -35.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.564 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -172.79 -64.83 0.05 OUTLIER Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.992 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.14 -30.57 49.6 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.848 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 11.1 tt0 -56.14 -48.03 77.03 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.129 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.69 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 4.1 t -52.8 -40.65 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.313 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.63 HD11 HD12 ' A' ' 65' ' ' LEU . 44.9 mt -54.16 -42.12 69.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.727 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.0 -52.48 65.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.848 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.54 -27.94 64.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.812 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.812 HD21 ' HD2' ' A' ' 48' ' ' PRO . 11.9 mt -67.67 -28.53 67.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.579 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.17 -17.74 4.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.877 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.55 -0.02 8.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.554 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.82 164.38 23.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 111.363 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.481 HG23 HD13 ' A' ' 76' ' ' LEU . 88.9 m -138.97 113.35 8.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.562 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.812 ' HD2' HD21 ' A' ' 43' ' ' LEU . 46.3 Cg_endo -68.82 158.44 57.85 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.271 1.981 . . . . 0.0 111.54 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.498 ' OD2' HD12 ' A' ' 5' ' ' ILE . 8.2 m-20 -80.53 -25.94 38.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.47 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.938 HG21 HG23 ' A' ' 115' ' ' VAL . 7.6 p -147.93 97.88 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.684 0.278 . . . . 0.0 111.111 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.711 HD22 HD21 ' A' ' 76' ' ' LEU . 18.6 tp -86.83 152.87 22.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.999 0.428 . . . . 0.0 111.989 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 106' ' ' PHE . 1.1 tt -134.87 114.41 12.54 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.074 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 t -114.9 136.98 52.51 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 111.919 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.414 ' C ' HG22 ' A' ' 55' ' ' ILE . 15.3 t70 -82.75 4.43 25.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.546 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.683 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 7.4 tt 41.84 82.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 12.2 ttp85 175.09 62.23 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.382 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.704 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 10.9 tpt -163.43 -61.13 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.801 ' HB2' ' HB3' ' A' ' 64' ' ' ALA . 17.9 Cg_endo -58.02 178.8 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.405 2.07 . . . . 0.0 112.616 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.77 -64.76 3.66 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.177 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.736 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 3.8 tpt -72.4 57.24 0.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.005 0.431 . . . . 0.0 110.099 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 0.4 OUTLIER 59.52 -81.8 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.237 -179.456 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.39 -31.29 0.15 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.566 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.662 HD11 ' O ' ' A' ' 84' ' ' HIS . 0.8 OUTLIER -60.27 -25.34 65.63 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.113 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.801 ' HB3' ' HB2' ' A' ' 58' ' ' PRO . . . -54.32 -34.17 60.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.926 0.393 . . . . 0.0 109.942 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.63 HD12 HD11 ' A' ' 40' ' ' LEU . 30.7 tp -56.82 -36.99 70.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.825 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.004 HD21 HD11 ' A' ' 80' ' ' ILE . 3.7 mm? -64.32 -44.53 91.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.848 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.776 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -57.21 -42.13 80.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.857 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.458 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 8.5 mm100 -65.18 -36.67 84.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.126 0.488 . . . . 0.0 110.487 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.786 HD12 ' HA ' ' A' ' 66' ' ' LEU . 59.2 mt -61.51 -39.75 84.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.083 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.776 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.64 -28.01 62.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.258 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -79.42 -39.36 32.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.567 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -96.66 -61.54 1.4 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.876 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.595 ' CE1' HD13 ' A' ' 43' ' ' LEU . 1.9 m80 -82.25 157.88 67.51 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.495 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -68.3 -76.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.612 2.208 . . . . 0.0 112.966 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.658 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 31.1 mtm -145.26 56.1 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.027 0.441 . . . . 0.0 111.124 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.711 HD21 HD22 ' A' ' 51' ' ' LEU . 17.6 tp -67.05 112.66 10.43 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.145 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 42.1 Cg_endo -67.28 118.75 5.81 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.462 2.108 . . . . 0.0 111.632 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.73 HG21 HD13 ' A' ' 69' ' ' ILE . 11.5 t -120.63 148.93 23.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 111.651 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.736 HG21 ' CD2' ' A' ' 114' ' ' LEU . 2.7 mt -117.2 113.66 43.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.121 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.004 HD11 HD21 ' A' ' 66' ' ' LEU . 18.3 mm -93.5 135.54 27.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.111 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.885 ' HE3' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -73.09 -55.52 6.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.215 0.531 . . . . 0.0 110.7 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.547 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.5 m -106.39 157.62 17.49 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.218 -0.301 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.743 ' HB1' ' CD2' ' A' ' 87' ' ' LEU . . . -121.49 37.4 4.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.884 0.373 . . . . 0.0 110.695 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.662 ' O ' HD11 ' A' ' 63' ' ' LEU . 2.8 p-80 -81.17 -172.81 3.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 74.91 -75.93 0.07 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.241 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.469 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -160.03 98.96 1.35 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.796 0.331 . . . . 0.0 111.45 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.833 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -47.81 -24.52 1.0 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.265 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.04 -42.11 27.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.889 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.413 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -72.25 -26.31 61.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.321 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.833 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.03 -45.79 72.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.45 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.59 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 15.0 t -67.6 -47.45 80.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 89' ' ' ALA . 2.7 p -63.34 -30.69 71.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.111 0.481 . . . . 0.0 110.16 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.792 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -59.04 -37.38 76.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.682 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.59 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 23.5 m-85 -59.04 -22.11 60.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.077 0.465 . . . . 0.0 110.014 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.63 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.3 -42.15 46.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.075 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.727 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp0? -76.13 -18.11 59.28 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.057 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 128.87 9.21 3.53 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.716 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.792 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -54.39 147.52 13.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 117.37 0.585 . . . . 0.0 111.433 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 56.2 t80 -86.68 -54.17 4.53 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.695 ' OD1' HG23 ' A' ' 79' ' ' ILE . 19.2 p30 171.51 -168.71 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.811 0.338 . . . . 0.0 111.273 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.57 ' CD2' ' HB ' ' A' ' 80' ' ' ILE . 11.3 m-85 -130.45 134.98 47.52 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.538 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.73 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -137.4 117.57 10.47 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.594 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 102' ' ' LEU . 58.8 Cg_exo -38.68 173.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.604 2.869 . . . . 0.0 114.501 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.885 ' HD2' ' HE3' ' A' ' 81' ' ' MET . 0.1 OUTLIER -36.91 -49.51 2.04 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.111 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.9 Cg_endo -47.8 123.81 8.94 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 N-CA-C 108.71 -1.304 . . . . 0.0 108.71 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.955 ' CZ ' HD21 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -156.89 -85.68 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.997 -177.043 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.9 p30 37.32 -162.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.857 0.361 . . . . 0.0 110.854 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.885 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -67.9 -52.52 38.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.587 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 32.1 m-20 -50.53 -56.63 10.76 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.549 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.658 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.6 mm-40 -78.27 -30.97 48.84 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.683 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.37 -54.31 4.87 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.755 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.885 HG21 HG23 ' A' ' 108' ' ' ILE . 32.2 t -55.07 -32.02 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.491 0.663 . . . . 0.0 110.156 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.34 -51.87 67.65 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.501 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.736 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.9 tp -75.3 -20.59 59.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.697 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.938 HG23 HG21 ' A' ' 50' ' ' VAL . 6.6 p -79.41 -50.0 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.092 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.496 ' N ' HG13 ' A' ' 115' ' ' VAL . 17.9 mt-10 -58.33 -43.97 88.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.666 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -24.33 67.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.96 0.409 . . . . 0.0 110.474 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.71 -59.05 2.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.979 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -64.95 -30.98 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.075 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 t -64.45 -37.18 86.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.076 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.8 m80 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 -179.863 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.477 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.479 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 4.0 mm -107.03 112.4 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.678 0.275 . . . . 0.0 111.09 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.865 HG11 ' CD2' ' A' ' 23' ' ' LEU . 5.9 p -109.95 119.2 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.808 0.337 . . . . 0.0 110.563 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.936 ' CD1' HG22 ' A' ' 31' ' ' THR . 34.8 m0 -112.55 131.77 55.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.802 0.334 . . . . 0.0 110.566 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -122.77 145.6 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.167 0.508 . . . . 0.0 112.283 -177.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.011 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -131.26 107.91 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.15 178.343 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 31.6 t0 170.76 107.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.869 0.366 . . . . 0.0 111.674 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.56 -40.59 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.7 OUTLIER 69.23 -159.3 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t 30.96 -87.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.677 ' O ' HG23 ' A' ' 18' ' ' VAL . 9.6 t -56.09 -57.49 11.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 0.0 110.518 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.38 -22.46 27.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.098 0.475 . . . . 0.0 110.186 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.739 ' HA ' HG21 ' A' ' 32' ' ' THR . 5.2 ttp180 -77.42 -59.24 2.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.398 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.407 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 87.8 t90 -46.35 -38.86 9.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.811 HG12 HD13 ' A' ' 108' ' ' ILE . 1.6 t -72.2 -62.51 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.011 0.434 . . . . 0.0 111.911 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.674 HD13 HD12 ' A' ' 108' ' ' ILE . 3.6 mm? -65.37 -25.75 67.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.142 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.622 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 8.9 pt-20 -67.77 -59.3 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.611 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 6.6 mmm180 -71.75 -48.16 48.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.931 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -57.78 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.049 0.452 . . . . 0.0 111.345 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.865 ' CD2' HG11 ' A' ' 6' ' ' VAL . 4.8 tp -63.96 -22.98 67.16 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.348 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.32 -33.95 72.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.24 -22.33 74.45 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.282 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.487 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.72 -16.0 58.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.658 0.266 . . . . 0.0 110.997 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.7 25.54 6.52 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.218 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.685 HD12 ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -130.68 168.72 16.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.897 0.849 . . . . 0.0 111.725 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.8 m -98.79 105.85 18.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.874 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.69 ' HA ' HG13 ' A' ' 6' ' ' VAL . 33.6 t -104.38 112.87 26.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.936 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.0 t -120.53 154.63 35.07 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.755 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 16.2 p -125.26 164.87 19.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.543 0.687 . . . . 0.0 112.794 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.011 ' HB2' HG13 ' A' ' 9' ' ' VAL . 47.4 m-85 -135.97 173.78 11.34 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.517 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.742 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -61.94 -60.94 2.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.499 ' N ' HG12 ' A' ' 9' ' ' VAL . 7.4 t-20 -151.36 -24.73 0.2 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.688 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 167.91 -58.78 0.21 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.922 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.538 ' N ' HD22 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -52.62 -26.95 15.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.853 0.358 . . . . 0.0 110.685 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.799 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -59.38 -60.31 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.802 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.841 HG22 ' CD1' ' A' ' 33' ' ' PHE . 39.4 t -48.58 -34.48 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.834 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.472 ' CD1' ' HA ' ' A' ' 37' ' ' ASN . 19.2 mt -57.48 -43.52 84.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.59 -53.78 51.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.16 0.505 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.24 71.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.905 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.761 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 12.2 mt -59.85 -29.84 68.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.9 -19.59 4.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.101 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 t -127.79 0.2 6.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -156.02 157.76 36.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.78 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.463 HG23 HD13 ' A' ' 76' ' ' LEU . 85.8 m -138.82 114.79 8.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.223 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.588 ' HD2' HD21 ' A' ' 43' ' ' LEU . 61.1 Cg_endo -74.39 154.94 45.95 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.083 1.855 . . . . 0.0 111.716 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.21 -23.99 40.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.749 0.309 . . . . 0.0 111.08 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.916 HG23 HD11 ' A' ' 79' ' ' ILE . 3.3 p -145.8 92.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.56 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.685 HD11 HG21 ' A' ' 39' ' ' VAL . 63.2 tp -86.61 152.45 22.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.233 0.539 . . . . 0.0 111.929 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.966 ' O ' HG23 ' A' ' 9' ' ' VAL . 4.8 mt -138.2 123.26 19.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.557 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.578 ' HB3' HD13 ' A' ' 80' ' ' ILE . 7.3 t -111.05 144.76 39.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 50.0 t0 -75.47 -11.06 59.96 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.761 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 82' ' ' THR . 1.7 tt 44.35 78.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.563 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 9.2 tpt180 172.05 76.08 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.679 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.632 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.24 -61.78 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.672 ' HD3' HD21 ' A' ' 65' ' ' LEU . 73.7 Cg_endo -74.13 -170.08 0.66 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.134 1.889 . . . . 0.0 113.504 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.3 -59.68 10.27 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.845 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.672 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 10.4 tpp -72.92 52.91 0.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.911 0.386 . . . . 0.0 110.602 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.81 -76.75 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.287 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.75 -32.04 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.189 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.605 HD12 ' H ' ' A' ' 63' ' ' LEU . 4.0 mp -51.79 -29.56 19.57 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -55.66 -32.49 63.25 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.929 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.688 HD13 ' HA3' ' A' ' 36' ' ' GLY . 13.5 mt -56.2 -44.39 79.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.544 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.933 HD21 HD11 ' A' ' 80' ' ' ILE . 30.5 mt -60.57 -44.36 96.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.122 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.628 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 9.8 mttt -49.75 -40.8 42.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.212 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -70.37 -35.64 73.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.203 0.525 . . . . 0.0 110.321 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.847 HD12 ' HA ' ' A' ' 66' ' ' LEU . 69.9 mt -62.42 -40.62 88.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.09 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.628 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -76.23 -25.01 54.61 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.705 -179.487 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -36.21 25.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.649 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.0 mtp85 -92.77 -25.74 18.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.739 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.761 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 14.9 m80 -124.25 152.72 68.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 120.862 0.363 . . . . 0.0 111.533 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.08 -83.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.083 2.522 . . . . 0.0 113.063 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.97 51.31 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.663 0.268 . . . . 0.0 111.073 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.518 HD21 HD22 ' A' ' 51' ' ' LEU . 55.3 tp -60.81 110.54 3.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.704 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.476 ' HD2' HD12 ' A' ' 76' ' ' LEU . 34.7 Cg_endo -64.84 115.7 3.4 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.103 1.868 . . . . 0.0 111.527 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.661 HG11 ' CD2' ' A' ' 66' ' ' LEU . 3.5 t -108.01 154.25 9.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.58 0.705 . . . . 0.0 111.525 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.916 HD11 HG23 ' A' ' 50' ' ' VAL . 3.5 mt -131.22 117.32 36.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.177 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.933 HD11 HD21 ' A' ' 66' ' ' LEU . 33.0 mm -93.42 143.51 11.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.997 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.733 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -94.3 -7.87 40.62 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.714 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.813 ' O ' HD13 ' A' ' 55' ' ' ILE . 3.0 m -147.52 129.11 15.05 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.93 0.395 . . . . 0.0 111.352 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB1' HD21 ' A' ' 87' ' ' LEU . . . -115.6 86.42 2.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -66.78 -159.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.935 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.7 34.15 0.53 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.673 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.468 ' HB2' HD13 ' A' ' 63' ' ' LEU . 1.3 m-20 -125.35 26.73 6.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.04 0.448 . . . . 0.0 110.333 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.633 HD13 ' CB ' ' A' ' 90' ' ' ALA . 1.1 mm? -44.54 -21.58 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.447 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -47.82 -47.26 31.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.521 0.2 . . . . 0.0 111.386 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.553 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -72.58 -22.45 60.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.856 0.36 . . . . 0.0 110.926 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.633 ' CB ' HD13 ' A' ' 87' ' ' LEU . . . -67.58 -49.02 65.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.374 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.595 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.4 t -57.71 -49.05 82.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.05 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -29.81 68.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.411 0.624 . . . . 0.0 109.901 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.602 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -58.53 -39.81 81.2 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.14 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 25.6 m-85 -61.31 -21.18 63.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.43 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.623 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.15 -42.59 55.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.706 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.623 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 1.2 pt20 -77.0 -15.1 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.817 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.32 13.44 4.81 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.626 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.602 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -55.52 143.77 28.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.146 0.473 . . . . 0.0 110.982 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.557 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 69.5 t80 -76.39 -53.96 7.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.222 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.4 t0 172.98 -166.1 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.947 0.403 . . . . 0.0 111.555 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.741 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.4 m-85 -129.05 118.97 23.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.347 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.465 HD23 ' HD1' ' A' ' 106' ' ' PHE . 5.9 tp -102.56 131.1 22.76 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.664 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.583 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 83.5 Cg_exo -47.48 168.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.551 2.168 . . . . 0.0 111.98 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.436 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -43.32 -46.36 15.7 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 88.1 Cg_exo -46.56 163.34 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 121.705 1.603 . . . . 0.0 110.763 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.744 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 5.0 t80 -169.39 -91.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.389 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.499 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.8 p-10 43.46 -174.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.73 0.3 . . . . 0.0 110.912 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.811 HD13 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.98 -48.14 76.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.225 0.536 . . . . 0.0 110.819 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 5.1 t70 -50.32 -57.18 8.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.082 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.681 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.5 mm-40 -79.25 -27.2 42.37 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.54 ' HB3' HD11 ' A' ' 19' ' ' LEU . . . -84.15 -53.43 5.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.578 ' HA ' HG12 ' A' ' 115' ' ' VAL . 42.3 t -59.17 -32.16 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.507 0.67 . . . . 0.0 110.17 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.89 -52.62 64.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.752 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.706 HD12 ' HD3' ' A' ' 117' ' ' ARG . 11.4 tp -75.67 -20.36 58.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.545 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 112' ' ' VAL . 3.6 p -78.28 -46.35 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.017 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.421 ' N ' HG13 ' A' ' 115' ' ' VAL . 43.6 mt-10 -61.95 -45.35 94.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.808 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.706 ' HD3' HD12 ' A' ' 114' ' ' LEU . 5.0 ptm180 -62.76 -25.7 68.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.671 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.557 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.93 -52.17 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.238 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.606 HD13 ' CD2' ' A' ' 28' ' ' LEU . 5.1 mt -68.31 -30.7 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.148 0.499 . . . . 0.0 110.738 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 m -65.28 -41.8 93.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.796 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.5 m80 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.734 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.728 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.676 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.728 HD13 ' C ' ' A' ' 4' ' ' GLY . 1.5 mm -107.8 112.29 39.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.764 0.316 . . . . 0.0 110.763 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.951 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.1 p -113.91 124.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.526 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 1.005 ' CD1' HG22 ' A' ' 31' ' ' THR . 53.2 m0 -116.71 133.35 56.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.702 0.287 . . . . 0.0 110.394 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -119.13 128.99 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.924 HG23 ' HA ' ' A' ' 53' ' ' SER . 2.7 m -117.65 118.77 59.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 110.419 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.474 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 17.2 t0 -173.45 -146.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.872 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -65.24 -4.46 5.25 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.6 t0 58.56 -147.5 0.5 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 122.543 -0.098 . . . . 0.0 111.234 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t 34.31 -87.87 0.01 OUTLIER 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.852 ' O ' HG23 ' A' ' 18' ' ' VAL . 39.2 m -58.1 -57.31 13.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.76 0.314 . . . . 0.0 110.988 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.58 -31.39 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.304 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.73 ' HA ' HG21 ' A' ' 32' ' ' THR . 15.4 ttp180 -72.37 -57.39 4.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.831 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.44 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 66.0 t90 -50.83 -42.4 58.45 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 14' ' ' SER . 0.9 OUTLIER -70.49 -58.77 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.184 0.516 . . . . 0.0 111.598 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.761 HD22 ' CD1' ' A' ' 108' ' ' ILE . 3.9 mm? -66.63 -26.99 67.34 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.67 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.589 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 12.2 pt-20 -66.87 -60.14 2.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.589 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.0 OUTLIER -72.35 -55.3 7.33 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.664 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.475 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -50.37 -57.25 8.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.0 111.815 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.951 ' CD2' HG11 ' A' ' 6' ' ' VAL . 4.6 tp -60.68 -25.24 66.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.438 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -68.76 -37.14 79.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.76 -23.69 70.91 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.513 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.414 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.69 -15.72 59.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.582 0.229 . . . . 0.0 110.977 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.14 25.04 6.58 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.39 -0.91 . . . . 0.0 114.29 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.666 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.24 170.06 15.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.78 0.79 . . . . 0.0 111.436 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.3 m -101.41 105.82 16.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.215 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.814 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 16.0 t -105.99 111.46 24.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.155 0.502 . . . . 0.0 111.952 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 1.005 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -121.26 155.64 34.2 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.73 HG21 ' HA ' ' A' ' 16' ' ' ARG . 32.6 p -126.02 159.99 31.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.559 0.695 . . . . 0.0 112.543 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.919 ' HB2' HG12 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -136.44 174.32 10.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.267 -179.019 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.641 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -63.04 -33.43 75.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.035 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.641 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 2.2 t30 -176.34 171.76 2.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.019 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.598 ' HA2' HG21 ' A' ' 9' ' ' VAL . . . -50.26 -25.27 7.93 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.144 -1.027 . . . . 0.0 111.907 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.504 ' N ' HD21 ' A' ' 65' ' ' LEU . 1.3 t30 -58.58 -52.21 66.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.673 0.273 . . . . 0.0 110.63 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.6 tt0 -51.95 -51.54 56.44 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.669 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.734 HG21 HD11 ' A' ' 51' ' ' LEU . 52.2 t -50.72 -35.1 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.133 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.2 mt -54.98 -43.1 73.21 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.04 -47.79 64.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.879 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.99 80.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.707 HD13 ' CE1' ' A' ' 73' ' ' HIS . 14.7 mt -67.19 -25.0 65.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.239 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.23 -15.3 23.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.766 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.2 -4.97 8.39 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.646 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -167.07 165.96 15.41 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.932 0.396 . . . . 0.0 110.844 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.72 HG23 HD23 ' A' ' 76' ' ' LEU . 89.0 m -138.79 120.85 10.35 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.452 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.679 ' HD2' HD21 ' A' ' 43' ' ' LEU . 93.0 Cg_endo -80.61 162.11 21.8 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.087 1.858 . . . . 0.0 111.638 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -74.01 -27.9 61.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 0.0 110.849 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.789 HG21 HG23 ' A' ' 115' ' ' VAL . 3.3 p -145.14 154.95 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.734 HD11 HG21 ' A' ' 39' ' ' VAL . 9.5 tp -152.98 136.75 16.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 111.342 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.659 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -111.45 122.59 48.25 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.924 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -106.83 137.95 43.91 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.474 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 29.1 t0 -73.02 171.33 13.06 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.342 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.675 HG13 ' O ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -157.97 93.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.383 -178.556 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.83 44.12 2.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.579 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 8.1 ttp 59.89 46.14 1.26 Allowed Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 55.2 Cg_endo -71.1 -73.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.296 1.997 . . . . 0.0 112.188 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.412 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -112.15 -27.73 3.85 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.233 -0.508 . . . . 0.0 111.851 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.943 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 16.0 ttm -155.63 64.39 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.361 . . . . 0.0 110.456 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.675 ' O ' HG13 ' A' ' 55' ' ' ILE . 2.4 t70 71.87 -23.54 0.19 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.172 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.614 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 136.44 -29.55 2.78 Favored Glycine 0 CA--C 1.506 -0.505 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.874 ' HA ' HD23 ' A' ' 66' ' ' LEU . 2.2 mp -70.11 -19.85 63.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.891 -0.655 . . . . 0.0 110.296 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.943 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.64 -30.75 44.43 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.128 0.49 . . . . 0.0 109.819 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.554 HD11 ' C ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -59.63 -48.39 81.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.537 178.682 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.874 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.5 mm? -48.74 -41.72 33.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.018 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.713 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 16.9 tttp -58.78 -43.73 90.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.351 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -62.73 -38.83 92.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.221 0.534 . . . . 0.0 110.648 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 66' ' ' LEU . 73.5 mt -57.41 -40.22 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.814 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.713 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.34 -22.56 47.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.15 -43.5 86.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.862 0.363 . . . . 0.0 111.85 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -99.3 -31.97 11.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.037 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.707 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -112.68 138.2 21.99 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.764 -179.262 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.37 -68.15 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.261 1.974 . . . . 0.0 112.554 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mpp? -148.45 53.67 1.01 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 110.736 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.79 HD22 ' HD2' ' A' ' 77' ' ' PRO . 3.1 tm? -55.26 115.06 8.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.419 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.79 ' HD2' HD22 ' A' ' 76' ' ' LEU . 10.0 Cg_endo -53.5 121.51 9.62 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.615 2.21 . . . . 0.0 112.213 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.79 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.2 t -127.99 149.36 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.22 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.699 HG21 HD23 ' A' ' 114' ' ' LEU . 1.6 mp -137.4 116.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.586 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.752 HG22 ' H ' ' A' ' 82' ' ' THR . 25.3 mm -92.65 142.98 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.276 0.56 . . . . 0.0 111.944 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.524 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.87 -9.7 59.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.984 -178.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.752 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.4 m -147.6 152.45 37.94 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.611 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.804 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -161.66 73.51 0.43 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.62 -21.12 17.83 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.3 m -159.84 175.76 12.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.049 0.452 . . . . 0.0 111.451 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.631 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER 54.42 29.25 10.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.411 -179.636 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.496 HD13 ' CB ' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -50.56 -21.06 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.546 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -47.81 -52.68 17.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.678 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -68.56 -19.77 64.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.315 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.66 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -66.75 -54.43 22.87 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.833 0.349 . . . . 0.0 111.011 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.647 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 4.1 t -62.23 -45.06 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.5 p -60.7 -27.05 67.58 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -59.09 -50.18 75.04 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.483 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.647 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -59.68 -33.63 71.82 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.901 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -39.72 69.48 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.449 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.58 ' HB2' ' CB ' ' A' ' 70' ' ' LYS . 7.6 pt20 -93.3 -7.42 44.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 132.02 82.36 0.22 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.766 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.79 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.46 139.18 2.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.559 0.218 . . . . 0.0 110.552 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 38.1 t80 -74.94 -53.76 8.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.347 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.701 ' OD2' HD11 ' A' ' 114' ' ' LEU . 38.5 p-10 177.71 -168.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.0 111.256 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.804 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 7.6 m-85 -123.1 152.76 40.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.802 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 103' ' ' PRO . 0.7 OUTLIER -143.02 142.79 22.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.759 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.669 ' O ' HD12 ' A' ' 102' ' ' LEU . 56.1 Cg_exo -51.68 165.44 0.73 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.382 2.054 . . . . 0.0 111.889 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -41.16 -51.05 8.07 Favored Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 3.9 Cg_endo -47.62 164.1 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.868 1.712 . . . . 0.0 110.353 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.86 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 174.98 -85.59 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.174 -0.211 . . . . 0.0 111.089 -179.415 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 48.4 -174.16 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.761 ' CD1' HD22 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -57.7 -49.95 79.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.191 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.505 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.2 t70 -50.99 -58.89 4.91 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.154 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.86 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 7.6 mm-40 -81.18 -28.67 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.73 -47.74 10.86 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.951 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.686 HG21 HG23 ' A' ' 108' ' ' ILE . 59.5 t -62.09 -32.68 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.591 0.71 . . . . 0.0 109.733 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.64 -50.36 74.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.913 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.701 HD11 ' OD2' ' A' ' 100' ' ' ASP . 15.4 tp -75.69 -21.15 57.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.747 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.789 HG23 HG21 ' A' ' 50' ' ' VAL . 4.1 p -79.52 -48.14 21.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.836 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.439 ' N ' HG13 ' A' ' 115' ' ' VAL . 49.8 mt-10 -65.72 -39.95 91.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.918 0.389 . . . . 0.0 110.326 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.8 mtp85 -65.38 -23.88 67.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.763 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -75.01 -49.1 20.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.221 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.8 mt -68.0 -30.69 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.714 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.5 m -73.32 -40.0 64.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.877 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 27.6 m80 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.009 179.9 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.898 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.898 HD13 ' C ' ' A' ' 4' ' ' GLY . 2.8 mm -124.42 118.85 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.056 HG23 HG13 ' A' ' 50' ' ' VAL . 9.0 p -105.68 122.85 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.952 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.911 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.2 m0 -107.87 137.41 45.93 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.674 -0.41 . . . . 0.0 109.975 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -131.06 144.45 37.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.331 -177.257 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.096 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -133.95 105.29 6.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.142 178.037 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 64.2 t0 166.9 118.3 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.442 ' CB ' HG12 ' A' ' 15' ' ' ILE . 2.4 t0 71.02 -16.36 0.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.1 t0 67.81 -139.63 0.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.253 -0.279 . . . . 0.0 110.985 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 t -32.82 -43.17 0.09 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.505 ' O ' HG23 ' A' ' 18' ' ' VAL . 36.1 t -53.15 -69.65 0.11 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 25.9 mm -63.94 -20.79 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.638 ' HA ' HG21 ' A' ' 32' ' ' THR . 7.1 ttp180 -68.03 -58.48 4.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.495 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 77.3 t90 -51.13 -44.87 61.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.735 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.805 HG12 HD13 ' A' ' 108' ' ' ILE . 2.4 t -62.92 -61.04 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.13 0.49 . . . . 0.0 111.975 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.683 HD23 HG21 ' A' ' 8' ' ' VAL . 14.2 tp -72.28 -21.69 61.32 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 14.6 pt-20 -66.93 -56.06 11.86 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.408 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.533 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -62.78 -56.93 13.09 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.459 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.82 -49.5 70.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 111.929 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.5 tm? -69.78 -24.07 63.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.181 0.515 . . . . 0.0 110.339 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.07 -32.74 70.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.4 -27.11 67.25 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.231 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.31 -15.38 59.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 110.513 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.71 24.5 13.42 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.873 -0.68 . . . . 0.0 114.214 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.618 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -124.14 164.15 20.04 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 118.32 1.06 . . . . 0.0 112.438 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.659 ' HB ' HG23 ' A' ' 5' ' ' ILE . 99.7 m -84.66 136.79 33.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.926 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -127.57 111.53 13.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.715 -179.007 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.911 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -123.55 147.33 47.38 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 71.7 p -126.25 159.49 32.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.469 0.652 . . . . 0.0 112.658 -178.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.096 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.2 m-85 -136.13 174.12 10.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.987 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.562 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -54.52 -51.17 65.97 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -177.002 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.589 ' N ' HG12 ' A' ' 9' ' ' VAL . 11.3 m-20 -171.24 -20.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.648 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . 169.46 -45.61 0.21 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.732 -1.223 . . . . 0.0 114.13 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.555 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -61.04 -39.17 88.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.447 0.624 . . . . 0.0 111.415 -178.759 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.857 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -57.86 -54.17 49.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.493 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.736 HG21 ' CG2' ' A' ' 9' ' ' VAL . 2.6 t -51.53 -47.19 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.322 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.834 HD13 ' HB3' ' A' ' 68' ' ' GLN . 15.0 mt -48.01 -43.58 30.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.91 -48.67 65.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.903 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.91 -27.68 67.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.28 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.607 HD13 ' NE2' ' A' ' 73' ' ' HIS . 17.6 mt -73.01 -23.96 60.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.946 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.83 -19.62 6.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.475 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.19 3.16 5.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.52 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -153.99 154.52 33.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.897 0.38 . . . . 0.0 111.518 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.743 HG23 HD13 ' A' ' 76' ' ' LEU . 75.9 m -138.86 113.18 8.36 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.426 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.542 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 72.7 Cg_endo -74.17 165.58 31.59 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.324 2.016 . . . . 0.0 111.266 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.427 ' OD2' ' HA2' ' A' ' 4' ' ' GLY . 93.5 m-20 -77.53 -30.67 52.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.855 0.359 . . . . 0.0 110.894 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.056 HG13 HG23 ' A' ' 6' ' ' VAL . 7.6 p -146.52 102.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.486 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.682 ' HB2' HD21 ' A' ' 76' ' ' LEU . 61.3 tp -87.26 137.19 32.56 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.844 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.6 mt -119.14 122.46 42.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.31 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.66 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -119.16 148.35 43.18 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.311 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.588 ' O ' HD21 ' A' ' 65' ' ' LEU . 7.0 t0 -76.66 -167.0 0.74 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.558 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.806 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -165.4 72.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.832 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 29.2 ttt180 177.18 63.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.954 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.485 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 1.1 tmm? -163.27 -61.85 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.86 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.723 ' HB2' ' HB3' ' A' ' 64' ' ' ALA . 33.0 Cg_endo -61.82 -171.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.394 2.063 . . . . 0.0 112.689 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.11 -78.61 0.1 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.437 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.644 ' O ' ' N ' ' A' ' 62' ' ' GLY . 2.7 mtt -69.91 64.52 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.394 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.461 ' HB2' ' CE1' ' A' ' 84' ' ' HIS . 6.0 p-10 48.73 -66.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.543 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.806 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -143.51 -39.63 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.82 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.82 HD23 ' HB2' ' A' ' 90' ' ' ALA . 1.8 mp -51.65 -25.18 6.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.414 . . . . 0.0 110.291 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.723 ' HB3' ' HB2' ' A' ' 58' ' ' PRO . . . -55.55 -33.62 64.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.373 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.588 HD21 ' O ' ' A' ' 54' ' ' ASP . 3.5 pp -65.17 -25.68 67.84 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.847 ' HA ' HD12 ' A' ' 69' ' ' ILE . 6.2 mp -66.1 -41.55 90.45 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 22.1 mmtm -53.06 -50.93 63.35 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.784 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.834 ' HB3' HD13 ' A' ' 40' ' ' LEU . 1.8 mt-30 -53.36 -43.89 68.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.76 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.995 HG23 ' CE1' ' A' ' 73' ' ' HIS . 61.6 mt -55.68 -45.53 79.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.003 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.525 ' CB ' ' HG3' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -63.71 -28.21 69.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.121 0.486 . . . . 0.0 110.67 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.44 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 20.3 mt-30 -77.07 -41.14 43.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.236 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -93.57 -73.2 0.57 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.372 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.995 ' CE1' HG23 ' A' ' 69' ' ' ILE . 7.6 p80 -110.55 76.97 1.2 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.75 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.456 ' HB2' ' OE1' ' A' ' 96' ' ' GLN . 72.7 Cg_endo -77.25 29.44 0.42 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.963 2.442 . . . . 0.0 114.011 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.0 mtp -134.19 -32.07 1.08 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.855 0.36 . . . . 0.0 111.564 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.743 HD13 HG23 ' A' ' 47' ' ' THR . 5.6 tp -66.34 141.87 97.47 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.306 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.561 ' HD2' HD12 ' A' ' 76' ' ' LEU . 78.7 Cg_endo -76.87 131.43 12.18 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.819 2.346 . . . . 0.0 112.304 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.763 HG21 HD13 ' A' ' 69' ' ' ILE . 2.7 t -111.41 141.52 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.058 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.689 HG21 HD23 ' A' ' 114' ' ' LEU . 2.6 mt -130.28 115.93 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.434 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 66' ' ' LEU . 32.2 mm -93.64 145.82 7.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.042 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.687 ' HA ' HD23 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -80.83 -24.64 38.32 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.347 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.624 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.0 m -148.03 149.44 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.755 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.771 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -126.93 68.23 1.26 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.754 0.311 . . . . 0.0 111.304 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.461 ' CE1' ' HB2' ' A' ' 61' ' ' ASP . 9.0 p80 -98.08 111.2 23.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.026 0.441 . . . . 0.0 111.569 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 t 54.39 168.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.022 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.553 ' HB2' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER 62.19 14.71 6.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.518 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.479 ' HA ' HD21 ' A' ' 63' ' ' LEU . 1.4 mt -46.38 -25.14 0.6 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -48.61 -41.12 29.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.865 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.494 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.93 -22.08 62.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.82 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -69.76 -34.51 73.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.942 0.401 . . . . 0.0 110.588 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.707 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.2 t -61.19 -45.15 99.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.141 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.443 ' O ' ' OE1' ' A' ' 95' ' ' GLN . 20.6 m -57.99 -48.78 78.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.561 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.675 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -47.21 -43.67 21.75 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.154 0.502 . . . . 0.0 110.943 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.707 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 11.2 m-85 -54.89 -26.31 34.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.044 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.639 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.5 -48.07 61.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.341 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.639 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 26.7 mm-40 -72.5 -18.8 61.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.721 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.38 27.83 1.42 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.845 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.675 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -62.21 146.78 49.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.349 0.574 . . . . 0.0 110.295 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 45.4 t80 -74.18 -54.14 8.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.109 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 0.9 OUTLIER 166.99 -162.69 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.157 0.503 . . . . 0.0 111.445 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.771 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.4 m-85 -131.31 153.21 49.81 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.355 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.874 HD22 ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -141.53 149.89 55.66 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.963 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 29.0 Cg_endo -64.42 161.21 35.71 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.493 2.129 . . . . 0.0 111.426 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -33.58 -51.25 0.79 Allowed Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.1 Cg_endo -47.47 162.41 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.729 1.619 . . . . 0.0 110.345 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.874 ' CE1' HD22 ' A' ' 102' ' ' LEU . 0.1 OUTLIER 177.85 -79.45 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.064 -178.738 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 3.0 p30 42.54 -168.27 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.862 HG23 HG21 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -67.98 -47.19 79.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.825 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -51.95 -57.98 7.85 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.773 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.67 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 13.5 mm-40 -77.45 -31.88 54.12 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.699 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . . . -83.32 -49.93 8.88 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.537 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.862 HG21 HG23 ' A' ' 108' ' ' ILE . 44.4 t -59.47 -31.54 46.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.526 0.679 . . . . 0.0 109.758 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.84 -51.34 70.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.964 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.689 HD23 HG21 ' A' ' 79' ' ' ILE . 6.9 tp -75.86 -21.59 57.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.641 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.2 p -79.44 -48.15 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.023 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.435 ' N ' HG13 ' A' ' 115' ' ' VAL . 40.7 mt-10 -65.09 -40.52 94.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.699 0.285 . . . . 0.0 110.769 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.558 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 2.4 ptm85 -62.6 -25.07 67.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 0.0 110.394 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -70.61 -49.81 43.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.077 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.6 mt -66.38 -31.87 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -31.98 70.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.715 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.956 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.356 -0.297 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 1.4 mp -114.96 120.96 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.798 0.333 . . . . 0.0 111.211 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.98 HG23 HG13 ' A' ' 50' ' ' VAL . 7.5 p -114.23 120.77 64.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.321 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.943 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.8 m0 -111.04 136.46 50.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.744 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -122.12 137.89 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.888 -178.167 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -121.43 115.25 46.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.157 0.503 . . . . 0.0 110.068 178.138 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 7.5 t70 -168.35 -154.45 0.14 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.597 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -66.32 -3.17 5.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 65.56 -154.08 0.26 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.263 -0.273 . . . . 0.0 111.107 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.407 ' HB3' ' H ' ' A' ' 14' ' ' SER . 3.5 t 34.56 -89.12 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.792 ' O ' HG23 ' A' ' 18' ' ' VAL . 17.1 m -54.22 -58.81 5.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.724 0.297 . . . . 0.0 111.395 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.48 ' O ' HD23 ' A' ' 19' ' ' LEU . 26.4 mm -62.96 -30.53 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.937 0.398 . . . . 0.0 110.937 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.721 ' HA ' HG21 ' A' ' 32' ' ' THR . 22.5 ttt85 -72.36 -47.46 49.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.947 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.421 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 52.6 t90 -60.4 -40.92 92.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 14' ' ' SER . 1.7 t -74.24 -43.09 50.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.97 0.414 . . . . 0.0 111.557 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.693 HD22 ' CD1' ' A' ' 108' ' ' ILE . 3.9 mm? -77.02 -27.57 54.63 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.1 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.664 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 16.7 pt-20 -67.89 -59.77 3.03 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.925 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.513 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -68.58 -55.96 9.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.575 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.09 -51.39 58.0 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.91 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.5 tp -67.35 -23.3 65.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.413 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -68.22 -36.64 79.84 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.36 -24.44 65.63 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.203 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.672 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.43 -15.6 58.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.741 0.305 . . . . 0.0 110.91 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.61 26.14 9.41 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.988 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.738 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.66 170.37 11.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.759 0.78 . . . . 0.0 111.808 179.616 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.3 m -101.4 105.88 16.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.343 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.664 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 4.9 t -102.25 114.57 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.992 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.943 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -123.79 150.38 44.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.721 HG21 ' HA ' ' A' ' 16' ' ' ARG . 70.8 p -122.06 163.78 18.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.894 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.2 m-85 -136.4 175.43 9.62 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.755 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.621 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.9 pp20? -60.35 -55.69 30.52 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -177.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 5.6 m-80 -150.81 -43.89 0.12 Allowed 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.736 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 177.51 -46.03 0.1 OUTLIER Glycine 0 C--N 1.318 -0.454 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.353 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.487 ' OD1' HD12 ' A' ' 40' ' ' LEU . 3.1 t30 -63.25 -27.73 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.796 0.332 . . . . 0.0 110.6 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -58.59 -55.45 34.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.712 179.392 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.83 HG21 HG22 ' A' ' 9' ' ' VAL . 3.4 t -50.53 -38.92 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.965 0.412 . . . . 0.0 111.123 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.487 HD12 ' OD1' ' A' ' 37' ' ' ASN . 13.3 mt -59.38 -44.07 92.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.52 -49.93 55.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.065 0.459 . . . . 0.0 111.108 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.09 -33.02 74.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.824 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.828 HD13 ' CE1' ' A' ' 73' ' ' HIS . 15.6 mt -62.15 -23.83 66.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.05 -20.42 16.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.791 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -116.56 -6.15 11.66 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -159.27 158.2 32.03 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.929 0.395 . . . . 0.0 111.012 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.9 m -138.71 114.93 8.76 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.954 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.597 ' CD ' HD21 ' A' ' 43' ' ' LEU . 91.0 Cg_endo -81.73 165.05 18.1 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.117 1.878 . . . . 0.0 111.53 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 5' ' ' ILE . 3.9 p30 -74.25 -59.81 2.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.123 0.487 . . . . 0.0 110.086 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.04 HG21 HG23 ' A' ' 115' ' ' VAL . 12.0 p -99.48 160.58 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.201 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 7' ' ' TRP . 32.1 tp -153.07 153.12 32.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.138 0.494 . . . . 0.0 111.676 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.955 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.2 mt -137.24 120.78 17.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.042 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.459 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -105.31 134.44 48.42 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.583 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.571 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 9.2 t70 -61.71 -28.43 69.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.636 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.937 HG21 HG22 ' A' ' 80' ' ' ILE . 0.3 OUTLIER 41.8 92.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.772 -179.738 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.547 ' O ' ' HG3' ' A' ' 57' ' ' MET . 0.0 OUTLIER -175.3 104.86 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.193 0.52 . . . . 0.0 112.124 179.237 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.547 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER 40.03 47.91 1.96 Allowed Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 178.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.634 ' HG3' ' HA2' ' A' ' 62' ' ' GLY . 98.6 Cg_endo -90.76 -53.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.511 2.141 . . . . 0.0 111.693 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.01 -21.9 0.12 Allowed Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.66 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.991 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 3.6 tpt -163.98 67.21 0.17 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.658 0.383 . . . . 0.0 110.071 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 71.95 -22.56 0.2 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.616 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.806 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 136.65 -27.68 2.93 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.74 ' HA ' HD23 ' A' ' 66' ' ' LEU . 5.1 mp -77.1 -19.97 56.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.991 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.77 -32.65 53.19 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.003 0.43 . . . . 0.0 110.455 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.548 HD13 ' HA3' ' A' ' 36' ' ' GLY . 14.7 mt -57.23 -44.42 83.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.538 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.029 HD11 HD11 ' A' ' 80' ' ' ILE . 3.5 mm? -55.02 -44.79 74.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.93 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.654 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -52.71 -45.06 66.76 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.17 179.591 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -67.45 -31.1 71.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.037 0.446 . . . . 0.0 110.601 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.835 HD12 ' HA ' ' A' ' 66' ' ' LEU . 94.5 mt -63.08 -41.06 91.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.755 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 3.4 pttp -74.76 -22.78 58.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.347 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.75 -31.95 31.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.395 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.1 mtt180 -106.81 -59.48 1.8 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 112.191 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.828 ' CE1' HD13 ' A' ' 43' ' ' LEU . 1.3 m80 -81.4 145.13 54.76 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.302 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -95.75 102.71 0.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.219 2.613 . . . . 0.0 113.14 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.577 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.6 mtt 54.26 35.97 24.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.809 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.564 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.1 tt -64.68 110.34 3.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.632 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 49' ' ' ASP . 51.1 Cg_exo -54.02 116.87 3.33 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.164 1.91 . . . . 0.0 111.713 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.685 HG21 HD13 ' A' ' 69' ' ' ILE . 2.4 t -122.1 146.07 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.321 0.581 . . . . 0.0 112.056 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.671 HG22 HD23 ' A' ' 102' ' ' LEU . 3.2 mt -122.07 116.94 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.957 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 66' ' ' LEU . 9.3 mm -93.42 120.82 43.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.23 0.538 . . . . 0.0 112.315 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.508 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -74.35 -8.86 57.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.286 -179.516 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.574 ' H ' HG21 ' A' ' 55' ' ' ILE . 3.0 m -147.52 136.01 21.74 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.09 0.472 . . . . 0.0 111.948 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.811 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -134.03 84.41 2.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.137 0.494 . . . . 0.0 110.562 178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -66.78 -157.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.016 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -86.07 40.53 0.87 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.621 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -129.26 36.07 4.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.075 0.464 . . . . 0.0 109.98 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.705 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -45.42 -21.57 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.917 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.67 -55.12 10.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.492 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.53 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -69.42 -22.99 63.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.358 . . . . 0.0 110.654 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.705 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.69 -44.41 74.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.577 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 10.8 t -65.11 -42.66 94.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.804 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 77.6 p -67.12 -23.56 65.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.977 0.418 . . . . 0.0 109.932 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.691 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -65.99 -37.5 86.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.285 0.564 . . . . 0.0 109.835 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.618 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.9 m-85 -68.29 -23.9 64.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.282 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 92' ' ' SER . 1.3 tm0? -74.87 -29.55 61.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.272 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.691 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -92.19 -17.19 25.22 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.06 24.75 1.44 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.944 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.598 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -68.92 145.94 53.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.118 0.459 . . . . 0.0 110.584 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 22.9 t80 -79.45 -53.39 6.94 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.45 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t0 179.42 -164.99 0.05 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.945 0.403 . . . . 0.0 111.932 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.811 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 7.8 m-85 -137.56 122.52 18.96 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.537 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 106' ' ' PHE . 0.9 OUTLIER -123.0 142.87 39.24 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.898 -179.622 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.626 ' O ' HD12 ' A' ' 102' ' ' LEU . 50.9 Cg_exo -54.55 175.39 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.874 2.383 . . . . 0.0 113.07 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -43.5 -53.1 12.38 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 6.3 Cg_endo -48.73 163.42 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.832 1.688 . . . . 0.0 110.442 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.866 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 172.87 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.539 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 45.65 -171.28 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.845 HG23 HG21 ' A' ' 112' ' ' VAL . 1.1 mp -60.13 -49.94 82.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.512 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 15.6 t0 -52.31 -58.57 6.25 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.866 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -80.35 -28.12 38.15 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.96 -52.16 6.56 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.589 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.845 HG21 HG23 ' A' ' 108' ' ' ILE . 40.1 t -57.75 -33.54 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.49 0.662 . . . . 0.0 110.082 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.0 -51.62 69.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.626 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.68 HD12 ' HD2' ' A' ' 117' ' ' ARG . 9.6 tp -75.53 -21.89 57.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.045 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 1.04 HG23 HG21 ' A' ' 50' ' ' VAL . 3.0 p -79.46 -52.16 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 115' ' ' VAL . 32.3 mt-10 -58.75 -40.14 82.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.648 0.261 . . . . 0.0 111.544 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.68 ' HD2' HD12 ' A' ' 114' ' ' LEU . 9.8 ptp180 -65.91 -23.73 66.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 0.0 110.774 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.494 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -71.71 -49.41 39.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.776 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.5 mt -71.05 -31.75 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.7 t -66.08 -34.64 78.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.721 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.09 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.838 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.838 HD13 ' C ' ' A' ' 4' ' ' GLY . 3.9 mm -125.92 120.04 56.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.861 HG23 HG13 ' A' ' 50' ' ' VAL . 7.4 p -110.77 132.17 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.59 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.969 ' CD1' HG22 ' A' ' 31' ' ' THR . 35.0 m0 -119.58 127.44 52.97 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -124.2 122.05 63.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.882 HG23 ' HA ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -111.07 113.63 44.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.201 178.24 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.795 ' HB3' HG21 ' A' ' 15' ' ' ILE . 15.8 t0 -177.36 68.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.195 0.521 . . . . 0.0 111.464 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.8 t70 69.13 -2.14 1.9 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 14' ' ' SER . 6.6 p-10 43.25 -126.8 0.81 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.481 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.62 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 1.7 t 34.94 -82.59 0.0 OUTLIER 'General case' 0 C--N 1.343 0.304 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.755 ' O ' HG23 ' A' ' 18' ' ' VAL . 15.2 t -82.46 -48.4 11.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.655 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.795 HG21 ' HB3' ' A' ' 10' ' ' ASP . 46.6 mm -63.73 -22.4 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.745 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 0.0 OUTLIER -81.58 -55.54 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.358 . . . . 0.0 111.552 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.547 ' H ' ' HG3' ' A' ' 16' ' ' ARG . 85.1 t90 -48.78 -41.69 33.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -70.44 -61.43 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.432 . . . . 0.0 112.058 -178.63 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.54 HD23 HG11 ' A' ' 8' ' ' VAL . 8.3 tp -66.3 -27.36 67.86 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.659 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.504 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . 12.4 pt-20 -67.7 -58.35 4.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.134 0.492 . . . . 0.0 111.446 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.491 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -54.39 -64.68 0.75 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.086 -179.333 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.34 -27.39 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.796 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.7 tm? -82.14 -29.85 31.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.383 0.611 . . . . 0.0 110.467 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.44 73.51 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.55 -26.79 70.04 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.393 -0.908 . . . . 0.0 110.95 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.426 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.27 -15.52 58.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.97 24.54 11.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.051 0.78 . . . . 0.0 115.051 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.67 HD13 HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -126.18 164.15 21.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.611 1.205 . . . . 0.0 112.372 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.805 ' HB ' HG23 ' A' ' 5' ' ' ILE . 79.0 m -79.75 129.09 34.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.038 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 1.8 p -121.67 111.2 16.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.976 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.969 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -135.85 134.03 38.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.745 ' OG1' ' HB3' ' A' ' 16' ' ' ARG . 43.6 p -115.61 155.09 28.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.687 ' CE1' HG23 ' A' ' 31' ' ' THR . 0.0 OUTLIER -136.58 174.1 10.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.226 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.535 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -58.42 -108.9 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.686 ' O ' HG11 ' A' ' 9' ' ' VAL . 24.3 m-80 -85.86 -179.92 6.91 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.565 ' CA ' ' HG ' ' A' ' 65' ' ' LEU . . . -68.71 0.25 14.83 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.391 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 8.2 t30 -81.28 -41.69 21.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.668 0.734 . . . . 0.0 109.507 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.535 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -51.92 -55.31 21.04 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.992 179.102 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.622 HG11 HD11 ' A' ' 51' ' ' LEU . 33.2 t -44.15 -35.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.151 0.501 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 37' ' ' ASN . 14.1 mt -61.84 -50.12 73.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.485 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.99 -48.26 82.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.324 0.583 . . . . 0.0 110.864 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.32 73.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.38 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.676 HD21 ' HD2' ' A' ' 48' ' ' PRO . 10.9 mt -66.62 -24.07 66.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.156 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.94 -18.4 60.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.669 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.55 -8.15 11.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -159.69 159.37 32.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.586 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.559 HG23 HD13 ' A' ' 76' ' ' LEU . 99.3 m -138.8 113.49 8.45 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.688 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.676 ' HD2' HD21 ' A' ' 43' ' ' LEU . 89.1 Cg_endo -80.0 165.34 21.89 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.215 1.944 . . . . 0.0 111.26 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.676 ' O ' ' HD2' ' A' ' 77' ' ' PRO . 3.3 p30 -74.38 -59.03 2.91 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.544 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.861 HG13 HG23 ' A' ' 6' ' ' VAL . 7.6 p -101.72 162.11 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.393 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.636 HD22 HD21 ' A' ' 76' ' ' LEU . 42.4 tp -152.86 152.25 31.33 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.013 0.435 . . . . 0.0 111.705 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -137.31 120.91 17.25 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.936 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.882 ' HA ' HG23 ' A' ' 9' ' ' VAL . 49.1 m -109.07 137.15 47.42 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 39.6 t0 -65.9 -20.59 66.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.694 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.686 HG21 ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER 47.22 79.71 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 112.106 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 171.36 85.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.487 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.651 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -163.3 -66.89 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.684 ' HG2' ' HB3' ' A' ' 64' ' ' ALA . 87.1 Cg_endo -77.4 -165.7 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.451 2.1 . . . . 0.0 113.677 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.98 -51.01 61.76 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.844 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.726 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -74.28 45.41 0.22 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 110.563 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 55.81 -82.15 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.658 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -143.12 -31.92 0.1 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.926 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.668 HD12 ' H ' ' A' ' 63' ' ' LEU . 1.4 mp -49.92 -26.85 4.53 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.726 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -55.33 -30.98 61.3 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.997 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.565 ' HG ' ' CA ' ' A' ' 36' ' ' GLY . 2.3 mm? -60.94 -50.21 74.34 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.983 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.775 HD23 HD12 ' A' ' 69' ' ' ILE . 51.7 mt -49.65 -46.48 49.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.092 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -50.28 -46.59 55.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.211 0.529 . . . . 0.0 110.176 179.404 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -63.38 -38.63 91.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.525 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.775 HD12 HD23 ' A' ' 66' ' ' LEU . 75.2 mt -61.35 -40.85 87.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.521 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 44.5 pttt -72.24 -21.35 61.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.19 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -31.8 62.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.586 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -106.25 -24.0 12.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.031 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.553 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 40.8 m-70 -141.97 86.16 10.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.71 15.57 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.01 2.473 . . . . 0.0 113.127 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.572 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 11.9 mtt -145.36 4.83 1.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.636 HD21 HD22 ' A' ' 51' ' ' LEU . 15.9 tp -76.39 107.44 4.59 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 49' ' ' ASP . 39.3 Cg_exo -58.99 121.14 9.45 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.578 2.185 . . . . 0.0 111.732 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.687 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.3 t -120.64 150.52 23.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.488 0.661 . . . . 0.0 111.922 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.677 ' O ' HD23 ' A' ' 52' ' ' LEU . 3.7 mt -131.79 116.32 30.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.634 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.785 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 13.4 mm -93.43 137.92 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.635 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -85.41 -15.19 43.88 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.512 -179.199 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.686 ' O ' HG21 ' A' ' 55' ' ' ILE . 2.7 m -147.27 163.66 35.69 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.06 -47.62 3.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 110.973 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 44.56 59.37 3.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.978 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 52.37 -170.5 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.782 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.553 ' HB2' HD13 ' A' ' 63' ' ' LEU . 54.1 m-20 59.94 31.88 20.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.52 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.854 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -46.48 -24.25 0.49 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.723 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.81 -45.56 29.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.24 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.595 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.78 -23.07 62.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.675 0.274 . . . . 0.0 111.411 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.854 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -66.81 -46.39 75.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.742 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.7 t -61.3 -36.85 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.8 m -60.93 -41.23 95.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.213 0.53 . . . . 0.0 110.237 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.721 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -54.76 -49.06 71.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.117 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.618 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 8.7 m-85 -51.39 -27.76 10.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.596 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.574 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -70.4 -39.75 74.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.315 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.574 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 7.2 pt20 -77.97 -18.18 56.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.028 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.0 4.99 5.41 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.378 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.721 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -53.1 132.71 38.56 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.269 0.535 . . . . 0.0 110.751 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.792 ' CD2' ' HB2' ' A' ' 118' ' ' ALA . 8.6 t80 -64.14 -53.44 49.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.488 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 0.4 OUTLIER 175.75 -161.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.041 0.448 . . . . 0.0 111.904 -179.683 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.785 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.7 m-85 -132.57 135.86 46.2 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.136 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 103' ' ' PRO . 1.3 pp -126.59 136.49 28.77 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.842 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.814 ' O ' HD12 ' A' ' 102' ' ' LEU . 52.7 Cg_exo -51.68 172.13 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.271 1.98 . . . . 0.0 111.908 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.613 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -41.86 -49.8 10.52 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.649 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.9 Cg_endo -47.91 164.4 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 121.94 1.76 . . . . 0.0 110.704 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.815 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 173.86 -90.16 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.287 -0.165 . . . . 0.0 111.064 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.4 p30 50.98 -178.85 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.754 ' HA ' HG23 ' A' ' 112' ' ' VAL . 1.2 mp -54.46 -49.49 65.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.442 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 9.6 t0 -51.89 -58.79 5.45 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.815 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 4.8 mm-40 -82.41 -27.83 31.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . . . -84.1 -47.27 11.08 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.873 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.754 HG23 ' HA ' ' A' ' 108' ' ' ILE . 53.4 t -62.73 -32.03 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.493 0.663 . . . . 0.0 109.505 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.32 -49.89 75.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.144 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.494 ' CD2' ' HB3' ' A' ' 102' ' ' LEU . 8.3 tp -75.64 -20.94 58.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.433 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.1 p -79.26 -49.41 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 115' ' ' VAL . 34.7 mt-10 -65.35 -44.24 88.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.631 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 117' ' ' ARG . 6.4 mmt180 -63.02 -23.88 67.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.408 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.792 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -73.18 -49.45 27.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.053 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.458 HG12 ' OD1' ' A' ' 49' ' ' ASP . 3.7 mt -67.02 -31.11 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.817 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 t -66.74 -43.11 85.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.752 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.7 m80 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.984 179.899 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.854 -0.098 . . . . 0.0 112.854 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 48' ' ' PRO . 3.4 mp -117.41 115.8 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 0.0 111.512 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.785 HG11 ' HG ' ' A' ' 23' ' ' LEU . 8.3 p -107.11 122.44 61.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.938 ' CD1' HG22 ' A' ' 31' ' ' THR . 35.2 m0 -112.42 137.92 49.91 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.587 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.709 HG13 ' HB2' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -126.55 147.92 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.095 -178.112 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -134.65 121.14 34.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.084 178.075 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.499 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 14.6 t0 -177.33 -147.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.905 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.53 -2.18 4.44 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 14' ' ' SER . 2.3 t70 55.49 -143.03 0.75 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 t 33.2 -90.22 0.01 OUTLIER 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.837 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.8 m -57.8 -52.84 63.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.704 0.288 . . . . 0.0 111.357 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 14.6 mm -62.62 -36.28 74.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.943 0.401 . . . . 0.0 111.556 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.509 ' HA ' HG21 ' A' ' 32' ' ' THR . 11.4 ttt-85 -68.84 -41.92 77.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.313 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.483 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . 33.3 t90 -65.12 -58.7 5.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.306 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 14' ' ' SER . 1.4 t -57.35 -43.61 82.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.106 -178.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.684 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 4.4 mm? -76.85 -31.72 57.04 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.742 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 17.0 pt-20 -64.73 -61.92 1.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.687 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.729 ' HD2' ' H ' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -52.69 -63.87 1.0 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 0.0 112.095 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.16 -35.99 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.374 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.785 ' HG ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -73.87 -30.26 62.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.886 0.374 . . . . 0.0 110.331 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.08 -35.03 79.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.76 69.28 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.129 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.39 -15.34 58.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.65 0.262 . . . . 0.0 111.03 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.64 26.03 10.25 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.73 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -137.44 176.0 9.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.46 0.63 . . . . 0.0 111.316 179.7 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.587 ' O ' HG12 ' A' ' 6' ' ' VAL . 22.2 m -105.87 131.51 53.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.432 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.742 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 2.0 t -119.71 114.31 21.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.86 0.362 . . . . 0.0 111.767 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.938 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -123.08 155.27 37.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 37.8 p -129.92 157.75 41.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.148 0.499 . . . . 0.0 112.167 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.805 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.5 m-85 -133.18 173.25 11.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.614 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.731 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -63.25 -47.21 83.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.199 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.614 ' O ' HG11 ' A' ' 9' ' ' VAL . 42.9 t30 -161.64 168.47 23.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.928 0.394 . . . . 0.0 110.666 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.701 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -49.75 -11.45 0.33 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.573 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -81.91 -45.36 15.56 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.603 0.701 . . . . 0.0 109.913 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.731 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 2.0 tt0 -55.28 -51.69 65.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.019 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.676 HG21 ' CG2' ' A' ' 9' ' ' VAL . 17.9 t -51.55 -33.13 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.035 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.385 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.627 HD13 ' HB3' ' A' ' 68' ' ' GLN . 17.3 mt -57.66 -51.68 68.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.011 0.434 . . . . 0.0 110.13 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.29 -47.45 85.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.746 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.74 -34.54 78.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.096 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.569 ' CD1' HG12 ' A' ' 39' ' ' VAL . 31.5 mt -68.24 -23.87 64.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.865 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.88 -15.33 29.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.329 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.24 -7.81 11.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -164.53 160.73 20.67 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 120.988 0.423 . . . . 0.0 111.46 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.3 m -138.8 112.76 8.34 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.262 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.934 ' HD2' HD11 ' A' ' 76' ' ' LEU . 6.5 Cg_exo -74.83 165.84 30.57 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.638 2.225 . . . . 0.0 111.487 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.11 -25.71 59.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.553 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.755 HG13 HG23 ' A' ' 6' ' ' VAL . 4.2 p -145.02 161.71 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.874 ' O ' HD12 ' A' ' 79' ' ' ILE . 33.1 tp -153.03 150.28 29.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.432 0.634 . . . . 0.0 112.362 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.857 ' O ' HG23 ' A' ' 9' ' ' VAL . 6.2 mt -128.28 115.91 19.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.971 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.627 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -107.95 135.45 49.31 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.167 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 24.0 t0 -75.89 170.96 15.22 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.599 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.661 HG13 ' HA3' ' A' ' 62' ' ' GLY . 1.3 tt -158.56 92.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.349 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.411 ' O ' ' CG ' ' A' ' 57' ' ' MET . 0.1 OUTLIER -124.65 56.91 1.28 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.954 0.407 . . . . 0.0 111.446 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.481 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 5.7 ptt? 47.97 41.75 1.02 Allowed Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 57' ' ' MET . 38.0 Cg_endo -65.44 -81.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.966 1.777 . . . . 0.0 111.319 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.39 -84.61 1.8 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . 1.015 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -87.77 61.18 6.31 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.788 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.6 OUTLIER 67.11 -21.9 0.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.345 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.661 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 135.79 -33.02 2.45 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.583 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 4.8 mp -65.19 -21.67 66.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.015 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.39 -36.4 61.41 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.929 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.701 ' HB3' ' HA3' ' A' ' 36' ' ' GLY . 14.1 mt -56.58 -45.91 81.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.527 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.82 ' HA ' HD12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -58.43 -49.02 78.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.209 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.488 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 7.5 tttp -53.61 -42.3 67.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.217 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.627 ' HB3' HD13 ' A' ' 40' ' ' LEU . 21.8 mm100 -62.33 -40.04 95.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.696 0.284 . . . . 0.0 111.049 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.015 HG22 ' HD2' ' A' ' 73' ' ' HIS . 28.0 mt -56.41 -51.09 68.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.219 0.533 . . . . 0.0 111.187 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.704 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -59.07 -29.63 67.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.225 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.421 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 2.2 mt-30 -69.93 -23.71 63.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.992 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -114.14 -15.05 12.29 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 1.015 ' HD2' HG22 ' A' ' 69' ' ' ILE . 1.7 p80 -106.73 166.34 11.31 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -87.12 -55.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.082 2.521 . . . . 0.0 112.278 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 19.6 mtp -157.38 43.3 0.34 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.619 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.934 HD11 ' HD2' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -72.0 113.32 19.29 Favored Pre-proline 0 N--CA 1.455 -0.188 0 C-N-CA 122.206 0.202 . . . . 0.0 111.407 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 39.9 Cg_endo -68.55 115.54 3.96 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 121.89 1.726 . . . . 0.0 111.945 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.598 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 6.1 t -98.82 150.36 5.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.082 0.467 . . . . 0.0 111.393 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.874 HD12 ' O ' ' A' ' 51' ' ' LEU . 2.1 mt -134.11 115.0 20.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.96 178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.689 HG22 ' H ' ' A' ' 82' ' ' THR . 27.6 mm -93.59 150.02 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.475 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -86.24 -20.05 29.05 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.432 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.689 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.1 m -141.17 142.25 34.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.215 0.531 . . . . 0.0 111.388 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.751 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -135.39 31.75 3.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.524 ' NE2' HG21 ' A' ' 82' ' ' THR . 0.1 OUTLIER -88.79 31.57 0.84 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.477 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.557 ' HB2' HD11 ' A' ' 63' ' ' LEU . 61.6 m -133.96 -161.94 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.713 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.406 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -56.34 86.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.589 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.801 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -51.2 -23.24 3.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 111.459 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.76 -44.9 39.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.958 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.583 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -66.92 -25.31 66.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.951 0.405 . . . . 0.0 111.21 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.801 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -72.57 -22.46 60.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.995 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.516 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 14.5 t -70.89 -41.39 77.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.059 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 32.8 m -65.79 -19.58 65.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.113 0.483 . . . . 0.0 109.935 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.618 ' CB ' HD22 ' A' ' 66' ' ' LEU . . . -64.52 -46.84 81.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.008 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.516 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.4 m-85 -63.93 -29.45 70.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.803 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.407 ' HB3' ' O ' ' A' ' 92' ' ' SER . 2.3 tm0? -63.65 -45.52 89.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.897 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.68 ' HG2' ' HB3' ' A' ' 70' ' ' LYS . 1.4 pp0? -75.03 -18.51 60.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.628 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.64 21.16 4.39 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.533 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.652 ' HB2' ' NE2' ' A' ' 96' ' ' GLN . . . -59.18 157.04 11.13 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 117.082 0.441 . . . . 0.0 110.99 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 21.2 t80 -82.19 -53.38 6.12 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.543 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 169.86 -165.4 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.092 0.472 . . . . 0.0 111.531 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.751 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.2 m-85 -124.17 119.33 29.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.612 HD22 ' CE1' ' A' ' 106' ' ' PHE . 6.0 tp -102.51 134.95 19.65 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.77 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 11.3 Cg_endo -52.66 170.79 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.462 2.108 . . . . 0.0 111.674 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -43.63 -46.83 18.91 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.437 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.77 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 73.4 Cg_exo -48.11 163.36 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.682 1.588 . . . . 0.0 110.416 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.722 ' HD1' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -174.65 -86.66 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.694 -178.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.7 p30 43.42 -170.97 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.621 0.248 . . . . 0.0 110.445 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.845 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -67.91 -45.39 84.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.36 0.6 . . . . 0.0 111.429 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 12.9 t70 -52.8 -55.86 19.9 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.868 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.666 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -79.85 -27.98 40.1 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.722 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.28 -54.26 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.85 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.845 HG21 HG23 ' A' ' 108' ' ' ILE . 36.5 t -58.09 -33.58 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.439 0.637 . . . . 0.0 110.3 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.566 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.19 -51.61 68.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.9 0.857 . . . . 0.0 109.512 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.704 ' CD2' HG21 ' A' ' 79' ' ' ILE . 6.6 tp -76.24 -21.01 56.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.76 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.692 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.1 p -79.45 -50.28 18.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.164 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.471 ' N ' HG13 ' A' ' 115' ' ' VAL . 82.9 mt-10 -65.07 -45.13 86.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.649 0.262 . . . . 0.0 110.538 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -62.01 -26.31 68.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 0.0 110.419 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -72.48 -57.45 4.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.17 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.6 mt -68.43 -30.79 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.132 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.2 m -67.52 -45.12 76.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.026 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 4.6 m80 . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 -179.824 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.1 mp -104.23 113.28 40.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.729 0.3 . . . . 0.0 111.163 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.827 HG11 ' CD2' ' A' ' 23' ' ' LEU . 2.8 p -106.06 129.64 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.665 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.932 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.8 m0 -117.76 141.99 47.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.655 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -134.32 133.5 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.297 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.92 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -117.66 108.85 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.996 178.355 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 37.0 t0 166.84 120.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.436 ' HB3' HG12 ' A' ' 15' ' ' ILE . 1.1 t0 69.75 -45.2 0.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.133 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 16' ' ' ARG . 40.9 t0 75.15 -98.74 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.367 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' ASP . 5.7 p -26.67 -87.73 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.69 ' O ' HG23 ' A' ' 18' ' ' VAL . 35.3 m -54.98 -39.14 68.68 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG12 ' HB3' ' A' ' 11' ' ' ASP . 21.4 mm -68.47 -20.49 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.624 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -74.79 -58.54 3.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 111.236 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.437 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 49.9 t90 -49.96 -41.94 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.498 . . . . 0.0 112.237 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.792 HG12 HD13 ' A' ' 108' ' ' ILE . 1.6 t -70.44 -62.26 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.026 0.441 . . . . 0.0 111.734 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.61 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 3.8 mm? -63.7 -27.36 69.16 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.536 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.677 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 15.1 pt-20 -67.18 -61.06 2.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.654 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 1.1 mmm180 -67.51 -56.88 7.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.409 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -49.25 -59.58 3.55 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.931 0.396 . . . . 0.0 111.718 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.827 ' CD2' HG11 ' A' ' 6' ' ' VAL . 4.0 tp -61.4 -20.98 63.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.068 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -66.55 -38.5 87.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.97 -24.61 65.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.585 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.645 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.82 -15.59 58.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.664 0.269 . . . . 0.0 111.013 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.25 25.74 7.71 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.833 -0.698 . . . . 0.0 113.767 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.703 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.72 170.64 13.58 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 117.5 0.65 . . . . 0.0 111.609 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.0 m -107.26 105.47 15.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.086 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.746 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 2.1 t -98.94 118.1 34.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.177 0.513 . . . . 0.0 112.133 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.932 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -119.7 156.59 30.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.3 p -132.76 152.32 51.8 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.92 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -129.08 174.31 9.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.713 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -57.92 -108.46 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.501 -178.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -78.79 -68.44 0.65 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.115 0.484 . . . . 0.0 111.938 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.878 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -171.91 -33.67 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.046 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.485 ' OD1' HD12 ' A' ' 40' ' ' LEU . 29.7 m-20 -62.14 -30.75 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.692 0.282 . . . . 0.0 110.733 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -54.22 -52.65 60.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.853 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.918 HG11 HD11 ' A' ' 51' ' ' LEU . 63.1 t -54.74 -47.14 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.048 0.451 . . . . 0.0 110.62 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.651 HD13 ' HB2' ' A' ' 68' ' ' GLN . 22.5 mt -50.9 -43.15 59.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.112 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.96 -47.71 67.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.274 0.559 . . . . 0.0 110.715 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.34 -31.81 73.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.5 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.632 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 10.6 mt -61.45 -26.3 67.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.111 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.73 -17.47 60.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.305 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.43 -6.21 11.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.72 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -161.88 162.21 29.16 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.828 0.347 . . . . 0.0 111.075 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.512 HG23 HD13 ' A' ' 76' ' ' LEU . 77.0 m -138.97 112.66 8.2 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.154 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.615 ' HD2' HD21 ' A' ' 43' ' ' LEU . 73.5 Cg_endo -76.58 164.31 30.65 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.899 1.733 . . . . 0.0 111.539 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.49 -23.54 58.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.809 0.338 . . . . 0.0 110.761 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.723 HG13 HG23 ' A' ' 6' ' ' VAL . 6.3 p -145.17 161.58 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.918 HD11 HG11 ' A' ' 39' ' ' VAL . 22.9 tp -151.45 148.42 28.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.524 0.678 . . . . 0.0 112.073 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.893 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 mt -135.72 126.01 26.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.792 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.595 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -111.13 145.25 38.93 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -178.633 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 49.6 t0 -74.16 -19.4 60.57 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.27 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.778 HD13 ' O ' ' A' ' 82' ' ' THR . 7.0 tt 44.96 86.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.63 99.44 0.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.558 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 55.39 44.85 1.76 Allowed Pre-proline 0 N--CA 1.47 0.575 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 177.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.595 ' CD ' ' HA2' ' A' ' 62' ' ' GLY . 26.8 Cg_endo -91.9 -35.87 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.958 2.439 . . . . 0.0 112.422 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.06 -24.91 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.302 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.895 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 23.3 ttt -152.43 71.43 0.94 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.69 -35.45 0.24 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.1 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.641 ' C ' HG13 ' A' ' 55' ' ' ILE . . . 157.82 -34.54 0.53 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.577 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 5.3 mp -66.85 -25.05 66.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.768 0.318 . . . . 0.0 110.485 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.895 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.98 -26.02 23.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.656 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.565 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 76.2 mt -55.96 -40.27 73.0 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.151 0.5 . . . . 0.0 110.061 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.898 ' HA ' HD12 ' A' ' 69' ' ' ILE . 4.8 mp -70.33 -39.43 74.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.049 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.709 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.0 tmtt? -55.2 -42.99 74.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.299 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.651 ' HB2' HD13 ' A' ' 40' ' ' LEU . 12.1 mm100 -69.05 -37.5 78.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.735 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.898 HD12 ' HA ' ' A' ' 66' ' ' LEU . 13.2 mt -62.83 -23.1 32.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.803 0.335 . . . . 0.0 110.849 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.709 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 2.5 mtmp? -75.18 -50.72 15.33 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.105 0.955 . . . . 0.0 109.291 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.13 -33.21 74.04 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.337 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.516 ' NH1' ' HB3' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -94.13 -28.7 15.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.665 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.632 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 40.5 m-70 -153.54 82.4 4.69 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.653 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.709 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 55.5 Cg_endo -71.28 31.76 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.738 2.292 . . . . 0.0 113.172 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -143.78 -37.21 0.34 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.1 0.476 . . . . 0.0 111.238 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.558 HD23 ' CG2' ' A' ' 69' ' ' ILE . 6.7 tp -50.77 129.8 28.02 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.512 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.699 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 51.9 Cg_endo -73.24 122.98 8.44 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.729 2.286 . . . . 0.0 112.181 179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.731 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.3 t -110.28 142.78 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.125 0.488 . . . . 0.0 111.253 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.815 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.1 mt -133.89 113.52 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.383 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.822 ' CG1' HD21 ' A' ' 66' ' ' LEU . 18.9 mm -93.42 137.28 22.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.102 0.477 . . . . 0.0 112.127 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.682 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.84 -4.04 59.06 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.349 -179.168 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.778 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.5 m -148.03 144.19 27.75 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.584 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.775 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -143.78 61.41 1.37 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.336 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -98.93 -22.78 15.6 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.469 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -84.33 -166.49 1.46 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.169 0.509 . . . . 0.0 111.996 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -54.76 97.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.777 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.851 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -51.24 -21.68 2.24 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.3 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -48.59 -45.04 37.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.277 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.577 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.69 -20.61 66.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.804 0.335 . . . . 0.0 110.89 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.851 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -72.98 -32.2 65.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.711 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.562 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.9 t -65.71 -42.73 93.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 19.7 m -63.49 -19.91 65.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.382 . . . . 0.0 110.012 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.724 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -66.37 -44.95 81.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.451 0.643 . . . . 0.0 109.842 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.562 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 5.0 m-85 -65.88 -23.88 66.74 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.868 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.431 ' HB3' ' O ' ' A' ' 92' ' ' SER . 2.0 tm0? -69.1 -36.39 77.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.307 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.724 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -86.68 -18.27 31.67 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.706 179.06 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.13 21.27 3.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.304 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.731 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -65.04 152.79 42.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.212 0.506 . . . . 0.0 110.182 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.547 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 38.6 t80 -81.96 -54.0 5.68 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.441 ' OD2' ' CD2' ' A' ' 99' ' ' PHE . 14.7 p30 174.77 -170.76 0.05 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.993 0.425 . . . . 0.0 111.685 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.775 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 5.1 m-85 -119.72 125.67 49.22 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.771 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.708 HD12 ' HD2' ' A' ' 103' ' ' PRO . 11.0 tp -102.87 139.33 20.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.458 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.714 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 20.9 Cg_endo -58.88 171.83 1.91 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.092 1.861 . . . . 0.0 111.096 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.493 ' HE3' ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -43.18 -45.88 13.98 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.809 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.714 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 87.3 Cg_exo -47.44 163.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.676 1.584 . . . . 0.0 110.843 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.802 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 3.2 t80 -167.56 -92.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.995 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 5.3 p-10 44.12 -173.79 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.654 0.264 . . . . 0.0 110.586 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.792 HD13 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.66 -47.14 81.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.386 0.612 . . . . 0.0 110.849 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.1 t70 -51.01 -58.12 6.88 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.212 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.668 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.7 mm-40 -79.13 -26.77 42.8 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.15 -53.16 5.71 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.138 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.628 HG21 HG23 ' A' ' 108' ' ' ILE . 43.9 t -59.97 -31.45 47.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.507 0.67 . . . . 0.0 110.084 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.23 -50.96 70.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.626 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.704 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 23.8 tp -75.46 -20.46 58.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.517 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.2 p -79.27 -48.03 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.055 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.447 ' N ' HG13 ' A' ' 115' ' ' VAL . 4.1 mt-10 -61.12 -45.66 93.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.726 0.298 . . . . 0.0 110.838 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.613 ' HD2' HD12 ' A' ' 114' ' ' LEU . 4.1 ptp180 -64.2 -23.73 67.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.897 0.379 . . . . 0.0 110.687 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.547 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.22 -49.46 35.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.938 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.1 mt -66.2 -30.89 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.6 m -68.37 -44.01 76.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.3 m80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 -179.761 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.885 ' O ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.232 0 N-CA-C 112.034 -0.426 . . . . 0.0 112.034 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.885 HD13 ' O ' ' A' ' 4' ' ' GLY . 6.3 mm -129.39 113.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.849 HG23 HG13 ' A' ' 50' ' ' VAL . 9.2 p -105.56 127.69 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.838 ' CD1' HG22 ' A' ' 31' ' ' THR . 24.6 m0 -114.67 132.81 56.27 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -127.99 139.8 50.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.005 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -128.38 105.37 13.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.187 179.029 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 58.1 t0 166.72 119.45 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.424 0.453 . . . . 0.0 110.682 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.407 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 72.79 -28.11 0.19 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 10' ' ' ASP . 7.9 t0 73.02 -133.38 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.978 -0.101 . . . . 0.0 110.943 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.1 t -30.71 -48.47 0.11 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.661 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.1 t -53.95 -68.18 0.2 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.654 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.588 ' CG2' HD12 ' A' ' 19' ' ' LEU . 24.8 mm -62.31 -20.76 25.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.55 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.628 ' HA ' HG21 ' A' ' 32' ' ' THR . 6.0 ttt180 -70.53 -60.57 2.19 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.651 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.519 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 57.1 t90 -49.98 -44.52 50.92 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 111.912 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.731 HG12 HD13 ' A' ' 108' ' ' ILE . 1.3 t -64.97 -59.14 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.588 HD12 ' CG2' ' A' ' 15' ' ' ILE . 56.4 mt -70.75 -26.33 63.31 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.558 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 12.8 pt-20 -63.81 -57.88 8.54 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.769 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 2.4 mmp_? -63.75 -60.04 3.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.905 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.88 -56.17 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.977 0.417 . . . . 0.0 111.85 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.531 HD12 ' CG1' ' A' ' 6' ' ' VAL . 1.5 tm? -64.95 -23.75 67.32 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.015 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -71.28 -32.6 68.87 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.56 -26.49 66.65 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.385 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.558 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.31 -15.65 59.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.812 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.01 23.09 11.86 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.798 -0.715 . . . . 0.0 114.326 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.558 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -123.45 163.62 20.52 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.418 1.109 . . . . 0.0 112.167 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.592 ' HB ' HG23 ' A' ' 5' ' ' ILE . 89.9 m -84.53 136.35 33.84 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.626 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -127.97 108.51 10.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.645 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.838 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -121.68 147.59 45.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.9 p -125.59 161.44 27.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.63 0.728 . . . . 0.0 112.958 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.005 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.3 m-85 -136.12 173.86 11.25 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.108 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.475 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.6 pp20? -61.56 -60.51 3.58 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -152.97 -23.79 0.15 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.737 ' C ' HD21 ' A' ' 65' ' ' LEU . . . 166.44 -56.83 0.24 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.067 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.483 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -47.89 -37.5 14.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.014 -179.363 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.876 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 8.3 tt0 -58.42 -55.44 34.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.742 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.747 HG21 ' CG2' ' A' ' 9' ' ' VAL . 2.9 t -51.18 -46.48 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.107 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.627 HD21 ' CD1' ' A' ' 65' ' ' LEU . 31.7 mt -46.55 -45.57 18.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.21 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.07 -48.75 69.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.113 0.482 . . . . 0.0 111.326 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.79 -35.35 79.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.45 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.595 ' HG ' HG12 ' A' ' 39' ' ' VAL . 16.6 mt -63.38 -25.37 68.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.27 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -16.95 22.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.218 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.5 t -121.11 -5.39 9.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.472 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -156.53 160.04 39.13 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.91 0.386 . . . . 0.0 111.665 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.5 m -139.2 112.0 7.94 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.625 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 58.8 Cg_endo -69.47 166.43 27.28 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.717 2.278 . . . . 0.0 111.839 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.86 -27.01 33.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.849 HG13 HG23 ' A' ' 6' ' ' VAL . 4.8 p -147.95 101.17 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.425 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.881 ' O ' HD12 ' A' ' 79' ' ' ILE . 62.7 tp -87.15 141.74 28.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.409 0.623 . . . . 0.0 112.491 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.839 ' O ' HG23 ' A' ' 9' ' ' VAL . 5.3 mt -124.35 117.51 24.65 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -112.5 146.71 37.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.021 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.743 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 20.4 t0 -77.2 179.4 6.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.95 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.757 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.1 tt -156.23 78.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.798 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 50.7 ttp85 176.71 69.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.564 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.467 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -160.9 -67.09 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.879 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 57' ' ' MET . 35.6 Cg_endo -64.86 -176.06 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.536 2.158 . . . . 0.0 113.033 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.8 -54.34 38.14 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.486 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.587 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -78.14 49.23 0.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.733 0.301 . . . . 0.0 110.75 179.675 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.61 -72.13 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.757 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -149.47 -35.51 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.261 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.884 ' HA ' HD23 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -54.61 -21.42 10.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.11 179.693 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.527 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.75 -36.23 62.1 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.737 HD21 ' C ' ' A' ' 36' ' ' GLY . 1.1 tm? -59.97 -40.92 90.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.154 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.884 HD23 ' HA ' ' A' ' 63' ' ' LEU . 4.3 mm? -54.39 -43.94 71.87 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.17 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 53.9 tttm -56.9 -43.46 81.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.319 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.583 ' HB3' HD13 ' A' ' 40' ' ' LEU . 21.0 mm100 -60.93 -34.7 75.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.233 0.54 . . . . 0.0 110.147 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.983 HG23 ' CE1' ' A' ' 73' ' ' HIS . 92.5 mt -58.92 -39.84 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.527 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -69.61 -29.03 66.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.036 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.432 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -70.89 -35.36 72.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.986 -179.83 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.63 -71.64 0.71 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.527 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.983 ' CE1' HG23 ' A' ' 69' ' ' ILE . 4.6 p80 -112.22 71.96 1.15 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.458 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.542 ' O ' ' HG2' ' A' ' 75' ' ' MET . 62.4 Cg_endo -73.62 50.67 2.08 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.595 2.197 . . . . 0.0 113.675 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 8.8 mtm -156.64 -39.51 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.856 HD12 ' HD2' ' A' ' 77' ' ' PRO . 8.7 tp -59.57 130.33 87.8 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-O 120.945 0.403 . . . . 0.0 112.041 -178.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.856 ' HD2' HD12 ' A' ' 76' ' ' LEU . 47.3 Cg_endo -68.55 115.29 3.83 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.307 2.671 . . . . 0.0 113.871 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.95 HG21 HD13 ' A' ' 69' ' ' ILE . 3.2 t -98.38 151.79 4.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.407 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.881 HD12 ' O ' ' A' ' 51' ' ' LEU . 2.0 mt -136.57 114.56 14.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.064 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.617 HD11 HD21 ' A' ' 66' ' ' LEU . 17.9 mm -93.7 146.03 7.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.521 ' HE2' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.45 -14.53 56.94 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.785 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.602 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.8 m -148.43 161.96 40.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.1 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.701 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -145.24 64.04 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.856 0.36 . . . . 0.0 111.246 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.471 ' CD2' ' H ' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -98.89 111.86 24.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.987 0.422 . . . . 0.0 111.558 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.8 t 60.59 161.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.647 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.474 ' HB2' HD13 ' A' ' 63' ' ' LEU . 24.9 m-20 61.91 18.99 10.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.475 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.704 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -46.44 -22.68 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -48.06 -50.17 28.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.34 -20.01 65.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.689 0.281 . . . . 0.0 111.503 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.704 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -63.95 -57.17 10.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.809 0.338 . . . . 0.0 111.008 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.614 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.3 t -62.93 -43.47 99.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.5 m -58.8 -31.68 68.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.183 0.516 . . . . 0.0 110.458 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.689 ' HB1' HD12 ' A' ' 66' ' ' LEU . . . -63.65 -43.68 96.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.36 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.614 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 2.6 m-85 -59.59 -22.19 61.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.545 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.583 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.77 -37.99 54.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.099 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.583 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 2.1 pp0? -100.04 -13.34 19.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.752 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 147.59 82.88 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.615 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.832 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.53 111.24 0.56 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.293 0.568 . . . . 0.0 111.611 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -55.22 -49.81 71.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.919 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.527 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER 173.92 -161.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.067 0.46 . . . . 0.0 111.918 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.701 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.9 m-85 -127.16 130.21 49.32 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.377 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.603 ' HB2' HD22 ' A' ' 114' ' ' LEU . 4.2 tp -108.27 142.43 25.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.11 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.677 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 17.8 Cg_endo -58.99 163.69 11.23 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.261 1.974 . . . . 0.0 111.372 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.421 ' HE2' ' OG1' ' A' ' 82' ' ' THR . 0.5 OUTLIER -36.25 -47.69 1.52 Allowed Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.613 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 84.2 Cg_exo -47.03 163.22 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.818 1.679 . . . . 0.0 110.756 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.669 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 3.6 t80 -165.55 -92.19 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.167 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.4 p-10 42.48 -173.69 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.874 0.369 . . . . 0.0 110.628 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.876 HG23 HG21 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -67.83 -47.49 79.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.285 0.564 . . . . 0.0 111.487 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 12.2 t70 -51.75 -57.58 8.86 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.713 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.669 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.5 mm-40 -78.45 -29.09 46.73 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.564 ' HB3' HD21 ' A' ' 19' ' ' LEU . . . -83.34 -54.55 4.91 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.061 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.876 HG21 HG23 ' A' ' 108' ' ' ILE . 39.6 t -57.2 -32.4 40.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.476 0.655 . . . . 0.0 110.162 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -58.84 -53.15 61.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.064 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.623 HD12 ' HD2' ' A' ' 117' ' ' ARG . 33.4 tp -74.62 -21.39 59.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.98 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.646 HG12 ' HA ' ' A' ' 112' ' ' VAL . 5.1 p -79.57 -50.16 18.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.161 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.457 ' N ' HG13 ' A' ' 115' ' ' VAL . 94.7 mt-10 -65.47 -40.07 92.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.78 0.324 . . . . 0.0 111.026 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.623 ' HD2' HD12 ' A' ' 114' ' ' LEU . 5.6 ptp180 -65.96 -27.52 68.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.461 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.19 -51.99 26.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.004 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.1 mt -65.29 -31.86 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.161 0.505 . . . . 0.0 111.033 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -43.58 76.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 2.2 mp -124.2 113.49 36.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.478 0.656 . . . . 0.0 111.022 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.885 HG23 HG13 ' A' ' 50' ' ' VAL . 10.4 p -107.21 120.36 58.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.502 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.928 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.0 m0 -112.26 145.8 39.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.069 0.461 . . . . 0.0 110.222 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.949 ' CG1' HG22 ' A' ' 32' ' ' THR . 0.2 OUTLIER -137.29 149.67 25.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -176.145 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.98 HG13 ' HB2' ' A' ' 33' ' ' PHE . 1.4 t -133.28 105.17 7.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.787 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.58 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 44.1 t0 166.85 122.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.687 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.416 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 72.04 -40.92 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.821 179.696 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 37.6 t0 75.28 -121.92 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.849 -0.159 . . . . 0.0 110.729 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.4 t -31.33 -47.54 0.11 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.515 ' O ' HG23 ' A' ' 18' ' ' VAL . 47.5 t -63.8 -63.32 1.2 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.342 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.961 HG22 HG21 ' A' ' 32' ' ' THR . 20.1 mm -63.21 -25.16 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.418 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.469 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 7.3 ttt180 -61.58 -58.05 9.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.02 0.438 . . . . 0.0 111.445 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.477 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 53.5 t90 -56.69 -46.28 81.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.649 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.708 HG12 HD13 ' A' ' 108' ' ' ILE . 2.0 t -65.47 -44.41 94.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.534 HD12 ' CD1' ' A' ' 108' ' ' ILE . 5.6 tp -83.06 -23.97 32.93 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.732 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 26.5 pt-20 -66.78 -56.19 11.56 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.729 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.3 mmm180 -65.51 -56.33 12.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.122 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.62 -45.65 73.73 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.811 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.3 tm? -69.21 -26.71 64.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.531 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.22 -32.44 73.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.14 -29.02 71.64 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.21 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.549 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.76 -15.37 59.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 110.982 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.45 26.06 11.43 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.695 -0.765 . . . . 0.0 113.863 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.549 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -133.74 171.2 14.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.75 0.775 . . . . 0.0 111.903 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.647 ' O ' HG12 ' A' ' 6' ' ' VAL . 25.8 m -94.27 128.82 40.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.225 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.732 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 1.8 t -122.97 120.94 34.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.264 0.554 . . . . 0.0 111.865 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.928 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -134.3 132.32 39.43 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.961 HG21 HG22 ' A' ' 15' ' ' ILE . 76.5 p -107.97 159.28 16.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.484 0.659 . . . . 0.0 112.27 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.98 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.7 m-85 -131.96 174.2 10.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.12 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.498 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -63.36 -106.78 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.92 -178.425 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.433 ' O ' HD21 ' A' ' 65' ' ' LEU . 10.9 p30 -88.85 -49.56 6.74 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.87 ' HA3' HD23 ' A' ' 65' ' ' LEU . . . 173.83 -43.37 0.15 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.066 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.607 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 67.0 m-80 -53.08 -24.72 10.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 111.2 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -57.2 -60.02 4.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.43 179.419 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.722 HG21 HD11 ' A' ' 51' ' ' LEU . 72.7 t -58.65 -35.94 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.722 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.709 HD13 ' HB3' ' A' ' 68' ' ' GLN . 40.3 mt -47.17 -46.14 23.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 0.0 110.489 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.63 -45.95 34.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.972 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.56 -29.81 66.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.865 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.695 ' CD1' HG12 ' A' ' 39' ' ' VAL . 12.2 mt -72.05 -23.54 61.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.664 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.32 -17.71 13.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.606 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.55 -7.25 9.69 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.595 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -159.67 159.14 32.64 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.74 0.305 . . . . 0.0 111.397 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.593 HG23 HD13 ' A' ' 76' ' ' LEU . 93.5 m -138.75 114.33 8.63 Favored Pre-proline 0 N--CA 1.454 -0.263 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.713 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.686 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.9 Cg_endo -78.69 165.04 25.21 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.371 2.047 . . . . 0.0 111.331 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.03 -26.68 60.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.929 0.395 . . . . 0.0 110.451 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.885 HG13 HG23 ' A' ' 6' ' ' VAL . 10.0 p -145.11 161.09 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.722 HD11 HG21 ' A' ' 39' ' ' VAL . 13.5 tp -152.92 140.08 19.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.222 0.534 . . . . 0.0 112.3 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.88 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -104.55 137.6 42.16 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.489 179.436 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.661 ' OG ' HD22 ' A' ' 65' ' ' LEU . 26.2 t -127.72 133.98 49.55 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 32.0 t0 -83.08 172.87 12.26 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.242 0.544 . . . . 0.0 111.499 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.729 HG21 ' HB ' ' A' ' 82' ' ' THR . 0.6 OUTLIER -140.24 84.05 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.956 -179.551 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -111.49 36.28 3.3 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.744 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.694 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 52.87 53.28 11.81 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 178.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HG3' HD11 ' A' ' 65' ' ' LEU . 43.5 Cg_endo -75.02 -65.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.322 2.015 . . . . 0.0 111.831 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.44 -27.25 1.21 Allowed Glycine 0 CA--C 1.518 0.239 0 N-CA-C 111.824 -0.511 . . . . 0.0 111.824 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.726 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -155.09 63.09 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.694 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 4.3 p-10 54.12 -82.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.026 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.686 ' HA3' ' HB ' ' A' ' 55' ' ' ILE . . . -137.46 -24.24 0.43 Allowed Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.691 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.915 HD23 ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -77.51 -19.11 56.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.735 0.268 . . . . 0.0 111.106 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.726 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -55.14 -31.26 61.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.336 0.588 . . . . 0.0 109.897 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.87 HD23 ' HA3' ' A' ' 36' ' ' GLY . 6.6 mp -67.5 -36.27 80.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.425 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.796 HD13 ' HB2' ' A' ' 93' ' ' ALA . 14.1 mt -63.22 -42.64 99.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.912 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 50.4 tttm -55.01 -54.2 45.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.882 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.709 ' HB3' HD13 ' A' ' 40' ' ' LEU . 2.4 mt-30 -54.75 -43.13 72.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.154 179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.737 HD13 HG21 ' A' ' 78' ' ' VAL . 21.0 mt -59.17 -40.55 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.131 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -74.2 -23.07 59.15 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.981 -179.245 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -68.41 -51.21 46.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -93.48 -35.58 12.88 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.687 ' CE1' HD13 ' A' ' 43' ' ' LEU . 1.2 m80 -99.65 144.04 27.57 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.603 -178.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 73' ' ' HIS . 27.9 Cg_exo -61.58 -70.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.623 2.215 . . . . 0.0 112.711 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 60.7 mtt -147.77 52.96 1.04 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.936 0.398 . . . . 0.0 111.516 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.593 HD13 HG23 ' A' ' 47' ' ' THR . 5.5 tp -72.34 113.8 24.03 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.639 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -53.49 132.73 50.2 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.191 1.928 . . . . 0.0 111.793 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.737 HG21 HD13 ' A' ' 69' ' ' ILE . 2.5 t -126.67 146.64 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.566 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.68 HG21 HD23 ' A' ' 114' ' ' LEU . 3.3 mt -126.88 116.39 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.955 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.822 HD13 ' CD1' ' A' ' 101' ' ' TYR . 1.4 mp -94.16 145.44 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.889 0.376 . . . . 0.0 111.306 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.708 ' HE1' HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -87.68 -22.21 24.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.248 -178.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.729 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.4 m -147.68 145.65 28.98 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.371 -0.206 . . . . 0.0 110.453 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.406 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -103.32 -29.28 11.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.73 0.3 . . . . 0.0 111.606 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.481 ' HB2' HD11 ' A' ' 55' ' ' ILE . 3.3 m-70 44.75 -92.67 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.448 ' O ' HD11 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -141.26 -172.84 3.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.942 0.401 . . . . 0.0 111.479 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 58.15 33.29 23.01 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.007 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.58 ' HA ' HD21 ' A' ' 63' ' ' LEU . 3.2 mt -48.82 -21.17 0.59 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.409 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -47.82 -44.55 28.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.636 0.255 . . . . 0.0 111.45 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -69.68 -21.61 63.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.577 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.915 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -68.11 -32.94 73.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.65 0.262 . . . . 0.0 111.026 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.533 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 9.8 t -71.27 -39.05 72.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.552 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 95.0 p -69.46 -20.23 63.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.805 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.796 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -66.84 -42.47 85.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.365 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.533 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 7.6 m-85 -64.6 -25.83 68.14 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -77.2 -38.51 51.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.62 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.687 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.7 pp0? -77.42 -18.45 57.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.295 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.11 -10.53 5.64 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.453 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.487 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -48.37 155.79 0.48 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.068 0.434 . . . . 0.0 111.329 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.65 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 18.7 t80 -86.41 -53.89 4.74 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.492 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER 169.23 -166.06 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.855 0.36 . . . . 0.0 111.337 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.822 ' CD1' HD13 ' A' ' 80' ' ' ILE . 3.4 m-85 -121.46 133.83 55.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.287 0.565 . . . . 0.0 111.292 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.809 HD12 ' HD2' ' A' ' 103' ' ' PRO . 3.9 tp -120.76 141.63 32.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.905 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.809 ' HD2' HD12 ' A' ' 102' ' ' LEU . 19.5 Cg_endo -56.66 168.24 2.41 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.418 2.079 . . . . 0.0 111.815 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.572 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -43.09 -54.0 9.79 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.886 -0.143 . . . . 0.0 111.179 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 7.2 Cg_endo -48.43 163.88 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.878 1.719 . . . . 0.0 110.384 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.848 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 173.81 -86.89 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.4 p30 50.12 -178.58 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.736 HG23 HG21 ' A' ' 112' ' ' VAL . 1.1 mp -55.83 -47.55 79.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.509 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 4.4 t70 -54.57 -58.63 6.72 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.822 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.848 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 5.5 mm-40 -81.93 -25.59 34.78 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.19 -51.16 7.73 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.518 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.736 HG21 HG23 ' A' ' 108' ' ' ILE . 46.5 t -61.24 -32.75 53.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.486 0.66 . . . . 0.0 110.099 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -58.98 -50.62 73.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.218 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.68 HD23 HG21 ' A' ' 79' ' ' ILE . 7.5 tp -77.1 -21.03 54.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.42 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 112' ' ' VAL . 3.0 p -78.18 -47.49 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.751 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 52.9 mt-10 -62.73 -42.4 99.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.83 0.348 . . . . 0.0 110.571 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -66.53 -24.48 66.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.612 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.65 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -73.23 -54.15 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.936 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -61.13 -31.44 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.981 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.0 t -70.06 -41.07 74.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.009 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.053 0.454 . . . . 0.0 111.024 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.4 mp -107.91 115.54 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.853 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.8 HG11 ' CD2' ' A' ' 23' ' ' LEU . 3.0 p -107.01 126.69 63.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.937 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.777 ' CD1' HG22 ' A' ' 31' ' ' THR . 32.8 m0 -114.48 147.26 39.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.886 0.374 . . . . 0.0 110.643 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.968 HG21 HD23 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -137.28 145.75 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.924 0.392 . . . . 0.0 111.669 -178.526 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.899 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -129.28 112.14 24.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.231 178.323 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.697 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 7.5 t70 -165.21 -154.29 0.21 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.142 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.423 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -67.05 8.77 0.25 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.422 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 10' ' ' ASP . 2.9 p30 45.39 -143.84 0.21 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t 34.97 -91.78 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.817 ' O ' HG23 ' A' ' 18' ' ' VAL . 12.2 m -58.62 -52.33 66.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.703 0.287 . . . . 0.0 111.192 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.3 mm -62.69 -29.13 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.217 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.831 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.2 OUTLIER -72.79 -57.66 3.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.806 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.412 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 77.1 t90 -50.2 -40.33 46.79 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 14' ' ' SER . 1.8 t -71.42 -56.41 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.968 HD23 HG21 ' A' ' 8' ' ' VAL . 6.0 tp -71.59 -23.02 61.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.685 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.79 -60.08 2.81 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.535 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.57 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.0 mmm180 -72.64 -52.86 13.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.866 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.465 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -50.62 -60.01 3.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.975 0.416 . . . . 0.0 111.598 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.8 ' CD2' HG11 ' A' ' 6' ' ' VAL . 4.5 tp -61.82 -22.7 65.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.288 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -67.56 -37.49 82.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.8 -24.31 68.12 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.571 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.48 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.11 -15.61 59.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.664 0.269 . . . . 0.0 110.924 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.57 24.06 7.61 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.963 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.636 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -130.37 172.14 12.18 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 117.686 0.743 . . . . 0.0 111.376 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 m -105.7 105.77 15.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.465 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.764 ' HA ' HG13 ' A' ' 6' ' ' VAL . 5.7 t -100.57 115.64 30.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.136 0.493 . . . . 0.0 112.235 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.777 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -117.82 156.33 28.54 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.831 HG21 ' HA ' ' A' ' 16' ' ' ARG . 29.8 p -130.12 161.05 31.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.229 0.537 . . . . 0.0 111.439 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.864 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.5 m-85 -133.57 174.46 10.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.42 -178.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.527 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.4 pp20? -59.04 -49.57 77.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -154.52 -51.43 0.09 Allowed 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.99 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.788 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -175.92 -44.38 0.06 OUTLIER Glycine 0 C--N 1.315 -0.597 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.967 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.434 ' OD1' HD12 ' A' ' 40' ' ' LEU . 17.7 m-20 -62.49 -27.38 69.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.018 0.437 . . . . 0.0 110.648 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.674 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -59.65 -47.6 84.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.012 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.846 HG21 HG22 ' A' ' 9' ' ' VAL . 21.4 t -62.38 -42.07 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.977 0.418 . . . . 0.0 111.063 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.604 HD13 ' CB ' ' A' ' 68' ' ' GLN . 25.8 mt -52.07 -42.28 63.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.731 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.79 -48.35 38.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.199 0.523 . . . . 0.0 110.947 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.92 -32.15 72.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.009 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.728 HD13 ' CE1' ' A' ' 73' ' ' HIS . 12.9 mt -68.89 -21.32 64.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.609 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.19 -19.99 37.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.706 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.88 -1.15 6.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -153.69 153.27 31.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.942 0.401 . . . . 0.0 111.007 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.716 HG23 HD13 ' A' ' 76' ' ' LEU . 95.5 m -139.02 112.55 8.15 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.247 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.7 Cg_endo -77.42 164.2 28.96 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.944 1.763 . . . . 0.0 111.325 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.37 -25.6 59.6 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.693 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.596 HG13 HG23 ' A' ' 6' ' ' VAL . 4.8 p -145.07 159.68 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.005 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.535 HD11 HG11 ' A' ' 39' ' ' VAL . 14.9 tp -152.94 155.81 37.71 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.235 0.541 . . . . 0.0 112.179 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.899 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.7 mt -136.52 127.55 27.76 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.373 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.597 ' HB3' HD12 ' A' ' 80' ' ' ILE . 42.4 t -106.68 140.27 39.81 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.697 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 10.0 t0 -65.8 -35.87 81.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.697 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.866 HG21 HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER 45.12 90.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.971 0.415 . . . . 0.0 110.632 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.91 90.31 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.595 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 53.6 44.99 2.14 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.457 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.626 ' HG3' ' HA2' ' A' ' 62' ' ' GLY . 90.0 Cg_endo -89.3 -54.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.574 2.183 . . . . 0.0 112.139 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.43 -19.42 0.09 OUTLIER Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.633 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.947 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 3.0 tpt -163.59 69.85 0.21 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.146 0.498 . . . . 0.0 110.132 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.54 -22.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.303 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.626 ' HA2' ' HG3' ' A' ' 58' ' ' PRO . . . 139.83 -34.86 1.98 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.236 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.776 HD13 ' HB3' ' A' ' 86' ' ' ASP . 4.9 mp -72.67 -16.32 61.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.509 -0.345 . . . . 0.0 111.047 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.947 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.68 -33.34 55.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.216 0.532 . . . . 0.0 110.191 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.564 HD13 ' HA3' ' A' ' 36' ' ' GLY . 49.6 mt -60.98 -35.62 77.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.561 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.906 HD11 HD11 ' A' ' 80' ' ' ILE . 3.6 mm? -61.28 -45.04 96.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.164 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.573 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 61.2 tttt -54.44 -41.48 69.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.62 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.604 ' CB ' HD13 ' A' ' 40' ' ' LEU . 11.6 mm100 -67.46 -33.41 75.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.627 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 66' ' ' LEU . 92.8 mt -63.96 -38.37 82.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.829 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.36 -24.47 46.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.758 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.09 -34.25 20.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.825 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.86 -25.57 16.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.728 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -126.36 163.4 40.55 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.795 0.331 . . . . 0.0 111.265 -179.605 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 40.1 Cg_endo -72.07 -81.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.571 2.181 . . . . 0.0 112.857 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.629 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.0 mpt? -138.95 48.09 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 111.152 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.716 HD13 HG23 ' A' ' 47' ' ' THR . 4.7 tp -63.72 118.01 40.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.793 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.24 119.04 5.88 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.146 1.897 . . . . 0.0 111.87 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.554 HG21 HG21 ' A' ' 69' ' ' ILE . 2.3 t -117.11 139.71 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.271 0.558 . . . . 0.0 111.554 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.768 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.9 mt -123.7 115.47 45.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.445 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.906 HD11 HD11 ' A' ' 66' ' ' LEU . 4.8 mm -93.53 127.47 45.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.637 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 1.1 ptp -80.26 -2.09 43.6 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.625 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.807 ' HB ' HG23 ' A' ' 55' ' ' ILE . 2.7 m -147.87 142.87 26.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.73 0.3 . . . . 0.0 110.715 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.913 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -162.93 65.22 0.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.908 0.385 . . . . 0.0 111.004 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -98.26 -45.57 6.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.186 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.39 165.74 17.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 111.293 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.776 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.4 OUTLIER 59.91 24.08 13.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.429 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.606 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 4.7 mt -48.73 -21.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -48.01 -55.23 10.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.662 0.268 . . . . 0.0 111.58 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.475 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -60.0 -20.56 58.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.748 0.309 . . . . 0.0 111.095 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -66.96 -39.07 87.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.44 . . . . 0.0 110.419 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.601 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 16.2 t -64.99 -45.27 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.362 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 p -61.34 -32.39 72.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 110.403 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.679 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -58.83 -39.03 80.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.115 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.601 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 20.3 m-85 -61.76 -20.9 64.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.99 0.424 . . . . 0.0 110.164 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.648 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.49 -42.51 52.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.444 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.679 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -75.66 -16.56 60.17 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.029 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.23 24.43 2.22 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.297 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.553 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -65.85 140.13 58.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.819 0.31 . . . . 0.0 110.5 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 47.9 t80 -72.52 -53.67 11.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.198 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.623 ' OD2' HD11 ' A' ' 114' ' ' LEU . 47.4 p-10 178.26 -160.69 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.709 0.29 . . . . 0.0 111.38 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.913 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 8.1 m-85 -141.87 113.36 7.71 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.726 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.653 HD11 ' O ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -105.33 142.8 25.47 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.593 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.63 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 9.4 Cg_endo -51.01 166.97 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.002 2.468 . . . . 0.0 112.212 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.701 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -40.89 -42.94 4.04 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.701 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 3.6 Cg_endo -45.99 163.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.02 1.814 . . . . 0.0 110.328 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.831 ' HE2' HD22 ' A' ' 52' ' ' LEU . 43.6 t80 -169.93 -95.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.947 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.6 p30 44.27 -172.39 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.691 0.281 . . . . 0.0 110.551 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.786 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -67.71 -47.79 78.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.14 0.495 . . . . 0.0 112.069 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 37.3 m-20 -52.29 -54.53 30.28 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.716 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.687 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.4 mm-40 -80.24 -30.11 38.47 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.5 -51.0 7.72 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.2 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.734 ' HA ' HG12 ' A' ' 115' ' ' VAL . 40.6 t -61.47 -32.91 54.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.498 0.666 . . . . 0.0 110.241 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.34 -50.55 73.16 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.818 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.623 HD11 ' OD2' ' A' ' 100' ' ' ASP . 13.6 tp -77.65 -21.17 52.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.443 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.734 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.5 p -79.44 -50.74 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.494 ' N ' HG13 ' A' ' 115' ' ' VAL . 25.5 mt-10 -62.75 -42.45 99.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 110.843 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -63.28 -23.71 67.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.436 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.498 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -73.1 -55.98 5.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.067 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.9 mt -65.47 -31.6 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.13 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.5 t -66.77 -40.18 88.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.956 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 9.2 m80 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.176 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.462 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.405 HG23 ' HB ' ' A' ' 29' ' ' THR . 2.3 mp -122.19 113.48 38.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.787 0.327 . . . . 0.0 111.357 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.798 HG23 HG13 ' A' ' 50' ' ' VAL . 11.8 p -105.45 131.51 54.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.365 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.824 ' CD1' HG22 ' A' ' 31' ' ' THR . 32.1 m0 -118.1 135.99 53.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.797 0.332 . . . . 0.0 110.764 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -127.19 138.21 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.9 -178.307 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.021 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -125.64 115.73 44.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.66 178.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.911 ' HB2' ' HE2' ' A' ' 81' ' ' MET . 12.5 t0 -170.95 -149.05 0.06 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.802 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -66.05 -3.04 4.69 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.443 ' OD1' ' HD3' ' A' ' 16' ' ' ARG . 2.4 t70 55.15 -141.24 0.87 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.304 0.113 . . . . 0.0 111.304 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 t 36.12 -92.25 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.811 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.2 t -60.47 -50.11 74.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.765 0.317 . . . . 0.0 111.044 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.86 -32.43 55.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 111.3 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.827 ' HA ' HG21 ' A' ' 32' ' ' THR . 11.8 ttt180 -70.98 -59.48 2.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.213 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.434 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 64.7 t90 -47.88 -44.47 29.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 14' ' ' SER . 1.9 t -67.59 -61.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.048 0.452 . . . . 0.0 111.932 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.573 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 37.1 mt -66.72 -25.63 66.62 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.615 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 19.8 pt-20 -66.05 -59.13 4.1 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.56 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.615 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.5 mmt180 -74.54 -59.94 2.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.133 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.01 -51.84 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.598 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.1 tm? -62.71 -31.99 73.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.173 0.511 . . . . 0.0 110.789 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 28' ' ' LEU . . . -65.32 -34.89 79.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.651 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.22 -24.49 67.34 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.452 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.91 -15.6 59.63 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 111.153 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.79 14.0 16.76 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.809 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -127.12 172.51 10.47 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.85 0.825 . . . . 0.0 111.449 179.809 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 6' ' ' VAL . 57.2 m -105.56 113.95 27.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.309 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 35.8 t -107.62 114.43 28.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.172 0.51 . . . . 0.0 111.935 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.824 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -118.12 154.23 32.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.827 HG21 ' HA ' ' A' ' 16' ' ' ARG . 44.7 p -126.35 159.52 32.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.214 0.53 . . . . 0.0 112.12 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.021 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.8 m-85 -134.18 174.05 10.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.921 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -60.4 -53.55 56.23 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -176.654 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -156.88 -32.09 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.885 0.766 . . . . 0.0 112.844 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.739 ' HA3' ' HG ' ' A' ' 65' ' ' LEU . . . 167.79 -51.41 0.23 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.012 -1.089 . . . . 0.0 113.383 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.537 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -56.18 -29.87 61.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.864 0.364 . . . . 0.0 110.837 -179.206 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -62.46 -53.9 48.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.8 HG21 HG22 ' A' ' 9' ' ' VAL . 4.8 t -53.81 -37.59 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.382 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.769 HD21 ' CD1' ' A' ' 65' ' ' LEU . 17.7 mt -54.21 -43.05 70.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.04 0.448 . . . . 0.0 110.441 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.87 -47.15 66.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.993 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.02 -35.02 79.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.197 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.556 HD13 ' CE1' ' A' ' 73' ' ' HIS . 17.3 mt -66.52 -24.5 66.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.883 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.08 -19.06 17.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.961 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.13 -8.95 9.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -149.49 157.34 43.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.396 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.589 HG23 HD23 ' A' ' 76' ' ' LEU . 67.0 m -139.2 112.66 8.05 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.361 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.524 ' CD ' HD21 ' A' ' 43' ' ' LEU . 73.9 Cg_endo -75.56 165.43 30.5 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.143 1.896 . . . . 0.0 111.298 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.85 -25.09 59.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.019 0.437 . . . . 0.0 110.334 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.798 HG13 HG23 ' A' ' 6' ' ' VAL . 6.4 p -145.84 161.99 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.807 ' O ' HD12 ' A' ' 79' ' ' ILE . 19.3 tp -152.83 144.88 23.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.504 0.668 . . . . 0.0 111.623 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.904 HD22 ' CZ ' ' A' ' 106' ' ' PHE . 2.2 mt -127.92 115.26 18.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.687 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -106.87 143.68 34.61 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.848 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.561 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 15.6 t0 -73.5 176.84 5.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.734 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.887 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 6.6 tt -153.07 81.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.69 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 172.96 54.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.341 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.429 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.23 -62.5 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.454 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.606 ' HG2' ' HA2' ' A' ' 62' ' ' GLY . 18.9 Cg_endo -56.4 -177.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.672 2.248 . . . . 0.0 112.833 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -50.44 -75.53 0.21 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.59 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.777 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -71.26 59.88 0.28 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 110.462 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.29 -73.57 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.312 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.887 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.77 -35.82 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.083 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.868 ' HA ' HD23 ' A' ' 66' ' ' LEU . 2.8 mp -55.24 -24.11 26.02 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.605 0.241 . . . . 0.0 111.032 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -55.4 -35.86 65.78 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.254 0.549 . . . . 0.0 109.996 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.769 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -58.46 -40.6 83.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.009 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.868 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.4 mm? -57.92 -43.23 86.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -55.25 -45.16 76.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.51 178.901 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -66.22 -34.27 77.65 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.932 0.396 . . . . 0.0 110.423 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.811 HD12 ' HA ' ' A' ' 66' ' ' LEU . 55.9 mt -60.18 -44.67 95.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.597 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -74.72 -21.4 59.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.601 -179.279 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 -35.02 26.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.625 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -100.45 -39.82 7.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.556 ' CE1' HD13 ' A' ' 43' ' ' LEU . 2.1 m80 -102.12 151.79 38.12 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.696 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -96.37 102.3 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.252 2.635 . . . . 0.0 113.027 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.632 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 22.8 mtm 57.0 30.66 18.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.024 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.589 HD23 HG23 ' A' ' 47' ' ' THR . 2.2 tm? -64.99 111.4 5.8 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.527 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.432 ' HD2' HD22 ' A' ' 76' ' ' LEU . 43.8 Cg_exo -57.91 116.31 3.14 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.605 2.203 . . . . 0.0 112.531 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.875 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 1.6 t -116.4 151.01 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.646 0.736 . . . . 0.0 111.994 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.857 ' HB ' HD23 ' A' ' 52' ' ' LEU . 1.9 mp -139.67 119.26 13.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.759 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.63 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 21.8 mm -93.67 150.38 3.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.242 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.911 ' HE2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -82.35 -27.98 31.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.387 -177.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.66 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 18.0 m -133.98 157.35 46.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.567 0.222 . . . . 0.0 110.588 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.618 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -148.94 62.2 1.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.962 0.411 . . . . 0.0 111.326 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 -93.98 0.12 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.706 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.46 160.35 22.71 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.078 0.466 . . . . 0.0 112.0 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.511 ' HB2' HD13 ' A' ' 63' ' ' LEU . 3.7 m-20 62.26 15.87 7.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.603 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.606 ' HA ' HD21 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -47.28 -23.46 0.56 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.507 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.31 -48.17 36.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.512 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -64.68 -20.52 66.35 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.582 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -58.72 -33.72 70.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.528 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.609 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.2 t -67.44 -36.92 77.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.582 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.527 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 16.5 m -63.31 -20.12 65.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.241 0.544 . . . . 0.0 109.706 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.751 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.65 -53.75 8.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.751 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.609 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.3 m-85 -59.31 -33.87 71.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.142 0.496 . . . . 0.0 110.675 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.2 pp0? -74.65 -38.02 62.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.051 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.751 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 2.9 pp0? -74.59 -18.31 60.59 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.897 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.0 -6.57 3.44 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.574 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.875 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -58.98 148.93 28.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.067 0.434 . . . . 0.0 111.62 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.509 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 40.8 t80 -78.07 -53.06 7.82 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.717 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.545 ' OD2' HD11 ' A' ' 114' ' ' LEU . 13.4 p30 -179.96 -166.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.328 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.618 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 3.0 m-85 -127.68 141.33 51.64 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.165 0.507 . . . . 0.0 111.402 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.63 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 4.5 tp -102.41 145.91 31.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.541 ' O ' HG23 ' A' ' 82' ' ' THR . 29.2 Cg_endo -68.89 -39.81 7.74 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.032 1.821 . . . . 0.0 112.36 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.686 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER 173.85 -48.77 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.773 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.4 Cg_endo -47.62 163.99 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.887 1.725 . . . . 0.0 109.78 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.904 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 2.5 t80 -166.09 -91.74 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.972 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.538 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.9 p-10 41.76 -174.94 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.997 0.427 . . . . 0.0 110.979 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.954 HG23 HG21 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -67.97 -49.55 67.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.392 0.615 . . . . 0.0 111.396 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.564 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -49.68 -57.77 6.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.974 -179.526 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.713 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.1 mm-40 -76.44 -29.97 57.18 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.569 ' HB3' HD21 ' A' ' 19' ' ' LEU . . . -83.19 -60.38 2.17 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.771 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.954 HG21 HG23 ' A' ' 108' ' ' ILE . 32.6 t -50.93 -33.74 12.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.45 0.643 . . . . 0.0 110.416 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.72 -51.05 71.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.379 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.831 HD23 HG21 ' A' ' 79' ' ' ILE . 9.3 tp -76.82 -20.31 56.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.814 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 112' ' ' VAL . 3.7 p -79.34 -48.77 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.151 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.463 ' N ' HG13 ' A' ' 115' ' ' VAL . 22.8 mt-10 -61.97 -46.75 87.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.853 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.56 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 4.5 ptm180 -64.0 -23.44 67.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.823 0.344 . . . . 0.0 110.701 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.509 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.65 -50.98 21.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.47 -30.93 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.262 0.553 . . . . 0.0 110.783 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.7 m -70.15 -40.85 74.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.838 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.6 m170 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.845 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.761 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.242 -0.343 . . . . 0.0 112.242 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.761 HD13 ' C ' ' A' ' 4' ' ' GLY . 5.3 mm -123.63 112.44 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.061 0.457 . . . . 0.0 111.578 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.12 HG11 HD13 ' A' ' 23' ' ' LEU . 2.8 p -115.78 120.89 66.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.86 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.94 ' CD1' HG22 ' A' ' 31' ' ' THR . 29.8 m0 -112.85 142.86 45.02 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.144 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.71 HG21 HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -132.69 144.77 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.261 -178.409 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.038 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -132.08 121.57 46.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.225 178.176 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.5 t0 -176.42 -148.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.284 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.27 -1.77 3.7 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.1 -146.72 0.5 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 121.288 -0.165 . . . . 0.0 110.843 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 14' ' ' SER . 85.5 p 34.06 -93.1 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.836 ' O ' HG23 ' A' ' 18' ' ' VAL . 49.7 p -52.88 -58.07 8.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.257 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.6 mm -60.61 -31.41 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.01 0.433 . . . . 0.0 111.253 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.695 ' HA ' HG21 ' A' ' 32' ' ' THR . 13.5 ttt85 -72.86 -59.51 2.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.82 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.466 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 16.9 t90 -46.99 -43.76 19.63 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -68.39 -62.85 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.806 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.738 ' HG ' HD12 ' A' ' 23' ' ' LEU . 6.1 tp -67.89 -21.77 65.13 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.724 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.0 pt-20 -67.54 -60.06 2.86 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.672 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.555 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -75.02 -47.3 29.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.521 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -54.89 -58.52 7.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.748 0.309 . . . . 0.0 111.772 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.12 HD13 HG11 ' A' ' 6' ' ' VAL . 2.8 mt -59.01 -28.24 66.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -61.77 -36.89 82.36 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.5 -24.99 71.25 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.457 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.652 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.67 -15.57 59.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 110.957 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.76 25.95 7.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.486 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.031 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.44 172.26 11.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.374 0.587 . . . . 0.0 111.401 179.654 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.2 m -104.1 109.46 21.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.22 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.724 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 7.6 t -106.65 110.51 22.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.198 0.523 . . . . 0.0 111.898 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.94 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.3 t -121.26 151.79 39.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.917 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.8 p -124.75 161.09 27.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.288 0.566 . . . . 0.0 112.108 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.038 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.3 m-85 -133.07 174.37 10.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.742 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.596 ' HG2' ' HG3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.66 -51.85 68.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -176.772 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -162.62 -24.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.7 0.682 . . . . 0.0 112.744 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.733 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 163.79 -52.25 0.29 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.387 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -52.68 -33.69 48.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.724 0.297 . . . . 0.0 111.012 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.635 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -61.91 -54.32 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.731 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.859 HG21 ' CG2' ' A' ' 9' ' ' VAL . 2.9 t -54.58 -38.86 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.562 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.615 HD13 ' HB3' ' A' ' 68' ' ' GLN . 24.6 mt -52.26 -44.75 65.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.914 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.2 66.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.177 0.513 . . . . 0.0 111.048 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.46 94.18 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.547 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.622 ' HG ' HG12 ' A' ' 39' ' ' VAL . 21.7 mt -59.13 -26.48 64.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.473 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.48 -14.8 8.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.293 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.41 -9.51 10.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.98 165.16 32.54 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.087 0.47 . . . . 0.0 111.829 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.625 ' CG2' HD23 ' A' ' 76' ' ' LEU . 91.0 m -138.3 118.31 9.92 Favored Pre-proline 0 N--CA 1.452 -0.353 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.898 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.619 ' O ' HD21 ' A' ' 76' ' ' LEU . 73.6 Cg_endo -75.63 157.03 40.29 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.526 2.151 . . . . 0.0 111.991 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -73.76 -28.16 61.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 0.0 110.725 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.813 HG21 HG23 ' A' ' 115' ' ' VAL . 7.3 p -145.23 99.61 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.768 ' O ' HD12 ' A' ' 79' ' ' ILE . 63.7 tp -87.15 145.61 26.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.48 0.657 . . . . 0.0 112.184 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.858 HD23 ' HB ' ' A' ' 79' ' ' ILE . 5.1 mt -132.85 114.43 14.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.801 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -111.3 149.95 30.36 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.287 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 18.5 t0 -80.14 -178.18 6.42 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.695 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.808 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 2.6 tt -159.92 73.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.588 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 177.56 63.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.94 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.485 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 3.1 tpp -163.5 -62.36 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.596 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 19.6 Cg_endo -59.49 -178.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.544 2.162 . . . . 0.0 113.03 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.81 -66.25 2.89 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.54 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.3 OUTLIER -72.97 54.62 0.38 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.52 -75.8 0.01 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.838 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.808 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -145.12 -32.74 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.761 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.685 HD22 ' O ' ' A' ' 86' ' ' ASP . 1.4 mp -61.98 -16.46 51.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.503 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.526 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -54.59 -35.26 63.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.316 0.579 . . . . 0.0 109.72 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.733 HD13 ' HA3' ' A' ' 36' ' ' GLY . 7.7 mt -63.6 -38.78 92.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.745 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.867 ' HA ' HD12 ' A' ' 69' ' ' ILE . 7.4 mp -52.35 -47.47 66.07 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 1.5 ttmp? -51.79 -43.39 63.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.701 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.615 ' HB3' HD13 ' A' ' 40' ' ' LEU . 12.1 mm-40 -65.62 -35.75 81.72 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.613 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.921 HG23 ' CE1' ' A' ' 73' ' ' HIS . 82.3 mt -63.06 -44.95 99.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.188 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 3.9 pttt -65.8 -23.67 66.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.187 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -28.32 41.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.297 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -112.31 -71.73 0.74 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.796 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.921 ' CE1' HG23 ' A' ' 69' ' ' ILE . 6.1 p80 -112.38 66.3 0.83 Allowed Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.494 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.572 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 25.8 Cg_endo -63.33 -31.99 72.88 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 113.576 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.538 ' HA ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -88.89 -19.81 25.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.51 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.926 HD22 ' HD2' ' A' ' 77' ' ' PRO . 3.1 tm? -62.83 118.44 42.0 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.619 0.247 . . . . 0.0 111.42 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.926 ' HD2' HD22 ' A' ' 76' ' ' LEU . 52.7 Cg_exo -54.15 115.88 2.67 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.722 2.281 . . . . 0.0 113.087 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.789 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -113.98 142.39 26.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.015 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.858 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.1 mt -130.12 115.85 34.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.943 0.402 . . . . 0.0 110.55 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.687 HG22 ' H ' ' A' ' 82' ' ' THR . 25.1 mm -93.85 145.74 7.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.466 ' HE2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -78.72 -19.92 51.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.028 -179.11 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.687 ' H ' HG22 ' A' ' 80' ' ' ILE . 6.0 m -147.65 157.54 43.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.006 ' HB1' HD23 ' A' ' 87' ' ' LEU . . . -133.48 50.69 2.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.996 0.427 . . . . 0.0 111.166 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.56 -176.14 3.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.956 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.1 t 71.25 -76.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.423 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.685 ' O ' HD22 ' A' ' 63' ' ' LEU . 7.6 m-20 -139.08 77.52 1.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.841 0.353 . . . . 0.0 111.121 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 1.006 HD23 ' HB1' ' A' ' 83' ' ' ALA . 3.4 tm? -52.19 -21.8 3.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.62 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.06 -56.63 8.46 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.34 -24.26 67.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.7 ' HB3' HD22 ' A' ' 87' ' ' LEU . . . -57.84 -63.07 1.37 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.82 0.343 . . . . 0.0 111.825 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.404 HG13 ' HE2' ' A' ' 94' ' ' TYR . 11.6 t -56.57 -38.45 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.921 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.417 ' HA ' ' HB3' ' A' ' 95' ' ' GLN . 1.4 m -60.48 -33.53 72.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.744 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.734 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -68.12 -46.66 70.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.202 0.525 . . . . 0.0 111.118 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.633 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -75.83 -23.74 55.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.873 178.676 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -74.48 -33.67 62.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.939 178.802 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 93' ' ' ALA . 15.2 pt20 -82.56 -18.47 41.29 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.442 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 75' ' ' MET . . . 161.94 -25.39 0.24 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.292 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.789 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -60.42 162.67 5.96 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.679 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 100' ' ' ASP . 28.4 t80 -74.57 -54.04 8.25 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.4 t0 170.5 -157.48 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.831 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.0 m-85 -129.14 123.01 31.05 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.464 ' HB2' HD22 ' A' ' 114' ' ' LEU . 3.8 tp -104.45 137.79 19.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.144 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.454 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 69.5 Cg_exo -50.81 168.57 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.293 1.995 . . . . 0.0 111.847 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.672 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -44.07 -44.11 16.44 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.36 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 4.4 Cg_endo -47.4 163.48 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.645 1.563 . . . . 0.0 110.466 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.694 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 9.4 t80 -166.66 -94.36 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.679 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 43.01 -174.07 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.796 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -67.55 -47.32 80.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.289 0.566 . . . . 0.0 111.557 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -51.98 -56.02 16.85 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.966 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.7 mm-40 -79.49 -28.35 41.47 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.24 -53.8 5.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.018 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.713 ' HA ' HG12 ' A' ' 115' ' ' VAL . 42.8 t -58.63 -31.92 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 121.417 0.627 . . . . 0.0 110.221 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.17 -53.54 56.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.461 178.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.746 HD23 HG21 ' A' ' 79' ' ' ILE . 8.5 tp -75.19 -20.5 59.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.095 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.813 HG23 HG21 ' A' ' 50' ' ' VAL . 5.3 p -79.23 -49.76 19.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.504 ' N ' HG13 ' A' ' 115' ' ' VAL . 16.2 mt-10 -68.59 -38.87 81.0 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.944 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.614 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 4.4 ptp85 -66.15 -26.13 67.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.063 0.459 . . . . 0.0 110.649 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.451 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.49 -51.44 23.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.025 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -64.9 -31.48 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.146 0.498 . . . . 0.0 110.787 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.7 m -71.59 -42.56 67.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.746 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.788 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.192 0 N-CA-C 112.818 -0.113 . . . . 0.0 112.818 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.69 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.4 mp -111.51 114.46 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.698 0.285 . . . . 0.0 110.985 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.996 HG11 HD13 ' A' ' 23' ' ' LEU . 7.7 p -105.53 116.11 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.248 179.314 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.838 ' CD1' HG22 ' A' ' 31' ' ' THR . 33.2 m0 -109.05 149.63 29.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.801 0.334 . . . . 0.0 111.35 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.679 HG21 HD23 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -139.5 148.51 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.548 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.9 HG22 HG21 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -134.18 118.37 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.139 177.435 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.3 t0 -173.64 -151.97 0.05 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.123 -179.356 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.34 -2.63 4.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.131 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 58.19 -137.73 0.88 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.009 178.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.9 p 34.74 -104.86 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.89 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -54.12 -42.73 69.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.567 0.223 . . . . 0.0 111.468 -179.178 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.8 mm -65.24 -36.26 77.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.063 0.458 . . . . 0.0 111.252 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.713 ' HA ' HG21 ' A' ' 32' ' ' THR . 26.4 ttt-85 -70.72 -56.31 6.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.829 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.461 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 69.9 t90 -48.81 -43.87 38.65 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 14' ' ' SER . 1.6 t -67.2 -59.83 3.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.843 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.732 ' HG ' HD12 ' A' ' 23' ' ' LEU . 7.1 tp -70.93 -22.58 62.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.361 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.601 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 11.1 pt-20 -66.59 -60.12 3.0 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.435 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.588 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.6 mmt180 -74.9 -51.0 14.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.052 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.485 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -51.01 -58.7 5.39 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.032 HD22 HD13 ' A' ' 28' ' ' LEU . 1.8 mt -59.7 -28.93 67.74 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -61.33 -37.4 83.14 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.345 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.52 -24.91 69.77 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.672 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.79 -15.52 59.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.693 0.282 . . . . 0.0 111.0 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.1 24.02 7.83 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.503 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.032 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.29 169.77 13.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 111.371 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.2 m -104.52 105.68 15.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.086 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.758 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 18.0 t -101.69 112.75 25.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.198 0.523 . . . . 0.0 111.992 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.838 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -122.13 152.95 39.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.18 178.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.713 HG21 ' HA ' ' A' ' 16' ' ' ARG . 38.1 p -126.74 152.5 46.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.267 0.556 . . . . 0.0 112.259 -179.084 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.883 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -129.21 174.04 9.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.54 -179.903 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.614 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -58.87 -104.65 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.025 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.412 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 5.7 m120 -85.23 -70.76 0.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.751 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -167.26 -31.2 0.02 OUTLIER Glycine 0 C--N 1.318 -0.423 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.203 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.451 ' HA ' HD12 ' A' ' 40' ' ' LEU . 59.1 m-20 -67.06 -31.3 71.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.506 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.7 tm-20 -52.99 -57.64 9.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.424 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.9 HG21 HG22 ' A' ' 9' ' ' VAL . 14.4 t -50.99 -42.71 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.297 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 37' ' ' ASN . 26.1 mt -51.74 -44.58 63.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.96 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.07 -50.37 70.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.913 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.25 70.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.924 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.94 HD13 ' NE2' ' A' ' 73' ' ' HIS . 3.3 mt -67.61 -24.28 65.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.433 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.74 -17.12 3.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.34 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.71 -3.96 7.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -154.89 157.38 37.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.998 0.428 . . . . 0.0 111.372 -179.82 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.549 HG23 HD12 ' A' ' 76' ' ' LEU . 90.7 m -139.33 110.87 7.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.788 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.744 ' HD2' HD11 ' A' ' 76' ' ' LEU . 59.3 Cg_endo -71.73 156.76 56.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.429 2.086 . . . . 0.0 112.011 178.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -75.34 -24.27 57.32 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.304 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.898 HG11 ' CG2' ' A' ' 115' ' ' VAL . 6.7 p -145.02 95.3 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.441 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.72 ' O ' HD12 ' A' ' 79' ' ' ILE . 28.0 tp -86.86 138.29 31.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.264 0.554 . . . . 0.0 111.884 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.796 HD23 ' HB ' ' A' ' 79' ' ' ILE . 4.4 mt -122.89 131.19 53.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.06 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.738 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -131.27 148.03 52.65 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.931 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 24.0 t0 -76.35 -164.47 0.4 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.315 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.77 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -170.66 77.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.276 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 179.38 56.41 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.86 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.619 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 12.7 tpt -157.7 -66.27 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.63 ' HG3' HD12 ' A' ' 65' ' ' LEU . 18.2 Cg_endo -58.06 -166.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.279 1.986 . . . . 0.0 112.877 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.84 -57.66 13.49 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.578 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.703 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -86.12 48.86 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.596 0.236 . . . . 0.0 110.831 179.808 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.521 ' HB3' HG13 ' A' ' 55' ' ' ILE . 0.3 OUTLIER 53.76 -83.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.991 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.77 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.84 -17.17 0.56 Allowed Glycine 0 CA--C 1.511 -0.161 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.032 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.914 HD13 ' OH ' ' A' ' 101' ' ' TYR . 1.8 tp -75.15 -12.89 60.4 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.192 0.52 . . . . 0.0 109.997 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.703 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -66.57 -64.87 0.76 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.5 178.53 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.883 HD22 ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -53.16 -22.94 7.18 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.856 179.834 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.883 ' N ' HD22 ' A' ' 65' ' ' LEU . 2.6 tp -62.19 -46.48 88.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.652 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 10.8 mtpp -55.62 -39.85 71.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.448 177.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.439 ' CG ' ' HA ' ' A' ' 65' ' ' LEU . 6.0 mm-40 -60.77 -33.23 72.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.038 178.816 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.008 HG23 ' ND1' ' A' ' 73' ' ' HIS . 96.3 mt -59.32 -48.09 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.873 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.652 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.25 -29.69 70.78 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.97 0.414 . . . . 0.0 110.749 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.482 ' HG3' ' HD2' ' A' ' 70' ' ' LYS . 7.8 mt-30 -80.87 -31.02 35.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.684 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.7 -56.82 3.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.619 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 1.008 ' ND1' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -91.04 157.3 43.25 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.385 -179.624 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.8 -59.14 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.446 2.097 . . . . 0.0 112.44 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.7 mtt -156.8 28.98 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.128 0.489 . . . . 0.0 110.428 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.744 HD11 ' HD2' ' A' ' 48' ' ' PRO . 1.8 tt -55.85 112.24 4.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.411 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 31.7 Cg_exo -62.63 114.54 2.43 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 121.836 1.691 . . . . 0.0 112.277 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.957 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -99.54 150.9 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.605 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.81 HG21 ' CD2' ' A' ' 114' ' ' LEU . 1.9 mp -133.74 115.44 21.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.82 0.343 . . . . 0.0 110.594 179.65 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.714 HG22 ' H ' ' A' ' 82' ' ' THR . 45.3 mm -97.25 149.32 5.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.223 0.535 . . . . 0.0 112.408 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.514 ' O ' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -82.07 -21.81 36.65 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.9 -178.746 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.737 ' O ' HG21 ' A' ' 55' ' ' ILE . 2.7 m -148.1 139.54 23.6 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.808 -0.558 . . . . 0.0 111.291 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.92 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -115.7 41.46 2.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.717 0.294 . . . . 0.0 111.583 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -81.18 54.47 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 0.0 110.831 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.9 p -159.19 -166.59 1.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.63 ' O ' HD23 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -61.35 85.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mt -49.13 -22.53 0.98 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.137 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -47.89 -45.93 31.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.889 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . . . -72.05 -19.43 61.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.477 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.499 ' HA ' HD11 ' A' ' 63' ' ' LEU . . . -75.64 -46.18 32.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.341 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.768 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 12.1 t -68.19 -38.36 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.501 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.5 p -69.93 -23.4 63.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.977 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.611 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -63.86 -42.82 97.46 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.235 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.768 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 1.1 m-85 -63.75 -27.65 69.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.456 178.701 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.86 -34.85 62.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.381 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.635 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 1.1 pt20 -98.67 -5.22 32.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.608 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 130.89 80.24 0.21 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.135 -179.453 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.957 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.56 134.87 1.86 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.188 0.518 . . . . 0.0 111.384 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 32.7 t80 -75.79 -54.2 7.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.727 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER 171.99 -164.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 0.0 111.449 -179.134 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.92 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 2.9 m-85 -125.89 119.92 29.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.989 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.643 HD23 ' CD2' ' A' ' 106' ' ' PHE . 4.3 tp -102.56 136.71 19.3 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.735 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 10.0 Cg_endo -49.22 167.88 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.664 2.243 . . . . 0.0 111.641 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -41.45 -49.93 9.2 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 111.369 0.137 . . . . 0.0 111.369 -178.747 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.735 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 71.0 Cg_exo -47.36 162.94 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.574 1.516 . . . . 0.0 110.028 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.74 ' HD1' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -175.3 -85.54 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.39 -178.419 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.3 p30 42.66 -168.41 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.781 HD13 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.78 -47.24 80.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.268 0.556 . . . . 0.0 111.489 -179.887 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 5.0 t0 -51.75 -57.55 8.94 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.911 -179.321 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 17.8 mm-40 -78.98 -27.77 43.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.016 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.74 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.34 -54.76 4.56 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.826 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.751 HG21 HG23 ' A' ' 108' ' ' ILE . 39.2 t -56.49 -32.17 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.523 0.677 . . . . 0.0 110.023 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.55 -52.42 65.24 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.499 178.293 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.81 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.4 tp -74.51 -21.49 59.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.789 -178.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.898 ' CG2' HG11 ' A' ' 50' ' ' VAL . 7.2 p -79.27 -51.86 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 120.376 -0.529 . . . . 0.0 112.019 -179.317 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.544 ' N ' HG13 ' A' ' 115' ' ' VAL . 20.2 mt-10 -64.53 -46.34 83.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.527 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -62.56 -27.65 69.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 114' ' ' LEU . . . -71.47 -54.66 9.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.219 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.62 -32.12 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.216 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 116' ' ' GLU . 0.4 OUTLIER -69.13 -40.52 78.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.829 179.861 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.967 -179.97 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.745 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.745 HD13 ' C ' ' A' ' 4' ' ' GLY . 2.2 mm -114.54 117.84 56.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.078 0.466 . . . . 0.0 112.133 -178.341 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.058 HG11 HD13 ' A' ' 23' ' ' LEU . 2.6 p -106.11 123.94 61.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.698 177.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.972 ' CD1' HG22 ' A' ' 31' ' ' THR . 38.1 m0 -115.62 141.54 47.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.736 HG13 HD13 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -128.72 135.24 62.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.384 0.611 . . . . 0.0 111.934 -178.416 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.076 HG12 ' H ' ' A' ' 54' ' ' ASP . 1.5 t -123.53 108.17 20.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.06 179.172 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.548 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 14.0 t70 -161.66 -149.92 0.18 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.408 -179.071 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.518 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 2.8 m-20 -66.32 -3.08 5.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.574 0.226 . . . . 0.0 111.595 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.8 t70 61.29 -144.8 0.45 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.392 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t 32.74 -90.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.846 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.0 m -55.87 -52.36 64.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.749 0.309 . . . . 0.0 111.21 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.1 mm -63.79 -31.65 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 111.173 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.71 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.6 ttm180 -73.09 -54.59 8.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.677 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.539 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 44.4 t90 -51.3 -42.87 61.47 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.888 HG12 HD13 ' A' ' 108' ' ' ILE . 2.1 t -68.17 -63.11 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.058 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.744 ' HA ' HD11 ' A' ' 108' ' ' ILE . 9.1 mt -65.86 -22.05 66.51 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.095 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.659 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.51 -56.91 7.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.219 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.535 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -77.87 -47.18 19.36 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.612 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.484 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -56.84 -58.07 9.72 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.752 0.311 . . . . 0.0 111.725 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.058 HD13 HG11 ' A' ' 6' ' ' VAL . 2.0 mt -61.29 -29.43 69.86 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -60.98 -34.15 74.32 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.426 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.59 -24.95 74.0 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.442 178.442 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.88 -15.56 59.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.726 179.645 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.82 25.15 7.73 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.817 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.011 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.21 170.4 11.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.267 0.534 . . . . 0.0 111.455 179.611 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.491 ' HB ' HG23 ' A' ' 5' ' ' ILE . 52.7 m -103.74 106.14 16.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.49 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.755 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.2 t -104.23 112.46 25.49 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.972 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -122.83 156.67 34.09 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.307 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 36.3 p -127.21 157.88 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.305 -178.392 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.847 ' HB2' HG22 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -135.92 171.49 14.38 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.81 -179.683 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.813 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -64.28 -49.68 70.87 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.017 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.813 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -162.79 167.06 23.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -178.402 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.679 ' N ' HG11 ' A' ' 9' ' ' VAL . . . -42.85 -27.79 0.61 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.382 -0.914 . . . . 0.0 112.735 -178.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.496 ' N ' HD12 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -64.09 -47.8 78.62 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.708 0.289 . . . . 0.0 110.753 179.371 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.671 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -51.82 -52.19 51.04 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.046 179.527 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.841 HG23 HG21 ' A' ' 9' ' ' VAL . 32.0 t -48.69 -40.97 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.025 0.44 . . . . 0.0 110.935 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.667 HD13 ' HB3' ' A' ' 68' ' ' GLN . 17.7 mt -50.17 -48.22 54.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.61 -48.95 75.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.487 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.52 -41.08 96.61 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.906 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.637 HD21 ' CD ' ' A' ' 48' ' ' PRO . 29.4 mt -61.2 -20.82 63.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.02 -14.45 3.7 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.63 -179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.69 -6.89 6.82 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.547 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.604 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.19 166.89 20.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.883 0.373 . . . . 0.0 111.801 -179.46 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.522 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 57.6 m -139.02 122.1 10.73 Favored Pre-proline 0 N--CA 1.454 -0.228 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.436 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.682 ' HD2' HD11 ' A' ' 76' ' ' LEU . 98.4 Cg_endo -79.46 155.35 24.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.304 2.003 . . . . 0.0 111.491 178.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.417 ' OD2' ' HA2' ' A' ' 4' ' ' GLY . 77.3 m-20 -75.34 -25.76 58.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.716 -179.32 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.911 HG11 ' CG2' ' A' ' 115' ' ' VAL . 3.8 p -145.69 91.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 39' ' ' VAL . 32.5 tp -87.12 144.49 26.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.228 -179.376 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.839 HD23 ' HB ' ' A' ' 79' ' ' ILE . 2.1 mt -125.95 137.5 53.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.934 178.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.712 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -133.57 135.61 44.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -178.197 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 1.076 ' H ' HG12 ' A' ' 9' ' ' VAL . 15.5 t0 -66.88 174.89 2.71 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.937 178.565 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.755 HG13 ' N ' ' A' ' 62' ' ' GLY . 6.8 tt -152.47 77.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.495 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER 176.67 65.7 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.188 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.634 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 1.6 ttt -158.46 -67.73 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 59.3 Cg_endo -70.18 -163.07 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.554 2.169 . . . . 0.0 113.035 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.62 -60.6 7.54 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.211 -179.753 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.905 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 1.8 mtp -84.39 45.36 1.11 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.839 0.32 . . . . 0.0 111.594 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.592 ' HB3' HG13 ' A' ' 55' ' ' ILE . 1.2 m-20 50.98 -75.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.366 179.154 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.755 ' N ' HG13 ' A' ' 55' ' ' ILE . . . -139.09 -33.17 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.386 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.761 HD22 ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -56.75 -22.82 38.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.737 0.303 . . . . 0.0 110.324 -179.862 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.905 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -63.19 -39.25 94.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.217 0.532 . . . . 0.0 110.291 178.203 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.652 HD23 ' HA2' ' A' ' 62' ' ' GLY . 2.3 mm? -59.52 -37.44 78.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.39 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.826 ' HA ' HD12 ' A' ' 69' ' ' ILE . 3.0 mm? -59.75 -42.85 94.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.81 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.611 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 2.5 tttt -56.3 -44.45 79.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.655 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.667 ' HB3' HD13 ' A' ' 40' ' ' LEU . 3.0 mt-30 -63.52 -39.46 94.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.161 0.505 . . . . 0.0 111.142 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.826 HD12 ' HA ' ' A' ' 66' ' ' LEU . 58.4 mt -57.43 -51.43 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.679 -178.846 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.74 -23.6 67.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.401 -179.829 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -49.72 70.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.191 -178.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -99.35 -20.54 16.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.401 -178.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.415 ' CE1' ' CD1' ' A' ' 43' ' ' LEU . 1.9 m80 -116.5 146.7 38.08 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.856 0.36 . . . . 0.0 111.152 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.85 -75.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.48 2.12 . . . . 0.0 112.74 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 38.3 mtp -149.54 57.69 1.0 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.058 0.456 . . . . 0.0 111.072 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.682 HD11 ' HD2' ' A' ' 48' ' ' PRO . 2.0 tt -66.88 118.49 55.55 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.717 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.529 ' N ' HD23 ' A' ' 76' ' ' LEU . 32.3 Cg_exo -58.61 115.34 2.47 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.552 1.501 . . . . 0.0 111.929 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.012 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -111.27 150.09 13.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.143 179.522 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.839 ' HB ' HD23 ' A' ' 52' ' ' LEU . 2.8 mt -136.83 115.39 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.997 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 53' ' ' SER . 14.2 mm -93.09 150.91 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 111.693 -178.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.738 ' HE3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -78.98 -27.01 43.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.195 -178.348 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 103' ' ' PRO . 2.8 m -143.29 170.7 15.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.883 ' HB1' HD21 ' A' ' 87' ' ' LEU . . . -127.61 45.57 2.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.675 ' O ' HD11 ' A' ' 63' ' ' LEU . 47.3 m-70 -69.34 -174.77 0.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 111.135 179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 86' ' ' ASP . 48.1 t 50.67 -165.34 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.879 179.241 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.761 ' O ' HD22 ' A' ' 63' ' ' LEU . 19.3 p-10 -59.49 101.26 0.1 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.798 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.883 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -55.9 -21.87 22.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.082 178.971 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -48.14 -45.9 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.28 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.604 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.69 -19.27 65.15 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.461 -179.349 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.737 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -65.45 -53.99 34.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.086 0.469 . . . . 0.0 110.329 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.567 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.7 t -62.27 -39.83 85.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.561 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.648 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 83.5 p -63.55 -15.03 56.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.941 178.651 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -75.77 -57.76 3.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.187 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.701 ' N ' ' HB3' ' A' ' 98' ' ' ALA . 3.3 m-85 -52.48 -34.15 47.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.134 -179.276 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.648 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -75.61 -33.5 60.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.012 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.495 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 10.0 pt20 -99.01 3.13 46.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.38 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.537 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 125.08 81.9 0.48 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.575 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 1.012 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.54 132.85 1.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.153 0.501 . . . . 0.0 111.723 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.425 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 74.8 t80 -75.08 -53.52 8.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.531 -179.165 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.611 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -178.49 -166.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.143 0.497 . . . . 0.0 111.821 -179.556 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.511 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 2.4 m-85 -125.79 140.4 52.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.322 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.714 HD23 ' HD1' ' A' ' 106' ' ' PHE . 5.3 tp -101.89 150.43 37.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.778 ' O ' HG23 ' A' ' 82' ' ' THR . 16.5 Cg_exo -69.08 -43.15 3.42 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.302 2.001 . . . . 0.0 111.533 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.523 ' HE2' ' HB2' ' A' ' 81' ' ' MET . 0.0 OUTLIER 172.81 -46.96 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.479 178.963 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 104' ' ' LYS . 75.9 Cg_exo -47.72 164.59 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.905 1.737 . . . . 0.0 109.614 178.081 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.797 ' CE1' HD22 ' A' ' 52' ' ' LEU . 6.0 t80 -166.18 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.133 -177.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 3.7 p30 44.26 -172.08 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.881 0.372 . . . . 0.0 110.611 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.888 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -68.1 -50.63 56.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.155 0.502 . . . . 0.0 111.994 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.594 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -50.4 -54.35 22.47 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.943 -178.504 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.69 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.2 mm-40 -80.02 -30.62 39.56 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.228 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.85 -51.47 7.16 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.962 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.692 ' HA ' HG12 ' A' ' 115' ' ' VAL . 41.5 t -60.3 -31.97 49.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.388 0.613 . . . . 0.0 110.379 179.231 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.75 -51.82 68.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.742 0.782 . . . . 0.0 109.409 178.346 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.751 ' CD2' HG21 ' A' ' 79' ' ' ILE . 6.5 tp -75.26 -20.78 59.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.873 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.911 ' CG2' HG11 ' A' ' 50' ' ' VAL . 6.0 p -78.78 -51.64 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.217 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.546 ' N ' HG13 ' A' ' 115' ' ' VAL . 40.5 mt-10 -68.53 -40.88 80.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.783 0.325 . . . . 0.0 110.537 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -66.56 -26.83 67.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.528 179.46 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 114' ' ' LEU . . . -71.62 -55.04 8.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.956 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -66.43 -31.37 53.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.054 0.454 . . . . 0.0 110.79 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.3 t -67.78 -44.03 78.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.969 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 CA-C-O 120.78 0.1 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.571 HG23 ' HB ' ' A' ' 29' ' ' THR . 3.1 mp -121.85 112.72 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.031 0.443 . . . . 0.0 110.898 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.121 HG11 HD13 ' A' ' 23' ' ' LEU . 8.9 p -113.73 126.05 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.886 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 1.096 ' CD1' HG22 ' A' ' 31' ' ' THR . 54.4 m0 -118.13 138.03 52.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.823 0.344 . . . . 0.0 110.801 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -123.61 119.21 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.895 -178.302 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.041 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -104.46 104.53 16.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.615 0.245 . . . . 0.0 110.357 179.212 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 63.9 t0 166.78 119.18 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.905 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.424 ' CB ' HG12 ' A' ' 15' ' ' ILE . 1.0 OUTLIER 73.84 -22.24 0.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 178.902 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 73.3 -140.97 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.532 -0.105 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.0 t -31.69 -44.15 0.07 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.202 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.559 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -53.16 -69.56 0.11 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.695 -179.608 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 24.0 mm -60.4 -20.3 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.718 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 35.0 ttp180 -73.27 -61.81 1.69 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.781 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.58 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 80.5 t90 -47.64 -48.03 28.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.111 -178.913 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.604 HG12 HD13 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -64.6 -61.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.113 0.482 . . . . 0.0 111.971 -179.023 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.783 HD21 ' HB3' ' A' ' 111' ' ' ALA . 31.8 mt -68.65 -22.09 64.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.957 -177.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.609 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 17.8 pt-20 -66.57 -57.75 6.62 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.495 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -59.11 -51.15 71.28 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.664 -179.587 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.415 ' CB ' HG13 ' A' ' 108' ' ' ILE . . . -58.29 -51.96 67.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 0.0 111.796 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.121 HD13 HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -67.24 -22.64 65.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.388 179.79 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.93 -34.84 78.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.027 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.65 -28.23 65.06 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.002 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.617 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.69 -15.48 59.78 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.895 0.378 . . . . 0.0 110.503 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.16 24.21 17.48 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.973 -0.632 . . . . 0.0 114.316 178.62 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.852 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -121.95 159.89 25.98 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 117.961 0.88 . . . . 0.0 112.751 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.571 ' HB ' HG23 ' A' ' 5' ' ' ILE . 55.2 m -81.0 126.77 31.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.431 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.609 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -116.75 108.03 15.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.154 -178.482 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 31' ' ' THR . . . . . 1.096 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -130.29 141.84 50.58 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.151 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 65.0 p -115.86 162.53 17.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.574 0.702 . . . . 0.0 112.823 -178.391 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.041 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.6 m-85 -135.85 173.51 11.63 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.491 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.7 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -62.91 -59.45 4.83 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -177.004 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.455 ' C ' HD13 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -151.22 -60.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.08 -178.729 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.641 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . -152.44 -55.75 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.579 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.557 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -54.35 -29.59 48.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.991 0.395 . . . . 0.0 111.009 -179.216 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.846 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -62.19 -60.74 3.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.668 179.348 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.701 HG21 HG21 ' A' ' 9' ' ' VAL . 22.0 t -48.8 -42.65 13.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.272 179.311 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.63 HD13 ' HB3' ' A' ' 68' ' ' GLN . 38.6 mt -45.64 -46.58 14.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.033 0.444 . . . . 0.0 110.455 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.95 -47.39 80.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.537 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB2' ' HE2' ' A' ' 33' ' ' PHE . . . -67.83 -41.26 83.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.991 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.589 HD13 HG23 ' A' ' 69' ' ' ILE . 19.4 mt -66.32 -29.29 69.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.19 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.04 -19.99 55.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.201 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 t -123.42 0.62 8.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.638 ' CG ' ' HH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -164.65 165.62 20.81 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.116 0.484 . . . . 0.0 111.062 -179.916 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.948 HG23 HD23 ' A' ' 76' ' ' LEU . 54.1 m -138.5 114.52 8.85 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.498 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.582 ' O ' HD21 ' A' ' 76' ' ' LEU . 91.0 Cg_endo -77.58 164.54 28.22 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.1 1.866 . . . . 0.0 111.978 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.552 ' OD1' HD12 ' A' ' 5' ' ' ILE . 7.2 m-20 -78.01 -31.15 50.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 110.401 179.777 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.646 HG13 HG23 ' A' ' 6' ' ' VAL . 3.4 p -145.22 149.05 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.532 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.855 HD12 ' HB2' ' A' ' 7' ' ' TRP . 0.6 OUTLIER -152.97 145.59 24.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.321 0.582 . . . . 0.0 112.31 -178.18 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.794 HD22 ' CZ ' ' A' ' 106' ' ' PHE . 1.2 mt -123.87 122.07 37.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.285 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -111.55 150.45 29.99 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.776 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.503 ' HA ' ' SD ' ' A' ' 81' ' ' MET . 15.8 t0 -77.48 169.72 17.82 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.465 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.662 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.5 tt -144.02 165.94 13.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.369 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 65.21 65.08 0.59 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.674 0.75 . . . . 0.0 111.297 -179.366 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.659 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -158.01 -63.02 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.685 179.293 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 68.7 Cg_endo -69.29 -157.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.505 2.136 . . . . 0.0 112.33 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.5 -72.94 0.6 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.069 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.799 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 1.5 ttt -71.22 57.51 0.23 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.916 0.388 . . . . 0.0 111.16 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.542 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 56.45 -77.58 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.537 -179.592 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.662 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.46 -31.27 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.389 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.86 ' HA ' HD23 ' A' ' 66' ' ' LEU . 1.7 mp -62.29 -17.1 57.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.745 0.307 . . . . 0.0 110.613 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.799 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -59.71 -37.98 80.38 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.014 0.435 . . . . 0.0 110.13 178.752 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.641 HD13 ' HA3' ' A' ' 36' ' ' GLY . 30.3 mt -61.26 -39.08 89.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.861 HD21 HD11 ' A' ' 80' ' ' ILE . 4.0 mm? -55.47 -43.51 75.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.142 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.656 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 23.6 ttmm -57.97 -42.51 85.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.768 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.63 ' HB3' HD13 ' A' ' 40' ' ' LEU . 3.2 mt-30 -65.51 -41.37 93.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.059 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.988 HG22 ' CD2' ' A' ' 73' ' ' HIS . 36.6 mt -57.25 -50.36 76.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.634 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.27 -24.01 67.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.254 -179.532 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -23.13 66.08 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.861 -0.335 . . . . 0.0 111.053 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -108.35 -20.18 13.22 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.988 ' CD2' HG22 ' A' ' 69' ' ' ILE . 6.2 p80 -113.64 166.99 10.11 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 112.106 -179.093 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 94.0 Cg_endo -88.27 -47.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.216 2.611 . . . . 0.0 111.837 178.641 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.613 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.2 mtt -157.45 54.37 0.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.948 HD23 HG23 ' A' ' 47' ' ' THR . 0.7 OUTLIER -76.61 112.6 22.83 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-O 120.62 0.247 . . . . 0.0 110.861 179.819 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.548 ' HD2' HD22 ' A' ' 76' ' ' LEU . 37.6 Cg_endo -66.81 115.47 3.6 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.158 1.906 . . . . 0.0 111.86 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.842 HG13 HD23 ' A' ' 51' ' ' LEU . 2.4 t -109.11 152.34 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.735 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.2 mt -136.09 118.07 20.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.096 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.861 HD11 HD21 ' A' ' 66' ' ' LEU . 15.4 mm -93.61 144.25 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.387 0.613 . . . . 0.0 112.167 -179.199 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.732 ' HE3' ' CZ ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -77.21 -15.99 59.25 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.014 -179.369 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.669 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.5 m -147.79 169.32 20.01 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.213 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -143.94 41.83 1.42 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.771 0.319 . . . . 0.0 111.488 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.527 ' CD2' HG21 ' A' ' 82' ' ' THR . 21.8 m-70 -68.62 113.74 6.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.963 0.411 . . . . 0.0 112.071 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 m 48.58 -177.52 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.925 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' HB2' HD13 ' A' ' 63' ' ' LEU . 6.5 m-20 52.24 26.22 3.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.155 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.795 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -56.14 -22.11 26.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.556 -179.919 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.32 -43.62 43.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.711 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.571 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.19 -23.42 62.96 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.323 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.795 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -64.7 -39.73 94.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.946 0.403 . . . . 0.0 110.492 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.593 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.1 t -69.88 -45.03 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.185 179.47 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.9 m -62.52 -28.89 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.583 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' A' ' 96' ' ' GLN . . . -62.13 -41.85 98.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.492 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.593 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.4 m-85 -61.43 -21.7 64.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.145 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.609 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -72.81 -42.18 64.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.772 -179.907 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.613 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.1 pt20 -77.55 -18.15 57.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.505 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.82 5.07 4.54 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.149 -1.024 . . . . 0.0 114.139 178.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -54.65 152.79 6.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.477 0.638 . . . . 0.0 111.311 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.472 ' HD2' HG12 ' A' ' 79' ' ' ILE . 39.3 t80 -85.7 -53.58 5.06 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.335 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.81 -163.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.18 0.514 . . . . 0.0 111.799 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.591 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.9 m-85 -131.66 122.11 25.42 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.624 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 103' ' ' PRO . 5.8 tp -103.69 141.03 21.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.728 -179.567 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 102' ' ' LEU . 19.6 Cg_endo -57.87 169.89 2.37 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.334 2.023 . . . . 0.0 111.591 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.661 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -44.22 -46.5 23.04 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -179.17 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 2.8 Cg_endo -46.49 163.62 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.826 1.684 . . . . 0.0 110.539 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.794 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 1.0 OUTLIER -166.41 -88.47 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.434 -177.812 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.546 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p-10 42.23 -175.48 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.959 0.409 . . . . 0.0 110.613 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.617 HD12 HD23 ' A' ' 19' ' ' LEU . 1.1 mp -68.01 -47.44 78.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.3 0.571 . . . . 0.0 111.652 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.643 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 68.1 m-20 -54.05 -54.96 32.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.831 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.746 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.9 mm-40 -77.65 -29.43 51.63 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.38 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.783 ' HB3' HD21 ' A' ' 19' ' ' LEU . . . -84.22 -57.34 3.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.015 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.601 HG21 HG23 ' A' ' 108' ' ' ILE . 43.9 t -54.67 -32.17 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.456 0.646 . . . . 0.0 110.142 179.013 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.85 -54.76 42.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.055 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.555 HD23 HG21 ' A' ' 79' ' ' ILE . 32.5 tp -73.33 -20.66 60.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.66 -179.138 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.734 HG21 HD11 ' A' ' 23' ' ' LEU . 2.4 p -79.06 -47.54 22.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.278 -178.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.08 -38.0 84.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.79 0.328 . . . . 0.0 110.462 179.706 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.2 mtt85 -65.04 -24.32 67.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.542 179.429 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.465 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.65 -52.55 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.066 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.7 mt -60.75 -31.49 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.107 0.479 . . . . 0.0 110.659 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.5 m -70.56 -43.5 69.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.704 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 32.2 m80 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.859 179.852 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.554 ' HA3' HD23 ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.567 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 2.2 mp -133.34 113.07 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.759 HG23 HG13 ' A' ' 50' ' ' VAL . 7.9 p -111.69 125.54 69.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.868 0.366 . . . . 0.0 111.433 179.204 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.841 ' CD1' HG22 ' A' ' 31' ' ' THR . 19.7 m0 -114.88 129.03 56.62 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.433 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.927 HG21 HD23 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -123.42 144.76 31.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.454 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.029 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -135.32 105.81 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.582 178.31 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.584 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 51.4 t0 167.49 120.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.637 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.431 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 70.86 -32.15 0.24 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.216 179.567 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 13' ' ' SER . 5.0 t70 73.75 -134.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 12' ' ' ASP . 47.6 t -21.0 -58.17 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 18' ' ' VAL . 19.4 m -53.04 -69.52 0.11 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.259 -179.088 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 26.7 mm -60.46 -20.38 20.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.737 ' HA ' HG21 ' A' ' 32' ' ' THR . 47.8 ttt180 -72.35 -61.45 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.861 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.42 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 75.9 t90 -47.46 -42.85 23.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.066 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.714 HG12 HD13 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -67.52 -62.16 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.736 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.927 HD23 HG21 ' A' ' 8' ' ' VAL . 8.6 tp -70.79 -21.6 62.47 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.573 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 22.7 pt-20 -67.47 -56.68 8.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.47 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.573 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 9.5 mmm-85 -68.51 -56.34 8.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.479 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.54 -36.94 64.82 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.693 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.1 tm? -73.7 -27.45 61.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.997 0.427 . . . . 0.0 110.687 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.42 -32.64 72.82 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.59 -25.71 71.66 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.432 178.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.567 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.77 -15.48 59.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.728 0.299 . . . . 0.0 111.135 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.64 25.34 8.69 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.487 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.567 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -134.98 178.27 7.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.632 0.716 . . . . 0.0 111.726 179.849 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' HG12 ' A' ' 6' ' ' VAL . 7.9 m -105.64 128.01 53.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.069 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HA ' HG13 ' A' ' 6' ' ' VAL . 42.6 t -123.11 113.01 18.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.134 0.492 . . . . 0.0 111.953 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.841 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.0 t -119.08 156.03 30.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.253 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.737 HG21 ' HA ' ' A' ' 16' ' ' ARG . 44.9 p -133.91 160.19 38.43 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.092 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.029 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.3 m-85 -135.86 174.16 10.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.421 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.55 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.89 -105.05 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.025 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.414 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 2.6 t-20 -84.57 -61.52 1.77 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.033 0.444 . . . . 0.0 111.978 -178.154 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.805 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -176.64 -37.01 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.074 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.967 ' N ' HD21 ' A' ' 65' ' ' LEU . 9.6 m-80 -60.18 -29.64 68.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.704 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -54.53 -54.8 36.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.424 179.791 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.637 HG21 ' CG2' ' A' ' 9' ' ' VAL . 6.6 t -49.39 -46.01 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.262 0.553 . . . . 0.0 110.907 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.713 HD13 ' HB3' ' A' ' 68' ' ' GLN . 30.3 mt -47.2 -43.46 21.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.306 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.87 82.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.31 0.576 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.22 77.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.1 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.053 HD13 ' CE1' ' A' ' 73' ' ' HIS . 5.3 mt -59.89 -24.46 64.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.201 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.84 -22.31 5.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.698 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.94 8.32 5.22 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.05 163.21 37.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.98 0.419 . . . . 0.0 111.198 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.86 HG23 HD23 ' A' ' 76' ' ' LEU . 77.7 m -138.39 118.56 9.91 Favored Pre-proline 0 N--CA 1.453 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.009 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.658 ' CD ' HD21 ' A' ' 43' ' ' LEU . 56.0 Cg_endo -69.69 154.96 67.36 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.165 1.91 . . . . 0.0 112.292 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB3' ' O ' ' A' ' 5' ' ' ILE . 26.8 t0 -79.38 -32.66 43.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.611 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.759 HG13 HG23 ' A' ' 6' ' ' VAL . 7.3 p -150.47 94.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.625 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.573 HD23 HG22 ' A' ' 78' ' ' VAL . 28.5 tp -84.48 153.84 23.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.042 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.867 HD23 ' HB ' ' A' ' 79' ' ' ILE . 2.7 mt -136.74 114.76 11.45 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.802 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.546 ' HB3' ' CD1' ' A' ' 80' ' ' ILE . 4.9 t -108.95 149.4 29.25 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.566 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.655 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 25.9 t0 -82.99 166.84 18.49 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.381 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.79 HG23 ' HB ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -155.5 108.95 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.994 -179.914 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.47 40.22 0.76 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.375 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.502 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER 66.94 51.06 0.62 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.434 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 62.6 Cg_endo -78.96 -77.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.812 2.341 . . . . 0.0 112.159 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.402 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -109.27 -29.78 3.85 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.815 179.526 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.984 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -152.47 65.78 0.82 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.095 0.474 . . . . 0.0 110.279 179.362 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.536 ' O ' HG12 ' A' ' 55' ' ' ILE . 0.5 OUTLIER 68.74 -22.99 0.14 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.872 179.824 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.638 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 135.24 -31.49 2.68 Favored Glycine 0 CA--C 1.502 -0.757 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.833 ' HA ' HD23 ' A' ' 66' ' ' LEU . 4.7 mp -70.16 -15.47 62.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.984 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.89 -37.98 64.31 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.061 0.458 . . . . 0.0 110.447 178.448 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.967 HD21 ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -58.15 -36.61 73.25 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.926 179.511 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.855 ' HA ' HD12 ' A' ' 69' ' ' ILE . 4.0 mm? -59.34 -43.61 92.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.494 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.568 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 14.0 mttt -52.59 -47.25 67.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.09 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.713 ' HB3' HD13 ' A' ' 40' ' ' LEU . 2.0 mt-30 -61.09 -32.19 71.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.059 179.162 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.855 HD12 ' HA ' ' A' ' 66' ' ' LEU . 10.7 mt -67.97 -41.6 84.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.166 -178.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 9.9 pttt -77.63 -24.88 49.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.955 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -74.25 -43.43 57.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.883 0.373 . . . . 0.0 111.888 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -89.45 -54.59 4.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.132 -179.06 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 1.053 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -89.96 135.49 30.17 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.261 -178.858 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -56.74 -64.84 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.512 2.142 . . . . 0.0 112.667 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.8 mtm -142.01 44.7 1.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.787 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.86 HD23 HG23 ' A' ' 47' ' ' THR . 2.9 tm? -63.01 111.17 4.39 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.037 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.619 ' HD2' HD22 ' A' ' 76' ' ' LEU . 38.7 Cg_exo -58.94 116.29 3.15 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.639 2.226 . . . . 0.0 113.013 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.966 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -118.55 153.29 20.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.68 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.867 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.6 mt -134.14 117.6 25.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.017 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.754 HG22 ' H ' ' A' ' 82' ' ' THR . 26.6 mm -93.57 141.76 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.219 0.533 . . . . 0.0 112.06 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.656 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -84.72 -11.73 55.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.558 -179.147 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.79 ' HB ' HG23 ' A' ' 55' ' ' ILE . 15.3 m -147.47 133.0 18.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.576 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.814 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -125.63 -1.53 7.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 179.702 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -69.32 67.48 0.19 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 0.0 110.256 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.5 m -155.98 -79.09 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.35 -179.34 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.568 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -145.62 79.39 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.68 -179.609 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.648 HD23 ' HB3' ' A' ' 90' ' ' ALA . 4.5 mt -46.12 -21.46 0.15 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.281 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.76 -57.44 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.572 0.225 . . . . 0.0 110.96 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.45 -20.87 62.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 110.87 179.292 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.648 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -69.65 -60.88 2.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.517 ' HA ' ' HD2' ' A' ' 94' ' ' TYR . 21.6 t -60.75 -46.12 96.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.486 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.7 m -56.81 -49.12 76.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.003 0.43 . . . . 0.0 111.246 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.587 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -62.93 -40.3 97.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.143 -179.403 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 1.04 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -71.17 -20.71 62.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.218 179.918 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.587 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.56 -38.68 62.63 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.465 179.174 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.587 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 2.6 pt20 -100.23 -17.43 17.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.323 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.75 66.79 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.496 -1.335 . . . . 0.0 114.081 -179.159 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 1.04 ' HB3' ' HA ' ' A' ' 94' ' ' TYR . . . -170.48 132.91 1.0 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.592 0.234 . . . . 0.0 110.553 178.572 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 45.2 t80 -62.92 -53.14 58.7 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.504 -178.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 178.23 -161.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 0.0 111.408 -179.306 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.814 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.2 m-85 -127.59 126.82 42.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.557 ' HB2' HD22 ' A' ' 114' ' ' LEU . 6.3 tp -108.03 135.38 19.88 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.81 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.425 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 77.3 Cg_exo -50.03 170.02 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.2 1.933 . . . . 0.0 111.453 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.659 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -44.6 -44.5 20.83 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.296 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 4.8 Cg_endo -47.58 163.4 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.739 1.626 . . . . 0.0 110.942 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.785 ' CE1' HD22 ' A' ' 52' ' ' LEU . 9.8 t80 -165.68 -95.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.717 -178.4 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.2 p-10 44.18 -174.03 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.126 -0.359 . . . . 0.0 110.896 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.898 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -68.02 -47.72 77.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.197 0.523 . . . . 0.0 111.633 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 23.3 t70 -51.15 -57.47 8.65 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.714 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.687 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.3 mm-40 -78.22 -29.44 48.27 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.206 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -82.16 -57.71 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.772 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.898 HG21 HG23 ' A' ' 108' ' ' ILE . 38.5 t -54.06 -32.46 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.467 0.651 . . . . 0.0 110.159 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.46 -51.65 68.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.885 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.836 HD23 HG21 ' A' ' 79' ' ' ILE . 19.3 tp -77.42 -20.55 54.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.791 -178.803 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.609 ' CG2' HG11 ' A' ' 50' ' ' VAL . 4.2 p -76.43 -46.84 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.496 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.421 ' N ' HG13 ' A' ' 115' ' ' VAL . 29.1 mt-10 -63.62 -52.46 60.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.738 0.304 . . . . 0.0 110.537 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 -57.58 -25.89 60.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.05 0.452 . . . . 0.0 110.508 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.436 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.77 -53.87 8.37 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.488 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 115' ' ' VAL . 3.4 mt -68.83 -32.92 56.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.029 0.442 . . . . 0.0 111.112 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.59 -48.53 47.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.32 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.1 m170 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.369 . . . . 0.0 111.124 -179.81 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.73 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.73 HD13 ' C ' ' A' ' 4' ' ' GLY . 3.5 mm -119.41 112.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.655 0.264 . . . . 0.0 111.56 -179.205 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.85 HG11 ' HG ' ' A' ' 23' ' ' LEU . 8.6 p -106.31 118.04 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.291 178.438 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.826 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.4 m0 -111.92 123.8 51.02 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.685 HG21 HD23 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -117.27 136.19 55.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.301 -177.255 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.946 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -121.55 115.65 47.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.855 178.338 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.677 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 5.0 t70 -169.8 -152.62 0.1 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.113 -178.818 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.36 6.22 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 14' ' ' SER . 3.9 p30 47.05 -146.5 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t 35.49 -88.58 0.01 OUTLIER 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.803 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.7 m -59.93 -54.48 45.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.68 0.276 . . . . 0.0 111.116 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.9 mm -62.75 -31.75 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.486 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.767 ' HA ' HG21 ' A' ' 32' ' ' THR . 5.9 ttp180 -69.11 -48.96 61.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.564 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.659 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 14.9 t90 -61.63 -58.37 8.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.02 -179.24 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 14' ' ' SER . 1.4 t -55.62 -40.47 59.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.185 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.685 HD23 HG21 ' A' ' 8' ' ' VAL . 5.1 tp -84.32 -24.8 29.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -177.67 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.659 ' HG2' ' O ' ' A' ' 17' ' ' TRP . 19.7 pt-20 -67.63 -59.63 3.19 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.605 -178.702 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.8 ' HD3' ' H ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -59.35 -65.28 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.138 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.47 -30.64 5.35 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.956 -179.046 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.85 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.8 tm? -78.89 -32.44 45.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.25 0.548 . . . . 0.0 110.276 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.22 73.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.198 178.372 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.16 -26.67 71.65 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.602 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.85 -15.39 59.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.865 0.364 . . . . 0.0 110.684 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.38 25.69 10.78 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.827 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.696 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -131.09 169.07 16.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.621 0.71 . . . . 0.0 111.697 179.771 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.6 m -96.93 116.24 28.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.658 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.632 ' HA ' HG13 ' A' ' 6' ' ' VAL . 51.5 t -110.24 114.61 28.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.395 0.616 . . . . 0.0 111.883 -179.428 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.826 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.0 t -125.26 155.61 39.86 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.519 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.767 HG21 ' HA ' ' A' ' 16' ' ' ARG . 66.9 p -129.08 164.86 22.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.259 0.552 . . . . 0.0 112.116 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.946 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.3 m-85 -136.43 174.57 10.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.799 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.618 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.1 pp20? -59.3 -55.68 31.73 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -177.718 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.431 ' O ' HD11 ' A' ' 65' ' ' LEU . 26.0 t30 -153.15 -39.58 0.1 Allowed 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.451 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.759 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 175.82 -51.06 0.12 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.4 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.482 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.65 -27.5 58.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.729 0.3 . . . . 0.0 110.768 -179.513 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.763 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -61.16 -55.28 34.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.692 179.031 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.763 HG22 ' CD1' ' A' ' 33' ' ' PHE . 67.3 t -52.46 -43.16 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.971 0.415 . . . . 0.0 111.138 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' ' 68' ' ' GLN . 14.2 mt -52.76 -43.22 65.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.401 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.59 -49.4 68.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.201 0.524 . . . . 0.0 110.621 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.67 -30.36 71.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.571 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.641 HD21 ' HD2' ' A' ' 48' ' ' PRO . 10.0 mt -61.91 -22.15 65.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.362 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.18 -15.1 59.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.35 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 t -120.77 -5.2 9.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.459 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -161.51 165.54 28.44 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.907 0.384 . . . . 0.0 111.517 -179.968 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.7 m -138.27 115.75 9.28 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.331 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.683 ' HD2' HD11 ' A' ' 76' ' ' LEU . 59.7 Cg_endo -72.73 147.23 44.57 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.495 2.13 . . . . 0.0 111.914 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 2.0 m-20 -77.71 -20.26 53.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.343 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.924 HG23 HD11 ' A' ' 79' ' ' ILE . 3.2 p -148.63 95.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.965 0.412 . . . . 0.0 110.168 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 79' ' ' ILE . 12.7 tp -86.74 151.75 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.293 -178.693 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.876 ' O ' HG23 ' A' ' 9' ' ' VAL . 15.5 mt -135.97 116.17 13.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.596 179.04 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.58 ' HB2' HD13 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -105.77 141.01 37.93 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -177.226 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.677 ' OD2' ' HA ' ' A' ' 10' ' ' ASP . 9.8 t70 -70.85 -28.36 64.53 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.957 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.689 HG13 ' C ' ' A' ' 62' ' ' GLY . 2.7 tt 45.98 83.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.556 0.217 . . . . 0.0 111.459 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.04 96.4 0.27 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.62 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.6 OUTLIER 58.04 46.37 1.78 Allowed Pre-proline 0 N--CA 1.466 0.352 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 178.352 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 57' ' ' MET . 87.9 Cg_endo -90.36 -55.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.987 2.458 . . . . 0.0 111.927 178.798 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.93 -18.59 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.422 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.975 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 10.2 tpt -158.75 71.54 0.55 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.18 0.514 . . . . 0.0 109.802 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.404 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 0.4 OUTLIER 66.77 -31.27 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.9 179.832 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.689 ' C ' HG13 ' A' ' 55' ' ' ILE . . . 155.17 -34.07 0.66 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.823 -179.005 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' A' ' 90' ' ' ALA . 5.4 mp -72.47 -25.87 61.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.89 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.975 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.78 -30.34 44.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.283 0.563 . . . . 0.0 109.72 178.495 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.579 HD11 ' HA3' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -47.94 -52.8 18.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.931 178.816 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.034 HD23 HD11 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -58.27 -53.07 62.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.245 179.127 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.746 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -43.24 -38.34 2.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.383 179.728 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.579 ' HB3' HD13 ' A' ' 40' ' ' LEU . 18.9 mm100 -71.39 -38.07 71.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.166 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.868 HD12 ' HA ' ' A' ' 66' ' ' LEU . 16.6 mt -64.33 -36.35 76.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.962 -179.202 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.746 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -73.44 -29.85 62.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.979 -179.907 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.66 -41.32 99.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.835 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -97.3 -23.09 16.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.782 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.46 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 56.2 m-70 -146.33 85.24 7.47 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.844 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.531 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 73.3 Cg_endo -75.53 13.11 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.948 2.432 . . . . 0.0 113.018 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.7 mtt -134.33 -0.62 2.96 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.61 0.243 . . . . 0.0 111.172 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.683 HD11 ' HD2' ' A' ' 48' ' ' PRO . 1.6 tt -76.54 113.16 26.54 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.487 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 45.5 Cg_endo -67.72 116.69 4.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.366 2.044 . . . . 0.0 111.81 178.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.763 ' HB ' HD21 ' A' ' 66' ' ' LEU . 3.1 t -115.47 151.22 17.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.539 0.685 . . . . 0.0 112.347 -178.817 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.924 HD11 HG23 ' A' ' 50' ' ' VAL . 1.1 mp -129.23 117.29 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.696 178.63 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.034 HD11 HD23 ' A' ' 66' ' ' LEU . 5.8 mm -93.52 133.15 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.594 -178.827 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.567 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.87 -1.88 49.19 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.488 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.588 ' HB ' HG23 ' A' ' 55' ' ' ILE . 2.4 m -148.0 158.92 44.31 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.091 -0.381 . . . . 0.0 110.069 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.736 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -163.19 57.59 0.19 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.866 0.365 . . . . 0.0 111.813 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -98.99 -20.39 16.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.695 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.412 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -84.48 -168.46 2.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.175 0.512 . . . . 0.0 112.339 -178.76 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.457 ' O ' HD22 ' A' ' 63' ' ' LEU . 4.5 m-20 -52.56 89.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.93 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.737 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -46.64 -22.96 0.34 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.555 179.042 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.98 -44.91 30.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . . . -65.82 -19.93 66.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.886 0.374 . . . . 0.0 111.363 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.737 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -75.78 -28.59 58.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.634 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.537 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.5 t -59.19 -38.84 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.536 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.6 m -65.35 -21.75 66.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.644 178.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.676 ' HB1' ' CB ' ' A' ' 98' ' ' ALA . . . -66.65 -47.65 71.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.857 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.537 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.4 m-85 -62.4 -24.32 67.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.076 179.34 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -42.17 59.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.261 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -77.73 -11.02 59.84 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.068 179.477 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.85 15.34 10.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.93 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.676 ' CB ' ' HB1' ' A' ' 93' ' ' ALA . . . -56.84 138.87 52.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.75 0.275 . . . . 0.0 110.499 179.576 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 17.1 t80 -69.14 -52.78 24.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.688 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.5 -161.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.766 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 6.6 m-85 -132.09 118.92 20.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.452 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.654 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 5.1 tp -102.44 140.89 21.53 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.332 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.707 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 22.1 Cg_endo -59.06 168.7 4.28 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.098 1.865 . . . . 0.0 111.047 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.607 ' HE3' ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -41.79 -43.35 6.34 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.329 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.707 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 80.4 Cg_exo -47.05 163.02 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.345 1.363 . . . . 0.0 110.317 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.714 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 2.9 t80 -166.44 -91.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.461 -177.335 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.543 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.7 p-10 43.42 -176.31 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 120.854 0.359 . . . . 0.0 110.442 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.854 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -67.96 -45.23 84.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.303 0.573 . . . . 0.0 111.072 -179.837 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.6 t0 -52.15 -57.25 10.17 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.879 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.702 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.2 mm-40 -78.84 -29.34 44.57 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.2 -51.87 6.69 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.124 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.854 HG21 HG23 ' A' ' 108' ' ' ILE . 42.0 t -59.58 -32.3 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 121.589 0.709 . . . . 0.0 110.085 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.27 -50.94 71.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.362 178.386 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.654 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 12.5 tp -79.01 -20.5 48.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.56 -178.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 112' ' ' VAL . 5.4 p -74.94 -51.8 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.012 -179.182 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.527 ' N ' HG13 ' A' ' 115' ' ' VAL . 84.3 mt-10 -68.31 -37.87 81.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.877 0.37 . . . . 0.0 110.901 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -63.1 -23.99 67.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.457 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.436 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.94 -54.82 8.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.24 -30.71 50.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.111 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 m -66.96 -46.75 73.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 7.3 m80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.163 -179.719 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.1 mp -111.08 112.99 42.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.962 0.41 . . . . 0.0 111.113 -179.634 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.9 HG11 ' CD2' ' A' ' 23' ' ' LEU . 5.8 p -108.15 128.94 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.715 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.869 ' CD1' HG22 ' A' ' 31' ' ' THR . 36.0 m0 -115.93 144.38 44.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.573 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.4 t -134.9 147.82 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.109 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.026 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -134.55 105.1 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.608 177.679 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.602 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 57.1 t0 166.85 123.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.804 0.335 . . . . 0.0 111.336 179.144 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.481 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER 69.49 -21.78 0.16 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 178.849 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 10' ' ' ASP . 14.7 t70 70.56 -130.44 0.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 O-C-N 122.41 -0.181 . . . . 0.0 111.19 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 t -37.27 -45.36 0.65 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.044 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.652 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -53.94 -64.19 0.91 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.168 -179.639 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.663 HG23 HD23 ' A' ' 19' ' ' LEU . 32.1 mm -68.31 -20.63 25.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.696 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -68.84 -55.46 11.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.427 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.417 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 59.5 t90 -54.58 -43.96 72.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.795 0.331 . . . . 0.0 111.651 -179.776 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.714 HG12 HD13 ' A' ' 108' ' ' ILE . 1.4 t -68.46 -46.88 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.761 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.663 HD23 HG23 ' A' ' 15' ' ' ILE . 3.9 mm? -81.67 -23.85 36.64 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.539 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 14.0 pt-20 -67.66 -60.36 2.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.814 -179.151 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.6 mmt180 -63.92 -59.34 4.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.137 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.09 -54.24 21.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 111.932 -179.15 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.9 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.7 tp -65.26 -22.7 66.89 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.282 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -68.21 -36.79 80.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.25 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.26 -26.34 63.74 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.338 178.846 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.739 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.69 -15.47 59.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.703 0.287 . . . . 0.0 111.111 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.96 26.15 9.9 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.673 178.96 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.739 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -124.51 169.45 11.87 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.442 0.621 . . . . 0.0 111.224 179.53 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.2 m -104.17 106.46 16.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.166 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.685 ' HA ' HG13 ' A' ' 6' ' ' VAL . 11.4 t -101.76 115.06 29.69 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.058 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.869 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -118.94 156.63 29.22 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.902 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.696 HG21 ' HA ' ' A' ' 16' ' ' ARG . 18.3 p -129.84 162.79 27.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.658 0.742 . . . . 0.0 112.761 -179.283 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.026 ' HB2' HG13 ' A' ' 9' ' ' VAL . 20.0 m-85 -135.95 173.55 11.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.966 -179.078 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.662 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.5 pp20? -57.63 -59.52 5.07 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -177.319 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.493 ' HB2' ' HG3' ' A' ' 57' ' ' MET . 71.6 m-20 -152.54 -29.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.399 0.545 . . . . 0.0 112.466 -179.274 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.561 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 172.27 -59.19 0.16 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.892 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.423 ' N ' HD22 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -48.1 -31.35 5.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.852 0.358 . . . . 0.0 110.662 -179.701 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.843 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -60.87 -56.41 21.48 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.491 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.778 HG22 ' CD1' ' A' ' 33' ' ' PHE . 5.0 t -53.86 -42.67 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.754 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.76 HD13 ' CB ' ' A' ' 68' ' ' GLN . 14.3 mt -53.95 -43.71 70.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.72 -50.67 68.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.55 68.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.51 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.679 HD21 ' HD2' ' A' ' 48' ' ' PRO . 9.0 mt -65.85 -25.15 67.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.062 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.45 -19.28 61.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.337 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 t -119.32 -1.78 10.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.903 -179.737 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -163.16 158.71 22.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.997 0.427 . . . . 0.0 111.1 -179.849 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.885 HG23 HD13 ' A' ' 76' ' ' LEU . 65.5 m -139.09 112.26 8.05 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.406 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.679 ' HD2' HD21 ' A' ' 43' ' ' LEU . 57.9 Cg_endo -71.36 164.35 36.03 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.921 1.747 . . . . 0.0 111.281 179.209 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.64 -24.1 58.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.907 0.384 . . . . 0.0 110.581 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.822 HG13 HG23 ' A' ' 6' ' ' VAL . 7.3 p -145.22 161.88 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.626 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.653 HD22 HD21 ' A' ' 76' ' ' LEU . 30.8 tp -152.83 155.88 37.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.214 0.53 . . . . 0.0 112.251 -178.605 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.88 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -138.01 121.08 16.73 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.831 -179.801 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.517 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -105.73 138.96 41.04 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.873 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.584 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 53.0 t0 -69.76 -19.3 63.53 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.995 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.624 HD11 ' CE1' ' A' ' 84' ' ' HIS . 5.2 tt 46.16 73.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.224 0.535 . . . . 0.0 111.604 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.17 75.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.489 179.754 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -163.13 -61.16 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.623 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.728 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 59.7 Cg_endo -70.38 -169.32 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.524 2.149 . . . . 0.0 113.656 -178.549 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.71 -58.29 15.36 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.51 179.873 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.768 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -73.72 51.79 0.38 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.145 0.497 . . . . 0.0 110.274 179.475 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.19 -80.11 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.329 -179.297 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.549 ' HA3' ' CA ' ' A' ' 55' ' ' ILE . . . -143.54 -31.98 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.368 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.733 ' HA ' HD13 ' A' ' 66' ' ' LEU . 3.8 mp -53.76 -24.11 14.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.768 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -61.29 -33.93 74.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.263 178.621 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.728 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 16.0 mt -60.41 -32.53 71.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.74 179.463 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.816 ' HA ' HD12 ' A' ' 69' ' ' ILE . 5.8 mp -67.22 -42.55 83.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.379 179.558 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.622 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 5.2 mttt -54.21 -41.47 68.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.657 178.742 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.76 ' CB ' HD13 ' A' ' 40' ' ' LEU . 80.2 mm-40 -63.28 -43.16 98.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.816 HD12 ' HA ' ' A' ' 66' ' ' LEU . 5.6 mt -66.47 -36.26 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.701 -178.946 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.622 ' HG2' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -73.66 -28.46 61.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.934 0.397 . . . . 0.0 110.92 179.853 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.427 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -72.94 -34.78 66.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.987 -179.823 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -93.48 -59.25 2.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.261 179.171 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.41 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 68.4 m-70 -111.83 85.15 6.03 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.355 179.463 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 56.2 Cg_endo -71.17 20.18 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.725 2.283 . . . . 0.0 113.282 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.504 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 29.1 mtm -144.15 0.93 1.08 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.885 HD13 HG23 ' A' ' 47' ' ' THR . 15.1 tp -76.17 114.87 41.72 Favored Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 179.8 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.31 120.64 8.16 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.471 2.114 . . . . 0.0 111.882 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.548 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -115.47 149.29 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.255 0.55 . . . . 0.0 111.885 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.699 HG21 HD23 ' A' ' 114' ' ' LEU . 3.6 mt -132.73 114.51 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.534 178.978 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.643 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 11.4 mm -93.78 138.28 20.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.19 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.626 ' HB3' ' HD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.15 -9.34 57.98 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.25 -179.338 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.64 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.7 m -147.44 168.6 21.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.714 0.292 . . . . 0.0 110.671 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 84' ' ' HIS . . . -143.22 -18.89 0.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 179.646 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.624 ' CE1' HD11 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 23.14 -98.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.247 0.619 . . . . 0.0 112.372 -179.677 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 m -129.29 -176.91 4.03 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.92 0.391 . . . . 0.0 111.245 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.554 ' O ' HD22 ' A' ' 63' ' ' LEU . 5.6 t70 61.64 31.49 18.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.113 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mt -49.61 -21.64 1.07 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.768 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.92 -38.73 17.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.129 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.534 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -74.3 -20.39 60.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.123 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.668 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -71.08 -27.53 63.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.962 0.41 . . . . 0.0 110.109 178.947 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.573 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.4 t -69.08 -41.53 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.09 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.2 m -61.93 -26.46 68.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.054 0.454 . . . . 0.0 110.026 179.134 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -63.9 -46.01 86.75 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.929 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.573 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 10.2 m-85 -59.96 -23.78 63.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.555 179.199 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -36.97 65.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.984 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.532 ' HB3' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -82.87 -3.5 56.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.733 -179.901 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.85 18.02 13.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.129 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.548 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -61.21 145.1 52.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.965 0.383 . . . . 0.0 110.164 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.532 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 36.9 t80 -72.87 -53.69 10.72 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.776 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.445 ' OD2' HD11 ' A' ' 114' ' ' LEU . 12.9 p30 172.61 -167.45 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.821 0.344 . . . . 0.0 111.287 -179.283 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.643 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.3 m-85 -125.6 117.44 23.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.064 0.459 . . . . 0.0 110.736 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.815 HD12 ' HD2' ' A' ' 103' ' ' PRO . 7.3 tp -103.01 134.16 19.94 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.577 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.815 ' HD2' HD12 ' A' ' 102' ' ' LEU . 19.3 Cg_endo -57.71 177.51 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.385 2.057 . . . . 0.0 111.562 179.264 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.621 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -40.02 -51.41 5.76 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.182 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 7.1 Cg_endo -48.13 163.88 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.304 2.003 . . . . 0.0 111.532 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.626 ' HD2' ' HB3' ' A' ' 81' ' ' MET . 0.0 OUTLIER 173.92 -88.7 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.132 -179.609 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.781 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 47.77 -177.21 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.752 ' HA ' HG23 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -64.67 -49.03 82.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 C-N-CA 119.714 -0.795 . . . . 0.0 112.344 -178.727 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.649 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -53.89 -55.25 28.57 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.175 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.617 ' CG ' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.72 -28.16 24.82 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.704 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.781 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -82.81 -47.41 11.92 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.612 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.752 HG23 ' HA ' ' A' ' 108' ' ' ILE . 45.3 t -64.3 -32.9 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.474 0.654 . . . . 0.0 109.507 178.262 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -57.97 -47.95 81.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.172 178.5 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.699 HD23 HG21 ' A' ' 79' ' ' ILE . 6.3 tp -78.91 -22.39 45.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.981 -179.313 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 112' ' ' VAL . 2.3 p -79.37 -49.92 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.822 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.445 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 24.8 mt-10 -55.88 -48.46 75.54 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.626 0.25 . . . . 0.0 111.373 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.466 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -61.42 -23.25 65.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.867 0.365 . . . . 0.0 110.82 179.729 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.532 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.53 -48.2 42.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.92 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.2 mt -72.43 -30.76 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.198 0.523 . . . . 0.0 110.523 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 t -69.77 -45.12 68.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.013 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.949 0.404 . . . . 0.0 111.416 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.15 151.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.195 0.521 . . . . 0.0 111.27 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 1.042 ' HG2' HD11 ' A' ' 5' ' ' ILE . 6.1 tpt180 -74.13 -75.05 0.17 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.712 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.711 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 95.24 91.9 1.73 Allowed Glycine 0 C--N 1.323 -0.162 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.658 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.042 HD11 ' HG2' ' A' ' 3' ' ' ARG . 4.2 mm -116.74 112.51 39.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.597 0.237 . . . . 0.0 111.393 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.931 HG11 ' CD2' ' A' ' 23' ' ' LEU . 4.8 p -107.27 117.31 52.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.46 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.833 ' CD1' HG22 ' A' ' 31' ' ' THR . 34.3 m0 -108.03 137.96 45.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 0.0 111.109 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.5 t -124.2 141.92 42.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -128.03 114.1 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.743 177.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.594 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.2 t0 -171.63 -152.02 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.55 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -66.33 -2.44 4.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.6 OUTLIER 59.01 -148.04 0.48 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 121.201 -0.2 . . . . 0.0 111.299 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 t 34.58 -89.41 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.807 ' O ' HG23 ' A' ' 18' ' ' VAL . 61.6 m -55.65 -55.16 35.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.873 0.368 . . . . 0.0 110.971 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.5 mm -63.58 -34.73 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.112 0.482 . . . . 0.0 111.073 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.713 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.7 OUTLIER -69.39 -53.79 17.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.944 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.444 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 85.6 t90 -52.52 -45.11 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 14' ' ' SER . 1.4 t -67.94 -57.96 7.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.219 0.533 . . . . 0.0 111.424 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.666 ' HA ' HD11 ' A' ' 108' ' ' ILE . 3.6 mm? -67.04 -27.71 67.62 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 15.8 pt-20 -67.55 -59.89 3.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.558 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.5 mmt180 -75.66 -52.38 10.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.551 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -54.15 -54.04 45.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.811 0.339 . . . . 0.0 111.853 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.931 ' CD2' HG11 ' A' ' 6' ' ' VAL . 5.2 tp -64.3 -25.93 68.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.198 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -68.32 -33.31 74.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.99 -22.77 74.26 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.385 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.602 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.99 -15.59 59.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 110.84 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.73 21.99 8.33 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.64 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.717 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.85 170.84 11.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.397 0.599 . . . . 0.0 111.35 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.1 m -105.11 106.51 17.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.917 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 8.5 t -105.83 114.47 28.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.391 0.615 . . . . 0.0 112.188 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.833 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -122.66 156.78 33.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.576 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.713 HG21 ' HA ' ' A' ' 16' ' ' ARG . 33.9 p -127.81 156.63 42.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.451 0.643 . . . . 0.0 112.234 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.904 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -128.47 174.12 9.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.242 -179.391 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.502 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -57.61 -52.33 65.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -160.21 -37.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.658 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . 178.43 -55.82 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.498 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.421 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 55.5 m-80 -56.97 -26.9 60.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 110.689 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -63.91 -48.51 76.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.527 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.731 HG21 HG22 ' A' ' 9' ' ' VAL . 13.5 t -58.99 -32.78 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.447 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.73 HD11 ' OE1' ' A' ' 68' ' ' GLN . 32.7 mt -56.21 -47.56 78.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.335 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.99 -47.95 76.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.339 0.59 . . . . 0.0 110.258 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.15 -32.67 72.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.698 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.645 ' HG ' HG12 ' A' ' 39' ' ' VAL . 15.6 mt -67.47 -27.65 67.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.054 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.34 -15.87 40.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.492 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 m -123.22 -5.51 8.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.82 ' HG3' ' N ' ' A' ' 47' ' ' THR . 1.3 tttt -155.55 166.57 33.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.309 0.576 . . . . 0.0 111.615 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.82 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 96.7 m -138.29 112.75 8.7 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.796 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.559 ' HG2' HD11 ' A' ' 76' ' ' LEU . 56.5 Cg_endo -71.44 158.1 54.9 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.465 2.11 . . . . 0.0 111.657 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.94 -30.59 50.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.78 0.324 . . . . 0.0 111.037 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.029 HG21 HG23 ' A' ' 115' ' ' VAL . 5.9 p -145.26 94.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.446 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.623 HD22 HD21 ' A' ' 76' ' ' LEU . 38.2 tp -83.21 141.26 32.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.432 0.634 . . . . 0.0 112.209 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.931 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -124.33 119.62 29.81 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.588 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.701 ' HA ' HG23 ' A' ' 9' ' ' VAL . 1.4 m -115.28 148.08 39.63 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 28.1 t0 -82.87 -178.0 6.95 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.348 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.69 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.1 tt -160.0 74.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 121.137 0.494 . . . . 0.0 112.095 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 177.05 58.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.646 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.529 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.33 -63.03 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.908 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.529 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 23.0 Cg_endo -60.22 -165.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.669 2.246 . . . . 0.0 113.356 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.03 -65.06 3.32 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.69 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.941 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -85.19 53.18 2.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.995 0.426 . . . . 0.0 110.94 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.465 ' HB3' HG13 ' A' ' 55' ' ' ILE . 1.2 m-20 55.74 -68.45 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.681 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -152.16 -35.62 0.03 OUTLIER Glycine 0 CA--C 1.507 -0.44 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.271 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.832 HD22 ' O ' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -53.64 -28.24 31.75 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.941 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -61.2 -34.42 75.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.658 HD22 ' HA3' ' A' ' 36' ' ' GLY . 74.1 mt -59.98 -35.99 76.19 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.672 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.756 ' HA ' HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -61.83 -51.06 69.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.433 178.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.691 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 11.9 tttp -47.36 -44.93 24.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.082 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.73 ' OE1' HD11 ' A' ' 40' ' ' LEU . 2.5 mt-30 -60.76 -43.18 98.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.202 0.525 . . . . 0.0 110.174 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.832 HD13 HG21 ' A' ' 78' ' ' VAL . 10.6 mt -64.98 -37.94 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.06 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.691 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -77.21 -23.48 51.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.541 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -67.17 -43.41 82.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.126 0.488 . . . . 0.0 111.233 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.83 -26.55 13.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.176 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.524 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 59.3 m-70 -130.25 76.23 78.11 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.751 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.576 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 73.5 Cg_endo -75.21 40.22 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.616 2.21 . . . . 0.0 112.236 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 59.1 mtt -153.97 -39.19 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.722 HD13 HG23 ' A' ' 47' ' ' THR . 16.8 tp -55.01 112.31 3.96 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.916 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.634 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 59.4 Cg_endo -73.41 141.21 31.38 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.934 1.756 . . . . 0.0 111.985 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.832 HG21 HD13 ' A' ' 69' ' ' ILE . 2.3 t -128.93 151.58 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.335 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.574 HD12 ' HG ' ' A' ' 52' ' ' LEU . 1.5 mt -120.93 118.54 56.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.991 0.424 . . . . 0.0 111.135 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.737 HD11 HD23 ' A' ' 66' ' ' LEU . 16.3 mm -95.01 142.68 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.509 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.464 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -82.31 -16.83 47.94 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.104 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.619 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.6 m -148.14 144.54 27.86 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.906 -0.717 . . . . 0.0 111.989 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.826 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -129.68 40.44 3.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.839 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.51 -12.07 41.08 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.44 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -92.98 -164.14 1.14 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.641 0.258 . . . . 0.0 110.613 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.832 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -53.84 93.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.758 0.314 . . . . 0.0 111.334 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.436 ' HA ' ' CD2' ' A' ' 63' ' ' LEU . 1.7 mt -59.52 -21.89 60.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.741 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.0 -43.47 29.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.333 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.625 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -68.95 -23.15 64.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.688 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.757 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -67.86 -23.01 65.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.754 0.311 . . . . 0.0 110.273 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.643 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.4 t -69.03 -41.95 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.464 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.608 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 91.3 p -60.45 -18.2 49.6 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.751 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.72 -53.91 7.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.431 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.643 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.2 m-85 -58.75 -31.43 68.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.064 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.608 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -75.88 -34.62 60.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.816 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.751 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 3.1 pp0? -80.75 -18.26 48.31 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.607 0.241 . . . . 0.0 110.82 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.27 32.56 2.33 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.207 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.661 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -65.01 169.82 4.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.238 0.519 . . . . 0.0 110.998 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.634 ' HD1' ' HB2' ' A' ' 77' ' ' PRO . 0.1 OUTLIER -85.55 -55.24 4.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.727 0.298 . . . . 0.0 110.941 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 99' ' ' PHE . 0.1 OUTLIER 164.77 -162.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.884 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.826 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.1 m-85 -132.86 112.49 11.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.127 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.648 HD22 ' CE1' ' A' ' 106' ' ' PHE . 4.8 tp -102.96 142.97 25.66 Favored Pre-proline 0 C--O 1.226 -0.169 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.275 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.742 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 19.3 Cg_endo -56.66 170.6 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.344 2.029 . . . . 0.0 111.196 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -44.5 -47.24 26.47 Favored Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.742 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 75.1 Cg_exo -47.99 162.01 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.376 1.384 . . . . 0.0 110.288 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.791 ' HD1' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -176.65 -83.98 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.291 -178.572 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.4 p30 41.93 -168.56 0.0 OUTLIER 'General case' 0 C--O 1.231 0.113 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.691 HD13 HG12 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -67.66 -51.5 50.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 121.243 0.544 . . . . 0.0 111.421 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.613 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.9 t70 -48.96 -57.42 6.52 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.433 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.3 mm-40 -77.02 -31.19 56.21 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.791 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.34 -53.7 5.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.175 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.739 ' HA ' HG12 ' A' ' 115' ' ' VAL . 42.0 t -56.53 -32.41 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.428 0.632 . . . . 0.0 110.158 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -58.63 -52.72 64.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.821 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.505 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.9 tp -71.81 -25.69 62.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.816 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 1.029 HG23 HG21 ' A' ' 50' ' ' VAL . 10.0 p -79.24 -54.18 12.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.538 ' N ' HG13 ' A' ' 115' ' ' VAL . 1.8 mt-10 -57.57 -62.47 1.77 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.735 0.303 . . . . 0.0 111.515 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 117' ' ' ARG . 0.4 OUTLIER -53.32 -28.65 29.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.287 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.597 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.91 -49.28 20.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.871 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.914 HD11 HG22 ' A' ' 115' ' ' VAL . 5.6 mt -64.58 -31.42 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.125 0.488 . . . . 0.0 110.482 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.8 t -64.95 -33.9 77.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.748 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -73.76 -27.99 61.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.762 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -78.88 -55.93 4.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.87 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 59.51 174.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.052 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -179.923 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.866 0.365 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.66 155.11 22.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.903 ' HG3' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -84.43 -33.52 23.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.061 0.458 . . . . 0.0 110.817 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.767 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 79.61 94.51 0.34 Allowed Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.42 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.903 HD11 ' HG3' ' A' ' 3' ' ' ARG . 2.8 mm -114.18 112.54 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 111.28 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.949 HG11 ' CD2' ' A' ' 23' ' ' LEU . 8.4 p -113.66 125.48 70.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.325 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.966 ' CD1' HG22 ' A' ' 31' ' ' THR . 35.5 m0 -115.38 139.08 50.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.626 0.251 . . . . 0.0 110.823 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -132.31 138.29 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.043 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -128.11 107.22 15.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.668 178.569 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 48.6 t0 166.85 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.239 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.487 ' HB3' HG12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 71.06 -41.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.484 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 16' ' ' ARG . 38.8 t70 74.62 -106.3 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.971 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 12' ' ' ASP . 52.2 p -23.57 -84.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.734 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.9 m -53.46 -45.42 69.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.487 HG12 ' HB3' ' A' ' 11' ' ' ASP . 27.1 mm -67.94 -20.48 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.822 0.344 . . . . 0.0 111.741 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.638 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.7 ttt180 -79.2 -54.92 5.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 111.689 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.447 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 65.0 t90 -52.37 -42.75 64.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.489 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 14' ' ' SER . 1.7 t -71.38 -51.18 35.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.038 0.447 . . . . 0.0 111.92 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.613 HD22 ' CD1' ' A' ' 108' ' ' ILE . 4.4 mm? -70.82 -28.66 64.78 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.466 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.694 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 23.6 pt-20 -67.59 -58.96 3.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.491 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.4 mmt180 -63.15 -58.01 8.65 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.07 -55.43 27.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.987 0.423 . . . . 0.0 111.474 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.949 ' CD2' HG11 ' A' ' 6' ' ' VAL . 14.3 tp -66.62 -19.71 65.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.467 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.6 -33.34 70.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.53 -26.6 68.45 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.235 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.546 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.87 -15.63 59.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.629 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.77 25.65 9.66 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.781 -0.723 . . . . 0.0 114.795 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.803 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -120.0 164.74 15.65 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.61 1.205 . . . . 0.0 112.313 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.0 m -94.57 111.26 23.02 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.257 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 1.1 m -102.35 118.95 37.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.293 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.966 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -128.88 136.1 49.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.675 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 55.2 p -113.99 157.62 22.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.043 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.8 m-85 -134.8 173.8 11.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.904 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.602 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.9 pp20? -61.3 -58.06 9.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -156.3 -23.05 0.1 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.725 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 165.12 -59.32 0.25 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.717 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.544 ' N ' HD22 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -47.37 -32.91 5.31 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.148 0.499 . . . . 0.0 110.704 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.771 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -60.95 -60.89 3.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.613 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.84 HG21 ' CG2' ' A' ' 9' ' ' VAL . 1.9 t -53.86 -34.65 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.329 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.717 HD13 ' HB2' ' A' ' 68' ' ' GLN . 32.0 mt -48.81 -52.34 24.59 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.054 0.454 . . . . 0.0 110.406 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -47.97 83.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.108 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.59 -35.16 80.09 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.771 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.872 HD13 ' HD2' ' A' ' 73' ' ' HIS . 23.2 mt -68.32 -19.93 64.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.612 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.18 -11.98 58.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.296 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.29 -3.79 7.4 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -155.49 161.45 40.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.986 0.422 . . . . 0.0 111.31 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.43 HG23 ' CG ' ' A' ' 76' ' ' LEU . 21.1 m -138.47 112.37 8.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.952 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.649 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 73.9 Cg_endo -74.6 164.91 32.78 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.12 1.88 . . . . 0.0 111.822 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.43 -24.03 34.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.997 0.427 . . . . 0.0 110.472 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.851 HG11 ' CG2' ' A' ' 115' ' ' VAL . 7.5 p -149.97 91.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.491 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.669 HD23 HG22 ' A' ' 78' ' ' VAL . 57.9 tp -84.25 149.73 25.91 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.242 0.544 . . . . 0.0 111.906 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.873 HD22 ' CE2' ' A' ' 106' ' ' PHE . 5.3 mt -133.73 114.06 13.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.052 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.666 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -109.18 144.02 37.83 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 9.7 t0 -73.34 -171.9 1.05 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.756 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.727 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 8.6 tt -169.96 84.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 120.878 0.371 . . . . 0.0 111.703 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 167.9 59.87 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.171 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -161.0 -63.06 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.095 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.46 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 22.5 Cg_endo -59.47 -173.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.765 2.31 . . . . 0.0 113.471 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.98 -66.67 2.67 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.58 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.671 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 2.3 ttm -72.15 57.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.038 0.447 . . . . 0.0 110.367 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.91 -79.09 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.186 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.727 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -146.53 -28.69 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.866 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.735 HD13 ' HB3' ' A' ' 86' ' ' ASP . 3.7 mp -63.16 -19.19 64.25 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.916 0.358 . . . . 0.0 110.703 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.671 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -53.57 -22.76 9.04 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.083 0.468 . . . . 0.0 110.863 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.725 HD13 ' HA3' ' A' ' 36' ' ' GLY . 5.8 mt -69.62 -40.79 76.38 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.317 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.729 HD23 ' CB ' ' A' ' 93' ' ' ALA . 6.6 mp -56.61 -41.23 76.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.419 0.628 . . . . 0.0 109.938 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -53.75 -53.13 56.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.07 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.717 ' HB2' HD13 ' A' ' 40' ' ' LEU . 10.8 mm-40 -69.18 -29.34 67.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.182 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.019 HG23 ' NE2' ' A' ' 73' ' ' HIS . 1.5 mm -52.87 -52.75 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.136 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -68.68 -31.03 69.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.283 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -78.99 -23.34 44.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.692 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -85.95 -73.27 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.07 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 1.019 ' NE2' HG23 ' A' ' 69' ' ' ILE . 11.2 p80 -89.35 167.26 18.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.211 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.63 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 89.0 Cg_endo -78.29 72.27 6.36 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.782 2.322 . . . . 0.0 112.912 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.632 ' HB2' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER 54.09 34.37 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.403 179.114 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 77' ' ' PRO . 0.1 OUTLIER -63.1 121.04 66.71 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.712 ' N ' HD22 ' A' ' 76' ' ' LEU . 10.7 Cg_endo -53.58 132.31 48.28 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.846 2.364 . . . . 0.0 113.19 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.669 HG22 HD23 ' A' ' 51' ' ' LEU . 2.9 t -123.41 154.29 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.541 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.794 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.6 mt -131.56 117.17 34.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.212 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 53' ' ' SER . 11.5 mm -93.57 150.45 3.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.624 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.554 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -87.02 -19.43 28.68 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.696 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.67 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.7 m -147.03 171.0 15.95 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.656 0.265 . . . . 0.0 110.996 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.5 ' H ' HG22 ' A' ' 82' ' ' THR . . . -122.34 -20.99 5.95 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.729 0.3 . . . . 0.0 111.459 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.416 ' H ' HG22 ' A' ' 82' ' ' THR . 4.2 m-70 45.07 29.71 0.52 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 73.3 m 67.92 -3.99 1.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.735 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -92.5 39.19 1.02 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.045 0.45 . . . . 0.0 110.301 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.739 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -48.44 -21.05 0.48 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.292 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -47.49 -57.65 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.445 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.64 -24.52 67.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.567 0.222 . . . . 0.0 111.537 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.739 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.69 -33.21 73.58 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.666 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.1 t -62.99 -45.37 99.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.607 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 91.7 p -60.3 -34.1 73.3 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.426 0.632 . . . . 0.0 109.89 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.729 ' CB ' HD23 ' A' ' 66' ' ' LEU . . . -59.72 -41.39 90.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.48 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.666 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.8 m-85 -61.91 -21.57 64.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.065 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.632 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.78 -43.41 72.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.503 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.632 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 6.8 pm0 -82.13 -19.12 40.69 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.12 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.63 38.95 0.64 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.662 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.693 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -63.57 154.25 33.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.145 0.472 . . . . 0.0 110.237 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.718 ' CZ ' ' HB1' ' A' ' 118' ' ' ALA . 2.2 t80 -79.79 -53.58 6.65 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.71 -162.68 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.769 0.319 . . . . 0.0 111.065 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.582 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.0 m-85 -142.63 139.36 31.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.172 0.511 . . . . 0.0 111.132 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 2.1 tp -101.92 140.8 21.5 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.489 ' O ' HG23 ' A' ' 82' ' ' THR . 35.4 Cg_exo -61.42 -34.54 86.28 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.077 1.851 . . . . 0.0 111.962 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.676 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER 167.54 -50.63 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.245 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.7 Cg_endo -47.85 163.79 0.19 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.008 1.805 . . . . 0.0 109.94 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.873 ' CE2' HD22 ' A' ' 52' ' ' LEU . 26.7 t80 -168.46 -92.13 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.329 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 3.7 p30 41.78 -171.24 0.0 OUTLIER 'General case' 0 C--N 1.335 -0.063 0 CA-C-O 120.961 0.41 . . . . 0.0 111.117 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.896 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -68.11 -49.98 62.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 7.9 m-20 -51.11 -57.11 9.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.819 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -76.31 -30.54 57.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.508 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . . . -83.61 -56.97 3.43 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.021 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.896 HG21 HG23 ' A' ' 108' ' ' ILE . 43.3 t -54.43 -30.38 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.459 0.647 . . . . 0.0 109.987 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.07 -54.6 44.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.574 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.794 ' CD2' HG21 ' A' ' 79' ' ' ILE . 6.7 tp -71.4 -22.37 61.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.522 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.851 ' CG2' HG11 ' A' ' 50' ' ' VAL . 4.3 p -79.45 -50.34 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.936 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.471 ' N ' HG13 ' A' ' 115' ' ' VAL . 23.0 mt-10 -62.73 -46.7 86.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.01 0.433 . . . . 0.0 109.908 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -64.91 -25.71 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.176 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.718 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -69.67 -53.41 18.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.093 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.5 mt -66.13 -31.38 53.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.096 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.5 p -70.26 -43.69 69.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.13 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -64.66 -30.66 71.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.41 -55.36 6.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.173 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 56.48 173.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.834 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.016 0.436 . . . . 0.0 110.96 -179.823 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mmt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.732 0.301 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 60.22 160.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.724 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -61.74 -17.58 56.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.057 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.13 92.99 0.23 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.211 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.78 112.33 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.686 0.279 . . . . 0.0 111.355 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.975 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.1 p -107.2 125.65 63.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.79 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.91 ' CD1' HG22 ' A' ' 31' ' ' THR . 33.1 m0 -112.82 145.24 40.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.038 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.693 ' HB ' HG22 ' A' ' 32' ' ' THR . 0.5 OUTLIER -139.09 137.21 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.138 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.998 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -126.35 105.14 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.483 178.099 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.581 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 60.8 t0 166.81 118.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.887 0.375 . . . . 0.0 111.243 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.469 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.6 OUTLIER 72.26 -21.59 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.118 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 10' ' ' ASP . 8.5 t0 70.47 -135.31 0.05 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.579 -0.076 . . . . 0.0 110.849 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.4 m -33.55 -45.41 0.17 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.3 m -53.38 -67.57 0.24 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.948 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.542 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 25.1 mm -65.84 -20.6 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.453 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.62 ' HA ' HG21 ' A' ' 32' ' ' THR . 12.5 ttt-85 -72.39 -61.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.401 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.496 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 71.4 t90 -48.31 -44.28 33.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.175 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.945 HG12 HD13 ' A' ' 108' ' ' ILE . 1.9 t -64.82 -62.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.919 0.39 . . . . 0.0 111.859 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.569 ' HA ' HD11 ' A' ' 108' ' ' ILE . 7.4 tp -71.51 -19.45 62.18 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 13.8 pt-20 -67.96 -57.71 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.687 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.564 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.28 -56.62 11.69 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.993 -179.022 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.8 -56.34 16.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 0.0 111.441 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.975 ' CD2' HG11 ' A' ' 6' ' ' VAL . 13.5 tp -64.42 -19.75 65.72 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.33 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.12 -37.66 75.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.6 -25.01 62.7 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.197 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.39 -15.9 59.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.74 0.305 . . . . 0.0 110.768 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.75 26.18 9.28 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.748 -0.739 . . . . 0.0 114.714 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.699 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -122.41 166.14 15.21 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.478 1.139 . . . . 0.0 112.121 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.5 m -94.98 114.96 26.84 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.34 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -105.17 109.17 21.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.985 -178.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.91 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -121.8 137.58 54.71 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.693 HG22 ' HB ' ' A' ' 8' ' ' VAL . 74.5 p -117.34 160.83 20.5 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.998 ' HB2' HG13 ' A' ' 9' ' ' VAL . 7.6 m-85 -136.03 174.52 10.52 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.077 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.659 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.5 pp20? -60.88 -63.29 1.35 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.538 ' N ' HG12 ' A' ' 9' ' ' VAL . 27.1 m120 -153.89 -22.74 0.14 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.856 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 172.41 -63.42 0.14 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.862 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.484 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -48.31 -29.38 3.83 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.875 0.369 . . . . 0.0 111.043 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.86 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -63.25 -58.1 8.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.127 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.749 HG21 ' CG2' ' A' ' 9' ' ' VAL . 20.4 t -49.08 -46.27 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.195 0.521 . . . . 0.0 110.899 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.585 HD22 ' CD1' ' A' ' 69' ' ' ILE . 2.1 mt -49.9 -44.86 50.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.003 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.41 81.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.309 0.576 . . . . 0.0 110.937 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.56 -31.55 67.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.217 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.664 ' CD1' HG12 ' A' ' 39' ' ' VAL . 9.6 mt -65.67 -27.51 68.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.93 -20.08 21.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.608 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.9 t -126.76 1.92 6.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.818 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.497 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -153.99 159.79 41.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 111.049 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 1.051 HG23 HD23 ' A' ' 76' ' ' LEU . 96.3 m -138.67 112.75 8.43 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.238 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.722 ' HD2' HD21 ' A' ' 76' ' ' LEU . 93.9 Cg_endo -77.12 152.52 31.33 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.04 1.827 . . . . 0.0 111.751 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -74.57 -29.12 61.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.816 0.341 . . . . 0.0 110.692 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.68 HG13 HG23 ' A' ' 6' ' ' VAL . 7.5 p -145.32 94.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.484 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.817 HD23 HG22 ' A' ' 78' ' ' VAL . 63.2 tp -86.95 150.92 23.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.473 0.654 . . . . 0.0 112.282 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.878 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.5 mt -131.76 124.98 30.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.778 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.719 ' HA ' HG23 ' A' ' 9' ' ' VAL . 3.8 m -127.91 150.62 49.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 25.2 t0 -82.7 170.69 14.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.363 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.89 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 3.7 tt -147.15 82.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.842 0.353 . . . . 0.0 111.524 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 174.0 61.12 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.892 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.437 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.55 -62.79 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.68 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 22.5 Cg_endo -58.39 -170.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.249 2.633 . . . . 0.0 113.29 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.68 -71.41 0.75 Allowed Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.327 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.916 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -73.03 59.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.0 110.343 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.81 -74.8 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.46 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.89 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -150.26 -32.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.46 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.882 ' HA ' HD13 ' A' ' 66' ' ' LEU . 3.2 mp -59.08 -20.33 52.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.864 0.364 . . . . 0.0 110.366 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.916 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -58.14 -31.37 67.13 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.466 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.856 HD13 ' HA3' ' A' ' 36' ' ' GLY . 5.9 mt -65.08 -39.61 93.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.409 . . . . 0.0 110.583 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.882 HD13 ' HA ' ' A' ' 63' ' ' LEU . 6.0 mp -60.08 -43.36 95.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.74 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -54.07 -42.51 69.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.235 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.548 ' HB2' HD13 ' A' ' 40' ' ' LEU . 41.1 mm-40 -61.3 -34.14 74.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.236 0.541 . . . . 0.0 110.053 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.598 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 49.7 mm -59.69 -41.68 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.114 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' CB ' ' HB2' ' A' ' 96' ' ' GLN . 11.9 pttp -74.72 -27.78 60.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.249 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.424 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 1.3 mt-30 -63.73 -42.48 97.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.04 0.447 . . . . 0.0 111.267 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 72' ' ' ARG . 12.4 mtt85 -103.7 -49.99 3.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.276 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.586 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 4.1 m-70 -88.58 135.26 32.67 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.615 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.11 -76.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.849 2.366 . . . . 0.0 112.664 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 21.4 mtm -140.92 52.75 1.59 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.456 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.051 HD23 HG23 ' A' ' 47' ' ' THR . 2.2 tm? -56.49 111.6 3.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.214 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.52 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 26.7 Cg_exo -62.35 115.36 2.82 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.27 1.98 . . . . 0.0 112.158 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.953 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -121.82 153.3 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.805 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.773 HG21 ' CD2' ' A' ' 114' ' ' LEU . 3.2 mt -130.64 117.78 40.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.308 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.637 HG22 ' H ' ' A' ' 82' ' ' THR . 19.3 mm -93.86 149.28 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.262 0.553 . . . . 0.0 112.407 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.583 ' N ' ' HE2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -84.7 -18.63 34.66 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.501 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.648 ' O ' HG21 ' A' ' 55' ' ' ILE . 3.3 m -147.44 160.98 41.96 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.722 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.834 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -111.09 -24.76 10.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.091 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 47.03 -171.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.344 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.35 53.0 2.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.873 0.368 . . . . 0.0 111.165 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.524 ' HB2' HD13 ' A' ' 63' ' ' LEU . 5.6 m-20 -158.98 28.38 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.834 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 2.0 mt -46.38 -21.39 0.16 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.79 -56.13 8.09 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -64.65 -19.94 66.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.639 0.257 . . . . 0.0 111.467 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -65.14 -50.99 63.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.342 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.652 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.7 t -65.35 -48.92 81.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.94 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -58.96 -25.04 63.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.956 0.408 . . . . 0.0 110.218 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.561 ' HB1' HD23 ' A' ' 66' ' ' LEU . . . -61.56 -51.86 66.81 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.443 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.665 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 2.7 m-85 -55.83 -30.57 61.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.01 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -37.62 56.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.461 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.538 ' HB2' ' CB ' ' A' ' 70' ' ' LYS . 1.7 pt20 -100.07 4.71 44.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 123.08 81.9 0.56 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.026 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.953 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.7 126.96 1.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 0.0 111.241 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 78.6 t80 -64.77 -53.41 47.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.379 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.665 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.6 OUTLIER 178.2 -169.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.881 0.372 . . . . 0.0 111.086 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.532 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.2 m-85 -123.84 118.72 27.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.471 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.665 HD23 ' CE2' ' A' ' 106' ' ' PHE . 5.7 tp -102.45 134.11 20.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 8.1 Cg_endo -49.4 166.66 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.697 2.265 . . . . 0.0 112.036 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.637 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -41.13 -50.08 8.17 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.547 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.7 Cg_endo -47.69 162.6 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.768 1.646 . . . . 0.0 110.441 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.873 ' HD1' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -171.58 -87.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.87 -178.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.7 p30 43.25 -170.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.59 0.233 . . . . 0.0 110.396 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.945 HD13 HG12 ' A' ' 18' ' ' VAL . 1.2 mp -68.04 -45.98 82.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.225 0.536 . . . . 0.0 111.336 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.564 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 7.4 t0 -51.72 -58.17 7.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.695 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.669 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 1.4 mm-40 -78.29 -27.69 47.37 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.873 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.24 -57.02 3.34 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.722 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.684 HG21 HG23 ' A' ' 108' ' ' ILE . 41.3 t -54.23 -31.82 22.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.557 0.694 . . . . 0.0 110.158 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.84 -52.48 63.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.745 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.773 ' CD2' HG21 ' A' ' 79' ' ' ILE . 13.6 tp -74.3 -20.66 60.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.625 -1.171 . . . . 0.0 112.791 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 112' ' ' VAL . 9.8 p -79.32 -50.12 18.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.934 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.507 ' N ' HG13 ' A' ' 115' ' ' VAL . 43.8 mt-10 -64.22 -41.57 96.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.001 0.429 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -67.56 -25.01 65.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.872 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.99 -54.11 8.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.047 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.4 mt -62.61 -31.34 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.084 0.468 . . . . 0.0 110.508 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.1 m -68.55 -38.11 80.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.741 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -29.59 70.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.88 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -69.23 -37.75 78.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.993 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -75.3 -170.15 1.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.902 179.925 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.812 0.339 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.505 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -88.54 159.92 17.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.953 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -62.45 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.222 0.534 . . . . 0.0 111.736 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.594 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 153.45 103.45 0.23 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.367 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.594 HD13 ' O ' ' A' ' 4' ' ' GLY . 16.9 mm -130.46 112.86 23.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.772 0.32 . . . . 0.0 111.32 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.861 HG23 HG13 ' A' ' 50' ' ' VAL . 7.8 p -107.69 136.01 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.727 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.99 ' CD1' HG22 ' A' ' 31' ' ' THR . 38.5 m0 -122.17 127.37 49.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -118.08 132.23 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -177.78 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.989 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -116.79 105.11 17.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.12 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.54 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 37.4 t0 173.87 100.66 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.411 ' HB3' ' CG1' ' A' ' 15' ' ' ILE . 3.2 t0 65.44 -15.03 0.11 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 10' ' ' ASP . 3.7 p-10 45.27 -152.56 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.55 0.159 . . . . 0.0 110.893 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 1.8 t 32.53 -91.73 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.75 ' O ' HG23 ' A' ' 18' ' ' VAL . 48.3 t -56.25 -57.49 11.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.625 0.25 . . . . 0.0 110.766 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 10' ' ' ASP . 27.1 mm -60.17 -20.78 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.443 . . . . 0.0 110.36 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.628 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.4 ttm180 -78.78 -58.8 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.601 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.413 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 75.1 t90 -49.16 -41.35 36.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.157 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 14' ' ' SER . 1.3 t -68.15 -57.84 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 111' ' ' ALA . 4.2 tp -69.95 -25.4 63.63 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.644 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 23.0 pt-20 -67.69 -57.62 6.06 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.84 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.509 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 6.4 mmt180 -58.49 -53.1 62.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.017 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.43 77.52 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.794 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.3 tm? -76.67 -28.95 56.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.246 0.546 . . . . 0.0 110.474 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.67 -32.25 73.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.424 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.28 -24.64 70.74 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.385 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.06 -14.9 59.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.87 0.367 . . . . 0.0 110.879 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.41 23.33 10.4 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.516 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.604 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -130.96 170.72 14.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 117.471 0.635 . . . . 0.0 111.524 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.626 ' O ' HG12 ' A' ' 6' ' ' VAL . 31.0 m -96.93 141.74 29.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.236 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.644 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -127.54 119.35 25.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.815 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.99 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -131.71 135.63 47.01 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 38.9 p -108.62 163.17 13.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.989 ' HB2' HG13 ' A' ' 9' ' ' VAL . 39.5 m-85 -137.47 174.03 11.03 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.79 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.763 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.0 pp20? -62.83 -60.4 3.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.563 ' N ' HG12 ' A' ' 9' ' ' VAL . 18.4 t-20 -155.38 -32.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.316 0.507 . . . . 0.0 112.19 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.536 ' HA3' HD21 ' A' ' 65' ' ' LEU . . . -179.14 -65.71 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.484 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -47.72 -27.6 2.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 111.221 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.763 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -57.23 -60.83 3.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.685 HG13 ' HE3' ' A' ' 7' ' ' TRP . 65.4 t -50.71 -45.9 27.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.794 HD21 ' CD1' ' A' ' 65' ' ' LEU . 8.6 mt -46.24 -41.52 13.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.287 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.99 -47.81 67.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.926 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.16 -31.28 67.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.32 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.716 HD21 ' HD2' ' A' ' 48' ' ' PRO . 10.9 mt -61.36 -29.06 69.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.088 0.47 . . . . 0.0 111.042 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.56 -20.04 29.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.483 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 m -118.89 -8.49 10.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.863 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -156.3 157.99 36.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.784 0.326 . . . . 0.0 110.988 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.854 HG23 HD23 ' A' ' 76' ' ' LEU . 78.6 m -138.62 112.85 8.48 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.279 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.716 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.3 Cg_endo -76.94 162.35 32.22 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 121.874 1.716 . . . . 0.0 111.388 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.505 ' OD2' ' HB3' ' A' ' 2' ' ' GLN . 0.9 OUTLIER -73.76 -21.03 60.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.876 0.37 . . . . 0.0 110.925 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.861 HG13 HG23 ' A' ' 6' ' ' VAL . 4.4 p -148.6 163.67 5.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.816 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.682 HD11 HG21 ' A' ' 39' ' ' VAL . 23.5 tp -152.83 154.18 34.61 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.314 0.578 . . . . 0.0 112.307 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.977 ' O ' HG23 ' A' ' 9' ' ' VAL . 4.8 mt -137.79 122.05 18.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.513 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.73 ' O ' ' HE3' ' A' ' 81' ' ' MET . 1.3 m -106.55 144.76 32.76 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.591 ' O ' HG23 ' A' ' 55' ' ' ILE . 46.0 t0 -79.05 -11.7 60.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.741 HD13 ' HB ' ' A' ' 82' ' ' THR . 0.7 OUTLIER 51.53 154.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.684 0.754 . . . . 0.0 111.589 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.67 ' H ' ' C ' ' A' ' 61' ' ' ASP . 5.1 ttt180 84.38 72.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.767 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.483 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.44 -67.07 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.621 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 51.8 Cg_endo -66.25 -160.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.154 2.569 . . . . 0.0 113.028 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.17 13.4 50.32 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.392 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.847 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -152.05 47.65 0.77 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.67 ' C ' ' H ' ' A' ' 56' ' ' ARG . 1.0 OUTLIER 45.77 -86.14 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.569 -178.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.735 ' HA3' ' HB ' ' A' ' 55' ' ' ILE . . . -124.03 -30.5 1.02 Allowed Glycine 0 CA--C 1.508 -0.392 0 C-N-CA 119.863 -1.161 . . . . 0.0 112.901 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.776 HD23 ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -63.74 -19.48 64.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -65.31 -34.16 77.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.794 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -57.51 -45.4 85.01 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.352 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.037 HD13 ' HB2' ' A' ' 93' ' ' ALA . 4.9 mt -53.96 -47.0 71.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.53 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.743 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 9.4 tttt -51.98 -43.91 63.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.316 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.474 ' CB ' HD13 ' A' ' 40' ' ' LEU . 9.3 mm100 -65.84 -38.64 89.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.123 0.487 . . . . 0.0 110.279 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.525 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 30.3 mm -61.94 -42.07 93.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.913 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.743 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -70.6 -27.23 63.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.834 -179.08 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -68.76 -39.37 80.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.247 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.99 -54.79 2.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.029 0.443 . . . . 0.0 111.945 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.661 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -83.21 145.2 48.36 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.193 -178.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.33 -79.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.724 2.283 . . . . 0.0 113.214 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.736 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 11.5 mtt -127.13 45.68 2.66 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.84 0.352 . . . . 0.0 111.689 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.854 HD23 HG23 ' A' ' 47' ' ' THR . 1.4 tm? -58.64 106.97 0.8 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.505 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.47 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 48.3 Cg_exo -58.14 116.38 3.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.453 2.102 . . . . 0.0 112.249 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.759 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -112.88 152.17 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.041 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.759 ' HB ' HD23 ' A' ' 52' ' ' LEU . 5.9 mt -142.73 114.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.593 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.678 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 3.8 mm -94.29 131.38 41.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.315 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.814 ' HE1' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -75.38 -6.39 49.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.429 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.741 ' HB ' HD13 ' A' ' 55' ' ' ILE . 2.9 m -145.68 158.04 43.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.602 0.239 . . . . 0.0 110.381 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.681 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -143.57 47.1 1.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.339 . . . . 0.0 110.705 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.418 ' CD2' HG21 ' A' ' 82' ' ' THR . 6.6 m-70 -76.13 108.97 9.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.824 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 m 51.94 178.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.717 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.562 ' CB ' HD13 ' A' ' 63' ' ' LEU . 1.1 m-20 62.28 14.41 6.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.438 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -45.88 -23.71 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -48.33 -45.6 35.47 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -73.78 -19.85 60.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.776 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -58.82 -36.87 75.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 0.0 110.219 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.552 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.6 t -65.75 -37.26 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.491 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 m -66.9 -25.12 66.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.181 0.515 . . . . 0.0 109.693 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 1.037 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -64.33 -47.96 77.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.768 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.552 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.3 m-85 -61.61 -26.98 68.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.48 0.657 . . . . 0.0 109.399 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -41.62 41.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.544 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.736 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.6 pp0? -75.94 -16.95 59.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.806 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.13 -2.39 8.38 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.152 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.759 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -55.94 156.67 5.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.857 0.328 . . . . 0.0 110.875 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.501 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 52.7 t80 -86.79 -53.52 4.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.777 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.49 -161.63 0.02 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.842 0.353 . . . . 0.0 111.677 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.681 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 5.2 m-85 -127.86 124.4 37.42 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.259 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 114' ' ' LEU . 5.8 tp -106.65 137.42 19.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.289 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.727 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 12.3 Cg_endo -53.48 165.75 1.49 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.273 1.982 . . . . 0.0 111.115 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.432 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -41.62 -45.41 7.99 Favored Pre-proline 0 N--CA 1.468 0.461 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.315 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.727 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 80.6 Cg_exo -47.07 162.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 121.774 1.649 . . . . 0.0 110.531 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.762 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 3.8 t80 -164.21 -95.54 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.237 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p30 43.14 -173.25 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 120.814 0.34 . . . . 0.0 110.597 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.795 HG23 HG21 ' A' ' 112' ' ' VAL . 1.2 mp -67.47 -48.87 75.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 11.6 m-20 -52.18 -55.47 20.8 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.847 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.706 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.6 mm-40 -78.0 -30.69 50.24 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.664 ' HB3' HD11 ' A' ' 19' ' ' LEU . . . -82.51 -59.6 2.47 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.77 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.795 HG21 HG23 ' A' ' 108' ' ' ILE . 39.8 t -51.72 -33.87 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.505 0.669 . . . . 0.0 110.5 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.76 -51.43 69.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.76 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.626 HD22 HD13 ' A' ' 102' ' ' LEU . 19.8 tp -76.04 -21.17 57.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.959 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 112' ' ' VAL . 5.9 p -79.42 -48.95 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.655 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.477 ' N ' HG13 ' A' ' 115' ' ' VAL . 70.4 mt-10 -61.58 -52.2 65.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.73 0.3 . . . . 0.0 111.1 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.588 ' HD2' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -61.19 -24.57 66.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.77 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.56 -53.6 9.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 111.303 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.606 HD11 HG22 ' A' ' 115' ' ' VAL . 4.9 mt -68.1 -31.32 51.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.481 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.0 p -66.06 -44.48 84.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.52 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -74.6 -28.83 61.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.746 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -78.02 -57.34 3.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.577 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.4 172.43 13.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.828 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.888 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.726 0.298 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.64 133.64 55.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.108 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.74 ' HB3' HD11 ' A' ' 5' ' ' ILE . 1.7 ttt180 -56.54 -23.21 38.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.916 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 56.31 77.99 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.803 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.74 HD11 ' HB3' ' A' ' 3' ' ' ARG . 2.5 mp -116.36 118.94 60.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.516 0.198 . . . . 0.0 110.651 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.909 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.1 p -116.35 123.96 72.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.681 0.277 . . . . 0.0 110.8 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.919 ' CD1' HG22 ' A' ' 31' ' ' THR . 43.9 m0 -115.49 131.3 56.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.85 0.357 . . . . 0.0 110.642 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -121.47 139.79 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.781 -178.259 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.026 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -126.47 105.81 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.07 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.484 ' HB2' ' SD ' ' A' ' 81' ' ' MET . 43.0 t0 174.52 105.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.705 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.59 -15.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 10' ' ' ASP . 2.6 p30 44.44 -155.22 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.46 0.118 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 1.5 t 30.68 -89.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.634 ' O ' HG23 ' A' ' 18' ' ' VAL . 23.3 m -54.37 -57.49 11.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.37 . . . . 0.0 110.481 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 10' ' ' ASP . 35.5 mm -60.48 -20.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.167 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.764 ' HA ' HG21 ' A' ' 32' ' ' THR . 5.8 ttt-85 -77.37 -61.09 2.1 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.808 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.422 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 70.3 t90 -45.58 -42.75 11.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.797 HG12 HD13 ' A' ' 108' ' ' ILE . 1.8 t -66.95 -62.65 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.04 0.448 . . . . 0.0 112.058 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.486 ' HA ' HD11 ' A' ' 108' ' ' ILE . 12.3 mt -67.12 -26.43 66.69 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.579 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 23.2 pt-20 -65.34 -56.45 12.54 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.104 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.538 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.5 mmm180 -62.97 -58.64 6.63 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.094 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.05 -44.1 67.17 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.909 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.5 tp -73.35 -24.79 60.4 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.431 . . . . 0.0 110.47 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.74 -34.99 77.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.24 -24.22 68.77 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.31 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.634 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.04 -15.78 58.62 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.64 0.257 . . . . 0.0 111.034 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.07 26.2 8.52 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.957 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.702 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.74 170.28 12.31 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 117.987 0.894 . . . . 0.0 111.61 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.2 m -99.56 105.68 17.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.644 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.677 ' HA ' HG13 ' A' ' 6' ' ' VAL . 40.9 t -101.07 111.98 24.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.238 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.919 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -121.36 151.81 39.71 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.764 HG21 ' HA ' ' A' ' 16' ' ' ARG . 68.7 p -125.09 160.15 29.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.026 ' HB2' HG13 ' A' ' 9' ' ' VAL . 5.6 m-85 -135.94 173.86 11.25 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.491 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.508 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.8 pp20? -60.57 -59.23 5.73 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -150.46 -30.2 0.2 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.581 0.628 . . . . 0.0 112.49 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.625 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . 168.24 -56.37 0.22 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.435 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -45.88 -34.22 3.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.942 0.401 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.854 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.2 tp10 -60.97 -56.8 16.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.363 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.762 HG21 ' CG2' ' A' ' 9' ' ' VAL . 3.6 t -49.54 -40.94 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.951 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 68' ' ' GLN . 14.0 mt -55.56 -43.51 75.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.828 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.35 -49.56 59.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.001 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.28 -26.31 66.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.82 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.749 ' CD1' HG12 ' A' ' 39' ' ' VAL . 8.1 mt -71.28 -24.61 62.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.482 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.0 -16.42 43.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.643 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 m -120.26 -6.82 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.591 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -158.72 156.2 29.43 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.674 0.273 . . . . 0.0 110.85 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 1.006 HG23 HD12 ' A' ' 76' ' ' LEU . 67.5 m -139.42 113.0 7.94 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.506 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.683 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 96.8 Cg_endo -76.42 166.06 28.11 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.22 1.947 . . . . 0.0 111.433 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.407 ' O ' ' HD2' ' A' ' 77' ' ' PRO . 28.8 m-20 -73.91 -63.09 1.29 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.852 HG13 HG23 ' A' ' 6' ' ' VAL . 4.9 p -95.12 156.25 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.672 HD12 ' O ' ' A' ' 7' ' ' TRP . 50.1 tp -152.85 133.31 13.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.383 0.611 . . . . 0.0 111.856 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.743 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.6 mt -119.67 116.1 25.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.037 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.564 ' HA ' HG23 ' A' ' 9' ' ' VAL . 1.3 t -107.57 146.77 31.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.502 0.668 . . . . 0.0 112.489 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 7.2 t0 -74.43 -178.66 3.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.924 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.583 ' CG2' ' HB ' ' A' ' 82' ' ' THR . 3.3 tt -157.08 86.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.267 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 163.91 58.73 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.711 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.609 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 6.2 tpt -162.76 -63.79 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.609 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 12.1 Cg_endo -53.26 -164.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.065 2.51 . . . . 0.0 113.112 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.56 6.6 72.49 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.801 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.602 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -152.1 51.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.326 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.5 ' OD2' HD12 ' A' ' 63' ' ' LEU . 1.3 p-10 48.71 -71.44 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.147 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 55' ' ' ILE . . . -141.95 -36.48 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.999 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.873 ' HA ' HD23 ' A' ' 66' ' ' LEU . 1.3 mp -56.76 -18.69 13.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.284 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -63.24 -45.61 90.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.625 HD22 ' HA3' ' A' ' 36' ' ' GLY . 12.0 mt -56.49 -33.76 66.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.601 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.873 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.7 mm? -60.42 -43.81 96.38 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.692 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 14.4 ttmt -56.35 -41.07 75.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.277 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.599 ' HB3' HD13 ' A' ' 40' ' ' LEU . 70.5 mm-40 -70.07 -34.59 73.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.7 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.922 HG23 ' NE2' ' A' ' 73' ' ' HIS . 21.7 mt -67.05 -38.59 81.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.392 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.692 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.57 -24.14 61.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.998 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -78.9 -34.59 44.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.043 0.449 . . . . 0.0 110.935 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -94.04 -69.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.546 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.922 ' NE2' HG23 ' A' ' 69' ' ' ILE . 2.2 p80 -117.66 75.01 9.39 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.071 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.586 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 61.6 Cg_endo -74.96 57.11 4.44 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.299 1.999 . . . . 0.0 112.733 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.428 ' HG3' ' C ' ' A' ' 74' ' ' PRO . 51.3 mtp -154.37 -41.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.101 0.477 . . . . 0.0 111.008 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.006 HD12 HG23 ' A' ' 47' ' ' THR . 2.6 tt -58.12 122.29 57.49 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.911 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.532 ' HD3' ' CE2' ' A' ' 122' ' ' TYR . 18.7 Cg_endo -59.46 118.61 5.52 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.819 2.346 . . . . 0.0 112.513 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.709 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -99.36 148.07 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.849 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.659 ' HB ' HD23 ' A' ' 52' ' ' LEU . 2.7 mt -140.2 113.69 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.181 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.684 HG22 ' H ' ' A' ' 82' ' ' THR . 24.9 mm -93.42 149.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.131 0.491 . . . . 0.0 112.198 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.532 ' HE2' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.39 -13.48 49.26 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.869 -178.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.684 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.6 m -147.78 160.47 42.7 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.046 -0.409 . . . . 0.0 110.682 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.817 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -154.84 65.51 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 0.0 111.17 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.43 -93.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.824 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.63 -176.57 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.305 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.523 ' O ' HD22 ' A' ' 63' ' ' LEU . 85.2 m-20 58.88 14.42 3.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.583 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.804 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -44.47 -25.33 0.25 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -48.02 -42.65 28.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.032 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.603 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.04 -21.37 63.19 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.554 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.687 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -62.56 -41.62 99.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.98 0.419 . . . . 0.0 110.069 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.6 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.8 t -58.35 -39.64 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.437 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.8 p -61.45 -37.73 84.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.41 0.624 . . . . 0.0 110.146 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.67 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -54.83 -43.58 73.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.42 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.6 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 34.0 m-85 -59.16 -22.71 61.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.984 0.421 . . . . 0.0 110.503 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.651 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -71.99 -42.94 65.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.585 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.67 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -75.78 -18.1 59.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.99 15.95 4.59 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.433 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.709 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -56.59 148.48 19.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.143 0.471 . . . . 0.0 110.539 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.511 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 61.0 t80 -79.81 -53.89 6.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.199 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.406 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER 174.91 -158.9 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.002 0.429 . . . . 0.0 111.579 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.817 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.3 m-85 -131.87 125.77 32.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.653 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 6.0 tp -103.01 140.63 21.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.063 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.719 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 18.7 Cg_endo -56.28 165.15 4.49 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.031 1.821 . . . . 0.0 110.448 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -42.53 -43.87 8.76 Favored Pre-proline 0 N--CA 1.467 0.397 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.038 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.719 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 82.0 Cg_exo -47.12 163.88 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.672 1.581 . . . . 0.0 110.818 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.692 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 1.2 t80 -162.49 -92.08 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.528 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.559 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p-10 42.35 -177.12 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.898 0.38 . . . . 0.0 110.889 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.797 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -67.9 -44.79 84.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.355 0.598 . . . . 0.0 111.174 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.1 t70 -53.84 -57.28 11.48 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.787 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.692 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.6 mm-40 -78.53 -28.43 46.14 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.09 -54.24 4.97 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.184 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.753 HG21 HG23 ' A' ' 108' ' ' ILE . 43.8 t -57.49 -32.4 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.558 0.694 . . . . 0.0 109.956 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.44 -51.93 67.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.769 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.653 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 19.4 tp -76.66 -20.67 56.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.82 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.4 p -79.13 -48.62 21.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.723 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.465 ' N ' HG13 ' A' ' 115' ' ' VAL . 71.8 mt-10 -65.25 -45.49 84.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.949 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 20.4 mtp-105 -63.6 -24.01 67.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.905 0.383 . . . . 0.0 110.803 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.511 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -75.04 -51.15 14.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.133 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -65.61 -31.22 52.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.134 0.492 . . . . 0.0 110.975 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.6 t -70.96 -43.77 67.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.129 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -76.89 -27.57 55.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.097 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.532 ' CE2' ' HD3' ' A' ' 77' ' ' PRO . 6.2 t80 -79.55 -56.47 4.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.038 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 58.5 170.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.953 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.817 0.342 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -74.87 146.17 42.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.323 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.68 9.25 1.9 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.816 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.741 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 71.06 89.11 0.1 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.575 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.1 mp -111.55 119.35 59.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.871 0.367 . . . . 0.0 111.364 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.826 HG23 HG13 ' A' ' 50' ' ' VAL . 11.5 p -105.09 127.86 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.076 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.881 ' CD1' HG22 ' A' ' 31' ' ' THR . 29.5 m0 -115.29 143.7 44.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.786 HG21 HD23 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -136.85 143.66 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.043 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -133.38 104.73 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.068 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.61 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 43.0 t0 166.47 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.9 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.459 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 71.19 -23.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.94 0.496 . . . . 0.0 112.146 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 10' ' ' ASP . 10.6 t0 69.33 -131.51 0.08 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 122.53 -0.106 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 t -34.08 -45.05 0.19 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.704 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.2 m -54.67 -67.31 0.28 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 27.8 mm -64.38 -20.45 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.714 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.614 ' HA ' HG21 ' A' ' 32' ' ' THR . 53.3 ttt180 -70.3 -61.37 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.849 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.472 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 70.5 t90 -50.36 -43.6 54.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.954 0.407 . . . . 0.0 111.715 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.855 HG12 HD13 ' A' ' 108' ' ' ILE . 1.4 t -65.82 -61.11 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.002 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.786 HD23 HG21 ' A' ' 8' ' ' VAL . 9.8 tp -71.66 -20.71 61.91 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.667 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 21.2 pt-20 -67.47 -56.94 7.57 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.152 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.541 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 8.7 mmm180 -65.62 -59.42 3.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.215 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.34 -42.73 61.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.807 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.4 tm? -70.43 -26.6 63.74 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.007 0.432 . . . . 0.0 110.516 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.3 76.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.67 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.44 -26.15 69.3 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.27 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.543 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.74 -16.32 59.52 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.743 0.306 . . . . 0.0 111.068 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.41 25.81 8.55 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.455 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.741 ' HB3' ' O ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -136.58 175.2 9.83 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 117.382 0.591 . . . . 0.0 111.355 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.599 ' O ' HG12 ' A' ' 6' ' ' VAL . 3.0 m -106.03 134.61 48.89 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.087 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.667 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 12.2 t -124.3 110.54 14.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.456 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.881 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -110.66 155.42 22.43 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 81.2 p -131.69 159.34 38.66 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.043 ' HB2' HG13 ' A' ' 9' ' ' VAL . 5.8 m-85 -135.8 173.49 11.65 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.927 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.602 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 1.6 pp20? -61.95 -60.81 3.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.742 ' O ' HD11 ' A' ' 65' ' ' LEU . 29.2 m120 -150.69 -52.47 0.14 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 118.318 0.508 . . . . 0.0 111.581 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.657 ' CA ' HD11 ' A' ' 65' ' ' LEU . . . -159.11 -62.03 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.944 -1.122 . . . . 0.0 114.0 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.534 ' HA ' HD12 ' A' ' 40' ' ' LEU . 56.1 m-20 -52.42 -27.67 16.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.979 0.389 . . . . 0.0 111.617 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -62.48 -56.98 12.98 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.482 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.789 HG21 ' CG2' ' A' ' 9' ' ' VAL . 3.0 t -56.61 -40.64 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.151 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.612 HD13 ' CB ' ' A' ' 68' ' ' GLN . 20.2 mt -50.3 -42.57 52.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.008 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.36 81.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.245 0.545 . . . . 0.0 110.875 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.76 78.96 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.653 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.534 ' HG ' HG12 ' A' ' 39' ' ' VAL . 17.4 mt -59.0 -26.65 64.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.964 0.411 . . . . 0.0 111.132 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.95 -20.84 25.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.64 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.72 1.35 8.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.7 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.46 ' HB3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -156.37 159.43 38.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 111.438 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.486 HG23 HD23 ' A' ' 76' ' ' LEU . 86.9 m -139.41 113.08 7.96 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.189 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.564 ' HG2' HD21 ' A' ' 76' ' ' LEU . 78.0 Cg_endo -77.39 153.75 31.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.023 1.815 . . . . 0.0 111.624 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -73.81 -26.1 60.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.826 HG13 HG23 ' A' ' 6' ' ' VAL . 6.2 p -146.14 94.93 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.751 ' O ' HD12 ' A' ' 79' ' ' ILE . 56.6 tp -86.53 151.18 23.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.353 0.597 . . . . 0.0 112.151 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.771 ' O ' HG23 ' A' ' 9' ' ' VAL . 7.3 mt -132.99 114.13 13.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.899 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.956 ' HB3' HD13 ' A' ' 65' ' ' LEU . 1.5 m -114.15 149.91 34.97 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.626 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 29.2 t0 -78.14 173.47 12.21 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.636 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.764 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -145.09 74.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 120.993 0.425 . . . . 0.0 111.16 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 17.6 ttt-85 176.23 61.08 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.549 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.29 -62.8 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.549 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 20.1 Cg_endo -59.4 -174.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.532 2.154 . . . . 0.0 113.101 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.01 -72.39 0.54 Allowed Glycine 0 C--N 1.335 0.493 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.58 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.672 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -71.99 56.26 0.31 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.398 179.458 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.63 -77.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.839 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.764 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -136.33 -39.01 0.16 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.466 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.798 HD23 ' HB2' ' A' ' 90' ' ' ALA . 1.2 mp -51.7 -25.42 7.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.837 0.351 . . . . 0.0 110.496 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -58.73 -33.43 70.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.956 HD13 ' HB3' ' A' ' 53' ' ' SER . 0.4 OUTLIER -50.32 -44.64 54.33 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.898 178.723 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.644 ' HG ' ' HB2' ' A' ' 93' ' ' ALA . 3.1 mm? -60.67 -42.15 96.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.483 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.575 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -44.73 -60.68 1.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.404 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.645 ' OE1' ' HA ' ' A' ' 65' ' ' LEU . 9.4 mp0 -59.21 -37.01 76.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.839 0.352 . . . . 0.0 110.185 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.597 HG21 ' CG2' ' A' ' 78' ' ' VAL . 4.3 mm -64.13 -42.77 96.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.084 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 1.9 ptpp? -76.64 -24.28 53.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.609 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -86.26 -39.42 16.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.428 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.72 -62.92 1.38 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.278 0.561 . . . . 0.0 111.772 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.529 ' CE1' HD13 ' A' ' 43' ' ' LEU . 1.1 m80 -81.42 136.93 48.69 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.979 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.44 -69.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.622 2.215 . . . . 0.0 113.106 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.406 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 1.1 mpt? -144.66 37.28 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 111.601 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.671 HD11 HD22 ' A' ' 51' ' ' LEU . 1.1 tm? -59.94 105.65 0.6 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.407 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.639 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 10.9 Cg_endo -54.07 136.17 66.46 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.468 2.112 . . . . 0.0 112.195 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.729 HG13 HD23 ' A' ' 51' ' ' LEU . 2.1 t -132.89 152.37 35.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.909 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.768 HG21 ' CD2' ' A' ' 114' ' ' LEU . 3.6 mt -132.18 118.6 37.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.403 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 53' ' ' SER . 21.7 mm -93.86 142.98 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.019 0.438 . . . . 0.0 111.887 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.662 ' HE3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -75.46 -20.84 58.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.568 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.599 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.4 m -147.59 161.22 41.57 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.365 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.678 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -133.49 57.75 1.79 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.909 0.385 . . . . 0.0 111.705 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -98.47 -179.81 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.999 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER 63.92 -155.59 0.31 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.059 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.525 ' O ' HD22 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -60.23 78.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.271 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.709 ' HA ' HD21 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -52.8 -22.0 4.82 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.346 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -48.25 -50.76 28.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.606 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -56.24 -19.89 15.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.012 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.798 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -70.27 -35.88 74.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.64 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.613 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.8 t -67.06 -38.26 80.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.865 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.578 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 4.2 m -61.5 -18.62 59.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.325 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.782 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.82 -57.03 4.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.324 0.583 . . . . 0.0 111.542 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.613 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -54.22 -33.64 58.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.078 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -76.58 -35.31 58.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.244 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.782 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -77.78 -18.5 56.35 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.218 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.41 -11.71 3.25 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.926 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.692 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -54.96 156.2 3.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.307 0.554 . . . . 0.0 111.323 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.473 ' HD2' HG12 ' A' ' 79' ' ' ILE . 49.9 t80 -79.72 -53.58 6.67 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.252 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.541 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.5 OUTLIER 171.96 -163.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.033 0.444 . . . . 0.0 111.532 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.678 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 2.8 m-85 -125.69 122.32 36.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.259 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' MET . 3.6 tp -102.24 140.66 21.35 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.195 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.753 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 12.7 Cg_endo -54.58 163.68 3.61 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.637 2.225 . . . . 0.0 111.437 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -41.08 -45.8 6.65 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -178.355 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.753 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 88.7 Cg_exo -47.39 163.49 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.624 1.549 . . . . 0.0 110.671 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.749 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 12.0 t80 -165.77 -92.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.732 -178.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.565 ' O ' ' O ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER 40.11 -174.09 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.772 0.32 . . . . 0.0 111.189 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.855 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -68.08 -51.74 45.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.056 0.455 . . . . 0.0 111.835 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.2 p-10 -49.2 -56.05 10.51 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.942 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.749 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.7 mm-40 -76.59 -30.88 57.15 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.25 -58.5 3.02 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.903 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.677 HG21 HG23 ' A' ' 108' ' ' ILE . 40.0 t -53.03 -31.29 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 121.699 0.762 . . . . 0.0 110.212 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.53 -50.74 72.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.921 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.768 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.8 tp -76.95 -20.73 55.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.925 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.646 HG12 ' HA ' ' A' ' 112' ' ' VAL . 9.7 p -77.76 -48.73 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.954 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.504 ' N ' HG13 ' A' ' 115' ' ' VAL . 40.4 mt-10 -62.7 -44.07 97.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.032 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.663 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 7.8 ptm180 -68.14 -23.7 64.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 111.07 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.97 -50.91 17.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.812 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 115' ' ' VAL . 4.3 mt -70.19 -32.18 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.6 t -69.63 -42.11 74.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.033 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -70.59 -28.02 64.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.16 -54.41 5.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.844 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.97 169.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.059 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.792 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -150.26 163.01 39.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.879 0.371 . . . . 0.0 111.05 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.09 -20.15 17.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.031 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.06 100.95 1.23 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.518 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.469 HG21 ' CE ' ' A' ' 46' ' ' LYS . 2.1 mp -131.88 112.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 111.598 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.765 HG11 ' HG ' ' A' ' 23' ' ' LEU . 12.2 p -107.24 130.24 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.873 ' CD1' HG22 ' A' ' 31' ' ' THR . 23.5 m0 -119.14 135.3 54.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -129.06 136.81 58.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -176.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.88 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -122.49 105.79 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.538 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 55.8 t0 170.28 118.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.458 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 2.2 t70 71.05 -43.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.419 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 49.6 t0 75.59 -107.09 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.947 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 12' ' ' ASP . 31.3 p -23.73 -83.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.714 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.0 m -52.93 -47.56 67.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.455 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.446 ' CG1' ' HB3' ' A' ' 11' ' ' ASP . 19.6 mm -64.64 -20.31 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.761 0.315 . . . . 0.0 111.628 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.481 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 7.1 ttp180 -70.75 -60.94 1.96 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.752 0.31 . . . . 0.0 111.586 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.562 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 37.9 t90 -52.08 -44.32 64.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.735 HG12 HD13 ' A' ' 108' ' ' ILE . 1.2 t -64.04 -49.91 79.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.616 ' HA ' HD11 ' A' ' 108' ' ' ILE . 43.3 mt -84.07 -22.1 31.31 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.618 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 1.2 pp20? -66.42 -59.02 4.06 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.511 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' HG2' ' CD ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -64.58 -62.85 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.01 -53.98 7.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.944 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.765 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.5 tm? -62.76 -29.21 70.52 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.729 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -66.5 -33.91 76.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.516 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.37 -25.24 69.79 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.396 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.578 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.97 -15.08 59.76 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.678 0.275 . . . . 0.0 111.053 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.58 23.46 10.14 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.63 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.578 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -133.52 174.64 10.2 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.532 0.666 . . . . 0.0 111.722 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 m -102.81 117.33 34.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.281 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.68 ' HB2' HD12 ' A' ' 23' ' ' LEU . 8.8 t -113.93 113.23 24.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.513 0.673 . . . . 0.0 111.533 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.873 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -118.87 156.55 29.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.405 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 31.1 p -135.04 152.11 51.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.426 0.631 . . . . 0.0 112.348 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.88 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -129.64 174.31 9.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.054 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.635 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -58.34 -106.33 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.441 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -86.14 -71.8 0.52 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.359 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.762 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -161.16 -39.21 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.411 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -31.63 69.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.901 0.35 . . . . 0.0 110.683 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.772 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -51.84 -57.31 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.634 178.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.828 HG21 HG22 ' A' ' 9' ' ' VAL . 2.9 t -56.85 -47.89 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.964 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.452 HD13 ' CB ' ' A' ' 68' ' ' GLN . 38.1 mt -46.18 -42.75 14.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.868 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.42 -50.07 69.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.799 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.49 -28.73 67.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.104 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.936 HD13 ' CE1' ' A' ' 73' ' ' HIS . 7.3 mt -71.04 -20.95 62.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.455 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.85 -18.15 20.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.074 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 m -126.35 9.43 7.25 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.823 ' HG3' ' N ' ' A' ' 47' ' ' THR . 3.4 tttt -158.15 163.53 37.48 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.439 0.638 . . . . 0.0 112.153 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.978 HG23 HD13 ' A' ' 76' ' ' LEU . 97.8 m -138.83 111.46 8.1 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.192 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' O ' HD11 ' A' ' 76' ' ' LEU . 61.2 Cg_endo -74.41 165.52 31.57 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.447 2.098 . . . . 0.0 111.284 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -82.43 -27.97 31.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.867 0.365 . . . . 0.0 110.818 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.756 HG13 HG23 ' A' ' 6' ' ' VAL . 3.4 p -149.61 99.45 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.41 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.846 ' O ' HD12 ' A' ' 79' ' ' ILE . 47.4 tp -86.96 141.93 28.34 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.938 HD23 ' HB ' ' A' ' 79' ' ' ILE . 6.2 mt -124.42 115.03 20.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.042 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.699 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -109.69 141.79 41.78 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.092 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 8.3 t0 -71.38 -171.82 0.66 Allowed 'General case' 0 C--O 1.23 0.055 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.931 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.96 HD11 ' CE1' ' A' ' 84' ' ' HIS . 2.7 tt -170.13 79.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.218 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.8 78.91 1.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.541 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 2.4 ptt? 43.21 49.92 5.38 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.56 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 50.6 Cg_endo -83.14 -74.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.305 2.003 . . . . 0.0 111.663 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.25 -21.34 3.43 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.976 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 4.3 ttm -163.74 68.28 0.19 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 110.225 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.66 -25.1 0.15 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.167 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.79 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 137.68 -27.68 2.81 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.586 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 4.3 mp -75.17 -17.98 60.28 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.976 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.43 -24.5 12.82 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.844 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.612 ' O ' HG13 ' A' ' 69' ' ' ILE . 7.4 mp -62.13 -42.36 99.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.842 ' HA ' HD12 ' A' ' 69' ' ' ILE . 85.9 mt -64.19 -42.72 96.54 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.304 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 9.9 tptm -48.39 -56.37 8.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.736 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.452 ' CB ' HD13 ' A' ' 40' ' ' LEU . 24.8 mm-40 -59.61 -32.45 70.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.931 HG23 ' ND1' ' A' ' 73' ' ' HIS . 97.1 mt -59.98 -46.01 94.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.969 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -67.0 -27.61 67.58 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -86.03 -37.02 19.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -89.85 -61.97 1.57 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.866 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.936 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -84.96 147.29 47.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.063 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -95.17 103.68 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.227 2.618 . . . . 0.0 112.437 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 18.3 mtm 54.35 24.58 5.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.086 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.978 HD13 HG23 ' A' ' 47' ' ' THR . 10.6 tp -69.15 114.36 22.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.99 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.54 120.63 8.64 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.309 2.006 . . . . 0.0 111.991 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.921 HG21 HD13 ' A' ' 69' ' ' ILE . 1.8 t -117.46 151.47 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.293 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.938 ' HB ' HD23 ' A' ' 52' ' ' LEU . 2.3 mp -131.15 120.39 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.895 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.639 HG22 ' H ' ' A' ' 82' ' ' THR . 18.0 mm -95.49 147.2 6.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.989 0.423 . . . . 0.0 111.375 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.76 ' HE3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.18 -18.42 46.31 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.214 -179.02 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.927 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.9 m -147.77 153.53 39.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.374 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.71 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -134.58 -2.02 2.75 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.744 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.96 ' CE1' HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 23.43 -95.66 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.205 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 m -141.15 -12.78 0.93 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.462 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 3.7 t70 -78.86 44.49 0.55 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.941 0.401 . . . . 0.0 111.361 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.948 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -52.12 -21.06 2.9 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.074 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -47.69 -56.51 7.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.662 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.699 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -68.68 -19.78 64.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.768 0.318 . . . . 0.0 111.247 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.948 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -70.76 -37.73 73.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.88 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.596 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.8 t -63.9 -41.92 94.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.287 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.604 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 23.8 m -61.39 -18.91 60.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 109.991 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.748 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.84 -52.49 10.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.097 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.596 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.0 m-85 -58.24 -33.85 69.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.164 0.507 . . . . 0.0 110.517 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.8 pp0? -76.39 -38.63 55.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.601 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.748 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.2 pp0? -73.12 -18.29 61.31 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.064 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.07 1.44 4.91 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.861 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.612 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -56.82 159.52 3.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.283 0.542 . . . . 0.0 111.537 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.531 ' HB3' HG13 ' A' ' 79' ' ' ILE . 84.0 t80 -85.08 -53.97 4.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.425 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 2.2 t70 173.11 -165.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 111.117 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.71 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.1 m-85 -127.55 122.55 33.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.582 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.412 ' HB2' HD22 ' A' ' 114' ' ' LEU . 1.8 tp -102.58 141.04 21.69 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.837 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.714 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 15.8 Cg_endo -55.52 166.31 2.72 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.363 2.042 . . . . 0.0 111.398 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.431 ' HE2' ' HA ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -42.02 -46.64 10.29 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.411 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.714 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 83.0 Cg_exo -47.23 163.75 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 121.805 1.67 . . . . 0.0 110.727 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.76 ' CE1' ' HE3' ' A' ' 81' ' ' MET . 4.1 t80 -165.75 -93.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.36 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.5 p-10 43.92 -175.78 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.706 0.288 . . . . 0.0 110.506 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.836 HG23 HG21 ' A' ' 112' ' ' VAL . 1.1 mp -67.96 -45.4 83.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.365 0.602 . . . . 0.0 111.381 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 30.9 t0 -52.14 -58.08 7.68 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.662 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.692 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.4 mm-40 -77.82 -30.06 50.93 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -82.99 -53.62 5.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.256 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.836 HG21 HG23 ' A' ' 108' ' ' ILE . 47.7 t -57.79 -32.75 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.431 0.634 . . . . 0.0 110.097 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.57 -52.91 63.51 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.227 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.792 ' CD2' HG21 ' A' ' 79' ' ' ILE . 6.9 tp -75.07 -20.51 59.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.042 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 112' ' ' VAL . 6.0 p -79.18 -43.67 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.601 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.404 ' N ' HG13 ' A' ' 115' ' ' VAL . 16.5 mt-10 -59.89 -51.81 68.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.69 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.4 ' NE ' HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -59.67 -23.82 63.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 110.853 179.467 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.46 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.66 -52.59 11.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.486 HD13 HD22 ' A' ' 28' ' ' LEU . 4.4 mt -71.57 -32.46 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.117 0.484 . . . . 0.0 111.244 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 t -66.06 -33.65 76.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.506 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -69.32 -26.63 64.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.761 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.37 -57.41 3.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.829 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -177.7 4.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.961 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.948 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.635 0.255 . . . . 0.0 111.555 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.08 178.61 8.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.653 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.679 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -174.2 -33.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.903 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.45 72.65 0.93 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.553 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.3 mp -108.97 112.41 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.841 0.353 . . . . 0.0 111.039 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.899 HG11 ' CD2' ' A' ' 23' ' ' LEU . 6.5 p -109.24 118.46 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.942 ' CD1' HG22 ' A' ' 31' ' ' THR . 37.5 m0 -109.62 140.21 43.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.188 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.626 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -125.09 144.85 33.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.194 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.104 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -133.14 106.79 10.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.053 0.454 . . . . 0.0 110.957 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 34' ' ' GLU . 8.5 t0 -162.05 -154.46 0.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.746 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.2 -1.56 3.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 62.47 -151.59 0.36 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.474 -0.141 . . . . 0.0 111.013 179.067 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 t 36.32 -90.34 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.772 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.3 t -55.06 -56.5 19.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.672 0.273 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.9 mm -64.3 -30.88 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.299 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.828 ' HA ' HG21 ' A' ' 32' ' ' THR . 8.5 ttm-85 -71.78 -53.3 13.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.628 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.441 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 72.9 t90 -54.07 -40.73 67.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 14' ' ' SER . 2.8 t -69.04 -56.65 11.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.66 HD13 HD12 ' A' ' 108' ' ' ILE . 7.0 tp -72.38 -23.13 61.07 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.679 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . 14.6 pt-20 -67.31 -59.23 3.58 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.492 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.544 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 11.4 mmm-85 -74.62 -53.84 8.58 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.79 -56.15 17.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 111.786 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.899 ' CD2' HG11 ' A' ' 6' ' ' VAL . 11.4 tp -66.02 -21.36 66.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.639 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.33 -34.83 73.14 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.34 -26.52 68.04 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.349 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.433 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.2 -15.95 59.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.649 0.261 . . . . 0.0 110.676 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.2 24.83 8.19 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.679 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -121.37 165.2 15.88 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.75 1.275 . . . . 0.0 112.438 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.8 m -88.74 109.08 19.85 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.16 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.679 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -101.9 115.62 30.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.414 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.942 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -133.62 132.19 40.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.828 HG21 ' HA ' ' A' ' 16' ' ' ARG . 59.2 p -105.87 164.14 12.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.489 0.661 . . . . 0.0 112.523 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.104 ' HB2' HG13 ' A' ' 9' ' ' VAL . 4.2 m-85 -135.79 173.42 11.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.071 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.592 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 2.0 pp20? -61.53 -49.52 76.38 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.704 ' HB3' ' HB2' ' A' ' 57' ' ' MET . 19.6 m-20 -165.96 -35.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.564 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -172.79 -64.83 0.05 OUTLIER Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.992 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.14 -30.57 49.6 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.848 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 11.1 tt0 -56.14 -48.03 77.03 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.129 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.69 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 4.1 t -52.8 -40.65 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.313 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.63 HD11 HD12 ' A' ' 65' ' ' LEU . 44.9 mt -54.16 -42.12 69.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.727 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.0 -52.48 65.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.848 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.54 -27.94 64.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.812 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.812 HD21 ' HD2' ' A' ' 48' ' ' PRO . 11.9 mt -67.67 -28.53 67.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.579 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.17 -17.74 4.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.877 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.55 -0.02 8.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.554 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.82 164.38 23.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 111.363 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.481 HG23 HD13 ' A' ' 76' ' ' LEU . 88.9 m -138.97 113.35 8.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.562 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.812 ' HD2' HD21 ' A' ' 43' ' ' LEU . 46.3 Cg_endo -68.82 158.44 57.85 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.271 1.981 . . . . 0.0 111.54 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.498 ' OD2' HD12 ' A' ' 5' ' ' ILE . 8.2 m-20 -80.53 -25.94 38.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.47 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.938 HG21 HG23 ' A' ' 115' ' ' VAL . 7.6 p -147.93 97.88 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.684 0.278 . . . . 0.0 111.111 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.711 HD22 HD21 ' A' ' 76' ' ' LEU . 18.6 tp -86.83 152.87 22.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.999 0.428 . . . . 0.0 111.989 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 106' ' ' PHE . 1.1 tt -134.87 114.41 12.54 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.074 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 t -114.9 136.98 52.51 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 111.919 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.414 ' C ' HG22 ' A' ' 55' ' ' ILE . 15.3 t70 -82.75 4.43 25.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.546 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.683 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 7.4 tt 41.84 82.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 12.2 ttp85 175.09 62.23 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.382 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.704 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 10.9 tpt -163.43 -61.13 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.801 ' HB2' ' HB3' ' A' ' 64' ' ' ALA . 17.9 Cg_endo -58.02 178.8 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.405 2.07 . . . . 0.0 112.616 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.77 -64.76 3.66 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.177 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.736 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 3.8 tpt -72.4 57.24 0.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.005 0.431 . . . . 0.0 110.099 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 0.4 OUTLIER 59.52 -81.8 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.237 -179.456 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.39 -31.29 0.15 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.566 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.662 HD11 ' O ' ' A' ' 84' ' ' HIS . 0.8 OUTLIER -60.27 -25.34 65.63 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.113 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.801 ' HB3' ' HB2' ' A' ' 58' ' ' PRO . . . -54.32 -34.17 60.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.926 0.393 . . . . 0.0 109.942 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.63 HD12 HD11 ' A' ' 40' ' ' LEU . 30.7 tp -56.82 -36.99 70.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.825 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.004 HD21 HD11 ' A' ' 80' ' ' ILE . 3.7 mm? -64.32 -44.53 91.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.848 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.776 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -57.21 -42.13 80.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.857 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.458 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 8.5 mm100 -65.18 -36.67 84.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.126 0.488 . . . . 0.0 110.487 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.786 HD12 ' HA ' ' A' ' 66' ' ' LEU . 59.2 mt -61.51 -39.75 84.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.083 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.776 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.64 -28.01 62.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.258 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -79.42 -39.36 32.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.567 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -96.66 -61.54 1.4 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.876 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.595 ' CE1' HD13 ' A' ' 43' ' ' LEU . 1.9 m80 -82.25 157.88 67.51 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.495 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -68.3 -76.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.612 2.208 . . . . 0.0 112.966 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.658 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 31.1 mtm -145.26 56.1 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.027 0.441 . . . . 0.0 111.124 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.711 HD21 HD22 ' A' ' 51' ' ' LEU . 17.6 tp -67.05 112.66 10.43 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.145 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 42.1 Cg_endo -67.28 118.75 5.81 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.462 2.108 . . . . 0.0 111.632 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.73 HG21 HD13 ' A' ' 69' ' ' ILE . 11.5 t -120.63 148.93 23.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 111.651 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.736 HG21 ' CD2' ' A' ' 114' ' ' LEU . 2.7 mt -117.2 113.66 43.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.121 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.004 HD11 HD21 ' A' ' 66' ' ' LEU . 18.3 mm -93.5 135.54 27.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.111 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.888 ' HE3' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -73.09 -55.52 6.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.215 0.531 . . . . 0.0 110.7 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.547 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.5 m -106.39 157.62 17.49 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.218 -0.301 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.743 ' HB1' ' CD2' ' A' ' 87' ' ' LEU . . . -121.49 37.4 4.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.884 0.373 . . . . 0.0 110.695 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.662 ' O ' HD11 ' A' ' 63' ' ' LEU . 2.8 p-80 -81.17 -172.81 3.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 74.91 -75.93 0.07 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.241 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.469 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -160.03 98.96 1.35 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.796 0.331 . . . . 0.0 111.45 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.833 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -47.81 -24.52 1.0 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.265 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.04 -42.11 27.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.889 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.413 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -72.25 -26.31 61.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.321 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.833 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.03 -45.79 72.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.45 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.59 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 15.0 t -67.6 -47.45 80.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 89' ' ' ALA . 2.7 p -63.34 -30.69 71.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.111 0.481 . . . . 0.0 110.16 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.792 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -59.04 -37.38 76.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.682 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.59 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 23.5 m-85 -59.04 -22.11 60.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.077 0.465 . . . . 0.0 110.014 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.63 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.3 -42.15 46.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.075 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.727 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp0? -76.13 -18.11 59.28 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.057 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 128.87 9.21 3.53 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.716 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.792 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -54.39 147.52 13.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 117.37 0.585 . . . . 0.0 111.433 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 56.2 t80 -86.68 -54.17 4.53 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.695 ' OD1' HG23 ' A' ' 79' ' ' ILE . 19.2 p30 171.51 -168.71 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.811 0.338 . . . . 0.0 111.273 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.57 ' CD2' ' HB ' ' A' ' 80' ' ' ILE . 11.3 m-85 -130.45 134.98 47.52 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.538 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.73 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -137.4 117.57 10.47 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.594 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 102' ' ' LEU . 58.8 Cg_exo -38.68 173.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.604 2.869 . . . . 0.0 114.501 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.888 ' HD2' ' HE3' ' A' ' 81' ' ' MET . 0.1 OUTLIER -36.91 -49.51 2.04 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.111 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.9 Cg_endo -47.8 123.81 8.94 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 N-CA-C 108.71 -1.304 . . . . 0.0 108.71 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.955 ' CZ ' HD21 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -156.89 -85.68 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.997 -177.043 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.9 p30 37.32 -162.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.857 0.361 . . . . 0.0 110.854 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.885 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -67.9 -52.52 38.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.587 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 32.1 m-20 -50.53 -56.63 10.76 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.549 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.658 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.6 mm-40 -78.27 -30.97 48.84 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.683 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.37 -54.31 4.87 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.755 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.885 HG21 HG23 ' A' ' 108' ' ' ILE . 32.2 t -55.07 -32.02 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.491 0.663 . . . . 0.0 110.156 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.34 -51.87 67.65 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.501 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.736 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.9 tp -75.3 -20.59 59.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.697 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.938 HG23 HG21 ' A' ' 50' ' ' VAL . 6.6 p -79.41 -50.0 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.092 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.496 ' N ' HG13 ' A' ' 115' ' ' VAL . 17.9 mt-10 -58.33 -43.97 88.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.666 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -24.33 67.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.96 0.409 . . . . 0.0 110.474 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.71 -59.05 2.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.979 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -64.95 -30.98 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.075 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 t -64.45 -37.18 86.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.076 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -78.7 -25.8 44.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.29 -52.2 29.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.01 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -75.23 176.36 7.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.93 179.893 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 125' ' ' BEF . . . . . 0.465 ' F1 ' ' HE1' ' A' ' 81' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.853 0.358 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 61.22 155.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.704 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.08 70.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.021 0.439 . . . . 0.0 111.198 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.477 ' C ' HD13 ' A' ' 5' ' ' ILE . . . -98.52 84.29 0.67 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.409 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.479 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 4.0 mm -107.03 112.4 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.678 0.275 . . . . 0.0 111.09 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.865 HG11 ' CD2' ' A' ' 23' ' ' LEU . 5.9 p -109.95 119.2 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.808 0.337 . . . . 0.0 110.563 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.936 ' CD1' HG22 ' A' ' 31' ' ' THR . 34.8 m0 -112.55 131.77 55.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.802 0.334 . . . . 0.0 110.566 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -122.77 145.6 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.167 0.508 . . . . 0.0 112.283 -177.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.011 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -131.26 107.91 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.15 178.343 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 31.6 t0 170.76 107.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.869 0.366 . . . . 0.0 111.674 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.56 -40.59 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.7 OUTLIER 69.23 -159.3 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t 30.96 -87.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.677 ' O ' HG23 ' A' ' 18' ' ' VAL . 9.6 t -56.09 -57.49 11.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 0.0 110.518 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.38 -22.46 27.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.098 0.475 . . . . 0.0 110.186 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.739 ' HA ' HG21 ' A' ' 32' ' ' THR . 5.2 ttp180 -77.42 -59.24 2.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.398 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.407 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 87.8 t90 -46.35 -38.86 9.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.811 HG12 HD13 ' A' ' 108' ' ' ILE . 1.6 t -72.2 -62.51 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.011 0.434 . . . . 0.0 111.911 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.674 HD13 HD12 ' A' ' 108' ' ' ILE . 3.6 mm? -65.37 -25.75 67.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.142 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.622 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 8.9 pt-20 -67.77 -59.3 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.611 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 6.6 mmm180 -71.75 -48.16 48.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.931 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -57.78 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.049 0.452 . . . . 0.0 111.345 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.865 ' CD2' HG11 ' A' ' 6' ' ' VAL . 4.8 tp -63.96 -22.98 67.16 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.348 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.32 -33.95 72.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.24 -22.33 74.45 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.282 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.487 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.72 -16.0 58.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.658 0.266 . . . . 0.0 110.997 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.7 25.54 6.52 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.218 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.685 HD12 ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -130.68 168.72 16.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.897 0.849 . . . . 0.0 111.725 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.8 m -98.79 105.85 18.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.874 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.69 ' HA ' HG13 ' A' ' 6' ' ' VAL . 33.6 t -104.38 112.87 26.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.936 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.0 t -120.53 154.63 35.07 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.755 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 16.2 p -125.26 164.87 19.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.543 0.687 . . . . 0.0 112.794 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.011 ' HB2' HG13 ' A' ' 9' ' ' VAL . 47.4 m-85 -135.97 173.78 11.34 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.517 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.742 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -61.94 -60.94 2.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.499 ' N ' HG12 ' A' ' 9' ' ' VAL . 7.4 t-20 -151.36 -24.73 0.2 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.688 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 167.91 -58.78 0.21 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.922 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.538 ' N ' HD22 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -52.62 -26.95 15.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.853 0.358 . . . . 0.0 110.685 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.799 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -59.38 -60.31 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.802 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.841 HG22 ' CD1' ' A' ' 33' ' ' PHE . 39.4 t -48.58 -34.48 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.834 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.472 ' CD1' ' HA ' ' A' ' 37' ' ' ASN . 19.2 mt -57.48 -43.52 84.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.59 -53.78 51.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.16 0.505 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.24 71.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.905 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.761 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 12.2 mt -59.85 -29.84 68.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.9 -19.59 4.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.101 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 t -127.79 0.2 6.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -156.02 157.76 36.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.78 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.463 HG23 HD13 ' A' ' 76' ' ' LEU . 85.8 m -138.82 114.79 8.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.223 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.588 ' HD2' HD21 ' A' ' 43' ' ' LEU . 61.1 Cg_endo -74.39 154.94 45.95 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.083 1.855 . . . . 0.0 111.716 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.21 -23.99 40.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.749 0.309 . . . . 0.0 111.08 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.916 HG23 HD11 ' A' ' 79' ' ' ILE . 3.3 p -145.8 92.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.56 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.685 HD11 HG21 ' A' ' 39' ' ' VAL . 63.2 tp -86.61 152.45 22.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.233 0.539 . . . . 0.0 111.929 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.966 ' O ' HG23 ' A' ' 9' ' ' VAL . 4.8 mt -138.2 123.26 19.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.557 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.578 ' HB3' HD13 ' A' ' 80' ' ' ILE . 7.3 t -111.05 144.76 39.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 50.0 t0 -75.47 -11.06 59.96 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.761 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 82' ' ' THR . 1.7 tt 44.35 78.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.563 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 9.2 tpt180 172.05 76.08 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.679 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.632 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.24 -61.78 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.672 ' HD3' HD21 ' A' ' 65' ' ' LEU . 73.7 Cg_endo -74.13 -170.08 0.66 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.134 1.889 . . . . 0.0 113.504 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.3 -59.68 10.27 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.845 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.672 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 10.4 tpp -72.92 52.91 0.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.911 0.386 . . . . 0.0 110.602 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.81 -76.75 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.287 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.75 -32.04 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.189 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.605 HD12 ' H ' ' A' ' 63' ' ' LEU . 4.0 mp -51.79 -29.56 19.57 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -55.66 -32.49 63.25 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.929 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.688 HD13 ' HA3' ' A' ' 36' ' ' GLY . 13.5 mt -56.2 -44.39 79.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.544 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.933 HD21 HD11 ' A' ' 80' ' ' ILE . 30.5 mt -60.57 -44.36 96.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.122 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.628 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 9.8 mttt -49.75 -40.8 42.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.212 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -70.37 -35.64 73.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.203 0.525 . . . . 0.0 110.321 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.847 HD12 ' HA ' ' A' ' 66' ' ' LEU . 69.9 mt -62.42 -40.62 88.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.09 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.628 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -76.23 -25.01 54.61 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.705 -179.487 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -36.21 25.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.649 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.0 mtp85 -92.77 -25.74 18.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.739 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.761 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 14.9 m80 -124.25 152.72 68.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 120.862 0.363 . . . . 0.0 111.533 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.08 -83.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.083 2.522 . . . . 0.0 113.063 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.97 51.31 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.663 0.268 . . . . 0.0 111.073 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.518 HD21 HD22 ' A' ' 51' ' ' LEU . 55.3 tp -60.81 110.54 3.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.704 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.476 ' HD2' HD12 ' A' ' 76' ' ' LEU . 34.7 Cg_endo -64.84 115.7 3.4 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.103 1.868 . . . . 0.0 111.527 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.661 HG11 ' CD2' ' A' ' 66' ' ' LEU . 3.5 t -108.01 154.25 9.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.58 0.705 . . . . 0.0 111.525 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.916 HD11 HG23 ' A' ' 50' ' ' VAL . 3.5 mt -131.22 117.32 36.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.177 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.933 HD11 HD21 ' A' ' 66' ' ' LEU . 33.0 mm -93.42 143.51 11.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.997 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.733 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -94.3 -7.87 40.62 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.714 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.813 ' O ' HD13 ' A' ' 55' ' ' ILE . 3.0 m -147.52 129.11 15.05 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.93 0.395 . . . . 0.0 111.352 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB1' HD21 ' A' ' 87' ' ' LEU . . . -115.6 86.42 2.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -66.78 -159.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.935 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.7 34.15 0.53 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.673 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.468 ' HB2' HD13 ' A' ' 63' ' ' LEU . 1.3 m-20 -125.35 26.73 6.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.04 0.448 . . . . 0.0 110.333 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.633 HD13 ' CB ' ' A' ' 90' ' ' ALA . 1.1 mm? -44.54 -21.58 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.447 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -47.82 -47.26 31.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.521 0.2 . . . . 0.0 111.386 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.553 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -72.58 -22.45 60.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.856 0.36 . . . . 0.0 110.926 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.633 ' CB ' HD13 ' A' ' 87' ' ' LEU . . . -67.58 -49.02 65.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.374 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.595 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.4 t -57.71 -49.05 82.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.05 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -29.81 68.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.411 0.624 . . . . 0.0 109.901 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.602 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -58.53 -39.81 81.2 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.14 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 25.6 m-85 -61.31 -21.18 63.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.43 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.623 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.15 -42.59 55.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.706 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.623 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 1.2 pt20 -77.0 -15.1 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.817 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.32 13.44 4.81 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.626 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.602 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -55.52 143.77 28.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.146 0.473 . . . . 0.0 110.982 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.557 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 69.5 t80 -76.39 -53.96 7.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.222 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.4 t0 172.98 -166.1 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.947 0.403 . . . . 0.0 111.555 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.741 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.4 m-85 -129.05 118.97 23.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.347 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.465 HD23 ' HD1' ' A' ' 106' ' ' PHE . 5.9 tp -102.56 131.1 22.76 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.664 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.583 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 83.5 Cg_exo -47.48 168.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.551 2.168 . . . . 0.0 111.98 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.436 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -43.32 -46.36 15.7 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 88.1 Cg_exo -46.56 163.34 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 121.705 1.603 . . . . 0.0 110.763 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.744 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 5.0 t80 -169.39 -91.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.389 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.499 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.8 p-10 43.46 -174.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.73 0.3 . . . . 0.0 110.912 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.811 HD13 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.98 -48.14 76.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.225 0.536 . . . . 0.0 110.819 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 5.1 t70 -50.32 -57.18 8.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.082 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.681 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.5 mm-40 -79.25 -27.2 42.37 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.54 ' HB3' HD11 ' A' ' 19' ' ' LEU . . . -84.15 -53.43 5.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.578 ' HA ' HG12 ' A' ' 115' ' ' VAL . 42.3 t -59.17 -32.16 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.507 0.67 . . . . 0.0 110.17 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.89 -52.62 64.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.752 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.706 HD12 ' HD3' ' A' ' 117' ' ' ARG . 11.4 tp -75.67 -20.36 58.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.545 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 112' ' ' VAL . 3.6 p -78.28 -46.35 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.017 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.421 ' N ' HG13 ' A' ' 115' ' ' VAL . 43.6 mt-10 -61.95 -45.35 94.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.808 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.706 ' HD3' HD12 ' A' ' 114' ' ' LEU . 5.0 ptm180 -62.76 -25.7 68.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.671 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.557 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.93 -52.17 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.238 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.606 HD13 ' CD2' ' A' ' 28' ' ' LEU . 5.1 mt -68.31 -30.7 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.148 0.499 . . . . 0.0 110.738 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 m -65.28 -41.8 93.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.796 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -61.03 -31.26 70.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.734 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -88.13 -50.22 6.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.719 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 58.61 163.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.006 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.441 ' C ' ' H ' ' A' ' 3' ' ' ARG . 5.3 ttt . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 120.729 0.299 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 1' ' ' MET . 1.4 mt-30 71.27 -41.78 0.51 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.49 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.894 ' CG ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER 80.94 -55.71 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.361 0.601 . . . . 0.0 110.672 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.728 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 76.9 68.52 1.51 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.814 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.894 HD11 ' CG ' ' A' ' 3' ' ' ARG . 1.5 mm -107.8 112.29 39.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.764 0.316 . . . . 0.0 110.763 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.951 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.1 p -113.91 124.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.526 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 1.005 ' CD1' HG22 ' A' ' 31' ' ' THR . 53.2 m0 -116.71 133.35 56.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.702 0.287 . . . . 0.0 110.394 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -119.13 128.99 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.924 HG23 ' HA ' ' A' ' 53' ' ' SER . 2.7 m -117.65 118.77 59.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 110.419 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.474 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 17.2 t0 -173.45 -146.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.872 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -65.24 -4.46 5.25 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.6 t0 58.56 -147.5 0.5 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 122.543 -0.098 . . . . 0.0 111.234 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t 34.31 -87.87 0.01 OUTLIER 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.852 ' O ' HG23 ' A' ' 18' ' ' VAL . 39.2 m -58.1 -57.31 13.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.76 0.314 . . . . 0.0 110.988 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.58 -31.39 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.304 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.73 ' HA ' HG21 ' A' ' 32' ' ' THR . 15.4 ttp180 -72.37 -57.39 4.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.831 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.44 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 66.0 t90 -50.83 -42.4 58.45 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 14' ' ' SER . 0.9 OUTLIER -70.49 -58.77 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.184 0.516 . . . . 0.0 111.598 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.761 HD22 ' CD1' ' A' ' 108' ' ' ILE . 3.9 mm? -66.63 -26.99 67.34 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.67 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.589 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 12.2 pt-20 -66.87 -60.14 2.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.589 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.0 OUTLIER -72.35 -55.3 7.33 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.664 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.475 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -50.37 -57.25 8.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.0 111.815 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.951 ' CD2' HG11 ' A' ' 6' ' ' VAL . 4.6 tp -60.68 -25.24 66.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.438 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -68.76 -37.14 79.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.76 -23.69 70.91 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.513 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.414 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.69 -15.72 59.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.582 0.229 . . . . 0.0 110.977 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.14 25.04 6.58 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.39 -0.91 . . . . 0.0 114.29 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.666 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.24 170.06 15.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.78 0.79 . . . . 0.0 111.436 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.3 m -101.41 105.82 16.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.215 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.814 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 16.0 t -105.99 111.46 24.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.155 0.502 . . . . 0.0 111.952 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 1.005 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -121.26 155.64 34.2 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.73 HG21 ' HA ' ' A' ' 16' ' ' ARG . 32.6 p -126.02 159.99 31.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.559 0.695 . . . . 0.0 112.543 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.919 ' HB2' HG12 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -136.44 174.32 10.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.267 -179.019 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.641 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -63.04 -33.43 75.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.035 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.641 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 2.2 t30 -176.34 171.76 2.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.019 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.598 ' HA2' HG21 ' A' ' 9' ' ' VAL . . . -50.26 -25.27 7.93 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.144 -1.027 . . . . 0.0 111.907 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.504 ' N ' HD21 ' A' ' 65' ' ' LEU . 1.3 t30 -58.58 -52.21 66.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.673 0.273 . . . . 0.0 110.63 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.6 tt0 -51.95 -51.54 56.44 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.669 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.734 HG21 HD11 ' A' ' 51' ' ' LEU . 52.2 t -50.72 -35.1 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.133 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.2 mt -54.98 -43.1 73.21 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.04 -47.79 64.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.879 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.99 80.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.707 HD13 ' CE1' ' A' ' 73' ' ' HIS . 14.7 mt -67.19 -25.0 65.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.239 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.23 -15.3 23.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.766 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.2 -4.97 8.39 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.646 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -167.07 165.96 15.41 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.932 0.396 . . . . 0.0 110.844 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.72 HG23 HD23 ' A' ' 76' ' ' LEU . 89.0 m -138.79 120.85 10.35 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.452 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.679 ' HD2' HD21 ' A' ' 43' ' ' LEU . 93.0 Cg_endo -80.61 162.11 21.8 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.087 1.858 . . . . 0.0 111.638 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -74.01 -27.9 61.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 0.0 110.849 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.789 HG21 HG23 ' A' ' 115' ' ' VAL . 3.3 p -145.14 154.95 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.734 HD11 HG21 ' A' ' 39' ' ' VAL . 9.5 tp -152.98 136.75 16.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 111.342 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.659 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -111.45 122.59 48.25 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.924 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -106.83 137.95 43.91 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.474 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 29.1 t0 -73.02 171.33 13.06 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.342 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.675 HG13 ' O ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -157.97 93.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.383 -178.556 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.83 44.12 2.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.579 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 8.1 ttp 59.89 46.14 1.26 Allowed Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 55.2 Cg_endo -71.1 -73.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.296 1.997 . . . . 0.0 112.188 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.412 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -112.15 -27.73 3.85 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.233 -0.508 . . . . 0.0 111.851 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.943 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 16.0 ttm -155.63 64.39 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.361 . . . . 0.0 110.456 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.675 ' O ' HG13 ' A' ' 55' ' ' ILE . 2.4 t70 71.87 -23.54 0.19 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.172 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.614 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 136.44 -29.55 2.78 Favored Glycine 0 CA--C 1.506 -0.505 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.874 ' HA ' HD23 ' A' ' 66' ' ' LEU . 2.2 mp -70.11 -19.85 63.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.891 -0.655 . . . . 0.0 110.296 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.943 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.64 -30.75 44.43 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.128 0.49 . . . . 0.0 109.819 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.554 HD11 ' C ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -59.63 -48.39 81.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.537 178.682 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.874 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.5 mm? -48.74 -41.72 33.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.018 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.713 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 16.9 tttp -58.78 -43.73 90.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.351 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -62.73 -38.83 92.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.221 0.534 . . . . 0.0 110.648 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 66' ' ' LEU . 73.5 mt -57.41 -40.22 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.814 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.713 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.34 -22.56 47.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.15 -43.5 86.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.862 0.363 . . . . 0.0 111.85 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -99.3 -31.97 11.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.037 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.707 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -112.68 138.2 21.99 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.764 -179.262 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.37 -68.15 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.261 1.974 . . . . 0.0 112.554 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mpp? -148.45 53.67 1.01 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 110.736 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.79 HD22 ' HD2' ' A' ' 77' ' ' PRO . 3.1 tm? -55.26 115.06 8.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.419 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.79 ' HD2' HD22 ' A' ' 76' ' ' LEU . 10.0 Cg_endo -53.5 121.51 9.62 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.615 2.21 . . . . 0.0 112.213 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.79 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.2 t -127.99 149.36 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.22 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.699 HG21 HD23 ' A' ' 114' ' ' LEU . 1.6 mp -137.4 116.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.586 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.752 HG22 ' H ' ' A' ' 82' ' ' THR . 25.3 mm -92.65 142.98 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.276 0.56 . . . . 0.0 111.944 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.524 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.87 -9.7 59.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.984 -178.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.752 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.4 m -147.6 152.45 37.94 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.611 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.804 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -161.66 73.51 0.43 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.62 -21.12 17.83 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.3 m -159.84 175.76 12.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.049 0.452 . . . . 0.0 111.451 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.631 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER 54.42 29.25 10.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.411 -179.636 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.496 HD13 ' CB ' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -50.56 -21.06 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.546 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -47.81 -52.68 17.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.678 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -68.56 -19.77 64.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.315 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.66 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -66.75 -54.43 22.87 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.833 0.349 . . . . 0.0 111.011 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.647 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 4.1 t -62.23 -45.06 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.5 p -60.7 -27.05 67.58 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -59.09 -50.18 75.04 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.483 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.647 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -59.68 -33.63 71.82 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.901 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -39.72 69.48 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.449 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.58 ' HB2' ' CB ' ' A' ' 70' ' ' LYS . 7.6 pt20 -93.3 -7.42 44.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 132.02 82.36 0.22 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.766 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.79 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.46 139.18 2.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.559 0.218 . . . . 0.0 110.552 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 38.1 t80 -74.94 -53.76 8.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.347 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.701 ' OD2' HD11 ' A' ' 114' ' ' LEU . 38.5 p-10 177.71 -168.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.0 111.256 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.804 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 7.6 m-85 -123.1 152.76 40.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.802 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 103' ' ' PRO . 0.7 OUTLIER -143.02 142.79 22.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.759 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.669 ' O ' HD12 ' A' ' 102' ' ' LEU . 56.1 Cg_exo -51.68 165.44 0.73 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.382 2.054 . . . . 0.0 111.889 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -41.16 -51.05 8.07 Favored Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 3.9 Cg_endo -47.62 164.1 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.868 1.712 . . . . 0.0 110.353 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.86 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 174.98 -85.59 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.174 -0.211 . . . . 0.0 111.089 -179.415 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 48.4 -174.16 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.761 ' CD1' HD22 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -57.7 -49.95 79.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.191 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.505 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.2 t70 -50.99 -58.89 4.91 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.154 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.86 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 7.6 mm-40 -81.18 -28.67 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.73 -47.74 10.86 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.951 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.686 HG21 HG23 ' A' ' 108' ' ' ILE . 59.5 t -62.09 -32.68 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.591 0.71 . . . . 0.0 109.733 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.64 -50.36 74.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.913 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.701 HD11 ' OD2' ' A' ' 100' ' ' ASP . 15.4 tp -75.69 -21.15 57.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.747 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.789 HG23 HG21 ' A' ' 50' ' ' VAL . 4.1 p -79.52 -48.14 21.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.836 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.439 ' N ' HG13 ' A' ' 115' ' ' VAL . 49.8 mt-10 -65.72 -39.95 91.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.918 0.389 . . . . 0.0 110.326 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.8 mtp85 -65.38 -23.88 67.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.763 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -75.01 -49.1 20.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.221 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.8 mt -68.0 -30.69 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.714 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.5 m -73.32 -40.0 64.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.877 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -77.9 -29.14 50.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.009 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -71.33 -51.85 22.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.853 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.27 170.9 15.16 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.986 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.885 0.374 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -161.22 -23.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.622 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.527 ' HG3' HG12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -74.39 50.32 0.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.859 0.362 . . . . 0.0 111.021 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.898 ' C ' HD13 ' A' ' 5' ' ' ILE . . . -68.05 89.77 0.21 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.898 HD13 ' C ' ' A' ' 4' ' ' GLY . 2.8 mm -124.42 118.85 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.056 HG23 HG13 ' A' ' 50' ' ' VAL . 9.0 p -105.68 122.85 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.952 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.911 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.2 m0 -107.87 137.41 45.93 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.674 -0.41 . . . . 0.0 109.975 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -131.06 144.45 37.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.331 -177.257 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.096 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -133.95 105.29 6.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.142 178.037 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 64.2 t0 166.9 118.3 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.442 ' CB ' HG12 ' A' ' 15' ' ' ILE . 2.4 t0 71.02 -16.36 0.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.1 t0 67.81 -139.63 0.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.253 -0.279 . . . . 0.0 110.985 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 t -32.82 -43.17 0.09 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.505 ' O ' HG23 ' A' ' 18' ' ' VAL . 36.1 t -53.15 -69.65 0.11 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 25.9 mm -63.94 -20.79 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.638 ' HA ' HG21 ' A' ' 32' ' ' THR . 7.1 ttp180 -68.03 -58.48 4.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.495 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 77.3 t90 -51.13 -44.87 61.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.735 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.805 HG12 HD13 ' A' ' 108' ' ' ILE . 2.4 t -62.92 -61.04 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.13 0.49 . . . . 0.0 111.975 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.683 HD23 HG21 ' A' ' 8' ' ' VAL . 14.2 tp -72.28 -21.69 61.32 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 14.6 pt-20 -66.93 -56.06 11.86 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.408 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.533 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -62.78 -56.93 13.09 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.459 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.82 -49.5 70.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 111.929 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.5 tm? -69.78 -24.07 63.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.181 0.515 . . . . 0.0 110.339 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.07 -32.74 70.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.4 -27.11 67.25 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.231 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.31 -15.38 59.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 110.513 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.71 24.5 13.42 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.873 -0.68 . . . . 0.0 114.214 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.618 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -124.14 164.15 20.04 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 118.32 1.06 . . . . 0.0 112.438 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.659 ' HB ' HG23 ' A' ' 5' ' ' ILE . 99.7 m -84.66 136.79 33.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.926 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -127.57 111.53 13.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.715 -179.007 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.911 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -123.55 147.33 47.38 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 71.7 p -126.25 159.49 32.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.469 0.652 . . . . 0.0 112.658 -178.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.096 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.2 m-85 -136.13 174.12 10.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.987 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.562 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -54.52 -51.17 65.97 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -177.002 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.589 ' N ' HG12 ' A' ' 9' ' ' VAL . 11.3 m-20 -171.24 -20.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.648 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . 169.46 -45.61 0.21 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.732 -1.223 . . . . 0.0 114.13 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.555 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -61.04 -39.17 88.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.447 0.624 . . . . 0.0 111.415 -178.759 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.857 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -57.86 -54.17 49.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.493 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.736 HG21 ' CG2' ' A' ' 9' ' ' VAL . 2.6 t -51.53 -47.19 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.322 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.834 HD13 ' HB3' ' A' ' 68' ' ' GLN . 15.0 mt -48.01 -43.58 30.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.91 -48.67 65.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.903 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.91 -27.68 67.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.28 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.607 HD13 ' NE2' ' A' ' 73' ' ' HIS . 17.6 mt -73.01 -23.96 60.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.946 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.83 -19.62 6.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.475 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.19 3.16 5.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.52 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -153.99 154.52 33.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.897 0.38 . . . . 0.0 111.518 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.743 HG23 HD13 ' A' ' 76' ' ' LEU . 75.9 m -138.86 113.18 8.36 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.426 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.542 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 72.7 Cg_endo -74.17 165.58 31.59 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.324 2.016 . . . . 0.0 111.266 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.427 ' OD2' ' HA2' ' A' ' 4' ' ' GLY . 93.5 m-20 -77.53 -30.67 52.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.855 0.359 . . . . 0.0 110.894 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.056 HG13 HG23 ' A' ' 6' ' ' VAL . 7.6 p -146.52 102.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.486 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.682 ' HB2' HD21 ' A' ' 76' ' ' LEU . 61.3 tp -87.26 137.19 32.56 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.844 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.6 mt -119.14 122.46 42.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.31 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.66 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -119.16 148.35 43.18 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.311 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.588 ' O ' HD21 ' A' ' 65' ' ' LEU . 7.0 t0 -76.66 -167.0 0.74 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.558 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.806 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -165.4 72.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.832 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 29.2 ttt180 177.18 63.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.954 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.485 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 1.1 tmm? -163.27 -61.85 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.86 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.723 ' HB2' ' HB3' ' A' ' 64' ' ' ALA . 33.0 Cg_endo -61.82 -171.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.394 2.063 . . . . 0.0 112.689 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.11 -78.61 0.1 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.437 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.644 ' O ' ' N ' ' A' ' 62' ' ' GLY . 2.7 mtt -69.91 64.52 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.394 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.461 ' HB2' ' CE1' ' A' ' 84' ' ' HIS . 6.0 p-10 48.73 -66.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.543 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.806 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -143.51 -39.63 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.82 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.82 HD23 ' HB2' ' A' ' 90' ' ' ALA . 1.8 mp -51.65 -25.18 6.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.414 . . . . 0.0 110.291 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.723 ' HB3' ' HB2' ' A' ' 58' ' ' PRO . . . -55.55 -33.62 64.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.373 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.588 HD21 ' O ' ' A' ' 54' ' ' ASP . 3.5 pp -65.17 -25.68 67.84 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.847 ' HA ' HD12 ' A' ' 69' ' ' ILE . 6.2 mp -66.1 -41.55 90.45 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 22.1 mmtm -53.06 -50.93 63.35 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.784 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.834 ' HB3' HD13 ' A' ' 40' ' ' LEU . 1.8 mt-30 -53.36 -43.89 68.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.76 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.995 HG23 ' CE1' ' A' ' 73' ' ' HIS . 61.6 mt -55.68 -45.53 79.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.003 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.525 ' CB ' ' HG3' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -63.71 -28.21 69.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.121 0.486 . . . . 0.0 110.67 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.44 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 20.3 mt-30 -77.07 -41.14 43.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.236 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -93.57 -73.2 0.57 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.372 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.995 ' CE1' HG23 ' A' ' 69' ' ' ILE . 7.6 p80 -110.55 76.97 1.2 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.75 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.456 ' HB2' ' OE1' ' A' ' 96' ' ' GLN . 72.7 Cg_endo -77.25 29.44 0.42 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.963 2.442 . . . . 0.0 114.011 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.0 mtp -134.19 -32.07 1.08 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.855 0.36 . . . . 0.0 111.564 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.743 HD13 HG23 ' A' ' 47' ' ' THR . 5.6 tp -66.34 141.87 97.47 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.306 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.561 ' HD2' HD12 ' A' ' 76' ' ' LEU . 78.7 Cg_endo -76.87 131.43 12.18 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.819 2.346 . . . . 0.0 112.304 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.763 HG21 HD13 ' A' ' 69' ' ' ILE . 2.7 t -111.41 141.52 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.058 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.689 HG21 HD23 ' A' ' 114' ' ' LEU . 2.6 mt -130.28 115.93 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.434 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 66' ' ' LEU . 32.2 mm -93.64 145.82 7.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.042 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.687 ' HA ' HD23 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -80.83 -24.64 38.32 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.347 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.624 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.0 m -148.03 149.44 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.755 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.771 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -126.93 68.23 1.26 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.754 0.311 . . . . 0.0 111.304 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.461 ' CE1' ' HB2' ' A' ' 61' ' ' ASP . 9.0 p80 -98.08 111.2 23.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.026 0.441 . . . . 0.0 111.569 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 t 54.39 168.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.022 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.553 ' HB2' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER 62.19 14.71 6.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.518 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.479 ' HA ' HD21 ' A' ' 63' ' ' LEU . 1.4 mt -46.38 -25.14 0.6 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -48.61 -41.12 29.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.865 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.494 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.93 -22.08 62.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.82 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -69.76 -34.51 73.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.942 0.401 . . . . 0.0 110.588 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.707 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.2 t -61.19 -45.15 99.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.141 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.443 ' O ' ' OE1' ' A' ' 95' ' ' GLN . 20.6 m -57.99 -48.78 78.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.561 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.675 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -47.21 -43.67 21.75 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.154 0.502 . . . . 0.0 110.943 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.707 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 11.2 m-85 -54.89 -26.31 34.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.044 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.639 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.5 -48.07 61.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.341 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.639 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 26.7 mm-40 -72.5 -18.8 61.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.721 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.38 27.83 1.42 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.845 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.675 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -62.21 146.78 49.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.349 0.574 . . . . 0.0 110.295 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 45.4 t80 -74.18 -54.14 8.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.109 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 0.9 OUTLIER 166.99 -162.69 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.157 0.503 . . . . 0.0 111.445 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.771 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.4 m-85 -131.31 153.21 49.81 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.355 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.874 HD22 ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -141.53 149.89 55.66 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.963 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 29.0 Cg_endo -64.42 161.21 35.71 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.493 2.129 . . . . 0.0 111.426 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -33.58 -51.25 0.79 Allowed Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.1 Cg_endo -47.47 162.41 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.729 1.619 . . . . 0.0 110.345 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.874 ' CE1' HD22 ' A' ' 102' ' ' LEU . 0.1 OUTLIER 177.85 -79.45 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.064 -178.738 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 3.0 p30 42.54 -168.27 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.862 HG23 HG21 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -67.98 -47.19 79.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.825 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -51.95 -57.98 7.85 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.773 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.67 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 13.5 mm-40 -77.45 -31.88 54.12 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.699 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . . . -83.32 -49.93 8.88 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.537 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.862 HG21 HG23 ' A' ' 108' ' ' ILE . 44.4 t -59.47 -31.54 46.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.526 0.679 . . . . 0.0 109.758 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.84 -51.34 70.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.964 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.689 HD23 HG21 ' A' ' 79' ' ' ILE . 6.9 tp -75.86 -21.59 57.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.641 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.2 p -79.44 -48.15 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.023 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.435 ' N ' HG13 ' A' ' 115' ' ' VAL . 40.7 mt-10 -65.09 -40.52 94.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.699 0.285 . . . . 0.0 110.769 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.558 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 2.4 ptm85 -62.6 -25.07 67.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 0.0 110.394 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -70.61 -49.81 43.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.077 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.6 mt -66.38 -31.87 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -31.98 70.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.715 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.65 -24.98 63.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.956 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -66.32 -46.78 75.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.85 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.429 ' H ' ' HG2' ' A' ' 123' ' ' GLN . 3.9 pt20 -78.31 -55.33 5.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.16 0.505 . . . . 0.0 111.337 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 . . . . . 0 C--N 1.32 -0.705 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.085 -179.933 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.877 0.37 . . . . 0.0 111.494 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -87.48 155.93 19.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.097 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.418 ' HD2' HG13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -75.85 2.9 11.15 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.636 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.24 82.36 0.34 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.356 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 1.4 mp -114.96 120.96 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.798 0.333 . . . . 0.0 111.211 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.98 HG23 HG13 ' A' ' 50' ' ' VAL . 7.5 p -114.23 120.77 64.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.321 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.943 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.8 m0 -111.04 136.46 50.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.744 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -122.12 137.89 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.888 -178.167 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -121.43 115.25 46.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.157 0.503 . . . . 0.0 110.068 178.138 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 7.5 t70 -168.35 -154.45 0.14 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.597 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -66.32 -3.17 5.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 65.56 -154.08 0.26 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.263 -0.273 . . . . 0.0 111.107 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.407 ' HB3' ' H ' ' A' ' 14' ' ' SER . 3.5 t 34.56 -89.12 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.792 ' O ' HG23 ' A' ' 18' ' ' VAL . 17.1 m -54.22 -58.81 5.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.724 0.297 . . . . 0.0 111.395 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.48 ' O ' HD23 ' A' ' 19' ' ' LEU . 26.4 mm -62.96 -30.53 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.937 0.398 . . . . 0.0 110.937 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.721 ' HA ' HG21 ' A' ' 32' ' ' THR . 22.5 ttt85 -72.36 -47.46 49.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.947 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.421 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 52.6 t90 -60.4 -40.92 92.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 14' ' ' SER . 1.7 t -74.24 -43.09 50.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.97 0.414 . . . . 0.0 111.557 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.693 HD22 ' CD1' ' A' ' 108' ' ' ILE . 3.9 mm? -77.02 -27.57 54.63 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.1 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.664 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 16.7 pt-20 -67.89 -59.77 3.03 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.925 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.513 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -68.58 -55.96 9.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.575 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.09 -51.39 58.0 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.91 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.5 tp -67.35 -23.3 65.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.413 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -68.22 -36.64 79.84 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.36 -24.44 65.63 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.203 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.672 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.43 -15.6 58.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.741 0.305 . . . . 0.0 110.91 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.61 26.14 9.41 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.988 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.738 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.66 170.37 11.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.759 0.78 . . . . 0.0 111.808 179.616 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.3 m -101.4 105.88 16.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.343 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.664 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 4.9 t -102.25 114.57 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.992 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.943 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -123.79 150.38 44.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.721 HG21 ' HA ' ' A' ' 16' ' ' ARG . 70.8 p -122.06 163.78 18.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.894 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.2 m-85 -136.4 175.43 9.62 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.755 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.621 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.9 pp20? -60.35 -55.69 30.52 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -177.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 5.6 m-80 -150.81 -43.89 0.12 Allowed 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.736 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 177.51 -46.03 0.1 OUTLIER Glycine 0 C--N 1.318 -0.454 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.353 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.487 ' OD1' HD12 ' A' ' 40' ' ' LEU . 3.1 t30 -63.25 -27.73 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.796 0.332 . . . . 0.0 110.6 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -58.59 -55.45 34.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.712 179.392 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.83 HG21 HG22 ' A' ' 9' ' ' VAL . 3.4 t -50.53 -38.92 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.965 0.412 . . . . 0.0 111.123 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.487 HD12 ' OD1' ' A' ' 37' ' ' ASN . 13.3 mt -59.38 -44.07 92.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.52 -49.93 55.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.065 0.459 . . . . 0.0 111.108 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.09 -33.02 74.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.824 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.828 HD13 ' CE1' ' A' ' 73' ' ' HIS . 15.6 mt -62.15 -23.83 66.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.05 -20.42 16.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.791 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -116.56 -6.15 11.66 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -159.27 158.2 32.03 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.929 0.395 . . . . 0.0 111.012 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.9 m -138.71 114.93 8.76 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.954 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.597 ' CD ' HD21 ' A' ' 43' ' ' LEU . 91.0 Cg_endo -81.73 165.05 18.1 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.117 1.878 . . . . 0.0 111.53 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 5' ' ' ILE . 3.9 p30 -74.25 -59.81 2.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.123 0.487 . . . . 0.0 110.086 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.04 HG21 HG23 ' A' ' 115' ' ' VAL . 12.0 p -99.48 160.58 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.201 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 7' ' ' TRP . 32.1 tp -153.07 153.12 32.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.138 0.494 . . . . 0.0 111.676 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.955 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.2 mt -137.24 120.78 17.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.042 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.459 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -105.31 134.44 48.42 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.583 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.571 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 9.2 t70 -61.71 -28.43 69.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.636 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.937 HG21 HG22 ' A' ' 80' ' ' ILE . 0.3 OUTLIER 41.8 92.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.772 -179.738 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.547 ' O ' ' HG3' ' A' ' 57' ' ' MET . 0.0 OUTLIER -175.3 104.86 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.193 0.52 . . . . 0.0 112.124 179.237 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.547 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER 40.03 47.91 1.96 Allowed Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 178.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.634 ' HG3' ' HA2' ' A' ' 62' ' ' GLY . 98.6 Cg_endo -90.76 -53.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.511 2.141 . . . . 0.0 111.693 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.01 -21.9 0.12 Allowed Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.66 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.991 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 3.6 tpt -163.98 67.21 0.17 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.658 0.383 . . . . 0.0 110.071 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 71.95 -22.56 0.2 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.616 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.806 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 136.65 -27.68 2.93 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.74 ' HA ' HD23 ' A' ' 66' ' ' LEU . 5.1 mp -77.1 -19.97 56.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.991 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.77 -32.65 53.19 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.003 0.43 . . . . 0.0 110.455 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.548 HD13 ' HA3' ' A' ' 36' ' ' GLY . 14.7 mt -57.23 -44.42 83.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.538 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.029 HD11 HD11 ' A' ' 80' ' ' ILE . 3.5 mm? -55.02 -44.79 74.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.93 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.654 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -52.71 -45.06 66.76 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.17 179.591 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -67.45 -31.1 71.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.037 0.446 . . . . 0.0 110.601 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.835 HD12 ' HA ' ' A' ' 66' ' ' LEU . 94.5 mt -63.08 -41.06 91.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.755 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 3.4 pttp -74.76 -22.78 58.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.347 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.75 -31.95 31.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.395 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.1 mtt180 -106.81 -59.48 1.8 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 112.191 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.828 ' CE1' HD13 ' A' ' 43' ' ' LEU . 1.3 m80 -81.4 145.13 54.76 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.302 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -95.75 102.71 0.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.219 2.613 . . . . 0.0 113.14 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.577 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.6 mtt 54.26 35.97 24.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.809 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.564 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.1 tt -64.68 110.34 3.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.632 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.463 ' HG3' ' CZ ' ' A' ' 122' ' ' TYR . 51.1 Cg_exo -54.02 116.87 3.33 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.164 1.91 . . . . 0.0 111.713 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.685 HG21 HD13 ' A' ' 69' ' ' ILE . 2.4 t -122.1 146.07 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.321 0.581 . . . . 0.0 112.056 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.671 HG22 HD23 ' A' ' 102' ' ' LEU . 3.2 mt -122.07 116.94 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.957 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 66' ' ' LEU . 9.3 mm -93.42 120.82 43.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.23 0.538 . . . . 0.0 112.315 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.508 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -74.35 -8.86 57.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.286 -179.516 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.574 ' H ' HG21 ' A' ' 55' ' ' ILE . 3.0 m -147.52 136.01 21.74 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.09 0.472 . . . . 0.0 111.948 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.811 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -134.03 84.41 2.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.137 0.494 . . . . 0.0 110.562 178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -66.78 -157.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.016 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -86.07 40.53 0.87 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.621 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -129.26 36.07 4.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.075 0.464 . . . . 0.0 109.98 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.705 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -45.42 -21.57 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.917 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.67 -55.12 10.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.492 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.53 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -69.42 -22.99 63.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.358 . . . . 0.0 110.654 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.705 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.69 -44.41 74.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.577 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 10.8 t -65.11 -42.66 94.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.804 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 77.6 p -67.12 -23.56 65.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.977 0.418 . . . . 0.0 109.932 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.691 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -65.99 -37.5 86.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.285 0.564 . . . . 0.0 109.835 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.618 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.9 m-85 -68.29 -23.9 64.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.282 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 92' ' ' SER . 1.3 tm0? -74.87 -29.55 61.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.272 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.691 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -92.19 -17.19 25.22 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.06 24.75 1.44 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.944 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.598 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -68.92 145.94 53.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.118 0.459 . . . . 0.0 110.584 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 22.9 t80 -79.45 -53.39 6.94 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.45 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t0 179.42 -164.99 0.05 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.945 0.403 . . . . 0.0 111.932 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.811 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 7.8 m-85 -137.56 122.52 18.96 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.537 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 106' ' ' PHE . 0.9 OUTLIER -123.0 142.87 39.24 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.898 -179.622 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.626 ' O ' HD12 ' A' ' 102' ' ' LEU . 50.9 Cg_exo -54.55 175.39 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.874 2.383 . . . . 0.0 113.07 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -43.5 -53.1 12.38 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 6.3 Cg_endo -48.73 163.42 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.832 1.688 . . . . 0.0 110.442 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.866 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 172.87 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.539 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 45.65 -171.28 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.845 HG23 HG21 ' A' ' 112' ' ' VAL . 1.1 mp -60.13 -49.94 82.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.512 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 15.6 t0 -52.31 -58.57 6.25 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.866 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -80.35 -28.12 38.15 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.96 -52.16 6.56 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.589 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.845 HG21 HG23 ' A' ' 108' ' ' ILE . 40.1 t -57.75 -33.54 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.49 0.662 . . . . 0.0 110.082 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.0 -51.62 69.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.626 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.68 HD12 ' HD2' ' A' ' 117' ' ' ARG . 9.6 tp -75.53 -21.89 57.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.045 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 1.04 HG23 HG21 ' A' ' 50' ' ' VAL . 3.0 p -79.46 -52.16 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 115' ' ' VAL . 32.3 mt-10 -58.75 -40.14 82.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.648 0.261 . . . . 0.0 111.544 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.68 ' HD2' HD12 ' A' ' 114' ' ' LEU . 9.8 ptp180 -65.91 -23.73 66.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 0.0 110.774 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.494 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -71.71 -49.41 39.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.776 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.5 mt -71.05 -31.75 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.7 t -66.08 -34.64 78.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.721 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -78.21 -23.73 47.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.09 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.463 ' CZ ' ' HG3' ' A' ' 77' ' ' PRO . 0.3 OUTLIER -71.99 -59.19 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.98 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -76.41 173.05 11.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.85 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 N--CA 1.465 0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.564 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptm . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -96.58 -18.65 19.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 111.138 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.747 ' CG ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -66.34 -1.06 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.757 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.838 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 92.26 89.72 1.48 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.728 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.838 HD13 ' C ' ' A' ' 4' ' ' GLY . 3.9 mm -125.92 120.04 56.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.861 HG23 HG13 ' A' ' 50' ' ' VAL . 7.4 p -110.77 132.17 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.59 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.969 ' CD1' HG22 ' A' ' 31' ' ' THR . 35.0 m0 -119.58 127.44 52.97 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -124.2 122.05 63.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.882 HG23 ' HA ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -111.07 113.63 44.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.201 178.24 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.795 ' HB3' HG21 ' A' ' 15' ' ' ILE . 15.8 t0 -177.36 68.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.195 0.521 . . . . 0.0 111.464 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.8 t70 69.13 -2.14 1.9 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 14' ' ' SER . 6.6 p-10 43.25 -126.8 0.81 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.481 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.62 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 1.7 t 34.94 -82.59 0.0 OUTLIER 'General case' 0 C--N 1.343 0.304 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.755 ' O ' HG23 ' A' ' 18' ' ' VAL . 15.2 t -82.46 -48.4 11.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.655 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.795 HG21 ' HB3' ' A' ' 10' ' ' ASP . 46.6 mm -63.73 -22.4 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.745 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 0.0 OUTLIER -81.58 -55.54 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.358 . . . . 0.0 111.552 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.547 ' H ' ' HG3' ' A' ' 16' ' ' ARG . 85.1 t90 -48.78 -41.69 33.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -70.44 -61.43 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.432 . . . . 0.0 112.058 -178.63 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.54 HD23 HG11 ' A' ' 8' ' ' VAL . 8.3 tp -66.3 -27.36 67.86 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.659 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.504 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . 12.4 pt-20 -67.7 -58.35 4.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.134 0.492 . . . . 0.0 111.446 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.491 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -54.39 -64.68 0.75 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.086 -179.333 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.34 -27.39 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.796 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.7 tm? -82.14 -29.85 31.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.383 0.611 . . . . 0.0 110.467 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.44 73.51 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.55 -26.79 70.04 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.393 -0.908 . . . . 0.0 110.95 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.426 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.27 -15.52 58.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.97 24.54 11.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.051 0.78 . . . . 0.0 115.051 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.67 HD13 HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -126.18 164.15 21.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.611 1.205 . . . . 0.0 112.372 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.805 ' HB ' HG23 ' A' ' 5' ' ' ILE . 79.0 m -79.75 129.09 34.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.038 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 1.8 p -121.67 111.2 16.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.976 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.969 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -135.85 134.03 38.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.745 ' OG1' ' HB3' ' A' ' 16' ' ' ARG . 43.6 p -115.61 155.09 28.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.687 ' CE1' HG23 ' A' ' 31' ' ' THR . 0.0 OUTLIER -136.58 174.1 10.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.226 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.535 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -58.42 -108.9 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.686 ' O ' HG11 ' A' ' 9' ' ' VAL . 24.3 m-80 -85.86 -179.92 6.91 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.565 ' CA ' ' HG ' ' A' ' 65' ' ' LEU . . . -68.71 0.25 14.83 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.391 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 8.2 t30 -81.28 -41.69 21.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.668 0.734 . . . . 0.0 109.507 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.535 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -51.92 -55.31 21.04 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.992 179.102 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.622 HG11 HD11 ' A' ' 51' ' ' LEU . 33.2 t -44.15 -35.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.151 0.501 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 37' ' ' ASN . 14.1 mt -61.84 -50.12 73.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.485 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.99 -48.26 82.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.324 0.583 . . . . 0.0 110.864 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.32 73.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.38 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.676 HD21 ' HD2' ' A' ' 48' ' ' PRO . 10.9 mt -66.62 -24.07 66.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.156 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.94 -18.4 60.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.669 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.55 -8.15 11.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -159.69 159.37 32.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.586 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.559 HG23 HD13 ' A' ' 76' ' ' LEU . 99.3 m -138.8 113.49 8.45 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.688 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.676 ' HD2' HD21 ' A' ' 43' ' ' LEU . 89.1 Cg_endo -80.0 165.34 21.89 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.215 1.944 . . . . 0.0 111.26 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.676 ' O ' ' HD2' ' A' ' 77' ' ' PRO . 3.3 p30 -74.38 -59.03 2.91 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.544 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.861 HG13 HG23 ' A' ' 6' ' ' VAL . 7.6 p -101.72 162.11 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.393 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.636 HD22 HD21 ' A' ' 76' ' ' LEU . 42.4 tp -152.86 152.25 31.33 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.013 0.435 . . . . 0.0 111.705 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -137.31 120.91 17.25 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.936 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.882 ' HA ' HG23 ' A' ' 9' ' ' VAL . 49.1 m -109.07 137.15 47.42 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 39.6 t0 -65.9 -20.59 66.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.694 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.686 HG21 ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER 47.22 79.71 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 112.106 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 171.36 85.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.487 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.651 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -163.3 -66.89 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.684 ' HG2' ' HB3' ' A' ' 64' ' ' ALA . 87.1 Cg_endo -77.4 -165.7 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.451 2.1 . . . . 0.0 113.677 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.98 -51.01 61.76 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.844 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.726 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -74.28 45.41 0.22 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 110.563 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 55.81 -82.15 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.658 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -143.12 -31.92 0.1 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.926 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.668 HD12 ' H ' ' A' ' 63' ' ' LEU . 1.4 mp -49.92 -26.85 4.53 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.726 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -55.33 -30.98 61.3 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.997 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.565 ' HG ' ' CA ' ' A' ' 36' ' ' GLY . 2.3 mm? -60.94 -50.21 74.34 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.983 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.775 HD23 HD12 ' A' ' 69' ' ' ILE . 51.7 mt -49.65 -46.48 49.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.092 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -50.28 -46.59 55.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.211 0.529 . . . . 0.0 110.176 179.404 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -63.38 -38.63 91.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.525 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.775 HD12 HD23 ' A' ' 66' ' ' LEU . 75.2 mt -61.35 -40.85 87.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.521 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 44.5 pttt -72.24 -21.35 61.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.19 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -31.8 62.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.586 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -106.25 -24.0 12.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.031 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.553 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 40.8 m-70 -141.97 86.16 10.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.71 15.57 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.01 2.473 . . . . 0.0 113.127 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.572 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 11.9 mtt -145.36 4.83 1.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.636 HD21 HD22 ' A' ' 51' ' ' LEU . 15.9 tp -76.39 107.44 4.59 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 49' ' ' ASP . 39.3 Cg_exo -58.99 121.14 9.45 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.578 2.185 . . . . 0.0 111.732 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.687 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.3 t -120.64 150.52 23.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.488 0.661 . . . . 0.0 111.922 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.677 ' O ' HD23 ' A' ' 52' ' ' LEU . 3.7 mt -131.79 116.32 30.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.634 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.785 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 13.4 mm -93.43 137.92 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.635 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -85.41 -15.19 43.88 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.512 -179.199 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.686 ' O ' HG21 ' A' ' 55' ' ' ILE . 2.7 m -147.27 163.66 35.69 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.06 -47.62 3.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 110.973 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 44.56 59.37 3.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.978 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 52.37 -170.5 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.782 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.553 ' HB2' HD13 ' A' ' 63' ' ' LEU . 54.1 m-20 59.94 31.88 20.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.52 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.854 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -46.48 -24.25 0.49 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.723 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.81 -45.56 29.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.24 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.595 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.78 -23.07 62.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.675 0.274 . . . . 0.0 111.411 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.854 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -66.81 -46.39 75.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.742 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.7 t -61.3 -36.85 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.8 m -60.93 -41.23 95.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.213 0.53 . . . . 0.0 110.237 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.721 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -54.76 -49.06 71.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.117 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.618 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 8.7 m-85 -51.39 -27.76 10.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.596 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.574 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -70.4 -39.75 74.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.315 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.574 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 7.2 pt20 -77.97 -18.18 56.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.028 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.0 4.99 5.41 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.378 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.721 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -53.1 132.71 38.56 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.269 0.535 . . . . 0.0 110.751 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.792 ' CD2' ' HB2' ' A' ' 118' ' ' ALA . 8.6 t80 -64.14 -53.44 49.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.488 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 0.4 OUTLIER 175.75 -161.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.041 0.448 . . . . 0.0 111.904 -179.683 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.785 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.7 m-85 -132.57 135.86 46.2 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.136 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 103' ' ' PRO . 1.3 pp -126.59 136.49 28.77 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.842 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.814 ' O ' HD12 ' A' ' 102' ' ' LEU . 52.7 Cg_exo -51.68 172.13 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.271 1.98 . . . . 0.0 111.908 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.613 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -41.86 -49.8 10.52 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.649 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.9 Cg_endo -47.91 164.4 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 121.94 1.76 . . . . 0.0 110.704 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.815 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 173.86 -90.16 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.287 -0.165 . . . . 0.0 111.064 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.4 p30 50.98 -178.85 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.754 ' HA ' HG23 ' A' ' 112' ' ' VAL . 1.2 mp -54.46 -49.49 65.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.442 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 9.6 t0 -51.89 -58.79 5.45 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.815 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 4.8 mm-40 -82.41 -27.83 31.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . . . -84.1 -47.27 11.08 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.873 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.754 HG23 ' HA ' ' A' ' 108' ' ' ILE . 53.4 t -62.73 -32.03 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.493 0.663 . . . . 0.0 109.505 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.32 -49.89 75.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.144 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.494 ' CD2' ' HB3' ' A' ' 102' ' ' LEU . 8.3 tp -75.64 -20.94 58.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.433 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.1 p -79.26 -49.41 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 115' ' ' VAL . 34.7 mt-10 -65.35 -44.24 88.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.631 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 117' ' ' ARG . 6.4 mmt180 -63.02 -23.88 67.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.408 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.792 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -73.18 -49.45 27.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.053 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.458 HG12 ' OD1' ' A' ' 49' ' ' ASP . 3.7 mt -67.02 -31.11 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.817 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 t -66.74 -43.11 85.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.752 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -68.46 -26.89 65.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.984 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -66.77 -53.23 35.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.534 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.35 -176.37 3.1 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.407 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--N 1.331 -0.239 0 CA-C-O 120.912 0.387 . . . . 0.0 110.83 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.891 0.377 . . . . 0.0 111.466 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.78 162.47 13.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.869 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.624 ' HD3' HD11 ' A' ' 5' ' ' ILE . 6.4 ttt180 -68.73 -52.28 32.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.09 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 67.36 85.85 0.09 OUTLIER Glycine 0 C--N 1.32 -0.33 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.854 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.624 HD11 ' HD3' ' A' ' 3' ' ' ARG . 3.4 mp -117.41 115.8 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 0.0 111.512 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.785 HG11 ' HG ' ' A' ' 23' ' ' LEU . 8.3 p -107.11 122.44 61.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.938 ' CD1' HG22 ' A' ' 31' ' ' THR . 35.2 m0 -112.42 137.92 49.91 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.587 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.709 HG13 ' HB2' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -126.55 147.92 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.095 -178.112 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -134.65 121.14 34.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.084 178.075 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.499 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 14.6 t0 -177.33 -147.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.905 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.53 -2.18 4.44 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 14' ' ' SER . 2.3 t70 55.49 -143.03 0.75 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 t 33.2 -90.22 0.01 OUTLIER 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.837 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.8 m -57.8 -52.84 63.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.704 0.288 . . . . 0.0 111.357 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 14.6 mm -62.62 -36.28 74.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.943 0.401 . . . . 0.0 111.556 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.509 ' HA ' HG21 ' A' ' 32' ' ' THR . 11.4 ttt-85 -68.84 -41.92 77.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.313 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.483 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . 33.3 t90 -65.12 -58.7 5.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.306 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 14' ' ' SER . 1.4 t -57.35 -43.61 82.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.106 -178.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.684 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 4.4 mm? -76.85 -31.72 57.04 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.742 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 17.0 pt-20 -64.73 -61.92 1.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.687 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.729 ' HD2' ' H ' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -52.69 -63.87 1.0 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 0.0 112.095 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.16 -35.99 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.374 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.785 ' HG ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -73.87 -30.26 62.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.886 0.374 . . . . 0.0 110.331 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.08 -35.03 79.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.76 69.28 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.129 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.39 -15.34 58.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.65 0.262 . . . . 0.0 111.03 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.64 26.03 10.25 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.73 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -137.44 176.0 9.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.46 0.63 . . . . 0.0 111.316 179.7 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.587 ' O ' HG12 ' A' ' 6' ' ' VAL . 22.2 m -105.87 131.51 53.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.432 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.742 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 2.0 t -119.71 114.31 21.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.86 0.362 . . . . 0.0 111.767 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.938 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -123.08 155.27 37.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 37.8 p -129.92 157.75 41.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.148 0.499 . . . . 0.0 112.167 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.805 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.5 m-85 -133.18 173.25 11.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.614 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.731 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -63.25 -47.21 83.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.199 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.614 ' O ' HG11 ' A' ' 9' ' ' VAL . 42.9 t30 -161.64 168.47 23.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.928 0.394 . . . . 0.0 110.666 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.701 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -49.75 -11.45 0.33 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.573 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -81.91 -45.36 15.56 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.603 0.701 . . . . 0.0 109.913 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.731 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 2.0 tt0 -55.28 -51.69 65.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.019 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.676 HG21 ' CG2' ' A' ' 9' ' ' VAL . 17.9 t -51.55 -33.13 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.035 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.385 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.627 HD13 ' HB3' ' A' ' 68' ' ' GLN . 17.3 mt -57.66 -51.68 68.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.011 0.434 . . . . 0.0 110.13 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.29 -47.45 85.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.746 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.74 -34.54 78.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.096 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.569 ' CD1' HG12 ' A' ' 39' ' ' VAL . 31.5 mt -68.24 -23.87 64.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.865 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.88 -15.33 29.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.329 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.24 -7.81 11.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -164.53 160.73 20.67 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 120.988 0.423 . . . . 0.0 111.46 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.3 m -138.8 112.76 8.34 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.262 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.934 ' HD2' HD11 ' A' ' 76' ' ' LEU . 6.5 Cg_exo -74.83 165.84 30.57 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.638 2.225 . . . . 0.0 111.487 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.11 -25.71 59.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.553 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.755 HG13 HG23 ' A' ' 6' ' ' VAL . 4.2 p -145.02 161.71 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.874 ' O ' HD12 ' A' ' 79' ' ' ILE . 33.1 tp -153.03 150.28 29.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.432 0.634 . . . . 0.0 112.362 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.857 ' O ' HG23 ' A' ' 9' ' ' VAL . 6.2 mt -128.28 115.91 19.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.971 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.627 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -107.95 135.45 49.31 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.167 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 24.0 t0 -75.89 170.96 15.22 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.599 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.661 HG13 ' HA3' ' A' ' 62' ' ' GLY . 1.3 tt -158.56 92.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.349 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.411 ' O ' ' CG ' ' A' ' 57' ' ' MET . 0.1 OUTLIER -124.65 56.91 1.28 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.954 0.407 . . . . 0.0 111.446 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.481 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 5.7 ptt? 47.97 41.75 1.02 Allowed Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 57' ' ' MET . 38.0 Cg_endo -65.44 -81.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.966 1.777 . . . . 0.0 111.319 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.39 -84.61 1.8 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . 1.015 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -87.77 61.18 6.31 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.6 OUTLIER 67.11 -21.9 0.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.345 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.661 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 135.79 -33.02 2.45 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.583 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 4.8 mp -65.19 -21.67 66.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.015 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.39 -36.4 61.41 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.929 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.701 ' HB3' ' HA3' ' A' ' 36' ' ' GLY . 14.1 mt -56.58 -45.91 81.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.527 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.82 ' HA ' HD12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -58.43 -49.02 78.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.209 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.488 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 7.5 tttp -53.61 -42.3 67.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.217 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.627 ' HB3' HD13 ' A' ' 40' ' ' LEU . 21.8 mm100 -62.33 -40.04 95.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.696 0.284 . . . . 0.0 111.049 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.015 HG22 ' HD2' ' A' ' 73' ' ' HIS . 28.0 mt -56.41 -51.09 68.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.219 0.533 . . . . 0.0 111.187 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.704 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -59.07 -29.63 67.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.225 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.421 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 2.2 mt-30 -69.93 -23.71 63.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.992 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -114.14 -15.05 12.29 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 1.015 ' HD2' HG22 ' A' ' 69' ' ' ILE . 1.7 p80 -106.73 166.34 11.31 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -87.12 -55.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.082 2.521 . . . . 0.0 112.278 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 19.6 mtp -157.38 43.3 0.34 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.619 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.934 HD11 ' HD2' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -72.0 113.32 19.29 Favored Pre-proline 0 N--CA 1.455 -0.188 0 C-N-CA 122.206 0.202 . . . . 0.0 111.407 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 39.9 Cg_endo -68.55 115.54 3.96 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 121.89 1.726 . . . . 0.0 111.945 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.598 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 6.1 t -98.82 150.36 5.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.082 0.467 . . . . 0.0 111.393 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.874 HD12 ' O ' ' A' ' 51' ' ' LEU . 2.1 mt -134.11 115.0 20.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.96 178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.689 HG22 ' H ' ' A' ' 82' ' ' THR . 27.6 mm -93.59 150.02 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.475 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -86.24 -20.05 29.05 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.432 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.689 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.1 m -141.17 142.25 34.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.215 0.531 . . . . 0.0 111.388 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.751 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -135.39 31.75 3.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.524 ' NE2' HG21 ' A' ' 82' ' ' THR . 0.1 OUTLIER -88.79 31.57 0.84 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.477 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.557 ' HB2' HD11 ' A' ' 63' ' ' LEU . 61.6 m -133.96 -161.94 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.713 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.406 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -56.34 86.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.589 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.801 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -51.2 -23.24 3.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 111.459 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.76 -44.9 39.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.958 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.583 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -66.92 -25.31 66.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.951 0.405 . . . . 0.0 111.21 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.801 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -72.57 -22.46 60.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.995 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.516 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 14.5 t -70.89 -41.39 77.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.059 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 32.8 m -65.79 -19.58 65.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.113 0.483 . . . . 0.0 109.935 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.618 ' CB ' HD22 ' A' ' 66' ' ' LEU . . . -64.52 -46.84 81.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.008 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.516 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.4 m-85 -63.93 -29.45 70.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.803 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.407 ' HB3' ' O ' ' A' ' 92' ' ' SER . 2.3 tm0? -63.65 -45.52 89.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.897 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.68 ' HG2' ' HB3' ' A' ' 70' ' ' LYS . 1.4 pp0? -75.03 -18.51 60.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.628 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.64 21.16 4.39 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.533 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.652 ' HB2' ' NE2' ' A' ' 96' ' ' GLN . . . -59.18 157.04 11.13 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 117.082 0.441 . . . . 0.0 110.99 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 21.2 t80 -82.19 -53.38 6.12 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.543 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 169.86 -165.4 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.092 0.472 . . . . 0.0 111.531 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.751 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.2 m-85 -124.17 119.33 29.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.612 HD22 ' CE1' ' A' ' 106' ' ' PHE . 6.0 tp -102.51 134.95 19.65 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.77 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 11.3 Cg_endo -52.66 170.79 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.462 2.108 . . . . 0.0 111.674 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -43.63 -46.83 18.91 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.437 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.77 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 73.4 Cg_exo -48.11 163.36 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.682 1.588 . . . . 0.0 110.416 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.722 ' HD1' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -174.65 -86.66 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.694 -178.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.7 p30 43.42 -170.97 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.621 0.248 . . . . 0.0 110.445 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.845 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -67.91 -45.39 84.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.36 0.6 . . . . 0.0 111.429 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 12.9 t70 -52.8 -55.86 19.9 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.868 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.666 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -79.85 -27.98 40.1 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.722 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.28 -54.26 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.85 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.845 HG21 HG23 ' A' ' 108' ' ' ILE . 36.5 t -58.09 -33.58 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.439 0.637 . . . . 0.0 110.3 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.566 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.19 -51.61 68.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.9 0.857 . . . . 0.0 109.512 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.704 ' CD2' HG21 ' A' ' 79' ' ' ILE . 6.6 tp -76.24 -21.01 56.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.76 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.692 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.1 p -79.45 -50.28 18.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.164 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.471 ' N ' HG13 ' A' ' 115' ' ' VAL . 82.9 mt-10 -65.07 -45.13 86.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.649 0.262 . . . . 0.0 110.538 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -62.01 -26.31 68.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 0.0 110.419 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -72.48 -57.45 4.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.17 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.6 mt -68.43 -30.79 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.132 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.2 m -67.52 -45.12 76.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.026 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -66.7 -27.79 67.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.78 -57.62 3.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.986 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -75.6 179.19 5.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.844 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.894 0.378 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.98 -175.52 5.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.604 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -9.96 38.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.378 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 88.65 84.84 1.25 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.955 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.1 mp -104.23 113.28 40.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.729 0.3 . . . . 0.0 111.163 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.827 HG11 ' CD2' ' A' ' 23' ' ' LEU . 2.8 p -106.06 129.64 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.665 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.932 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.8 m0 -117.76 141.99 47.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.655 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -134.32 133.5 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.297 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.92 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -117.66 108.85 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.996 178.355 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 37.0 t0 166.84 120.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.436 ' HB3' HG12 ' A' ' 15' ' ' ILE . 1.1 t0 69.75 -45.2 0.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.133 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 16' ' ' ARG . 40.9 t0 75.15 -98.74 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.367 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' ASP . 5.7 p -26.67 -87.73 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.69 ' O ' HG23 ' A' ' 18' ' ' VAL . 35.3 m -54.98 -39.14 68.68 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG12 ' HB3' ' A' ' 11' ' ' ASP . 21.4 mm -68.47 -20.49 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.624 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -74.79 -58.54 3.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 111.236 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.437 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 49.9 t90 -49.96 -41.94 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.498 . . . . 0.0 112.237 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.792 HG12 HD13 ' A' ' 108' ' ' ILE . 1.6 t -70.44 -62.26 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.026 0.441 . . . . 0.0 111.734 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.61 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 3.8 mm? -63.7 -27.36 69.16 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.536 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.677 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 15.1 pt-20 -67.18 -61.06 2.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.654 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 1.1 mmm180 -67.51 -56.88 7.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.409 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -49.25 -59.58 3.55 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.931 0.396 . . . . 0.0 111.718 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.827 ' CD2' HG11 ' A' ' 6' ' ' VAL . 4.0 tp -61.4 -20.98 63.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.068 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -66.55 -38.5 87.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.97 -24.61 65.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.585 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.645 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.82 -15.59 58.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.664 0.269 . . . . 0.0 111.013 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.25 25.74 7.71 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.833 -0.698 . . . . 0.0 113.767 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.703 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.72 170.64 13.58 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 117.5 0.65 . . . . 0.0 111.609 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.0 m -107.26 105.47 15.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.086 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.746 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 2.1 t -98.94 118.1 34.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.177 0.513 . . . . 0.0 112.133 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.932 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -119.7 156.59 30.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.3 p -132.76 152.32 51.8 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.92 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -129.08 174.31 9.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.713 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -57.92 -108.46 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.501 -178.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -78.79 -68.44 0.65 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.115 0.484 . . . . 0.0 111.938 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.878 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -171.91 -33.67 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.046 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.485 ' OD1' HD12 ' A' ' 40' ' ' LEU . 29.7 m-20 -62.14 -30.75 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.692 0.282 . . . . 0.0 110.733 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -54.22 -52.65 60.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.853 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.918 HG11 HD11 ' A' ' 51' ' ' LEU . 63.1 t -54.74 -47.14 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.048 0.451 . . . . 0.0 110.62 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.651 HD13 ' HB2' ' A' ' 68' ' ' GLN . 22.5 mt -50.9 -43.15 59.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.112 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.96 -47.71 67.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.274 0.559 . . . . 0.0 110.715 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.34 -31.81 73.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.5 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.632 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 10.6 mt -61.45 -26.3 67.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.111 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.73 -17.47 60.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.305 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.43 -6.21 11.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.72 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -161.88 162.21 29.16 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.828 0.347 . . . . 0.0 111.075 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.512 HG23 HD13 ' A' ' 76' ' ' LEU . 77.0 m -138.97 112.66 8.2 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.154 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.615 ' HD2' HD21 ' A' ' 43' ' ' LEU . 73.5 Cg_endo -76.58 164.31 30.65 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.899 1.733 . . . . 0.0 111.539 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.49 -23.54 58.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.809 0.338 . . . . 0.0 110.761 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.723 HG13 HG23 ' A' ' 6' ' ' VAL . 6.3 p -145.17 161.58 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.918 HD11 HG11 ' A' ' 39' ' ' VAL . 22.9 tp -151.45 148.42 28.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.524 0.678 . . . . 0.0 112.073 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.893 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 mt -135.72 126.01 26.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.792 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.595 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -111.13 145.25 38.93 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -178.633 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 49.6 t0 -74.16 -19.4 60.57 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.27 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.778 HD13 ' O ' ' A' ' 82' ' ' THR . 7.0 tt 44.96 86.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.63 99.44 0.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.558 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 55.39 44.85 1.76 Allowed Pre-proline 0 N--CA 1.47 0.575 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 177.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.595 ' CD ' ' HA2' ' A' ' 62' ' ' GLY . 26.8 Cg_endo -91.9 -35.87 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.958 2.439 . . . . 0.0 112.422 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.06 -24.91 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.302 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.895 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 23.3 ttt -152.43 71.43 0.94 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.69 -35.45 0.24 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.1 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.641 ' C ' HG13 ' A' ' 55' ' ' ILE . . . 157.82 -34.54 0.53 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.577 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 5.3 mp -66.85 -25.05 66.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.768 0.318 . . . . 0.0 110.485 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.895 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.98 -26.02 23.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.656 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.565 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 76.2 mt -55.96 -40.27 73.0 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.151 0.5 . . . . 0.0 110.061 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.898 ' HA ' HD12 ' A' ' 69' ' ' ILE . 4.8 mp -70.33 -39.43 74.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.049 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.709 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.0 tmtt? -55.2 -42.99 74.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.299 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.651 ' HB2' HD13 ' A' ' 40' ' ' LEU . 12.1 mm100 -69.05 -37.5 78.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.735 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.898 HD12 ' HA ' ' A' ' 66' ' ' LEU . 13.2 mt -62.83 -23.1 32.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.803 0.335 . . . . 0.0 110.849 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.709 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 2.5 mtmp? -75.18 -50.72 15.33 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.105 0.955 . . . . 0.0 109.291 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.13 -33.21 74.04 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.337 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.516 ' NH1' ' HB3' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -94.13 -28.7 15.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.665 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.632 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 40.5 m-70 -153.54 82.4 4.69 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.653 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.709 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 55.5 Cg_endo -71.28 31.76 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.738 2.292 . . . . 0.0 113.172 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -143.78 -37.21 0.34 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.1 0.476 . . . . 0.0 111.238 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.558 HD23 ' CG2' ' A' ' 69' ' ' ILE . 6.7 tp -50.77 129.8 28.02 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.512 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.699 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 51.9 Cg_endo -73.24 122.98 8.44 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.729 2.286 . . . . 0.0 112.181 179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.731 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.3 t -110.28 142.78 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.125 0.488 . . . . 0.0 111.253 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.815 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.1 mt -133.89 113.52 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.383 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.822 ' CG1' HD21 ' A' ' 66' ' ' LEU . 18.9 mm -93.42 137.28 22.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.102 0.477 . . . . 0.0 112.127 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.682 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.84 -4.04 59.06 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.349 -179.168 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.778 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.5 m -148.03 144.19 27.75 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.584 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.775 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -143.78 61.41 1.37 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.336 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -98.93 -22.78 15.6 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.469 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -84.33 -166.49 1.46 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.169 0.509 . . . . 0.0 111.996 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -54.76 97.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.777 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.851 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -51.24 -21.68 2.24 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.3 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -48.59 -45.04 37.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.277 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.577 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.69 -20.61 66.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.804 0.335 . . . . 0.0 110.89 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.851 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -72.98 -32.2 65.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.711 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.562 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.9 t -65.71 -42.73 93.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 19.7 m -63.49 -19.91 65.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.382 . . . . 0.0 110.012 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.724 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -66.37 -44.95 81.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.451 0.643 . . . . 0.0 109.842 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.562 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 5.0 m-85 -65.88 -23.88 66.74 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.868 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.431 ' HB3' ' O ' ' A' ' 92' ' ' SER . 2.0 tm0? -69.1 -36.39 77.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.307 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.724 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -86.68 -18.27 31.67 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.706 179.06 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.13 21.27 3.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.304 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.731 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -65.04 152.79 42.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.212 0.506 . . . . 0.0 110.182 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.547 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 38.6 t80 -81.96 -54.0 5.68 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.441 ' OD2' ' CD2' ' A' ' 99' ' ' PHE . 14.7 p30 174.77 -170.76 0.05 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.993 0.425 . . . . 0.0 111.685 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.775 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 5.1 m-85 -119.72 125.67 49.22 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.771 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.708 HD12 ' HD2' ' A' ' 103' ' ' PRO . 11.0 tp -102.87 139.33 20.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.458 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.714 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 20.9 Cg_endo -58.88 171.83 1.91 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.092 1.861 . . . . 0.0 111.096 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.493 ' HE3' ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -43.18 -45.88 13.98 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.714 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 87.3 Cg_exo -47.44 163.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.676 1.584 . . . . 0.0 110.843 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.802 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 3.2 t80 -167.56 -92.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.995 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 5.3 p-10 44.12 -173.79 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.654 0.264 . . . . 0.0 110.586 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.792 HD13 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.66 -47.14 81.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.386 0.612 . . . . 0.0 110.849 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.1 t70 -51.01 -58.12 6.88 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.212 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.668 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.7 mm-40 -79.13 -26.77 42.8 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.15 -53.16 5.71 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.138 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.628 HG21 HG23 ' A' ' 108' ' ' ILE . 43.9 t -59.97 -31.45 47.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.507 0.67 . . . . 0.0 110.084 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.23 -50.96 70.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.626 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.704 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 23.8 tp -75.46 -20.46 58.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.517 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.2 p -79.27 -48.03 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.055 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.447 ' N ' HG13 ' A' ' 115' ' ' VAL . 4.1 mt-10 -61.12 -45.66 93.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.726 0.298 . . . . 0.0 110.838 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.613 ' HD2' HD12 ' A' ' 114' ' ' LEU . 4.1 ptp180 -64.2 -23.73 67.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.897 0.379 . . . . 0.0 110.687 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.547 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.22 -49.46 35.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.938 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.1 mt -66.2 -30.89 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.6 m -68.37 -44.01 76.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -62.47 -31.13 71.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 77' ' ' PRO . 0.3 OUTLIER -85.11 -51.12 6.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.897 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 59.39 175.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.985 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mtt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.754 0.311 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.3 154.28 33.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.804 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 1.016 ' HG3' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -56.86 -34.28 67.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.053 0.454 . . . . 0.0 110.855 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.885 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 93.2 110.54 2.01 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.034 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.016 HD11 ' HG3' ' A' ' 3' ' ' ARG . 6.3 mm -129.39 113.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.849 HG23 HG13 ' A' ' 50' ' ' VAL . 9.2 p -105.56 127.69 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.838 ' CD1' HG22 ' A' ' 31' ' ' THR . 24.6 m0 -114.67 132.81 56.27 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -127.99 139.8 50.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.005 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -128.38 105.37 13.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.187 179.029 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 58.1 t0 166.72 119.45 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.424 0.453 . . . . 0.0 110.682 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.407 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 72.79 -28.11 0.19 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 10' ' ' ASP . 7.9 t0 73.02 -133.38 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.978 -0.101 . . . . 0.0 110.943 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.1 t -30.71 -48.47 0.11 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.661 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.1 t -53.95 -68.18 0.2 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.654 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.588 ' CG2' HD12 ' A' ' 19' ' ' LEU . 24.8 mm -62.31 -20.76 25.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.55 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.628 ' HA ' HG21 ' A' ' 32' ' ' THR . 6.0 ttt180 -70.53 -60.57 2.19 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.651 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.519 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 57.1 t90 -49.98 -44.52 50.92 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 111.912 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.731 HG12 HD13 ' A' ' 108' ' ' ILE . 1.3 t -64.97 -59.14 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.588 HD12 ' CG2' ' A' ' 15' ' ' ILE . 56.4 mt -70.75 -26.33 63.31 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.558 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 12.8 pt-20 -63.81 -57.88 8.54 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.769 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 2.4 mmp_? -63.75 -60.04 3.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.905 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.88 -56.17 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.977 0.417 . . . . 0.0 111.85 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.531 HD12 ' CG1' ' A' ' 6' ' ' VAL . 1.5 tm? -64.95 -23.75 67.32 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.015 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -71.28 -32.6 68.87 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.56 -26.49 66.65 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.385 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.558 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.31 -15.65 59.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.812 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.01 23.09 11.86 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.798 -0.715 . . . . 0.0 114.326 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.558 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -123.45 163.62 20.52 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.418 1.109 . . . . 0.0 112.167 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.592 ' HB ' HG23 ' A' ' 5' ' ' ILE . 89.9 m -84.53 136.35 33.84 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.626 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -127.97 108.51 10.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.645 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.838 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -121.68 147.59 45.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.9 p -125.59 161.44 27.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.63 0.728 . . . . 0.0 112.958 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.005 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.3 m-85 -136.12 173.86 11.25 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.108 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.475 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.6 pp20? -61.56 -60.51 3.58 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -152.97 -23.79 0.15 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.737 ' C ' HD21 ' A' ' 65' ' ' LEU . . . 166.44 -56.83 0.24 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.067 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.483 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -47.89 -37.5 14.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.014 -179.363 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.876 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 8.3 tt0 -58.42 -55.44 34.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.742 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.747 HG21 ' CG2' ' A' ' 9' ' ' VAL . 2.9 t -51.18 -46.48 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.107 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.627 HD21 ' CD1' ' A' ' 65' ' ' LEU . 31.7 mt -46.55 -45.57 18.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.21 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.07 -48.75 69.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.113 0.482 . . . . 0.0 111.326 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.79 -35.35 79.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.45 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.595 ' HG ' HG12 ' A' ' 39' ' ' VAL . 16.6 mt -63.38 -25.37 68.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.27 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -16.95 22.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.218 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.5 t -121.11 -5.39 9.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.472 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -156.53 160.04 39.13 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.91 0.386 . . . . 0.0 111.665 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.5 m -139.2 112.0 7.94 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.625 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 58.8 Cg_endo -69.47 166.43 27.28 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.717 2.278 . . . . 0.0 111.839 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.86 -27.01 33.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.849 HG13 HG23 ' A' ' 6' ' ' VAL . 4.8 p -147.95 101.17 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.425 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.881 ' O ' HD12 ' A' ' 79' ' ' ILE . 62.7 tp -87.15 141.74 28.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.409 0.623 . . . . 0.0 112.491 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.839 ' O ' HG23 ' A' ' 9' ' ' VAL . 5.3 mt -124.35 117.51 24.65 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -112.5 146.71 37.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.021 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.743 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 20.4 t0 -77.2 179.4 6.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.95 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.757 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.1 tt -156.23 78.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.798 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 50.7 ttp85 176.71 69.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.564 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.467 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -160.9 -67.09 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.879 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 57' ' ' MET . 35.6 Cg_endo -64.86 -176.06 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.536 2.158 . . . . 0.0 113.033 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.8 -54.34 38.14 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.486 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.587 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -78.14 49.23 0.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.733 0.301 . . . . 0.0 110.75 179.675 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.61 -72.13 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.757 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -149.47 -35.51 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.261 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.884 ' HA ' HD23 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -54.61 -21.42 10.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.11 179.693 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.527 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.75 -36.23 62.1 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.737 HD21 ' C ' ' A' ' 36' ' ' GLY . 1.1 tm? -59.97 -40.92 90.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.154 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.884 HD23 ' HA ' ' A' ' 63' ' ' LEU . 4.3 mm? -54.39 -43.94 71.87 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.17 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 53.9 tttm -56.9 -43.46 81.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.319 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.583 ' HB3' HD13 ' A' ' 40' ' ' LEU . 21.0 mm100 -60.93 -34.7 75.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.233 0.54 . . . . 0.0 110.147 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.983 HG23 ' CE1' ' A' ' 73' ' ' HIS . 92.5 mt -58.92 -39.84 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.527 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -69.61 -29.03 66.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.036 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.432 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -70.89 -35.36 72.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.986 -179.83 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.63 -71.64 0.71 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.527 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.983 ' CE1' HG23 ' A' ' 69' ' ' ILE . 4.6 p80 -112.22 71.96 1.15 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.458 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.542 ' O ' ' HG2' ' A' ' 75' ' ' MET . 62.4 Cg_endo -73.62 50.67 2.08 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.595 2.197 . . . . 0.0 113.675 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 8.8 mtm -156.64 -39.51 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.856 HD12 ' HD2' ' A' ' 77' ' ' PRO . 8.7 tp -59.57 130.33 87.8 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-O 120.945 0.403 . . . . 0.0 112.041 -178.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.856 ' HD2' HD12 ' A' ' 76' ' ' LEU . 47.3 Cg_endo -68.55 115.29 3.83 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.307 2.671 . . . . 0.0 113.871 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.95 HG21 HD13 ' A' ' 69' ' ' ILE . 3.2 t -98.38 151.79 4.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.407 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.881 HD12 ' O ' ' A' ' 51' ' ' LEU . 2.0 mt -136.57 114.56 14.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.064 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.617 HD11 HD21 ' A' ' 66' ' ' LEU . 17.9 mm -93.7 146.03 7.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.521 ' HE2' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.45 -14.53 56.94 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.602 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.8 m -148.43 161.96 40.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.1 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.701 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -145.24 64.04 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.856 0.36 . . . . 0.0 111.246 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.471 ' CD2' ' H ' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -98.89 111.86 24.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.987 0.422 . . . . 0.0 111.558 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.8 t 60.59 161.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.647 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.474 ' HB2' HD13 ' A' ' 63' ' ' LEU . 24.9 m-20 61.91 18.99 10.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.475 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.704 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -46.44 -22.68 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -48.06 -50.17 28.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.34 -20.01 65.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.689 0.281 . . . . 0.0 111.503 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.704 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -63.95 -57.17 10.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.809 0.338 . . . . 0.0 111.008 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.614 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.3 t -62.93 -43.47 99.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.5 m -58.8 -31.68 68.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.183 0.516 . . . . 0.0 110.458 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.689 ' HB1' HD12 ' A' ' 66' ' ' LEU . . . -63.65 -43.68 96.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.36 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.614 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 2.6 m-85 -59.59 -22.19 61.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.545 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.583 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.77 -37.99 54.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.099 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.583 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 2.1 pp0? -100.04 -13.34 19.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.752 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 147.59 82.88 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.615 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.832 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.53 111.24 0.56 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.293 0.568 . . . . 0.0 111.611 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -55.22 -49.81 71.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.919 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.527 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER 173.92 -161.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.067 0.46 . . . . 0.0 111.918 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.701 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.9 m-85 -127.16 130.21 49.32 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.377 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.603 ' HB2' HD22 ' A' ' 114' ' ' LEU . 4.2 tp -108.27 142.43 25.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.11 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.677 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 17.8 Cg_endo -58.99 163.69 11.23 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.261 1.974 . . . . 0.0 111.372 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.421 ' HE2' ' OG1' ' A' ' 82' ' ' THR . 0.5 OUTLIER -36.25 -47.69 1.52 Allowed Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.613 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 84.2 Cg_exo -47.03 163.22 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.818 1.679 . . . . 0.0 110.756 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.669 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 3.6 t80 -165.55 -92.19 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.167 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.4 p-10 42.48 -173.69 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.874 0.369 . . . . 0.0 110.628 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.876 HG23 HG21 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -67.83 -47.49 79.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.285 0.564 . . . . 0.0 111.487 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 12.2 t70 -51.75 -57.58 8.86 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.713 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.669 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.5 mm-40 -78.45 -29.09 46.73 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.564 ' HB3' HD21 ' A' ' 19' ' ' LEU . . . -83.34 -54.55 4.91 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.061 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.876 HG21 HG23 ' A' ' 108' ' ' ILE . 39.6 t -57.2 -32.4 40.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.476 0.655 . . . . 0.0 110.162 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -58.84 -53.15 61.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.064 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.623 HD12 ' HD2' ' A' ' 117' ' ' ARG . 33.4 tp -74.62 -21.39 59.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.98 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.646 HG12 ' HA ' ' A' ' 112' ' ' VAL . 5.1 p -79.57 -50.16 18.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.161 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.457 ' N ' HG13 ' A' ' 115' ' ' VAL . 94.7 mt-10 -65.47 -40.07 92.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.78 0.324 . . . . 0.0 111.026 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.623 ' HD2' HD12 ' A' ' 114' ' ' LEU . 5.6 ptp180 -65.96 -27.52 68.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.461 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.19 -51.99 26.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.004 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.1 mt -65.29 -31.86 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.161 0.505 . . . . 0.0 111.033 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -43.58 76.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.52 -24.44 66.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -67.47 -43.75 80.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.982 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -75.53 170.25 16.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.986 179.806 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.957 0.408 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -162.78 173.68 13.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.785 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.43 -9.56 19.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.412 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 90.46 99.98 1.16 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.256 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 2.2 mp -124.2 113.49 36.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.478 0.656 . . . . 0.0 111.022 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.885 HG23 HG13 ' A' ' 50' ' ' VAL . 10.4 p -107.21 120.36 58.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.502 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.928 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.0 m0 -112.26 145.8 39.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.069 0.461 . . . . 0.0 110.222 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.949 ' CG1' HG22 ' A' ' 32' ' ' THR . 0.2 OUTLIER -137.29 149.67 25.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -176.145 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.98 HG13 ' HB2' ' A' ' 33' ' ' PHE . 1.4 t -133.28 105.17 7.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.787 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.58 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 44.1 t0 166.85 122.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.687 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.416 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 72.04 -40.92 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.821 179.696 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 37.6 t0 75.28 -121.92 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.849 -0.159 . . . . 0.0 110.729 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.4 t -31.33 -47.54 0.11 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.515 ' O ' HG23 ' A' ' 18' ' ' VAL . 47.5 t -63.8 -63.32 1.2 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.342 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.961 HG22 HG21 ' A' ' 32' ' ' THR . 20.1 mm -63.21 -25.16 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.418 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.469 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 7.3 ttt180 -61.58 -58.05 9.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.02 0.438 . . . . 0.0 111.445 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.477 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 53.5 t90 -56.69 -46.28 81.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.649 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.708 HG12 HD13 ' A' ' 108' ' ' ILE . 2.0 t -65.47 -44.41 94.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.534 HD12 ' CD1' ' A' ' 108' ' ' ILE . 5.6 tp -83.06 -23.97 32.93 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.732 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 26.5 pt-20 -66.78 -56.19 11.56 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.729 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.3 mmm180 -65.51 -56.33 12.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.122 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.62 -45.65 73.73 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.811 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.3 tm? -69.21 -26.71 64.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.531 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.22 -32.44 73.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.14 -29.02 71.64 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.21 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.549 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.76 -15.37 59.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 110.982 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.45 26.06 11.43 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.695 -0.765 . . . . 0.0 113.863 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.549 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -133.74 171.2 14.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.75 0.775 . . . . 0.0 111.903 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.647 ' O ' HG12 ' A' ' 6' ' ' VAL . 25.8 m -94.27 128.82 40.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.225 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.732 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 1.8 t -122.97 120.94 34.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.264 0.554 . . . . 0.0 111.865 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.928 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -134.3 132.32 39.43 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.961 HG21 HG22 ' A' ' 15' ' ' ILE . 76.5 p -107.97 159.28 16.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.484 0.659 . . . . 0.0 112.27 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.98 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.7 m-85 -131.96 174.2 10.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.12 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.498 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -63.36 -106.78 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.92 -178.425 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.433 ' O ' HD21 ' A' ' 65' ' ' LEU . 10.9 p30 -88.85 -49.56 6.74 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.87 ' HA3' HD23 ' A' ' 65' ' ' LEU . . . 173.83 -43.37 0.15 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.066 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.607 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 67.0 m-80 -53.08 -24.72 10.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 111.2 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -57.2 -60.02 4.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.43 179.419 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.722 HG21 HD11 ' A' ' 51' ' ' LEU . 72.7 t -58.65 -35.94 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.722 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.709 HD13 ' HB3' ' A' ' 68' ' ' GLN . 40.3 mt -47.17 -46.14 23.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 0.0 110.489 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.63 -45.95 34.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.972 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.56 -29.81 66.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.865 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.695 ' CD1' HG12 ' A' ' 39' ' ' VAL . 12.2 mt -72.05 -23.54 61.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.664 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.32 -17.71 13.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.606 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.55 -7.25 9.69 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.595 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -159.67 159.14 32.64 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.74 0.305 . . . . 0.0 111.397 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.593 HG23 HD13 ' A' ' 76' ' ' LEU . 93.5 m -138.75 114.33 8.63 Favored Pre-proline 0 N--CA 1.454 -0.263 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.713 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.686 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.9 Cg_endo -78.69 165.04 25.21 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.371 2.047 . . . . 0.0 111.331 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.03 -26.68 60.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.929 0.395 . . . . 0.0 110.451 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.885 HG13 HG23 ' A' ' 6' ' ' VAL . 10.0 p -145.11 161.09 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.722 HD11 HG21 ' A' ' 39' ' ' VAL . 13.5 tp -152.92 140.08 19.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.222 0.534 . . . . 0.0 112.3 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.88 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -104.55 137.6 42.16 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.489 179.436 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.661 ' OG ' HD22 ' A' ' 65' ' ' LEU . 26.2 t -127.72 133.98 49.55 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 32.0 t0 -83.08 172.87 12.26 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.242 0.544 . . . . 0.0 111.499 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.729 HG21 ' HB ' ' A' ' 82' ' ' THR . 0.6 OUTLIER -140.24 84.05 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.956 -179.551 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -111.49 36.28 3.3 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.744 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.694 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 52.87 53.28 11.81 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 178.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HG3' HD11 ' A' ' 65' ' ' LEU . 43.5 Cg_endo -75.02 -65.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.322 2.015 . . . . 0.0 111.831 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.44 -27.25 1.21 Allowed Glycine 0 CA--C 1.518 0.239 0 N-CA-C 111.824 -0.511 . . . . 0.0 111.824 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.726 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -155.09 63.09 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.694 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 4.3 p-10 54.12 -82.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.026 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.686 ' HA3' ' HB ' ' A' ' 55' ' ' ILE . . . -137.46 -24.24 0.43 Allowed Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.691 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.915 HD23 ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -77.51 -19.11 56.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.735 0.268 . . . . 0.0 111.106 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.726 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -55.14 -31.26 61.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.336 0.588 . . . . 0.0 109.897 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.87 HD23 ' HA3' ' A' ' 36' ' ' GLY . 6.6 mp -67.5 -36.27 80.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.425 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.796 HD13 ' HB2' ' A' ' 93' ' ' ALA . 14.1 mt -63.22 -42.64 99.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.912 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 50.4 tttm -55.01 -54.2 45.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.882 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.709 ' HB3' HD13 ' A' ' 40' ' ' LEU . 2.4 mt-30 -54.75 -43.13 72.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.154 179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.737 HD13 HG21 ' A' ' 78' ' ' VAL . 21.0 mt -59.17 -40.55 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.131 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -74.2 -23.07 59.15 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.981 -179.245 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -68.41 -51.21 46.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -93.48 -35.58 12.88 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.687 ' CE1' HD13 ' A' ' 43' ' ' LEU . 1.2 m80 -99.65 144.04 27.57 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.603 -178.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 73' ' ' HIS . 27.9 Cg_exo -61.58 -70.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.623 2.215 . . . . 0.0 112.711 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 60.7 mtt -147.77 52.96 1.04 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.936 0.398 . . . . 0.0 111.516 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.593 HD13 HG23 ' A' ' 47' ' ' THR . 5.5 tp -72.34 113.8 24.03 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.639 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -53.49 132.73 50.2 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.191 1.928 . . . . 0.0 111.793 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.737 HG21 HD13 ' A' ' 69' ' ' ILE . 2.5 t -126.67 146.64 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.566 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.68 HG21 HD23 ' A' ' 114' ' ' LEU . 3.3 mt -126.88 116.39 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.955 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.822 HD13 ' CD1' ' A' ' 101' ' ' TYR . 1.4 mp -94.16 145.44 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.889 0.376 . . . . 0.0 111.306 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.708 ' HE1' HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -87.68 -22.21 24.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.248 -178.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.729 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.4 m -147.68 145.65 28.98 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.371 -0.206 . . . . 0.0 110.453 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.406 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -103.32 -29.28 11.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.73 0.3 . . . . 0.0 111.606 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.481 ' HB2' HD11 ' A' ' 55' ' ' ILE . 3.3 m-70 44.75 -92.67 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.448 ' O ' HD11 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -141.26 -172.84 3.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.942 0.401 . . . . 0.0 111.479 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 58.15 33.29 23.01 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.007 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.58 ' HA ' HD21 ' A' ' 63' ' ' LEU . 3.2 mt -48.82 -21.17 0.59 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.409 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -47.82 -44.55 28.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.636 0.255 . . . . 0.0 111.45 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -69.68 -21.61 63.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.577 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.915 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -68.11 -32.94 73.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.65 0.262 . . . . 0.0 111.026 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.533 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 9.8 t -71.27 -39.05 72.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.552 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 95.0 p -69.46 -20.23 63.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.805 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.796 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -66.84 -42.47 85.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.365 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.533 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 7.6 m-85 -64.6 -25.83 68.14 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -77.2 -38.51 51.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.62 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.687 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.7 pp0? -77.42 -18.45 57.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.295 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.11 -10.53 5.64 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.453 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.487 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -48.37 155.79 0.48 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.068 0.434 . . . . 0.0 111.329 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.65 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 18.7 t80 -86.41 -53.89 4.74 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.492 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER 169.23 -166.06 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.855 0.36 . . . . 0.0 111.337 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.822 ' CD1' HD13 ' A' ' 80' ' ' ILE . 3.4 m-85 -121.46 133.83 55.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.287 0.565 . . . . 0.0 111.292 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.809 HD12 ' HD2' ' A' ' 103' ' ' PRO . 3.9 tp -120.76 141.63 32.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.905 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.809 ' HD2' HD12 ' A' ' 102' ' ' LEU . 19.5 Cg_endo -56.66 168.24 2.41 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.418 2.079 . . . . 0.0 111.815 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.572 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -43.09 -54.0 9.79 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.886 -0.143 . . . . 0.0 111.179 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 7.2 Cg_endo -48.43 163.88 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.878 1.719 . . . . 0.0 110.384 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.848 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 173.81 -86.89 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.4 p30 50.12 -178.58 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.736 HG23 HG21 ' A' ' 112' ' ' VAL . 1.1 mp -55.83 -47.55 79.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.509 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 4.4 t70 -54.57 -58.63 6.72 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.822 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.848 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 5.5 mm-40 -81.93 -25.59 34.78 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.19 -51.16 7.73 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.518 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.736 HG21 HG23 ' A' ' 108' ' ' ILE . 46.5 t -61.24 -32.75 53.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.486 0.66 . . . . 0.0 110.099 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -58.98 -50.62 73.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.218 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.68 HD23 HG21 ' A' ' 79' ' ' ILE . 7.5 tp -77.1 -21.03 54.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.42 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 112' ' ' VAL . 3.0 p -78.18 -47.49 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.751 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 52.9 mt-10 -62.73 -42.4 99.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.83 0.348 . . . . 0.0 110.571 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -66.53 -24.48 66.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.612 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.65 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -73.23 -54.15 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.936 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -61.13 -31.44 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.981 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.0 t -70.06 -41.07 74.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.009 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.55 -42.56 98.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.053 0.454 . . . . 0.0 111.024 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -76.44 -52.76 9.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.023 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 59.51 177.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.809 0.337 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -68.32 143.69 55.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.825 ' HE ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -61.38 -20.56 63.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.118 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.95 93.37 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.544 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.825 HD11 ' HE ' ' A' ' 3' ' ' ARG . 3.4 mp -107.91 115.54 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.853 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.8 HG11 ' CD2' ' A' ' 23' ' ' LEU . 3.0 p -107.01 126.69 63.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.937 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.777 ' CD1' HG22 ' A' ' 31' ' ' THR . 32.8 m0 -114.48 147.26 39.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.886 0.374 . . . . 0.0 110.643 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.968 HG21 HD23 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -137.28 145.75 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.924 0.392 . . . . 0.0 111.669 -178.526 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.899 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -129.28 112.14 24.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.231 178.323 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.697 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 7.5 t70 -165.21 -154.29 0.21 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.142 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.423 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -67.05 8.77 0.25 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.422 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 10' ' ' ASP . 2.9 p30 45.39 -143.84 0.21 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t 34.97 -91.78 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.817 ' O ' HG23 ' A' ' 18' ' ' VAL . 12.2 m -58.62 -52.33 66.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.703 0.287 . . . . 0.0 111.192 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.3 mm -62.69 -29.13 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.217 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.831 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.2 OUTLIER -72.79 -57.66 3.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.806 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.412 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 77.1 t90 -50.2 -40.33 46.79 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 14' ' ' SER . 1.8 t -71.42 -56.41 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.968 HD23 HG21 ' A' ' 8' ' ' VAL . 6.0 tp -71.59 -23.02 61.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.685 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.79 -60.08 2.81 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.535 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.57 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.0 mmm180 -72.64 -52.86 13.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.866 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.465 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -50.62 -60.01 3.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.975 0.416 . . . . 0.0 111.598 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.8 ' CD2' HG11 ' A' ' 6' ' ' VAL . 4.5 tp -61.82 -22.7 65.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.288 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -67.56 -37.49 82.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.8 -24.31 68.12 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.571 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.48 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.11 -15.61 59.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.664 0.269 . . . . 0.0 110.924 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.57 24.06 7.61 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.963 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.636 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -130.37 172.14 12.18 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 117.686 0.743 . . . . 0.0 111.376 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 m -105.7 105.77 15.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.465 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.764 ' HA ' HG13 ' A' ' 6' ' ' VAL . 5.7 t -100.57 115.64 30.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.136 0.493 . . . . 0.0 112.235 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.777 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -117.82 156.33 28.54 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.831 HG21 ' HA ' ' A' ' 16' ' ' ARG . 29.8 p -130.12 161.05 31.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.229 0.537 . . . . 0.0 111.439 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.864 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.5 m-85 -133.57 174.46 10.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.42 -178.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.527 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.4 pp20? -59.04 -49.57 77.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -154.52 -51.43 0.09 Allowed 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.99 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.788 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -175.92 -44.38 0.06 OUTLIER Glycine 0 C--N 1.315 -0.597 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.967 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.434 ' OD1' HD12 ' A' ' 40' ' ' LEU . 17.7 m-20 -62.49 -27.38 69.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.018 0.437 . . . . 0.0 110.648 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.674 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -59.65 -47.6 84.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.012 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.846 HG21 HG22 ' A' ' 9' ' ' VAL . 21.4 t -62.38 -42.07 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.977 0.418 . . . . 0.0 111.063 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.604 HD13 ' CB ' ' A' ' 68' ' ' GLN . 25.8 mt -52.07 -42.28 63.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.731 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.79 -48.35 38.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.199 0.523 . . . . 0.0 110.947 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.92 -32.15 72.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.009 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.728 HD13 ' CE1' ' A' ' 73' ' ' HIS . 12.9 mt -68.89 -21.32 64.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.609 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.19 -19.99 37.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.706 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.88 -1.15 6.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -153.69 153.27 31.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.942 0.401 . . . . 0.0 111.007 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.716 HG23 HD13 ' A' ' 76' ' ' LEU . 95.5 m -139.02 112.55 8.15 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.247 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.7 Cg_endo -77.42 164.2 28.96 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.944 1.763 . . . . 0.0 111.325 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.37 -25.6 59.6 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.693 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.596 HG13 HG23 ' A' ' 6' ' ' VAL . 4.8 p -145.07 159.68 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.005 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.535 HD11 HG11 ' A' ' 39' ' ' VAL . 14.9 tp -152.94 155.81 37.71 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.235 0.541 . . . . 0.0 112.179 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.899 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.7 mt -136.52 127.55 27.76 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.373 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.597 ' HB3' HD12 ' A' ' 80' ' ' ILE . 42.4 t -106.68 140.27 39.81 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.697 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 10.0 t0 -65.8 -35.87 81.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.697 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.866 HG21 HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER 45.12 90.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.971 0.415 . . . . 0.0 110.632 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.91 90.31 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.595 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 53.6 44.99 2.14 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.457 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.626 ' HG3' ' HA2' ' A' ' 62' ' ' GLY . 90.0 Cg_endo -89.3 -54.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.574 2.183 . . . . 0.0 112.139 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.43 -19.42 0.09 OUTLIER Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.633 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.947 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 3.0 tpt -163.59 69.85 0.21 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.146 0.498 . . . . 0.0 110.132 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.54 -22.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.303 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.626 ' HA2' ' HG3' ' A' ' 58' ' ' PRO . . . 139.83 -34.86 1.98 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.236 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.776 HD13 ' HB3' ' A' ' 86' ' ' ASP . 4.9 mp -72.67 -16.32 61.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.509 -0.345 . . . . 0.0 111.047 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.947 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.68 -33.34 55.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.216 0.532 . . . . 0.0 110.191 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.564 HD13 ' HA3' ' A' ' 36' ' ' GLY . 49.6 mt -60.98 -35.62 77.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.561 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.906 HD11 HD11 ' A' ' 80' ' ' ILE . 3.6 mm? -61.28 -45.04 96.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.164 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.573 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 61.2 tttt -54.44 -41.48 69.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.62 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.604 ' CB ' HD13 ' A' ' 40' ' ' LEU . 11.6 mm100 -67.46 -33.41 75.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.627 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 66' ' ' LEU . 92.8 mt -63.96 -38.37 82.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.829 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.36 -24.47 46.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.758 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.09 -34.25 20.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.825 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.86 -25.57 16.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.728 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -126.36 163.4 40.55 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.795 0.331 . . . . 0.0 111.265 -179.605 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 40.1 Cg_endo -72.07 -81.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.571 2.181 . . . . 0.0 112.857 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.629 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.0 mpt? -138.95 48.09 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 111.152 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.716 HD13 HG23 ' A' ' 47' ' ' THR . 4.7 tp -63.72 118.01 40.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.793 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.24 119.04 5.88 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.146 1.897 . . . . 0.0 111.87 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.554 HG21 HG21 ' A' ' 69' ' ' ILE . 2.3 t -117.11 139.71 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.271 0.558 . . . . 0.0 111.554 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.768 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.9 mt -123.7 115.47 45.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.445 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.906 HD11 HD11 ' A' ' 66' ' ' LEU . 4.8 mm -93.53 127.47 45.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.637 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 1.1 ptp -80.26 -2.09 43.6 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.625 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.807 ' HB ' HG23 ' A' ' 55' ' ' ILE . 2.7 m -147.87 142.87 26.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.73 0.3 . . . . 0.0 110.715 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.913 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -162.93 65.22 0.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.908 0.385 . . . . 0.0 111.004 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -98.26 -45.57 6.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.186 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.39 165.74 17.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 111.293 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.776 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.4 OUTLIER 59.91 24.08 13.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.429 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.606 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 4.7 mt -48.73 -21.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -48.01 -55.23 10.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.662 0.268 . . . . 0.0 111.58 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.475 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -60.0 -20.56 58.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.748 0.309 . . . . 0.0 111.095 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -66.96 -39.07 87.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.44 . . . . 0.0 110.419 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.601 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 16.2 t -64.99 -45.27 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.362 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 p -61.34 -32.39 72.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 110.403 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.679 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -58.83 -39.03 80.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.115 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.601 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 20.3 m-85 -61.76 -20.9 64.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.99 0.424 . . . . 0.0 110.164 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.648 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.49 -42.51 52.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.444 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.679 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -75.66 -16.56 60.17 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.029 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.23 24.43 2.22 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.297 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.553 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -65.85 140.13 58.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.819 0.31 . . . . 0.0 110.5 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 47.9 t80 -72.52 -53.67 11.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.198 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.623 ' OD2' HD11 ' A' ' 114' ' ' LEU . 47.4 p-10 178.26 -160.69 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.709 0.29 . . . . 0.0 111.38 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.913 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 8.1 m-85 -141.87 113.36 7.71 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.726 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.653 HD11 ' O ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -105.33 142.8 25.47 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.593 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.63 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 9.4 Cg_endo -51.01 166.97 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.002 2.468 . . . . 0.0 112.212 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.701 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -40.89 -42.94 4.04 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.701 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 3.6 Cg_endo -45.99 163.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.02 1.814 . . . . 0.0 110.328 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.831 ' HE2' HD22 ' A' ' 52' ' ' LEU . 43.6 t80 -169.93 -95.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.947 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.6 p30 44.27 -172.39 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.691 0.281 . . . . 0.0 110.551 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.786 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -67.71 -47.79 78.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.14 0.495 . . . . 0.0 112.069 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 37.3 m-20 -52.29 -54.53 30.28 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.716 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.687 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.4 mm-40 -80.24 -30.11 38.47 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.5 -51.0 7.72 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.2 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.734 ' HA ' HG12 ' A' ' 115' ' ' VAL . 40.6 t -61.47 -32.91 54.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.498 0.666 . . . . 0.0 110.241 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.34 -50.55 73.16 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.818 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.623 HD11 ' OD2' ' A' ' 100' ' ' ASP . 13.6 tp -77.65 -21.17 52.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.443 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.734 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.5 p -79.44 -50.74 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.494 ' N ' HG13 ' A' ' 115' ' ' VAL . 25.5 mt-10 -62.75 -42.45 99.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 110.843 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -63.28 -23.71 67.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.436 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.498 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -73.1 -55.98 5.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.067 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.9 mt -65.47 -31.6 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.13 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.5 t -66.77 -40.18 88.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.956 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -68.41 -24.88 64.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.176 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -72.05 -47.85 48.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.974 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -76.5 -55.28 5.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.213 0.53 . . . . 0.0 111.126 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.874 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.7 0.285 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.52 160.84 26.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.343 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.765 ' HE ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -75.35 0.32 17.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.492 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 85.69 92.92 0.83 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.866 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.765 HD11 ' HE ' ' A' ' 3' ' ' ARG . 2.3 mp -122.19 113.48 38.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.787 0.327 . . . . 0.0 111.357 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.798 HG23 HG13 ' A' ' 50' ' ' VAL . 11.8 p -105.45 131.51 54.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.365 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.824 ' CD1' HG22 ' A' ' 31' ' ' THR . 32.1 m0 -118.1 135.99 53.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.797 0.332 . . . . 0.0 110.764 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -127.19 138.21 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.9 -178.307 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.021 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -125.64 115.73 44.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.66 178.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.911 ' HB2' ' HE2' ' A' ' 81' ' ' MET . 12.5 t0 -170.95 -149.05 0.06 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.802 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -66.05 -3.04 4.69 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.443 ' OD1' ' HD3' ' A' ' 16' ' ' ARG . 2.4 t70 55.15 -141.24 0.87 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.304 0.113 . . . . 0.0 111.304 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 t 36.12 -92.25 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.811 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.2 t -60.47 -50.11 74.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.765 0.317 . . . . 0.0 111.044 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.86 -32.43 55.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 111.3 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.827 ' HA ' HG21 ' A' ' 32' ' ' THR . 11.8 ttt180 -70.98 -59.48 2.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.213 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.434 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 64.7 t90 -47.88 -44.47 29.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 14' ' ' SER . 1.9 t -67.59 -61.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.048 0.452 . . . . 0.0 111.932 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.573 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 37.1 mt -66.72 -25.63 66.62 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.615 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 19.8 pt-20 -66.05 -59.13 4.1 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.56 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.615 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.5 mmt180 -74.54 -59.94 2.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.133 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.01 -51.84 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.598 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.1 tm? -62.71 -31.99 73.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.173 0.511 . . . . 0.0 110.789 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 28' ' ' LEU . . . -65.32 -34.89 79.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.651 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.22 -24.49 67.34 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.452 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.91 -15.6 59.63 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 111.153 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.79 14.0 16.76 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.809 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -127.12 172.51 10.47 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.85 0.825 . . . . 0.0 111.449 179.809 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 6' ' ' VAL . 57.2 m -105.56 113.95 27.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.309 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 35.8 t -107.62 114.43 28.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.172 0.51 . . . . 0.0 111.935 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.824 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -118.12 154.23 32.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.827 HG21 ' HA ' ' A' ' 16' ' ' ARG . 44.7 p -126.35 159.52 32.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.214 0.53 . . . . 0.0 112.12 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.021 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.8 m-85 -134.18 174.05 10.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.921 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -60.4 -53.55 56.23 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -176.654 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -156.88 -32.09 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.885 0.766 . . . . 0.0 112.844 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.739 ' HA3' ' HG ' ' A' ' 65' ' ' LEU . . . 167.79 -51.41 0.23 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.012 -1.089 . . . . 0.0 113.383 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.537 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -56.18 -29.87 61.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.864 0.364 . . . . 0.0 110.837 -179.206 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -62.46 -53.9 48.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.8 HG21 HG22 ' A' ' 9' ' ' VAL . 4.8 t -53.81 -37.59 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.382 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.769 HD21 ' CD1' ' A' ' 65' ' ' LEU . 17.7 mt -54.21 -43.05 70.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.04 0.448 . . . . 0.0 110.441 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.87 -47.15 66.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.993 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.02 -35.02 79.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.197 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.556 HD13 ' CE1' ' A' ' 73' ' ' HIS . 17.3 mt -66.52 -24.5 66.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.883 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.08 -19.06 17.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.961 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.13 -8.95 9.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -149.49 157.34 43.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.396 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.589 HG23 HD23 ' A' ' 76' ' ' LEU . 67.0 m -139.2 112.66 8.05 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.361 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.524 ' CD ' HD21 ' A' ' 43' ' ' LEU . 73.9 Cg_endo -75.56 165.43 30.5 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.143 1.896 . . . . 0.0 111.298 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.85 -25.09 59.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.019 0.437 . . . . 0.0 110.334 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.798 HG13 HG23 ' A' ' 6' ' ' VAL . 6.4 p -145.84 161.99 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.807 ' O ' HD12 ' A' ' 79' ' ' ILE . 19.3 tp -152.83 144.88 23.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.504 0.668 . . . . 0.0 111.623 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.904 HD22 ' CZ ' ' A' ' 106' ' ' PHE . 2.2 mt -127.92 115.26 18.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.687 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -106.87 143.68 34.61 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.561 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 15.6 t0 -73.5 176.84 5.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.734 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.887 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 6.6 tt -153.07 81.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.69 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 172.96 54.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.341 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.429 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.23 -62.5 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.454 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.606 ' HG2' ' HA2' ' A' ' 62' ' ' GLY . 18.9 Cg_endo -56.4 -177.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.672 2.248 . . . . 0.0 112.833 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -50.44 -75.53 0.21 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.59 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.777 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -71.26 59.88 0.28 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 110.462 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.29 -73.57 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.312 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.887 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.77 -35.82 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.083 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.868 ' HA ' HD23 ' A' ' 66' ' ' LEU . 2.8 mp -55.24 -24.11 26.02 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.605 0.241 . . . . 0.0 111.032 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -55.4 -35.86 65.78 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.254 0.549 . . . . 0.0 109.996 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.769 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -58.46 -40.6 83.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.009 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.868 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.4 mm? -57.92 -43.23 86.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -55.25 -45.16 76.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.51 178.901 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -66.22 -34.27 77.65 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.932 0.396 . . . . 0.0 110.423 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.811 HD12 ' HA ' ' A' ' 66' ' ' LEU . 55.9 mt -60.18 -44.67 95.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.597 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -74.72 -21.4 59.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.601 -179.279 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 -35.02 26.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.625 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -100.45 -39.82 7.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.556 ' CE1' HD13 ' A' ' 43' ' ' LEU . 2.1 m80 -102.12 151.79 38.12 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.696 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -96.37 102.3 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.252 2.635 . . . . 0.0 113.027 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.632 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 22.8 mtm 57.0 30.66 18.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.024 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.589 HD23 HG23 ' A' ' 47' ' ' THR . 2.2 tm? -64.99 111.4 5.8 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.527 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.432 ' HD2' HD22 ' A' ' 76' ' ' LEU . 43.8 Cg_exo -57.91 116.31 3.14 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.605 2.203 . . . . 0.0 112.531 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.875 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 1.6 t -116.4 151.01 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.646 0.736 . . . . 0.0 111.994 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.857 ' HB ' HD23 ' A' ' 52' ' ' LEU . 1.9 mp -139.67 119.26 13.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.759 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.63 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 21.8 mm -93.67 150.38 3.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.242 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.911 ' HE2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -82.35 -27.98 31.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.387 -177.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.66 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 18.0 m -133.98 157.35 46.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.567 0.222 . . . . 0.0 110.588 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.618 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -148.94 62.2 1.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.962 0.411 . . . . 0.0 111.326 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.57 -93.98 0.12 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.706 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.46 160.35 22.71 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.078 0.466 . . . . 0.0 112.0 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.511 ' HB2' HD13 ' A' ' 63' ' ' LEU . 3.7 m-20 62.26 15.87 7.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.603 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.606 ' HA ' HD21 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -47.28 -23.46 0.56 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.507 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.31 -48.17 36.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.512 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -64.68 -20.52 66.35 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.582 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -58.72 -33.72 70.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.528 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.609 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.2 t -67.44 -36.92 77.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.582 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.527 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 16.5 m -63.31 -20.12 65.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.241 0.544 . . . . 0.0 109.706 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.751 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.65 -53.75 8.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.751 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.609 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.3 m-85 -59.31 -33.87 71.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.142 0.496 . . . . 0.0 110.675 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.2 pp0? -74.65 -38.02 62.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.051 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.751 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 2.9 pp0? -74.59 -18.31 60.59 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.897 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.0 -6.57 3.44 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.574 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.875 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -58.98 148.93 28.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.067 0.434 . . . . 0.0 111.62 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.509 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 40.8 t80 -78.07 -53.06 7.82 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.717 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.545 ' OD2' HD11 ' A' ' 114' ' ' LEU . 13.4 p30 -179.96 -166.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.328 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.618 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 3.0 m-85 -127.68 141.33 51.64 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.165 0.507 . . . . 0.0 111.402 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.63 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 4.5 tp -102.41 145.91 31.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.541 ' O ' HG23 ' A' ' 82' ' ' THR . 29.2 Cg_endo -68.89 -39.81 7.74 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.032 1.821 . . . . 0.0 112.36 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.686 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER 173.85 -48.77 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.773 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.4 Cg_endo -47.62 163.99 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.887 1.725 . . . . 0.0 109.78 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.904 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 2.5 t80 -166.09 -91.74 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.972 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.538 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.9 p-10 41.76 -174.94 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.997 0.427 . . . . 0.0 110.979 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.954 HG23 HG21 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -67.97 -49.55 67.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.392 0.615 . . . . 0.0 111.396 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.564 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -49.68 -57.77 6.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.974 -179.526 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.713 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.1 mm-40 -76.44 -29.97 57.18 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.569 ' HB3' HD21 ' A' ' 19' ' ' LEU . . . -83.19 -60.38 2.17 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.771 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.954 HG21 HG23 ' A' ' 108' ' ' ILE . 32.6 t -50.93 -33.74 12.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.45 0.643 . . . . 0.0 110.416 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.72 -51.05 71.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.379 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.831 HD23 HG21 ' A' ' 79' ' ' ILE . 9.3 tp -76.82 -20.31 56.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.814 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 112' ' ' VAL . 3.7 p -79.34 -48.77 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.151 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.463 ' N ' HG13 ' A' ' 115' ' ' VAL . 22.8 mt-10 -61.97 -46.75 87.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.853 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.56 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 4.5 ptm180 -64.0 -23.44 67.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.823 0.344 . . . . 0.0 110.701 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.509 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.65 -50.98 21.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.47 -30.93 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.262 0.553 . . . . 0.0 110.783 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.7 m -70.15 -40.85 74.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.838 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -76.77 -25.25 53.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.82 -24.48 24.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.234 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.88 158.95 38.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.971 0.415 . . . . 0.0 110.999 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.905 -179.897 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.6 mtp . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.78 0.324 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.557 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 0.9 OUTLIER -107.64 -40.33 5.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.48 179.719 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.794 ' HG2' HD11 ' A' ' 5' ' ' ILE . 1.6 ptp180 66.54 -25.74 0.11 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.514 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.761 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 101.91 93.29 2.2 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.242 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.794 HD11 ' HG2' ' A' ' 3' ' ' ARG . 5.3 mm -123.63 112.44 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.061 0.457 . . . . 0.0 111.578 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.12 HG11 HD13 ' A' ' 23' ' ' LEU . 2.8 p -115.78 120.89 66.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.86 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.94 ' CD1' HG22 ' A' ' 31' ' ' THR . 29.8 m0 -112.85 142.86 45.02 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.144 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.71 HG21 HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -132.69 144.77 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.261 -178.409 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.038 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -132.08 121.57 46.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.225 178.176 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.5 t0 -176.42 -148.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.284 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.27 -1.77 3.7 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.1 -146.72 0.5 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 121.288 -0.165 . . . . 0.0 110.843 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 14' ' ' SER . 85.5 p 34.06 -93.1 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.836 ' O ' HG23 ' A' ' 18' ' ' VAL . 49.7 p -52.88 -58.07 8.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.257 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.6 mm -60.61 -31.41 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.01 0.433 . . . . 0.0 111.253 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.695 ' HA ' HG21 ' A' ' 32' ' ' THR . 13.5 ttt85 -72.86 -59.51 2.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.82 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.466 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 16.9 t90 -46.99 -43.76 19.63 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -68.39 -62.85 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.806 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.738 ' HG ' HD12 ' A' ' 23' ' ' LEU . 6.1 tp -67.89 -21.77 65.13 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.724 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.0 pt-20 -67.54 -60.06 2.86 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.672 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.555 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -75.02 -47.3 29.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.521 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -54.89 -58.52 7.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.748 0.309 . . . . 0.0 111.772 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.12 HD13 HG11 ' A' ' 6' ' ' VAL . 2.8 mt -59.01 -28.24 66.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -61.77 -36.89 82.36 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.5 -24.99 71.25 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.457 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.652 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.67 -15.57 59.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 110.957 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.76 25.95 7.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.486 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.031 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.44 172.26 11.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.374 0.587 . . . . 0.0 111.401 179.654 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.2 m -104.1 109.46 21.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.22 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.724 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 7.6 t -106.65 110.51 22.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.198 0.523 . . . . 0.0 111.898 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.94 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.3 t -121.26 151.79 39.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.917 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.8 p -124.75 161.09 27.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.288 0.566 . . . . 0.0 112.108 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.038 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.3 m-85 -133.07 174.37 10.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.742 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.596 ' HG2' ' HG3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.66 -51.85 68.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -176.772 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -162.62 -24.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.7 0.682 . . . . 0.0 112.744 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.733 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 163.79 -52.25 0.29 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.387 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -52.68 -33.69 48.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.724 0.297 . . . . 0.0 111.012 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.635 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -61.91 -54.32 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.731 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.859 HG21 ' CG2' ' A' ' 9' ' ' VAL . 2.9 t -54.58 -38.86 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.562 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.615 HD13 ' HB3' ' A' ' 68' ' ' GLN . 24.6 mt -52.26 -44.75 65.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.914 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.2 66.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.177 0.513 . . . . 0.0 111.048 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.46 94.18 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.547 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.622 ' HG ' HG12 ' A' ' 39' ' ' VAL . 21.7 mt -59.13 -26.48 64.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.473 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.48 -14.8 8.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.293 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.41 -9.51 10.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.98 165.16 32.54 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.087 0.47 . . . . 0.0 111.829 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.625 ' CG2' HD23 ' A' ' 76' ' ' LEU . 91.0 m -138.3 118.31 9.92 Favored Pre-proline 0 N--CA 1.452 -0.353 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.898 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.619 ' O ' HD21 ' A' ' 76' ' ' LEU . 73.6 Cg_endo -75.63 157.03 40.29 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.526 2.151 . . . . 0.0 111.991 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -73.76 -28.16 61.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 0.0 110.725 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.813 HG21 HG23 ' A' ' 115' ' ' VAL . 7.3 p -145.23 99.61 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.768 ' O ' HD12 ' A' ' 79' ' ' ILE . 63.7 tp -87.15 145.61 26.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.48 0.657 . . . . 0.0 112.184 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.858 HD23 ' HB ' ' A' ' 79' ' ' ILE . 5.1 mt -132.85 114.43 14.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.801 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -111.3 149.95 30.36 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.287 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 18.5 t0 -80.14 -178.18 6.42 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.695 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.808 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 2.6 tt -159.92 73.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.588 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 177.56 63.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.94 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.485 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 3.1 tpp -163.5 -62.36 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.596 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 19.6 Cg_endo -59.49 -178.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.544 2.162 . . . . 0.0 113.03 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.81 -66.25 2.89 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.54 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.3 OUTLIER -72.97 54.62 0.38 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.52 -75.8 0.01 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.838 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.808 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -145.12 -32.74 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.761 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.685 HD22 ' O ' ' A' ' 86' ' ' ASP . 1.4 mp -61.98 -16.46 51.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.503 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.526 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -54.59 -35.26 63.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.316 0.579 . . . . 0.0 109.72 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.733 HD13 ' HA3' ' A' ' 36' ' ' GLY . 7.7 mt -63.6 -38.78 92.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.745 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.867 ' HA ' HD12 ' A' ' 69' ' ' ILE . 7.4 mp -52.35 -47.47 66.07 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 1.5 ttmp? -51.79 -43.39 63.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.701 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.615 ' HB3' HD13 ' A' ' 40' ' ' LEU . 12.1 mm-40 -65.62 -35.75 81.72 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.613 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.921 HG23 ' CE1' ' A' ' 73' ' ' HIS . 82.3 mt -63.06 -44.95 99.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.188 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 3.9 pttt -65.8 -23.67 66.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.187 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -28.32 41.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.297 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -112.31 -71.73 0.74 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.796 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.921 ' CE1' HG23 ' A' ' 69' ' ' ILE . 6.1 p80 -112.38 66.3 0.83 Allowed Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.494 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.572 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 25.8 Cg_endo -63.33 -31.99 72.88 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 113.576 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.538 ' HA ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -88.89 -19.81 25.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.51 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.926 HD22 ' HD2' ' A' ' 77' ' ' PRO . 3.1 tm? -62.83 118.44 42.0 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.619 0.247 . . . . 0.0 111.42 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.926 ' HD2' HD22 ' A' ' 76' ' ' LEU . 52.7 Cg_exo -54.15 115.88 2.67 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.722 2.281 . . . . 0.0 113.087 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.789 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -113.98 142.39 26.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.015 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.858 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.1 mt -130.12 115.85 34.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.943 0.402 . . . . 0.0 110.55 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.687 HG22 ' H ' ' A' ' 82' ' ' THR . 25.1 mm -93.85 145.74 7.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.466 ' HE2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -78.72 -19.92 51.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.028 -179.11 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.687 ' H ' HG22 ' A' ' 80' ' ' ILE . 6.0 m -147.65 157.54 43.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.006 ' HB1' HD23 ' A' ' 87' ' ' LEU . . . -133.48 50.69 2.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.996 0.427 . . . . 0.0 111.166 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.56 -176.14 3.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.956 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.1 t 71.25 -76.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.423 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.685 ' O ' HD22 ' A' ' 63' ' ' LEU . 7.6 m-20 -139.08 77.52 1.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.841 0.353 . . . . 0.0 111.121 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 1.006 HD23 ' HB1' ' A' ' 83' ' ' ALA . 3.4 tm? -52.19 -21.8 3.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.62 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.06 -56.63 8.46 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.34 -24.26 67.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.7 ' HB3' HD22 ' A' ' 87' ' ' LEU . . . -57.84 -63.07 1.37 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.82 0.343 . . . . 0.0 111.825 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.404 HG13 ' HE2' ' A' ' 94' ' ' TYR . 11.6 t -56.57 -38.45 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.921 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.417 ' HA ' ' HB3' ' A' ' 95' ' ' GLN . 1.4 m -60.48 -33.53 72.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.744 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.734 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -68.12 -46.66 70.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.202 0.525 . . . . 0.0 111.118 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.633 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -75.83 -23.74 55.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.873 178.676 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -74.48 -33.67 62.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.939 178.802 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 93' ' ' ALA . 15.2 pt20 -82.56 -18.47 41.29 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.442 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 75' ' ' MET . . . 161.94 -25.39 0.24 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.292 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.789 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -60.42 162.67 5.96 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.679 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 100' ' ' ASP . 28.4 t80 -74.57 -54.04 8.25 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.4 t0 170.5 -157.48 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.831 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.0 m-85 -129.14 123.01 31.05 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.464 ' HB2' HD22 ' A' ' 114' ' ' LEU . 3.8 tp -104.45 137.79 19.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.144 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.454 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 69.5 Cg_exo -50.81 168.57 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.293 1.995 . . . . 0.0 111.847 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.672 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -44.07 -44.11 16.44 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.36 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 4.4 Cg_endo -47.4 163.48 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.645 1.563 . . . . 0.0 110.466 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.694 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 9.4 t80 -166.66 -94.36 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.679 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 43.01 -174.07 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.796 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -67.55 -47.32 80.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.289 0.566 . . . . 0.0 111.557 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -51.98 -56.02 16.85 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.966 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.7 mm-40 -79.49 -28.35 41.47 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.24 -53.8 5.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.018 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.713 ' HA ' HG12 ' A' ' 115' ' ' VAL . 42.8 t -58.63 -31.92 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 121.417 0.627 . . . . 0.0 110.221 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.17 -53.54 56.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.461 178.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.746 HD23 HG21 ' A' ' 79' ' ' ILE . 8.5 tp -75.19 -20.5 59.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.095 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.813 HG23 HG21 ' A' ' 50' ' ' VAL . 5.3 p -79.23 -49.76 19.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.504 ' N ' HG13 ' A' ' 115' ' ' VAL . 16.2 mt-10 -68.59 -38.87 81.0 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.944 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.614 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 4.4 ptp85 -66.15 -26.13 67.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.063 0.459 . . . . 0.0 110.649 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.451 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.49 -51.44 23.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.025 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -64.9 -31.48 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.146 0.498 . . . . 0.0 110.787 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.7 m -71.59 -42.56 67.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.746 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -30.37 69.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.788 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -74.08 -47.76 34.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.553 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -76.57 159.33 30.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.878 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.672 0.272 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 56.99 169.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.96 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.735 ' HB3' HD11 ' A' ' 5' ' ' ILE . 2.0 tpm_? -63.57 -22.1 66.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.798 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 56.78 76.29 0.21 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.818 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.735 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.4 mp -111.51 114.46 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.698 0.285 . . . . 0.0 110.985 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.996 HG11 HD13 ' A' ' 23' ' ' LEU . 7.7 p -105.53 116.11 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.248 179.314 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.838 ' CD1' HG22 ' A' ' 31' ' ' THR . 33.2 m0 -109.05 149.63 29.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.801 0.334 . . . . 0.0 111.35 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.679 HG21 HD23 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -139.5 148.51 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.548 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.9 HG22 HG21 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -134.18 118.37 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.139 177.435 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.3 t0 -173.64 -151.97 0.05 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.123 -179.356 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.34 -2.63 4.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.131 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 58.19 -137.73 0.88 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.009 178.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.9 p 34.74 -104.86 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.89 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -54.12 -42.73 69.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.567 0.223 . . . . 0.0 111.468 -179.178 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.8 mm -65.24 -36.26 77.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.063 0.458 . . . . 0.0 111.252 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.713 ' HA ' HG21 ' A' ' 32' ' ' THR . 26.4 ttt-85 -70.72 -56.31 6.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.829 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.461 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 69.9 t90 -48.81 -43.87 38.65 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 14' ' ' SER . 1.6 t -67.2 -59.83 3.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.843 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.732 ' HG ' HD12 ' A' ' 23' ' ' LEU . 7.1 tp -70.93 -22.58 62.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.361 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.601 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 11.1 pt-20 -66.59 -60.12 3.0 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.435 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.588 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.6 mmt180 -74.9 -51.0 14.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.052 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.485 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -51.01 -58.7 5.39 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.032 HD22 HD13 ' A' ' 28' ' ' LEU . 1.8 mt -59.7 -28.93 67.74 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -61.33 -37.4 83.14 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.345 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.52 -24.91 69.77 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.672 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.79 -15.52 59.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.693 0.282 . . . . 0.0 111.0 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.1 24.02 7.83 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.503 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.032 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.29 169.77 13.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 111.371 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.2 m -104.52 105.68 15.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.086 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.758 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 18.0 t -101.69 112.75 25.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.198 0.523 . . . . 0.0 111.992 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.838 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -122.13 152.95 39.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.18 178.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.713 HG21 ' HA ' ' A' ' 16' ' ' ARG . 38.1 p -126.74 152.5 46.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.267 0.556 . . . . 0.0 112.259 -179.084 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.883 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -129.21 174.04 9.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.54 -179.903 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.614 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -58.87 -104.65 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.025 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.412 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 5.7 m120 -85.23 -70.76 0.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.751 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -167.26 -31.2 0.02 OUTLIER Glycine 0 C--N 1.318 -0.423 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.203 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.451 ' HA ' HD12 ' A' ' 40' ' ' LEU . 59.1 m-20 -67.06 -31.3 71.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.506 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.7 tm-20 -52.99 -57.64 9.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.424 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.9 HG21 HG22 ' A' ' 9' ' ' VAL . 14.4 t -50.99 -42.71 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.297 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 37' ' ' ASN . 26.1 mt -51.74 -44.58 63.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.96 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.07 -50.37 70.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.913 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.25 70.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.924 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.94 HD13 ' NE2' ' A' ' 73' ' ' HIS . 3.3 mt -67.61 -24.28 65.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.433 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.74 -17.12 3.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.34 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.71 -3.96 7.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -154.89 157.38 37.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.998 0.428 . . . . 0.0 111.372 -179.82 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.549 HG23 HD12 ' A' ' 76' ' ' LEU . 90.7 m -139.33 110.87 7.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.788 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.744 ' HD2' HD11 ' A' ' 76' ' ' LEU . 59.3 Cg_endo -71.73 156.76 56.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.429 2.086 . . . . 0.0 112.011 178.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -75.34 -24.27 57.32 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.304 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.898 HG11 ' CG2' ' A' ' 115' ' ' VAL . 6.7 p -145.02 95.3 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.441 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.72 ' O ' HD12 ' A' ' 79' ' ' ILE . 28.0 tp -86.86 138.29 31.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.264 0.554 . . . . 0.0 111.884 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.796 HD23 ' HB ' ' A' ' 79' ' ' ILE . 4.4 mt -122.89 131.19 53.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.06 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.738 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -131.27 148.03 52.65 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.931 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 24.0 t0 -76.35 -164.47 0.4 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.315 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.77 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -170.66 77.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.276 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.408 ' HG2' ' F3 ' ' A' ' 125' ' ' BEF . 4.6 ptm180 179.38 56.41 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.86 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.619 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 12.7 tpt -157.7 -66.27 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.63 ' HG3' HD12 ' A' ' 65' ' ' LEU . 18.2 Cg_endo -58.06 -166.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.279 1.986 . . . . 0.0 112.877 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.84 -57.66 13.49 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.578 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.703 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -86.12 48.86 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.596 0.236 . . . . 0.0 110.831 179.808 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.521 ' HB3' HG13 ' A' ' 55' ' ' ILE . 0.3 OUTLIER 53.76 -83.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.991 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.77 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.84 -17.17 0.56 Allowed Glycine 0 CA--C 1.511 -0.161 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.032 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.914 HD13 ' OH ' ' A' ' 101' ' ' TYR . 1.8 tp -75.15 -12.89 60.4 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.192 0.52 . . . . 0.0 109.997 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.703 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -66.57 -64.87 0.76 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.5 178.53 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.883 HD22 ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -53.16 -22.94 7.18 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.856 179.834 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.883 ' N ' HD22 ' A' ' 65' ' ' LEU . 2.6 tp -62.19 -46.48 88.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.652 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 10.8 mtpp -55.62 -39.85 71.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.448 177.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.439 ' CG ' ' HA ' ' A' ' 65' ' ' LEU . 6.0 mm-40 -60.77 -33.23 72.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.038 178.816 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.008 HG23 ' ND1' ' A' ' 73' ' ' HIS . 96.3 mt -59.32 -48.09 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.873 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.652 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.25 -29.69 70.78 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.97 0.414 . . . . 0.0 110.749 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.482 ' HG3' ' HD2' ' A' ' 70' ' ' LYS . 7.8 mt-30 -80.87 -31.02 35.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.684 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.7 -56.82 3.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.619 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 1.008 ' ND1' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -91.04 157.3 43.25 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.385 -179.624 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.8 -59.14 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.446 2.097 . . . . 0.0 112.44 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.7 mtt -156.8 28.98 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.128 0.489 . . . . 0.0 110.428 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.744 HD11 ' HD2' ' A' ' 48' ' ' PRO . 1.8 tt -55.85 112.24 4.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.411 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 31.7 Cg_exo -62.63 114.54 2.43 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 121.836 1.691 . . . . 0.0 112.277 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.957 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -99.54 150.9 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.605 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.81 HG21 ' CD2' ' A' ' 114' ' ' LEU . 1.9 mp -133.74 115.44 21.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.82 0.343 . . . . 0.0 110.594 179.65 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.714 HG22 ' H ' ' A' ' 82' ' ' THR . 45.3 mm -97.25 149.32 5.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.223 0.535 . . . . 0.0 112.408 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.514 ' O ' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -82.07 -21.81 36.65 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.9 -178.746 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.737 ' O ' HG21 ' A' ' 55' ' ' ILE . 2.7 m -148.1 139.54 23.6 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.808 -0.558 . . . . 0.0 111.291 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.92 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -115.7 41.46 2.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.717 0.294 . . . . 0.0 111.583 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -81.18 54.47 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 0.0 110.831 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.9 p -159.19 -166.59 1.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.63 ' O ' HD23 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -61.35 85.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mt -49.13 -22.53 0.98 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.137 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -47.89 -45.93 31.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.889 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . . . -72.05 -19.43 61.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.477 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' HA ' HD11 ' A' ' 63' ' ' LEU . . . -75.64 -46.18 32.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.341 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.768 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 12.1 t -68.19 -38.36 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.501 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.5 p -69.93 -23.4 63.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.977 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.611 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -63.86 -42.82 97.46 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.235 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.768 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 1.1 m-85 -63.75 -27.65 69.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.456 178.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.86 -34.85 62.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.381 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.635 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 1.1 pt20 -98.67 -5.22 32.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.608 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 130.89 80.24 0.21 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.135 -179.453 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.957 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.56 134.87 1.86 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.188 0.518 . . . . 0.0 111.384 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 32.7 t80 -75.79 -54.2 7.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.727 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER 171.99 -164.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 0.0 111.449 -179.134 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.92 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 2.9 m-85 -125.89 119.92 29.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.989 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.643 HD23 ' CD2' ' A' ' 106' ' ' PHE . 4.3 tp -102.56 136.71 19.3 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.735 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 10.0 Cg_endo -49.22 167.88 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.664 2.243 . . . . 0.0 111.641 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -41.45 -49.93 9.2 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 111.369 0.137 . . . . 0.0 111.369 -178.747 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.735 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 71.0 Cg_exo -47.36 162.94 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.574 1.516 . . . . 0.0 110.028 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.74 ' HD1' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -175.3 -85.54 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.39 -178.419 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.3 p30 42.66 -168.41 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.781 HD13 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.78 -47.24 80.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.268 0.556 . . . . 0.0 111.489 -179.887 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 5.0 t0 -51.75 -57.55 8.94 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.911 -179.321 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 17.8 mm-40 -78.98 -27.77 43.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.016 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.74 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.34 -54.76 4.56 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.826 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.751 HG21 HG23 ' A' ' 108' ' ' ILE . 39.2 t -56.49 -32.17 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.523 0.677 . . . . 0.0 110.023 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.55 -52.42 65.24 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.499 178.293 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.81 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.4 tp -74.51 -21.49 59.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.789 -178.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.898 ' CG2' HG11 ' A' ' 50' ' ' VAL . 7.2 p -79.27 -51.86 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 120.376 -0.529 . . . . 0.0 112.019 -179.317 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.544 ' N ' HG13 ' A' ' 115' ' ' VAL . 20.2 mt-10 -64.53 -46.34 83.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.527 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -62.56 -27.65 69.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 114' ' ' LEU . . . -71.47 -54.66 9.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.219 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.62 -32.12 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.216 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 116' ' ' GLU . 0.4 OUTLIER -69.13 -40.52 78.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.829 179.861 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -57.83 -27.27 63.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.967 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -84.43 -52.7 5.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.736 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -76.57 173.16 11.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.757 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 179.858 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 125' ' ' BEF . . . . . 0.408 ' F3 ' ' HG2' ' A' ' 56' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.645 0.259 . . . . 0.0 111.492 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -123.65 -18.51 6.09 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.421 ' O ' ' OD2' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -73.37 47.99 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.307 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.745 ' C ' HD13 ' A' ' 5' ' ' ILE . . . -68.62 81.59 0.22 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 178.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.745 HD13 ' C ' ' A' ' 4' ' ' GLY . 2.2 mm -114.54 117.84 56.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.078 0.466 . . . . 0.0 112.133 -178.341 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.058 HG11 HD13 ' A' ' 23' ' ' LEU . 2.6 p -106.11 123.94 61.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.698 177.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.972 ' CD1' HG22 ' A' ' 31' ' ' THR . 38.1 m0 -115.62 141.54 47.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.736 HG13 HD13 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -128.72 135.24 62.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.384 0.611 . . . . 0.0 111.934 -178.416 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.076 HG12 ' H ' ' A' ' 54' ' ' ASP . 1.5 t -123.53 108.17 20.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.06 179.172 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.548 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 14.0 t70 -161.66 -149.92 0.18 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.408 -179.071 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.518 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 2.8 m-20 -66.32 -3.08 5.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.574 0.226 . . . . 0.0 111.595 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.8 t70 61.29 -144.8 0.45 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.392 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t 32.74 -90.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.846 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.0 m -55.87 -52.36 64.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.749 0.309 . . . . 0.0 111.21 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.1 mm -63.79 -31.65 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 111.173 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.71 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.6 ttm180 -73.09 -54.59 8.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.677 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.539 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 44.4 t90 -51.3 -42.87 61.47 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.888 HG12 HD13 ' A' ' 108' ' ' ILE . 2.1 t -68.17 -63.11 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.058 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.744 ' HA ' HD11 ' A' ' 108' ' ' ILE . 9.1 mt -65.86 -22.05 66.51 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.095 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.659 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.51 -56.91 7.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.219 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.535 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -77.87 -47.18 19.36 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.612 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.484 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -56.84 -58.07 9.72 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.752 0.311 . . . . 0.0 111.725 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.058 HD13 HG11 ' A' ' 6' ' ' VAL . 2.0 mt -61.29 -29.43 69.86 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -60.98 -34.15 74.32 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.426 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.59 -24.95 74.0 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.442 178.442 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.88 -15.56 59.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.726 179.645 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.82 25.15 7.73 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.817 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.011 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.21 170.4 11.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.267 0.534 . . . . 0.0 111.455 179.611 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.491 ' HB ' HG23 ' A' ' 5' ' ' ILE . 52.7 m -103.74 106.14 16.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.49 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.755 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.2 t -104.23 112.46 25.49 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.972 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -122.83 156.67 34.09 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.307 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 36.3 p -127.21 157.88 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.305 -178.392 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.847 ' HB2' HG22 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -135.92 171.49 14.38 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.81 -179.683 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.813 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -64.28 -49.68 70.87 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.017 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.813 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -162.79 167.06 23.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -178.402 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.679 ' N ' HG11 ' A' ' 9' ' ' VAL . . . -42.85 -27.79 0.61 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.382 -0.914 . . . . 0.0 112.735 -178.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.496 ' N ' HD12 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -64.09 -47.8 78.62 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.708 0.289 . . . . 0.0 110.753 179.371 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.671 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -51.82 -52.19 51.04 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.046 179.527 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.841 HG23 HG21 ' A' ' 9' ' ' VAL . 32.0 t -48.69 -40.97 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.025 0.44 . . . . 0.0 110.935 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.667 HD13 ' HB3' ' A' ' 68' ' ' GLN . 17.7 mt -50.17 -48.22 54.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.61 -48.95 75.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.487 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.52 -41.08 96.61 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.906 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.637 HD21 ' CD ' ' A' ' 48' ' ' PRO . 29.4 mt -61.2 -20.82 63.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.02 -14.45 3.7 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.63 -179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.69 -6.89 6.82 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.547 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.604 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.19 166.89 20.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.883 0.373 . . . . 0.0 111.801 -179.46 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.522 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 57.6 m -139.02 122.1 10.73 Favored Pre-proline 0 N--CA 1.454 -0.228 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.436 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.682 ' HD2' HD11 ' A' ' 76' ' ' LEU . 98.4 Cg_endo -79.46 155.35 24.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.304 2.003 . . . . 0.0 111.491 178.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 3' ' ' ARG . 77.3 m-20 -75.34 -25.76 58.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.716 -179.32 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.911 HG11 ' CG2' ' A' ' 115' ' ' VAL . 3.8 p -145.69 91.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 39' ' ' VAL . 32.5 tp -87.12 144.49 26.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.228 -179.376 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.839 HD23 ' HB ' ' A' ' 79' ' ' ILE . 2.1 mt -125.95 137.5 53.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.934 178.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.712 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -133.57 135.61 44.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -178.197 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 1.076 ' H ' HG12 ' A' ' 9' ' ' VAL . 15.5 t0 -66.88 174.89 2.71 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.937 178.565 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.755 HG13 ' N ' ' A' ' 62' ' ' GLY . 6.8 tt -152.47 77.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.495 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER 176.67 65.7 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.188 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.634 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 1.6 ttt -158.46 -67.73 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 59.3 Cg_endo -70.18 -163.07 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.554 2.169 . . . . 0.0 113.035 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.62 -60.6 7.54 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.211 -179.753 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.905 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 1.8 mtp -84.39 45.36 1.11 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.839 0.32 . . . . 0.0 111.594 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.592 ' HB3' HG13 ' A' ' 55' ' ' ILE . 1.2 m-20 50.98 -75.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.366 179.154 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.755 ' N ' HG13 ' A' ' 55' ' ' ILE . . . -139.09 -33.17 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.386 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.761 HD22 ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -56.75 -22.82 38.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.737 0.303 . . . . 0.0 110.324 -179.862 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.905 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -63.19 -39.25 94.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.217 0.532 . . . . 0.0 110.291 178.203 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.652 HD23 ' HA2' ' A' ' 62' ' ' GLY . 2.3 mm? -59.52 -37.44 78.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.39 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.826 ' HA ' HD12 ' A' ' 69' ' ' ILE . 3.0 mm? -59.75 -42.85 94.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.81 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.611 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 2.5 tttt -56.3 -44.45 79.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.655 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.667 ' HB3' HD13 ' A' ' 40' ' ' LEU . 3.0 mt-30 -63.52 -39.46 94.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.161 0.505 . . . . 0.0 111.142 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.826 HD12 ' HA ' ' A' ' 66' ' ' LEU . 58.4 mt -57.43 -51.43 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.679 -178.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.74 -23.6 67.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.401 -179.829 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -49.72 70.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.191 -178.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -99.35 -20.54 16.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.401 -178.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.415 ' CE1' ' CD1' ' A' ' 43' ' ' LEU . 1.9 m80 -116.5 146.7 38.08 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.856 0.36 . . . . 0.0 111.152 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.85 -75.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.48 2.12 . . . . 0.0 112.74 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 38.3 mtp -149.54 57.69 1.0 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.058 0.456 . . . . 0.0 111.072 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.682 HD11 ' HD2' ' A' ' 48' ' ' PRO . 2.0 tt -66.88 118.49 55.55 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.717 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.529 ' N ' HD23 ' A' ' 76' ' ' LEU . 32.3 Cg_exo -58.61 115.34 2.47 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.552 1.501 . . . . 0.0 111.929 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.012 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -111.27 150.09 13.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.143 179.522 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.839 ' HB ' HD23 ' A' ' 52' ' ' LEU . 2.8 mt -136.83 115.39 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.997 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 53' ' ' SER . 14.2 mm -93.09 150.91 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 111.693 -178.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.738 ' HE3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -78.98 -27.01 43.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.195 -178.348 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 103' ' ' PRO . 2.8 m -143.29 170.7 15.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.883 ' HB1' HD21 ' A' ' 87' ' ' LEU . . . -127.61 45.57 2.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.675 ' O ' HD11 ' A' ' 63' ' ' LEU . 47.3 m-70 -69.34 -174.77 0.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 111.135 179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 86' ' ' ASP . 48.1 t 50.67 -165.34 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.879 179.241 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.761 ' O ' HD22 ' A' ' 63' ' ' LEU . 19.3 p-10 -59.49 101.26 0.1 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.798 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.883 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -55.9 -21.87 22.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.082 178.971 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -48.14 -45.9 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.28 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.604 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.69 -19.27 65.15 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.461 -179.349 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.737 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -65.45 -53.99 34.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.086 0.469 . . . . 0.0 110.329 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.567 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.7 t -62.27 -39.83 85.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.561 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.648 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 83.5 p -63.55 -15.03 56.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.941 178.651 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -75.77 -57.76 3.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.187 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.701 ' N ' ' HB3' ' A' ' 98' ' ' ALA . 3.3 m-85 -52.48 -34.15 47.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.134 -179.276 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.648 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -75.61 -33.5 60.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.012 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.495 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 10.0 pt20 -99.01 3.13 46.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.38 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.537 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 125.08 81.9 0.48 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.575 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.012 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.54 132.85 1.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.153 0.501 . . . . 0.0 111.723 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.425 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 74.8 t80 -75.08 -53.52 8.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.531 -179.165 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.611 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -178.49 -166.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.143 0.497 . . . . 0.0 111.821 -179.556 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.511 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 2.4 m-85 -125.79 140.4 52.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.322 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.714 HD23 ' HD1' ' A' ' 106' ' ' PHE . 5.3 tp -101.89 150.43 37.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.778 ' O ' HG23 ' A' ' 82' ' ' THR . 16.5 Cg_exo -69.08 -43.15 3.42 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.302 2.001 . . . . 0.0 111.533 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.523 ' HE2' ' HB2' ' A' ' 81' ' ' MET . 0.0 OUTLIER 172.81 -46.96 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.479 178.963 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 104' ' ' LYS . 75.9 Cg_exo -47.72 164.59 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.905 1.737 . . . . 0.0 109.614 178.081 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.797 ' CE1' HD22 ' A' ' 52' ' ' LEU . 6.0 t80 -166.18 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.133 -177.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 3.7 p30 44.26 -172.08 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.881 0.372 . . . . 0.0 110.611 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.888 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -68.1 -50.63 56.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.155 0.502 . . . . 0.0 111.994 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.594 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -50.4 -54.35 22.47 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.943 -178.504 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.69 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.2 mm-40 -80.02 -30.62 39.56 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.228 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.85 -51.47 7.16 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.962 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.692 ' HA ' HG12 ' A' ' 115' ' ' VAL . 41.5 t -60.3 -31.97 49.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.388 0.613 . . . . 0.0 110.379 179.231 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.75 -51.82 68.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.742 0.782 . . . . 0.0 109.409 178.346 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.751 ' CD2' HG21 ' A' ' 79' ' ' ILE . 6.5 tp -75.26 -20.78 59.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.873 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.911 ' CG2' HG11 ' A' ' 50' ' ' VAL . 6.0 p -78.78 -51.64 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.217 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.546 ' N ' HG13 ' A' ' 115' ' ' VAL . 40.5 mt-10 -68.53 -40.88 80.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.783 0.325 . . . . 0.0 110.537 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -66.56 -26.83 67.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.528 179.46 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 114' ' ' LEU . . . -71.62 -55.04 8.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.956 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -66.43 -31.37 53.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.054 0.454 . . . . 0.0 110.79 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.3 t -67.78 -44.03 78.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.969 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.04 -24.28 65.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.11 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.48 -40.52 77.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.028 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -75.87 -174.57 2.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.793 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.783 0.325 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.655 ' O ' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -126.6 175.84 7.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.866 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 72.75 2.85 4.51 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.725 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.01 102.94 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.938 179.596 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.655 HD11 ' O ' ' A' ' 2' ' ' GLN . 3.1 mp -121.85 112.72 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.031 0.443 . . . . 0.0 110.898 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.121 HG11 HD13 ' A' ' 23' ' ' LEU . 8.9 p -113.73 126.05 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.886 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 1.096 ' CD1' HG22 ' A' ' 31' ' ' THR . 54.4 m0 -118.13 138.03 52.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.823 0.344 . . . . 0.0 110.801 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -123.61 119.21 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.895 -178.302 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.041 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -104.46 104.53 16.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.615 0.245 . . . . 0.0 110.357 179.212 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 63.9 t0 166.78 119.18 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.905 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.424 ' CB ' HG12 ' A' ' 15' ' ' ILE . 1.0 OUTLIER 73.84 -22.24 0.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 178.902 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 73.3 -140.97 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.532 -0.105 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.0 t -31.69 -44.15 0.07 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.202 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.559 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -53.16 -69.56 0.11 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.695 -179.608 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 24.0 mm -60.4 -20.3 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.718 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 35.0 ttp180 -73.27 -61.81 1.69 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.781 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.58 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 80.5 t90 -47.64 -48.03 28.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.111 -178.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.604 HG12 HD13 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -64.6 -61.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.113 0.482 . . . . 0.0 111.971 -179.023 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.783 HD21 ' HB3' ' A' ' 111' ' ' ALA . 31.8 mt -68.65 -22.09 64.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.957 -177.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.609 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 17.8 pt-20 -66.57 -57.75 6.62 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.495 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -59.11 -51.15 71.28 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.664 -179.587 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.415 ' CB ' HG13 ' A' ' 108' ' ' ILE . . . -58.29 -51.96 67.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 0.0 111.796 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.121 HD13 HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -67.24 -22.64 65.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.388 179.79 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.93 -34.84 78.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.027 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.65 -28.23 65.06 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.002 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.617 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.69 -15.48 59.78 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.895 0.378 . . . . 0.0 110.503 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.16 24.21 17.48 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.973 -0.632 . . . . 0.0 114.316 178.62 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.852 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -121.95 159.89 25.98 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 117.961 0.88 . . . . 0.0 112.751 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.571 ' HB ' HG23 ' A' ' 5' ' ' ILE . 55.2 m -81.0 126.77 31.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.431 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.609 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -116.75 108.03 15.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.154 -178.482 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 31' ' ' THR . . . . . 1.096 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -130.29 141.84 50.58 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.151 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 65.0 p -115.86 162.53 17.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.574 0.702 . . . . 0.0 112.823 -178.391 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.041 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.6 m-85 -135.85 173.51 11.63 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.491 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.7 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -62.91 -59.45 4.83 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -177.004 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.455 ' C ' HD13 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -151.22 -60.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.08 -178.729 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.641 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . -152.44 -55.75 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.579 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.557 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -54.35 -29.59 48.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.991 0.395 . . . . 0.0 111.009 -179.216 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.846 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -62.19 -60.74 3.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.668 179.348 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.701 HG21 HG21 ' A' ' 9' ' ' VAL . 22.0 t -48.8 -42.65 13.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.272 179.311 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.63 HD13 ' HB3' ' A' ' 68' ' ' GLN . 38.6 mt -45.64 -46.58 14.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.033 0.444 . . . . 0.0 110.455 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.95 -47.39 80.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.537 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB2' ' HE2' ' A' ' 33' ' ' PHE . . . -67.83 -41.26 83.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.991 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.589 HD13 HG23 ' A' ' 69' ' ' ILE . 19.4 mt -66.32 -29.29 69.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.19 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.04 -19.99 55.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.201 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 t -123.42 0.62 8.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.638 ' CG ' ' HH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -164.65 165.62 20.81 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.116 0.484 . . . . 0.0 111.062 -179.916 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.948 HG23 HD23 ' A' ' 76' ' ' LEU . 54.1 m -138.5 114.52 8.85 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.498 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.582 ' O ' HD21 ' A' ' 76' ' ' LEU . 91.0 Cg_endo -77.58 164.54 28.22 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.1 1.866 . . . . 0.0 111.978 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.552 ' OD1' HD12 ' A' ' 5' ' ' ILE . 7.2 m-20 -78.01 -31.15 50.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 110.401 179.777 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.646 HG13 HG23 ' A' ' 6' ' ' VAL . 3.4 p -145.22 149.05 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.532 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.855 HD12 ' HB2' ' A' ' 7' ' ' TRP . 0.6 OUTLIER -152.97 145.59 24.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.321 0.582 . . . . 0.0 112.31 -178.18 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.794 HD22 ' CZ ' ' A' ' 106' ' ' PHE . 1.2 mt -123.87 122.07 37.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.285 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -111.55 150.45 29.99 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.776 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.503 ' HA ' ' SD ' ' A' ' 81' ' ' MET . 15.8 t0 -77.48 169.72 17.82 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.465 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.662 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.5 tt -144.02 165.94 13.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.369 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 65.21 65.08 0.59 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.674 0.75 . . . . 0.0 111.297 -179.366 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.659 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -158.01 -63.02 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.685 179.293 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 68.7 Cg_endo -69.29 -157.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.505 2.136 . . . . 0.0 112.33 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.5 -72.94 0.6 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.069 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.799 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 1.5 ttt -71.22 57.51 0.23 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.916 0.388 . . . . 0.0 111.16 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.542 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 56.45 -77.58 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.537 -179.592 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.662 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.46 -31.27 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.389 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.86 ' HA ' HD23 ' A' ' 66' ' ' LEU . 1.7 mp -62.29 -17.1 57.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.745 0.307 . . . . 0.0 110.613 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.799 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -59.71 -37.98 80.38 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.014 0.435 . . . . 0.0 110.13 178.752 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.641 HD13 ' HA3' ' A' ' 36' ' ' GLY . 30.3 mt -61.26 -39.08 89.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.861 HD21 HD11 ' A' ' 80' ' ' ILE . 4.0 mm? -55.47 -43.51 75.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.142 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.656 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 23.6 ttmm -57.97 -42.51 85.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.768 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.63 ' HB3' HD13 ' A' ' 40' ' ' LEU . 3.2 mt-30 -65.51 -41.37 93.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.059 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.988 HG22 ' CD2' ' A' ' 73' ' ' HIS . 36.6 mt -57.25 -50.36 76.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.634 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.27 -24.01 67.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.254 -179.532 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -23.13 66.08 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.861 -0.335 . . . . 0.0 111.053 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -108.35 -20.18 13.22 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.988 ' CD2' HG22 ' A' ' 69' ' ' ILE . 6.2 p80 -113.64 166.99 10.11 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 112.106 -179.093 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 94.0 Cg_endo -88.27 -47.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.216 2.611 . . . . 0.0 111.837 178.641 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.613 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.2 mtt -157.45 54.37 0.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.948 HD23 HG23 ' A' ' 47' ' ' THR . 0.7 OUTLIER -76.61 112.6 22.83 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-O 120.62 0.247 . . . . 0.0 110.861 179.819 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.548 ' HD2' HD22 ' A' ' 76' ' ' LEU . 37.6 Cg_endo -66.81 115.47 3.6 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.158 1.906 . . . . 0.0 111.86 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.842 HG13 HD23 ' A' ' 51' ' ' LEU . 2.4 t -109.11 152.34 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.735 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.2 mt -136.09 118.07 20.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.096 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.861 HD11 HD21 ' A' ' 66' ' ' LEU . 15.4 mm -93.61 144.25 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.387 0.613 . . . . 0.0 112.167 -179.199 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.732 ' HE3' ' CZ ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -77.21 -15.99 59.25 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.014 -179.369 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.669 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.5 m -147.79 169.32 20.01 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.213 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -143.94 41.83 1.42 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.771 0.319 . . . . 0.0 111.488 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.527 ' CD2' HG21 ' A' ' 82' ' ' THR . 21.8 m-70 -68.62 113.74 6.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.963 0.411 . . . . 0.0 112.071 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 m 48.58 -177.52 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.925 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' HB2' HD13 ' A' ' 63' ' ' LEU . 6.5 m-20 52.24 26.22 3.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.155 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.795 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -56.14 -22.11 26.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.556 -179.919 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.32 -43.62 43.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.711 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.571 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.19 -23.42 62.96 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.323 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.795 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -64.7 -39.73 94.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.946 0.403 . . . . 0.0 110.492 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.593 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.1 t -69.88 -45.03 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.185 179.47 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.9 m -62.52 -28.89 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.583 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' A' ' 96' ' ' GLN . . . -62.13 -41.85 98.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.492 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.593 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.4 m-85 -61.43 -21.7 64.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.145 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.609 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -72.81 -42.18 64.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.772 -179.907 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.613 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.1 pt20 -77.55 -18.15 57.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.505 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.82 5.07 4.54 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.149 -1.024 . . . . 0.0 114.139 178.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -54.65 152.79 6.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.477 0.638 . . . . 0.0 111.311 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.472 ' HD2' HG12 ' A' ' 79' ' ' ILE . 39.3 t80 -85.7 -53.58 5.06 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.335 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.81 -163.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.18 0.514 . . . . 0.0 111.799 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.591 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.9 m-85 -131.66 122.11 25.42 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.624 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 103' ' ' PRO . 5.8 tp -103.69 141.03 21.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.728 -179.567 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 102' ' ' LEU . 19.6 Cg_endo -57.87 169.89 2.37 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.334 2.023 . . . . 0.0 111.591 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.661 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -44.22 -46.5 23.04 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -179.17 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 2.8 Cg_endo -46.49 163.62 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.826 1.684 . . . . 0.0 110.539 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.794 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 1.0 OUTLIER -166.41 -88.47 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.434 -177.812 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.546 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p-10 42.23 -175.48 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.959 0.409 . . . . 0.0 110.613 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.617 HD12 HD23 ' A' ' 19' ' ' LEU . 1.1 mp -68.01 -47.44 78.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.3 0.571 . . . . 0.0 111.652 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.643 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 68.1 m-20 -54.05 -54.96 32.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.831 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.746 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.9 mm-40 -77.65 -29.43 51.63 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.38 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.783 ' HB3' HD21 ' A' ' 19' ' ' LEU . . . -84.22 -57.34 3.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.015 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.601 HG21 HG23 ' A' ' 108' ' ' ILE . 43.9 t -54.67 -32.17 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.456 0.646 . . . . 0.0 110.142 179.013 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.85 -54.76 42.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.055 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.555 HD23 HG21 ' A' ' 79' ' ' ILE . 32.5 tp -73.33 -20.66 60.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.66 -179.138 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.734 HG21 HD11 ' A' ' 23' ' ' LEU . 2.4 p -79.06 -47.54 22.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.278 -178.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.08 -38.0 84.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.79 0.328 . . . . 0.0 110.462 179.706 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.2 mtt85 -65.04 -24.32 67.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.542 179.429 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.465 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.65 -52.55 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.066 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.7 mt -60.75 -31.49 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.107 0.479 . . . . 0.0 110.659 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.5 m -70.56 -43.5 69.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.704 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -77.29 -28.92 53.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.859 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -75.64 -56.1 5.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.807 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 58.72 171.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.804 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mmt . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.872 0.368 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -152.31 139.55 19.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.504 ' CG ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -59.08 -21.05 58.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.045 179.696 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.554 ' HA3' HD23 ' A' ' 28' ' ' LEU . . . 81.63 106.41 0.37 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.538 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.567 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 2.2 mp -133.34 113.07 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.759 HG23 HG13 ' A' ' 50' ' ' VAL . 7.9 p -111.69 125.54 69.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.868 0.366 . . . . 0.0 111.433 179.204 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.841 ' CD1' HG22 ' A' ' 31' ' ' THR . 19.7 m0 -114.88 129.03 56.62 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.433 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.927 HG21 HD23 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -123.42 144.76 31.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.454 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.029 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -135.32 105.81 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.582 178.31 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.584 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 51.4 t0 167.49 120.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.637 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.431 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 70.86 -32.15 0.24 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.216 179.567 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 13' ' ' SER . 5.0 t70 73.75 -134.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 12' ' ' ASP . 47.6 t -21.0 -58.17 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 18' ' ' VAL . 19.4 m -53.04 -69.52 0.11 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.259 -179.088 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 26.7 mm -60.46 -20.38 20.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.737 ' HA ' HG21 ' A' ' 32' ' ' THR . 47.8 ttt180 -72.35 -61.45 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.861 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.42 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 75.9 t90 -47.46 -42.85 23.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.066 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.714 HG12 HD13 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -67.52 -62.16 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.736 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.927 HD23 HG21 ' A' ' 8' ' ' VAL . 8.6 tp -70.79 -21.6 62.47 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.573 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 22.7 pt-20 -67.47 -56.68 8.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.47 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.573 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 9.5 mmm-85 -68.51 -56.34 8.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.479 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.54 -36.94 64.82 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.693 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.1 tm? -73.7 -27.45 61.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.997 0.427 . . . . 0.0 110.687 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.42 -32.64 72.82 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.59 -25.71 71.66 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.432 178.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.567 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.77 -15.48 59.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.728 0.299 . . . . 0.0 111.135 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.64 25.34 8.69 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.487 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.567 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -134.98 178.27 7.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.632 0.716 . . . . 0.0 111.726 179.849 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' HG12 ' A' ' 6' ' ' VAL . 7.9 m -105.64 128.01 53.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.069 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HA ' HG13 ' A' ' 6' ' ' VAL . 42.6 t -123.11 113.01 18.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.134 0.492 . . . . 0.0 111.953 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.841 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.0 t -119.08 156.03 30.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.253 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.737 HG21 ' HA ' ' A' ' 16' ' ' ARG . 44.9 p -133.91 160.19 38.43 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.092 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.029 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.3 m-85 -135.86 174.16 10.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.421 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.55 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.89 -105.05 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.025 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.414 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 2.6 t-20 -84.57 -61.52 1.77 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.033 0.444 . . . . 0.0 111.978 -178.154 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.805 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -176.64 -37.01 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.074 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.967 ' N ' HD21 ' A' ' 65' ' ' LEU . 9.6 m-80 -60.18 -29.64 68.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.704 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -54.53 -54.8 36.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.424 179.791 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.637 HG21 ' CG2' ' A' ' 9' ' ' VAL . 6.6 t -49.39 -46.01 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.262 0.553 . . . . 0.0 110.907 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.713 HD13 ' HB3' ' A' ' 68' ' ' GLN . 30.3 mt -47.2 -43.46 21.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.306 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.87 82.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.31 0.576 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.22 77.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.1 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.053 HD13 ' CE1' ' A' ' 73' ' ' HIS . 5.3 mt -59.89 -24.46 64.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.201 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.84 -22.31 5.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.698 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.94 8.32 5.22 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.05 163.21 37.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.98 0.419 . . . . 0.0 111.198 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.86 HG23 HD23 ' A' ' 76' ' ' LEU . 77.7 m -138.39 118.56 9.91 Favored Pre-proline 0 N--CA 1.453 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.009 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.658 ' CD ' HD21 ' A' ' 43' ' ' LEU . 56.0 Cg_endo -69.69 154.96 67.36 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.165 1.91 . . . . 0.0 112.292 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB3' ' O ' ' A' ' 5' ' ' ILE . 26.8 t0 -79.38 -32.66 43.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.611 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.759 HG13 HG23 ' A' ' 6' ' ' VAL . 7.3 p -150.47 94.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.625 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.573 HD23 HG22 ' A' ' 78' ' ' VAL . 28.5 tp -84.48 153.84 23.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.042 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.867 HD23 ' HB ' ' A' ' 79' ' ' ILE . 2.7 mt -136.74 114.76 11.45 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.802 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.546 ' HB3' ' CD1' ' A' ' 80' ' ' ILE . 4.9 t -108.95 149.4 29.25 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.566 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.655 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 25.9 t0 -82.99 166.84 18.49 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.381 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.79 HG23 ' HB ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -155.5 108.95 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.994 -179.914 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.47 40.22 0.76 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.375 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.502 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER 66.94 51.06 0.62 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.434 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 62.6 Cg_endo -78.96 -77.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.812 2.341 . . . . 0.0 112.159 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.402 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -109.27 -29.78 3.85 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.815 179.526 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.984 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -152.47 65.78 0.82 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.095 0.474 . . . . 0.0 110.279 179.362 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.536 ' O ' HG12 ' A' ' 55' ' ' ILE . 0.5 OUTLIER 68.74 -22.99 0.14 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.872 179.824 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.638 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 135.24 -31.49 2.68 Favored Glycine 0 CA--C 1.502 -0.757 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.833 ' HA ' HD23 ' A' ' 66' ' ' LEU . 4.7 mp -70.16 -15.47 62.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.984 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.89 -37.98 64.31 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.061 0.458 . . . . 0.0 110.447 178.448 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.967 HD21 ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -58.15 -36.61 73.25 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.926 179.511 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.855 ' HA ' HD12 ' A' ' 69' ' ' ILE . 4.0 mm? -59.34 -43.61 92.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.494 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.568 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 14.0 mttt -52.59 -47.25 67.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.09 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.713 ' HB3' HD13 ' A' ' 40' ' ' LEU . 2.0 mt-30 -61.09 -32.19 71.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.059 179.162 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.855 HD12 ' HA ' ' A' ' 66' ' ' LEU . 10.7 mt -67.97 -41.6 84.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.166 -178.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 9.9 pttt -77.63 -24.88 49.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.955 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -74.25 -43.43 57.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.883 0.373 . . . . 0.0 111.888 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -89.45 -54.59 4.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.132 -179.06 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 1.053 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -89.96 135.49 30.17 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.261 -178.858 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -56.74 -64.84 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.512 2.142 . . . . 0.0 112.667 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.8 mtm -142.01 44.7 1.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.787 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.86 HD23 HG23 ' A' ' 47' ' ' THR . 2.9 tm? -63.01 111.17 4.39 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.037 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.619 ' HD2' HD22 ' A' ' 76' ' ' LEU . 38.7 Cg_exo -58.94 116.29 3.15 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.639 2.226 . . . . 0.0 113.013 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.966 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -118.55 153.29 20.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.68 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.867 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.6 mt -134.14 117.6 25.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.017 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.754 HG22 ' H ' ' A' ' 82' ' ' THR . 26.6 mm -93.57 141.76 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.219 0.533 . . . . 0.0 112.06 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.656 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -84.72 -11.73 55.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.558 -179.147 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.79 ' HB ' HG23 ' A' ' 55' ' ' ILE . 15.3 m -147.47 133.0 18.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.576 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.814 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -125.63 -1.53 7.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 179.702 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -69.32 67.48 0.19 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 0.0 110.256 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.5 m -155.98 -79.09 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.35 -179.34 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.568 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -145.62 79.39 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.68 -179.609 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.648 HD23 ' HB3' ' A' ' 90' ' ' ALA . 4.5 mt -46.12 -21.46 0.15 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.281 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.76 -57.44 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.572 0.225 . . . . 0.0 110.96 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.45 -20.87 62.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 110.87 179.292 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.648 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -69.65 -60.88 2.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.517 ' HA ' ' HD2' ' A' ' 94' ' ' TYR . 21.6 t -60.75 -46.12 96.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.486 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.7 m -56.81 -49.12 76.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.003 0.43 . . . . 0.0 111.246 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.587 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -62.93 -40.3 97.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.143 -179.403 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 1.04 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -71.17 -20.71 62.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.218 179.918 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.587 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.56 -38.68 62.63 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.465 179.174 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.587 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 2.6 pt20 -100.23 -17.43 17.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.323 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.75 66.79 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.496 -1.335 . . . . 0.0 114.081 -179.159 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.04 ' HB3' ' HA ' ' A' ' 94' ' ' TYR . . . -170.48 132.91 1.0 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.592 0.234 . . . . 0.0 110.553 178.572 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 45.2 t80 -62.92 -53.14 58.7 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.504 -178.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 178.23 -161.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 0.0 111.408 -179.306 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.814 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.2 m-85 -127.59 126.82 42.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.557 ' HB2' HD22 ' A' ' 114' ' ' LEU . 6.3 tp -108.03 135.38 19.88 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.81 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.425 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 77.3 Cg_exo -50.03 170.02 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.2 1.933 . . . . 0.0 111.453 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.659 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -44.6 -44.5 20.83 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.296 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 4.8 Cg_endo -47.58 163.4 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.739 1.626 . . . . 0.0 110.942 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.785 ' CE1' HD22 ' A' ' 52' ' ' LEU . 9.8 t80 -165.68 -95.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.717 -178.4 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.2 p-10 44.18 -174.03 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.126 -0.359 . . . . 0.0 110.896 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.898 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -68.02 -47.72 77.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.197 0.523 . . . . 0.0 111.633 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 23.3 t70 -51.15 -57.47 8.65 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.714 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.687 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.3 mm-40 -78.22 -29.44 48.27 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.206 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -82.16 -57.71 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.772 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.898 HG21 HG23 ' A' ' 108' ' ' ILE . 38.5 t -54.06 -32.46 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.467 0.651 . . . . 0.0 110.159 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.46 -51.65 68.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.885 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.836 HD23 HG21 ' A' ' 79' ' ' ILE . 19.3 tp -77.42 -20.55 54.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.791 -178.803 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.609 ' CG2' HG11 ' A' ' 50' ' ' VAL . 4.2 p -76.43 -46.84 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.496 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.421 ' N ' HG13 ' A' ' 115' ' ' VAL . 29.1 mt-10 -63.62 -52.46 60.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.738 0.304 . . . . 0.0 110.537 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 -57.58 -25.89 60.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.05 0.452 . . . . 0.0 110.508 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.436 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.77 -53.87 8.37 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.488 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 115' ' ' VAL . 3.4 mt -68.83 -32.92 56.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.029 0.442 . . . . 0.0 111.112 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.59 -48.53 47.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.32 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -59.32 -25.24 64.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.369 . . . . 0.0 111.124 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -68.92 -50.3 50.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.678 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -76.36 165.44 24.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.835 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 -179.971 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 mtt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 120.994 0.426 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.94 154.07 23.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.1 -179.729 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -153.93 72.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.702 179.449 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.73 ' C ' HD13 ' A' ' 5' ' ' ILE . . . -99.84 99.56 2.08 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.762 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.73 HD13 ' C ' ' A' ' 4' ' ' GLY . 3.5 mm -119.41 112.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.655 0.264 . . . . 0.0 111.56 -179.205 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.85 HG11 ' HG ' ' A' ' 23' ' ' LEU . 8.6 p -106.31 118.04 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.291 178.438 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.826 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.4 m0 -111.92 123.8 51.02 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.685 HG21 HD23 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -117.27 136.19 55.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.301 -177.255 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.946 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -121.55 115.65 47.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.855 178.338 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.677 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 5.0 t70 -169.8 -152.62 0.1 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.113 -178.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.36 6.22 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 14' ' ' SER . 3.9 p30 47.05 -146.5 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t 35.49 -88.58 0.01 OUTLIER 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.803 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.7 m -59.93 -54.48 45.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.68 0.276 . . . . 0.0 111.116 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.9 mm -62.75 -31.75 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.486 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.767 ' HA ' HG21 ' A' ' 32' ' ' THR . 5.9 ttp180 -69.11 -48.96 61.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.564 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.659 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 14.9 t90 -61.63 -58.37 8.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.02 -179.24 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 14' ' ' SER . 1.4 t -55.62 -40.47 59.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.185 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.685 HD23 HG21 ' A' ' 8' ' ' VAL . 5.1 tp -84.32 -24.8 29.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -177.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.659 ' HG2' ' O ' ' A' ' 17' ' ' TRP . 19.7 pt-20 -67.63 -59.63 3.19 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.605 -178.702 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.8 ' HD3' ' H ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -59.35 -65.28 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.138 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.47 -30.64 5.35 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.956 -179.046 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.85 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.8 tm? -78.89 -32.44 45.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.25 0.548 . . . . 0.0 110.276 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.22 73.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.198 178.372 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.16 -26.67 71.65 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.602 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.85 -15.39 59.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.865 0.364 . . . . 0.0 110.684 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.38 25.69 10.78 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.827 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.696 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -131.09 169.07 16.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.621 0.71 . . . . 0.0 111.697 179.771 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.6 m -96.93 116.24 28.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.658 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.632 ' HA ' HG13 ' A' ' 6' ' ' VAL . 51.5 t -110.24 114.61 28.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.395 0.616 . . . . 0.0 111.883 -179.428 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.826 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.0 t -125.26 155.61 39.86 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.519 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.767 HG21 ' HA ' ' A' ' 16' ' ' ARG . 66.9 p -129.08 164.86 22.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.259 0.552 . . . . 0.0 112.116 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.946 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.3 m-85 -136.43 174.57 10.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.799 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.618 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.1 pp20? -59.3 -55.68 31.73 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -177.718 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.431 ' O ' HD11 ' A' ' 65' ' ' LEU . 26.0 t30 -153.15 -39.58 0.1 Allowed 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.451 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.759 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 175.82 -51.06 0.12 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.4 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.482 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.65 -27.5 58.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.729 0.3 . . . . 0.0 110.768 -179.513 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.763 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -61.16 -55.28 34.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.692 179.031 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.763 HG22 ' CD1' ' A' ' 33' ' ' PHE . 67.3 t -52.46 -43.16 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.971 0.415 . . . . 0.0 111.138 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' ' 68' ' ' GLN . 14.2 mt -52.76 -43.22 65.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.401 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.59 -49.4 68.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.201 0.524 . . . . 0.0 110.621 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.67 -30.36 71.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.571 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.641 HD21 ' HD2' ' A' ' 48' ' ' PRO . 10.0 mt -61.91 -22.15 65.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.362 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.18 -15.1 59.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.35 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 t -120.77 -5.2 9.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.459 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -161.51 165.54 28.44 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.907 0.384 . . . . 0.0 111.517 -179.968 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.7 m -138.27 115.75 9.28 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.331 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.683 ' HD2' HD11 ' A' ' 76' ' ' LEU . 59.7 Cg_endo -72.73 147.23 44.57 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.495 2.13 . . . . 0.0 111.914 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 2.0 m-20 -77.71 -20.26 53.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.343 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.924 HG23 HD11 ' A' ' 79' ' ' ILE . 3.2 p -148.63 95.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.965 0.412 . . . . 0.0 110.168 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 79' ' ' ILE . 12.7 tp -86.74 151.75 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.293 -178.693 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.876 ' O ' HG23 ' A' ' 9' ' ' VAL . 15.5 mt -135.97 116.17 13.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.596 179.04 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.58 ' HB2' HD13 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -105.77 141.01 37.93 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -177.226 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.677 ' OD2' ' HA ' ' A' ' 10' ' ' ASP . 9.8 t70 -70.85 -28.36 64.53 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.957 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.689 HG13 ' C ' ' A' ' 62' ' ' GLY . 2.7 tt 45.98 83.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.556 0.217 . . . . 0.0 111.459 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.04 96.4 0.27 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.62 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.6 OUTLIER 58.04 46.37 1.78 Allowed Pre-proline 0 N--CA 1.466 0.352 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 178.352 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 57' ' ' MET . 87.9 Cg_endo -90.36 -55.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.987 2.458 . . . . 0.0 111.927 178.798 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.93 -18.59 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.422 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.975 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 10.2 tpt -158.75 71.54 0.55 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.18 0.514 . . . . 0.0 109.802 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.404 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 0.4 OUTLIER 66.77 -31.27 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.9 179.832 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.689 ' C ' HG13 ' A' ' 55' ' ' ILE . . . 155.17 -34.07 0.66 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.823 -179.005 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' A' ' 90' ' ' ALA . 5.4 mp -72.47 -25.87 61.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.89 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.975 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.78 -30.34 44.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.283 0.563 . . . . 0.0 109.72 178.495 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.579 HD11 ' HA3' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -47.94 -52.8 18.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.931 178.816 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.034 HD23 HD11 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -58.27 -53.07 62.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.245 179.127 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.746 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -43.24 -38.34 2.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.383 179.728 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.579 ' HB3' HD13 ' A' ' 40' ' ' LEU . 18.9 mm100 -71.39 -38.07 71.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.166 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.868 HD12 ' HA ' ' A' ' 66' ' ' LEU . 16.6 mt -64.33 -36.35 76.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.962 -179.202 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.746 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -73.44 -29.85 62.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.979 -179.907 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.66 -41.32 99.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.835 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -97.3 -23.09 16.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.782 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.46 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 56.2 m-70 -146.33 85.24 7.47 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.844 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.531 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 73.3 Cg_endo -75.53 13.11 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.948 2.432 . . . . 0.0 113.018 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.7 mtt -134.33 -0.62 2.96 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.61 0.243 . . . . 0.0 111.172 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.683 HD11 ' HD2' ' A' ' 48' ' ' PRO . 1.6 tt -76.54 113.16 26.54 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.487 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 45.5 Cg_endo -67.72 116.69 4.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.366 2.044 . . . . 0.0 111.81 178.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.763 ' HB ' HD21 ' A' ' 66' ' ' LEU . 3.1 t -115.47 151.22 17.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.539 0.685 . . . . 0.0 112.347 -178.817 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.924 HD11 HG23 ' A' ' 50' ' ' VAL . 1.1 mp -129.23 117.29 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.696 178.63 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.034 HD11 HD23 ' A' ' 66' ' ' LEU . 5.8 mm -93.52 133.15 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.594 -178.827 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.567 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.87 -1.88 49.19 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.488 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.588 ' HB ' HG23 ' A' ' 55' ' ' ILE . 2.4 m -148.0 158.92 44.31 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.091 -0.381 . . . . 0.0 110.069 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.736 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -163.19 57.59 0.19 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.866 0.365 . . . . 0.0 111.813 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -98.99 -20.39 16.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.695 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.412 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -84.48 -168.46 2.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.175 0.512 . . . . 0.0 112.339 -178.76 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.457 ' O ' HD22 ' A' ' 63' ' ' LEU . 4.5 m-20 -52.56 89.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.93 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.737 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -46.64 -22.96 0.34 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.555 179.042 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.98 -44.91 30.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . . . -65.82 -19.93 66.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.886 0.374 . . . . 0.0 111.363 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.737 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -75.78 -28.59 58.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.634 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.537 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.5 t -59.19 -38.84 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.536 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.6 m -65.35 -21.75 66.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.644 178.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.676 ' HB1' ' CB ' ' A' ' 98' ' ' ALA . . . -66.65 -47.65 71.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.857 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.537 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.4 m-85 -62.4 -24.32 67.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.076 179.34 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -42.17 59.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.261 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -77.73 -11.02 59.84 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.068 179.477 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.85 15.34 10.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.93 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.676 ' CB ' ' HB1' ' A' ' 93' ' ' ALA . . . -56.84 138.87 52.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.75 0.275 . . . . 0.0 110.499 179.576 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 17.1 t80 -69.14 -52.78 24.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.688 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.5 -161.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.766 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 6.6 m-85 -132.09 118.92 20.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.452 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.654 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 5.1 tp -102.44 140.89 21.53 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.332 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.707 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 22.1 Cg_endo -59.06 168.7 4.28 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.098 1.865 . . . . 0.0 111.047 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.607 ' HE3' ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -41.79 -43.35 6.34 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.329 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.707 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 80.4 Cg_exo -47.05 163.02 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.345 1.363 . . . . 0.0 110.317 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.714 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 2.9 t80 -166.44 -91.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.461 -177.335 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.543 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.7 p-10 43.42 -176.31 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 120.854 0.359 . . . . 0.0 110.442 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.854 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -67.96 -45.23 84.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.303 0.573 . . . . 0.0 111.072 -179.837 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.6 t0 -52.15 -57.25 10.17 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.879 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.702 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.2 mm-40 -78.84 -29.34 44.57 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.2 -51.87 6.69 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.124 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.854 HG21 HG23 ' A' ' 108' ' ' ILE . 42.0 t -59.58 -32.3 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 121.589 0.709 . . . . 0.0 110.085 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.27 -50.94 71.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.362 178.386 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.654 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 12.5 tp -79.01 -20.5 48.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.56 -178.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 112' ' ' VAL . 5.4 p -74.94 -51.8 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.012 -179.182 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.527 ' N ' HG13 ' A' ' 115' ' ' VAL . 84.3 mt-10 -68.31 -37.87 81.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.877 0.37 . . . . 0.0 110.901 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -63.1 -23.99 67.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.457 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.436 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.94 -54.82 8.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.24 -30.71 50.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.111 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 m -66.96 -46.75 73.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -57.79 -26.55 62.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.163 -179.719 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -78.47 -57.48 3.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.969 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -75.62 -173.91 2.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.854 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mtp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.827 0.346 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.26 155.93 44.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.666 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -16.68 48.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.12 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.5 92.33 0.67 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.005 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.1 mp -111.08 112.99 42.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.962 0.41 . . . . 0.0 111.113 -179.634 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.9 HG11 ' CD2' ' A' ' 23' ' ' LEU . 5.8 p -108.15 128.94 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.715 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.869 ' CD1' HG22 ' A' ' 31' ' ' THR . 36.0 m0 -115.93 144.38 44.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.573 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.4 t -134.9 147.82 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.109 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.026 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -134.55 105.1 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.608 177.679 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.602 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 57.1 t0 166.85 123.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.804 0.335 . . . . 0.0 111.336 179.144 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.481 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER 69.49 -21.78 0.16 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 178.849 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 10' ' ' ASP . 14.7 t70 70.56 -130.44 0.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 O-C-N 122.41 -0.181 . . . . 0.0 111.19 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 t -37.27 -45.36 0.65 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.044 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.652 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -53.94 -64.19 0.91 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.168 -179.639 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.663 HG23 HD23 ' A' ' 19' ' ' LEU . 32.1 mm -68.31 -20.63 25.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.696 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -68.84 -55.46 11.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.427 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.417 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 59.5 t90 -54.58 -43.96 72.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.795 0.331 . . . . 0.0 111.651 -179.776 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.714 HG12 HD13 ' A' ' 108' ' ' ILE . 1.4 t -68.46 -46.88 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.761 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.663 HD23 HG23 ' A' ' 15' ' ' ILE . 3.9 mm? -81.67 -23.85 36.64 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.539 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 14.0 pt-20 -67.66 -60.36 2.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.814 -179.151 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.6 mmt180 -63.92 -59.34 4.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.137 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.09 -54.24 21.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 111.932 -179.15 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.9 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.7 tp -65.26 -22.7 66.89 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.282 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -68.21 -36.79 80.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.25 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.26 -26.34 63.74 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.338 178.846 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.739 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.69 -15.47 59.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.703 0.287 . . . . 0.0 111.111 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.96 26.15 9.9 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.673 178.96 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.739 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -124.51 169.45 11.87 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.442 0.621 . . . . 0.0 111.224 179.53 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.2 m -104.17 106.46 16.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.166 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.685 ' HA ' HG13 ' A' ' 6' ' ' VAL . 11.4 t -101.76 115.06 29.69 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.058 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.869 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -118.94 156.63 29.22 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.902 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.696 HG21 ' HA ' ' A' ' 16' ' ' ARG . 18.3 p -129.84 162.79 27.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.658 0.742 . . . . 0.0 112.761 -179.283 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.026 ' HB2' HG13 ' A' ' 9' ' ' VAL . 20.0 m-85 -135.95 173.55 11.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.966 -179.078 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.662 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.5 pp20? -57.63 -59.52 5.07 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -177.319 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.493 ' HB2' ' HG3' ' A' ' 57' ' ' MET . 71.6 m-20 -152.54 -29.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.399 0.545 . . . . 0.0 112.466 -179.274 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.561 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 172.27 -59.19 0.16 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.892 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.423 ' N ' HD22 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -48.1 -31.35 5.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.852 0.358 . . . . 0.0 110.662 -179.701 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.843 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -60.87 -56.41 21.48 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.491 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.778 HG22 ' CD1' ' A' ' 33' ' ' PHE . 5.0 t -53.86 -42.67 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.754 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.76 HD13 ' CB ' ' A' ' 68' ' ' GLN . 14.3 mt -53.95 -43.71 70.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.72 -50.67 68.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.55 68.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.51 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.679 HD21 ' HD2' ' A' ' 48' ' ' PRO . 9.0 mt -65.85 -25.15 67.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.062 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.45 -19.28 61.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.337 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 t -119.32 -1.78 10.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.903 -179.737 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -163.16 158.71 22.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.997 0.427 . . . . 0.0 111.1 -179.849 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.885 HG23 HD13 ' A' ' 76' ' ' LEU . 65.5 m -139.09 112.26 8.05 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.406 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.679 ' HD2' HD21 ' A' ' 43' ' ' LEU . 57.9 Cg_endo -71.36 164.35 36.03 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.921 1.747 . . . . 0.0 111.281 179.209 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.64 -24.1 58.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.907 0.384 . . . . 0.0 110.581 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.822 HG13 HG23 ' A' ' 6' ' ' VAL . 7.3 p -145.22 161.88 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.626 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.653 HD22 HD21 ' A' ' 76' ' ' LEU . 30.8 tp -152.83 155.88 37.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.214 0.53 . . . . 0.0 112.251 -178.605 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.88 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -138.01 121.08 16.73 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.831 -179.801 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.517 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -105.73 138.96 41.04 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.873 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.584 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 53.0 t0 -69.76 -19.3 63.53 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.995 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.624 HD11 ' CE1' ' A' ' 84' ' ' HIS . 5.2 tt 46.16 73.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.224 0.535 . . . . 0.0 111.604 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.17 75.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.489 179.754 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -163.13 -61.16 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.623 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.728 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 59.7 Cg_endo -70.38 -169.32 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.524 2.149 . . . . 0.0 113.656 -178.549 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.71 -58.29 15.36 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.51 179.873 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.768 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -73.72 51.79 0.38 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.145 0.497 . . . . 0.0 110.274 179.475 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.19 -80.11 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.329 -179.297 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.549 ' HA3' ' CA ' ' A' ' 55' ' ' ILE . . . -143.54 -31.98 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.368 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.733 ' HA ' HD13 ' A' ' 66' ' ' LEU . 3.8 mp -53.76 -24.11 14.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.768 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -61.29 -33.93 74.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.263 178.621 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.728 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 16.0 mt -60.41 -32.53 71.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.74 179.463 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.816 ' HA ' HD12 ' A' ' 69' ' ' ILE . 5.8 mp -67.22 -42.55 83.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.379 179.558 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.622 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 5.2 mttt -54.21 -41.47 68.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.657 178.742 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.76 ' CB ' HD13 ' A' ' 40' ' ' LEU . 80.2 mm-40 -63.28 -43.16 98.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.816 HD12 ' HA ' ' A' ' 66' ' ' LEU . 5.6 mt -66.47 -36.26 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.701 -178.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.622 ' HG2' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -73.66 -28.46 61.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.934 0.397 . . . . 0.0 110.92 179.853 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.427 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -72.94 -34.78 66.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.987 -179.823 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -93.48 -59.25 2.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.261 179.171 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.41 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 68.4 m-70 -111.83 85.15 6.03 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.355 179.463 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 56.2 Cg_endo -71.17 20.18 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.725 2.283 . . . . 0.0 113.282 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.504 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 29.1 mtm -144.15 0.93 1.08 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.885 HD13 HG23 ' A' ' 47' ' ' THR . 15.1 tp -76.17 114.87 41.72 Favored Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 179.8 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.31 120.64 8.16 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.471 2.114 . . . . 0.0 111.882 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.548 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -115.47 149.29 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.255 0.55 . . . . 0.0 111.885 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.699 HG21 HD23 ' A' ' 114' ' ' LEU . 3.6 mt -132.73 114.51 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.534 178.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.643 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 11.4 mm -93.78 138.28 20.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.19 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.626 ' HB3' ' HD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.15 -9.34 57.98 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.25 -179.338 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.64 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.7 m -147.44 168.6 21.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.714 0.292 . . . . 0.0 110.671 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 84' ' ' HIS . . . -143.22 -18.89 0.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 179.646 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.624 ' CE1' HD11 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 23.14 -98.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.247 0.619 . . . . 0.0 112.372 -179.677 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 m -129.29 -176.91 4.03 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.92 0.391 . . . . 0.0 111.245 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.554 ' O ' HD22 ' A' ' 63' ' ' LEU . 5.6 t70 61.64 31.49 18.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.113 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mt -49.61 -21.64 1.07 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.768 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.92 -38.73 17.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.129 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.534 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -74.3 -20.39 60.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.123 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.668 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -71.08 -27.53 63.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.962 0.41 . . . . 0.0 110.109 178.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.573 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.4 t -69.08 -41.53 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.09 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.2 m -61.93 -26.46 68.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.054 0.454 . . . . 0.0 110.026 179.134 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -63.9 -46.01 86.75 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.929 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.573 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 10.2 m-85 -59.96 -23.78 63.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.555 179.199 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -36.97 65.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.984 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.532 ' HB3' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -82.87 -3.5 56.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.733 -179.901 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.85 18.02 13.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.129 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.548 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -61.21 145.1 52.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.965 0.383 . . . . 0.0 110.164 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.532 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 36.9 t80 -72.87 -53.69 10.72 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.776 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.445 ' OD2' HD11 ' A' ' 114' ' ' LEU . 12.9 p30 172.61 -167.45 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.821 0.344 . . . . 0.0 111.287 -179.283 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.643 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.3 m-85 -125.6 117.44 23.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.064 0.459 . . . . 0.0 110.736 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.815 HD12 ' HD2' ' A' ' 103' ' ' PRO . 7.3 tp -103.01 134.16 19.94 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.577 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.815 ' HD2' HD12 ' A' ' 102' ' ' LEU . 19.3 Cg_endo -57.71 177.51 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.385 2.057 . . . . 0.0 111.562 179.264 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.621 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -40.02 -51.41 5.76 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.182 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 7.1 Cg_endo -48.13 163.88 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.304 2.003 . . . . 0.0 111.532 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.626 ' HD2' ' HB3' ' A' ' 81' ' ' MET . 0.0 OUTLIER 173.92 -88.7 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.132 -179.609 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.781 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 47.77 -177.21 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.752 ' HA ' HG23 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -64.67 -49.03 82.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 C-N-CA 119.714 -0.795 . . . . 0.0 112.344 -178.727 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.649 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -53.89 -55.25 28.57 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.175 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.617 ' CG ' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.72 -28.16 24.82 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.704 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.781 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -82.81 -47.41 11.92 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.612 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.752 HG23 ' HA ' ' A' ' 108' ' ' ILE . 45.3 t -64.3 -32.9 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.474 0.654 . . . . 0.0 109.507 178.262 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -57.97 -47.95 81.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.172 178.5 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.699 HD23 HG21 ' A' ' 79' ' ' ILE . 6.3 tp -78.91 -22.39 45.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.981 -179.313 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 112' ' ' VAL . 2.3 p -79.37 -49.92 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.822 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.445 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 24.8 mt-10 -55.88 -48.46 75.54 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.626 0.25 . . . . 0.0 111.373 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.466 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -61.42 -23.25 65.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.867 0.365 . . . . 0.0 110.82 179.729 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.532 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.53 -48.2 42.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.92 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.2 mt -72.43 -30.76 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.198 0.523 . . . . 0.0 110.523 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 t -69.77 -45.12 68.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.013 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.69 -25.31 68.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -75.3 -56.21 4.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 -179.652 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -76.52 -173.63 2.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.818 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.711 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.454 -0.131 0 N-CA-C 112.658 -0.177 . . . . 0.0 112.658 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.801 HG21 ' NZ ' ' A' ' 46' ' ' LYS . 4.2 mm -116.74 112.51 39.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.597 0.237 . . . . 0.0 111.393 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.931 HG11 ' CD2' ' A' ' 23' ' ' LEU . 4.8 p -107.27 117.31 52.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.46 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.833 ' CD1' HG22 ' A' ' 31' ' ' THR . 34.3 m0 -108.03 137.96 45.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 0.0 111.109 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.5 t -124.2 141.92 42.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -128.03 114.1 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.743 177.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.594 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.2 t0 -171.63 -152.02 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.55 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -66.33 -2.44 4.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.6 OUTLIER 59.01 -148.04 0.48 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 121.201 -0.2 . . . . 0.0 111.299 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 t 34.58 -89.41 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.807 ' O ' HG23 ' A' ' 18' ' ' VAL . 61.6 m -55.65 -55.16 35.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.873 0.368 . . . . 0.0 110.971 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.5 mm -63.58 -34.73 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.112 0.482 . . . . 0.0 111.073 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.713 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.7 OUTLIER -69.39 -53.79 17.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.944 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.444 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 85.6 t90 -52.52 -45.11 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 14' ' ' SER . 1.4 t -67.94 -57.96 7.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.219 0.533 . . . . 0.0 111.424 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.666 ' HA ' HD11 ' A' ' 108' ' ' ILE . 3.6 mm? -67.04 -27.71 67.62 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 15.8 pt-20 -67.55 -59.89 3.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.558 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.5 mmt180 -75.66 -52.38 10.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.551 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -54.15 -54.04 45.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.811 0.339 . . . . 0.0 111.853 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.931 ' CD2' HG11 ' A' ' 6' ' ' VAL . 5.2 tp -64.3 -25.93 68.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.198 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -68.32 -33.31 74.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.99 -22.77 74.26 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.385 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.602 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.99 -15.59 59.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 110.84 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.73 21.99 8.33 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.64 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.717 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.85 170.84 11.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.397 0.599 . . . . 0.0 111.35 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.1 m -105.11 106.51 17.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.917 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 8.5 t -105.83 114.47 28.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.391 0.615 . . . . 0.0 112.188 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.833 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -122.66 156.78 33.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.576 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.713 HG21 ' HA ' ' A' ' 16' ' ' ARG . 33.9 p -127.81 156.63 42.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.451 0.643 . . . . 0.0 112.234 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.904 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -128.47 174.12 9.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.242 -179.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.502 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -57.61 -52.33 65.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -160.21 -37.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.658 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . 178.43 -55.82 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.498 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.421 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 17.2 m120 -56.97 -26.9 60.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 110.689 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -63.91 -48.51 76.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.527 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.731 HG21 HG22 ' A' ' 9' ' ' VAL . 13.5 t -58.99 -32.78 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.447 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.73 HD11 ' OE1' ' A' ' 68' ' ' GLN . 32.7 mt -56.21 -47.56 78.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.335 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.99 -47.95 76.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.339 0.59 . . . . 0.0 110.258 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.15 -32.67 72.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.698 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.645 ' HG ' HG12 ' A' ' 39' ' ' VAL . 15.6 mt -67.47 -27.65 67.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.054 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.34 -15.87 40.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.492 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 m -123.22 -5.51 8.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.82 ' HG3' ' N ' ' A' ' 47' ' ' THR . 1.3 tttt -155.55 166.57 33.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.309 0.576 . . . . 0.0 111.615 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.82 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 96.7 m -138.29 112.75 8.7 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.796 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.559 ' HG2' HD11 ' A' ' 76' ' ' LEU . 56.5 Cg_endo -71.44 158.1 54.9 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.465 2.11 . . . . 0.0 111.657 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.94 -30.59 50.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.78 0.324 . . . . 0.0 111.037 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.029 HG21 HG23 ' A' ' 115' ' ' VAL . 5.9 p -145.26 94.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.446 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.623 HD22 HD21 ' A' ' 76' ' ' LEU . 38.2 tp -83.21 141.26 32.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.432 0.634 . . . . 0.0 112.209 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.931 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -124.33 119.62 29.81 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.588 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.701 ' HA ' HG23 ' A' ' 9' ' ' VAL . 1.4 m -115.28 148.08 39.63 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 28.1 t0 -82.87 -178.0 6.95 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.348 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.69 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.1 tt -160.0 74.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 121.137 0.494 . . . . 0.0 112.095 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 177.05 58.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.646 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.529 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.33 -63.03 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.908 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.529 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 23.0 Cg_endo -60.22 -165.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.669 2.246 . . . . 0.0 113.356 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.03 -65.06 3.32 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.69 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.941 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -85.19 53.18 2.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.995 0.426 . . . . 0.0 110.94 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.465 ' HB3' HG13 ' A' ' 55' ' ' ILE . 1.2 m-20 55.74 -68.45 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.681 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -152.16 -35.62 0.03 OUTLIER Glycine 0 CA--C 1.507 -0.44 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.271 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.832 HD22 ' O ' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -53.64 -28.24 31.75 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.941 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -61.2 -34.42 75.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.658 HD22 ' HA3' ' A' ' 36' ' ' GLY . 74.1 mt -59.98 -35.99 76.19 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.672 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.756 ' HA ' HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -61.83 -51.06 69.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.433 178.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.691 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 11.9 tttp -47.36 -44.93 24.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.082 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.73 ' OE1' HD11 ' A' ' 40' ' ' LEU . 2.5 mt-30 -60.76 -43.18 98.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.202 0.525 . . . . 0.0 110.174 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.832 HD13 HG21 ' A' ' 78' ' ' VAL . 10.6 mt -64.98 -37.94 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.06 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.691 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -77.21 -23.48 51.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.541 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -67.17 -43.41 82.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.126 0.488 . . . . 0.0 111.233 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.83 -26.55 13.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.176 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.524 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 59.3 m-70 -130.25 76.23 78.11 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.751 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.576 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 73.5 Cg_endo -75.21 40.22 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.616 2.21 . . . . 0.0 112.236 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 59.1 mtt -153.97 -39.19 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.722 HD13 HG23 ' A' ' 47' ' ' THR . 16.8 tp -55.01 112.31 3.96 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.916 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.634 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 59.4 Cg_endo -73.41 141.21 31.38 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.934 1.756 . . . . 0.0 111.985 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.832 HG21 HD13 ' A' ' 69' ' ' ILE . 2.3 t -128.93 151.58 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.335 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.574 HD12 ' HG ' ' A' ' 52' ' ' LEU . 1.5 mt -120.93 118.54 56.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.991 0.424 . . . . 0.0 111.135 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.737 HD11 HD23 ' A' ' 66' ' ' LEU . 16.3 mm -95.01 142.68 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.509 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.464 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -82.31 -16.83 47.94 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.619 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.6 m -148.14 144.54 27.86 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.906 -0.717 . . . . 0.0 111.989 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.826 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -129.68 40.44 3.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.839 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.422 ' HD2' ' N ' ' A' ' 85' ' ' SER . 1.1 p-80 -89.51 -12.07 41.08 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.44 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -92.98 -164.14 1.14 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.641 0.258 . . . . 0.0 110.613 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.832 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -53.84 93.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.758 0.314 . . . . 0.0 111.334 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.436 ' HA ' ' CD2' ' A' ' 63' ' ' LEU . 1.7 mt -59.52 -21.89 60.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.741 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.0 -43.47 29.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.333 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.625 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -68.95 -23.15 64.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.688 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.757 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -67.86 -23.01 65.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.754 0.311 . . . . 0.0 110.273 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.643 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.4 t -69.03 -41.95 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.464 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.608 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 91.3 p -60.45 -18.2 49.6 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.751 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.72 -53.91 7.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.431 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.643 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.2 m-85 -58.75 -31.43 68.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.064 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.608 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -75.88 -34.62 60.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.816 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.751 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 3.1 pp0? -80.75 -18.26 48.31 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.607 0.241 . . . . 0.0 110.82 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.27 32.56 2.33 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.207 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.661 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -65.01 169.82 4.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.238 0.519 . . . . 0.0 110.998 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.634 ' HD1' ' HB2' ' A' ' 77' ' ' PRO . 0.1 OUTLIER -85.55 -55.24 4.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.727 0.298 . . . . 0.0 110.941 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 99' ' ' PHE . 0.1 OUTLIER 164.77 -162.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.884 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.826 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.1 m-85 -132.86 112.49 11.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.127 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.648 HD22 ' CE1' ' A' ' 106' ' ' PHE . 4.8 tp -102.96 142.97 25.66 Favored Pre-proline 0 C--O 1.226 -0.169 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.275 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.742 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 19.3 Cg_endo -56.66 170.6 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.344 2.029 . . . . 0.0 111.196 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -44.5 -47.24 26.47 Favored Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.742 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 75.1 Cg_exo -47.99 162.01 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.376 1.384 . . . . 0.0 110.288 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.791 ' HD1' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -176.65 -83.98 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.291 -178.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.4 p30 41.93 -168.56 0.0 OUTLIER 'General case' 0 C--O 1.231 0.113 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.691 HD13 HG12 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -67.66 -51.5 50.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 121.243 0.544 . . . . 0.0 111.421 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.613 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.9 t70 -48.96 -57.42 6.52 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.433 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.3 mm-40 -77.02 -31.19 56.21 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.791 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.34 -53.7 5.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.175 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.739 ' HA ' HG12 ' A' ' 115' ' ' VAL . 42.0 t -56.53 -32.41 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.428 0.632 . . . . 0.0 110.158 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -58.63 -52.72 64.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.821 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.505 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.9 tp -71.81 -25.69 62.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.816 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 1.029 HG23 HG21 ' A' ' 50' ' ' VAL . 10.0 p -79.24 -54.18 12.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.538 ' N ' HG13 ' A' ' 115' ' ' VAL . 1.8 mt-10 -57.57 -62.47 1.77 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.735 0.303 . . . . 0.0 111.515 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 117' ' ' ARG . 0.4 OUTLIER -53.32 -28.65 29.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.287 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.597 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.91 -49.28 20.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.871 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.914 HD11 HG22 ' A' ' 115' ' ' VAL . 5.6 mt -64.58 -31.42 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.125 0.488 . . . . 0.0 110.482 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.8 t -64.95 -33.9 77.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.748 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.7 m80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.762 179.696 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.767 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.767 HD13 ' C ' ' A' ' 4' ' ' GLY . 2.8 mm -114.18 112.54 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 111.28 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.949 HG11 ' CD2' ' A' ' 23' ' ' LEU . 8.4 p -113.66 125.48 70.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.325 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.966 ' CD1' HG22 ' A' ' 31' ' ' THR . 35.5 m0 -115.38 139.08 50.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.626 0.251 . . . . 0.0 110.823 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -132.31 138.29 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.043 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -128.11 107.22 15.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.668 178.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 48.6 t0 166.85 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.239 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.487 ' HB3' HG12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 71.06 -41.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.484 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 16' ' ' ARG . 38.8 t70 74.62 -106.3 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.971 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 12' ' ' ASP . 52.2 p -23.57 -84.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.734 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.9 m -53.46 -45.42 69.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.487 HG12 ' HB3' ' A' ' 11' ' ' ASP . 27.1 mm -67.94 -20.48 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.822 0.344 . . . . 0.0 111.741 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.638 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.7 ttt180 -79.2 -54.92 5.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 111.689 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.447 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 65.0 t90 -52.37 -42.75 64.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.489 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 14' ' ' SER . 1.7 t -71.38 -51.18 35.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.038 0.447 . . . . 0.0 111.92 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.613 HD22 ' CD1' ' A' ' 108' ' ' ILE . 4.4 mm? -70.82 -28.66 64.78 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.466 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.694 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 23.6 pt-20 -67.59 -58.96 3.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.491 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.4 mmt180 -63.15 -58.01 8.65 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.07 -55.43 27.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.987 0.423 . . . . 0.0 111.474 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.949 ' CD2' HG11 ' A' ' 6' ' ' VAL . 14.3 tp -66.62 -19.71 65.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.467 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.6 -33.34 70.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.53 -26.6 68.45 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.235 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.546 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.87 -15.63 59.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.629 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.77 25.65 9.66 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.781 -0.723 . . . . 0.0 114.795 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.803 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -120.0 164.74 15.65 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.61 1.205 . . . . 0.0 112.313 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.0 m -94.57 111.26 23.02 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.257 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 1.1 m -102.35 118.95 37.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.293 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.966 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -128.88 136.1 49.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.675 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 55.2 p -113.99 157.62 22.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.043 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.8 m-85 -134.8 173.8 11.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.904 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.602 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.9 pp20? -61.3 -58.06 9.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' A' ' 54' ' ' ASP . 1.9 t30 -156.3 -23.05 0.1 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.725 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 165.12 -59.32 0.25 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.717 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.544 ' N ' HD22 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -47.37 -32.91 5.31 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.148 0.499 . . . . 0.0 110.704 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.771 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -60.95 -60.89 3.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.613 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.84 HG21 ' CG2' ' A' ' 9' ' ' VAL . 1.9 t -53.86 -34.65 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.329 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.717 HD13 ' HB2' ' A' ' 68' ' ' GLN . 32.0 mt -48.81 -52.34 24.59 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.054 0.454 . . . . 0.0 110.406 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -47.97 83.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.108 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.59 -35.16 80.09 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.771 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.872 HD13 ' HD2' ' A' ' 73' ' ' HIS . 23.2 mt -68.32 -19.93 64.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.612 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.18 -11.98 58.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.296 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.29 -3.79 7.4 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -155.49 161.45 40.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.986 0.422 . . . . 0.0 111.31 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.43 HG23 ' CG ' ' A' ' 76' ' ' LEU . 21.1 m -138.47 112.37 8.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.952 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.649 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 73.9 Cg_endo -74.6 164.91 32.78 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.12 1.88 . . . . 0.0 111.822 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.43 -24.03 34.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.997 0.427 . . . . 0.0 110.472 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.851 HG11 ' CG2' ' A' ' 115' ' ' VAL . 7.5 p -149.97 91.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.491 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.669 HD23 HG22 ' A' ' 78' ' ' VAL . 57.9 tp -84.25 149.73 25.91 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.242 0.544 . . . . 0.0 111.906 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.873 HD22 ' CE2' ' A' ' 106' ' ' PHE . 5.3 mt -133.73 114.06 13.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.052 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.666 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -109.18 144.02 37.83 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 9.7 t0 -73.34 -171.9 1.05 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.756 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.727 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 8.6 tt -169.96 84.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 120.878 0.371 . . . . 0.0 111.703 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 167.9 59.87 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.171 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -161.0 -63.06 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.46 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 22.5 Cg_endo -59.47 -173.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.765 2.31 . . . . 0.0 113.471 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.98 -66.67 2.67 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.58 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.671 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 2.3 ttm -72.15 57.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.038 0.447 . . . . 0.0 110.367 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.91 -79.09 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.186 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.727 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -146.53 -28.69 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.866 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.735 HD13 ' HB3' ' A' ' 86' ' ' ASP . 3.7 mp -63.16 -19.19 64.25 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.916 0.358 . . . . 0.0 110.703 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.671 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -53.57 -22.76 9.04 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.083 0.468 . . . . 0.0 110.863 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.725 HD13 ' HA3' ' A' ' 36' ' ' GLY . 5.8 mt -69.62 -40.79 76.38 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.317 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.729 HD23 ' CB ' ' A' ' 93' ' ' ALA . 6.6 mp -56.61 -41.23 76.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.419 0.628 . . . . 0.0 109.938 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -53.75 -53.13 56.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.07 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.717 ' HB2' HD13 ' A' ' 40' ' ' LEU . 10.8 mm-40 -69.18 -29.34 67.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.182 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.019 HG23 ' NE2' ' A' ' 73' ' ' HIS . 1.5 mm -52.87 -52.75 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.136 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -68.68 -31.03 69.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.283 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.495 ' NE2' ' HG2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.99 -23.34 44.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.692 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.495 ' HG2' ' NE2' ' A' ' 71' ' ' GLN . 10.4 mmt180 -85.95 -73.27 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.07 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 1.019 ' NE2' HG23 ' A' ' 69' ' ' ILE . 11.2 p80 -89.35 167.26 18.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.211 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.63 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 89.0 Cg_endo -78.29 72.27 6.36 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.782 2.322 . . . . 0.0 112.912 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.632 ' HB2' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER 54.09 34.37 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.403 179.114 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 77' ' ' PRO . 0.1 OUTLIER -63.1 121.04 66.71 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.712 ' N ' HD22 ' A' ' 76' ' ' LEU . 10.7 Cg_endo -53.58 132.31 48.28 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.846 2.364 . . . . 0.0 113.19 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.669 HG22 HD23 ' A' ' 51' ' ' LEU . 2.9 t -123.41 154.29 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.541 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.794 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.6 mt -131.56 117.17 34.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.212 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 53' ' ' SER . 11.5 mm -93.57 150.45 3.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.624 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.554 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -87.02 -19.43 28.68 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.67 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.7 m -147.03 171.0 15.95 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.656 0.265 . . . . 0.0 110.996 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.5 ' H ' HG22 ' A' ' 82' ' ' THR . . . -122.34 -20.99 5.95 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.729 0.3 . . . . 0.0 111.459 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.416 ' H ' HG22 ' A' ' 82' ' ' THR . 4.2 m-70 45.07 29.71 0.52 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 73.3 m 67.92 -3.99 1.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.735 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -92.5 39.19 1.02 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.045 0.45 . . . . 0.0 110.301 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.739 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -48.44 -21.05 0.48 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.292 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -47.49 -57.65 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.445 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.64 -24.52 67.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.567 0.222 . . . . 0.0 111.537 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.739 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.69 -33.21 73.58 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.666 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.1 t -62.99 -45.37 99.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.607 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 91.7 p -60.3 -34.1 73.3 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.426 0.632 . . . . 0.0 109.89 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.729 ' CB ' HD23 ' A' ' 66' ' ' LEU . . . -59.72 -41.39 90.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.48 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.666 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.8 m-85 -61.91 -21.57 64.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.065 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.632 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.78 -43.41 72.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.503 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.632 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 6.8 pm0 -82.13 -19.12 40.69 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.12 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.63 38.95 0.64 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.662 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.693 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -63.57 154.25 33.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.145 0.472 . . . . 0.0 110.237 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.718 ' CZ ' ' HB1' ' A' ' 118' ' ' ALA . 2.2 t80 -79.79 -53.58 6.65 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.71 -162.68 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.769 0.319 . . . . 0.0 111.065 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.582 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.0 m-85 -142.63 139.36 31.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.172 0.511 . . . . 0.0 111.132 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 2.1 tp -101.92 140.8 21.5 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.489 ' O ' HG23 ' A' ' 82' ' ' THR . 35.4 Cg_exo -61.42 -34.54 86.28 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.077 1.851 . . . . 0.0 111.962 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.676 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER 167.54 -50.63 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.245 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.7 Cg_endo -47.85 163.79 0.19 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.008 1.805 . . . . 0.0 109.94 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.873 ' CE2' HD22 ' A' ' 52' ' ' LEU . 26.7 t80 -168.46 -92.13 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.329 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 3.7 p30 41.78 -171.24 0.0 OUTLIER 'General case' 0 C--N 1.335 -0.063 0 CA-C-O 120.961 0.41 . . . . 0.0 111.117 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.896 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -68.11 -49.98 62.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 7.9 m-20 -51.11 -57.11 9.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.819 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -76.31 -30.54 57.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.508 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . . . -83.61 -56.97 3.43 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.021 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.896 HG21 HG23 ' A' ' 108' ' ' ILE . 43.3 t -54.43 -30.38 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.459 0.647 . . . . 0.0 109.987 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.07 -54.6 44.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.574 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.794 ' CD2' HG21 ' A' ' 79' ' ' ILE . 6.7 tp -71.4 -22.37 61.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.522 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.851 ' CG2' HG11 ' A' ' 50' ' ' VAL . 4.3 p -79.45 -50.34 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.936 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.471 ' N ' HG13 ' A' ' 115' ' ' VAL . 23.0 mt-10 -62.73 -46.7 86.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.01 0.433 . . . . 0.0 109.908 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -64.91 -25.71 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.176 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.718 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -69.67 -53.41 18.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.093 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.5 mt -66.13 -31.38 53.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.096 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.5 p -70.26 -43.69 69.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.13 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.3 m80 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 -179.848 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.211 -0.355 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.78 112.33 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.686 0.279 . . . . 0.0 111.355 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.975 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.1 p -107.2 125.65 63.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.79 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.91 ' CD1' HG22 ' A' ' 31' ' ' THR . 33.1 m0 -112.82 145.24 40.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.038 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.693 ' HB ' HG22 ' A' ' 32' ' ' THR . 0.5 OUTLIER -139.09 137.21 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.138 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.998 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -126.35 105.14 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.483 178.099 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.581 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 60.8 t0 166.81 118.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.887 0.375 . . . . 0.0 111.243 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.469 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.6 OUTLIER 72.26 -21.59 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.118 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 10' ' ' ASP . 8.5 t0 70.47 -135.31 0.05 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.579 -0.076 . . . . 0.0 110.849 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.4 m -33.55 -45.41 0.17 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.3 m -53.38 -67.57 0.24 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.948 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.542 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 25.1 mm -65.84 -20.6 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.453 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.62 ' HA ' HG21 ' A' ' 32' ' ' THR . 12.5 ttt-85 -72.39 -61.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.401 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.496 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 71.4 t90 -48.31 -44.28 33.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.175 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.945 HG12 HD13 ' A' ' 108' ' ' ILE . 1.9 t -64.82 -62.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.919 0.39 . . . . 0.0 111.859 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.569 ' HA ' HD11 ' A' ' 108' ' ' ILE . 7.4 tp -71.51 -19.45 62.18 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 13.8 pt-20 -67.96 -57.71 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.687 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.564 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.28 -56.62 11.69 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.993 -179.022 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.8 -56.34 16.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 0.0 111.441 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.975 ' CD2' HG11 ' A' ' 6' ' ' VAL . 13.5 tp -64.42 -19.75 65.72 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.33 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.12 -37.66 75.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.6 -25.01 62.7 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.197 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.39 -15.9 59.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.74 0.305 . . . . 0.0 110.768 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.75 26.18 9.28 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.748 -0.739 . . . . 0.0 114.714 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.699 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -122.41 166.14 15.21 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.478 1.139 . . . . 0.0 112.121 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.5 m -94.98 114.96 26.84 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.34 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -105.17 109.17 21.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.985 -178.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.91 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -121.8 137.58 54.71 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.693 HG22 ' HB ' ' A' ' 8' ' ' VAL . 74.5 p -117.34 160.83 20.5 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.998 ' HB2' HG13 ' A' ' 9' ' ' VAL . 7.6 m-85 -136.03 174.52 10.52 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.077 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.659 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.5 pp20? -60.88 -63.29 1.35 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.538 ' N ' HG12 ' A' ' 9' ' ' VAL . 68.3 m-80 -153.89 -22.74 0.14 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.856 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 172.41 -63.42 0.14 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.862 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.484 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -48.31 -29.38 3.83 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.875 0.369 . . . . 0.0 111.043 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.86 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -63.25 -58.1 8.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.127 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.749 HG21 ' CG2' ' A' ' 9' ' ' VAL . 20.4 t -49.08 -46.27 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.195 0.521 . . . . 0.0 110.899 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.585 HD22 ' CD1' ' A' ' 69' ' ' ILE . 2.1 mt -49.9 -44.86 50.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.003 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.41 81.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.309 0.576 . . . . 0.0 110.937 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.56 -31.55 67.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.217 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.664 ' CD1' HG12 ' A' ' 39' ' ' VAL . 9.6 mt -65.67 -27.51 68.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.93 -20.08 21.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.608 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.9 t -126.76 1.92 6.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.818 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.497 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -153.99 159.79 41.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 111.049 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 1.051 HG23 HD23 ' A' ' 76' ' ' LEU . 96.3 m -138.67 112.75 8.43 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.238 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.722 ' HD2' HD21 ' A' ' 76' ' ' LEU . 93.9 Cg_endo -77.12 152.52 31.33 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.04 1.827 . . . . 0.0 111.751 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -74.57 -29.12 61.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.816 0.341 . . . . 0.0 110.692 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.68 HG13 HG23 ' A' ' 6' ' ' VAL . 7.5 p -145.32 94.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.484 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.817 HD23 HG22 ' A' ' 78' ' ' VAL . 63.2 tp -86.95 150.92 23.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.473 0.654 . . . . 0.0 112.282 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.878 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.5 mt -131.76 124.98 30.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.778 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.719 ' HA ' HG23 ' A' ' 9' ' ' VAL . 3.8 m -127.91 150.62 49.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 25.2 t0 -82.7 170.69 14.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.363 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.89 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 3.7 tt -147.15 82.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.842 0.353 . . . . 0.0 111.524 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 174.0 61.12 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.892 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.437 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.55 -62.79 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.68 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 22.5 Cg_endo -58.39 -170.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.249 2.633 . . . . 0.0 113.29 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.68 -71.41 0.75 Allowed Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.327 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.916 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -73.03 59.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.0 110.343 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.81 -74.8 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.46 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.89 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -150.26 -32.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.46 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.882 ' HA ' HD13 ' A' ' 66' ' ' LEU . 3.2 mp -59.08 -20.33 52.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.864 0.364 . . . . 0.0 110.366 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.916 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -58.14 -31.37 67.13 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.466 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.856 HD13 ' HA3' ' A' ' 36' ' ' GLY . 5.9 mt -65.08 -39.61 93.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.409 . . . . 0.0 110.583 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.882 HD13 ' HA ' ' A' ' 63' ' ' LEU . 6.0 mp -60.08 -43.36 95.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.74 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -54.07 -42.51 69.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.235 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.548 ' HB2' HD13 ' A' ' 40' ' ' LEU . 41.1 mm-40 -61.3 -34.14 74.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.236 0.541 . . . . 0.0 110.053 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.598 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 49.7 mm -59.69 -41.68 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.114 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.538 ' CB ' ' HB2' ' A' ' 96' ' ' GLN . 11.9 pttp -74.72 -27.78 60.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.249 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.424 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 1.3 mt-30 -63.73 -42.48 97.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.04 0.447 . . . . 0.0 111.267 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 72' ' ' ARG . 12.4 mtt85 -103.7 -49.99 3.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.276 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.586 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 4.1 m-70 -88.58 135.26 32.67 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.615 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.11 -76.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.849 2.366 . . . . 0.0 112.664 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 21.4 mtm -140.92 52.75 1.59 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.456 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.051 HD23 HG23 ' A' ' 47' ' ' THR . 2.2 tm? -56.49 111.6 3.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.214 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.52 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 26.7 Cg_exo -62.35 115.36 2.82 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.27 1.98 . . . . 0.0 112.158 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.953 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -121.82 153.3 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.805 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.773 HG21 ' CD2' ' A' ' 114' ' ' LEU . 3.2 mt -130.64 117.78 40.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.308 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.637 HG22 ' H ' ' A' ' 82' ' ' THR . 19.3 mm -93.86 149.28 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.262 0.553 . . . . 0.0 112.407 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.583 ' N ' ' HE2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -84.7 -18.63 34.66 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.501 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.648 ' O ' HG21 ' A' ' 55' ' ' ILE . 3.3 m -147.44 160.98 41.96 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.722 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.834 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -111.09 -24.76 10.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.091 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 47.03 -171.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.344 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.35 53.0 2.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.873 0.368 . . . . 0.0 111.165 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.524 ' HB2' HD13 ' A' ' 63' ' ' LEU . 5.6 m-20 -158.98 28.38 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.834 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 2.0 mt -46.38 -21.39 0.16 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.79 -56.13 8.09 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -64.65 -19.94 66.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.639 0.257 . . . . 0.0 111.467 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -65.14 -50.99 63.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.342 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.652 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.7 t -65.35 -48.92 81.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.94 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -58.96 -25.04 63.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.956 0.408 . . . . 0.0 110.218 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.561 ' HB1' HD23 ' A' ' 66' ' ' LEU . . . -61.56 -51.86 66.81 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.443 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.665 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 2.7 m-85 -55.83 -30.57 61.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.01 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -37.62 56.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.461 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.538 ' HB2' ' CB ' ' A' ' 70' ' ' LYS . 1.7 pt20 -100.07 4.71 44.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 123.08 81.9 0.56 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.026 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.953 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.7 126.96 1.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 0.0 111.241 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 78.6 t80 -64.77 -53.41 47.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.379 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.665 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.6 OUTLIER 178.2 -169.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.881 0.372 . . . . 0.0 111.086 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.532 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.2 m-85 -123.84 118.72 27.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.471 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.665 HD23 ' CE2' ' A' ' 106' ' ' PHE . 5.7 tp -102.45 134.11 20.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 8.1 Cg_endo -49.4 166.66 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.697 2.265 . . . . 0.0 112.036 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.637 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -41.13 -50.08 8.17 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.547 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.7 Cg_endo -47.69 162.6 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.768 1.646 . . . . 0.0 110.441 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.873 ' HD1' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -171.58 -87.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.87 -178.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.7 p30 43.25 -170.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.59 0.233 . . . . 0.0 110.396 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.945 HD13 HG12 ' A' ' 18' ' ' VAL . 1.2 mp -68.04 -45.98 82.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.225 0.536 . . . . 0.0 111.336 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.564 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 7.4 t0 -51.72 -58.17 7.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.695 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.669 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 1.4 mm-40 -78.29 -27.69 47.37 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.873 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.24 -57.02 3.34 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.722 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.684 HG21 HG23 ' A' ' 108' ' ' ILE . 41.3 t -54.23 -31.82 22.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.557 0.694 . . . . 0.0 110.158 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.84 -52.48 63.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.745 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.773 ' CD2' HG21 ' A' ' 79' ' ' ILE . 13.6 tp -74.3 -20.66 60.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.625 -1.171 . . . . 0.0 112.791 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 112' ' ' VAL . 9.8 p -79.32 -50.12 18.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.934 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.507 ' N ' HG13 ' A' ' 115' ' ' VAL . 43.8 mt-10 -64.22 -41.57 96.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.001 0.429 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -67.56 -25.01 65.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.872 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.99 -54.11 8.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.047 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.4 mt -62.61 -31.34 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.084 0.468 . . . . 0.0 110.508 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.1 m -68.55 -38.11 80.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.741 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.594 ' O ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.594 HD13 ' O ' ' A' ' 4' ' ' GLY . 16.9 mm -130.46 112.86 23.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.772 0.32 . . . . 0.0 111.32 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.861 HG23 HG13 ' A' ' 50' ' ' VAL . 7.8 p -107.69 136.01 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.727 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.99 ' CD1' HG22 ' A' ' 31' ' ' THR . 38.5 m0 -122.17 127.37 49.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -118.08 132.23 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -177.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.989 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -116.79 105.11 17.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.12 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.54 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 37.4 t0 173.87 100.66 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.411 ' HB3' ' CG1' ' A' ' 15' ' ' ILE . 3.2 t0 65.44 -15.03 0.11 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 10' ' ' ASP . 3.7 p-10 45.27 -152.56 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.55 0.159 . . . . 0.0 110.893 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 1.8 t 32.53 -91.73 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.75 ' O ' HG23 ' A' ' 18' ' ' VAL . 48.3 t -56.25 -57.49 11.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.625 0.25 . . . . 0.0 110.766 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 10' ' ' ASP . 27.1 mm -60.17 -20.78 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.443 . . . . 0.0 110.36 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.628 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.4 ttm180 -78.78 -58.8 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.601 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.413 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 75.1 t90 -49.16 -41.35 36.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.157 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 14' ' ' SER . 1.3 t -68.15 -57.84 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 111' ' ' ALA . 4.2 tp -69.95 -25.4 63.63 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.644 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 23.0 pt-20 -67.69 -57.62 6.06 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.84 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.509 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 6.4 mmt180 -58.49 -53.1 62.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.017 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.43 77.52 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.794 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.3 tm? -76.67 -28.95 56.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.246 0.546 . . . . 0.0 110.474 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.67 -32.25 73.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.424 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.28 -24.64 70.74 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.385 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.06 -14.9 59.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.87 0.367 . . . . 0.0 110.879 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.41 23.33 10.4 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.516 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.604 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -130.96 170.72 14.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 117.471 0.635 . . . . 0.0 111.524 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.626 ' O ' HG12 ' A' ' 6' ' ' VAL . 31.0 m -96.93 141.74 29.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.236 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.644 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -127.54 119.35 25.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.815 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.99 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -131.71 135.63 47.01 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 38.9 p -108.62 163.17 13.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.989 ' HB2' HG13 ' A' ' 9' ' ' VAL . 39.5 m-85 -137.47 174.03 11.03 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.79 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.763 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.0 pp20? -62.83 -60.4 3.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.563 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -155.38 -32.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.316 0.507 . . . . 0.0 112.19 -179.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.536 ' HA3' HD21 ' A' ' 65' ' ' LEU . . . -179.14 -65.71 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.484 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.671 HD22 HD12 ' A' ' 40' ' ' LEU . 13.9 m120 -47.72 -27.6 2.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 111.221 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.763 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -57.23 -60.83 3.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.685 HG13 ' HE3' ' A' ' 7' ' ' TRP . 65.4 t -50.71 -45.9 27.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.794 HD21 ' CD1' ' A' ' 65' ' ' LEU . 8.6 mt -46.24 -41.52 13.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.287 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.99 -47.81 67.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.926 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.16 -31.28 67.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.32 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.716 HD21 ' HD2' ' A' ' 48' ' ' PRO . 10.9 mt -61.36 -29.06 69.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.088 0.47 . . . . 0.0 111.042 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.56 -20.04 29.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.483 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 m -118.89 -8.49 10.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.863 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -156.3 157.99 36.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.784 0.326 . . . . 0.0 110.988 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.854 HG23 HD23 ' A' ' 76' ' ' LEU . 78.6 m -138.62 112.85 8.48 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.279 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.716 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.3 Cg_endo -76.94 162.35 32.22 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 121.874 1.716 . . . . 0.0 111.388 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 0.9 OUTLIER -73.76 -21.03 60.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.876 0.37 . . . . 0.0 110.925 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.861 HG13 HG23 ' A' ' 6' ' ' VAL . 4.4 p -148.6 163.67 5.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.816 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.682 HD11 HG21 ' A' ' 39' ' ' VAL . 23.5 tp -152.83 154.18 34.61 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.314 0.578 . . . . 0.0 112.307 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.977 ' O ' HG23 ' A' ' 9' ' ' VAL . 4.8 mt -137.79 122.05 18.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.513 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.73 ' O ' ' HE3' ' A' ' 81' ' ' MET . 1.3 m -106.55 144.76 32.76 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.591 ' O ' HG23 ' A' ' 55' ' ' ILE . 46.0 t0 -79.05 -11.7 60.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.741 HD13 ' HB ' ' A' ' 82' ' ' THR . 0.7 OUTLIER 51.53 154.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.684 0.754 . . . . 0.0 111.589 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.67 ' H ' ' C ' ' A' ' 61' ' ' ASP . 5.1 ttt180 84.38 72.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.767 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.483 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.44 -67.07 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.621 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 51.8 Cg_endo -66.25 -160.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.154 2.569 . . . . 0.0 113.028 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.17 13.4 50.32 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.392 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.847 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -152.05 47.65 0.77 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.67 ' C ' ' H ' ' A' ' 56' ' ' ARG . 1.0 OUTLIER 45.77 -86.14 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.569 -178.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.735 ' HA3' ' HB ' ' A' ' 55' ' ' ILE . . . -124.03 -30.5 1.02 Allowed Glycine 0 CA--C 1.508 -0.392 0 C-N-CA 119.863 -1.161 . . . . 0.0 112.901 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.776 HD23 ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -63.74 -19.48 64.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -65.31 -34.16 77.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.794 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -57.51 -45.4 85.01 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.352 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.037 HD13 ' HB2' ' A' ' 93' ' ' ALA . 4.9 mt -53.96 -47.0 71.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.53 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.743 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 9.4 tttt -51.98 -43.91 63.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.316 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.474 ' CB ' HD13 ' A' ' 40' ' ' LEU . 9.3 mm100 -65.84 -38.64 89.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.123 0.487 . . . . 0.0 110.279 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.551 HG23 ' HD2' ' A' ' 73' ' ' HIS . 30.3 mm -61.94 -42.07 93.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.913 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.743 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -70.6 -27.23 63.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.834 -179.08 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -68.76 -39.37 80.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.247 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.99 -54.79 2.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.029 0.443 . . . . 0.0 111.945 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.669 ' CD2' HD13 ' A' ' 43' ' ' LEU . 2.1 m-70 -83.21 145.2 48.36 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.193 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.33 -79.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.724 2.283 . . . . 0.0 113.214 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.736 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 11.5 mtt -127.13 45.68 2.66 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.84 0.352 . . . . 0.0 111.689 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.854 HD23 HG23 ' A' ' 47' ' ' THR . 1.4 tm? -58.64 106.97 0.8 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.505 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.47 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 48.3 Cg_exo -58.14 116.38 3.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.453 2.102 . . . . 0.0 112.249 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.759 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -112.88 152.17 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.041 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.759 ' HB ' HD23 ' A' ' 52' ' ' LEU . 5.9 mt -142.73 114.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.593 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.678 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 3.8 mm -94.29 131.38 41.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.315 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.814 ' HE1' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -75.38 -6.39 49.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.429 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.741 ' HB ' HD13 ' A' ' 55' ' ' ILE . 2.9 m -145.68 158.04 43.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.602 0.239 . . . . 0.0 110.381 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.681 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -143.57 47.1 1.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.339 . . . . 0.0 110.705 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.418 ' CD2' HG21 ' A' ' 82' ' ' THR . 6.6 m-70 -76.13 108.97 9.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.824 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 m 51.94 178.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.717 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.562 ' CB ' HD13 ' A' ' 63' ' ' LEU . 1.1 m-20 62.28 14.41 6.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.438 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -45.88 -23.71 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -48.33 -45.6 35.47 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -73.78 -19.85 60.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.776 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -58.82 -36.87 75.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 0.0 110.219 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.552 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.6 t -65.75 -37.26 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.491 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 m -66.9 -25.12 66.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.181 0.515 . . . . 0.0 109.693 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 1.037 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -64.33 -47.96 77.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.768 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.552 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.3 m-85 -61.61 -26.98 68.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.48 0.657 . . . . 0.0 109.399 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -41.62 41.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.544 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.736 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.6 pp0? -75.94 -16.95 59.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.806 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.13 -2.39 8.38 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.152 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.759 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -55.94 156.67 5.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.857 0.328 . . . . 0.0 110.875 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.501 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 52.7 t80 -86.79 -53.52 4.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.777 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.49 -161.63 0.02 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.842 0.353 . . . . 0.0 111.677 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.681 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 5.2 m-85 -127.86 124.4 37.42 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.259 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 114' ' ' LEU . 5.8 tp -106.65 137.42 19.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.289 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.727 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 12.3 Cg_endo -53.48 165.75 1.49 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.273 1.982 . . . . 0.0 111.115 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.432 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -41.62 -45.41 7.99 Favored Pre-proline 0 N--CA 1.468 0.461 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.727 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 80.6 Cg_exo -47.07 162.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 121.774 1.649 . . . . 0.0 110.531 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.762 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 3.8 t80 -164.21 -95.54 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.237 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p30 43.14 -173.25 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 120.814 0.34 . . . . 0.0 110.597 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.795 HG23 HG21 ' A' ' 112' ' ' VAL . 1.2 mp -67.47 -48.87 75.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 11.6 m-20 -52.18 -55.47 20.8 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.847 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.706 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.6 mm-40 -78.0 -30.69 50.24 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.664 ' HB3' HD11 ' A' ' 19' ' ' LEU . . . -82.51 -59.6 2.47 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.77 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.795 HG21 HG23 ' A' ' 108' ' ' ILE . 39.8 t -51.72 -33.87 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.505 0.669 . . . . 0.0 110.5 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.76 -51.43 69.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.76 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.626 HD22 HD13 ' A' ' 102' ' ' LEU . 19.8 tp -76.04 -21.17 57.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.959 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 112' ' ' VAL . 5.9 p -79.42 -48.95 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.655 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.477 ' N ' HG13 ' A' ' 115' ' ' VAL . 70.4 mt-10 -61.58 -52.2 65.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.73 0.3 . . . . 0.0 111.1 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.588 ' HD2' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -61.19 -24.57 66.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.77 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.56 -53.6 9.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 111.303 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.606 HD11 HG22 ' A' ' 115' ' ' VAL . 4.9 mt -68.1 -31.32 51.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.481 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.0 p -66.06 -44.48 84.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.52 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 6.7 m80 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.746 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.803 -0.119 . . . . 0.0 112.803 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.683 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 2.5 mp -116.36 118.94 60.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.516 0.198 . . . . 0.0 110.651 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.909 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.1 p -116.35 123.96 72.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.681 0.277 . . . . 0.0 110.8 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.919 ' CD1' HG22 ' A' ' 31' ' ' THR . 43.9 m0 -115.49 131.3 56.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.85 0.357 . . . . 0.0 110.642 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -121.47 139.79 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.781 -178.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.026 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -126.47 105.81 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.07 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.484 ' HB2' ' SD ' ' A' ' 81' ' ' MET . 43.0 t0 174.52 105.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.705 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.59 -15.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 10' ' ' ASP . 2.6 p30 44.44 -155.22 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.46 0.118 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 1.5 t 30.68 -89.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.634 ' O ' HG23 ' A' ' 18' ' ' VAL . 23.3 m -54.37 -57.49 11.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.37 . . . . 0.0 110.481 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 10' ' ' ASP . 35.5 mm -60.48 -20.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.167 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.764 ' HA ' HG21 ' A' ' 32' ' ' THR . 5.8 ttt-85 -77.37 -61.09 2.1 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.808 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.422 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 70.3 t90 -45.58 -42.75 11.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.797 HG12 HD13 ' A' ' 108' ' ' ILE . 1.8 t -66.95 -62.65 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.04 0.448 . . . . 0.0 112.058 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.486 ' HA ' HD11 ' A' ' 108' ' ' ILE . 12.3 mt -67.12 -26.43 66.69 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.579 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 23.2 pt-20 -65.34 -56.45 12.54 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.104 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.538 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.5 mmm180 -62.97 -58.64 6.63 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.094 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.05 -44.1 67.17 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.909 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.5 tp -73.35 -24.79 60.4 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.431 . . . . 0.0 110.47 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.74 -34.99 77.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.24 -24.22 68.77 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.31 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.634 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.04 -15.78 58.62 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.64 0.257 . . . . 0.0 111.034 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.07 26.2 8.52 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.957 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.702 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.74 170.28 12.31 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 117.987 0.894 . . . . 0.0 111.61 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.2 m -99.56 105.68 17.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.644 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.677 ' HA ' HG13 ' A' ' 6' ' ' VAL . 40.9 t -101.07 111.98 24.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.238 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.919 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -121.36 151.81 39.71 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.764 HG21 ' HA ' ' A' ' 16' ' ' ARG . 68.7 p -125.09 160.15 29.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.026 ' HB2' HG13 ' A' ' 9' ' ' VAL . 5.6 m-85 -135.94 173.86 11.25 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.491 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.508 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.8 pp20? -60.57 -59.23 5.73 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -150.46 -30.2 0.2 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.581 0.628 . . . . 0.0 112.49 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.625 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . 168.24 -56.37 0.22 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.435 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -45.88 -34.22 3.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.942 0.401 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.854 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.2 tp10 -60.97 -56.8 16.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.363 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.762 HG21 ' CG2' ' A' ' 9' ' ' VAL . 3.6 t -49.54 -40.94 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.951 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 68' ' ' GLN . 14.0 mt -55.56 -43.51 75.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.828 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.35 -49.56 59.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.001 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.28 -26.31 66.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.82 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.749 ' CD1' HG12 ' A' ' 39' ' ' VAL . 8.1 mt -71.28 -24.61 62.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.482 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.0 -16.42 43.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.643 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 m -120.26 -6.82 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.591 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -158.72 156.2 29.43 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.674 0.273 . . . . 0.0 110.85 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 1.006 HG23 HD12 ' A' ' 76' ' ' LEU . 67.5 m -139.42 113.0 7.94 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.506 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.683 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 96.8 Cg_endo -76.42 166.06 28.11 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.22 1.947 . . . . 0.0 111.433 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.407 ' O ' ' HD2' ' A' ' 77' ' ' PRO . 28.8 m-20 -73.91 -63.09 1.29 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.852 HG13 HG23 ' A' ' 6' ' ' VAL . 4.9 p -95.12 156.25 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.672 HD12 ' O ' ' A' ' 7' ' ' TRP . 50.1 tp -152.85 133.31 13.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.383 0.611 . . . . 0.0 111.856 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.743 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.6 mt -119.67 116.1 25.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.037 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.564 ' HA ' HG23 ' A' ' 9' ' ' VAL . 1.3 t -107.57 146.77 31.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.502 0.668 . . . . 0.0 112.489 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 7.2 t0 -74.43 -178.66 3.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.924 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.583 ' CG2' ' HB ' ' A' ' 82' ' ' THR . 3.3 tt -157.08 86.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.267 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 163.91 58.73 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.711 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.609 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 6.2 tpt -162.76 -63.79 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.609 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 12.1 Cg_endo -53.26 -164.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.065 2.51 . . . . 0.0 113.112 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.56 6.6 72.49 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.801 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.602 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -152.1 51.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.5 ' OD2' HD12 ' A' ' 63' ' ' LEU . 1.3 p-10 48.71 -71.44 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.147 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 55' ' ' ILE . . . -141.95 -36.48 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.999 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.873 ' HA ' HD23 ' A' ' 66' ' ' LEU . 1.3 mp -56.76 -18.69 13.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.284 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -63.24 -45.61 90.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.625 HD22 ' HA3' ' A' ' 36' ' ' GLY . 12.0 mt -56.49 -33.76 66.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.601 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.873 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.7 mm? -60.42 -43.81 96.38 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.692 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 14.4 ttmt -56.35 -41.07 75.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.277 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.599 ' HB3' HD13 ' A' ' 40' ' ' LEU . 70.5 mm-40 -70.07 -34.59 73.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.7 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.922 HG23 ' NE2' ' A' ' 73' ' ' HIS . 21.7 mt -67.05 -38.59 81.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.392 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.692 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.57 -24.14 61.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.998 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -78.9 -34.59 44.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.043 0.449 . . . . 0.0 110.935 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -94.04 -69.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.546 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.922 ' NE2' HG23 ' A' ' 69' ' ' ILE . 2.2 p80 -117.66 75.01 9.39 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.071 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.586 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 61.6 Cg_endo -74.96 57.11 4.44 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.299 1.999 . . . . 0.0 112.733 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.428 ' HG3' ' C ' ' A' ' 74' ' ' PRO . 51.3 mtp -154.37 -41.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.101 0.477 . . . . 0.0 111.008 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.006 HD12 HG23 ' A' ' 47' ' ' THR . 2.6 tt -58.12 122.29 57.49 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.911 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.451 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 18.7 Cg_endo -59.46 118.61 5.52 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.819 2.346 . . . . 0.0 112.513 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.709 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -99.36 148.07 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.849 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.659 ' HB ' HD23 ' A' ' 52' ' ' LEU . 2.7 mt -140.2 113.69 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.181 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.684 HG22 ' H ' ' A' ' 82' ' ' THR . 24.9 mm -93.42 149.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.131 0.491 . . . . 0.0 112.198 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.532 ' HE2' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.39 -13.48 49.26 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.869 -178.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.684 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.6 m -147.78 160.47 42.7 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.046 -0.409 . . . . 0.0 110.682 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.817 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -154.84 65.51 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 0.0 111.17 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.422 ' CD2' ' H ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -78.43 -93.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.824 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.422 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -98.63 -176.57 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.305 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.523 ' O ' HD22 ' A' ' 63' ' ' LEU . 85.2 m-20 58.88 14.42 3.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.583 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.804 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -44.47 -25.33 0.25 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -48.02 -42.65 28.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.032 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.603 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.04 -21.37 63.19 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.554 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.687 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -62.56 -41.62 99.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.98 0.419 . . . . 0.0 110.069 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.6 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.8 t -58.35 -39.64 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.437 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.8 p -61.45 -37.73 84.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.41 0.624 . . . . 0.0 110.146 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.67 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -54.83 -43.58 73.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.42 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.6 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 34.0 m-85 -59.16 -22.71 61.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.984 0.421 . . . . 0.0 110.503 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.651 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -71.99 -42.94 65.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.585 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.67 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -75.78 -18.1 59.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.99 15.95 4.59 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.433 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.709 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -56.59 148.48 19.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.143 0.471 . . . . 0.0 110.539 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.511 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 61.0 t80 -79.81 -53.89 6.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.199 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.406 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER 174.91 -158.9 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.002 0.429 . . . . 0.0 111.579 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.817 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.3 m-85 -131.87 125.77 32.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.653 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 6.0 tp -103.01 140.63 21.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.063 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.719 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 18.7 Cg_endo -56.28 165.15 4.49 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.031 1.821 . . . . 0.0 110.448 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -42.53 -43.87 8.76 Favored Pre-proline 0 N--CA 1.467 0.397 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.719 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 82.0 Cg_exo -47.12 163.88 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.672 1.581 . . . . 0.0 110.818 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.692 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 1.2 t80 -162.49 -92.08 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.528 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.559 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p-10 42.35 -177.12 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.898 0.38 . . . . 0.0 110.889 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.797 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -67.9 -44.79 84.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.355 0.598 . . . . 0.0 111.174 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.1 t70 -53.84 -57.28 11.48 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.787 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.692 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.6 mm-40 -78.53 -28.43 46.14 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.09 -54.24 4.97 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.184 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.753 HG21 HG23 ' A' ' 108' ' ' ILE . 43.8 t -57.49 -32.4 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.558 0.694 . . . . 0.0 109.956 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.44 -51.93 67.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.769 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.653 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 19.4 tp -76.66 -20.67 56.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.82 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.4 p -79.13 -48.62 21.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.723 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.465 ' N ' HG13 ' A' ' 115' ' ' VAL . 71.8 mt-10 -65.25 -45.49 84.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.949 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 20.4 mtp-105 -63.6 -24.01 67.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.905 0.383 . . . . 0.0 110.803 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.511 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -75.04 -51.15 14.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.133 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -65.61 -31.22 52.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.134 0.492 . . . . 0.0 110.975 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.6 t -70.96 -43.77 67.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.129 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.1 m80 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.097 -179.814 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.741 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.749 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.1 mp -111.55 119.35 59.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.871 0.367 . . . . 0.0 111.364 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.826 HG23 HG13 ' A' ' 50' ' ' VAL . 11.5 p -105.09 127.86 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.076 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.881 ' CD1' HG22 ' A' ' 31' ' ' THR . 29.5 m0 -115.29 143.7 44.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.786 HG21 HD23 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -136.85 143.66 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.043 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -133.38 104.73 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.068 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.61 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 43.0 t0 166.47 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.9 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.459 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 71.19 -23.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.94 0.496 . . . . 0.0 112.146 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 10' ' ' ASP . 10.6 t0 69.33 -131.51 0.08 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 122.53 -0.106 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 t -34.08 -45.05 0.19 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.704 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.2 m -54.67 -67.31 0.28 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 27.8 mm -64.38 -20.45 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.714 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.614 ' HA ' HG21 ' A' ' 32' ' ' THR . 53.3 ttt180 -70.3 -61.37 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.849 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.472 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 70.5 t90 -50.36 -43.6 54.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.954 0.407 . . . . 0.0 111.715 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.855 HG12 HD13 ' A' ' 108' ' ' ILE . 1.4 t -65.82 -61.11 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.002 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.786 HD23 HG21 ' A' ' 8' ' ' VAL . 9.8 tp -71.66 -20.71 61.91 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.667 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 21.2 pt-20 -67.47 -56.94 7.57 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.152 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.541 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 8.7 mmm180 -65.62 -59.42 3.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.215 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.34 -42.73 61.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.807 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.4 tm? -70.43 -26.6 63.74 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.007 0.432 . . . . 0.0 110.516 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.3 76.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.67 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.44 -26.15 69.3 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.27 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.543 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.74 -16.32 59.52 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.743 0.306 . . . . 0.0 111.068 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.41 25.81 8.55 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.455 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.741 ' HB3' ' O ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -136.58 175.2 9.83 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 117.382 0.591 . . . . 0.0 111.355 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.599 ' O ' HG12 ' A' ' 6' ' ' VAL . 3.0 m -106.03 134.61 48.89 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.087 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.667 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 12.2 t -124.3 110.54 14.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.456 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.881 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -110.66 155.42 22.43 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 81.2 p -131.69 159.34 38.66 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.043 ' HB2' HG13 ' A' ' 9' ' ' VAL . 5.8 m-85 -135.8 173.49 11.65 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.927 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.602 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 1.6 pp20? -61.95 -60.81 3.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.742 ' O ' HD11 ' A' ' 65' ' ' LEU . 29.2 m120 -150.69 -52.47 0.14 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 118.318 0.508 . . . . 0.0 111.581 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.657 ' CA ' HD11 ' A' ' 65' ' ' LEU . . . -159.11 -62.03 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.944 -1.122 . . . . 0.0 114.0 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.718 HD22 HD12 ' A' ' 40' ' ' LEU . 12.4 m120 -52.42 -27.67 16.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.979 0.389 . . . . 0.0 111.617 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -62.48 -56.98 12.98 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.482 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.789 HG21 ' CG2' ' A' ' 9' ' ' VAL . 3.0 t -56.61 -40.64 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.151 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.718 HD12 HD22 ' A' ' 37' ' ' ASN . 20.2 mt -50.3 -42.57 52.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.008 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.36 81.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.245 0.545 . . . . 0.0 110.875 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.76 78.96 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.653 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.586 HD13 ' CD2' ' A' ' 73' ' ' HIS . 17.4 mt -59.0 -26.65 64.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.964 0.411 . . . . 0.0 111.132 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.95 -20.84 25.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.64 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.72 1.35 8.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.7 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.46 ' HB3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -156.37 159.43 38.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 111.438 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.486 HG23 HD23 ' A' ' 76' ' ' LEU . 86.9 m -139.41 113.08 7.96 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.189 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.564 ' HG2' HD21 ' A' ' 76' ' ' LEU . 78.0 Cg_endo -77.39 153.75 31.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.023 1.815 . . . . 0.0 111.624 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -73.81 -26.1 60.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.826 HG13 HG23 ' A' ' 6' ' ' VAL . 6.2 p -146.14 94.93 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.751 ' O ' HD12 ' A' ' 79' ' ' ILE . 56.6 tp -86.53 151.18 23.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.353 0.597 . . . . 0.0 112.151 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.771 ' O ' HG23 ' A' ' 9' ' ' VAL . 7.3 mt -132.99 114.13 13.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.899 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.956 ' HB3' HD13 ' A' ' 65' ' ' LEU . 1.5 m -114.15 149.91 34.97 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.626 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 29.2 t0 -78.14 173.47 12.21 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.636 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.764 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -145.09 74.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 120.993 0.425 . . . . 0.0 111.16 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 17.6 ttt-85 176.23 61.08 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.549 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.29 -62.8 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.549 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 20.1 Cg_endo -59.4 -174.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.532 2.154 . . . . 0.0 113.101 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.01 -72.39 0.54 Allowed Glycine 0 C--N 1.335 0.493 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.58 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.672 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -71.99 56.26 0.31 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.398 179.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.63 -77.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.839 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.764 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -136.33 -39.01 0.16 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.466 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.798 HD23 ' HB2' ' A' ' 90' ' ' ALA . 1.2 mp -51.7 -25.42 7.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.837 0.351 . . . . 0.0 110.496 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -58.73 -33.43 70.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.956 HD13 ' HB3' ' A' ' 53' ' ' SER . 0.4 OUTLIER -50.32 -44.64 54.33 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.898 178.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.644 ' HG ' ' HB2' ' A' ' 93' ' ' ALA . 3.1 mm? -60.67 -42.15 96.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.483 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.575 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -44.73 -60.68 1.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.404 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.645 ' OE1' ' HA ' ' A' ' 65' ' ' LEU . 9.4 mp0 -59.21 -37.01 76.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.839 0.352 . . . . 0.0 110.185 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.672 HG23 ' HD2' ' A' ' 73' ' ' HIS . 4.3 mm -64.13 -42.77 96.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.084 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 1.9 ptpp? -76.64 -24.28 53.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.609 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.26 -39.42 16.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.428 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.72 -62.92 1.38 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.278 0.561 . . . . 0.0 111.772 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.672 ' HD2' HG23 ' A' ' 69' ' ' ILE . 2.1 m-70 -81.42 136.93 48.69 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.979 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.44 -69.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.622 2.215 . . . . 0.0 113.106 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.406 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 1.1 mpt? -144.66 37.28 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 111.601 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.671 HD11 HD22 ' A' ' 51' ' ' LEU . 1.1 tm? -59.94 105.65 0.6 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.407 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.639 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 10.9 Cg_endo -54.07 136.17 66.46 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.468 2.112 . . . . 0.0 112.195 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.729 HG13 HD23 ' A' ' 51' ' ' LEU . 2.1 t -132.89 152.37 35.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.909 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.768 HG21 ' CD2' ' A' ' 114' ' ' LEU . 3.6 mt -132.18 118.6 37.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.403 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 53' ' ' SER . 21.7 mm -93.86 142.98 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.019 0.438 . . . . 0.0 111.887 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.662 ' HE3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -75.46 -20.84 58.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.568 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.599 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.4 m -147.59 161.22 41.57 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.365 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.678 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -133.49 57.75 1.79 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.909 0.385 . . . . 0.0 111.705 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -98.47 -179.81 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.999 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER 63.92 -155.59 0.31 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.059 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.525 ' O ' HD22 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -60.23 78.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.271 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.709 ' HA ' HD21 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -52.8 -22.0 4.82 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -48.25 -50.76 28.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.606 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -56.24 -19.89 15.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.012 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.798 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -70.27 -35.88 74.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.64 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.613 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.8 t -67.06 -38.26 80.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.865 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.578 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 4.2 m -61.5 -18.62 59.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.325 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.782 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.82 -57.03 4.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.324 0.583 . . . . 0.0 111.542 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.613 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -54.22 -33.64 58.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.078 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -76.58 -35.31 58.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.244 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.782 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -77.78 -18.5 56.35 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.218 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.41 -11.71 3.25 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.926 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.692 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -54.96 156.2 3.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.307 0.554 . . . . 0.0 111.323 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.473 ' HD2' HG12 ' A' ' 79' ' ' ILE . 49.9 t80 -79.72 -53.58 6.67 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.252 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.541 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.5 OUTLIER 171.96 -163.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.033 0.444 . . . . 0.0 111.532 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.678 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 2.8 m-85 -125.69 122.32 36.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.259 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' MET . 3.6 tp -102.24 140.66 21.35 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.195 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.753 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 12.7 Cg_endo -54.58 163.68 3.61 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.637 2.225 . . . . 0.0 111.437 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -41.08 -45.8 6.65 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -178.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.753 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 88.7 Cg_exo -47.39 163.49 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.624 1.549 . . . . 0.0 110.671 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.749 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 12.0 t80 -165.77 -92.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.732 -178.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.565 ' O ' ' O ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER 40.11 -174.09 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.772 0.32 . . . . 0.0 111.189 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.855 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -68.08 -51.74 45.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.056 0.455 . . . . 0.0 111.835 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.2 p-10 -49.2 -56.05 10.51 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.942 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.749 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.7 mm-40 -76.59 -30.88 57.15 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.25 -58.5 3.02 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.903 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.677 HG21 HG23 ' A' ' 108' ' ' ILE . 40.0 t -53.03 -31.29 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 121.699 0.762 . . . . 0.0 110.212 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.53 -50.74 72.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.921 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.768 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.8 tp -76.95 -20.73 55.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.925 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.646 HG12 ' HA ' ' A' ' 112' ' ' VAL . 9.7 p -77.76 -48.73 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.954 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.504 ' N ' HG13 ' A' ' 115' ' ' VAL . 40.4 mt-10 -62.7 -44.07 97.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.032 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.663 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 7.8 ptm180 -68.14 -23.7 64.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 111.07 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.97 -50.91 17.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.812 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 115' ' ' VAL . 4.3 mt -70.19 -32.18 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.6 t -69.63 -42.11 74.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.033 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.2 m80 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.917 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.469 HG21 ' CE ' ' A' ' 46' ' ' LYS . 2.1 mp -131.88 112.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 111.598 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.765 HG11 ' HG ' ' A' ' 23' ' ' LEU . 12.2 p -107.24 130.24 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.873 ' CD1' HG22 ' A' ' 31' ' ' THR . 23.5 m0 -119.14 135.3 54.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -129.06 136.81 58.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -176.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.88 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -122.49 105.79 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.538 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 55.8 t0 170.28 118.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.458 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 2.2 t70 71.05 -43.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.419 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 49.6 t0 75.59 -107.09 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.947 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 12' ' ' ASP . 31.3 p -23.73 -83.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.714 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.0 m -52.93 -47.56 67.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.455 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.446 ' CG1' ' HB3' ' A' ' 11' ' ' ASP . 19.6 mm -64.64 -20.31 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.761 0.315 . . . . 0.0 111.628 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.481 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 7.1 ttp180 -70.75 -60.94 1.96 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.752 0.31 . . . . 0.0 111.586 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.562 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 37.9 t90 -52.08 -44.32 64.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.735 HG12 HD13 ' A' ' 108' ' ' ILE . 1.2 t -64.04 -49.91 79.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.616 ' HA ' HD11 ' A' ' 108' ' ' ILE . 43.3 mt -84.07 -22.1 31.31 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.618 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 1.2 pp20? -66.42 -59.02 4.06 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.511 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.458 ' HG2' ' CD ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -64.58 -62.85 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.01 -53.98 7.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.944 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.765 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.5 tm? -62.76 -29.21 70.52 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.729 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -66.5 -33.91 76.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.516 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.37 -25.24 69.79 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.396 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.578 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.97 -15.08 59.76 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.678 0.275 . . . . 0.0 111.053 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.58 23.46 10.14 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.63 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.578 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -133.52 174.64 10.2 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.532 0.666 . . . . 0.0 111.722 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 m -102.81 117.33 34.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.281 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.68 ' HB2' HD12 ' A' ' 23' ' ' LEU . 8.8 t -113.93 113.23 24.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.513 0.673 . . . . 0.0 111.533 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.873 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -118.87 156.55 29.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.405 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 31.1 p -135.04 152.11 51.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.426 0.631 . . . . 0.0 112.348 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.88 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -129.64 174.31 9.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.054 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.635 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -58.34 -106.33 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.441 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -86.14 -71.8 0.52 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.762 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -161.16 -39.21 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.411 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.52 -31.63 69.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.901 0.35 . . . . 0.0 110.683 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.772 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -51.84 -57.31 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.634 178.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.828 HG21 HG22 ' A' ' 9' ' ' VAL . 2.9 t -56.85 -47.89 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.964 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.452 HD13 ' CB ' ' A' ' 68' ' ' GLN . 38.1 mt -46.18 -42.75 14.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.868 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.42 -50.07 69.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.799 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.49 -28.73 67.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.104 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.936 HD13 ' CE1' ' A' ' 73' ' ' HIS . 7.3 mt -71.04 -20.95 62.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.455 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.85 -18.15 20.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.074 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 m -126.35 9.43 7.25 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.823 ' HG3' ' N ' ' A' ' 47' ' ' THR . 3.4 tttt -158.15 163.53 37.48 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.439 0.638 . . . . 0.0 112.153 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.978 HG23 HD13 ' A' ' 76' ' ' LEU . 97.8 m -138.83 111.46 8.1 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.192 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' O ' HD11 ' A' ' 76' ' ' LEU . 61.2 Cg_endo -74.41 165.52 31.57 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.447 2.098 . . . . 0.0 111.284 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -82.43 -27.97 31.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.867 0.365 . . . . 0.0 110.818 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.756 HG13 HG23 ' A' ' 6' ' ' VAL . 3.4 p -149.61 99.45 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.41 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.846 ' O ' HD12 ' A' ' 79' ' ' ILE . 47.4 tp -86.96 141.93 28.34 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.938 HD23 ' HB ' ' A' ' 79' ' ' ILE . 6.2 mt -124.42 115.03 20.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.042 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.699 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -109.69 141.79 41.78 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.092 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 8.3 t0 -71.38 -171.82 0.66 Allowed 'General case' 0 C--O 1.23 0.055 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.931 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.96 HD11 ' CE1' ' A' ' 84' ' ' HIS . 2.7 tt -170.13 79.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.218 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.8 78.91 1.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.541 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 2.4 ptt? 43.21 49.92 5.38 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.56 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 50.6 Cg_endo -83.14 -74.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.305 2.003 . . . . 0.0 111.663 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.25 -21.34 3.43 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.976 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 4.3 ttm -163.74 68.28 0.19 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 110.225 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.66 -25.1 0.15 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.167 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.79 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 137.68 -27.68 2.81 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.586 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 4.3 mp -75.17 -17.98 60.28 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.976 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.43 -24.5 12.82 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.844 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.612 ' O ' HG13 ' A' ' 69' ' ' ILE . 7.4 mp -62.13 -42.36 99.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.842 ' HA ' HD12 ' A' ' 69' ' ' ILE . 85.9 mt -64.19 -42.72 96.54 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.304 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 9.9 tptm -48.39 -56.37 8.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.736 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.452 ' CB ' HD13 ' A' ' 40' ' ' LEU . 24.8 mm-40 -59.61 -32.45 70.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.931 HG23 ' ND1' ' A' ' 73' ' ' HIS . 97.1 mt -59.98 -46.01 94.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.969 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -67.0 -27.61 67.58 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -86.03 -37.02 19.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -89.85 -61.97 1.57 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.866 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.936 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -84.96 147.29 47.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.063 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -95.17 103.68 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.227 2.618 . . . . 0.0 112.437 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 18.3 mtm 54.35 24.58 5.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.086 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.978 HD13 HG23 ' A' ' 47' ' ' THR . 10.6 tp -69.15 114.36 22.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.99 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.54 120.63 8.64 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.309 2.006 . . . . 0.0 111.991 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.921 HG21 HD13 ' A' ' 69' ' ' ILE . 1.8 t -117.46 151.47 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.293 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.938 ' HB ' HD23 ' A' ' 52' ' ' LEU . 2.3 mp -131.15 120.39 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.895 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.639 HG22 ' H ' ' A' ' 82' ' ' THR . 18.0 mm -95.49 147.2 6.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.989 0.423 . . . . 0.0 111.375 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.76 ' HE3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.18 -18.42 46.31 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.214 -179.02 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.927 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.9 m -147.77 153.53 39.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.374 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.71 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -134.58 -2.02 2.75 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.744 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.96 ' CE1' HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 23.43 -95.66 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.205 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 m -141.15 -12.78 0.93 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.462 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 3.7 t70 -78.86 44.49 0.55 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.941 0.401 . . . . 0.0 111.361 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.948 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -52.12 -21.06 2.9 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.074 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -47.69 -56.51 7.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.662 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.699 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -68.68 -19.78 64.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.768 0.318 . . . . 0.0 111.247 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.948 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -70.76 -37.73 73.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.88 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.596 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.8 t -63.9 -41.92 94.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.287 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.604 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 23.8 m -61.39 -18.91 60.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 109.991 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.748 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.84 -52.49 10.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.097 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.596 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.0 m-85 -58.24 -33.85 69.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.164 0.507 . . . . 0.0 110.517 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.8 pp0? -76.39 -38.63 55.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.601 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.748 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.2 pp0? -73.12 -18.29 61.31 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.064 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.07 1.44 4.91 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.861 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.612 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -56.82 159.52 3.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.283 0.542 . . . . 0.0 111.537 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.531 ' HB3' HG13 ' A' ' 79' ' ' ILE . 84.0 t80 -85.08 -53.97 4.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.425 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 2.2 t70 173.11 -165.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 111.117 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.71 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.1 m-85 -127.55 122.55 33.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.582 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.412 ' HB2' HD22 ' A' ' 114' ' ' LEU . 1.8 tp -102.58 141.04 21.69 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.837 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.714 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 15.8 Cg_endo -55.52 166.31 2.72 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.363 2.042 . . . . 0.0 111.398 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.431 ' HE2' ' HA ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -42.02 -46.64 10.29 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.714 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 83.0 Cg_exo -47.23 163.75 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 121.805 1.67 . . . . 0.0 110.727 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.76 ' CE1' ' HE3' ' A' ' 81' ' ' MET . 4.1 t80 -165.75 -93.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.36 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.5 p-10 43.92 -175.78 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.706 0.288 . . . . 0.0 110.506 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.836 HG23 HG21 ' A' ' 112' ' ' VAL . 1.1 mp -67.96 -45.4 83.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.365 0.602 . . . . 0.0 111.381 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 30.9 t0 -52.14 -58.08 7.68 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.662 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.692 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.4 mm-40 -77.82 -30.06 50.93 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -82.99 -53.62 5.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.256 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.836 HG21 HG23 ' A' ' 108' ' ' ILE . 47.7 t -57.79 -32.75 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.431 0.634 . . . . 0.0 110.097 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.57 -52.91 63.51 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.227 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.792 ' CD2' HG21 ' A' ' 79' ' ' ILE . 6.9 tp -75.07 -20.51 59.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.042 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 112' ' ' VAL . 6.0 p -79.18 -43.67 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.601 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.404 ' N ' HG13 ' A' ' 115' ' ' VAL . 16.5 mt-10 -59.89 -51.81 68.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.69 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.4 ' NE ' HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -59.67 -23.82 63.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 110.853 179.467 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.46 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.66 -52.59 11.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.486 HD13 HD22 ' A' ' 28' ' ' LEU . 4.4 mt -71.57 -32.46 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.117 0.484 . . . . 0.0 111.244 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 t -66.06 -33.65 76.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.506 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.761 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.498 HD12 ' OD2' ' A' ' 49' ' ' ASP . 3.3 mp -108.97 112.41 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.841 0.353 . . . . 0.0 111.039 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.899 HG11 ' CD2' ' A' ' 23' ' ' LEU . 6.5 p -109.24 118.46 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.942 ' CD1' HG22 ' A' ' 31' ' ' THR . 37.5 m0 -109.62 140.21 43.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.188 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.626 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -125.09 144.85 33.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.194 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.104 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -133.14 106.79 10.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.053 0.454 . . . . 0.0 110.957 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 34' ' ' GLU . 8.5 t0 -162.05 -154.46 0.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.746 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.2 -1.56 3.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 62.47 -151.59 0.36 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.474 -0.141 . . . . 0.0 111.013 179.067 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 t 36.32 -90.34 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.772 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.3 t -55.06 -56.5 19.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.672 0.273 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.9 mm -64.3 -30.88 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.299 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.828 ' HA ' HG21 ' A' ' 32' ' ' THR . 8.5 ttm-85 -71.78 -53.3 13.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.628 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.441 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 72.9 t90 -54.07 -40.73 67.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 14' ' ' SER . 2.8 t -69.04 -56.65 11.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.66 HD13 HD12 ' A' ' 108' ' ' ILE . 7.0 tp -72.38 -23.13 61.07 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.679 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . 14.6 pt-20 -67.31 -59.23 3.58 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.492 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.544 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 11.4 mmm-85 -74.62 -53.84 8.58 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.79 -56.15 17.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 111.786 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.899 ' CD2' HG11 ' A' ' 6' ' ' VAL . 11.4 tp -66.02 -21.36 66.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.639 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.33 -34.83 73.14 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.34 -26.52 68.04 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.349 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.433 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.2 -15.95 59.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.649 0.261 . . . . 0.0 110.676 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.2 24.83 8.19 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.679 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -121.37 165.2 15.88 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.75 1.275 . . . . 0.0 112.438 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.8 m -88.74 109.08 19.85 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.16 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.679 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -101.9 115.62 30.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.414 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.942 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -133.62 132.19 40.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.828 HG21 ' HA ' ' A' ' 16' ' ' ARG . 59.2 p -105.87 164.14 12.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.489 0.661 . . . . 0.0 112.523 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.104 ' HB2' HG13 ' A' ' 9' ' ' VAL . 4.2 m-85 -135.79 173.42 11.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.071 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.592 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 2.0 pp20? -61.53 -49.52 76.38 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.704 ' HB3' ' HB2' ' A' ' 57' ' ' MET . 19.6 m-20 -165.96 -35.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.564 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -172.79 -64.83 0.05 OUTLIER Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.992 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.14 -30.57 49.6 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.848 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 11.1 tt0 -56.14 -48.03 77.03 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.129 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.69 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 4.1 t -52.8 -40.65 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.313 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.63 HD11 HD12 ' A' ' 65' ' ' LEU . 44.9 mt -54.16 -42.12 69.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.727 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.0 -52.48 65.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.848 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.54 -27.94 64.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.812 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.812 HD21 ' HD2' ' A' ' 48' ' ' PRO . 11.9 mt -67.67 -28.53 67.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.579 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.17 -17.74 4.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.877 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.55 -0.02 8.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.554 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.82 164.38 23.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 111.363 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.481 HG23 HD13 ' A' ' 76' ' ' LEU . 88.9 m -138.97 113.35 8.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.562 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.812 ' HD2' HD21 ' A' ' 43' ' ' LEU . 46.3 Cg_endo -68.82 158.44 57.85 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.271 1.981 . . . . 0.0 111.54 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.498 ' OD2' HD12 ' A' ' 5' ' ' ILE . 8.2 m-20 -80.53 -25.94 38.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.47 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.938 HG21 HG23 ' A' ' 115' ' ' VAL . 7.6 p -147.93 97.88 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.684 0.278 . . . . 0.0 111.111 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.711 HD22 HD21 ' A' ' 76' ' ' LEU . 18.6 tp -86.83 152.87 22.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.999 0.428 . . . . 0.0 111.989 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 106' ' ' PHE . 1.1 tt -134.87 114.41 12.54 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.074 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 t -114.9 136.98 52.51 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 111.919 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.414 ' C ' HG22 ' A' ' 55' ' ' ILE . 15.3 t70 -82.75 4.43 25.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.546 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.683 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 7.4 tt 41.84 82.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 12.2 ttp85 175.09 62.23 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.382 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.704 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 10.9 tpt -163.43 -61.13 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.801 ' HB2' ' HB3' ' A' ' 64' ' ' ALA . 17.9 Cg_endo -58.02 178.8 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.405 2.07 . . . . 0.0 112.616 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.77 -64.76 3.66 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.177 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.736 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 3.8 tpt -72.4 57.24 0.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.005 0.431 . . . . 0.0 110.099 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 0.4 OUTLIER 59.52 -81.8 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.237 -179.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.39 -31.29 0.15 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.566 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.662 HD11 ' O ' ' A' ' 84' ' ' HIS . 0.8 OUTLIER -60.27 -25.34 65.63 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.113 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.801 ' HB3' ' HB2' ' A' ' 58' ' ' PRO . . . -54.32 -34.17 60.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.926 0.393 . . . . 0.0 109.942 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.63 HD12 HD11 ' A' ' 40' ' ' LEU . 30.7 tp -56.82 -36.99 70.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.825 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.004 HD21 HD11 ' A' ' 80' ' ' ILE . 3.7 mm? -64.32 -44.53 91.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.848 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.776 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -57.21 -42.13 80.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.857 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.458 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 8.5 mm100 -65.18 -36.67 84.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.126 0.488 . . . . 0.0 110.487 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.786 HD12 ' HA ' ' A' ' 66' ' ' LEU . 59.2 mt -61.51 -39.75 84.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.083 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.776 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.64 -28.01 62.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.258 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -79.42 -39.36 32.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.567 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -96.66 -61.54 1.4 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.876 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.668 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 2.6 m-70 -82.25 157.88 67.51 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.495 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -68.3 -76.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.612 2.208 . . . . 0.0 112.966 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.658 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 31.1 mtm -145.26 56.1 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.027 0.441 . . . . 0.0 111.124 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.711 HD21 HD22 ' A' ' 51' ' ' LEU . 17.6 tp -67.05 112.66 10.43 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.145 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 42.1 Cg_endo -67.28 118.75 5.81 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.462 2.108 . . . . 0.0 111.632 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.73 HG21 HD13 ' A' ' 69' ' ' ILE . 11.5 t -120.63 148.93 23.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 111.651 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.736 HG21 ' CD2' ' A' ' 114' ' ' LEU . 2.7 mt -117.2 113.66 43.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.121 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.004 HD11 HD21 ' A' ' 66' ' ' LEU . 18.3 mm -93.5 135.54 27.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.111 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.885 ' HE3' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -73.09 -55.52 6.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.215 0.531 . . . . 0.0 110.7 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.547 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.5 m -106.39 157.62 17.49 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.218 -0.301 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.743 ' HB1' ' CD2' ' A' ' 87' ' ' LEU . . . -121.49 37.4 4.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.884 0.373 . . . . 0.0 110.695 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.662 ' O ' HD11 ' A' ' 63' ' ' LEU . 7.7 p80 -81.17 -172.81 3.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 74.91 -75.93 0.07 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.241 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.469 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -160.03 98.96 1.35 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.796 0.331 . . . . 0.0 111.45 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.833 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -47.81 -24.52 1.0 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.265 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.04 -42.11 27.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.889 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.413 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -72.25 -26.31 61.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.321 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.833 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.03 -45.79 72.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.45 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.59 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 15.0 t -67.6 -47.45 80.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 89' ' ' ALA . 2.7 p -63.34 -30.69 71.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.111 0.481 . . . . 0.0 110.16 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.792 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -59.04 -37.38 76.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.682 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.59 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 23.5 m-85 -59.04 -22.11 60.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.077 0.465 . . . . 0.0 110.014 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.63 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.3 -42.15 46.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.075 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.727 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp0? -76.13 -18.11 59.28 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.057 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 128.87 9.21 3.53 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.716 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.792 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -54.39 147.52 13.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 117.37 0.585 . . . . 0.0 111.433 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 56.2 t80 -86.68 -54.17 4.53 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.695 ' OD1' HG23 ' A' ' 79' ' ' ILE . 19.2 p30 171.51 -168.71 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.811 0.338 . . . . 0.0 111.273 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.57 ' CD2' ' HB ' ' A' ' 80' ' ' ILE . 11.3 m-85 -130.45 134.98 47.52 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.538 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.73 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -137.4 117.57 10.47 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.594 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 102' ' ' LEU . 58.8 Cg_exo -38.68 173.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.604 2.869 . . . . 0.0 114.501 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.885 ' HD2' ' HE3' ' A' ' 81' ' ' MET . 0.1 OUTLIER -36.91 -49.51 2.04 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.111 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.9 Cg_endo -47.8 123.81 8.94 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 N-CA-C 108.71 -1.304 . . . . 0.0 108.71 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.955 ' CZ ' HD21 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -156.89 -85.68 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.997 -177.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.9 p30 37.32 -162.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.857 0.361 . . . . 0.0 110.854 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.885 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -67.9 -52.52 38.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.587 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 32.1 m-20 -50.53 -56.63 10.76 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.549 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.658 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.6 mm-40 -78.27 -30.97 48.84 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.683 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.37 -54.31 4.87 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.755 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.885 HG21 HG23 ' A' ' 108' ' ' ILE . 32.2 t -55.07 -32.02 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.491 0.663 . . . . 0.0 110.156 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.34 -51.87 67.65 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.501 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.736 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.9 tp -75.3 -20.59 59.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.697 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.938 HG23 HG21 ' A' ' 50' ' ' VAL . 6.6 p -79.41 -50.0 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.092 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.496 ' N ' HG13 ' A' ' 115' ' ' VAL . 17.9 mt-10 -58.33 -43.97 88.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.666 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -24.33 67.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.96 0.409 . . . . 0.0 110.474 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.71 -59.05 2.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.979 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -64.95 -30.98 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.075 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 t -64.45 -37.18 86.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.076 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.8 m80 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 -179.863 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.477 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.479 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 4.0 mm -107.03 112.4 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.678 0.275 . . . . 0.0 111.09 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.865 HG11 ' CD2' ' A' ' 23' ' ' LEU . 5.9 p -109.95 119.2 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.808 0.337 . . . . 0.0 110.563 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.936 ' CD1' HG22 ' A' ' 31' ' ' THR . 34.8 m0 -112.55 131.77 55.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.802 0.334 . . . . 0.0 110.566 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -122.77 145.6 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.167 0.508 . . . . 0.0 112.283 -177.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.011 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -131.26 107.91 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.15 178.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 31.6 t0 170.76 107.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.869 0.366 . . . . 0.0 111.674 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.56 -40.59 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.7 OUTLIER 69.23 -159.3 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t 30.96 -87.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.677 ' O ' HG23 ' A' ' 18' ' ' VAL . 9.6 t -56.09 -57.49 11.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 0.0 110.518 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.38 -22.46 27.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.098 0.475 . . . . 0.0 110.186 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.739 ' HA ' HG21 ' A' ' 32' ' ' THR . 5.2 ttp180 -77.42 -59.24 2.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.398 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.407 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 87.8 t90 -46.35 -38.86 9.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.811 HG12 HD13 ' A' ' 108' ' ' ILE . 1.6 t -72.2 -62.51 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.011 0.434 . . . . 0.0 111.911 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.674 HD13 HD12 ' A' ' 108' ' ' ILE . 3.6 mm? -65.37 -25.75 67.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.142 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.622 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 8.9 pt-20 -67.77 -59.3 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.611 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 6.6 mmm180 -71.75 -48.16 48.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.931 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -57.78 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.049 0.452 . . . . 0.0 111.345 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.865 ' CD2' HG11 ' A' ' 6' ' ' VAL . 4.8 tp -63.96 -22.98 67.16 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.348 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.32 -33.95 72.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.24 -22.33 74.45 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.282 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.487 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.72 -16.0 58.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.658 0.266 . . . . 0.0 110.997 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.7 25.54 6.52 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.218 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.685 HD12 ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -130.68 168.72 16.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.897 0.849 . . . . 0.0 111.725 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.8 m -98.79 105.85 18.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.874 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.69 ' HA ' HG13 ' A' ' 6' ' ' VAL . 33.6 t -104.38 112.87 26.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.936 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.0 t -120.53 154.63 35.07 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.755 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 16.2 p -125.26 164.87 19.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.543 0.687 . . . . 0.0 112.794 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.011 ' HB2' HG13 ' A' ' 9' ' ' VAL . 47.4 m-85 -135.97 173.78 11.34 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.517 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.742 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -61.94 -60.94 2.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.499 ' N ' HG12 ' A' ' 9' ' ' VAL . 7.4 t-20 -151.36 -24.73 0.2 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.688 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 167.91 -58.78 0.21 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.922 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.538 ' N ' HD22 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -52.62 -26.95 15.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.853 0.358 . . . . 0.0 110.685 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.799 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -59.38 -60.31 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.802 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.841 HG22 ' CD1' ' A' ' 33' ' ' PHE . 39.4 t -48.58 -34.48 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.834 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.472 ' CD1' ' HA ' ' A' ' 37' ' ' ASN . 19.2 mt -57.48 -43.52 84.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.59 -53.78 51.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.16 0.505 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.24 71.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.905 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.746 ' HG ' HG12 ' A' ' 39' ' ' VAL . 12.2 mt -59.85 -29.84 68.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.9 -19.59 4.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.101 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 t -127.79 0.2 6.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -156.02 157.76 36.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.78 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.463 HG23 HD13 ' A' ' 76' ' ' LEU . 85.8 m -138.82 114.79 8.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.223 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.588 ' HD2' HD21 ' A' ' 43' ' ' LEU . 61.1 Cg_endo -74.39 154.94 45.95 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.083 1.855 . . . . 0.0 111.716 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.21 -23.99 40.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.749 0.309 . . . . 0.0 111.08 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.916 HG23 HD11 ' A' ' 79' ' ' ILE . 3.3 p -145.8 92.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.56 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.685 HD11 HG21 ' A' ' 39' ' ' VAL . 63.2 tp -86.61 152.45 22.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.233 0.539 . . . . 0.0 111.929 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.966 ' O ' HG23 ' A' ' 9' ' ' VAL . 4.8 mt -138.2 123.26 19.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.557 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.578 ' HB3' HD13 ' A' ' 80' ' ' ILE . 7.3 t -111.05 144.76 39.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 50.0 t0 -75.47 -11.06 59.96 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.761 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 82' ' ' THR . 1.7 tt 44.35 78.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.563 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 9.2 tpt180 172.05 76.08 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.679 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.632 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.24 -61.78 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.672 ' HD3' HD21 ' A' ' 65' ' ' LEU . 73.7 Cg_endo -74.13 -170.08 0.66 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.134 1.889 . . . . 0.0 113.504 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.3 -59.68 10.27 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.845 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.672 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 10.4 tpp -72.92 52.91 0.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.911 0.386 . . . . 0.0 110.602 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.81 -76.75 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.287 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.75 -32.04 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.189 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.605 HD12 ' H ' ' A' ' 63' ' ' LEU . 4.0 mp -51.79 -29.56 19.57 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -55.66 -32.49 63.25 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.929 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.688 HD13 ' HA3' ' A' ' 36' ' ' GLY . 13.5 mt -56.2 -44.39 79.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.544 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.933 HD21 HD11 ' A' ' 80' ' ' ILE . 30.5 mt -60.57 -44.36 96.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.122 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.628 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 9.8 mttt -49.75 -40.8 42.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.212 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -70.37 -35.64 73.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.203 0.525 . . . . 0.0 110.321 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.847 HD12 ' HA ' ' A' ' 66' ' ' LEU . 69.9 mt -62.42 -40.62 88.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.09 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.628 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -76.23 -25.01 54.61 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.705 -179.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -36.21 25.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.649 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.0 mtp85 -92.77 -25.74 18.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.739 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.71 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 40.0 m-70 -124.25 152.72 68.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 120.862 0.363 . . . . 0.0 111.533 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.08 -83.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.083 2.522 . . . . 0.0 113.063 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.97 51.31 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.663 0.268 . . . . 0.0 111.073 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.518 HD21 HD22 ' A' ' 51' ' ' LEU . 55.3 tp -60.81 110.54 3.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.704 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.476 ' HD2' HD12 ' A' ' 76' ' ' LEU . 34.7 Cg_endo -64.84 115.7 3.4 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.103 1.868 . . . . 0.0 111.527 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.661 HG11 ' CD2' ' A' ' 66' ' ' LEU . 3.5 t -108.01 154.25 9.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.58 0.705 . . . . 0.0 111.525 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.916 HD11 HG23 ' A' ' 50' ' ' VAL . 3.5 mt -131.22 117.32 36.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.177 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.933 HD11 HD21 ' A' ' 66' ' ' LEU . 33.0 mm -93.42 143.51 11.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.997 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.733 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -94.3 -7.87 40.62 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.714 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.813 ' O ' HD13 ' A' ' 55' ' ' ILE . 3.0 m -147.52 129.11 15.05 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.93 0.395 . . . . 0.0 111.352 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB1' HD21 ' A' ' 87' ' ' LEU . . . -115.6 86.42 2.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -66.78 -159.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.935 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.7 34.15 0.53 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.673 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.468 ' HB2' HD13 ' A' ' 63' ' ' LEU . 1.3 m-20 -125.35 26.73 6.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.04 0.448 . . . . 0.0 110.333 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.633 HD13 ' CB ' ' A' ' 90' ' ' ALA . 1.1 mm? -44.54 -21.58 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.447 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -47.82 -47.26 31.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.521 0.2 . . . . 0.0 111.386 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.553 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -72.58 -22.45 60.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.856 0.36 . . . . 0.0 110.926 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.633 ' CB ' HD13 ' A' ' 87' ' ' LEU . . . -67.58 -49.02 65.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.374 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.595 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.4 t -57.71 -49.05 82.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.05 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -29.81 68.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.411 0.624 . . . . 0.0 109.901 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.602 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -58.53 -39.81 81.2 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.14 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 25.6 m-85 -61.31 -21.18 63.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.43 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.623 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.15 -42.59 55.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.706 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.623 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 1.2 pt20 -77.0 -15.1 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.817 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.32 13.44 4.81 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.626 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.602 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -55.52 143.77 28.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.146 0.473 . . . . 0.0 110.982 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.557 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 69.5 t80 -76.39 -53.96 7.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.222 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.4 t0 172.98 -166.1 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.947 0.403 . . . . 0.0 111.555 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.741 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.4 m-85 -129.05 118.97 23.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.347 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.465 HD23 ' HD1' ' A' ' 106' ' ' PHE . 5.9 tp -102.56 131.1 22.76 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.664 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.583 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 83.5 Cg_exo -47.48 168.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.551 2.168 . . . . 0.0 111.98 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.436 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -43.32 -46.36 15.7 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 88.1 Cg_exo -46.56 163.34 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 121.705 1.603 . . . . 0.0 110.763 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.744 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 5.0 t80 -169.39 -91.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.389 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.499 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.8 p-10 43.46 -174.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.73 0.3 . . . . 0.0 110.912 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.811 HD13 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.98 -48.14 76.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.225 0.536 . . . . 0.0 110.819 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 5.1 t70 -50.32 -57.18 8.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.082 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.681 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.5 mm-40 -79.25 -27.2 42.37 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.54 ' HB3' HD11 ' A' ' 19' ' ' LEU . . . -84.15 -53.43 5.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.578 ' HA ' HG12 ' A' ' 115' ' ' VAL . 42.3 t -59.17 -32.16 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.507 0.67 . . . . 0.0 110.17 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.89 -52.62 64.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.752 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.706 HD12 ' HD3' ' A' ' 117' ' ' ARG . 11.4 tp -75.67 -20.36 58.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.545 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 112' ' ' VAL . 3.6 p -78.28 -46.35 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.017 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.421 ' N ' HG13 ' A' ' 115' ' ' VAL . 43.6 mt-10 -61.95 -45.35 94.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.808 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.706 ' HD3' HD12 ' A' ' 114' ' ' LEU . 5.0 ptm180 -62.76 -25.7 68.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.671 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.557 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.93 -52.17 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.238 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.606 HD13 ' CD2' ' A' ' 28' ' ' LEU . 5.1 mt -68.31 -30.7 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.148 0.499 . . . . 0.0 110.738 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 m -65.28 -41.8 93.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.796 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.5 m80 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.734 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.728 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.676 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.728 HD13 ' C ' ' A' ' 4' ' ' GLY . 1.5 mm -107.8 112.29 39.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.764 0.316 . . . . 0.0 110.763 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.951 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.1 p -113.91 124.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.526 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 1.005 ' CD1' HG22 ' A' ' 31' ' ' THR . 53.2 m0 -116.71 133.35 56.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.702 0.287 . . . . 0.0 110.394 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -119.13 128.99 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.924 HG23 ' HA ' ' A' ' 53' ' ' SER . 2.7 m -117.65 118.77 59.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 110.419 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.474 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 17.2 t0 -173.45 -146.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.872 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -65.24 -4.46 5.25 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.6 t0 58.56 -147.5 0.5 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 122.543 -0.098 . . . . 0.0 111.234 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t 34.31 -87.87 0.01 OUTLIER 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.852 ' O ' HG23 ' A' ' 18' ' ' VAL . 39.2 m -58.1 -57.31 13.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.76 0.314 . . . . 0.0 110.988 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.58 -31.39 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.304 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.73 ' HA ' HG21 ' A' ' 32' ' ' THR . 15.4 ttp180 -72.37 -57.39 4.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.831 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.44 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 66.0 t90 -50.83 -42.4 58.45 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 14' ' ' SER . 0.9 OUTLIER -70.49 -58.77 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.184 0.516 . . . . 0.0 111.598 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.761 HD22 ' CD1' ' A' ' 108' ' ' ILE . 3.9 mm? -66.63 -26.99 67.34 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.67 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.589 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 12.2 pt-20 -66.87 -60.14 2.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.589 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.0 OUTLIER -72.35 -55.3 7.33 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.475 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -50.37 -57.25 8.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.0 111.815 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.951 ' CD2' HG11 ' A' ' 6' ' ' VAL . 4.6 tp -60.68 -25.24 66.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.438 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -68.76 -37.14 79.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.76 -23.69 70.91 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.513 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.414 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.69 -15.72 59.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.582 0.229 . . . . 0.0 110.977 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.14 25.04 6.58 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.39 -0.91 . . . . 0.0 114.29 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.666 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.24 170.06 15.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.78 0.79 . . . . 0.0 111.436 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.3 m -101.41 105.82 16.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.215 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.814 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 16.0 t -105.99 111.46 24.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.155 0.502 . . . . 0.0 111.952 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 1.005 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -121.26 155.64 34.2 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.73 HG21 ' HA ' ' A' ' 16' ' ' ARG . 32.6 p -126.02 159.99 31.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.559 0.695 . . . . 0.0 112.543 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.919 ' HB2' HG12 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -136.44 174.32 10.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.267 -179.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.641 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -63.04 -33.43 75.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.035 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.641 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 2.2 t30 -176.34 171.76 2.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.019 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.598 ' HA2' HG21 ' A' ' 9' ' ' VAL . . . -50.26 -25.27 7.93 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.144 -1.027 . . . . 0.0 111.907 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.504 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -58.58 -52.21 66.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.673 0.273 . . . . 0.0 110.63 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.6 tt0 -51.95 -51.54 56.44 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.669 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.734 HG21 HD11 ' A' ' 51' ' ' LEU . 52.2 t -50.72 -35.1 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.133 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.2 mt -54.98 -43.1 73.21 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.04 -47.79 64.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.879 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.99 80.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.679 HD21 ' HD2' ' A' ' 48' ' ' PRO . 14.7 mt -67.19 -25.0 65.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.239 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.23 -15.3 23.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.766 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.2 -4.97 8.39 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.646 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -167.07 165.96 15.41 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.932 0.396 . . . . 0.0 110.844 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.72 HG23 HD23 ' A' ' 76' ' ' LEU . 89.0 m -138.79 120.85 10.35 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.452 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.679 ' HD2' HD21 ' A' ' 43' ' ' LEU . 93.0 Cg_endo -80.61 162.11 21.8 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.087 1.858 . . . . 0.0 111.638 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -74.01 -27.9 61.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 0.0 110.849 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.789 HG21 HG23 ' A' ' 115' ' ' VAL . 3.3 p -145.14 154.95 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.734 HD11 HG21 ' A' ' 39' ' ' VAL . 9.5 tp -152.98 136.75 16.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 111.342 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.659 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -111.45 122.59 48.25 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.924 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -106.83 137.95 43.91 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.474 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 29.1 t0 -73.02 171.33 13.06 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.342 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.675 HG13 ' O ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -157.97 93.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.383 -178.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.83 44.12 2.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.579 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 8.1 ttp 59.89 46.14 1.26 Allowed Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 55.2 Cg_endo -71.1 -73.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.296 1.997 . . . . 0.0 112.188 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.412 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -112.15 -27.73 3.85 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.233 -0.508 . . . . 0.0 111.851 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.943 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 16.0 ttm -155.63 64.39 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.361 . . . . 0.0 110.456 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.675 ' O ' HG13 ' A' ' 55' ' ' ILE . 2.4 t70 71.87 -23.54 0.19 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.172 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.614 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 136.44 -29.55 2.78 Favored Glycine 0 CA--C 1.506 -0.505 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.874 ' HA ' HD23 ' A' ' 66' ' ' LEU . 2.2 mp -70.11 -19.85 63.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.891 -0.655 . . . . 0.0 110.296 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.943 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.64 -30.75 44.43 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.128 0.49 . . . . 0.0 109.819 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.554 HD11 ' C ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -59.63 -48.39 81.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.537 178.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.874 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.5 mm? -48.74 -41.72 33.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.018 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.713 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 16.9 tttp -58.78 -43.73 90.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.351 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -62.73 -38.83 92.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.221 0.534 . . . . 0.0 110.648 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 66' ' ' LEU . 73.5 mt -57.41 -40.22 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.814 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.713 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.34 -22.56 47.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.15 -43.5 86.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.862 0.363 . . . . 0.0 111.85 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -99.3 -31.97 11.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.037 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.546 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 1.9 m-70 -112.68 138.2 21.99 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.764 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.37 -68.15 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.261 1.974 . . . . 0.0 112.554 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mpp? -148.45 53.67 1.01 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 110.736 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.79 HD22 ' HD2' ' A' ' 77' ' ' PRO . 3.1 tm? -55.26 115.06 8.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.419 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.79 ' HD2' HD22 ' A' ' 76' ' ' LEU . 10.0 Cg_endo -53.5 121.51 9.62 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.615 2.21 . . . . 0.0 112.213 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.79 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.2 t -127.99 149.36 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.22 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.699 HG21 HD23 ' A' ' 114' ' ' LEU . 1.6 mp -137.4 116.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.586 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.752 HG22 ' H ' ' A' ' 82' ' ' THR . 25.3 mm -92.65 142.98 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.276 0.56 . . . . 0.0 111.944 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.524 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.87 -9.7 59.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.984 -178.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.752 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.4 m -147.6 152.45 37.94 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.611 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.804 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -161.66 73.51 0.43 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.494 ' CD2' ' H ' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -96.62 -21.12 17.83 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.29 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.3 m -159.84 175.76 12.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.049 0.452 . . . . 0.0 111.451 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.631 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER 54.42 29.25 10.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.411 -179.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.496 HD13 ' CB ' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -50.56 -21.06 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.546 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -47.81 -52.68 17.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.678 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -68.56 -19.77 64.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.315 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.66 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -66.75 -54.43 22.87 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.833 0.349 . . . . 0.0 111.011 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.647 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 4.1 t -62.23 -45.06 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.5 p -60.7 -27.05 67.58 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -59.09 -50.18 75.04 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.483 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.647 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -59.68 -33.63 71.82 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.901 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -39.72 69.48 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.449 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.58 ' HB2' ' CB ' ' A' ' 70' ' ' LYS . 7.6 pt20 -93.3 -7.42 44.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 132.02 82.36 0.22 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.766 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.79 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.46 139.18 2.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.559 0.218 . . . . 0.0 110.552 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 38.1 t80 -74.94 -53.76 8.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.347 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.701 ' OD2' HD11 ' A' ' 114' ' ' LEU . 38.5 p-10 177.71 -168.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.0 111.256 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.804 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 7.6 m-85 -123.1 152.76 40.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.802 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 103' ' ' PRO . 0.7 OUTLIER -143.02 142.79 22.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.759 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.669 ' O ' HD12 ' A' ' 102' ' ' LEU . 56.1 Cg_exo -51.68 165.44 0.73 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.382 2.054 . . . . 0.0 111.889 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -41.16 -51.05 8.07 Favored Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 3.9 Cg_endo -47.62 164.1 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.868 1.712 . . . . 0.0 110.353 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.86 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 174.98 -85.59 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.174 -0.211 . . . . 0.0 111.089 -179.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 48.4 -174.16 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.761 ' CD1' HD22 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -57.7 -49.95 79.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.191 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.505 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.2 t70 -50.99 -58.89 4.91 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.154 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.86 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 7.6 mm-40 -81.18 -28.67 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.73 -47.74 10.86 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.951 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.686 HG21 HG23 ' A' ' 108' ' ' ILE . 59.5 t -62.09 -32.68 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.591 0.71 . . . . 0.0 109.733 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.64 -50.36 74.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.913 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.701 HD11 ' OD2' ' A' ' 100' ' ' ASP . 15.4 tp -75.69 -21.15 57.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.747 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.789 HG23 HG21 ' A' ' 50' ' ' VAL . 4.1 p -79.52 -48.14 21.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.836 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.439 ' N ' HG13 ' A' ' 115' ' ' VAL . 49.8 mt-10 -65.72 -39.95 91.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.918 0.389 . . . . 0.0 110.326 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.8 mtp85 -65.38 -23.88 67.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.763 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -75.01 -49.1 20.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.221 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.8 mt -68.0 -30.69 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.714 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.5 m -73.32 -40.0 64.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.877 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 27.6 m80 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.009 179.9 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.898 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.898 HD13 ' C ' ' A' ' 4' ' ' GLY . 2.8 mm -124.42 118.85 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.056 HG23 HG13 ' A' ' 50' ' ' VAL . 9.0 p -105.68 122.85 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.952 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.911 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.2 m0 -107.87 137.41 45.93 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.674 -0.41 . . . . 0.0 109.975 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -131.06 144.45 37.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.331 -177.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.096 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -133.95 105.29 6.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.142 178.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 64.2 t0 166.9 118.3 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.442 ' CB ' HG12 ' A' ' 15' ' ' ILE . 2.4 t0 71.02 -16.36 0.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.1 t0 67.81 -139.63 0.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.253 -0.279 . . . . 0.0 110.985 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 t -32.82 -43.17 0.09 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.505 ' O ' HG23 ' A' ' 18' ' ' VAL . 36.1 t -53.15 -69.65 0.11 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 25.9 mm -63.94 -20.79 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.638 ' HA ' HG21 ' A' ' 32' ' ' THR . 7.1 ttp180 -68.03 -58.48 4.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.495 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 77.3 t90 -51.13 -44.87 61.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.735 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.805 HG12 HD13 ' A' ' 108' ' ' ILE . 2.4 t -62.92 -61.04 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.13 0.49 . . . . 0.0 111.975 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.683 HD23 HG21 ' A' ' 8' ' ' VAL . 14.2 tp -72.28 -21.69 61.32 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 14.6 pt-20 -66.93 -56.06 11.86 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.408 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.533 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -62.78 -56.93 13.09 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.459 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.82 -49.5 70.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 111.929 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.5 tm? -69.78 -24.07 63.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.181 0.515 . . . . 0.0 110.339 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.07 -32.74 70.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.4 -27.11 67.25 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.231 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.31 -15.38 59.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 110.513 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.71 24.5 13.42 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.873 -0.68 . . . . 0.0 114.214 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.618 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -124.14 164.15 20.04 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 118.32 1.06 . . . . 0.0 112.438 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.659 ' HB ' HG23 ' A' ' 5' ' ' ILE . 99.7 m -84.66 136.79 33.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.926 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -127.57 111.53 13.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.715 -179.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.911 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -123.55 147.33 47.38 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 71.7 p -126.25 159.49 32.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.469 0.652 . . . . 0.0 112.658 -178.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.096 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.2 m-85 -136.13 174.12 10.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.987 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.562 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -54.52 -51.17 65.97 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -177.002 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.589 ' N ' HG12 ' A' ' 9' ' ' VAL . 11.3 m-20 -171.24 -20.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.648 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . 169.46 -45.61 0.21 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.732 -1.223 . . . . 0.0 114.13 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.555 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -61.04 -39.17 88.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.447 0.624 . . . . 0.0 111.415 -178.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.857 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -57.86 -54.17 49.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.493 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.736 HG21 ' CG2' ' A' ' 9' ' ' VAL . 2.6 t -51.53 -47.19 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.322 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.834 HD13 ' HB3' ' A' ' 68' ' ' GLN . 15.0 mt -48.01 -43.58 30.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.91 -48.67 65.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.903 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.91 -27.68 67.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.28 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.607 HD13 ' NE2' ' A' ' 73' ' ' HIS . 17.6 mt -73.01 -23.96 60.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.946 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.83 -19.62 6.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.475 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.19 3.16 5.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.52 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -153.99 154.52 33.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.897 0.38 . . . . 0.0 111.518 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.743 HG23 HD13 ' A' ' 76' ' ' LEU . 75.9 m -138.86 113.18 8.36 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.426 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.542 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 72.7 Cg_endo -74.17 165.58 31.59 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.324 2.016 . . . . 0.0 111.266 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.427 ' OD2' ' HA2' ' A' ' 4' ' ' GLY . 93.5 m-20 -77.53 -30.67 52.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.855 0.359 . . . . 0.0 110.894 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.056 HG13 HG23 ' A' ' 6' ' ' VAL . 7.6 p -146.52 102.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.486 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.682 ' HB2' HD21 ' A' ' 76' ' ' LEU . 61.3 tp -87.26 137.19 32.56 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.844 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.6 mt -119.14 122.46 42.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.31 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.66 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -119.16 148.35 43.18 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.588 ' O ' HD21 ' A' ' 65' ' ' LEU . 7.0 t0 -76.66 -167.0 0.74 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.558 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.806 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -165.4 72.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.832 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 29.2 ttt180 177.18 63.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.954 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.485 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 1.1 tmm? -163.27 -61.85 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.86 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.723 ' HB2' ' HB3' ' A' ' 64' ' ' ALA . 33.0 Cg_endo -61.82 -171.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.394 2.063 . . . . 0.0 112.689 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.11 -78.61 0.1 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.437 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.644 ' O ' ' N ' ' A' ' 62' ' ' GLY . 2.7 mtt -69.91 64.52 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.394 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.461 ' HB2' ' CE1' ' A' ' 84' ' ' HIS . 6.0 p-10 48.73 -66.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.543 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.806 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -143.51 -39.63 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.82 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.82 HD23 ' HB2' ' A' ' 90' ' ' ALA . 1.8 mp -51.65 -25.18 6.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.414 . . . . 0.0 110.291 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.723 ' HB3' ' HB2' ' A' ' 58' ' ' PRO . . . -55.55 -33.62 64.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.373 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.588 HD21 ' O ' ' A' ' 54' ' ' ASP . 3.5 pp -65.17 -25.68 67.84 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.847 ' HA ' HD12 ' A' ' 69' ' ' ILE . 6.2 mp -66.1 -41.55 90.45 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 22.1 mmtm -53.06 -50.93 63.35 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.784 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.834 ' HB3' HD13 ' A' ' 40' ' ' LEU . 1.8 mt-30 -53.36 -43.89 68.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.76 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.995 HG23 ' CE1' ' A' ' 73' ' ' HIS . 61.6 mt -55.68 -45.53 79.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.003 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.525 ' CB ' ' HG3' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -63.71 -28.21 69.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.121 0.486 . . . . 0.0 110.67 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.44 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 4.3 mt-30 -77.07 -41.14 43.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.236 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -93.57 -73.2 0.57 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.372 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.995 ' CE1' HG23 ' A' ' 69' ' ' ILE . 7.6 p80 -110.55 76.97 1.2 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.75 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.456 ' HB2' ' OE1' ' A' ' 96' ' ' GLN . 72.7 Cg_endo -77.25 29.44 0.42 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.963 2.442 . . . . 0.0 114.011 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.0 mtp -134.19 -32.07 1.08 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.855 0.36 . . . . 0.0 111.564 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.743 HD13 HG23 ' A' ' 47' ' ' THR . 5.6 tp -66.34 141.87 97.47 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.306 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.561 ' HD2' HD12 ' A' ' 76' ' ' LEU . 78.7 Cg_endo -76.87 131.43 12.18 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.819 2.346 . . . . 0.0 112.304 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.763 HG21 HD13 ' A' ' 69' ' ' ILE . 2.7 t -111.41 141.52 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.058 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.689 HG21 HD23 ' A' ' 114' ' ' LEU . 2.6 mt -130.28 115.93 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.434 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 66' ' ' LEU . 32.2 mm -93.64 145.82 7.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.042 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.687 ' HA ' HD23 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -80.83 -24.64 38.32 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.347 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.624 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.0 m -148.03 149.44 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.755 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.771 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -126.93 68.23 1.26 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.754 0.311 . . . . 0.0 111.304 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.461 ' CE1' ' HB2' ' A' ' 61' ' ' ASP . 9.0 p80 -98.08 111.2 23.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.026 0.441 . . . . 0.0 111.569 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 t 54.39 168.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.022 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.553 ' HB2' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER 62.19 14.71 6.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.518 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.479 ' HA ' HD21 ' A' ' 63' ' ' LEU . 1.4 mt -46.38 -25.14 0.6 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -48.61 -41.12 29.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.865 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.494 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.93 -22.08 62.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.82 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -69.76 -34.51 73.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.942 0.401 . . . . 0.0 110.588 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.707 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.2 t -61.19 -45.15 99.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.141 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.591 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 20.6 m -57.99 -48.78 78.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.561 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.675 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -47.21 -43.67 21.75 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.154 0.502 . . . . 0.0 110.943 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.707 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 11.2 m-85 -54.89 -26.31 34.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.044 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.639 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.5 -48.07 61.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.341 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.639 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 26.7 mm-40 -72.5 -18.8 61.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.721 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.38 27.83 1.42 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.845 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.675 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -62.21 146.78 49.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.349 0.574 . . . . 0.0 110.295 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 45.4 t80 -74.18 -54.14 8.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.109 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 0.9 OUTLIER 166.99 -162.69 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.157 0.503 . . . . 0.0 111.445 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.771 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.4 m-85 -131.31 153.21 49.81 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.355 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.874 HD22 ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -141.53 149.89 55.66 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.963 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 29.0 Cg_endo -64.42 161.21 35.71 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.493 2.129 . . . . 0.0 111.426 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -33.58 -51.25 0.79 Allowed Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.1 Cg_endo -47.47 162.41 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.729 1.619 . . . . 0.0 110.345 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.874 ' CE1' HD22 ' A' ' 102' ' ' LEU . 0.1 OUTLIER 177.85 -79.45 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.064 -178.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 3.0 p30 42.54 -168.27 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.862 HG23 HG21 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -67.98 -47.19 79.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.825 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -51.95 -57.98 7.85 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.773 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.67 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 13.5 mm-40 -77.45 -31.88 54.12 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.699 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . . . -83.32 -49.93 8.88 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.537 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.862 HG21 HG23 ' A' ' 108' ' ' ILE . 44.4 t -59.47 -31.54 46.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.526 0.679 . . . . 0.0 109.758 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.84 -51.34 70.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.964 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.689 HD23 HG21 ' A' ' 79' ' ' ILE . 6.9 tp -75.86 -21.59 57.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.641 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.2 p -79.44 -48.15 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.023 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.435 ' N ' HG13 ' A' ' 115' ' ' VAL . 40.7 mt-10 -65.09 -40.52 94.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.699 0.285 . . . . 0.0 110.769 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.558 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 2.4 ptm85 -62.6 -25.07 67.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 0.0 110.394 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -70.61 -49.81 43.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.077 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.6 mt -66.38 -31.87 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -31.98 70.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.715 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.956 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.356 -0.297 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 1.4 mp -114.96 120.96 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.798 0.333 . . . . 0.0 111.211 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.98 HG23 HG13 ' A' ' 50' ' ' VAL . 7.5 p -114.23 120.77 64.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.321 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.943 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.8 m0 -111.04 136.46 50.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.744 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -122.12 137.89 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.888 -178.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -121.43 115.25 46.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.157 0.503 . . . . 0.0 110.068 178.138 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 7.5 t70 -168.35 -154.45 0.14 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.597 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -66.32 -3.17 5.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 65.56 -154.08 0.26 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.263 -0.273 . . . . 0.0 111.107 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.407 ' HB3' ' H ' ' A' ' 14' ' ' SER . 3.5 t 34.56 -89.12 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.792 ' O ' HG23 ' A' ' 18' ' ' VAL . 17.1 m -54.22 -58.81 5.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.724 0.297 . . . . 0.0 111.395 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.48 ' O ' HD23 ' A' ' 19' ' ' LEU . 26.4 mm -62.96 -30.53 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.937 0.398 . . . . 0.0 110.937 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.721 ' HA ' HG21 ' A' ' 32' ' ' THR . 22.5 ttt85 -72.36 -47.46 49.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.947 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.421 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 52.6 t90 -60.4 -40.92 92.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 14' ' ' SER . 1.7 t -74.24 -43.09 50.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.97 0.414 . . . . 0.0 111.557 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.693 HD22 ' CD1' ' A' ' 108' ' ' ILE . 3.9 mm? -77.02 -27.57 54.63 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.1 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.664 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 16.7 pt-20 -67.89 -59.77 3.03 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.925 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.513 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -68.58 -55.96 9.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.09 -51.39 58.0 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.91 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.5 tp -67.35 -23.3 65.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.413 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -68.22 -36.64 79.84 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.36 -24.44 65.63 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.203 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.672 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.43 -15.6 58.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.741 0.305 . . . . 0.0 110.91 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.61 26.14 9.41 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.988 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.738 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.66 170.37 11.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.759 0.78 . . . . 0.0 111.808 179.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.3 m -101.4 105.88 16.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.343 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.664 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 4.9 t -102.25 114.57 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.992 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.943 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -123.79 150.38 44.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.721 HG21 ' HA ' ' A' ' 16' ' ' ARG . 70.8 p -122.06 163.78 18.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.894 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.2 m-85 -136.4 175.43 9.62 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.755 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.621 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.9 pp20? -60.35 -55.69 30.52 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -177.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 5.6 m-80 -150.81 -43.89 0.12 Allowed 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.736 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 177.51 -46.03 0.1 OUTLIER Glycine 0 C--N 1.318 -0.454 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.353 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.647 ' ND2' HD12 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -63.25 -27.73 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.796 0.332 . . . . 0.0 110.6 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -58.59 -55.45 34.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.712 179.392 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.83 HG21 HG22 ' A' ' 9' ' ' VAL . 3.4 t -50.53 -38.92 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.965 0.412 . . . . 0.0 111.123 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.647 HD12 ' ND2' ' A' ' 37' ' ' ASN . 13.3 mt -59.38 -44.07 92.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.52 -49.93 55.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.065 0.459 . . . . 0.0 111.108 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.09 -33.02 74.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.824 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.628 HD13 ' NE2' ' A' ' 73' ' ' HIS . 15.6 mt -62.15 -23.83 66.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.05 -20.42 16.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.791 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -116.56 -6.15 11.66 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -159.27 158.2 32.03 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.929 0.395 . . . . 0.0 111.012 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.9 m -138.71 114.93 8.76 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.954 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.597 ' CD ' HD21 ' A' ' 43' ' ' LEU . 91.0 Cg_endo -81.73 165.05 18.1 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.117 1.878 . . . . 0.0 111.53 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 5' ' ' ILE . 3.9 p30 -74.25 -59.81 2.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.123 0.487 . . . . 0.0 110.086 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.04 HG21 HG23 ' A' ' 115' ' ' VAL . 12.0 p -99.48 160.58 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.201 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 7' ' ' TRP . 32.1 tp -153.07 153.12 32.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.138 0.494 . . . . 0.0 111.676 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.955 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.2 mt -137.24 120.78 17.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.042 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.459 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -105.31 134.44 48.42 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.571 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 9.2 t70 -61.71 -28.43 69.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.636 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.937 HG21 HG22 ' A' ' 80' ' ' ILE . 0.3 OUTLIER 41.8 92.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.772 -179.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.547 ' O ' ' HG3' ' A' ' 57' ' ' MET . 0.0 OUTLIER -175.3 104.86 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.193 0.52 . . . . 0.0 112.124 179.237 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.547 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER 40.03 47.91 1.96 Allowed Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 178.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.634 ' HG3' ' HA2' ' A' ' 62' ' ' GLY . 98.6 Cg_endo -90.76 -53.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.511 2.141 . . . . 0.0 111.693 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.01 -21.9 0.12 Allowed Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.66 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.991 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 3.6 tpt -163.98 67.21 0.17 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.658 0.383 . . . . 0.0 110.071 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 71.95 -22.56 0.2 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.616 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.806 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 136.65 -27.68 2.93 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.74 ' HA ' HD23 ' A' ' 66' ' ' LEU . 5.1 mp -77.1 -19.97 56.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.991 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.77 -32.65 53.19 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.003 0.43 . . . . 0.0 110.455 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.548 HD13 ' HA3' ' A' ' 36' ' ' GLY . 14.7 mt -57.23 -44.42 83.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.538 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.029 HD11 HD11 ' A' ' 80' ' ' ILE . 3.5 mm? -55.02 -44.79 74.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.93 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.654 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -52.71 -45.06 66.76 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.17 179.591 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -67.45 -31.1 71.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.037 0.446 . . . . 0.0 110.601 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.835 HD12 ' HA ' ' A' ' 66' ' ' LEU . 94.5 mt -63.08 -41.06 91.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.755 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 3.4 pttp -74.76 -22.78 58.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.347 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.457 ' NE2' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -81.75 -31.95 31.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.395 -179.468 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.457 ' HG3' ' NE2' ' A' ' 71' ' ' GLN . 41.1 mtt180 -106.81 -59.48 1.8 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 112.191 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.628 ' NE2' HD13 ' A' ' 43' ' ' LEU . 2.2 m-70 -81.4 145.13 54.76 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.302 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -95.75 102.71 0.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.219 2.613 . . . . 0.0 113.14 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.577 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.6 mtt 54.26 35.97 24.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.809 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.564 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.1 tt -64.68 110.34 3.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.632 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 49' ' ' ASP . 51.1 Cg_exo -54.02 116.87 3.33 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.164 1.91 . . . . 0.0 111.713 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.685 HG21 HD13 ' A' ' 69' ' ' ILE . 2.4 t -122.1 146.07 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.321 0.581 . . . . 0.0 112.056 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.671 HG22 HD23 ' A' ' 102' ' ' LEU . 3.2 mt -122.07 116.94 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.957 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 66' ' ' LEU . 9.3 mm -93.42 120.82 43.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.23 0.538 . . . . 0.0 112.315 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.508 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -74.35 -8.86 57.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.286 -179.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.574 ' H ' HG21 ' A' ' 55' ' ' ILE . 3.0 m -147.52 136.01 21.74 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.09 0.472 . . . . 0.0 111.948 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.811 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -134.03 84.41 2.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.137 0.494 . . . . 0.0 110.562 178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.423 ' CE1' HG21 ' A' ' 82' ' ' THR . 56.8 m-70 -66.78 -157.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.016 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -86.07 40.53 0.87 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.621 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -129.26 36.07 4.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.075 0.464 . . . . 0.0 109.98 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.705 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -45.42 -21.57 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.917 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.67 -55.12 10.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.492 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.53 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -69.42 -22.99 63.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.358 . . . . 0.0 110.654 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.705 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.69 -44.41 74.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.577 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 10.8 t -65.11 -42.66 94.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.804 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 77.6 p -67.12 -23.56 65.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.977 0.418 . . . . 0.0 109.932 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.691 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -65.99 -37.5 86.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.285 0.564 . . . . 0.0 109.835 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.618 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.9 m-85 -68.29 -23.9 64.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.282 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.1 OUTLIER -74.87 -29.55 61.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.272 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.691 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -92.19 -17.19 25.22 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.06 24.75 1.44 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.944 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.598 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -68.92 145.94 53.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.118 0.459 . . . . 0.0 110.584 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 22.9 t80 -79.45 -53.39 6.94 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.45 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t0 179.42 -164.99 0.05 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.945 0.403 . . . . 0.0 111.932 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.811 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 7.8 m-85 -137.56 122.52 18.96 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.537 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 106' ' ' PHE . 0.9 OUTLIER -123.0 142.87 39.24 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.898 -179.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.626 ' O ' HD12 ' A' ' 102' ' ' LEU . 50.9 Cg_exo -54.55 175.39 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.874 2.383 . . . . 0.0 113.07 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -43.5 -53.1 12.38 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 6.3 Cg_endo -48.73 163.42 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.832 1.688 . . . . 0.0 110.442 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.866 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 172.87 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.539 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 45.65 -171.28 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.845 HG23 HG21 ' A' ' 112' ' ' VAL . 1.1 mp -60.13 -49.94 82.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.512 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 15.6 t0 -52.31 -58.57 6.25 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.866 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -80.35 -28.12 38.15 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.96 -52.16 6.56 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.589 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.845 HG21 HG23 ' A' ' 108' ' ' ILE . 40.1 t -57.75 -33.54 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.49 0.662 . . . . 0.0 110.082 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.0 -51.62 69.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.626 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.68 HD12 ' HD2' ' A' ' 117' ' ' ARG . 9.6 tp -75.53 -21.89 57.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.045 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 1.04 HG23 HG21 ' A' ' 50' ' ' VAL . 3.0 p -79.46 -52.16 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 115' ' ' VAL . 32.3 mt-10 -58.75 -40.14 82.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.648 0.261 . . . . 0.0 111.544 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.68 ' HD2' HD12 ' A' ' 114' ' ' LEU . 9.8 ptp180 -65.91 -23.73 66.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 0.0 110.774 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.494 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -71.71 -49.41 39.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.776 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.5 mt -71.05 -31.75 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.7 t -66.08 -34.64 78.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.721 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.09 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.838 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.838 HD13 ' C ' ' A' ' 4' ' ' GLY . 3.9 mm -125.92 120.04 56.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.861 HG23 HG13 ' A' ' 50' ' ' VAL . 7.4 p -110.77 132.17 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.59 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.969 ' CD1' HG22 ' A' ' 31' ' ' THR . 35.0 m0 -119.58 127.44 52.97 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -124.2 122.05 63.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.882 HG23 ' HA ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -111.07 113.63 44.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.201 178.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.795 ' HB3' HG21 ' A' ' 15' ' ' ILE . 15.8 t0 -177.36 68.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.195 0.521 . . . . 0.0 111.464 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.8 t70 69.13 -2.14 1.9 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 14' ' ' SER . 6.6 p-10 43.25 -126.8 0.81 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.481 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.62 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 1.7 t 34.94 -82.59 0.0 OUTLIER 'General case' 0 C--N 1.343 0.304 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.755 ' O ' HG23 ' A' ' 18' ' ' VAL . 15.2 t -82.46 -48.4 11.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.655 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.795 HG21 ' HB3' ' A' ' 10' ' ' ASP . 46.6 mm -63.73 -22.4 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.745 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 0.0 OUTLIER -81.58 -55.54 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.358 . . . . 0.0 111.552 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.547 ' H ' ' HG3' ' A' ' 16' ' ' ARG . 85.1 t90 -48.78 -41.69 33.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -70.44 -61.43 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.432 . . . . 0.0 112.058 -178.63 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.54 HD23 HG11 ' A' ' 8' ' ' VAL . 8.3 tp -66.3 -27.36 67.86 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.659 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.504 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . 12.4 pt-20 -67.7 -58.35 4.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.134 0.492 . . . . 0.0 111.446 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.491 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -54.39 -64.68 0.75 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.086 -179.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.34 -27.39 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.796 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.7 tm? -82.14 -29.85 31.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.383 0.611 . . . . 0.0 110.467 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.44 73.51 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.55 -26.79 70.04 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.393 -0.908 . . . . 0.0 110.95 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.426 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.27 -15.52 58.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.97 24.54 11.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.051 0.78 . . . . 0.0 115.051 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.67 HD13 HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -126.18 164.15 21.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.611 1.205 . . . . 0.0 112.372 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.805 ' HB ' HG23 ' A' ' 5' ' ' ILE . 79.0 m -79.75 129.09 34.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.038 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 1.8 p -121.67 111.2 16.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.976 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.969 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -135.85 134.03 38.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.745 ' OG1' ' HB3' ' A' ' 16' ' ' ARG . 43.6 p -115.61 155.09 28.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.687 ' CE1' HG23 ' A' ' 31' ' ' THR . 0.0 OUTLIER -136.58 174.1 10.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.226 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.535 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -58.42 -108.9 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.686 ' O ' HG11 ' A' ' 9' ' ' VAL . 24.3 m-80 -85.86 -179.92 6.91 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.565 ' CA ' ' HG ' ' A' ' 65' ' ' LEU . . . -68.71 0.25 14.83 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.391 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.495 ' ND2' HD12 ' A' ' 40' ' ' LEU . 1.8 t-20 -81.28 -41.69 21.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.668 0.734 . . . . 0.0 109.507 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.535 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -51.92 -55.31 21.04 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.992 179.102 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.622 HG11 HD11 ' A' ' 51' ' ' LEU . 33.2 t -44.15 -35.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.151 0.501 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.495 HD12 ' ND2' ' A' ' 37' ' ' ASN . 14.1 mt -61.84 -50.12 73.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.485 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.99 -48.26 82.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.324 0.583 . . . . 0.0 110.864 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.32 73.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.38 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.676 HD21 ' HD2' ' A' ' 48' ' ' PRO . 10.9 mt -66.62 -24.07 66.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.156 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.94 -18.4 60.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.669 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.55 -8.15 11.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -159.69 159.37 32.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.586 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.559 HG23 HD13 ' A' ' 76' ' ' LEU . 99.3 m -138.8 113.49 8.45 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.688 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.676 ' HD2' HD21 ' A' ' 43' ' ' LEU . 89.1 Cg_endo -80.0 165.34 21.89 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.215 1.944 . . . . 0.0 111.26 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.676 ' O ' ' HD2' ' A' ' 77' ' ' PRO . 3.3 p30 -74.38 -59.03 2.91 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.544 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.861 HG13 HG23 ' A' ' 6' ' ' VAL . 7.6 p -101.72 162.11 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.393 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.636 HD22 HD21 ' A' ' 76' ' ' LEU . 42.4 tp -152.86 152.25 31.33 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.013 0.435 . . . . 0.0 111.705 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -137.31 120.91 17.25 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.936 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.882 ' HA ' HG23 ' A' ' 9' ' ' VAL . 49.1 m -109.07 137.15 47.42 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 39.6 t0 -65.9 -20.59 66.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.694 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.686 HG21 ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER 47.22 79.71 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 112.106 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 171.36 85.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.487 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.651 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -163.3 -66.89 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.684 ' HG2' ' HB3' ' A' ' 64' ' ' ALA . 87.1 Cg_endo -77.4 -165.7 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.451 2.1 . . . . 0.0 113.677 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.98 -51.01 61.76 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.844 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.726 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -74.28 45.41 0.22 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 110.563 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 55.81 -82.15 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.658 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -143.12 -31.92 0.1 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.926 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.668 HD12 ' H ' ' A' ' 63' ' ' LEU . 1.4 mp -49.92 -26.85 4.53 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.726 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -55.33 -30.98 61.3 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.997 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.565 ' HG ' ' CA ' ' A' ' 36' ' ' GLY . 2.3 mm? -60.94 -50.21 74.34 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.983 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.775 HD23 HD12 ' A' ' 69' ' ' ILE . 51.7 mt -49.65 -46.48 49.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.092 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -50.28 -46.59 55.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.211 0.529 . . . . 0.0 110.176 179.404 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -63.38 -38.63 91.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.525 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.775 HD12 HD23 ' A' ' 66' ' ' LEU . 75.2 mt -61.35 -40.85 87.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.521 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 44.5 pttt -72.24 -21.35 61.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.19 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -31.8 62.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.586 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -106.25 -24.0 12.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.031 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.553 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 40.8 m-70 -141.97 86.16 10.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.71 15.57 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.01 2.473 . . . . 0.0 113.127 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.572 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 11.9 mtt -145.36 4.83 1.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.636 HD21 HD22 ' A' ' 51' ' ' LEU . 15.9 tp -76.39 107.44 4.59 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 49' ' ' ASP . 39.3 Cg_exo -58.99 121.14 9.45 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.578 2.185 . . . . 0.0 111.732 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.687 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.3 t -120.64 150.52 23.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.488 0.661 . . . . 0.0 111.922 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.677 ' O ' HD23 ' A' ' 52' ' ' LEU . 3.7 mt -131.79 116.32 30.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.634 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.785 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 13.4 mm -93.43 137.92 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.635 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -85.41 -15.19 43.88 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.512 -179.199 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.686 ' O ' HG21 ' A' ' 55' ' ' ILE . 2.7 m -147.27 163.66 35.69 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.06 -47.62 3.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 110.973 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 44.56 59.37 3.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.978 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 52.37 -170.5 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.782 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.553 ' HB2' HD13 ' A' ' 63' ' ' LEU . 54.1 m-20 59.94 31.88 20.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.52 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.854 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -46.48 -24.25 0.49 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.723 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.81 -45.56 29.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.24 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.595 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.78 -23.07 62.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.675 0.274 . . . . 0.0 111.411 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.854 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -66.81 -46.39 75.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.742 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.7 t -61.3 -36.85 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.8 m -60.93 -41.23 95.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.213 0.53 . . . . 0.0 110.237 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.721 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -54.76 -49.06 71.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.117 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.618 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 8.7 m-85 -51.39 -27.76 10.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.596 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.574 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -70.4 -39.75 74.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.315 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.574 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 7.2 pt20 -77.97 -18.18 56.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.028 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.0 4.99 5.41 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.378 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.721 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -53.1 132.71 38.56 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.269 0.535 . . . . 0.0 110.751 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.792 ' CD2' ' HB2' ' A' ' 118' ' ' ALA . 8.6 t80 -64.14 -53.44 49.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.488 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 0.4 OUTLIER 175.75 -161.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.041 0.448 . . . . 0.0 111.904 -179.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.785 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.7 m-85 -132.57 135.86 46.2 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.136 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 103' ' ' PRO . 1.3 pp -126.59 136.49 28.77 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.842 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.814 ' O ' HD12 ' A' ' 102' ' ' LEU . 52.7 Cg_exo -51.68 172.13 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.271 1.98 . . . . 0.0 111.908 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.613 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -41.86 -49.8 10.52 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.649 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.9 Cg_endo -47.91 164.4 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 121.94 1.76 . . . . 0.0 110.704 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.815 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 173.86 -90.16 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.287 -0.165 . . . . 0.0 111.064 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.4 p30 50.98 -178.85 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.754 ' HA ' HG23 ' A' ' 112' ' ' VAL . 1.2 mp -54.46 -49.49 65.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.442 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 9.6 t0 -51.89 -58.79 5.45 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.815 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 4.8 mm-40 -82.41 -27.83 31.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . . . -84.1 -47.27 11.08 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.873 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.754 HG23 ' HA ' ' A' ' 108' ' ' ILE . 53.4 t -62.73 -32.03 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.493 0.663 . . . . 0.0 109.505 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.32 -49.89 75.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.144 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.494 ' CD2' ' HB3' ' A' ' 102' ' ' LEU . 8.3 tp -75.64 -20.94 58.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.433 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.1 p -79.26 -49.41 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 115' ' ' VAL . 34.7 mt-10 -65.35 -44.24 88.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.631 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 117' ' ' ARG . 6.4 mmt180 -63.02 -23.88 67.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.408 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.792 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -73.18 -49.45 27.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.053 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.458 HG12 ' OD1' ' A' ' 49' ' ' ASP . 3.7 mt -67.02 -31.11 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.817 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 t -66.74 -43.11 85.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.752 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.7 m80 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.984 179.899 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.854 -0.098 . . . . 0.0 112.854 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 48' ' ' PRO . 3.4 mp -117.41 115.8 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 0.0 111.512 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.785 HG11 ' HG ' ' A' ' 23' ' ' LEU . 8.3 p -107.11 122.44 61.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.938 ' CD1' HG22 ' A' ' 31' ' ' THR . 35.2 m0 -112.42 137.92 49.91 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.587 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.709 HG13 ' HB2' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -126.55 147.92 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.095 -178.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -134.65 121.14 34.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.084 178.075 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.499 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 14.6 t0 -177.33 -147.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.905 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.53 -2.18 4.44 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 14' ' ' SER . 2.3 t70 55.49 -143.03 0.75 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 t 33.2 -90.22 0.01 OUTLIER 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.837 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.8 m -57.8 -52.84 63.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.704 0.288 . . . . 0.0 111.357 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 14.6 mm -62.62 -36.28 74.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.943 0.401 . . . . 0.0 111.556 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.509 ' HA ' HG21 ' A' ' 32' ' ' THR . 11.4 ttt-85 -68.84 -41.92 77.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.313 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.483 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . 33.3 t90 -65.12 -58.7 5.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.306 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 14' ' ' SER . 1.4 t -57.35 -43.61 82.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.106 -178.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.684 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 4.4 mm? -76.85 -31.72 57.04 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.742 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 17.0 pt-20 -64.73 -61.92 1.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.687 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.729 ' HD2' ' H ' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -52.69 -63.87 1.0 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 0.0 112.095 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.16 -35.99 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.374 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.785 ' HG ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -73.87 -30.26 62.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.886 0.374 . . . . 0.0 110.331 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.08 -35.03 79.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.76 69.28 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.129 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.39 -15.34 58.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.65 0.262 . . . . 0.0 111.03 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.64 26.03 10.25 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.73 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -137.44 176.0 9.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.46 0.63 . . . . 0.0 111.316 179.7 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.587 ' O ' HG12 ' A' ' 6' ' ' VAL . 22.2 m -105.87 131.51 53.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.432 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.742 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 2.0 t -119.71 114.31 21.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.86 0.362 . . . . 0.0 111.767 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.938 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -123.08 155.27 37.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 37.8 p -129.92 157.75 41.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.148 0.499 . . . . 0.0 112.167 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.805 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.5 m-85 -133.18 173.25 11.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.614 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.731 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -63.25 -47.21 83.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.199 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.614 ' O ' HG11 ' A' ' 9' ' ' VAL . 42.9 t30 -161.64 168.47 23.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.928 0.394 . . . . 0.0 110.666 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.701 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -49.75 -11.45 0.33 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.573 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -81.91 -45.36 15.56 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.603 0.701 . . . . 0.0 109.913 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.731 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 2.0 tt0 -55.28 -51.69 65.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.019 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.676 HG21 ' CG2' ' A' ' 9' ' ' VAL . 17.9 t -51.55 -33.13 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.035 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.385 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.627 HD13 ' HB3' ' A' ' 68' ' ' GLN . 17.3 mt -57.66 -51.68 68.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.011 0.434 . . . . 0.0 110.13 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.29 -47.45 85.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.746 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.74 -34.54 78.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.096 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.569 ' CD1' HG12 ' A' ' 39' ' ' VAL . 31.5 mt -68.24 -23.87 64.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.865 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.88 -15.33 29.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.329 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.24 -7.81 11.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -164.53 160.73 20.67 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 120.988 0.423 . . . . 0.0 111.46 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.3 m -138.8 112.76 8.34 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.262 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.934 ' HD2' HD11 ' A' ' 76' ' ' LEU . 6.5 Cg_exo -74.83 165.84 30.57 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.638 2.225 . . . . 0.0 111.487 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.11 -25.71 59.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.553 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.755 HG13 HG23 ' A' ' 6' ' ' VAL . 4.2 p -145.02 161.71 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.874 ' O ' HD12 ' A' ' 79' ' ' ILE . 33.1 tp -153.03 150.28 29.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.432 0.634 . . . . 0.0 112.362 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.857 ' O ' HG23 ' A' ' 9' ' ' VAL . 6.2 mt -128.28 115.91 19.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.971 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.627 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -107.95 135.45 49.31 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 24.0 t0 -75.89 170.96 15.22 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.599 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.661 HG13 ' HA3' ' A' ' 62' ' ' GLY . 1.3 tt -158.56 92.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.349 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.411 ' O ' ' CG ' ' A' ' 57' ' ' MET . 0.1 OUTLIER -124.65 56.91 1.28 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.954 0.407 . . . . 0.0 111.446 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.481 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 5.7 ptt? 47.97 41.75 1.02 Allowed Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 57' ' ' MET . 38.0 Cg_endo -65.44 -81.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.966 1.777 . . . . 0.0 111.319 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.39 -84.61 1.8 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 1.015 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -87.77 61.18 6.31 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.6 OUTLIER 67.11 -21.9 0.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.345 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.661 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 135.79 -33.02 2.45 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.583 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 4.8 mp -65.19 -21.67 66.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.015 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.39 -36.4 61.41 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.929 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.701 ' HB3' ' HA3' ' A' ' 36' ' ' GLY . 14.1 mt -56.58 -45.91 81.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.527 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.82 ' HA ' HD12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -58.43 -49.02 78.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.209 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.488 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 7.5 tttp -53.61 -42.3 67.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.217 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.627 ' HB3' HD13 ' A' ' 40' ' ' LEU . 21.8 mm100 -62.33 -40.04 95.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.696 0.284 . . . . 0.0 111.049 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.015 HG22 ' HD2' ' A' ' 73' ' ' HIS . 28.0 mt -56.41 -51.09 68.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.219 0.533 . . . . 0.0 111.187 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.704 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -59.07 -29.63 67.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.225 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.421 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 2.2 mt-30 -69.93 -23.71 63.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.992 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -114.14 -15.05 12.29 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 1.015 ' HD2' HG22 ' A' ' 69' ' ' ILE . 1.7 p80 -106.73 166.34 11.31 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -87.12 -55.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.082 2.521 . . . . 0.0 112.278 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 19.6 mtp -157.38 43.3 0.34 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.619 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.934 HD11 ' HD2' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -72.0 113.32 19.29 Favored Pre-proline 0 N--CA 1.455 -0.188 0 C-N-CA 122.206 0.202 . . . . 0.0 111.407 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 39.9 Cg_endo -68.55 115.54 3.96 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 121.89 1.726 . . . . 0.0 111.945 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.598 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 6.1 t -98.82 150.36 5.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.082 0.467 . . . . 0.0 111.393 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.874 HD12 ' O ' ' A' ' 51' ' ' LEU . 2.1 mt -134.11 115.0 20.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.96 178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.689 HG22 ' H ' ' A' ' 82' ' ' THR . 27.6 mm -93.59 150.02 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.475 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -86.24 -20.05 29.05 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.432 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.714 HG21 ' CE1' ' A' ' 84' ' ' HIS . 3.1 m -141.17 142.25 34.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.215 0.531 . . . . 0.0 111.388 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.751 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -135.39 31.75 3.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.714 ' CE1' HG21 ' A' ' 82' ' ' THR . 1.1 p-80 -88.79 31.57 0.84 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.477 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.557 ' HB2' HD11 ' A' ' 63' ' ' LEU . 61.6 m -133.96 -161.94 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.713 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.406 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -56.34 86.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.589 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.801 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -51.2 -23.24 3.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 111.459 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.76 -44.9 39.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.958 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.583 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -66.92 -25.31 66.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.951 0.405 . . . . 0.0 111.21 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.801 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -72.57 -22.46 60.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.995 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.516 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 14.5 t -70.89 -41.39 77.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.059 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 32.8 m -65.79 -19.58 65.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.113 0.483 . . . . 0.0 109.935 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.618 ' CB ' HD22 ' A' ' 66' ' ' LEU . . . -64.52 -46.84 81.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.008 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.516 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.4 m-85 -63.93 -29.45 70.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.803 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.637 HE22 ' HD2' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -63.65 -45.52 89.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.897 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.68 ' HG2' ' HB3' ' A' ' 70' ' ' LYS . 1.4 pp0? -75.03 -18.51 60.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.628 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.64 21.16 4.39 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.533 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.652 ' HB2' ' NE2' ' A' ' 96' ' ' GLN . . . -59.18 157.04 11.13 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 117.082 0.441 . . . . 0.0 110.99 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 21.2 t80 -82.19 -53.38 6.12 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.543 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 169.86 -165.4 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.092 0.472 . . . . 0.0 111.531 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.751 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.2 m-85 -124.17 119.33 29.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.612 HD22 ' CE1' ' A' ' 106' ' ' PHE . 6.0 tp -102.51 134.95 19.65 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.77 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 11.3 Cg_endo -52.66 170.79 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.462 2.108 . . . . 0.0 111.674 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -43.63 -46.83 18.91 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.437 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.77 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 73.4 Cg_exo -48.11 163.36 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.682 1.588 . . . . 0.0 110.416 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.722 ' HD1' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -174.65 -86.66 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.694 -178.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.7 p30 43.42 -170.97 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.621 0.248 . . . . 0.0 110.445 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.845 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -67.91 -45.39 84.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.36 0.6 . . . . 0.0 111.429 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 12.9 t70 -52.8 -55.86 19.9 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.868 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.666 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -79.85 -27.98 40.1 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.722 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.28 -54.26 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.85 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.845 HG21 HG23 ' A' ' 108' ' ' ILE . 36.5 t -58.09 -33.58 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.439 0.637 . . . . 0.0 110.3 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.566 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.19 -51.61 68.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.9 0.857 . . . . 0.0 109.512 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.704 ' CD2' HG21 ' A' ' 79' ' ' ILE . 6.6 tp -76.24 -21.01 56.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.76 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.692 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.1 p -79.45 -50.28 18.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.164 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.471 ' N ' HG13 ' A' ' 115' ' ' VAL . 82.9 mt-10 -65.07 -45.13 86.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.649 0.262 . . . . 0.0 110.538 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -62.01 -26.31 68.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 0.0 110.419 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -72.48 -57.45 4.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.17 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.6 mt -68.43 -30.79 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.132 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.2 m -67.52 -45.12 76.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.026 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 4.6 m80 . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 -179.824 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.1 mp -104.23 113.28 40.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.729 0.3 . . . . 0.0 111.163 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.827 HG11 ' CD2' ' A' ' 23' ' ' LEU . 2.8 p -106.06 129.64 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.665 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.932 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.8 m0 -117.76 141.99 47.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.655 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -134.32 133.5 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.92 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -117.66 108.85 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.996 178.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 37.0 t0 166.84 120.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.436 ' HB3' HG12 ' A' ' 15' ' ' ILE . 1.1 t0 69.75 -45.2 0.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.133 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 16' ' ' ARG . 40.9 t0 75.15 -98.74 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.367 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' ASP . 5.7 p -26.67 -87.73 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.69 ' O ' HG23 ' A' ' 18' ' ' VAL . 35.3 m -54.98 -39.14 68.68 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG12 ' HB3' ' A' ' 11' ' ' ASP . 21.4 mm -68.47 -20.49 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.624 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -74.79 -58.54 3.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 111.236 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.437 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 49.9 t90 -49.96 -41.94 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.498 . . . . 0.0 112.237 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.792 HG12 HD13 ' A' ' 108' ' ' ILE . 1.6 t -70.44 -62.26 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.026 0.441 . . . . 0.0 111.734 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.61 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 3.8 mm? -63.7 -27.36 69.16 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.536 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.677 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 15.1 pt-20 -67.18 -61.06 2.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.654 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 1.1 mmm180 -67.51 -56.88 7.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.409 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -49.25 -59.58 3.55 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.931 0.396 . . . . 0.0 111.718 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.827 ' CD2' HG11 ' A' ' 6' ' ' VAL . 4.0 tp -61.4 -20.98 63.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.068 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -66.55 -38.5 87.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.97 -24.61 65.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.585 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.645 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.82 -15.59 58.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.664 0.269 . . . . 0.0 111.013 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.25 25.74 7.71 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.833 -0.698 . . . . 0.0 113.767 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.703 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.72 170.64 13.58 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 117.5 0.65 . . . . 0.0 111.609 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.0 m -107.26 105.47 15.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.086 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.746 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 2.1 t -98.94 118.1 34.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.177 0.513 . . . . 0.0 112.133 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.932 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -119.7 156.59 30.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.3 p -132.76 152.32 51.8 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.92 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -129.08 174.31 9.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.713 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -57.92 -108.46 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.501 -178.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -78.79 -68.44 0.65 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.115 0.484 . . . . 0.0 111.938 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.878 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -171.91 -33.67 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.046 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.819 HD22 HD12 ' A' ' 40' ' ' LEU . 6.0 m120 -62.14 -30.75 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.692 0.282 . . . . 0.0 110.733 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -54.22 -52.65 60.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.853 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.918 HG11 HD11 ' A' ' 51' ' ' LEU . 63.1 t -54.74 -47.14 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.048 0.451 . . . . 0.0 110.62 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.819 HD12 HD22 ' A' ' 37' ' ' ASN . 22.5 mt -50.9 -43.15 59.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.112 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.96 -47.71 67.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.274 0.559 . . . . 0.0 110.715 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.34 -31.81 73.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.5 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.632 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 10.6 mt -61.45 -26.3 67.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.111 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.73 -17.47 60.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.305 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.43 -6.21 11.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.72 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -161.88 162.21 29.16 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.828 0.347 . . . . 0.0 111.075 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.512 HG23 HD13 ' A' ' 76' ' ' LEU . 77.0 m -138.97 112.66 8.2 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.154 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.615 ' HD2' HD21 ' A' ' 43' ' ' LEU . 73.5 Cg_endo -76.58 164.31 30.65 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.899 1.733 . . . . 0.0 111.539 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.49 -23.54 58.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.809 0.338 . . . . 0.0 110.761 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.723 HG13 HG23 ' A' ' 6' ' ' VAL . 6.3 p -145.17 161.58 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.918 HD11 HG11 ' A' ' 39' ' ' VAL . 22.9 tp -151.45 148.42 28.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.524 0.678 . . . . 0.0 112.073 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.893 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 mt -135.72 126.01 26.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.792 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.595 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -111.13 145.25 38.93 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -178.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 49.6 t0 -74.16 -19.4 60.57 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.27 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.778 HD13 ' O ' ' A' ' 82' ' ' THR . 7.0 tt 44.96 86.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.63 99.44 0.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.558 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 55.39 44.85 1.76 Allowed Pre-proline 0 N--CA 1.47 0.575 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 177.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.595 ' CD ' ' HA2' ' A' ' 62' ' ' GLY . 26.8 Cg_endo -91.9 -35.87 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.958 2.439 . . . . 0.0 112.422 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.06 -24.91 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.302 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.895 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 23.3 ttt -152.43 71.43 0.94 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.69 -35.45 0.24 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.1 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.641 ' C ' HG13 ' A' ' 55' ' ' ILE . . . 157.82 -34.54 0.53 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.577 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 5.3 mp -66.85 -25.05 66.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.768 0.318 . . . . 0.0 110.485 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.895 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.98 -26.02 23.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.656 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.565 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 76.2 mt -55.96 -40.27 73.0 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.151 0.5 . . . . 0.0 110.061 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.898 ' HA ' HD12 ' A' ' 69' ' ' ILE . 4.8 mp -70.33 -39.43 74.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.049 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.709 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.0 tmtt? -55.2 -42.99 74.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.299 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.651 ' HB2' HD13 ' A' ' 40' ' ' LEU . 12.1 mm100 -69.05 -37.5 78.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.735 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.898 HD12 ' HA ' ' A' ' 66' ' ' LEU . 13.2 mt -62.83 -23.1 32.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.803 0.335 . . . . 0.0 110.849 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.709 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 2.5 mtmp? -75.18 -50.72 15.33 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.105 0.955 . . . . 0.0 109.291 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -62.13 -33.21 74.04 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.337 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.516 ' NH1' ' HB3' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -94.13 -28.7 15.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.665 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.632 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 40.5 m-70 -153.54 82.4 4.69 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.653 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.709 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 55.5 Cg_endo -71.28 31.76 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.738 2.292 . . . . 0.0 113.172 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -143.78 -37.21 0.34 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.1 0.476 . . . . 0.0 111.238 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.558 HD23 ' CG2' ' A' ' 69' ' ' ILE . 6.7 tp -50.77 129.8 28.02 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.512 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.699 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 51.9 Cg_endo -73.24 122.98 8.44 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.729 2.286 . . . . 0.0 112.181 179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.731 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.3 t -110.28 142.78 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.125 0.488 . . . . 0.0 111.253 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.815 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.1 mt -133.89 113.52 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.383 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.822 ' CG1' HD21 ' A' ' 66' ' ' LEU . 18.9 mm -93.42 137.28 22.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.102 0.477 . . . . 0.0 112.127 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.682 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.84 -4.04 59.06 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.349 -179.168 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.778 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.5 m -148.03 144.19 27.75 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.584 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.775 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -143.78 61.41 1.37 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.336 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -98.93 -22.78 15.6 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.469 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -84.33 -166.49 1.46 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.169 0.509 . . . . 0.0 111.996 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -54.76 97.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.777 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.851 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -51.24 -21.68 2.24 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.3 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -48.59 -45.04 37.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.277 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.577 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.69 -20.61 66.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.804 0.335 . . . . 0.0 110.89 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.851 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -72.98 -32.2 65.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.711 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.562 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.9 t -65.71 -42.73 93.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 19.7 m -63.49 -19.91 65.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.382 . . . . 0.0 110.012 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.724 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -66.37 -44.95 81.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.451 0.643 . . . . 0.0 109.842 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.562 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 5.0 m-85 -65.88 -23.88 66.74 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.868 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.431 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -69.1 -36.39 77.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.307 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.724 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 3.9 pp0? -86.68 -18.27 31.67 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.706 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.13 21.27 3.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.304 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.731 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -65.04 152.79 42.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.212 0.506 . . . . 0.0 110.182 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.547 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 38.6 t80 -81.96 -54.0 5.68 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.441 ' OD2' ' CD2' ' A' ' 99' ' ' PHE . 14.7 p30 174.77 -170.76 0.05 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.993 0.425 . . . . 0.0 111.685 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.775 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 5.1 m-85 -119.72 125.67 49.22 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.771 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.708 HD12 ' HD2' ' A' ' 103' ' ' PRO . 11.0 tp -102.87 139.33 20.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.458 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.714 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 20.9 Cg_endo -58.88 171.83 1.91 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.092 1.861 . . . . 0.0 111.096 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.493 ' HE3' ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -43.18 -45.88 13.98 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.714 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 87.3 Cg_exo -47.44 163.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.676 1.584 . . . . 0.0 110.843 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.802 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 3.2 t80 -167.56 -92.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.995 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 5.3 p-10 44.12 -173.79 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.654 0.264 . . . . 0.0 110.586 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.792 HD13 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.66 -47.14 81.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.386 0.612 . . . . 0.0 110.849 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.1 t70 -51.01 -58.12 6.88 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.212 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.668 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.7 mm-40 -79.13 -26.77 42.8 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.15 -53.16 5.71 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.138 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.628 HG21 HG23 ' A' ' 108' ' ' ILE . 43.9 t -59.97 -31.45 47.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.507 0.67 . . . . 0.0 110.084 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.23 -50.96 70.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.626 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.704 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 23.8 tp -75.46 -20.46 58.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.517 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.2 p -79.27 -48.03 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.055 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.447 ' N ' HG13 ' A' ' 115' ' ' VAL . 4.1 mt-10 -61.12 -45.66 93.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.726 0.298 . . . . 0.0 110.838 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.613 ' HD2' HD12 ' A' ' 114' ' ' LEU . 4.1 ptp180 -64.2 -23.73 67.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.897 0.379 . . . . 0.0 110.687 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.547 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.22 -49.46 35.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.938 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.1 mt -66.2 -30.89 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.6 m -68.37 -44.01 76.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.3 m80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 -179.761 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.885 ' O ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.232 0 N-CA-C 112.034 -0.426 . . . . 0.0 112.034 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.885 HD13 ' O ' ' A' ' 4' ' ' GLY . 6.3 mm -129.39 113.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.849 HG23 HG13 ' A' ' 50' ' ' VAL . 9.2 p -105.56 127.69 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.838 ' CD1' HG22 ' A' ' 31' ' ' THR . 24.6 m0 -114.67 132.81 56.27 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -127.99 139.8 50.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.005 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -128.38 105.37 13.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.187 179.029 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 58.1 t0 166.72 119.45 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.424 0.453 . . . . 0.0 110.682 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.407 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 72.79 -28.11 0.19 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 10' ' ' ASP . 7.9 t0 73.02 -133.38 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.978 -0.101 . . . . 0.0 110.943 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.1 t -30.71 -48.47 0.11 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.661 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.1 t -53.95 -68.18 0.2 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.654 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.588 ' CG2' HD12 ' A' ' 19' ' ' LEU . 24.8 mm -62.31 -20.76 25.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.55 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.628 ' HA ' HG21 ' A' ' 32' ' ' THR . 6.0 ttt180 -70.53 -60.57 2.19 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.651 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.519 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 57.1 t90 -49.98 -44.52 50.92 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 111.912 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.731 HG12 HD13 ' A' ' 108' ' ' ILE . 1.3 t -64.97 -59.14 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.588 HD12 ' CG2' ' A' ' 15' ' ' ILE . 56.4 mt -70.75 -26.33 63.31 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.558 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 12.8 pt-20 -63.81 -57.88 8.54 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.769 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 2.4 mmp_? -63.75 -60.04 3.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.905 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.88 -56.17 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.977 0.417 . . . . 0.0 111.85 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.531 HD12 ' CG1' ' A' ' 6' ' ' VAL . 1.5 tm? -64.95 -23.75 67.32 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.015 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -71.28 -32.6 68.87 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.56 -26.49 66.65 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.385 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.558 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.31 -15.65 59.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.812 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.01 23.09 11.86 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.798 -0.715 . . . . 0.0 114.326 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.558 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -123.45 163.62 20.52 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.418 1.109 . . . . 0.0 112.167 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.592 ' HB ' HG23 ' A' ' 5' ' ' ILE . 89.9 m -84.53 136.35 33.84 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.626 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -127.97 108.51 10.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.645 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.838 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -121.68 147.59 45.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.9 p -125.59 161.44 27.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.63 0.728 . . . . 0.0 112.958 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.005 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.3 m-85 -136.12 173.86 11.25 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.108 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.475 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.6 pp20? -61.56 -60.51 3.58 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -152.97 -23.79 0.15 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.737 ' C ' HD21 ' A' ' 65' ' ' LEU . . . 166.44 -56.83 0.24 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.067 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.483 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -47.89 -37.5 14.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.014 -179.363 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.876 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 8.3 tt0 -58.42 -55.44 34.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.742 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.747 HG21 ' CG2' ' A' ' 9' ' ' VAL . 2.9 t -51.18 -46.48 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.107 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.627 HD21 ' CD1' ' A' ' 65' ' ' LEU . 31.7 mt -46.55 -45.57 18.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.21 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.07 -48.75 69.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.113 0.482 . . . . 0.0 111.326 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.79 -35.35 79.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.45 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.595 ' HG ' HG12 ' A' ' 39' ' ' VAL . 16.6 mt -63.38 -25.37 68.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.27 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -16.95 22.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.218 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.5 t -121.11 -5.39 9.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.472 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -156.53 160.04 39.13 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.91 0.386 . . . . 0.0 111.665 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.5 m -139.2 112.0 7.94 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.625 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 58.8 Cg_endo -69.47 166.43 27.28 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.717 2.278 . . . . 0.0 111.839 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.86 -27.01 33.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.849 HG13 HG23 ' A' ' 6' ' ' VAL . 4.8 p -147.95 101.17 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.425 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.881 ' O ' HD12 ' A' ' 79' ' ' ILE . 62.7 tp -87.15 141.74 28.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.409 0.623 . . . . 0.0 112.491 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.839 ' O ' HG23 ' A' ' 9' ' ' VAL . 5.3 mt -124.35 117.51 24.65 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -112.5 146.71 37.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.743 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 20.4 t0 -77.2 179.4 6.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.95 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.757 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.1 tt -156.23 78.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.798 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 50.7 ttp85 176.71 69.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.564 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.467 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -160.9 -67.09 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.879 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 57' ' ' MET . 35.6 Cg_endo -64.86 -176.06 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.536 2.158 . . . . 0.0 113.033 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.8 -54.34 38.14 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.486 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.587 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -78.14 49.23 0.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.733 0.301 . . . . 0.0 110.75 179.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.61 -72.13 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.757 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -149.47 -35.51 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.261 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.884 ' HA ' HD23 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -54.61 -21.42 10.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.11 179.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.527 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.75 -36.23 62.1 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.737 HD21 ' C ' ' A' ' 36' ' ' GLY . 1.1 tm? -59.97 -40.92 90.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.154 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.884 HD23 ' HA ' ' A' ' 63' ' ' LEU . 4.3 mm? -54.39 -43.94 71.87 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.17 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 53.9 tttm -56.9 -43.46 81.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.319 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.583 ' HB3' HD13 ' A' ' 40' ' ' LEU . 21.0 mm100 -60.93 -34.7 75.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.233 0.54 . . . . 0.0 110.147 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.983 HG23 ' CE1' ' A' ' 73' ' ' HIS . 92.5 mt -58.92 -39.84 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.527 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -69.61 -29.03 66.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.036 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.432 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -70.89 -35.36 72.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.986 -179.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.63 -71.64 0.71 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.527 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.983 ' CE1' HG23 ' A' ' 69' ' ' ILE . 4.6 p80 -112.22 71.96 1.15 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.458 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.542 ' O ' ' HG2' ' A' ' 75' ' ' MET . 62.4 Cg_endo -73.62 50.67 2.08 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.595 2.197 . . . . 0.0 113.675 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 8.8 mtm -156.64 -39.51 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.856 HD12 ' HD2' ' A' ' 77' ' ' PRO . 8.7 tp -59.57 130.33 87.8 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-O 120.945 0.403 . . . . 0.0 112.041 -178.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.856 ' HD2' HD12 ' A' ' 76' ' ' LEU . 47.3 Cg_endo -68.55 115.29 3.83 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.307 2.671 . . . . 0.0 113.871 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.95 HG21 HD13 ' A' ' 69' ' ' ILE . 3.2 t -98.38 151.79 4.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.407 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.881 HD12 ' O ' ' A' ' 51' ' ' LEU . 2.0 mt -136.57 114.56 14.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.064 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.617 HD11 HD21 ' A' ' 66' ' ' LEU . 17.9 mm -93.7 146.03 7.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.521 ' HE2' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.45 -14.53 56.94 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.602 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.8 m -148.43 161.96 40.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.1 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.701 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -145.24 64.04 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.856 0.36 . . . . 0.0 111.246 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.471 ' CD2' ' H ' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -98.89 111.86 24.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.987 0.422 . . . . 0.0 111.558 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.8 t 60.59 161.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.647 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.474 ' HB2' HD13 ' A' ' 63' ' ' LEU . 24.9 m-20 61.91 18.99 10.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.475 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.704 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -46.44 -22.68 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -48.06 -50.17 28.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.34 -20.01 65.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.689 0.281 . . . . 0.0 111.503 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.704 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -63.95 -57.17 10.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.809 0.338 . . . . 0.0 111.008 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.614 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.3 t -62.93 -43.47 99.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.5 m -58.8 -31.68 68.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.183 0.516 . . . . 0.0 110.458 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.689 ' HB1' HD12 ' A' ' 66' ' ' LEU . . . -63.65 -43.68 96.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.36 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.614 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 2.6 m-85 -59.59 -22.19 61.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.545 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.583 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.77 -37.99 54.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.099 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.583 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 2.1 pp0? -100.04 -13.34 19.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.752 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 147.59 82.88 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.615 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.832 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.53 111.24 0.56 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.293 0.568 . . . . 0.0 111.611 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -55.22 -49.81 71.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.919 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.527 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER 173.92 -161.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.067 0.46 . . . . 0.0 111.918 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.701 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.9 m-85 -127.16 130.21 49.32 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.377 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.603 ' HB2' HD22 ' A' ' 114' ' ' LEU . 4.2 tp -108.27 142.43 25.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.11 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.677 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 17.8 Cg_endo -58.99 163.69 11.23 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.261 1.974 . . . . 0.0 111.372 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.421 ' HE2' ' OG1' ' A' ' 82' ' ' THR . 0.5 OUTLIER -36.25 -47.69 1.52 Allowed Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.613 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 84.2 Cg_exo -47.03 163.22 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.818 1.679 . . . . 0.0 110.756 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.669 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 3.6 t80 -165.55 -92.19 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.167 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.4 p-10 42.48 -173.69 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.874 0.369 . . . . 0.0 110.628 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.876 HG23 HG21 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -67.83 -47.49 79.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.285 0.564 . . . . 0.0 111.487 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 12.2 t70 -51.75 -57.58 8.86 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.713 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.669 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.5 mm-40 -78.45 -29.09 46.73 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.564 ' HB3' HD21 ' A' ' 19' ' ' LEU . . . -83.34 -54.55 4.91 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.061 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.876 HG21 HG23 ' A' ' 108' ' ' ILE . 39.6 t -57.2 -32.4 40.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.476 0.655 . . . . 0.0 110.162 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -58.84 -53.15 61.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.064 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.623 HD12 ' HD2' ' A' ' 117' ' ' ARG . 33.4 tp -74.62 -21.39 59.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.98 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.646 HG12 ' HA ' ' A' ' 112' ' ' VAL . 5.1 p -79.57 -50.16 18.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.161 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.457 ' N ' HG13 ' A' ' 115' ' ' VAL . 94.7 mt-10 -65.47 -40.07 92.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.78 0.324 . . . . 0.0 111.026 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.623 ' HD2' HD12 ' A' ' 114' ' ' LEU . 5.6 ptp180 -65.96 -27.52 68.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.461 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.19 -51.99 26.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.004 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.1 mt -65.29 -31.86 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.161 0.505 . . . . 0.0 111.033 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -43.58 76.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 2.2 mp -124.2 113.49 36.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.478 0.656 . . . . 0.0 111.022 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.885 HG23 HG13 ' A' ' 50' ' ' VAL . 10.4 p -107.21 120.36 58.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.502 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.928 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.0 m0 -112.26 145.8 39.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.069 0.461 . . . . 0.0 110.222 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.949 ' CG1' HG22 ' A' ' 32' ' ' THR . 0.2 OUTLIER -137.29 149.67 25.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -176.145 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.98 HG13 ' HB2' ' A' ' 33' ' ' PHE . 1.4 t -133.28 105.17 7.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.787 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.58 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 44.1 t0 166.85 122.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.687 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.416 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 72.04 -40.92 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.821 179.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 37.6 t0 75.28 -121.92 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.849 -0.159 . . . . 0.0 110.729 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.4 t -31.33 -47.54 0.11 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.515 ' O ' HG23 ' A' ' 18' ' ' VAL . 47.5 t -63.8 -63.32 1.2 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.342 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.961 HG22 HG21 ' A' ' 32' ' ' THR . 20.1 mm -63.21 -25.16 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.418 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.469 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 7.3 ttt180 -61.58 -58.05 9.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.02 0.438 . . . . 0.0 111.445 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.477 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 53.5 t90 -56.69 -46.28 81.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.649 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.708 HG12 HD13 ' A' ' 108' ' ' ILE . 2.0 t -65.47 -44.41 94.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.534 HD12 ' CD1' ' A' ' 108' ' ' ILE . 5.6 tp -83.06 -23.97 32.93 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.732 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 26.5 pt-20 -66.78 -56.19 11.56 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.729 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.3 mmm180 -65.51 -56.33 12.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.122 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.62 -45.65 73.73 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.811 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.3 tm? -69.21 -26.71 64.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.531 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.22 -32.44 73.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.14 -29.02 71.64 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.21 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.549 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.76 -15.37 59.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 110.982 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.45 26.06 11.43 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.695 -0.765 . . . . 0.0 113.863 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.549 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -133.74 171.2 14.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.75 0.775 . . . . 0.0 111.903 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.647 ' O ' HG12 ' A' ' 6' ' ' VAL . 25.8 m -94.27 128.82 40.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.225 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.732 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 1.8 t -122.97 120.94 34.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.264 0.554 . . . . 0.0 111.865 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.928 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -134.3 132.32 39.43 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.961 HG21 HG22 ' A' ' 15' ' ' ILE . 76.5 p -107.97 159.28 16.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.484 0.659 . . . . 0.0 112.27 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.98 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.7 m-85 -131.96 174.2 10.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.12 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.498 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -63.36 -106.78 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.92 -178.425 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.433 ' O ' HD21 ' A' ' 65' ' ' LEU . 10.9 p30 -88.85 -49.56 6.74 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.87 ' HA3' HD23 ' A' ' 65' ' ' LEU . . . 173.83 -43.37 0.15 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.066 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.607 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 25.5 m120 -53.08 -24.72 10.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 111.2 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -57.2 -60.02 4.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.43 179.419 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.722 HG21 HD11 ' A' ' 51' ' ' LEU . 72.7 t -58.65 -35.94 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.722 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.837 HD11 HE21 ' A' ' 68' ' ' GLN . 40.3 mt -47.17 -46.14 23.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 0.0 110.489 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.63 -45.95 34.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.972 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.56 -29.81 66.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.865 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.695 ' CD1' HG12 ' A' ' 39' ' ' VAL . 12.2 mt -72.05 -23.54 61.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.664 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.32 -17.71 13.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.606 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.55 -7.25 9.69 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.595 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -159.67 159.14 32.64 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.74 0.305 . . . . 0.0 111.397 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.593 HG23 HD13 ' A' ' 76' ' ' LEU . 93.5 m -138.75 114.33 8.63 Favored Pre-proline 0 N--CA 1.454 -0.263 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.713 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.686 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.9 Cg_endo -78.69 165.04 25.21 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.371 2.047 . . . . 0.0 111.331 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.03 -26.68 60.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.929 0.395 . . . . 0.0 110.451 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.885 HG13 HG23 ' A' ' 6' ' ' VAL . 10.0 p -145.11 161.09 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.722 HD11 HG21 ' A' ' 39' ' ' VAL . 13.5 tp -152.92 140.08 19.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.222 0.534 . . . . 0.0 112.3 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.88 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -104.55 137.6 42.16 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.489 179.436 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.661 ' OG ' HD22 ' A' ' 65' ' ' LEU . 26.2 t -127.72 133.98 49.55 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 32.0 t0 -83.08 172.87 12.26 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.242 0.544 . . . . 0.0 111.499 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.729 HG21 ' HB ' ' A' ' 82' ' ' THR . 0.6 OUTLIER -140.24 84.05 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.956 -179.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -111.49 36.28 3.3 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.744 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.694 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 52.87 53.28 11.81 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 178.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HG3' HD11 ' A' ' 65' ' ' LEU . 43.5 Cg_endo -75.02 -65.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.322 2.015 . . . . 0.0 111.831 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.44 -27.25 1.21 Allowed Glycine 0 CA--C 1.518 0.239 0 N-CA-C 111.824 -0.511 . . . . 0.0 111.824 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.726 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -155.09 63.09 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.694 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 4.3 p-10 54.12 -82.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.026 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.686 ' HA3' ' HB ' ' A' ' 55' ' ' ILE . . . -137.46 -24.24 0.43 Allowed Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.691 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.915 HD23 ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -77.51 -19.11 56.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.735 0.268 . . . . 0.0 111.106 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.726 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -55.14 -31.26 61.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.336 0.588 . . . . 0.0 109.897 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.87 HD23 ' HA3' ' A' ' 36' ' ' GLY . 6.6 mp -67.5 -36.27 80.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.425 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.796 HD13 ' HB2' ' A' ' 93' ' ' ALA . 14.1 mt -63.22 -42.64 99.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.912 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 50.4 tttm -55.01 -54.2 45.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.882 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.837 HE21 HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -54.75 -43.13 72.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.154 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.737 HD13 HG21 ' A' ' 78' ' ' VAL . 21.0 mt -59.17 -40.55 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.131 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -74.2 -23.07 59.15 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.981 -179.245 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -68.41 -51.21 46.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -93.48 -35.58 12.88 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.595 ' CD2' HD13 ' A' ' 43' ' ' LEU . 2.3 m-70 -99.65 144.04 27.57 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.603 -178.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 73' ' ' HIS . 27.9 Cg_exo -61.58 -70.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.623 2.215 . . . . 0.0 112.711 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 60.7 mtt -147.77 52.96 1.04 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.936 0.398 . . . . 0.0 111.516 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.593 HD13 HG23 ' A' ' 47' ' ' THR . 5.5 tp -72.34 113.8 24.03 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.639 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -53.49 132.73 50.2 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.191 1.928 . . . . 0.0 111.793 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.737 HG21 HD13 ' A' ' 69' ' ' ILE . 2.5 t -126.67 146.64 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.566 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.68 HG21 HD23 ' A' ' 114' ' ' LEU . 3.3 mt -126.88 116.39 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.955 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.822 HD13 ' CD1' ' A' ' 101' ' ' TYR . 1.4 mp -94.16 145.44 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.889 0.376 . . . . 0.0 111.306 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.708 ' HE1' HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -87.68 -22.21 24.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.248 -178.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.729 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.4 m -147.68 145.65 28.98 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.371 -0.206 . . . . 0.0 110.453 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.406 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -103.32 -29.28 11.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.73 0.3 . . . . 0.0 111.606 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.481 ' HB2' HD11 ' A' ' 55' ' ' ILE . 3.3 m-70 44.75 -92.67 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.448 ' O ' HD11 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -141.26 -172.84 3.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.942 0.401 . . . . 0.0 111.479 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 58.15 33.29 23.01 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.007 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.58 ' HA ' HD21 ' A' ' 63' ' ' LEU . 3.2 mt -48.82 -21.17 0.59 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.409 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -47.82 -44.55 28.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.636 0.255 . . . . 0.0 111.45 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -69.68 -21.61 63.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.577 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.915 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -68.11 -32.94 73.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.65 0.262 . . . . 0.0 111.026 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.533 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 9.8 t -71.27 -39.05 72.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.552 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 95.0 p -69.46 -20.23 63.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.805 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.796 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -66.84 -42.47 85.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.365 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.533 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 7.6 m-85 -64.6 -25.83 68.14 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.2 -38.51 51.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.62 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.687 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.7 pp0? -77.42 -18.45 57.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.295 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.11 -10.53 5.64 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.453 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.487 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -48.37 155.79 0.48 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.068 0.434 . . . . 0.0 111.329 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.65 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 18.7 t80 -86.41 -53.89 4.74 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.492 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER 169.23 -166.06 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.855 0.36 . . . . 0.0 111.337 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.822 ' CD1' HD13 ' A' ' 80' ' ' ILE . 3.4 m-85 -121.46 133.83 55.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.287 0.565 . . . . 0.0 111.292 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.809 HD12 ' HD2' ' A' ' 103' ' ' PRO . 3.9 tp -120.76 141.63 32.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.905 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.809 ' HD2' HD12 ' A' ' 102' ' ' LEU . 19.5 Cg_endo -56.66 168.24 2.41 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.418 2.079 . . . . 0.0 111.815 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.572 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -43.09 -54.0 9.79 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.886 -0.143 . . . . 0.0 111.179 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 7.2 Cg_endo -48.43 163.88 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.878 1.719 . . . . 0.0 110.384 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.848 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 173.81 -86.89 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.4 p30 50.12 -178.58 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.736 HG23 HG21 ' A' ' 112' ' ' VAL . 1.1 mp -55.83 -47.55 79.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.509 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 4.4 t70 -54.57 -58.63 6.72 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.822 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.848 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 5.5 mm-40 -81.93 -25.59 34.78 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.19 -51.16 7.73 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.518 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.736 HG21 HG23 ' A' ' 108' ' ' ILE . 46.5 t -61.24 -32.75 53.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.486 0.66 . . . . 0.0 110.099 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -58.98 -50.62 73.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.218 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.68 HD23 HG21 ' A' ' 79' ' ' ILE . 7.5 tp -77.1 -21.03 54.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.42 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 112' ' ' VAL . 3.0 p -78.18 -47.49 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.751 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 52.9 mt-10 -62.73 -42.4 99.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.83 0.348 . . . . 0.0 110.571 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -66.53 -24.48 66.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.612 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.65 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -73.23 -54.15 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.936 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -61.13 -31.44 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.981 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.0 t -70.06 -41.07 74.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.009 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.053 0.454 . . . . 0.0 111.024 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.4 mp -107.91 115.54 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.853 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.8 HG11 ' CD2' ' A' ' 23' ' ' LEU . 3.0 p -107.01 126.69 63.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.937 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.777 ' CD1' HG22 ' A' ' 31' ' ' THR . 32.8 m0 -114.48 147.26 39.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.886 0.374 . . . . 0.0 110.643 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.968 HG21 HD23 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -137.28 145.75 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.924 0.392 . . . . 0.0 111.669 -178.526 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.899 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -129.28 112.14 24.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.231 178.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.697 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 7.5 t70 -165.21 -154.29 0.21 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.142 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.423 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -67.05 8.77 0.25 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.422 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 10' ' ' ASP . 2.9 p30 45.39 -143.84 0.21 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t 34.97 -91.78 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.817 ' O ' HG23 ' A' ' 18' ' ' VAL . 12.2 m -58.62 -52.33 66.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.703 0.287 . . . . 0.0 111.192 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.3 mm -62.69 -29.13 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.217 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.831 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.2 OUTLIER -72.79 -57.66 3.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.806 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.412 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 77.1 t90 -50.2 -40.33 46.79 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 14' ' ' SER . 1.8 t -71.42 -56.41 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.968 HD23 HG21 ' A' ' 8' ' ' VAL . 6.0 tp -71.59 -23.02 61.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.685 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.79 -60.08 2.81 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.535 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.57 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.0 mmm180 -72.64 -52.86 13.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.866 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.465 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -50.62 -60.01 3.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.975 0.416 . . . . 0.0 111.598 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.8 ' CD2' HG11 ' A' ' 6' ' ' VAL . 4.5 tp -61.82 -22.7 65.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.288 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -67.56 -37.49 82.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.8 -24.31 68.12 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.571 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.48 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.11 -15.61 59.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.664 0.269 . . . . 0.0 110.924 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.57 24.06 7.61 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.963 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.636 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -130.37 172.14 12.18 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 117.686 0.743 . . . . 0.0 111.376 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 m -105.7 105.77 15.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.465 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.764 ' HA ' HG13 ' A' ' 6' ' ' VAL . 5.7 t -100.57 115.64 30.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.136 0.493 . . . . 0.0 112.235 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.777 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -117.82 156.33 28.54 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.831 HG21 ' HA ' ' A' ' 16' ' ' ARG . 29.8 p -130.12 161.05 31.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.229 0.537 . . . . 0.0 111.439 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.864 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.5 m-85 -133.57 174.46 10.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.42 -178.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.527 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.4 pp20? -59.04 -49.57 77.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -154.52 -51.43 0.09 Allowed 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.99 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.788 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -175.92 -44.38 0.06 OUTLIER Glycine 0 C--N 1.315 -0.597 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.967 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.635 HD22 HD12 ' A' ' 40' ' ' LEU . 4.2 m120 -62.49 -27.38 69.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.018 0.437 . . . . 0.0 110.648 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.674 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -59.65 -47.6 84.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.012 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.846 HG21 HG22 ' A' ' 9' ' ' VAL . 21.4 t -62.38 -42.07 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.977 0.418 . . . . 0.0 111.063 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.635 HD12 HD22 ' A' ' 37' ' ' ASN . 25.8 mt -52.07 -42.28 63.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.731 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.79 -48.35 38.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.199 0.523 . . . . 0.0 110.947 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.92 -32.15 72.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.009 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.696 ' CD1' HG12 ' A' ' 39' ' ' VAL . 12.9 mt -68.89 -21.32 64.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.609 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.19 -19.99 37.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.706 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.88 -1.15 6.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -153.69 153.27 31.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.942 0.401 . . . . 0.0 111.007 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.716 HG23 HD13 ' A' ' 76' ' ' LEU . 95.5 m -139.02 112.55 8.15 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.247 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.7 Cg_endo -77.42 164.2 28.96 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.944 1.763 . . . . 0.0 111.325 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.37 -25.6 59.6 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.693 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.596 HG13 HG23 ' A' ' 6' ' ' VAL . 4.8 p -145.07 159.68 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.005 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.535 HD11 HG11 ' A' ' 39' ' ' VAL . 14.9 tp -152.94 155.81 37.71 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.235 0.541 . . . . 0.0 112.179 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.899 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.7 mt -136.52 127.55 27.76 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.373 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.597 ' HB3' HD12 ' A' ' 80' ' ' ILE . 42.4 t -106.68 140.27 39.81 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.697 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 10.0 t0 -65.8 -35.87 81.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.697 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.866 HG21 HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER 45.12 90.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.971 0.415 . . . . 0.0 110.632 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.91 90.31 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.595 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 53.6 44.99 2.14 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.457 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.626 ' HG3' ' HA2' ' A' ' 62' ' ' GLY . 90.0 Cg_endo -89.3 -54.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.574 2.183 . . . . 0.0 112.139 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.43 -19.42 0.09 OUTLIER Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.633 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.947 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 3.0 tpt -163.59 69.85 0.21 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.146 0.498 . . . . 0.0 110.132 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.54 -22.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.303 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.626 ' HA2' ' HG3' ' A' ' 58' ' ' PRO . . . 139.83 -34.86 1.98 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.236 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.776 HD13 ' HB3' ' A' ' 86' ' ' ASP . 4.9 mp -72.67 -16.32 61.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.509 -0.345 . . . . 0.0 111.047 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.947 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.68 -33.34 55.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.216 0.532 . . . . 0.0 110.191 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.564 HD13 ' HA3' ' A' ' 36' ' ' GLY . 49.6 mt -60.98 -35.62 77.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.561 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.906 HD11 HD11 ' A' ' 80' ' ' ILE . 3.6 mm? -61.28 -45.04 96.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.164 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.573 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 61.2 tttt -54.44 -41.48 69.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.62 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.604 ' CB ' HD13 ' A' ' 40' ' ' LEU . 11.6 mm100 -67.46 -33.41 75.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.627 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.634 HG23 ' HD2' ' A' ' 73' ' ' HIS . 92.8 mt -63.96 -38.37 82.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.829 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.36 -24.47 46.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.758 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.426 ' NE2' ' HG2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -86.09 -34.25 20.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.825 -178.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.426 ' HG2' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -94.86 -25.57 16.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.634 ' HD2' HG23 ' A' ' 69' ' ' ILE . 1.1 m-70 -126.36 163.4 40.55 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.795 0.331 . . . . 0.0 111.265 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 40.1 Cg_endo -72.07 -81.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.571 2.181 . . . . 0.0 112.857 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.629 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.0 mpt? -138.95 48.09 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 111.152 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.716 HD13 HG23 ' A' ' 47' ' ' THR . 4.7 tp -63.72 118.01 40.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.793 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.24 119.04 5.88 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.146 1.897 . . . . 0.0 111.87 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.554 HG21 HG21 ' A' ' 69' ' ' ILE . 2.3 t -117.11 139.71 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.271 0.558 . . . . 0.0 111.554 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.768 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.9 mt -123.7 115.47 45.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.445 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.906 HD11 HD11 ' A' ' 66' ' ' LEU . 4.8 mm -93.53 127.47 45.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.637 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 1.1 ptp -80.26 -2.09 43.6 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.625 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.807 ' HB ' HG23 ' A' ' 55' ' ' ILE . 2.7 m -147.87 142.87 26.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.73 0.3 . . . . 0.0 110.715 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.913 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -162.93 65.22 0.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.908 0.385 . . . . 0.0 111.004 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -98.26 -45.57 6.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.186 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.39 165.74 17.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 111.293 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.776 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.4 OUTLIER 59.91 24.08 13.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.429 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.606 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 4.7 mt -48.73 -21.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -48.01 -55.23 10.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.662 0.268 . . . . 0.0 111.58 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.475 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -60.0 -20.56 58.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.748 0.309 . . . . 0.0 111.095 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -66.96 -39.07 87.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.44 . . . . 0.0 110.419 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.601 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 16.2 t -64.99 -45.27 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.362 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 p -61.34 -32.39 72.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 110.403 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.679 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -58.83 -39.03 80.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.115 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.601 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 20.3 m-85 -61.76 -20.9 64.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.99 0.424 . . . . 0.0 110.164 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.648 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.49 -42.51 52.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.444 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.679 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -75.66 -16.56 60.17 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.029 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.23 24.43 2.22 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.297 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.553 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -65.85 140.13 58.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.819 0.31 . . . . 0.0 110.5 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 47.9 t80 -72.52 -53.67 11.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.198 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.623 ' OD2' HD11 ' A' ' 114' ' ' LEU . 47.4 p-10 178.26 -160.69 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.709 0.29 . . . . 0.0 111.38 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.913 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 8.1 m-85 -141.87 113.36 7.71 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.726 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.653 HD11 ' O ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -105.33 142.8 25.47 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.593 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.63 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 9.4 Cg_endo -51.01 166.97 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.002 2.468 . . . . 0.0 112.212 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.701 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -40.89 -42.94 4.04 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.701 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 3.6 Cg_endo -45.99 163.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.02 1.814 . . . . 0.0 110.328 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.831 ' HE2' HD22 ' A' ' 52' ' ' LEU . 43.6 t80 -169.93 -95.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.947 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.6 p30 44.27 -172.39 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.691 0.281 . . . . 0.0 110.551 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.786 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -67.71 -47.79 78.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.14 0.495 . . . . 0.0 112.069 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 37.3 m-20 -52.29 -54.53 30.28 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.716 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.687 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.4 mm-40 -80.24 -30.11 38.47 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.5 -51.0 7.72 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.2 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.734 ' HA ' HG12 ' A' ' 115' ' ' VAL . 40.6 t -61.47 -32.91 54.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.498 0.666 . . . . 0.0 110.241 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.34 -50.55 73.16 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.818 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.623 HD11 ' OD2' ' A' ' 100' ' ' ASP . 13.6 tp -77.65 -21.17 52.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.443 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.734 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.5 p -79.44 -50.74 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.494 ' N ' HG13 ' A' ' 115' ' ' VAL . 25.5 mt-10 -62.75 -42.45 99.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 110.843 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -63.28 -23.71 67.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.436 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.498 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -73.1 -55.98 5.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.067 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.9 mt -65.47 -31.6 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.13 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.5 t -66.77 -40.18 88.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.956 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 9.2 m80 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.176 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.462 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.405 HG23 ' HB ' ' A' ' 29' ' ' THR . 2.3 mp -122.19 113.48 38.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.787 0.327 . . . . 0.0 111.357 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.798 HG23 HG13 ' A' ' 50' ' ' VAL . 11.8 p -105.45 131.51 54.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.365 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.824 ' CD1' HG22 ' A' ' 31' ' ' THR . 32.1 m0 -118.1 135.99 53.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.797 0.332 . . . . 0.0 110.764 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -127.19 138.21 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.9 -178.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.021 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -125.64 115.73 44.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.66 178.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.911 ' HB2' ' HE2' ' A' ' 81' ' ' MET . 12.5 t0 -170.95 -149.05 0.06 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.802 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -66.05 -3.04 4.69 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.443 ' OD1' ' HD3' ' A' ' 16' ' ' ARG . 2.4 t70 55.15 -141.24 0.87 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.304 0.113 . . . . 0.0 111.304 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 t 36.12 -92.25 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.811 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.2 t -60.47 -50.11 74.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.765 0.317 . . . . 0.0 111.044 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.86 -32.43 55.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 111.3 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.827 ' HA ' HG21 ' A' ' 32' ' ' THR . 11.8 ttt180 -70.98 -59.48 2.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.213 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.434 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 64.7 t90 -47.88 -44.47 29.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 14' ' ' SER . 1.9 t -67.59 -61.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.048 0.452 . . . . 0.0 111.932 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.573 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 37.1 mt -66.72 -25.63 66.62 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.615 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 19.8 pt-20 -66.05 -59.13 4.1 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.56 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.615 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.5 mmt180 -74.54 -59.94 2.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.133 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.01 -51.84 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.598 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.1 tm? -62.71 -31.99 73.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.173 0.511 . . . . 0.0 110.789 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 28' ' ' LEU . . . -65.32 -34.89 79.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.651 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.22 -24.49 67.34 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.452 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.91 -15.6 59.63 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 111.153 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.79 14.0 16.76 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.809 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -127.12 172.51 10.47 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.85 0.825 . . . . 0.0 111.449 179.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 6' ' ' VAL . 57.2 m -105.56 113.95 27.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.309 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 35.8 t -107.62 114.43 28.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.172 0.51 . . . . 0.0 111.935 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.824 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -118.12 154.23 32.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.827 HG21 ' HA ' ' A' ' 16' ' ' ARG . 44.7 p -126.35 159.52 32.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.214 0.53 . . . . 0.0 112.12 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.021 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.8 m-85 -134.18 174.05 10.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.921 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -60.4 -53.55 56.23 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -176.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -156.88 -32.09 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.885 0.766 . . . . 0.0 112.844 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.739 ' HA3' ' HG ' ' A' ' 65' ' ' LEU . . . 167.79 -51.41 0.23 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.012 -1.089 . . . . 0.0 113.383 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.537 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -56.18 -29.87 61.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.864 0.364 . . . . 0.0 110.837 -179.206 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -62.46 -53.9 48.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.8 HG21 HG22 ' A' ' 9' ' ' VAL . 4.8 t -53.81 -37.59 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.382 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.769 HD21 ' CD1' ' A' ' 65' ' ' LEU . 17.7 mt -54.21 -43.05 70.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.04 0.448 . . . . 0.0 110.441 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.87 -47.15 66.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.993 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.02 -35.02 79.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.197 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' A' ' 73' ' ' HIS . 17.3 mt -66.52 -24.5 66.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.883 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.08 -19.06 17.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.961 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.13 -8.95 9.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -149.49 157.34 43.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.396 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.589 HG23 HD23 ' A' ' 76' ' ' LEU . 67.0 m -139.2 112.66 8.05 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.361 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.524 ' CD ' HD21 ' A' ' 43' ' ' LEU . 73.9 Cg_endo -75.56 165.43 30.5 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.143 1.896 . . . . 0.0 111.298 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.85 -25.09 59.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.019 0.437 . . . . 0.0 110.334 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.798 HG13 HG23 ' A' ' 6' ' ' VAL . 6.4 p -145.84 161.99 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.807 ' O ' HD12 ' A' ' 79' ' ' ILE . 19.3 tp -152.83 144.88 23.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.504 0.668 . . . . 0.0 111.623 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.904 HD22 ' CZ ' ' A' ' 106' ' ' PHE . 2.2 mt -127.92 115.26 18.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.687 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -106.87 143.68 34.61 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.561 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 15.6 t0 -73.5 176.84 5.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.734 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.887 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 6.6 tt -153.07 81.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.69 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 172.96 54.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.341 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.429 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.23 -62.5 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.454 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.606 ' HG2' ' HA2' ' A' ' 62' ' ' GLY . 18.9 Cg_endo -56.4 -177.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.672 2.248 . . . . 0.0 112.833 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -50.44 -75.53 0.21 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.59 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.777 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -71.26 59.88 0.28 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 110.462 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.29 -73.57 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.312 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.887 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.77 -35.82 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.083 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.868 ' HA ' HD23 ' A' ' 66' ' ' LEU . 2.8 mp -55.24 -24.11 26.02 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.605 0.241 . . . . 0.0 111.032 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -55.4 -35.86 65.78 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.254 0.549 . . . . 0.0 109.996 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.769 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -58.46 -40.6 83.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.009 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.868 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.4 mm? -57.92 -43.23 86.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -55.25 -45.16 76.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.51 178.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -66.22 -34.27 77.65 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.932 0.396 . . . . 0.0 110.423 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.811 HD12 ' HA ' ' A' ' 66' ' ' LEU . 55.9 mt -60.18 -44.67 95.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.597 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -74.72 -21.4 59.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.601 -179.279 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 -35.02 26.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.625 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -100.45 -39.82 7.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.532 ' CD2' HD13 ' A' ' 43' ' ' LEU . 3.2 m-70 -102.12 151.79 38.12 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.696 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -96.37 102.3 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.252 2.635 . . . . 0.0 113.027 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.632 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 22.8 mtm 57.0 30.66 18.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.024 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.589 HD23 HG23 ' A' ' 47' ' ' THR . 2.2 tm? -64.99 111.4 5.8 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.527 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.432 ' HD2' HD22 ' A' ' 76' ' ' LEU . 43.8 Cg_exo -57.91 116.31 3.14 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.605 2.203 . . . . 0.0 112.531 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.875 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 1.6 t -116.4 151.01 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.646 0.736 . . . . 0.0 111.994 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.857 ' HB ' HD23 ' A' ' 52' ' ' LEU . 1.9 mp -139.67 119.26 13.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.759 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.63 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 21.8 mm -93.67 150.38 3.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.242 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.911 ' HE2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -82.35 -27.98 31.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.387 -177.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.66 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 18.0 m -133.98 157.35 46.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.567 0.222 . . . . 0.0 110.588 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.618 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -148.94 62.2 1.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.962 0.411 . . . . 0.0 111.326 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.59 ' CD2' ' H ' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -90.57 -93.98 0.12 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.706 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.46 160.35 22.71 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.078 0.466 . . . . 0.0 112.0 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.511 ' HB2' HD13 ' A' ' 63' ' ' LEU . 3.7 m-20 62.26 15.87 7.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.603 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.606 ' HA ' HD21 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -47.28 -23.46 0.56 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.31 -48.17 36.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.512 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -64.68 -20.52 66.35 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.582 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -58.72 -33.72 70.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.528 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.609 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.2 t -67.44 -36.92 77.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.582 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.527 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 16.5 m -63.31 -20.12 65.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.241 0.544 . . . . 0.0 109.706 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.751 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.65 -53.75 8.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.751 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.609 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.3 m-85 -59.31 -33.87 71.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.142 0.496 . . . . 0.0 110.675 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.2 pp0? -74.65 -38.02 62.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.051 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.751 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 2.9 pp0? -74.59 -18.31 60.59 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.897 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.0 -6.57 3.44 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.574 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.875 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -58.98 148.93 28.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.067 0.434 . . . . 0.0 111.62 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.509 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 40.8 t80 -78.07 -53.06 7.82 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.717 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.545 ' OD2' HD11 ' A' ' 114' ' ' LEU . 13.4 p30 -179.96 -166.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.328 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.618 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 3.0 m-85 -127.68 141.33 51.64 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.165 0.507 . . . . 0.0 111.402 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.63 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 4.5 tp -102.41 145.91 31.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.541 ' O ' HG23 ' A' ' 82' ' ' THR . 29.2 Cg_endo -68.89 -39.81 7.74 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.032 1.821 . . . . 0.0 112.36 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.686 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER 173.85 -48.77 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.773 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.4 Cg_endo -47.62 163.99 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.887 1.725 . . . . 0.0 109.78 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.904 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 2.5 t80 -166.09 -91.74 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.972 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.538 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.9 p-10 41.76 -174.94 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.997 0.427 . . . . 0.0 110.979 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.954 HG23 HG21 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -67.97 -49.55 67.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.392 0.615 . . . . 0.0 111.396 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.564 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -49.68 -57.77 6.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.974 -179.526 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.713 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.1 mm-40 -76.44 -29.97 57.18 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.569 ' HB3' HD21 ' A' ' 19' ' ' LEU . . . -83.19 -60.38 2.17 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.771 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.954 HG21 HG23 ' A' ' 108' ' ' ILE . 32.6 t -50.93 -33.74 12.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.45 0.643 . . . . 0.0 110.416 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.72 -51.05 71.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.379 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.831 HD23 HG21 ' A' ' 79' ' ' ILE . 9.3 tp -76.82 -20.31 56.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.814 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 112' ' ' VAL . 3.7 p -79.34 -48.77 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.151 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.463 ' N ' HG13 ' A' ' 115' ' ' VAL . 22.8 mt-10 -61.97 -46.75 87.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.853 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.56 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 4.5 ptm180 -64.0 -23.44 67.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.823 0.344 . . . . 0.0 110.701 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.509 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.65 -50.98 21.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.47 -30.93 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.262 0.553 . . . . 0.0 110.783 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.7 m -70.15 -40.85 74.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.838 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.6 m170 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.845 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.761 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.242 -0.343 . . . . 0.0 112.242 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.761 HD13 ' C ' ' A' ' 4' ' ' GLY . 5.3 mm -123.63 112.44 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.061 0.457 . . . . 0.0 111.578 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.12 HG11 HD13 ' A' ' 23' ' ' LEU . 2.8 p -115.78 120.89 66.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.86 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.94 ' CD1' HG22 ' A' ' 31' ' ' THR . 29.8 m0 -112.85 142.86 45.02 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.144 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.71 HG21 HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -132.69 144.77 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.261 -178.409 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.038 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -132.08 121.57 46.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.225 178.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.5 t0 -176.42 -148.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.284 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.27 -1.77 3.7 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.1 -146.72 0.5 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 121.288 -0.165 . . . . 0.0 110.843 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 14' ' ' SER . 85.5 p 34.06 -93.1 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.836 ' O ' HG23 ' A' ' 18' ' ' VAL . 49.7 p -52.88 -58.07 8.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.257 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.6 mm -60.61 -31.41 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.01 0.433 . . . . 0.0 111.253 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.695 ' HA ' HG21 ' A' ' 32' ' ' THR . 13.5 ttt85 -72.86 -59.51 2.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.82 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.466 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 16.9 t90 -46.99 -43.76 19.63 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -68.39 -62.85 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.806 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.738 ' HG ' HD12 ' A' ' 23' ' ' LEU . 6.1 tp -67.89 -21.77 65.13 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.724 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.0 pt-20 -67.54 -60.06 2.86 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.672 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.555 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -75.02 -47.3 29.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.521 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -54.89 -58.52 7.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.748 0.309 . . . . 0.0 111.772 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.12 HD13 HG11 ' A' ' 6' ' ' VAL . 2.8 mt -59.01 -28.24 66.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -61.77 -36.89 82.36 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.5 -24.99 71.25 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.457 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.652 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.67 -15.57 59.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 110.957 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.76 25.95 7.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.486 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.031 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.44 172.26 11.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.374 0.587 . . . . 0.0 111.401 179.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.2 m -104.1 109.46 21.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.22 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.724 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 7.6 t -106.65 110.51 22.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.198 0.523 . . . . 0.0 111.898 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.94 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.3 t -121.26 151.79 39.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.917 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.8 p -124.75 161.09 27.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.288 0.566 . . . . 0.0 112.108 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.038 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.3 m-85 -133.07 174.37 10.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.742 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.596 ' HG2' ' HG3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.66 -51.85 68.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -176.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -162.62 -24.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.7 0.682 . . . . 0.0 112.744 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.733 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 163.79 -52.25 0.29 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.387 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -52.68 -33.69 48.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.724 0.297 . . . . 0.0 111.012 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.635 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -61.91 -54.32 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.731 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.859 HG21 ' CG2' ' A' ' 9' ' ' VAL . 2.9 t -54.58 -38.86 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.562 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.615 HD13 ' HB3' ' A' ' 68' ' ' GLN . 24.6 mt -52.26 -44.75 65.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.914 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.2 66.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.177 0.513 . . . . 0.0 111.048 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.46 94.18 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.547 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.622 ' HG ' HG12 ' A' ' 39' ' ' VAL . 21.7 mt -59.13 -26.48 64.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.473 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.48 -14.8 8.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.293 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.41 -9.51 10.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.98 165.16 32.54 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.087 0.47 . . . . 0.0 111.829 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.625 ' CG2' HD23 ' A' ' 76' ' ' LEU . 91.0 m -138.3 118.31 9.92 Favored Pre-proline 0 N--CA 1.452 -0.353 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.898 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.619 ' O ' HD21 ' A' ' 76' ' ' LEU . 73.6 Cg_endo -75.63 157.03 40.29 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.526 2.151 . . . . 0.0 111.991 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -73.76 -28.16 61.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 0.0 110.725 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.813 HG21 HG23 ' A' ' 115' ' ' VAL . 7.3 p -145.23 99.61 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.768 ' O ' HD12 ' A' ' 79' ' ' ILE . 63.7 tp -87.15 145.61 26.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.48 0.657 . . . . 0.0 112.184 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.858 HD23 ' HB ' ' A' ' 79' ' ' ILE . 5.1 mt -132.85 114.43 14.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.801 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -111.3 149.95 30.36 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 18.5 t0 -80.14 -178.18 6.42 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.695 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.808 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 2.6 tt -159.92 73.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.588 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 177.56 63.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.94 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.485 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 3.1 tpp -163.5 -62.36 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.596 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 19.6 Cg_endo -59.49 -178.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.544 2.162 . . . . 0.0 113.03 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.81 -66.25 2.89 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.54 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.3 OUTLIER -72.97 54.62 0.38 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.52 -75.8 0.01 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.838 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.808 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -145.12 -32.74 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.761 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.685 HD22 ' O ' ' A' ' 86' ' ' ASP . 1.4 mp -61.98 -16.46 51.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.503 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.526 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -54.59 -35.26 63.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.316 0.579 . . . . 0.0 109.72 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.733 HD13 ' HA3' ' A' ' 36' ' ' GLY . 7.7 mt -63.6 -38.78 92.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.745 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.867 ' HA ' HD12 ' A' ' 69' ' ' ILE . 7.4 mp -52.35 -47.47 66.07 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 1.5 ttmp? -51.79 -43.39 63.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.701 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.615 ' HB3' HD13 ' A' ' 40' ' ' LEU . 12.1 mm-40 -65.62 -35.75 81.72 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.613 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.921 HG23 ' CE1' ' A' ' 73' ' ' HIS . 82.3 mt -63.06 -44.95 99.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.188 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 3.9 pttt -65.8 -23.67 66.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.187 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -28.32 41.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.297 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -112.31 -71.73 0.74 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.796 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.921 ' CE1' HG23 ' A' ' 69' ' ' ILE . 6.1 p80 -112.38 66.3 0.83 Allowed Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.494 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.572 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 25.8 Cg_endo -63.33 -31.99 72.88 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 113.576 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.538 ' HA ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -88.89 -19.81 25.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.51 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.926 HD22 ' HD2' ' A' ' 77' ' ' PRO . 3.1 tm? -62.83 118.44 42.0 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.619 0.247 . . . . 0.0 111.42 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.926 ' HD2' HD22 ' A' ' 76' ' ' LEU . 52.7 Cg_exo -54.15 115.88 2.67 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.722 2.281 . . . . 0.0 113.087 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.789 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -113.98 142.39 26.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.015 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.858 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.1 mt -130.12 115.85 34.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.943 0.402 . . . . 0.0 110.55 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.687 HG22 ' H ' ' A' ' 82' ' ' THR . 25.1 mm -93.85 145.74 7.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.466 ' HE2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -78.72 -19.92 51.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.028 -179.11 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.687 ' H ' HG22 ' A' ' 80' ' ' ILE . 6.0 m -147.65 157.54 43.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.006 ' HB1' HD23 ' A' ' 87' ' ' LEU . . . -133.48 50.69 2.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.996 0.427 . . . . 0.0 111.166 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.56 -176.14 3.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.956 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.1 t 71.25 -76.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.423 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.685 ' O ' HD22 ' A' ' 63' ' ' LEU . 7.6 m-20 -139.08 77.52 1.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.841 0.353 . . . . 0.0 111.121 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 1.006 HD23 ' HB1' ' A' ' 83' ' ' ALA . 3.4 tm? -52.19 -21.8 3.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.62 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.06 -56.63 8.46 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.34 -24.26 67.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.7 ' HB3' HD22 ' A' ' 87' ' ' LEU . . . -57.84 -63.07 1.37 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.82 0.343 . . . . 0.0 111.825 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.404 HG13 ' HE2' ' A' ' 94' ' ' TYR . 11.6 t -56.57 -38.45 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.921 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.417 ' HA ' ' HB3' ' A' ' 95' ' ' GLN . 1.4 m -60.48 -33.53 72.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.744 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.734 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -68.12 -46.66 70.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.202 0.525 . . . . 0.0 111.118 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.633 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -75.83 -23.74 55.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.873 178.676 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -74.48 -33.67 62.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.939 178.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 93' ' ' ALA . 15.2 pt20 -82.56 -18.47 41.29 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.442 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 75' ' ' MET . . . 161.94 -25.39 0.24 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.292 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.789 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -60.42 162.67 5.96 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.679 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 100' ' ' ASP . 28.4 t80 -74.57 -54.04 8.25 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.4 t0 170.5 -157.48 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.831 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.0 m-85 -129.14 123.01 31.05 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.464 ' HB2' HD22 ' A' ' 114' ' ' LEU . 3.8 tp -104.45 137.79 19.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.144 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.454 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 69.5 Cg_exo -50.81 168.57 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.293 1.995 . . . . 0.0 111.847 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.672 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -44.07 -44.11 16.44 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 4.4 Cg_endo -47.4 163.48 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.645 1.563 . . . . 0.0 110.466 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.694 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 9.4 t80 -166.66 -94.36 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.679 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 43.01 -174.07 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.796 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -67.55 -47.32 80.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.289 0.566 . . . . 0.0 111.557 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -51.98 -56.02 16.85 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.966 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.7 mm-40 -79.49 -28.35 41.47 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.24 -53.8 5.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.018 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.713 ' HA ' HG12 ' A' ' 115' ' ' VAL . 42.8 t -58.63 -31.92 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 121.417 0.627 . . . . 0.0 110.221 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.17 -53.54 56.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.461 178.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.746 HD23 HG21 ' A' ' 79' ' ' ILE . 8.5 tp -75.19 -20.5 59.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.095 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.813 HG23 HG21 ' A' ' 50' ' ' VAL . 5.3 p -79.23 -49.76 19.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.504 ' N ' HG13 ' A' ' 115' ' ' VAL . 16.2 mt-10 -68.59 -38.87 81.0 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.944 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.614 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 4.4 ptp85 -66.15 -26.13 67.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.063 0.459 . . . . 0.0 110.649 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.451 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.49 -51.44 23.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.025 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -64.9 -31.48 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.146 0.498 . . . . 0.0 110.787 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.7 m -71.59 -42.56 67.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.746 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.788 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.192 0 N-CA-C 112.818 -0.113 . . . . 0.0 112.818 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.69 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.4 mp -111.51 114.46 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.698 0.285 . . . . 0.0 110.985 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.996 HG11 HD13 ' A' ' 23' ' ' LEU . 7.7 p -105.53 116.11 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.248 179.314 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.838 ' CD1' HG22 ' A' ' 31' ' ' THR . 33.2 m0 -109.05 149.63 29.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.801 0.334 . . . . 0.0 111.35 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.679 HG21 HD23 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -139.5 148.51 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.548 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.9 HG22 HG21 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -134.18 118.37 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.139 177.435 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.3 t0 -173.64 -151.97 0.05 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.123 -179.356 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.34 -2.63 4.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 58.19 -137.73 0.88 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.009 178.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.9 p 34.74 -104.86 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.89 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -54.12 -42.73 69.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.567 0.223 . . . . 0.0 111.468 -179.178 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.8 mm -65.24 -36.26 77.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.063 0.458 . . . . 0.0 111.252 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.713 ' HA ' HG21 ' A' ' 32' ' ' THR . 26.4 ttt-85 -70.72 -56.31 6.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.829 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.461 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 69.9 t90 -48.81 -43.87 38.65 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 14' ' ' SER . 1.6 t -67.2 -59.83 3.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.843 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.732 ' HG ' HD12 ' A' ' 23' ' ' LEU . 7.1 tp -70.93 -22.58 62.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.601 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 11.1 pt-20 -66.59 -60.12 3.0 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.435 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.588 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.6 mmt180 -74.9 -51.0 14.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.052 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.485 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -51.01 -58.7 5.39 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.032 HD22 HD13 ' A' ' 28' ' ' LEU . 1.8 mt -59.7 -28.93 67.74 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -61.33 -37.4 83.14 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.52 -24.91 69.77 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.672 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.79 -15.52 59.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.693 0.282 . . . . 0.0 111.0 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.1 24.02 7.83 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.503 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.032 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.29 169.77 13.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 111.371 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.2 m -104.52 105.68 15.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.086 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.758 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 18.0 t -101.69 112.75 25.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.198 0.523 . . . . 0.0 111.992 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.838 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -122.13 152.95 39.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.18 178.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.713 HG21 ' HA ' ' A' ' 16' ' ' ARG . 38.1 p -126.74 152.5 46.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.267 0.556 . . . . 0.0 112.259 -179.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.883 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -129.21 174.04 9.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.54 -179.903 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.614 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -58.87 -104.65 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.025 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.412 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 13.8 m-20 -85.23 -70.76 0.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.751 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -167.26 -31.2 0.02 OUTLIER Glycine 0 C--N 1.318 -0.423 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.203 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.639 HD22 HD12 ' A' ' 40' ' ' LEU . 16.4 m120 -67.06 -31.3 71.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.506 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.7 tm-20 -52.99 -57.64 9.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.424 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.9 HG21 HG22 ' A' ' 9' ' ' VAL . 14.4 t -50.99 -42.71 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.297 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.639 HD12 HD22 ' A' ' 37' ' ' ASN . 26.1 mt -51.74 -44.58 63.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.96 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.07 -50.37 70.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.913 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.25 70.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.924 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.94 HD13 ' NE2' ' A' ' 73' ' ' HIS . 3.3 mt -67.61 -24.28 65.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.433 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.74 -17.12 3.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.34 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.71 -3.96 7.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -154.89 157.38 37.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.998 0.428 . . . . 0.0 111.372 -179.82 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.549 HG23 HD12 ' A' ' 76' ' ' LEU . 90.7 m -139.33 110.87 7.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.788 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.744 ' HD2' HD11 ' A' ' 76' ' ' LEU . 59.3 Cg_endo -71.73 156.76 56.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.429 2.086 . . . . 0.0 112.011 178.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -75.34 -24.27 57.32 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.304 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.898 HG11 ' CG2' ' A' ' 115' ' ' VAL . 6.7 p -145.02 95.3 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.441 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.72 ' O ' HD12 ' A' ' 79' ' ' ILE . 28.0 tp -86.86 138.29 31.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.264 0.554 . . . . 0.0 111.884 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.796 HD23 ' HB ' ' A' ' 79' ' ' ILE . 4.4 mt -122.89 131.19 53.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.06 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.738 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -131.27 148.03 52.65 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.931 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 24.0 t0 -76.35 -164.47 0.4 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.315 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.77 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -170.66 77.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.276 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 179.38 56.41 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.86 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.619 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 12.7 tpt -157.7 -66.27 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.63 ' HG3' HD12 ' A' ' 65' ' ' LEU . 18.2 Cg_endo -58.06 -166.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.279 1.986 . . . . 0.0 112.877 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.84 -57.66 13.49 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.578 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.703 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -86.12 48.86 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.596 0.236 . . . . 0.0 110.831 179.808 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.521 ' HB3' HG13 ' A' ' 55' ' ' ILE . 0.3 OUTLIER 53.76 -83.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.991 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.77 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.84 -17.17 0.56 Allowed Glycine 0 CA--C 1.511 -0.161 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.032 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.914 HD13 ' OH ' ' A' ' 101' ' ' TYR . 1.8 tp -75.15 -12.89 60.4 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.192 0.52 . . . . 0.0 109.997 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.703 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -66.57 -64.87 0.76 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.5 178.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.883 HD22 ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -53.16 -22.94 7.18 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.856 179.834 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.883 ' N ' HD22 ' A' ' 65' ' ' LEU . 2.6 tp -62.19 -46.48 88.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.652 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 10.8 mtpp -55.62 -39.85 71.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.448 177.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.439 ' CG ' ' HA ' ' A' ' 65' ' ' LEU . 6.0 mm-40 -60.77 -33.23 72.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.038 178.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.008 HG23 ' ND1' ' A' ' 73' ' ' HIS . 96.3 mt -59.32 -48.09 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.873 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.652 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.25 -29.69 70.78 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.97 0.414 . . . . 0.0 110.749 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.482 ' HG3' ' HD2' ' A' ' 70' ' ' LYS . 7.8 mt-30 -80.87 -31.02 35.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.684 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.7 -56.82 3.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.619 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 1.008 ' ND1' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -91.04 157.3 43.25 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.385 -179.624 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.8 -59.14 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.446 2.097 . . . . 0.0 112.44 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.7 mtt -156.8 28.98 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.128 0.489 . . . . 0.0 110.428 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.744 HD11 ' HD2' ' A' ' 48' ' ' PRO . 1.8 tt -55.85 112.24 4.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.411 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 31.7 Cg_exo -62.63 114.54 2.43 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 121.836 1.691 . . . . 0.0 112.277 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.957 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -99.54 150.9 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.605 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.81 HG21 ' CD2' ' A' ' 114' ' ' LEU . 1.9 mp -133.74 115.44 21.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.82 0.343 . . . . 0.0 110.594 179.65 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.714 HG22 ' H ' ' A' ' 82' ' ' THR . 45.3 mm -97.25 149.32 5.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.223 0.535 . . . . 0.0 112.408 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.514 ' O ' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -82.07 -21.81 36.65 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.9 -178.746 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.737 ' O ' HG21 ' A' ' 55' ' ' ILE . 2.7 m -148.1 139.54 23.6 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.808 -0.558 . . . . 0.0 111.291 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.92 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -115.7 41.46 2.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.717 0.294 . . . . 0.0 111.583 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -81.18 54.47 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 0.0 110.831 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.9 p -159.19 -166.59 1.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.63 ' O ' HD23 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -61.35 85.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mt -49.13 -22.53 0.98 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.137 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -47.89 -45.93 31.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.889 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . . . -72.05 -19.43 61.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.477 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.499 ' HA ' HD11 ' A' ' 63' ' ' LEU . . . -75.64 -46.18 32.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.341 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.768 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 12.1 t -68.19 -38.36 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.501 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.5 p -69.93 -23.4 63.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.977 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.611 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -63.86 -42.82 97.46 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.235 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.768 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 1.1 m-85 -63.75 -27.65 69.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.456 178.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.86 -34.85 62.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.381 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.635 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 1.1 pt20 -98.67 -5.22 32.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.608 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 130.89 80.24 0.21 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.135 -179.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.957 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.56 134.87 1.86 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.188 0.518 . . . . 0.0 111.384 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 32.7 t80 -75.79 -54.2 7.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.727 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER 171.99 -164.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 0.0 111.449 -179.134 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.92 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 2.9 m-85 -125.89 119.92 29.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.989 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.643 HD23 ' CD2' ' A' ' 106' ' ' PHE . 4.3 tp -102.56 136.71 19.3 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.735 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 10.0 Cg_endo -49.22 167.88 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.664 2.243 . . . . 0.0 111.641 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -41.45 -49.93 9.2 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 111.369 0.137 . . . . 0.0 111.369 -178.747 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.735 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 71.0 Cg_exo -47.36 162.94 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.574 1.516 . . . . 0.0 110.028 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.74 ' HD1' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -175.3 -85.54 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.39 -178.419 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.3 p30 42.66 -168.41 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.781 HD13 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.78 -47.24 80.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.268 0.556 . . . . 0.0 111.489 -179.887 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 5.0 t0 -51.75 -57.55 8.94 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.911 -179.321 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 17.8 mm-40 -78.98 -27.77 43.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.016 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.74 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.34 -54.76 4.56 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.826 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.751 HG21 HG23 ' A' ' 108' ' ' ILE . 39.2 t -56.49 -32.17 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.523 0.677 . . . . 0.0 110.023 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.55 -52.42 65.24 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.499 178.293 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.81 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.4 tp -74.51 -21.49 59.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.789 -178.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.898 ' CG2' HG11 ' A' ' 50' ' ' VAL . 7.2 p -79.27 -51.86 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 120.376 -0.529 . . . . 0.0 112.019 -179.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.544 ' N ' HG13 ' A' ' 115' ' ' VAL . 20.2 mt-10 -64.53 -46.34 83.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.527 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -62.56 -27.65 69.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 114' ' ' LEU . . . -71.47 -54.66 9.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.219 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.62 -32.12 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.216 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 116' ' ' GLU . 0.4 OUTLIER -69.13 -40.52 78.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.829 179.861 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.967 -179.97 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.745 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.745 HD13 ' C ' ' A' ' 4' ' ' GLY . 2.2 mm -114.54 117.84 56.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.078 0.466 . . . . 0.0 112.133 -178.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.058 HG11 HD13 ' A' ' 23' ' ' LEU . 2.6 p -106.11 123.94 61.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.698 177.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.972 ' CD1' HG22 ' A' ' 31' ' ' THR . 38.1 m0 -115.62 141.54 47.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.736 HG13 HD13 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -128.72 135.24 62.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.384 0.611 . . . . 0.0 111.934 -178.416 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.076 HG12 ' H ' ' A' ' 54' ' ' ASP . 1.5 t -123.53 108.17 20.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.06 179.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.548 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 14.0 t70 -161.66 -149.92 0.18 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.408 -179.071 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.518 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 2.8 m-20 -66.32 -3.08 5.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.574 0.226 . . . . 0.0 111.595 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.8 t70 61.29 -144.8 0.45 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.392 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t 32.74 -90.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.846 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.0 m -55.87 -52.36 64.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.749 0.309 . . . . 0.0 111.21 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.1 mm -63.79 -31.65 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 111.173 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.71 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.6 ttm180 -73.09 -54.59 8.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.677 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.539 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 44.4 t90 -51.3 -42.87 61.47 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.888 HG12 HD13 ' A' ' 108' ' ' ILE . 2.1 t -68.17 -63.11 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.058 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.744 ' HA ' HD11 ' A' ' 108' ' ' ILE . 9.1 mt -65.86 -22.05 66.51 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.659 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.51 -56.91 7.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.219 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.535 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -77.87 -47.18 19.36 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.612 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.484 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -56.84 -58.07 9.72 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.752 0.311 . . . . 0.0 111.725 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.058 HD13 HG11 ' A' ' 6' ' ' VAL . 2.0 mt -61.29 -29.43 69.86 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -60.98 -34.15 74.32 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.59 -24.95 74.0 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.442 178.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.88 -15.56 59.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.726 179.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.82 25.15 7.73 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.817 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.011 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.21 170.4 11.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.267 0.534 . . . . 0.0 111.455 179.611 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.491 ' HB ' HG23 ' A' ' 5' ' ' ILE . 52.7 m -103.74 106.14 16.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.49 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.755 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.2 t -104.23 112.46 25.49 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.972 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -122.83 156.67 34.09 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.307 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 36.3 p -127.21 157.88 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.305 -178.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.847 ' HB2' HG22 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -135.92 171.49 14.38 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.81 -179.683 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.813 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -64.28 -49.68 70.87 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.017 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.813 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 2.1 t30 -162.79 167.06 23.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -178.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.679 ' N ' HG11 ' A' ' 9' ' ' VAL . . . -42.85 -27.79 0.61 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.382 -0.914 . . . . 0.0 112.735 -178.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.496 ' N ' HD12 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -64.09 -47.8 78.62 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.708 0.289 . . . . 0.0 110.753 179.371 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.671 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -51.82 -52.19 51.04 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.046 179.527 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.841 HG23 HG21 ' A' ' 9' ' ' VAL . 32.0 t -48.69 -40.97 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.025 0.44 . . . . 0.0 110.935 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.667 HD13 ' HB3' ' A' ' 68' ' ' GLN . 17.7 mt -50.17 -48.22 54.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.61 -48.95 75.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.487 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.52 -41.08 96.61 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.906 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.637 HD21 ' CD ' ' A' ' 48' ' ' PRO . 29.4 mt -61.2 -20.82 63.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.02 -14.45 3.7 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.63 -179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.69 -6.89 6.82 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.547 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.604 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.19 166.89 20.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.883 0.373 . . . . 0.0 111.801 -179.46 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.522 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 57.6 m -139.02 122.1 10.73 Favored Pre-proline 0 N--CA 1.454 -0.228 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.436 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.682 ' HD2' HD11 ' A' ' 76' ' ' LEU . 98.4 Cg_endo -79.46 155.35 24.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.304 2.003 . . . . 0.0 111.491 178.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.417 ' OD2' ' HA2' ' A' ' 4' ' ' GLY . 77.3 m-20 -75.34 -25.76 58.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.716 -179.32 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.911 HG11 ' CG2' ' A' ' 115' ' ' VAL . 3.8 p -145.69 91.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 39' ' ' VAL . 32.5 tp -87.12 144.49 26.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.228 -179.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.839 HD23 ' HB ' ' A' ' 79' ' ' ILE . 2.1 mt -125.95 137.5 53.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.934 178.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.712 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -133.57 135.61 44.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -178.197 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 1.076 ' H ' HG12 ' A' ' 9' ' ' VAL . 15.5 t0 -66.88 174.89 2.71 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.937 178.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.755 HG13 ' N ' ' A' ' 62' ' ' GLY . 6.8 tt -152.47 77.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.495 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER 176.67 65.7 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.188 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.634 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 1.6 ttt -158.46 -67.73 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 59.3 Cg_endo -70.18 -163.07 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.554 2.169 . . . . 0.0 113.035 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.62 -60.6 7.54 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.211 -179.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.905 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 1.8 mtp -84.39 45.36 1.11 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.839 0.32 . . . . 0.0 111.594 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.592 ' HB3' HG13 ' A' ' 55' ' ' ILE . 1.2 m-20 50.98 -75.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.366 179.154 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.755 ' N ' HG13 ' A' ' 55' ' ' ILE . . . -139.09 -33.17 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.386 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.761 HD22 ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -56.75 -22.82 38.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.737 0.303 . . . . 0.0 110.324 -179.862 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.905 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -63.19 -39.25 94.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.217 0.532 . . . . 0.0 110.291 178.203 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.652 HD23 ' HA2' ' A' ' 62' ' ' GLY . 2.3 mm? -59.52 -37.44 78.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.39 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.826 ' HA ' HD12 ' A' ' 69' ' ' ILE . 3.0 mm? -59.75 -42.85 94.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.81 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.611 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 2.5 tttt -56.3 -44.45 79.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.655 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.667 ' HB3' HD13 ' A' ' 40' ' ' LEU . 3.0 mt-30 -63.52 -39.46 94.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.161 0.505 . . . . 0.0 111.142 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.826 HD12 ' HA ' ' A' ' 66' ' ' LEU . 58.4 mt -57.43 -51.43 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.679 -178.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.74 -23.6 67.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.401 -179.829 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -49.72 70.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.191 -178.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -99.35 -20.54 16.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.401 -178.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.521 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 4.2 m-70 -116.5 146.7 38.08 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.856 0.36 . . . . 0.0 111.152 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.85 -75.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.48 2.12 . . . . 0.0 112.74 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 38.3 mtp -149.54 57.69 1.0 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.058 0.456 . . . . 0.0 111.072 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.682 HD11 ' HD2' ' A' ' 48' ' ' PRO . 2.0 tt -66.88 118.49 55.55 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.717 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.529 ' N ' HD23 ' A' ' 76' ' ' LEU . 32.3 Cg_exo -58.61 115.34 2.47 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.552 1.501 . . . . 0.0 111.929 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.012 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -111.27 150.09 13.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.143 179.522 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.839 ' HB ' HD23 ' A' ' 52' ' ' LEU . 2.8 mt -136.83 115.39 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.997 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 53' ' ' SER . 14.2 mm -93.09 150.91 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 111.693 -178.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.738 ' HE3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -78.98 -27.01 43.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.195 -178.348 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 103' ' ' PRO . 2.8 m -143.29 170.7 15.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.883 ' HB1' HD21 ' A' ' 87' ' ' LEU . . . -127.61 45.57 2.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.675 ' O ' HD11 ' A' ' 63' ' ' LEU . 47.3 m-70 -69.34 -174.77 0.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 111.135 179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 86' ' ' ASP . 48.1 t 50.67 -165.34 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.879 179.241 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.761 ' O ' HD22 ' A' ' 63' ' ' LEU . 19.3 p-10 -59.49 101.26 0.1 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.798 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.883 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -55.9 -21.87 22.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.082 178.971 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -48.14 -45.9 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.28 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.604 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.69 -19.27 65.15 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.461 -179.349 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.737 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -65.45 -53.99 34.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.086 0.469 . . . . 0.0 110.329 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.567 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.7 t -62.27 -39.83 85.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.561 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.648 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 83.5 p -63.55 -15.03 56.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.941 178.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -75.77 -57.76 3.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.187 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.701 ' N ' ' HB3' ' A' ' 98' ' ' ALA . 3.3 m-85 -52.48 -34.15 47.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.134 -179.276 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.648 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -75.61 -33.5 60.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.012 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.495 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 10.0 pt20 -99.01 3.13 46.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.38 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.537 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 125.08 81.9 0.48 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.575 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 1.012 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.54 132.85 1.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.153 0.501 . . . . 0.0 111.723 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.425 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 74.8 t80 -75.08 -53.52 8.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.531 -179.165 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.611 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -178.49 -166.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.143 0.497 . . . . 0.0 111.821 -179.556 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.511 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 2.4 m-85 -125.79 140.4 52.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.322 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.714 HD23 ' HD1' ' A' ' 106' ' ' PHE . 5.3 tp -101.89 150.43 37.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.778 ' O ' HG23 ' A' ' 82' ' ' THR . 16.5 Cg_exo -69.08 -43.15 3.42 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.302 2.001 . . . . 0.0 111.533 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.523 ' HE2' ' HB2' ' A' ' 81' ' ' MET . 0.0 OUTLIER 172.81 -46.96 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.479 178.963 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 104' ' ' LYS . 75.9 Cg_exo -47.72 164.59 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.905 1.737 . . . . 0.0 109.614 178.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.797 ' CE1' HD22 ' A' ' 52' ' ' LEU . 6.0 t80 -166.18 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.133 -177.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 3.7 p30 44.26 -172.08 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.881 0.372 . . . . 0.0 110.611 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.888 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -68.1 -50.63 56.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.155 0.502 . . . . 0.0 111.994 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.594 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -50.4 -54.35 22.47 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.943 -178.504 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.69 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.2 mm-40 -80.02 -30.62 39.56 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.228 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.85 -51.47 7.16 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.962 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.692 ' HA ' HG12 ' A' ' 115' ' ' VAL . 41.5 t -60.3 -31.97 49.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.388 0.613 . . . . 0.0 110.379 179.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.75 -51.82 68.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.742 0.782 . . . . 0.0 109.409 178.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.751 ' CD2' HG21 ' A' ' 79' ' ' ILE . 6.5 tp -75.26 -20.78 59.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.873 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.911 ' CG2' HG11 ' A' ' 50' ' ' VAL . 6.0 p -78.78 -51.64 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.217 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.546 ' N ' HG13 ' A' ' 115' ' ' VAL . 40.5 mt-10 -68.53 -40.88 80.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.783 0.325 . . . . 0.0 110.537 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -66.56 -26.83 67.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.528 179.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 114' ' ' LEU . . . -71.62 -55.04 8.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.956 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -66.43 -31.37 53.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.054 0.454 . . . . 0.0 110.79 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.3 t -67.78 -44.03 78.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.969 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 CA-C-O 120.78 0.1 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.571 HG23 ' HB ' ' A' ' 29' ' ' THR . 3.1 mp -121.85 112.72 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.031 0.443 . . . . 0.0 110.898 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.121 HG11 HD13 ' A' ' 23' ' ' LEU . 8.9 p -113.73 126.05 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.886 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 1.096 ' CD1' HG22 ' A' ' 31' ' ' THR . 54.4 m0 -118.13 138.03 52.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.823 0.344 . . . . 0.0 110.801 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -123.61 119.21 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.895 -178.302 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.041 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -104.46 104.53 16.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.615 0.245 . . . . 0.0 110.357 179.212 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 63.9 t0 166.78 119.18 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.905 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.424 ' CB ' HG12 ' A' ' 15' ' ' ILE . 1.0 OUTLIER 73.84 -22.24 0.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 178.902 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 73.3 -140.97 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.532 -0.105 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.0 t -31.69 -44.15 0.07 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.559 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -53.16 -69.56 0.11 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.695 -179.608 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 24.0 mm -60.4 -20.3 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.718 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 35.0 ttp180 -73.27 -61.81 1.69 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.781 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.58 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 80.5 t90 -47.64 -48.03 28.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.111 -178.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.604 HG12 HD13 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -64.6 -61.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.113 0.482 . . . . 0.0 111.971 -179.023 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.783 HD21 ' HB3' ' A' ' 111' ' ' ALA . 31.8 mt -68.65 -22.09 64.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.957 -177.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.609 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 17.8 pt-20 -66.57 -57.75 6.62 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.495 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -59.11 -51.15 71.28 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.664 -179.587 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.415 ' CB ' HG13 ' A' ' 108' ' ' ILE . . . -58.29 -51.96 67.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 0.0 111.796 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.121 HD13 HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -67.24 -22.64 65.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.388 179.79 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.93 -34.84 78.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.027 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.65 -28.23 65.06 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.002 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.617 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.69 -15.48 59.78 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.895 0.378 . . . . 0.0 110.503 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.16 24.21 17.48 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.973 -0.632 . . . . 0.0 114.316 178.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.852 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -121.95 159.89 25.98 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 117.961 0.88 . . . . 0.0 112.751 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.571 ' HB ' HG23 ' A' ' 5' ' ' ILE . 55.2 m -81.0 126.77 31.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.431 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.609 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -116.75 108.03 15.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.154 -178.482 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 1.096 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -130.29 141.84 50.58 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.151 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 65.0 p -115.86 162.53 17.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.574 0.702 . . . . 0.0 112.823 -178.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.041 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.6 m-85 -135.85 173.51 11.63 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.491 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.7 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -62.91 -59.45 4.83 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -177.004 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.519 HD22 HD11 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -151.22 -60.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.08 -178.729 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.641 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . -152.44 -55.75 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.579 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.557 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -54.35 -29.59 48.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.991 0.395 . . . . 0.0 111.009 -179.216 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.846 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -62.19 -60.74 3.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.668 179.348 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.701 HG21 HG21 ' A' ' 9' ' ' VAL . 22.0 t -48.8 -42.65 13.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.272 179.311 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.63 HD13 ' HB3' ' A' ' 68' ' ' GLN . 38.6 mt -45.64 -46.58 14.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.033 0.444 . . . . 0.0 110.455 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.95 -47.39 80.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.537 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB2' ' HE2' ' A' ' 33' ' ' PHE . . . -67.83 -41.26 83.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.991 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.589 HD13 HG23 ' A' ' 69' ' ' ILE . 19.4 mt -66.32 -29.29 69.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.19 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.04 -19.99 55.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.201 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 t -123.42 0.62 8.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.638 ' CG ' ' HH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -164.65 165.62 20.81 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.116 0.484 . . . . 0.0 111.062 -179.916 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.948 HG23 HD23 ' A' ' 76' ' ' LEU . 54.1 m -138.5 114.52 8.85 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.498 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.582 ' O ' HD21 ' A' ' 76' ' ' LEU . 91.0 Cg_endo -77.58 164.54 28.22 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.1 1.866 . . . . 0.0 111.978 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.552 ' OD1' HD12 ' A' ' 5' ' ' ILE . 7.2 m-20 -78.01 -31.15 50.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 110.401 179.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.646 HG13 HG23 ' A' ' 6' ' ' VAL . 3.4 p -145.22 149.05 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.855 HD12 ' HB2' ' A' ' 7' ' ' TRP . 0.6 OUTLIER -152.97 145.59 24.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.321 0.582 . . . . 0.0 112.31 -178.18 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.794 HD22 ' CZ ' ' A' ' 106' ' ' PHE . 1.2 mt -123.87 122.07 37.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.285 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -111.55 150.45 29.99 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.776 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.503 ' HA ' ' SD ' ' A' ' 81' ' ' MET . 15.8 t0 -77.48 169.72 17.82 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.465 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.662 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.5 tt -144.02 165.94 13.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.369 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 65.21 65.08 0.59 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.674 0.75 . . . . 0.0 111.297 -179.366 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.659 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -158.01 -63.02 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.685 179.293 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 68.7 Cg_endo -69.29 -157.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.505 2.136 . . . . 0.0 112.33 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.5 -72.94 0.6 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.069 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.799 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 1.5 ttt -71.22 57.51 0.23 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.916 0.388 . . . . 0.0 111.16 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.542 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 56.45 -77.58 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.537 -179.592 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.662 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.46 -31.27 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.389 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.86 ' HA ' HD23 ' A' ' 66' ' ' LEU . 1.7 mp -62.29 -17.1 57.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.745 0.307 . . . . 0.0 110.613 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.799 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -59.71 -37.98 80.38 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.014 0.435 . . . . 0.0 110.13 178.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.641 HD13 ' HA3' ' A' ' 36' ' ' GLY . 30.3 mt -61.26 -39.08 89.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.861 HD21 HD11 ' A' ' 80' ' ' ILE . 4.0 mm? -55.47 -43.51 75.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.142 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.656 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 23.6 ttmm -57.97 -42.51 85.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.768 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.63 ' HB3' HD13 ' A' ' 40' ' ' LEU . 3.2 mt-30 -65.51 -41.37 93.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.059 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.988 HG22 ' CD2' ' A' ' 73' ' ' HIS . 36.6 mt -57.25 -50.36 76.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.634 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.27 -24.01 67.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.254 -179.532 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -23.13 66.08 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.861 -0.335 . . . . 0.0 111.053 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -108.35 -20.18 13.22 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.988 ' CD2' HG22 ' A' ' 69' ' ' ILE . 6.2 p80 -113.64 166.99 10.11 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 112.106 -179.093 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 94.0 Cg_endo -88.27 -47.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.216 2.611 . . . . 0.0 111.837 178.641 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.613 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.2 mtt -157.45 54.37 0.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.948 HD23 HG23 ' A' ' 47' ' ' THR . 0.7 OUTLIER -76.61 112.6 22.83 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-O 120.62 0.247 . . . . 0.0 110.861 179.819 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.548 ' HD2' HD22 ' A' ' 76' ' ' LEU . 37.6 Cg_endo -66.81 115.47 3.6 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.158 1.906 . . . . 0.0 111.86 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.842 HG13 HD23 ' A' ' 51' ' ' LEU . 2.4 t -109.11 152.34 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.735 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.2 mt -136.09 118.07 20.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.096 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.861 HD11 HD21 ' A' ' 66' ' ' LEU . 15.4 mm -93.61 144.25 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.387 0.613 . . . . 0.0 112.167 -179.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.732 ' HE3' ' CZ ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -77.21 -15.99 59.25 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.014 -179.369 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.669 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.5 m -147.79 169.32 20.01 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.213 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -143.94 41.83 1.42 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.771 0.319 . . . . 0.0 111.488 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.527 ' CD2' HG21 ' A' ' 82' ' ' THR . 21.8 m-70 -68.62 113.74 6.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.963 0.411 . . . . 0.0 112.071 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 m 48.58 -177.52 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.925 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' HB2' HD13 ' A' ' 63' ' ' LEU . 6.5 m-20 52.24 26.22 3.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.155 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.795 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -56.14 -22.11 26.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.556 -179.919 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.32 -43.62 43.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.711 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.571 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.19 -23.42 62.96 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.323 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.795 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -64.7 -39.73 94.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.946 0.403 . . . . 0.0 110.492 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.593 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.1 t -69.88 -45.03 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.185 179.47 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.9 m -62.52 -28.89 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' A' ' 96' ' ' GLN . . . -62.13 -41.85 98.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.492 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.593 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.4 m-85 -61.43 -21.7 64.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.145 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.609 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -72.81 -42.18 64.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.772 -179.907 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.613 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.1 pt20 -77.55 -18.15 57.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.505 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.82 5.07 4.54 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.149 -1.024 . . . . 0.0 114.139 178.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -54.65 152.79 6.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.477 0.638 . . . . 0.0 111.311 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.472 ' HD2' HG12 ' A' ' 79' ' ' ILE . 39.3 t80 -85.7 -53.58 5.06 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.335 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.81 -163.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.18 0.514 . . . . 0.0 111.799 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.591 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.9 m-85 -131.66 122.11 25.42 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.624 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 103' ' ' PRO . 5.8 tp -103.69 141.03 21.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.728 -179.567 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 102' ' ' LEU . 19.6 Cg_endo -57.87 169.89 2.37 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.334 2.023 . . . . 0.0 111.591 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.661 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -44.22 -46.5 23.04 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -179.17 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 2.8 Cg_endo -46.49 163.62 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.826 1.684 . . . . 0.0 110.539 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.794 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 1.0 OUTLIER -166.41 -88.47 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.434 -177.812 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.546 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p-10 42.23 -175.48 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.959 0.409 . . . . 0.0 110.613 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.617 HD12 HD23 ' A' ' 19' ' ' LEU . 1.1 mp -68.01 -47.44 78.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.3 0.571 . . . . 0.0 111.652 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.643 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 68.1 m-20 -54.05 -54.96 32.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.831 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.746 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.9 mm-40 -77.65 -29.43 51.63 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.783 ' HB3' HD21 ' A' ' 19' ' ' LEU . . . -84.22 -57.34 3.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.015 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.601 HG21 HG23 ' A' ' 108' ' ' ILE . 43.9 t -54.67 -32.17 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.456 0.646 . . . . 0.0 110.142 179.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.85 -54.76 42.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.055 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.555 HD23 HG21 ' A' ' 79' ' ' ILE . 32.5 tp -73.33 -20.66 60.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.66 -179.138 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.734 HG21 HD11 ' A' ' 23' ' ' LEU . 2.4 p -79.06 -47.54 22.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.278 -178.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.08 -38.0 84.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.79 0.328 . . . . 0.0 110.462 179.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.2 mtt85 -65.04 -24.32 67.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.542 179.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.465 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.65 -52.55 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.066 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.7 mt -60.75 -31.49 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.107 0.479 . . . . 0.0 110.659 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.5 m -70.56 -43.5 69.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.704 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 32.2 m80 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.859 179.852 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.554 ' HA3' HD23 ' A' ' 28' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.261 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.567 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 2.2 mp -133.34 113.07 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.759 HG23 HG13 ' A' ' 50' ' ' VAL . 7.9 p -111.69 125.54 69.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.868 0.366 . . . . 0.0 111.433 179.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.841 ' CD1' HG22 ' A' ' 31' ' ' THR . 19.7 m0 -114.88 129.03 56.62 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.433 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.927 HG21 HD23 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -123.42 144.76 31.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.454 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.029 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -135.32 105.81 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.582 178.31 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.584 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 51.4 t0 167.49 120.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.637 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.431 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 70.86 -32.15 0.24 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.216 179.567 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 13' ' ' SER . 5.0 t70 73.75 -134.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 12' ' ' ASP . 47.6 t -21.0 -58.17 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 18' ' ' VAL . 19.4 m -53.04 -69.52 0.11 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.259 -179.088 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 26.7 mm -60.46 -20.38 20.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.737 ' HA ' HG21 ' A' ' 32' ' ' THR . 47.8 ttt180 -72.35 -61.45 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.861 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.42 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 75.9 t90 -47.46 -42.85 23.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.066 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.714 HG12 HD13 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -67.52 -62.16 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.736 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.927 HD23 HG21 ' A' ' 8' ' ' VAL . 8.6 tp -70.79 -21.6 62.47 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.573 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 22.7 pt-20 -67.47 -56.68 8.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.47 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.573 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 9.5 mmm-85 -68.51 -56.34 8.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.479 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.54 -36.94 64.82 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.693 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.1 tm? -73.7 -27.45 61.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.997 0.427 . . . . 0.0 110.687 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.42 -32.64 72.82 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.59 -25.71 71.66 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.432 178.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.567 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.77 -15.48 59.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.728 0.299 . . . . 0.0 111.135 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.64 25.34 8.69 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.487 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.567 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -134.98 178.27 7.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.632 0.716 . . . . 0.0 111.726 179.849 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' HG12 ' A' ' 6' ' ' VAL . 7.9 m -105.64 128.01 53.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.069 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HA ' HG13 ' A' ' 6' ' ' VAL . 42.6 t -123.11 113.01 18.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.134 0.492 . . . . 0.0 111.953 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.841 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.0 t -119.08 156.03 30.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.253 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.737 HG21 ' HA ' ' A' ' 16' ' ' ARG . 44.9 p -133.91 160.19 38.43 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.092 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.029 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.3 m-85 -135.86 174.16 10.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.421 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.55 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.89 -105.05 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.025 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.414 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -84.57 -61.52 1.77 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.033 0.444 . . . . 0.0 111.978 -178.154 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.805 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -176.64 -37.01 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.074 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.967 ' N ' HD21 ' A' ' 65' ' ' LEU . 3.0 m120 -60.18 -29.64 68.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.704 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -54.53 -54.8 36.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.424 179.791 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.637 HG21 ' CG2' ' A' ' 9' ' ' VAL . 6.6 t -49.39 -46.01 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.262 0.553 . . . . 0.0 110.907 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.713 HD13 ' HB3' ' A' ' 68' ' ' GLN . 30.3 mt -47.2 -43.46 21.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.306 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.87 82.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.31 0.576 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.22 77.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.1 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.853 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.3 mt -59.89 -24.46 64.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.201 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.84 -22.31 5.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.698 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.94 8.32 5.22 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.05 163.21 37.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.98 0.419 . . . . 0.0 111.198 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.86 HG23 HD23 ' A' ' 76' ' ' LEU . 77.7 m -138.39 118.56 9.91 Favored Pre-proline 0 N--CA 1.453 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.009 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.658 ' CD ' HD21 ' A' ' 43' ' ' LEU . 56.0 Cg_endo -69.69 154.96 67.36 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.165 1.91 . . . . 0.0 112.292 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB3' ' O ' ' A' ' 5' ' ' ILE . 26.8 t0 -79.38 -32.66 43.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.611 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.759 HG13 HG23 ' A' ' 6' ' ' VAL . 7.3 p -150.47 94.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.625 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.573 HD23 HG22 ' A' ' 78' ' ' VAL . 28.5 tp -84.48 153.84 23.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.867 HD23 ' HB ' ' A' ' 79' ' ' ILE . 2.7 mt -136.74 114.76 11.45 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.802 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.546 ' HB3' ' CD1' ' A' ' 80' ' ' ILE . 4.9 t -108.95 149.4 29.25 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.655 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 25.9 t0 -82.99 166.84 18.49 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.381 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.79 HG23 ' HB ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -155.5 108.95 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.994 -179.914 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.47 40.22 0.76 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.375 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.502 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER 66.94 51.06 0.62 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.434 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 62.6 Cg_endo -78.96 -77.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.812 2.341 . . . . 0.0 112.159 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.402 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -109.27 -29.78 3.85 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.815 179.526 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.984 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -152.47 65.78 0.82 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.095 0.474 . . . . 0.0 110.279 179.362 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.536 ' O ' HG12 ' A' ' 55' ' ' ILE . 0.5 OUTLIER 68.74 -22.99 0.14 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.872 179.824 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.638 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 135.24 -31.49 2.68 Favored Glycine 0 CA--C 1.502 -0.757 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.833 ' HA ' HD23 ' A' ' 66' ' ' LEU . 4.7 mp -70.16 -15.47 62.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.984 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.89 -37.98 64.31 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.061 0.458 . . . . 0.0 110.447 178.448 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.967 HD21 ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -58.15 -36.61 73.25 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.926 179.511 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.855 ' HA ' HD12 ' A' ' 69' ' ' ILE . 4.0 mm? -59.34 -43.61 92.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.494 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.568 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 14.0 mttt -52.59 -47.25 67.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.09 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.713 ' HB3' HD13 ' A' ' 40' ' ' LEU . 2.0 mt-30 -61.09 -32.19 71.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.059 179.162 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.855 HD12 ' HA ' ' A' ' 66' ' ' LEU . 10.7 mt -67.97 -41.6 84.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.166 -178.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 9.9 pttt -77.63 -24.88 49.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.955 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -74.25 -43.43 57.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.883 0.373 . . . . 0.0 111.888 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -89.45 -54.59 4.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.132 -179.06 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.853 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -89.96 135.49 30.17 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.261 -178.858 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -56.74 -64.84 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.512 2.142 . . . . 0.0 112.667 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.8 mtm -142.01 44.7 1.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.787 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.86 HD23 HG23 ' A' ' 47' ' ' THR . 2.9 tm? -63.01 111.17 4.39 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.037 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.619 ' HD2' HD22 ' A' ' 76' ' ' LEU . 38.7 Cg_exo -58.94 116.29 3.15 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.639 2.226 . . . . 0.0 113.013 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.966 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -118.55 153.29 20.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.68 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.867 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.6 mt -134.14 117.6 25.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.017 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.754 HG22 ' H ' ' A' ' 82' ' ' THR . 26.6 mm -93.57 141.76 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.219 0.533 . . . . 0.0 112.06 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.656 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -84.72 -11.73 55.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.558 -179.147 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.79 ' HB ' HG23 ' A' ' 55' ' ' ILE . 15.3 m -147.47 133.0 18.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.576 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.814 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -125.63 -1.53 7.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 179.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.581 ' HD2' HG23 ' A' ' 82' ' ' THR . 9.1 m-70 -69.32 67.48 0.19 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 0.0 110.256 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.5 m -155.98 -79.09 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.35 -179.34 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.568 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -145.62 79.39 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.68 -179.609 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.648 HD23 ' HB3' ' A' ' 90' ' ' ALA . 4.5 mt -46.12 -21.46 0.15 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.281 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.76 -57.44 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.572 0.225 . . . . 0.0 110.96 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.45 -20.87 62.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 110.87 179.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.648 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -69.65 -60.88 2.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.517 ' HA ' ' HD2' ' A' ' 94' ' ' TYR . 21.6 t -60.75 -46.12 96.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.486 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.7 m -56.81 -49.12 76.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.003 0.43 . . . . 0.0 111.246 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.587 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -62.93 -40.3 97.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.143 -179.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 1.04 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -71.17 -20.71 62.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.218 179.918 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.587 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.56 -38.68 62.63 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.465 179.174 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.587 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 2.6 pt20 -100.23 -17.43 17.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.75 66.79 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.496 -1.335 . . . . 0.0 114.081 -179.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 1.04 ' HB3' ' HA ' ' A' ' 94' ' ' TYR . . . -170.48 132.91 1.0 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.592 0.234 . . . . 0.0 110.553 178.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 45.2 t80 -62.92 -53.14 58.7 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.504 -178.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 178.23 -161.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 0.0 111.408 -179.306 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.814 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.2 m-85 -127.59 126.82 42.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.557 ' HB2' HD22 ' A' ' 114' ' ' LEU . 6.3 tp -108.03 135.38 19.88 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.81 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.425 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 77.3 Cg_exo -50.03 170.02 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.2 1.933 . . . . 0.0 111.453 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.659 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -44.6 -44.5 20.83 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.296 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 4.8 Cg_endo -47.58 163.4 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.739 1.626 . . . . 0.0 110.942 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.785 ' CE1' HD22 ' A' ' 52' ' ' LEU . 9.8 t80 -165.68 -95.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.717 -178.4 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.2 p-10 44.18 -174.03 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.126 -0.359 . . . . 0.0 110.896 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.898 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -68.02 -47.72 77.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.197 0.523 . . . . 0.0 111.633 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 23.3 t70 -51.15 -57.47 8.65 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.714 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.687 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.3 mm-40 -78.22 -29.44 48.27 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.206 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -82.16 -57.71 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.772 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.898 HG21 HG23 ' A' ' 108' ' ' ILE . 38.5 t -54.06 -32.46 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.467 0.651 . . . . 0.0 110.159 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.46 -51.65 68.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.885 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.836 HD23 HG21 ' A' ' 79' ' ' ILE . 19.3 tp -77.42 -20.55 54.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.791 -178.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.609 ' CG2' HG11 ' A' ' 50' ' ' VAL . 4.2 p -76.43 -46.84 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.496 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.421 ' N ' HG13 ' A' ' 115' ' ' VAL . 29.1 mt-10 -63.62 -52.46 60.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.738 0.304 . . . . 0.0 110.537 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 -57.58 -25.89 60.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.05 0.452 . . . . 0.0 110.508 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.436 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.77 -53.87 8.37 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.488 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 115' ' ' VAL . 3.4 mt -68.83 -32.92 56.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.029 0.442 . . . . 0.0 111.112 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.59 -48.53 47.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.32 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.1 m170 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.369 . . . . 0.0 111.124 -179.81 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.73 ' C ' HD13 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.73 HD13 ' C ' ' A' ' 4' ' ' GLY . 3.5 mm -119.41 112.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.655 0.264 . . . . 0.0 111.56 -179.205 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.85 HG11 ' HG ' ' A' ' 23' ' ' LEU . 8.6 p -106.31 118.04 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.291 178.438 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.826 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.4 m0 -111.92 123.8 51.02 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.685 HG21 HD23 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -117.27 136.19 55.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.301 -177.255 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.946 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -121.55 115.65 47.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.855 178.338 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.677 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 5.0 t70 -169.8 -152.62 0.1 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.113 -178.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.36 6.22 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 14' ' ' SER . 3.9 p30 47.05 -146.5 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t 35.49 -88.58 0.01 OUTLIER 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.803 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.7 m -59.93 -54.48 45.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.68 0.276 . . . . 0.0 111.116 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.9 mm -62.75 -31.75 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.486 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.767 ' HA ' HG21 ' A' ' 32' ' ' THR . 5.9 ttp180 -69.11 -48.96 61.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.564 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.659 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 14.9 t90 -61.63 -58.37 8.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.02 -179.24 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 14' ' ' SER . 1.4 t -55.62 -40.47 59.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.185 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.685 HD23 HG21 ' A' ' 8' ' ' VAL . 5.1 tp -84.32 -24.8 29.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -177.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.659 ' HG2' ' O ' ' A' ' 17' ' ' TRP . 19.7 pt-20 -67.63 -59.63 3.19 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.605 -178.702 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.8 ' HD3' ' H ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -59.35 -65.28 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.138 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.47 -30.64 5.35 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.956 -179.046 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.85 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.8 tm? -78.89 -32.44 45.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.25 0.548 . . . . 0.0 110.276 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.22 73.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.198 178.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.16 -26.67 71.65 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.602 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.85 -15.39 59.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.865 0.364 . . . . 0.0 110.684 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.38 25.69 10.78 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.827 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.696 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -131.09 169.07 16.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.621 0.71 . . . . 0.0 111.697 179.771 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.6 m -96.93 116.24 28.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.658 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.632 ' HA ' HG13 ' A' ' 6' ' ' VAL . 51.5 t -110.24 114.61 28.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.395 0.616 . . . . 0.0 111.883 -179.428 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.826 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.0 t -125.26 155.61 39.86 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.767 HG21 ' HA ' ' A' ' 16' ' ' ARG . 66.9 p -129.08 164.86 22.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.259 0.552 . . . . 0.0 112.116 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.946 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.3 m-85 -136.43 174.57 10.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.799 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.618 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.1 pp20? -59.3 -55.68 31.73 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -177.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.431 ' O ' HD11 ' A' ' 65' ' ' LEU . 10.6 t-20 -153.15 -39.58 0.1 Allowed 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.759 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 175.82 -51.06 0.12 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.4 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.482 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -56.65 -27.5 58.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.729 0.3 . . . . 0.0 110.768 -179.513 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.763 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -61.16 -55.28 34.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.692 179.031 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.763 HG22 ' CD1' ' A' ' 33' ' ' PHE . 67.3 t -52.46 -43.16 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.971 0.415 . . . . 0.0 111.138 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' ' 68' ' ' GLN . 14.2 mt -52.76 -43.22 65.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.401 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.59 -49.4 68.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.201 0.524 . . . . 0.0 110.621 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.67 -30.36 71.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.571 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.641 HD21 ' HD2' ' A' ' 48' ' ' PRO . 10.0 mt -61.91 -22.15 65.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.362 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.18 -15.1 59.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.35 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 t -120.77 -5.2 9.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.459 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -161.51 165.54 28.44 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.907 0.384 . . . . 0.0 111.517 -179.968 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.7 m -138.27 115.75 9.28 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.331 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.683 ' HD2' HD11 ' A' ' 76' ' ' LEU . 59.7 Cg_endo -72.73 147.23 44.57 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.495 2.13 . . . . 0.0 111.914 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 2.0 m-20 -77.71 -20.26 53.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.343 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.924 HG23 HD11 ' A' ' 79' ' ' ILE . 3.2 p -148.63 95.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.965 0.412 . . . . 0.0 110.168 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 79' ' ' ILE . 12.7 tp -86.74 151.75 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.293 -178.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.876 ' O ' HG23 ' A' ' 9' ' ' VAL . 15.5 mt -135.97 116.17 13.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.596 179.04 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.58 ' HB2' HD13 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -105.77 141.01 37.93 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -177.226 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.677 ' OD2' ' HA ' ' A' ' 10' ' ' ASP . 9.8 t70 -70.85 -28.36 64.53 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.957 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.689 HG13 ' C ' ' A' ' 62' ' ' GLY . 2.7 tt 45.98 83.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.556 0.217 . . . . 0.0 111.459 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.04 96.4 0.27 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.62 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.6 OUTLIER 58.04 46.37 1.78 Allowed Pre-proline 0 N--CA 1.466 0.352 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 178.352 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 57' ' ' MET . 87.9 Cg_endo -90.36 -55.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.987 2.458 . . . . 0.0 111.927 178.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.93 -18.59 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.422 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.975 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 10.2 tpt -158.75 71.54 0.55 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.18 0.514 . . . . 0.0 109.802 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.404 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 0.4 OUTLIER 66.77 -31.27 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.9 179.832 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.689 ' C ' HG13 ' A' ' 55' ' ' ILE . . . 155.17 -34.07 0.66 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.823 -179.005 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' A' ' 90' ' ' ALA . 5.4 mp -72.47 -25.87 61.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.89 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.975 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.78 -30.34 44.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.283 0.563 . . . . 0.0 109.72 178.495 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.579 HD11 ' HA3' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -47.94 -52.8 18.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.931 178.816 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.034 HD23 HD11 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -58.27 -53.07 62.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.245 179.127 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.746 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -43.24 -38.34 2.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.383 179.728 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.579 ' HB3' HD13 ' A' ' 40' ' ' LEU . 18.9 mm100 -71.39 -38.07 71.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.166 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.868 HD12 ' HA ' ' A' ' 66' ' ' LEU . 16.6 mt -64.33 -36.35 76.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.962 -179.202 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.746 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -73.44 -29.85 62.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.979 -179.907 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.66 -41.32 99.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.835 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -97.3 -23.09 16.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.782 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.46 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 56.2 m-70 -146.33 85.24 7.47 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.844 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.531 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 73.3 Cg_endo -75.53 13.11 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.948 2.432 . . . . 0.0 113.018 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.7 mtt -134.33 -0.62 2.96 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.61 0.243 . . . . 0.0 111.172 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.683 HD11 ' HD2' ' A' ' 48' ' ' PRO . 1.6 tt -76.54 113.16 26.54 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.487 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 45.5 Cg_endo -67.72 116.69 4.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.366 2.044 . . . . 0.0 111.81 178.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.763 ' HB ' HD21 ' A' ' 66' ' ' LEU . 3.1 t -115.47 151.22 17.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.539 0.685 . . . . 0.0 112.347 -178.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.924 HD11 HG23 ' A' ' 50' ' ' VAL . 1.1 mp -129.23 117.29 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.696 178.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.034 HD11 HD23 ' A' ' 66' ' ' LEU . 5.8 mm -93.52 133.15 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.594 -178.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.567 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.87 -1.88 49.19 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.488 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.588 ' HB ' HG23 ' A' ' 55' ' ' ILE . 2.4 m -148.0 158.92 44.31 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.091 -0.381 . . . . 0.0 110.069 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.736 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -163.19 57.59 0.19 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.866 0.365 . . . . 0.0 111.813 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -98.99 -20.39 16.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.695 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.412 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -84.48 -168.46 2.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.175 0.512 . . . . 0.0 112.339 -178.76 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.457 ' O ' HD22 ' A' ' 63' ' ' LEU . 4.5 m-20 -52.56 89.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.93 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.737 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -46.64 -22.96 0.34 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.555 179.042 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.98 -44.91 30.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . . . -65.82 -19.93 66.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.886 0.374 . . . . 0.0 111.363 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.737 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -75.78 -28.59 58.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.634 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.537 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.5 t -59.19 -38.84 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.536 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.6 m -65.35 -21.75 66.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.644 178.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.676 ' HB1' ' CB ' ' A' ' 98' ' ' ALA . . . -66.65 -47.65 71.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.857 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.537 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.4 m-85 -62.4 -24.32 67.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.076 179.34 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -42.17 59.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.261 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.632 HE22 HG23 ' A' ' 78' ' ' VAL . 2.3 pp0? -77.73 -11.02 59.84 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.068 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.85 15.34 10.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.93 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.676 ' CB ' ' HB1' ' A' ' 93' ' ' ALA . . . -56.84 138.87 52.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.75 0.275 . . . . 0.0 110.499 179.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 17.1 t80 -69.14 -52.78 24.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.688 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.5 -161.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.766 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 6.6 m-85 -132.09 118.92 20.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.452 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.654 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 5.1 tp -102.44 140.89 21.53 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.332 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.707 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 22.1 Cg_endo -59.06 168.7 4.28 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.098 1.865 . . . . 0.0 111.047 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.607 ' HE3' ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -41.79 -43.35 6.34 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.329 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.707 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 80.4 Cg_exo -47.05 163.02 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.345 1.363 . . . . 0.0 110.317 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.714 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 2.9 t80 -166.44 -91.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.461 -177.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.543 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.7 p-10 43.42 -176.31 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 120.854 0.359 . . . . 0.0 110.442 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.854 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -67.96 -45.23 84.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.303 0.573 . . . . 0.0 111.072 -179.837 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.6 t0 -52.15 -57.25 10.17 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.879 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.702 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.2 mm-40 -78.84 -29.34 44.57 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.2 -51.87 6.69 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.124 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.854 HG21 HG23 ' A' ' 108' ' ' ILE . 42.0 t -59.58 -32.3 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 121.589 0.709 . . . . 0.0 110.085 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.27 -50.94 71.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.362 178.386 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.654 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 12.5 tp -79.01 -20.5 48.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.56 -178.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 112' ' ' VAL . 5.4 p -74.94 -51.8 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.012 -179.182 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.527 ' N ' HG13 ' A' ' 115' ' ' VAL . 84.3 mt-10 -68.31 -37.87 81.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.877 0.37 . . . . 0.0 110.901 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -63.1 -23.99 67.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.457 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.436 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.94 -54.82 8.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.24 -30.71 50.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.111 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 m -66.96 -46.75 73.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 7.3 m80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.163 -179.719 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.1 mp -111.08 112.99 42.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.962 0.41 . . . . 0.0 111.113 -179.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.9 HG11 ' CD2' ' A' ' 23' ' ' LEU . 5.8 p -108.15 128.94 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.715 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.869 ' CD1' HG22 ' A' ' 31' ' ' THR . 36.0 m0 -115.93 144.38 44.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.573 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.4 t -134.9 147.82 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.109 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.026 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -134.55 105.1 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.608 177.679 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.602 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 57.1 t0 166.85 123.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.804 0.335 . . . . 0.0 111.336 179.144 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.481 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER 69.49 -21.78 0.16 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 178.849 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 10' ' ' ASP . 14.7 t70 70.56 -130.44 0.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 O-C-N 122.41 -0.181 . . . . 0.0 111.19 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 t -37.27 -45.36 0.65 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.044 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.652 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -53.94 -64.19 0.91 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.168 -179.639 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.663 HG23 HD23 ' A' ' 19' ' ' LEU . 32.1 mm -68.31 -20.63 25.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.696 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -68.84 -55.46 11.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.427 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.417 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 59.5 t90 -54.58 -43.96 72.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.795 0.331 . . . . 0.0 111.651 -179.776 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.714 HG12 HD13 ' A' ' 108' ' ' ILE . 1.4 t -68.46 -46.88 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.663 HD23 HG23 ' A' ' 15' ' ' ILE . 3.9 mm? -81.67 -23.85 36.64 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 14.0 pt-20 -67.66 -60.36 2.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.814 -179.151 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.6 mmt180 -63.92 -59.34 4.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.137 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.09 -54.24 21.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 111.932 -179.15 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.9 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.7 tp -65.26 -22.7 66.89 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.282 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -68.21 -36.79 80.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.25 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.26 -26.34 63.74 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.338 178.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.739 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.69 -15.47 59.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.703 0.287 . . . . 0.0 111.111 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.96 26.15 9.9 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.673 178.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.739 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -124.51 169.45 11.87 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.442 0.621 . . . . 0.0 111.224 179.53 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.2 m -104.17 106.46 16.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.166 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.685 ' HA ' HG13 ' A' ' 6' ' ' VAL . 11.4 t -101.76 115.06 29.69 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.058 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.869 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -118.94 156.63 29.22 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.696 HG21 ' HA ' ' A' ' 16' ' ' ARG . 18.3 p -129.84 162.79 27.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.658 0.742 . . . . 0.0 112.761 -179.283 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.026 ' HB2' HG13 ' A' ' 9' ' ' VAL . 20.0 m-85 -135.95 173.55 11.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.966 -179.078 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.662 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.5 pp20? -57.63 -59.52 5.07 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -177.319 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.493 ' HB2' ' HG3' ' A' ' 57' ' ' MET . 71.6 m-20 -152.54 -29.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.399 0.545 . . . . 0.0 112.466 -179.274 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.561 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 172.27 -59.19 0.16 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.892 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.423 ' N ' HD22 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -48.1 -31.35 5.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.852 0.358 . . . . 0.0 110.662 -179.701 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.843 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -60.87 -56.41 21.48 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.491 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.778 HG22 ' CD1' ' A' ' 33' ' ' PHE . 5.0 t -53.86 -42.67 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.754 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.76 HD13 ' CB ' ' A' ' 68' ' ' GLN . 14.3 mt -53.95 -43.71 70.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.72 -50.67 68.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.55 68.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.51 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.679 HD21 ' HD2' ' A' ' 48' ' ' PRO . 9.0 mt -65.85 -25.15 67.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.062 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.45 -19.28 61.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.337 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 t -119.32 -1.78 10.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.903 -179.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -163.16 158.71 22.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.997 0.427 . . . . 0.0 111.1 -179.849 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.885 HG23 HD13 ' A' ' 76' ' ' LEU . 65.5 m -139.09 112.26 8.05 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.406 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.679 ' HD2' HD21 ' A' ' 43' ' ' LEU . 57.9 Cg_endo -71.36 164.35 36.03 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.921 1.747 . . . . 0.0 111.281 179.209 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.64 -24.1 58.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.907 0.384 . . . . 0.0 110.581 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.822 HG13 HG23 ' A' ' 6' ' ' VAL . 7.3 p -145.22 161.88 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.626 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.653 HD22 HD21 ' A' ' 76' ' ' LEU . 30.8 tp -152.83 155.88 37.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.214 0.53 . . . . 0.0 112.251 -178.605 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.88 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -138.01 121.08 16.73 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.831 -179.801 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.517 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -105.73 138.96 41.04 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.873 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.584 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 53.0 t0 -69.76 -19.3 63.53 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.995 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.624 HD11 ' CE1' ' A' ' 84' ' ' HIS . 5.2 tt 46.16 73.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.224 0.535 . . . . 0.0 111.604 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.17 75.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.489 179.754 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -163.13 -61.16 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.623 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.728 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 59.7 Cg_endo -70.38 -169.32 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.524 2.149 . . . . 0.0 113.656 -178.549 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.71 -58.29 15.36 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.51 179.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.768 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -73.72 51.79 0.38 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.145 0.497 . . . . 0.0 110.274 179.475 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.19 -80.11 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.329 -179.297 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.549 ' HA3' ' CA ' ' A' ' 55' ' ' ILE . . . -143.54 -31.98 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.368 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.733 ' HA ' HD13 ' A' ' 66' ' ' LEU . 3.8 mp -53.76 -24.11 14.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.768 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -61.29 -33.93 74.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.263 178.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.728 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 16.0 mt -60.41 -32.53 71.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.74 179.463 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.816 ' HA ' HD12 ' A' ' 69' ' ' ILE . 5.8 mp -67.22 -42.55 83.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.379 179.558 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.622 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 5.2 mttt -54.21 -41.47 68.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.657 178.742 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.76 ' CB ' HD13 ' A' ' 40' ' ' LEU . 80.2 mm-40 -63.28 -43.16 98.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.816 HD12 ' HA ' ' A' ' 66' ' ' LEU . 5.6 mt -66.47 -36.26 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.701 -178.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.622 ' HG2' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -73.66 -28.46 61.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.934 0.397 . . . . 0.0 110.92 179.853 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.427 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -72.94 -34.78 66.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.987 -179.823 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -93.48 -59.25 2.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.261 179.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.41 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 68.4 m-70 -111.83 85.15 6.03 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.355 179.463 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 56.2 Cg_endo -71.17 20.18 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.725 2.283 . . . . 0.0 113.282 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.504 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 29.1 mtm -144.15 0.93 1.08 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.885 HD13 HG23 ' A' ' 47' ' ' THR . 15.1 tp -76.17 114.87 41.72 Favored Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 179.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.31 120.64 8.16 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.471 2.114 . . . . 0.0 111.882 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.548 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -115.47 149.29 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.255 0.55 . . . . 0.0 111.885 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.699 HG21 HD23 ' A' ' 114' ' ' LEU . 3.6 mt -132.73 114.51 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.534 178.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.643 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 11.4 mm -93.78 138.28 20.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.19 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.626 ' HB3' ' HD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.15 -9.34 57.98 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.25 -179.338 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.64 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.7 m -147.44 168.6 21.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.714 0.292 . . . . 0.0 110.671 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 84' ' ' HIS . . . -143.22 -18.89 0.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 179.646 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.624 ' CE1' HD11 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 23.14 -98.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.247 0.619 . . . . 0.0 112.372 -179.677 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 m -129.29 -176.91 4.03 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.92 0.391 . . . . 0.0 111.245 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.554 ' O ' HD22 ' A' ' 63' ' ' LEU . 5.6 t70 61.64 31.49 18.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.113 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mt -49.61 -21.64 1.07 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.768 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.92 -38.73 17.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.129 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.534 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -74.3 -20.39 60.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.123 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.668 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -71.08 -27.53 63.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.962 0.41 . . . . 0.0 110.109 178.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.573 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.4 t -69.08 -41.53 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.09 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.2 m -61.93 -26.46 68.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.054 0.454 . . . . 0.0 110.026 179.134 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -63.9 -46.01 86.75 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.929 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.573 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 10.2 m-85 -59.96 -23.78 63.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.555 179.199 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -36.97 65.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.984 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.532 ' HB3' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -82.87 -3.5 56.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.733 -179.901 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.85 18.02 13.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.129 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.548 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -61.21 145.1 52.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.965 0.383 . . . . 0.0 110.164 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.532 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 36.9 t80 -72.87 -53.69 10.72 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.776 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.445 ' OD2' HD11 ' A' ' 114' ' ' LEU . 12.9 p30 172.61 -167.45 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.821 0.344 . . . . 0.0 111.287 -179.283 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.643 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.3 m-85 -125.6 117.44 23.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.064 0.459 . . . . 0.0 110.736 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.815 HD12 ' HD2' ' A' ' 103' ' ' PRO . 7.3 tp -103.01 134.16 19.94 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.577 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.815 ' HD2' HD12 ' A' ' 102' ' ' LEU . 19.3 Cg_endo -57.71 177.51 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.385 2.057 . . . . 0.0 111.562 179.264 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.621 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -40.02 -51.41 5.76 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.182 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 7.1 Cg_endo -48.13 163.88 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.304 2.003 . . . . 0.0 111.532 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.626 ' HD2' ' HB3' ' A' ' 81' ' ' MET . 0.0 OUTLIER 173.92 -88.7 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.132 -179.609 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.781 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 47.77 -177.21 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.752 ' HA ' HG23 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -64.67 -49.03 82.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 C-N-CA 119.714 -0.795 . . . . 0.0 112.344 -178.727 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.649 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -53.89 -55.25 28.57 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.175 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.617 ' CG ' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.72 -28.16 24.82 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.704 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.781 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -82.81 -47.41 11.92 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.612 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.752 HG23 ' HA ' ' A' ' 108' ' ' ILE . 45.3 t -64.3 -32.9 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.474 0.654 . . . . 0.0 109.507 178.262 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -57.97 -47.95 81.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.172 178.5 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.699 HD23 HG21 ' A' ' 79' ' ' ILE . 6.3 tp -78.91 -22.39 45.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.981 -179.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 112' ' ' VAL . 2.3 p -79.37 -49.92 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.445 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 24.8 mt-10 -55.88 -48.46 75.54 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.626 0.25 . . . . 0.0 111.373 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.466 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -61.42 -23.25 65.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.867 0.365 . . . . 0.0 110.82 179.729 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.532 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.53 -48.2 42.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.92 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.2 mt -72.43 -30.76 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.198 0.523 . . . . 0.0 110.523 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 t -69.77 -45.12 68.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.013 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.949 0.404 . . . . 0.0 111.416 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.15 151.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.195 0.521 . . . . 0.0 111.27 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 1.042 ' HG2' HD11 ' A' ' 5' ' ' ILE . 6.1 tpt180 -74.13 -75.05 0.17 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.712 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.711 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 95.24 91.9 1.73 Allowed Glycine 0 C--N 1.323 -0.162 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.658 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.042 HD11 ' HG2' ' A' ' 3' ' ' ARG . 4.2 mm -116.74 112.51 39.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.597 0.237 . . . . 0.0 111.393 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.931 HG11 ' CD2' ' A' ' 23' ' ' LEU . 4.8 p -107.27 117.31 52.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.46 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.833 ' CD1' HG22 ' A' ' 31' ' ' THR . 34.3 m0 -108.03 137.96 45.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 0.0 111.109 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.5 t -124.2 141.92 42.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -128.03 114.1 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.743 177.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.594 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.2 t0 -171.63 -152.02 0.07 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.55 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -66.33 -2.44 4.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.6 OUTLIER 59.01 -148.04 0.48 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 121.201 -0.2 . . . . 0.0 111.299 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 t 34.58 -89.41 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.807 ' O ' HG23 ' A' ' 18' ' ' VAL . 61.6 m -55.65 -55.16 35.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.873 0.368 . . . . 0.0 110.971 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.5 mm -63.58 -34.73 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.112 0.482 . . . . 0.0 111.073 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.713 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.7 OUTLIER -69.39 -53.79 17.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.944 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.444 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 85.6 t90 -52.52 -45.11 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 14' ' ' SER . 1.4 t -67.94 -57.96 7.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.219 0.533 . . . . 0.0 111.424 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.666 ' HA ' HD11 ' A' ' 108' ' ' ILE . 3.6 mm? -67.04 -27.71 67.62 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 15.8 pt-20 -67.55 -59.89 3.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.558 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.5 mmt180 -75.66 -52.38 10.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.551 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -54.15 -54.04 45.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.811 0.339 . . . . 0.0 111.853 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.931 ' CD2' HG11 ' A' ' 6' ' ' VAL . 5.2 tp -64.3 -25.93 68.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.198 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -68.32 -33.31 74.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.99 -22.77 74.26 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.385 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.602 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.99 -15.59 59.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 110.84 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.73 21.99 8.33 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.64 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.717 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.85 170.84 11.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.397 0.599 . . . . 0.0 111.35 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.1 m -105.11 106.51 17.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.917 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 8.5 t -105.83 114.47 28.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.391 0.615 . . . . 0.0 112.188 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.833 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -122.66 156.78 33.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.576 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.713 HG21 ' HA ' ' A' ' 16' ' ' ARG . 33.9 p -127.81 156.63 42.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.451 0.643 . . . . 0.0 112.234 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.904 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -128.47 174.12 9.63 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.242 -179.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.502 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -57.61 -52.33 65.87 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -160.21 -37.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.658 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . 178.43 -55.82 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.498 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.421 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 17.2 m120 -56.97 -26.9 60.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 110.689 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.0 OUTLIER -63.91 -48.51 76.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.527 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.731 HG21 HG22 ' A' ' 9' ' ' VAL . 13.5 t -58.99 -32.78 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.447 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.73 HD11 ' OE1' ' A' ' 68' ' ' GLN . 32.7 mt -56.21 -47.56 78.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.335 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.99 -47.95 76.77 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.339 0.59 . . . . 0.0 110.258 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.15 -32.67 72.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.698 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.645 ' HG ' HG12 ' A' ' 39' ' ' VAL . 15.6 mt -67.47 -27.65 67.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.054 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.34 -15.87 40.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.492 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 m -123.22 -5.51 8.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.82 ' HG3' ' N ' ' A' ' 47' ' ' THR . 1.3 tttt -155.55 166.57 33.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.309 0.576 . . . . 0.0 111.615 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.82 ' N ' ' HG3' ' A' ' 46' ' ' LYS . 96.7 m -138.29 112.75 8.7 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.796 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.559 ' HG2' HD11 ' A' ' 76' ' ' LEU . 56.5 Cg_endo -71.44 158.1 54.9 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.465 2.11 . . . . 0.0 111.657 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.94 -30.59 50.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.78 0.324 . . . . 0.0 111.037 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.029 HG21 HG23 ' A' ' 115' ' ' VAL . 5.9 p -145.26 94.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.446 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.623 HD22 HD21 ' A' ' 76' ' ' LEU . 38.2 tp -83.21 141.26 32.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.432 0.634 . . . . 0.0 112.209 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.931 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -124.33 119.62 29.81 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.588 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.701 ' HA ' HG23 ' A' ' 9' ' ' VAL . 1.4 m -115.28 148.08 39.63 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 28.1 t0 -82.87 -178.0 6.95 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.348 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.69 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.1 tt -160.0 74.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-O 121.137 0.494 . . . . 0.0 112.095 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 177.05 58.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.646 179.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.529 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.33 -63.03 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.908 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.529 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 23.0 Cg_endo -60.22 -165.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.669 2.246 . . . . 0.0 113.356 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.03 -65.06 3.32 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.69 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.941 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -85.19 53.18 2.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.995 0.426 . . . . 0.0 110.94 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.465 ' HB3' HG13 ' A' ' 55' ' ' ILE . 1.2 m-20 55.74 -68.45 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.681 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -152.16 -35.62 0.03 OUTLIER Glycine 0 CA--C 1.507 -0.44 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.271 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.832 HD22 ' O ' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -53.64 -28.24 31.75 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.941 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -61.2 -34.42 75.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.658 HD22 ' HA3' ' A' ' 36' ' ' GLY . 74.1 mt -59.98 -35.99 76.19 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.672 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.756 ' HA ' HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -61.83 -51.06 69.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.433 178.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.691 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 11.9 tttp -47.36 -44.93 24.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.082 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.73 ' OE1' HD11 ' A' ' 40' ' ' LEU . 2.5 mt-30 -60.76 -43.18 98.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.202 0.525 . . . . 0.0 110.174 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.832 HD13 HG21 ' A' ' 78' ' ' VAL . 10.6 mt -64.98 -37.94 81.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.06 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.691 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -77.21 -23.48 51.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.541 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -67.17 -43.41 82.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.126 0.488 . . . . 0.0 111.233 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.83 -26.55 13.1 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.176 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.524 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 59.3 m-70 -130.25 76.23 78.11 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.751 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.576 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 73.5 Cg_endo -75.21 40.22 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.616 2.21 . . . . 0.0 112.236 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 59.1 mtt -153.97 -39.19 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.722 HD13 HG23 ' A' ' 47' ' ' THR . 16.8 tp -55.01 112.31 3.96 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.916 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.634 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 59.4 Cg_endo -73.41 141.21 31.38 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 121.934 1.756 . . . . 0.0 111.985 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.832 HG21 HD13 ' A' ' 69' ' ' ILE . 2.3 t -128.93 151.58 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.335 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.574 HD12 ' HG ' ' A' ' 52' ' ' LEU . 1.5 mt -120.93 118.54 56.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.991 0.424 . . . . 0.0 111.135 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.737 HD11 HD23 ' A' ' 66' ' ' LEU . 16.3 mm -95.01 142.68 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.509 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.464 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -82.31 -16.83 47.94 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.619 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.6 m -148.14 144.54 27.86 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.906 -0.717 . . . . 0.0 111.989 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.826 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -129.68 40.44 3.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.839 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.422 ' HD2' ' N ' ' A' ' 85' ' ' SER . 1.1 p-80 -89.51 -12.07 41.08 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.44 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -92.98 -164.14 1.14 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.641 0.258 . . . . 0.0 110.613 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.832 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -53.84 93.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.758 0.314 . . . . 0.0 111.334 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.436 ' HA ' ' CD2' ' A' ' 63' ' ' LEU . 1.7 mt -59.52 -21.89 60.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.741 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.0 -43.47 29.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.333 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.625 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -68.95 -23.15 64.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.688 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.757 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -67.86 -23.01 65.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.754 0.311 . . . . 0.0 110.273 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.643 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.4 t -69.03 -41.95 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.464 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.608 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 91.3 p -60.45 -18.2 49.6 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.751 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.72 -53.91 7.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.431 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.643 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.2 m-85 -58.75 -31.43 68.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.064 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.608 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -75.88 -34.62 60.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.816 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.751 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 3.1 pp0? -80.75 -18.26 48.31 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.607 0.241 . . . . 0.0 110.82 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.27 32.56 2.33 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.207 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.661 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -65.01 169.82 4.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.238 0.519 . . . . 0.0 110.998 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.634 ' HD1' ' HB2' ' A' ' 77' ' ' PRO . 0.1 OUTLIER -85.55 -55.24 4.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.727 0.298 . . . . 0.0 110.941 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 99' ' ' PHE . 0.1 OUTLIER 164.77 -162.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.884 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.826 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.1 m-85 -132.86 112.49 11.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.127 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.648 HD22 ' CE1' ' A' ' 106' ' ' PHE . 4.8 tp -102.96 142.97 25.66 Favored Pre-proline 0 C--O 1.226 -0.169 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.275 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.742 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 19.3 Cg_endo -56.66 170.6 1.27 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.344 2.029 . . . . 0.0 111.196 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -44.5 -47.24 26.47 Favored Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.742 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 75.1 Cg_exo -47.99 162.01 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.376 1.384 . . . . 0.0 110.288 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.791 ' HD1' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -176.65 -83.98 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.291 -178.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.4 p30 41.93 -168.56 0.0 OUTLIER 'General case' 0 C--O 1.231 0.113 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.691 HD13 HG12 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -67.66 -51.5 50.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-O 121.243 0.544 . . . . 0.0 111.421 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.613 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.9 t70 -48.96 -57.42 6.52 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.433 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.3 mm-40 -77.02 -31.19 56.21 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.791 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.34 -53.7 5.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.175 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.739 ' HA ' HG12 ' A' ' 115' ' ' VAL . 42.0 t -56.53 -32.41 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.428 0.632 . . . . 0.0 110.158 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -58.63 -52.72 64.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.821 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.505 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.9 tp -71.81 -25.69 62.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.816 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 1.029 HG23 HG21 ' A' ' 50' ' ' VAL . 10.0 p -79.24 -54.18 12.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.538 ' N ' HG13 ' A' ' 115' ' ' VAL . 1.8 mt-10 -57.57 -62.47 1.77 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.735 0.303 . . . . 0.0 111.515 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 117' ' ' ARG . 0.4 OUTLIER -53.32 -28.65 29.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.287 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.597 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.91 -49.28 20.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.871 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.914 HD11 HG22 ' A' ' 115' ' ' VAL . 5.6 mt -64.58 -31.42 53.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.125 0.488 . . . . 0.0 110.482 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.8 t -64.95 -33.9 77.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.748 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -73.76 -27.99 61.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.762 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -78.88 -55.93 4.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.87 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 59.51 174.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.052 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -179.923 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.866 0.365 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.66 155.11 22.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.903 ' HG3' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -84.43 -33.52 23.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.061 0.458 . . . . 0.0 110.817 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.767 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 79.61 94.51 0.34 Allowed Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.42 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.903 HD11 ' HG3' ' A' ' 3' ' ' ARG . 2.8 mm -114.18 112.54 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 111.28 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.949 HG11 ' CD2' ' A' ' 23' ' ' LEU . 8.4 p -113.66 125.48 70.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.325 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.966 ' CD1' HG22 ' A' ' 31' ' ' THR . 35.5 m0 -115.38 139.08 50.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.626 0.251 . . . . 0.0 110.823 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -132.31 138.29 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.043 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -128.11 107.22 15.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.668 178.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 48.6 t0 166.85 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.239 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.487 ' HB3' HG12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 71.06 -41.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.484 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 16' ' ' ARG . 38.8 t70 74.62 -106.3 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.971 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 12' ' ' ASP . 52.2 p -23.57 -84.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.734 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.9 m -53.46 -45.42 69.53 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.487 HG12 ' HB3' ' A' ' 11' ' ' ASP . 27.1 mm -67.94 -20.48 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.822 0.344 . . . . 0.0 111.741 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.638 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.7 ttt180 -79.2 -54.92 5.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.887 0.375 . . . . 0.0 111.689 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.447 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 65.0 t90 -52.37 -42.75 64.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.489 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 14' ' ' SER . 1.7 t -71.38 -51.18 35.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.038 0.447 . . . . 0.0 111.92 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.613 HD22 ' CD1' ' A' ' 108' ' ' ILE . 4.4 mm? -70.82 -28.66 64.78 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.466 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.694 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 23.6 pt-20 -67.59 -58.96 3.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.491 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.4 mmt180 -63.15 -58.01 8.65 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.07 -55.43 27.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.987 0.423 . . . . 0.0 111.474 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.949 ' CD2' HG11 ' A' ' 6' ' ' VAL . 14.3 tp -66.62 -19.71 65.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.467 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.6 -33.34 70.94 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.53 -26.6 68.45 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.235 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.546 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.87 -15.63 59.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.629 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.77 25.65 9.66 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.781 -0.723 . . . . 0.0 114.795 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.803 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -120.0 164.74 15.65 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.61 1.205 . . . . 0.0 112.313 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.0 m -94.57 111.26 23.02 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.257 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 1.1 m -102.35 118.95 37.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.293 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.966 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -128.88 136.1 49.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.675 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 55.2 p -113.99 157.62 22.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.043 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.8 m-85 -134.8 173.8 11.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.904 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.602 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.9 pp20? -61.3 -58.06 9.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' A' ' 54' ' ' ASP . 1.9 t30 -156.3 -23.05 0.1 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.725 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 165.12 -59.32 0.25 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.717 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.544 ' N ' HD22 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -47.37 -32.91 5.31 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.148 0.499 . . . . 0.0 110.704 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.771 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -60.95 -60.89 3.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.613 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.84 HG21 ' CG2' ' A' ' 9' ' ' VAL . 1.9 t -53.86 -34.65 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.329 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.717 HD13 ' HB2' ' A' ' 68' ' ' GLN . 32.0 mt -48.81 -52.34 24.59 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.054 0.454 . . . . 0.0 110.406 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -47.97 83.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.108 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.59 -35.16 80.09 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.771 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.872 HD13 ' HD2' ' A' ' 73' ' ' HIS . 23.2 mt -68.32 -19.93 64.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.612 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.18 -11.98 58.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.296 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.29 -3.79 7.4 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.5 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -155.49 161.45 40.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.986 0.422 . . . . 0.0 111.31 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.43 HG23 ' CG ' ' A' ' 76' ' ' LEU . 21.1 m -138.47 112.37 8.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.952 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.649 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 73.9 Cg_endo -74.6 164.91 32.78 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.12 1.88 . . . . 0.0 111.822 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -82.43 -24.03 34.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.997 0.427 . . . . 0.0 110.472 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.851 HG11 ' CG2' ' A' ' 115' ' ' VAL . 7.5 p -149.97 91.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.491 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.669 HD23 HG22 ' A' ' 78' ' ' VAL . 57.9 tp -84.25 149.73 25.91 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.242 0.544 . . . . 0.0 111.906 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.873 HD22 ' CE2' ' A' ' 106' ' ' PHE . 5.3 mt -133.73 114.06 13.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.052 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.666 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -109.18 144.02 37.83 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 9.7 t0 -73.34 -171.9 1.05 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.756 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.727 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 8.6 tt -169.96 84.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 120.878 0.371 . . . . 0.0 111.703 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 167.9 59.87 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.171 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -161.0 -63.06 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.46 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 22.5 Cg_endo -59.47 -173.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.765 2.31 . . . . 0.0 113.471 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.98 -66.67 2.67 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.58 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.671 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 2.3 ttm -72.15 57.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.038 0.447 . . . . 0.0 110.367 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.91 -79.09 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.186 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.727 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -146.53 -28.69 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.866 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.735 HD13 ' HB3' ' A' ' 86' ' ' ASP . 3.7 mp -63.16 -19.19 64.25 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.916 0.358 . . . . 0.0 110.703 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.671 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -53.57 -22.76 9.04 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.083 0.468 . . . . 0.0 110.863 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.725 HD13 ' HA3' ' A' ' 36' ' ' GLY . 5.8 mt -69.62 -40.79 76.38 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.317 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.729 HD23 ' CB ' ' A' ' 93' ' ' ALA . 6.6 mp -56.61 -41.23 76.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.419 0.628 . . . . 0.0 109.938 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -53.75 -53.13 56.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.07 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.717 ' HB2' HD13 ' A' ' 40' ' ' LEU . 10.8 mm-40 -69.18 -29.34 67.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.182 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.019 HG23 ' NE2' ' A' ' 73' ' ' HIS . 1.5 mm -52.87 -52.75 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.136 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -68.68 -31.03 69.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.283 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.495 ' NE2' ' HG2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.99 -23.34 44.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.692 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.495 ' HG2' ' NE2' ' A' ' 71' ' ' GLN . 10.4 mmt180 -85.95 -73.27 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.07 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 1.019 ' NE2' HG23 ' A' ' 69' ' ' ILE . 11.2 p80 -89.35 167.26 18.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.211 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.63 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 89.0 Cg_endo -78.29 72.27 6.36 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.782 2.322 . . . . 0.0 112.912 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.632 ' HB2' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER 54.09 34.37 19.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.403 179.114 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 77' ' ' PRO . 0.1 OUTLIER -63.1 121.04 66.71 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.712 ' N ' HD22 ' A' ' 76' ' ' LEU . 10.7 Cg_endo -53.58 132.31 48.28 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.846 2.364 . . . . 0.0 113.19 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.669 HG22 HD23 ' A' ' 51' ' ' LEU . 2.9 t -123.41 154.29 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.541 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.794 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.6 mt -131.56 117.17 34.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.212 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 53' ' ' SER . 11.5 mm -93.57 150.45 3.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.624 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.554 ' HA ' ' CB ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -87.02 -19.43 28.68 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.67 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.7 m -147.03 171.0 15.95 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.656 0.265 . . . . 0.0 110.996 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.5 ' H ' HG22 ' A' ' 82' ' ' THR . . . -122.34 -20.99 5.95 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.729 0.3 . . . . 0.0 111.459 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.416 ' H ' HG22 ' A' ' 82' ' ' THR . 4.2 m-70 45.07 29.71 0.52 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 73.3 m 67.92 -3.99 1.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.735 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -92.5 39.19 1.02 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.045 0.45 . . . . 0.0 110.301 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.739 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -48.44 -21.05 0.48 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.292 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -47.49 -57.65 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.445 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.64 -24.52 67.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.567 0.222 . . . . 0.0 111.537 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.739 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.69 -33.21 73.58 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.666 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.1 t -62.99 -45.37 99.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.607 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 91.7 p -60.3 -34.1 73.3 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.426 0.632 . . . . 0.0 109.89 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.729 ' CB ' HD23 ' A' ' 66' ' ' LEU . . . -59.72 -41.39 90.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.48 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.666 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.8 m-85 -61.91 -21.57 64.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.065 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.632 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.78 -43.41 72.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.503 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.632 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 6.8 pm0 -82.13 -19.12 40.69 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.12 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.63 38.95 0.64 Allowed Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.662 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.693 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -63.57 154.25 33.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.145 0.472 . . . . 0.0 110.237 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.718 ' CZ ' ' HB1' ' A' ' 118' ' ' ALA . 2.2 t80 -79.79 -53.58 6.65 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.71 -162.68 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.769 0.319 . . . . 0.0 111.065 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.582 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.0 m-85 -142.63 139.36 31.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.172 0.511 . . . . 0.0 111.132 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 2.1 tp -101.92 140.8 21.5 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.489 ' O ' HG23 ' A' ' 82' ' ' THR . 35.4 Cg_exo -61.42 -34.54 86.28 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.077 1.851 . . . . 0.0 111.962 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.676 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER 167.54 -50.63 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.245 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.7 Cg_endo -47.85 163.79 0.19 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.008 1.805 . . . . 0.0 109.94 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.873 ' CE2' HD22 ' A' ' 52' ' ' LEU . 26.7 t80 -168.46 -92.13 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.329 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 3.7 p30 41.78 -171.24 0.0 OUTLIER 'General case' 0 C--N 1.335 -0.063 0 CA-C-O 120.961 0.41 . . . . 0.0 111.117 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.896 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -68.11 -49.98 62.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 7.9 m-20 -51.11 -57.11 9.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.819 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -76.31 -30.54 57.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.508 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . . . -83.61 -56.97 3.43 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.021 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.896 HG21 HG23 ' A' ' 108' ' ' ILE . 43.3 t -54.43 -30.38 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.459 0.647 . . . . 0.0 109.987 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.07 -54.6 44.05 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.574 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.794 ' CD2' HG21 ' A' ' 79' ' ' ILE . 6.7 tp -71.4 -22.37 61.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.522 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.851 ' CG2' HG11 ' A' ' 50' ' ' VAL . 4.3 p -79.45 -50.34 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.936 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.471 ' N ' HG13 ' A' ' 115' ' ' VAL . 23.0 mt-10 -62.73 -46.7 86.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.01 0.433 . . . . 0.0 109.908 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -64.91 -25.71 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.176 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.718 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -69.67 -53.41 18.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.093 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.5 mt -66.13 -31.38 53.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.096 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.5 p -70.26 -43.69 69.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.13 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -64.66 -30.66 71.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.927 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.41 -55.36 6.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.173 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 56.48 173.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.834 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.016 0.436 . . . . 0.0 110.96 -179.823 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mmt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.732 0.301 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 60.22 160.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.724 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -61.74 -17.58 56.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.057 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.13 92.99 0.23 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.211 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.78 112.33 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.686 0.279 . . . . 0.0 111.355 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.975 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.1 p -107.2 125.65 63.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.79 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.91 ' CD1' HG22 ' A' ' 31' ' ' THR . 33.1 m0 -112.82 145.24 40.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.038 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.693 ' HB ' HG22 ' A' ' 32' ' ' THR . 0.5 OUTLIER -139.09 137.21 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.138 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.998 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -126.35 105.14 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.483 178.099 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.581 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 60.8 t0 166.81 118.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.887 0.375 . . . . 0.0 111.243 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.469 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.6 OUTLIER 72.26 -21.59 0.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.118 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 10' ' ' ASP . 8.5 t0 70.47 -135.31 0.05 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.579 -0.076 . . . . 0.0 110.849 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.4 m -33.55 -45.41 0.17 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.3 m -53.38 -67.57 0.24 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.948 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.542 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 25.1 mm -65.84 -20.6 27.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.453 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.62 ' HA ' HG21 ' A' ' 32' ' ' THR . 12.5 ttt-85 -72.39 -61.27 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.401 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.496 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 71.4 t90 -48.31 -44.28 33.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.175 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.945 HG12 HD13 ' A' ' 108' ' ' ILE . 1.9 t -64.82 -62.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.919 0.39 . . . . 0.0 111.859 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.569 ' HA ' HD11 ' A' ' 108' ' ' ILE . 7.4 tp -71.51 -19.45 62.18 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 13.8 pt-20 -67.96 -57.71 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.687 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.564 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.28 -56.62 11.69 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.993 -179.022 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.8 -56.34 16.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 0.0 111.441 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.975 ' CD2' HG11 ' A' ' 6' ' ' VAL . 13.5 tp -64.42 -19.75 65.72 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.33 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.12 -37.66 75.37 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.6 -25.01 62.7 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.197 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.566 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.39 -15.9 59.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.74 0.305 . . . . 0.0 110.768 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.75 26.18 9.28 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.748 -0.739 . . . . 0.0 114.714 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.699 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -122.41 166.14 15.21 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 118.478 1.139 . . . . 0.0 112.121 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.5 m -94.98 114.96 26.84 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.34 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -105.17 109.17 21.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.985 -178.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.91 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -121.8 137.58 54.71 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.693 HG22 ' HB ' ' A' ' 8' ' ' VAL . 74.5 p -117.34 160.83 20.5 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.998 ' HB2' HG13 ' A' ' 9' ' ' VAL . 7.6 m-85 -136.03 174.52 10.52 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.077 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.659 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.5 pp20? -60.88 -63.29 1.35 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.538 ' N ' HG12 ' A' ' 9' ' ' VAL . 68.3 m-80 -153.89 -22.74 0.14 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.856 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 172.41 -63.42 0.14 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.862 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.484 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -48.31 -29.38 3.83 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.875 0.369 . . . . 0.0 111.043 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.86 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -63.25 -58.1 8.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.127 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.749 HG21 ' CG2' ' A' ' 9' ' ' VAL . 20.4 t -49.08 -46.27 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.195 0.521 . . . . 0.0 110.899 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.585 HD22 ' CD1' ' A' ' 69' ' ' ILE . 2.1 mt -49.9 -44.86 50.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.003 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.41 81.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.309 0.576 . . . . 0.0 110.937 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.56 -31.55 67.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.217 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.664 ' CD1' HG12 ' A' ' 39' ' ' VAL . 9.6 mt -65.67 -27.51 68.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.93 -20.08 21.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.608 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.9 t -126.76 1.92 6.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.818 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.497 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -153.99 159.79 41.78 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 111.049 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 1.051 HG23 HD23 ' A' ' 76' ' ' LEU . 96.3 m -138.67 112.75 8.43 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.238 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.722 ' HD2' HD21 ' A' ' 76' ' ' LEU . 93.9 Cg_endo -77.12 152.52 31.33 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.04 1.827 . . . . 0.0 111.751 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -74.57 -29.12 61.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.816 0.341 . . . . 0.0 110.692 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.68 HG13 HG23 ' A' ' 6' ' ' VAL . 7.5 p -145.32 94.86 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.484 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.817 HD23 HG22 ' A' ' 78' ' ' VAL . 63.2 tp -86.95 150.92 23.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.473 0.654 . . . . 0.0 112.282 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.878 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.5 mt -131.76 124.98 30.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.778 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.719 ' HA ' HG23 ' A' ' 9' ' ' VAL . 3.8 m -127.91 150.62 49.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 25.2 t0 -82.7 170.69 14.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.363 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.89 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 3.7 tt -147.15 82.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.842 0.353 . . . . 0.0 111.524 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 174.0 61.12 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.892 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.437 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.55 -62.79 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.68 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 22.5 Cg_endo -58.39 -170.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.249 2.633 . . . . 0.0 113.29 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.68 -71.41 0.75 Allowed Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.327 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.916 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -73.03 59.09 0.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.406 . . . . 0.0 110.343 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.81 -74.8 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.46 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.89 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -150.26 -32.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.46 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.882 ' HA ' HD13 ' A' ' 66' ' ' LEU . 3.2 mp -59.08 -20.33 52.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.864 0.364 . . . . 0.0 110.366 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.916 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -58.14 -31.37 67.13 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.466 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.856 HD13 ' HA3' ' A' ' 36' ' ' GLY . 5.9 mt -65.08 -39.61 93.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.409 . . . . 0.0 110.583 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.882 HD13 ' HA ' ' A' ' 63' ' ' LEU . 6.0 mp -60.08 -43.36 95.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.74 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -54.07 -42.51 69.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.235 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.548 ' HB2' HD13 ' A' ' 40' ' ' LEU . 41.1 mm-40 -61.3 -34.14 74.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.236 0.541 . . . . 0.0 110.053 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.598 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 49.7 mm -59.69 -41.68 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.114 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' CB ' ' HB2' ' A' ' 96' ' ' GLN . 11.9 pttp -74.72 -27.78 60.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.249 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.424 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 1.3 mt-30 -63.73 -42.48 97.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.04 0.447 . . . . 0.0 111.267 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 72' ' ' ARG . 12.4 mtt85 -103.7 -49.99 3.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.276 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.586 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 4.1 m-70 -88.58 135.26 32.67 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.615 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.11 -76.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.849 2.366 . . . . 0.0 112.664 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 21.4 mtm -140.92 52.75 1.59 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.456 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.051 HD23 HG23 ' A' ' 47' ' ' THR . 2.2 tm? -56.49 111.6 3.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.214 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.52 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 26.7 Cg_exo -62.35 115.36 2.82 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.27 1.98 . . . . 0.0 112.158 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.953 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -121.82 153.3 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.805 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.773 HG21 ' CD2' ' A' ' 114' ' ' LEU . 3.2 mt -130.64 117.78 40.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.308 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.637 HG22 ' H ' ' A' ' 82' ' ' THR . 19.3 mm -93.86 149.28 4.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.262 0.553 . . . . 0.0 112.407 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.583 ' N ' ' HE2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -84.7 -18.63 34.66 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.501 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.648 ' O ' HG21 ' A' ' 55' ' ' ILE . 3.3 m -147.44 160.98 41.96 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.722 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.834 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -111.09 -24.76 10.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.091 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 47.03 -171.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.344 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.35 53.0 2.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.873 0.368 . . . . 0.0 111.165 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.524 ' HB2' HD13 ' A' ' 63' ' ' LEU . 5.6 m-20 -158.98 28.38 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.819 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.834 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 2.0 mt -46.38 -21.39 0.16 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.79 -56.13 8.09 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -64.65 -19.94 66.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.639 0.257 . . . . 0.0 111.467 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -65.14 -50.99 63.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.342 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.652 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.7 t -65.35 -48.92 81.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.94 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -58.96 -25.04 63.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.956 0.408 . . . . 0.0 110.218 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.561 ' HB1' HD23 ' A' ' 66' ' ' LEU . . . -61.56 -51.86 66.81 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.443 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.665 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 2.7 m-85 -55.83 -30.57 61.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.01 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -37.62 56.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.461 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.538 ' HB2' ' CB ' ' A' ' 70' ' ' LYS . 1.7 pt20 -100.07 4.71 44.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 123.08 81.9 0.56 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.026 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.953 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.7 126.96 1.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 0.0 111.241 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 78.6 t80 -64.77 -53.41 47.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.379 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.665 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.6 OUTLIER 178.2 -169.06 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.881 0.372 . . . . 0.0 111.086 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.532 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.2 m-85 -123.84 118.72 27.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.471 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.665 HD23 ' CE2' ' A' ' 106' ' ' PHE . 5.7 tp -102.45 134.11 20.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 8.1 Cg_endo -49.4 166.66 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.697 2.265 . . . . 0.0 112.036 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.637 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -41.13 -50.08 8.17 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.547 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.7 Cg_endo -47.69 162.6 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.768 1.646 . . . . 0.0 110.441 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.873 ' HD1' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -171.58 -87.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.87 -178.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.7 p30 43.25 -170.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.59 0.233 . . . . 0.0 110.396 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.945 HD13 HG12 ' A' ' 18' ' ' VAL . 1.2 mp -68.04 -45.98 82.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.225 0.536 . . . . 0.0 111.336 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.564 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 7.4 t0 -51.72 -58.17 7.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.695 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.669 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 1.4 mm-40 -78.29 -27.69 47.37 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.873 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.24 -57.02 3.34 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.722 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.684 HG21 HG23 ' A' ' 108' ' ' ILE . 41.3 t -54.23 -31.82 22.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.557 0.694 . . . . 0.0 110.158 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.84 -52.48 63.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.745 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.773 ' CD2' HG21 ' A' ' 79' ' ' ILE . 13.6 tp -74.3 -20.66 60.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.625 -1.171 . . . . 0.0 112.791 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 112' ' ' VAL . 9.8 p -79.32 -50.12 18.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.934 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.507 ' N ' HG13 ' A' ' 115' ' ' VAL . 43.8 mt-10 -64.22 -41.57 96.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.001 0.429 . . . . 0.0 110.487 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -67.56 -25.01 65.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.872 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.99 -54.11 8.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.047 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.4 mt -62.61 -31.34 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.084 0.468 . . . . 0.0 110.508 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.1 m -68.55 -38.11 80.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.741 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -29.59 70.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.88 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -69.23 -37.75 78.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.993 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -75.3 -170.15 1.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.902 179.925 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.812 0.339 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.505 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -88.54 159.92 17.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.953 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -62.45 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.222 0.534 . . . . 0.0 111.736 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.594 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 153.45 103.45 0.23 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.367 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.594 HD13 ' O ' ' A' ' 4' ' ' GLY . 16.9 mm -130.46 112.86 23.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.772 0.32 . . . . 0.0 111.32 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.861 HG23 HG13 ' A' ' 50' ' ' VAL . 7.8 p -107.69 136.01 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.727 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.99 ' CD1' HG22 ' A' ' 31' ' ' THR . 38.5 m0 -122.17 127.37 49.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -118.08 132.23 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -177.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.989 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -116.79 105.11 17.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.12 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.54 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 37.4 t0 173.87 100.66 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.411 ' HB3' ' CG1' ' A' ' 15' ' ' ILE . 3.2 t0 65.44 -15.03 0.11 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 10' ' ' ASP . 3.7 p-10 45.27 -152.56 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.55 0.159 . . . . 0.0 110.893 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 1.8 t 32.53 -91.73 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.75 ' O ' HG23 ' A' ' 18' ' ' VAL . 48.3 t -56.25 -57.49 11.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.625 0.25 . . . . 0.0 110.766 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 10' ' ' ASP . 27.1 mm -60.17 -20.78 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.443 . . . . 0.0 110.36 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.628 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.4 ttm180 -78.78 -58.8 3.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.601 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.413 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 75.1 t90 -49.16 -41.35 36.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.157 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 14' ' ' SER . 1.3 t -68.15 -57.84 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 111' ' ' ALA . 4.2 tp -69.95 -25.4 63.63 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.644 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 23.0 pt-20 -67.69 -57.62 6.06 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.84 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.509 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 6.4 mmt180 -58.49 -53.1 62.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.017 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.43 77.52 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.794 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.3 tm? -76.67 -28.95 56.15 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.246 0.546 . . . . 0.0 110.474 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.67 -32.25 73.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.424 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.28 -24.64 70.74 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.385 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.604 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.06 -14.9 59.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.87 0.367 . . . . 0.0 110.879 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.41 23.33 10.4 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.516 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.604 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -130.96 170.72 14.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 117.471 0.635 . . . . 0.0 111.524 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.626 ' O ' HG12 ' A' ' 6' ' ' VAL . 31.0 m -96.93 141.74 29.74 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.236 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.644 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -127.54 119.35 25.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.815 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.99 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -131.71 135.63 47.01 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 38.9 p -108.62 163.17 13.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.989 ' HB2' HG13 ' A' ' 9' ' ' VAL . 39.5 m-85 -137.47 174.03 11.03 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.79 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.763 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.0 pp20? -62.83 -60.4 3.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.563 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -155.38 -32.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.316 0.507 . . . . 0.0 112.19 -179.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.536 ' HA3' HD21 ' A' ' 65' ' ' LEU . . . -179.14 -65.71 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.484 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.671 HD22 HD12 ' A' ' 40' ' ' LEU . 13.9 m120 -47.72 -27.6 2.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 111.221 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.763 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -57.23 -60.83 3.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.685 HG13 ' HE3' ' A' ' 7' ' ' TRP . 65.4 t -50.71 -45.9 27.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 C-N-CA 120.119 -0.633 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.794 HD21 ' CD1' ' A' ' 65' ' ' LEU . 8.6 mt -46.24 -41.52 13.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.287 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.99 -47.81 67.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.926 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.16 -31.28 67.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.32 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.716 HD21 ' HD2' ' A' ' 48' ' ' PRO . 10.9 mt -61.36 -29.06 69.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.088 0.47 . . . . 0.0 111.042 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.56 -20.04 29.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.483 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 m -118.89 -8.49 10.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.863 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -156.3 157.99 36.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.784 0.326 . . . . 0.0 110.988 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.854 HG23 HD23 ' A' ' 76' ' ' LEU . 78.6 m -138.62 112.85 8.48 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.279 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.716 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.3 Cg_endo -76.94 162.35 32.22 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 121.874 1.716 . . . . 0.0 111.388 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.505 ' OD2' ' HB3' ' A' ' 2' ' ' GLN . 0.9 OUTLIER -73.76 -21.03 60.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.876 0.37 . . . . 0.0 110.925 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.861 HG13 HG23 ' A' ' 6' ' ' VAL . 4.4 p -148.6 163.67 5.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.816 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.682 HD11 HG21 ' A' ' 39' ' ' VAL . 23.5 tp -152.83 154.18 34.61 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.314 0.578 . . . . 0.0 112.307 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.977 ' O ' HG23 ' A' ' 9' ' ' VAL . 4.8 mt -137.79 122.05 18.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.513 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.73 ' O ' ' HE3' ' A' ' 81' ' ' MET . 1.3 m -106.55 144.76 32.76 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.591 ' O ' HG23 ' A' ' 55' ' ' ILE . 46.0 t0 -79.05 -11.7 60.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.741 HD13 ' HB ' ' A' ' 82' ' ' THR . 0.7 OUTLIER 51.53 154.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.684 0.754 . . . . 0.0 111.589 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.67 ' H ' ' C ' ' A' ' 61' ' ' ASP . 5.1 ttt180 84.38 72.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.767 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.483 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.44 -67.07 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.621 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 51.8 Cg_endo -66.25 -160.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.154 2.569 . . . . 0.0 113.028 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.17 13.4 50.32 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.392 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.847 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -152.05 47.65 0.77 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.67 ' C ' ' H ' ' A' ' 56' ' ' ARG . 1.0 OUTLIER 45.77 -86.14 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.569 -178.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.735 ' HA3' ' HB ' ' A' ' 55' ' ' ILE . . . -124.03 -30.5 1.02 Allowed Glycine 0 CA--C 1.508 -0.392 0 C-N-CA 119.863 -1.161 . . . . 0.0 112.901 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.776 HD23 ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -63.74 -19.48 64.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -65.31 -34.16 77.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.794 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -57.51 -45.4 85.01 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.352 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.037 HD13 ' HB2' ' A' ' 93' ' ' ALA . 4.9 mt -53.96 -47.0 71.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.53 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.743 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 9.4 tttt -51.98 -43.91 63.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.316 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.474 ' CB ' HD13 ' A' ' 40' ' ' LEU . 9.3 mm100 -65.84 -38.64 89.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.123 0.487 . . . . 0.0 110.279 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.551 HG23 ' HD2' ' A' ' 73' ' ' HIS . 30.3 mm -61.94 -42.07 93.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.913 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.743 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -70.6 -27.23 63.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.834 -179.08 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -68.76 -39.37 80.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.247 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.99 -54.79 2.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.029 0.443 . . . . 0.0 111.945 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.669 ' CD2' HD13 ' A' ' 43' ' ' LEU . 2.1 m-70 -83.21 145.2 48.36 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.193 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.33 -79.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.724 2.283 . . . . 0.0 113.214 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.736 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 11.5 mtt -127.13 45.68 2.66 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.84 0.352 . . . . 0.0 111.689 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.854 HD23 HG23 ' A' ' 47' ' ' THR . 1.4 tm? -58.64 106.97 0.8 Allowed Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.505 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.47 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 48.3 Cg_exo -58.14 116.38 3.2 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.453 2.102 . . . . 0.0 112.249 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.759 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -112.88 152.17 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.041 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.759 ' HB ' HD23 ' A' ' 52' ' ' LEU . 5.9 mt -142.73 114.8 3.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.593 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.678 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 3.8 mm -94.29 131.38 41.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.315 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.814 ' HE1' ' HB3' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -75.38 -6.39 49.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.429 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.741 ' HB ' HD13 ' A' ' 55' ' ' ILE . 2.9 m -145.68 158.04 43.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.602 0.239 . . . . 0.0 110.381 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.681 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -143.57 47.1 1.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.339 . . . . 0.0 110.705 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.418 ' CD2' HG21 ' A' ' 82' ' ' THR . 6.6 m-70 -76.13 108.97 9.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.824 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 m 51.94 178.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.717 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.562 ' CB ' HD13 ' A' ' 63' ' ' LEU . 1.1 m-20 62.28 14.41 6.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.438 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -45.88 -23.71 0.31 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -48.33 -45.6 35.47 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -73.78 -19.85 60.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.776 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -58.82 -36.87 75.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 0.0 110.219 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.552 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.6 t -65.75 -37.26 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.491 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 m -66.9 -25.12 66.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.181 0.515 . . . . 0.0 109.693 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 1.037 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -64.33 -47.96 77.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.768 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.552 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.3 m-85 -61.61 -26.98 68.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.48 0.657 . . . . 0.0 109.399 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -41.62 41.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.544 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.736 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.6 pp0? -75.94 -16.95 59.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.806 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.13 -2.39 8.38 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.152 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.759 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -55.94 156.67 5.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.857 0.328 . . . . 0.0 110.875 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.501 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 52.7 t80 -86.79 -53.52 4.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.777 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.49 -161.63 0.02 OUTLIER 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.842 0.353 . . . . 0.0 111.677 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.681 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 5.2 m-85 -127.86 124.4 37.42 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.259 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 114' ' ' LEU . 5.8 tp -106.65 137.42 19.46 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.289 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.727 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 12.3 Cg_endo -53.48 165.75 1.49 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.273 1.982 . . . . 0.0 111.115 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.432 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -41.62 -45.41 7.99 Favored Pre-proline 0 N--CA 1.468 0.461 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.727 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 80.6 Cg_exo -47.07 162.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 121.774 1.649 . . . . 0.0 110.531 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.762 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 3.8 t80 -164.21 -95.54 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.237 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.48 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p30 43.14 -173.25 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 120.814 0.34 . . . . 0.0 110.597 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.795 HG23 HG21 ' A' ' 112' ' ' VAL . 1.2 mp -67.47 -48.87 75.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 11.6 m-20 -52.18 -55.47 20.8 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.847 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.706 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.6 mm-40 -78.0 -30.69 50.24 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.664 ' HB3' HD11 ' A' ' 19' ' ' LEU . . . -82.51 -59.6 2.47 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.77 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.795 HG21 HG23 ' A' ' 108' ' ' ILE . 39.8 t -51.72 -33.87 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.505 0.669 . . . . 0.0 110.5 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.76 -51.43 69.8 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.76 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.626 HD22 HD13 ' A' ' 102' ' ' LEU . 19.8 tp -76.04 -21.17 57.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.959 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 112' ' ' VAL . 5.9 p -79.42 -48.95 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.655 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.477 ' N ' HG13 ' A' ' 115' ' ' VAL . 70.4 mt-10 -61.58 -52.2 65.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.73 0.3 . . . . 0.0 111.1 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.588 ' HD2' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -61.19 -24.57 66.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.77 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.56 -53.6 9.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.949 0.404 . . . . 0.0 111.303 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.606 HD11 HG22 ' A' ' 115' ' ' VAL . 4.9 mt -68.1 -31.32 51.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.481 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.0 p -66.06 -44.48 84.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.52 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -74.6 -28.83 61.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.746 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -78.02 -57.34 3.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.577 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.4 172.43 13.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.828 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.888 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.726 0.298 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.64 133.64 55.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.108 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.74 ' HB3' HD11 ' A' ' 5' ' ' ILE . 1.7 ttt180 -56.54 -23.21 38.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.916 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 56.31 77.99 0.14 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.803 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.74 HD11 ' HB3' ' A' ' 3' ' ' ARG . 2.5 mp -116.36 118.94 60.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.516 0.198 . . . . 0.0 110.651 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.909 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.1 p -116.35 123.96 72.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.681 0.277 . . . . 0.0 110.8 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.919 ' CD1' HG22 ' A' ' 31' ' ' THR . 43.9 m0 -115.49 131.3 56.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.85 0.357 . . . . 0.0 110.642 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -121.47 139.79 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.781 -178.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.026 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -126.47 105.81 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.07 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.484 ' HB2' ' SD ' ' A' ' 81' ' ' MET . 43.0 t0 174.52 105.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.705 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.59 -15.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 10' ' ' ASP . 2.6 p30 44.44 -155.22 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.46 0.118 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 1.5 t 30.68 -89.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.634 ' O ' HG23 ' A' ' 18' ' ' VAL . 23.3 m -54.37 -57.49 11.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.37 . . . . 0.0 110.481 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 10' ' ' ASP . 35.5 mm -60.48 -20.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.167 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.764 ' HA ' HG21 ' A' ' 32' ' ' THR . 5.8 ttt-85 -77.37 -61.09 2.1 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.808 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.422 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 70.3 t90 -45.58 -42.75 11.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.797 HG12 HD13 ' A' ' 108' ' ' ILE . 1.8 t -66.95 -62.65 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.04 0.448 . . . . 0.0 112.058 -178.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.486 ' HA ' HD11 ' A' ' 108' ' ' ILE . 12.3 mt -67.12 -26.43 66.69 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.579 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 23.2 pt-20 -65.34 -56.45 12.54 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.104 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.538 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.5 mmm180 -62.97 -58.64 6.63 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.094 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.05 -44.1 67.17 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.909 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.5 tp -73.35 -24.79 60.4 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.431 . . . . 0.0 110.47 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.74 -34.99 77.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.24 -24.22 68.77 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.321 -0.942 . . . . 0.0 111.31 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.634 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.04 -15.78 58.62 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.64 0.257 . . . . 0.0 111.034 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.07 26.2 8.52 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.957 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.702 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.74 170.28 12.31 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 117.987 0.894 . . . . 0.0 111.61 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.2 m -99.56 105.68 17.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.644 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.677 ' HA ' HG13 ' A' ' 6' ' ' VAL . 40.9 t -101.07 111.98 24.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.238 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.919 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -121.36 151.81 39.71 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.764 HG21 ' HA ' ' A' ' 16' ' ' ARG . 68.7 p -125.09 160.15 29.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.026 ' HB2' HG13 ' A' ' 9' ' ' VAL . 5.6 m-85 -135.94 173.86 11.25 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.491 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.508 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.8 pp20? -60.57 -59.23 5.73 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -150.46 -30.2 0.2 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.581 0.628 . . . . 0.0 112.49 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.625 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . 168.24 -56.37 0.22 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.435 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -45.88 -34.22 3.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.942 0.401 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.854 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.2 tp10 -60.97 -56.8 16.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.363 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.762 HG21 ' CG2' ' A' ' 9' ' ' VAL . 3.6 t -49.54 -40.94 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.951 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 68' ' ' GLN . 14.0 mt -55.56 -43.51 75.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.828 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.35 -49.56 59.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.001 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.28 -26.31 66.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.82 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.749 ' CD1' HG12 ' A' ' 39' ' ' VAL . 8.1 mt -71.28 -24.61 62.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.482 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.0 -16.42 43.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.643 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 m -120.26 -6.82 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.591 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -158.72 156.2 29.43 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.674 0.273 . . . . 0.0 110.85 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 1.006 HG23 HD12 ' A' ' 76' ' ' LEU . 67.5 m -139.42 113.0 7.94 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.506 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.683 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 96.8 Cg_endo -76.42 166.06 28.11 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.22 1.947 . . . . 0.0 111.433 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.407 ' O ' ' HD2' ' A' ' 77' ' ' PRO . 28.8 m-20 -73.91 -63.09 1.29 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.852 HG13 HG23 ' A' ' 6' ' ' VAL . 4.9 p -95.12 156.25 3.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.672 HD12 ' O ' ' A' ' 7' ' ' TRP . 50.1 tp -152.85 133.31 13.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.383 0.611 . . . . 0.0 111.856 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.743 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.6 mt -119.67 116.1 25.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.037 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.564 ' HA ' HG23 ' A' ' 9' ' ' VAL . 1.3 t -107.57 146.77 31.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.502 0.668 . . . . 0.0 112.489 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 7.2 t0 -74.43 -178.66 3.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.924 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.583 ' CG2' ' HB ' ' A' ' 82' ' ' THR . 3.3 tt -157.08 86.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.267 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 163.91 58.73 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.711 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.609 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 6.2 tpt -162.76 -63.79 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.609 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 12.1 Cg_endo -53.26 -164.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.065 2.51 . . . . 0.0 113.112 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.56 6.6 72.49 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.801 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.602 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -152.1 51.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.5 ' OD2' HD12 ' A' ' 63' ' ' LEU . 1.3 p-10 48.71 -71.44 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.147 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 55' ' ' ILE . . . -141.95 -36.48 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.999 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.873 ' HA ' HD23 ' A' ' 66' ' ' LEU . 1.3 mp -56.76 -18.69 13.57 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.284 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -63.24 -45.61 90.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.625 HD22 ' HA3' ' A' ' 36' ' ' GLY . 12.0 mt -56.49 -33.76 66.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.601 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.873 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.7 mm? -60.42 -43.81 96.38 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.692 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 14.4 ttmt -56.35 -41.07 75.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.277 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.599 ' HB3' HD13 ' A' ' 40' ' ' LEU . 70.5 mm-40 -70.07 -34.59 73.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.7 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.922 HG23 ' NE2' ' A' ' 73' ' ' HIS . 21.7 mt -67.05 -38.59 81.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.392 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.692 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.57 -24.14 61.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.998 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -78.9 -34.59 44.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.043 0.449 . . . . 0.0 110.935 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -94.04 -69.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.546 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.922 ' NE2' HG23 ' A' ' 69' ' ' ILE . 2.2 p80 -117.66 75.01 9.39 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.071 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.586 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 61.6 Cg_endo -74.96 57.11 4.44 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.299 1.999 . . . . 0.0 112.733 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.428 ' HG3' ' C ' ' A' ' 74' ' ' PRO . 51.3 mtp -154.37 -41.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.101 0.477 . . . . 0.0 111.008 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.006 HD12 HG23 ' A' ' 47' ' ' THR . 2.6 tt -58.12 122.29 57.49 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.911 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.532 ' HD3' ' CE2' ' A' ' 122' ' ' TYR . 18.7 Cg_endo -59.46 118.61 5.52 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.819 2.346 . . . . 0.0 112.513 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.709 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -99.36 148.07 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.849 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.659 ' HB ' HD23 ' A' ' 52' ' ' LEU . 2.7 mt -140.2 113.69 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.181 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.684 HG22 ' H ' ' A' ' 82' ' ' THR . 24.9 mm -93.42 149.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.131 0.491 . . . . 0.0 112.198 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.532 ' HE2' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.39 -13.48 49.26 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.869 -178.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.684 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.6 m -147.78 160.47 42.7 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.046 -0.409 . . . . 0.0 110.682 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.817 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -154.84 65.51 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.846 0.355 . . . . 0.0 111.17 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.422 ' CD2' ' H ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -78.43 -93.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.824 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.422 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -98.63 -176.57 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.305 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.523 ' O ' HD22 ' A' ' 63' ' ' LEU . 85.2 m-20 58.88 14.42 3.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.583 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.804 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -44.47 -25.33 0.25 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -48.02 -42.65 28.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.032 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.603 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.04 -21.37 63.19 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.554 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.687 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -62.56 -41.62 99.03 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.98 0.419 . . . . 0.0 110.069 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.6 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.8 t -58.35 -39.64 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.437 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.8 p -61.45 -37.73 84.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.41 0.624 . . . . 0.0 110.146 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.67 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -54.83 -43.58 73.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.42 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.6 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 34.0 m-85 -59.16 -22.71 61.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.984 0.421 . . . . 0.0 110.503 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.651 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -71.99 -42.94 65.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.585 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.67 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -75.78 -18.1 59.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 120.99 15.95 4.59 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.433 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.709 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -56.59 148.48 19.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.143 0.471 . . . . 0.0 110.539 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.511 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 61.0 t80 -79.81 -53.89 6.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.199 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.406 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER 174.91 -158.9 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.002 0.429 . . . . 0.0 111.579 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.817 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.3 m-85 -131.87 125.77 32.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.653 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 6.0 tp -103.01 140.63 21.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.063 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.719 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 18.7 Cg_endo -56.28 165.15 4.49 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.031 1.821 . . . . 0.0 110.448 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -42.53 -43.87 8.76 Favored Pre-proline 0 N--CA 1.467 0.397 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.719 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 82.0 Cg_exo -47.12 163.88 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.672 1.581 . . . . 0.0 110.818 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.692 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 1.2 t80 -162.49 -92.08 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.528 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.559 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p-10 42.35 -177.12 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.898 0.38 . . . . 0.0 110.889 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.797 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -67.9 -44.79 84.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.355 0.598 . . . . 0.0 111.174 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.1 t70 -53.84 -57.28 11.48 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.787 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.692 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.6 mm-40 -78.53 -28.43 46.14 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.09 -54.24 4.97 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.184 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.753 HG21 HG23 ' A' ' 108' ' ' ILE . 43.8 t -57.49 -32.4 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.558 0.694 . . . . 0.0 109.956 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.44 -51.93 67.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.769 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.653 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 19.4 tp -76.66 -20.67 56.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.82 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.4 p -79.13 -48.62 21.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.723 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.465 ' N ' HG13 ' A' ' 115' ' ' VAL . 71.8 mt-10 -65.25 -45.49 84.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.949 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 20.4 mtp-105 -63.6 -24.01 67.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.905 0.383 . . . . 0.0 110.803 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.511 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -75.04 -51.15 14.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.133 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -65.61 -31.22 52.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.134 0.492 . . . . 0.0 110.975 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.6 t -70.96 -43.77 67.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.129 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -76.89 -27.57 55.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.097 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.532 ' CE2' ' HD3' ' A' ' 77' ' ' PRO . 6.2 t80 -79.55 -56.47 4.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.038 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 58.5 170.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.953 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.817 0.342 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -74.87 146.17 42.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.323 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.68 9.25 1.9 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.816 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.741 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 71.06 89.11 0.1 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.575 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.1 mp -111.55 119.35 59.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.871 0.367 . . . . 0.0 111.364 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.826 HG23 HG13 ' A' ' 50' ' ' VAL . 11.5 p -105.09 127.86 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.076 179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.881 ' CD1' HG22 ' A' ' 31' ' ' THR . 29.5 m0 -115.29 143.7 44.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.786 HG21 HD23 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -136.85 143.66 34.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.043 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -133.38 104.73 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.068 177.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.61 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 43.0 t0 166.47 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.9 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.459 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 71.19 -23.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.94 0.496 . . . . 0.0 112.146 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 10' ' ' ASP . 10.6 t0 69.33 -131.51 0.08 Allowed 'General case' 0 CA--C 1.539 0.523 0 O-C-N 122.53 -0.106 . . . . 0.0 110.877 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 t -34.08 -45.05 0.19 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.704 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.2 m -54.67 -67.31 0.28 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 27.8 mm -64.38 -20.45 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.714 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.614 ' HA ' HG21 ' A' ' 32' ' ' THR . 53.3 ttt180 -70.3 -61.37 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.849 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.472 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 70.5 t90 -50.36 -43.6 54.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.954 0.407 . . . . 0.0 111.715 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.855 HG12 HD13 ' A' ' 108' ' ' ILE . 1.4 t -65.82 -61.11 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.002 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.786 HD23 HG21 ' A' ' 8' ' ' VAL . 9.8 tp -71.66 -20.71 61.91 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.667 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 21.2 pt-20 -67.47 -56.94 7.57 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.152 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.541 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 8.7 mmm180 -65.62 -59.42 3.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.215 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.34 -42.73 61.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.807 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.4 tm? -70.43 -26.6 63.74 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.007 0.432 . . . . 0.0 110.516 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.12 -34.3 76.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.67 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.44 -26.15 69.3 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.27 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.543 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.74 -16.32 59.52 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.743 0.306 . . . . 0.0 111.068 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.41 25.81 8.55 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.455 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.741 ' HB3' ' O ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -136.58 175.2 9.83 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 117.382 0.591 . . . . 0.0 111.355 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.599 ' O ' HG12 ' A' ' 6' ' ' VAL . 3.0 m -106.03 134.61 48.89 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.087 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.667 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 12.2 t -124.3 110.54 14.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.456 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.881 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -110.66 155.42 22.43 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 81.2 p -131.69 159.34 38.66 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.043 ' HB2' HG13 ' A' ' 9' ' ' VAL . 5.8 m-85 -135.8 173.49 11.65 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.927 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.602 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 1.6 pp20? -61.95 -60.81 3.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.742 ' O ' HD11 ' A' ' 65' ' ' LEU . 29.2 m120 -150.69 -52.47 0.14 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 118.318 0.508 . . . . 0.0 111.581 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.657 ' CA ' HD11 ' A' ' 65' ' ' LEU . . . -159.11 -62.03 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.944 -1.122 . . . . 0.0 114.0 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.718 HD22 HD12 ' A' ' 40' ' ' LEU . 12.4 m120 -52.42 -27.67 16.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.979 0.389 . . . . 0.0 111.617 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -62.48 -56.98 12.98 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.482 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.789 HG21 ' CG2' ' A' ' 9' ' ' VAL . 3.0 t -56.61 -40.64 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.151 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.718 HD12 HD22 ' A' ' 37' ' ' ASN . 20.2 mt -50.3 -42.57 52.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.008 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.36 81.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.245 0.545 . . . . 0.0 110.875 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.76 78.96 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.653 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.586 HD13 ' CD2' ' A' ' 73' ' ' HIS . 17.4 mt -59.0 -26.65 64.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.964 0.411 . . . . 0.0 111.132 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.95 -20.84 25.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.64 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.72 1.35 8.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.7 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.46 ' HB3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -156.37 159.43 38.74 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.072 0.463 . . . . 0.0 111.438 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.486 HG23 HD23 ' A' ' 76' ' ' LEU . 86.9 m -139.41 113.08 7.96 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.189 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.564 ' HG2' HD21 ' A' ' 76' ' ' LEU . 78.0 Cg_endo -77.39 153.75 31.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.023 1.815 . . . . 0.0 111.624 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -73.81 -26.1 60.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.856 0.36 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.826 HG13 HG23 ' A' ' 6' ' ' VAL . 6.2 p -146.14 94.93 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.751 ' O ' HD12 ' A' ' 79' ' ' ILE . 56.6 tp -86.53 151.18 23.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.353 0.597 . . . . 0.0 112.151 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.771 ' O ' HG23 ' A' ' 9' ' ' VAL . 7.3 mt -132.99 114.13 13.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.899 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.956 ' HB3' HD13 ' A' ' 65' ' ' LEU . 1.5 m -114.15 149.91 34.97 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.626 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 29.2 t0 -78.14 173.47 12.21 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.636 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.764 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -145.09 74.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-O 120.993 0.425 . . . . 0.0 111.16 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 17.6 ttt-85 176.23 61.08 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.699 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.549 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.29 -62.8 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.549 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 20.1 Cg_endo -59.4 -174.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.532 2.154 . . . . 0.0 113.101 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.01 -72.39 0.54 Allowed Glycine 0 C--N 1.335 0.493 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.58 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.672 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -71.99 56.26 0.31 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.398 179.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.63 -77.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.839 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.764 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -136.33 -39.01 0.16 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.466 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.798 HD23 ' HB2' ' A' ' 90' ' ' ALA . 1.2 mp -51.7 -25.42 7.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.837 0.351 . . . . 0.0 110.496 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -58.73 -33.43 70.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.956 HD13 ' HB3' ' A' ' 53' ' ' SER . 0.4 OUTLIER -50.32 -44.64 54.33 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.898 178.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.644 ' HG ' ' HB2' ' A' ' 93' ' ' ALA . 3.1 mm? -60.67 -42.15 96.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.483 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.575 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -44.73 -60.68 1.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.404 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.645 ' OE1' ' HA ' ' A' ' 65' ' ' LEU . 9.4 mp0 -59.21 -37.01 76.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.839 0.352 . . . . 0.0 110.185 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.672 HG23 ' HD2' ' A' ' 73' ' ' HIS . 4.3 mm -64.13 -42.77 96.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.084 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 1.9 ptpp? -76.64 -24.28 53.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.609 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.26 -39.42 16.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.428 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.72 -62.92 1.38 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.278 0.561 . . . . 0.0 111.772 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.672 ' HD2' HG23 ' A' ' 69' ' ' ILE . 2.1 m-70 -81.42 136.93 48.69 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.979 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.44 -69.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.622 2.215 . . . . 0.0 113.106 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.406 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 1.1 mpt? -144.66 37.28 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 111.601 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.671 HD11 HD22 ' A' ' 51' ' ' LEU . 1.1 tm? -59.94 105.65 0.6 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.407 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.639 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 10.9 Cg_endo -54.07 136.17 66.46 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.468 2.112 . . . . 0.0 112.195 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.729 HG13 HD23 ' A' ' 51' ' ' LEU . 2.1 t -132.89 152.37 35.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.909 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.768 HG21 ' CD2' ' A' ' 114' ' ' LEU . 3.6 mt -132.18 118.6 37.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.403 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 53' ' ' SER . 21.7 mm -93.86 142.98 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.019 0.438 . . . . 0.0 111.887 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.662 ' HE3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -75.46 -20.84 58.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.568 -178.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.599 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.4 m -147.59 161.22 41.57 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.365 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.678 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -133.49 57.75 1.79 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.909 0.385 . . . . 0.0 111.705 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -98.47 -179.81 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.999 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER 63.92 -155.59 0.31 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.059 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.525 ' O ' HD22 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -60.23 78.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.271 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.709 ' HA ' HD21 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -52.8 -22.0 4.82 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -48.25 -50.76 28.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.606 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -56.24 -19.89 15.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.012 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.798 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -70.27 -35.88 74.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.64 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.613 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.8 t -67.06 -38.26 80.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.865 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.578 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 4.2 m -61.5 -18.62 59.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.325 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.782 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.82 -57.03 4.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.324 0.583 . . . . 0.0 111.542 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.613 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -54.22 -33.64 58.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.078 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -76.58 -35.31 58.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.244 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.782 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -77.78 -18.5 56.35 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.218 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.41 -11.71 3.25 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.926 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.692 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -54.96 156.2 3.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.307 0.554 . . . . 0.0 111.323 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.473 ' HD2' HG12 ' A' ' 79' ' ' ILE . 49.9 t80 -79.72 -53.58 6.67 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.252 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.541 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.5 OUTLIER 171.96 -163.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.033 0.444 . . . . 0.0 111.532 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.678 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 2.8 m-85 -125.69 122.32 36.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.259 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' MET . 3.6 tp -102.24 140.66 21.35 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.195 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.753 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 12.7 Cg_endo -54.58 163.68 3.61 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.637 2.225 . . . . 0.0 111.437 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -41.08 -45.8 6.65 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -178.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.753 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 88.7 Cg_exo -47.39 163.49 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.624 1.549 . . . . 0.0 110.671 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.749 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 12.0 t80 -165.77 -92.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.732 -178.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.565 ' O ' ' O ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER 40.11 -174.09 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.772 0.32 . . . . 0.0 111.189 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.855 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -68.08 -51.74 45.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.056 0.455 . . . . 0.0 111.835 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.2 p-10 -49.2 -56.05 10.51 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.942 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.749 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.7 mm-40 -76.59 -30.88 57.15 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.25 -58.5 3.02 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.903 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.677 HG21 HG23 ' A' ' 108' ' ' ILE . 40.0 t -53.03 -31.29 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 121.699 0.762 . . . . 0.0 110.212 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.53 -50.74 72.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.921 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.768 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.8 tp -76.95 -20.73 55.77 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.925 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.646 HG12 ' HA ' ' A' ' 112' ' ' VAL . 9.7 p -77.76 -48.73 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.954 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.504 ' N ' HG13 ' A' ' 115' ' ' VAL . 40.4 mt-10 -62.7 -44.07 97.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.032 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.663 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 7.8 ptm180 -68.14 -23.7 64.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 111.07 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.97 -50.91 17.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.812 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 115' ' ' VAL . 4.3 mt -70.19 -32.18 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.6 t -69.63 -42.11 74.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.033 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -70.59 -28.02 64.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.16 -54.41 5.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.844 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.97 169.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.059 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.792 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 111.69 0.255 . . . . 0.0 111.69 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -150.26 163.01 39.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.879 0.371 . . . . 0.0 111.05 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.09 -20.15 17.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.031 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.06 100.95 1.23 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.518 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.469 HG21 ' CE ' ' A' ' 46' ' ' LYS . 2.1 mp -131.88 112.83 21.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 111.598 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.765 HG11 ' HG ' ' A' ' 23' ' ' LEU . 12.2 p -107.24 130.24 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.873 ' CD1' HG22 ' A' ' 31' ' ' THR . 23.5 m0 -119.14 135.3 54.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -129.06 136.81 58.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -176.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.88 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -122.49 105.79 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.538 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 55.8 t0 170.28 118.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.458 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 2.2 t70 71.05 -43.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.419 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 49.6 t0 75.59 -107.09 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.947 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 12' ' ' ASP . 31.3 p -23.73 -83.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.714 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.0 m -52.93 -47.56 67.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.455 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.446 ' CG1' ' HB3' ' A' ' 11' ' ' ASP . 19.6 mm -64.64 -20.31 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.761 0.315 . . . . 0.0 111.628 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.481 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 7.1 ttp180 -70.75 -60.94 1.96 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.752 0.31 . . . . 0.0 111.586 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.562 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 37.9 t90 -52.08 -44.32 64.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.735 HG12 HD13 ' A' ' 108' ' ' ILE . 1.2 t -64.04 -49.91 79.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.616 ' HA ' HD11 ' A' ' 108' ' ' ILE . 43.3 mt -84.07 -22.1 31.31 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.618 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 1.2 pp20? -66.42 -59.02 4.06 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.511 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' HG2' ' CD ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -64.58 -62.85 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.01 -53.98 7.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.978 0.418 . . . . 0.0 111.944 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.765 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.5 tm? -62.76 -29.21 70.52 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.729 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -66.5 -33.91 76.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.516 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.37 -25.24 69.79 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.396 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.578 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.97 -15.08 59.76 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.678 0.275 . . . . 0.0 111.053 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.58 23.46 10.14 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.63 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.578 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -133.52 174.64 10.2 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.532 0.666 . . . . 0.0 111.722 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 m -102.81 117.33 34.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.281 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.68 ' HB2' HD12 ' A' ' 23' ' ' LEU . 8.8 t -113.93 113.23 24.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.513 0.673 . . . . 0.0 111.533 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.873 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -118.87 156.55 29.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.405 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 31.1 p -135.04 152.11 51.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.426 0.631 . . . . 0.0 112.348 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.88 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -129.64 174.31 9.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.054 -179.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.635 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -58.34 -106.33 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.441 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -86.14 -71.8 0.52 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.762 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -161.16 -39.21 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.411 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.52 -31.63 69.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.901 0.35 . . . . 0.0 110.683 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.772 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -51.84 -57.31 9.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.634 178.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.828 HG21 HG22 ' A' ' 9' ' ' VAL . 2.9 t -56.85 -47.89 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.964 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.452 HD13 ' CB ' ' A' ' 68' ' ' GLN . 38.1 mt -46.18 -42.75 14.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.868 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.42 -50.07 69.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.799 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.49 -28.73 67.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.104 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.936 HD13 ' CE1' ' A' ' 73' ' ' HIS . 7.3 mt -71.04 -20.95 62.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.455 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.85 -18.15 20.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.074 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 m -126.35 9.43 7.25 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.823 ' HG3' ' N ' ' A' ' 47' ' ' THR . 3.4 tttt -158.15 163.53 37.48 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.439 0.638 . . . . 0.0 112.153 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.978 HG23 HD13 ' A' ' 76' ' ' LEU . 97.8 m -138.83 111.46 8.1 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.192 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' O ' HD11 ' A' ' 76' ' ' LEU . 61.2 Cg_endo -74.41 165.52 31.57 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.447 2.098 . . . . 0.0 111.284 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -82.43 -27.97 31.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.867 0.365 . . . . 0.0 110.818 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.756 HG13 HG23 ' A' ' 6' ' ' VAL . 3.4 p -149.61 99.45 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.41 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.846 ' O ' HD12 ' A' ' 79' ' ' ILE . 47.4 tp -86.96 141.93 28.34 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.938 HD23 ' HB ' ' A' ' 79' ' ' ILE . 6.2 mt -124.42 115.03 20.28 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.042 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.699 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -109.69 141.79 41.78 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.092 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 8.3 t0 -71.38 -171.82 0.66 Allowed 'General case' 0 C--O 1.23 0.055 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.931 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.96 HD11 ' CE1' ' A' ' 84' ' ' HIS . 2.7 tt -170.13 79.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.218 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.8 78.91 1.61 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.541 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 2.4 ptt? 43.21 49.92 5.38 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.56 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 50.6 Cg_endo -83.14 -74.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.305 2.003 . . . . 0.0 111.663 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.25 -21.34 3.43 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.976 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 4.3 ttm -163.74 68.28 0.19 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 110.225 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.66 -25.1 0.15 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.167 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.79 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 137.68 -27.68 2.81 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.586 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 89' ' ' ALA . 4.3 mp -75.17 -17.98 60.28 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.976 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.43 -24.5 12.82 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.844 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.612 ' O ' HG13 ' A' ' 69' ' ' ILE . 7.4 mp -62.13 -42.36 99.16 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.842 ' HA ' HD12 ' A' ' 69' ' ' ILE . 85.9 mt -64.19 -42.72 96.54 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.304 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 9.9 tptm -48.39 -56.37 8.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.736 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.452 ' CB ' HD13 ' A' ' 40' ' ' LEU . 24.8 mm-40 -59.61 -32.45 70.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.931 HG23 ' ND1' ' A' ' 73' ' ' HIS . 97.1 mt -59.98 -46.01 94.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.969 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -67.0 -27.61 67.58 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -86.03 -37.02 19.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.153 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -89.85 -61.97 1.57 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.866 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.936 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -84.96 147.29 47.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.063 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -95.17 103.68 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.227 2.618 . . . . 0.0 112.437 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.485 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 18.3 mtm 54.35 24.58 5.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.086 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.978 HD13 HG23 ' A' ' 47' ' ' THR . 10.6 tp -69.15 114.36 22.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.99 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.54 120.63 8.64 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.309 2.006 . . . . 0.0 111.991 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.921 HG21 HD13 ' A' ' 69' ' ' ILE . 1.8 t -117.46 151.47 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.293 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.938 ' HB ' HD23 ' A' ' 52' ' ' LEU . 2.3 mp -131.15 120.39 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.895 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.639 HG22 ' H ' ' A' ' 82' ' ' THR . 18.0 mm -95.49 147.2 6.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.989 0.423 . . . . 0.0 111.375 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.76 ' HE3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.18 -18.42 46.31 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.214 -179.02 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.927 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.9 m -147.77 153.53 39.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.374 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.71 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -134.58 -2.02 2.75 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.744 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.96 ' CE1' HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 23.43 -95.66 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.205 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 m -141.15 -12.78 0.93 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.462 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 3.7 t70 -78.86 44.49 0.55 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.941 0.401 . . . . 0.0 111.361 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.948 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -52.12 -21.06 2.9 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.074 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -47.69 -56.51 7.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.662 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.699 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -68.68 -19.78 64.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.768 0.318 . . . . 0.0 111.247 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.948 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -70.76 -37.73 73.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.88 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.596 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.8 t -63.9 -41.92 94.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.287 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.604 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 23.8 m -61.39 -18.91 60.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 109.991 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.748 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.84 -52.49 10.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.097 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.596 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.0 m-85 -58.24 -33.85 69.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.164 0.507 . . . . 0.0 110.517 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.8 pp0? -76.39 -38.63 55.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.601 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.748 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.2 pp0? -73.12 -18.29 61.31 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.064 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.07 1.44 4.91 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.861 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.612 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -56.82 159.52 3.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.283 0.542 . . . . 0.0 111.537 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.531 ' HB3' HG13 ' A' ' 79' ' ' ILE . 84.0 t80 -85.08 -53.97 4.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.425 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 2.2 t70 173.11 -165.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 111.117 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.71 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.1 m-85 -127.55 122.55 33.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.582 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.412 ' HB2' HD22 ' A' ' 114' ' ' LEU . 1.8 tp -102.58 141.04 21.69 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.837 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.714 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 15.8 Cg_endo -55.52 166.31 2.72 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.363 2.042 . . . . 0.0 111.398 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.431 ' HE2' ' HA ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -42.02 -46.64 10.29 Favored Pre-proline 0 N--CA 1.468 0.437 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.714 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 83.0 Cg_exo -47.23 163.75 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 121.805 1.67 . . . . 0.0 110.727 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.76 ' CE1' ' HE3' ' A' ' 81' ' ' MET . 4.1 t80 -165.75 -93.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.36 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.5 p-10 43.92 -175.78 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.706 0.288 . . . . 0.0 110.506 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.836 HG23 HG21 ' A' ' 112' ' ' VAL . 1.1 mp -67.96 -45.4 83.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.365 0.602 . . . . 0.0 111.381 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 30.9 t0 -52.14 -58.08 7.68 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.662 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.692 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.4 mm-40 -77.82 -30.06 50.93 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -82.99 -53.62 5.69 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.256 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.836 HG21 HG23 ' A' ' 108' ' ' ILE . 47.7 t -57.79 -32.75 43.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.431 0.634 . . . . 0.0 110.097 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.57 -52.91 63.51 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.227 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.792 ' CD2' HG21 ' A' ' 79' ' ' ILE . 6.9 tp -75.07 -20.51 59.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.042 -178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 112' ' ' VAL . 6.0 p -79.18 -43.67 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.601 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.404 ' N ' HG13 ' A' ' 115' ' ' VAL . 16.5 mt-10 -59.89 -51.81 68.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.69 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.4 ' NE ' HD12 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -59.67 -23.82 63.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.371 . . . . 0.0 110.853 179.467 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.46 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.66 -52.59 11.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.486 HD13 HD22 ' A' ' 28' ' ' LEU . 4.4 mt -71.57 -32.46 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.117 0.484 . . . . 0.0 111.244 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 t -66.06 -33.65 76.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.506 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -69.32 -26.63 64.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.761 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.37 -57.41 3.96 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.829 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -177.7 4.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.961 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.948 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.635 0.255 . . . . 0.0 111.555 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.08 178.61 8.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.653 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.679 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -174.2 -33.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.903 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.45 72.65 0.93 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.553 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.3 mp -108.97 112.41 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.841 0.353 . . . . 0.0 111.039 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.899 HG11 ' CD2' ' A' ' 23' ' ' LEU . 6.5 p -109.24 118.46 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.811 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.942 ' CD1' HG22 ' A' ' 31' ' ' THR . 37.5 m0 -109.62 140.21 43.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.188 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.626 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -125.09 144.85 33.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.194 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.104 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -133.14 106.79 10.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.053 0.454 . . . . 0.0 110.957 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 34' ' ' GLU . 8.5 t0 -162.05 -154.46 0.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.746 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.2 -1.56 3.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 62.47 -151.59 0.36 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.474 -0.141 . . . . 0.0 111.013 179.067 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 t 36.32 -90.34 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.772 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.3 t -55.06 -56.5 19.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.672 0.273 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.9 mm -64.3 -30.88 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.299 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.828 ' HA ' HG21 ' A' ' 32' ' ' THR . 8.5 ttm-85 -71.78 -53.3 13.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.628 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.441 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 72.9 t90 -54.07 -40.73 67.43 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 14' ' ' SER . 2.8 t -69.04 -56.65 11.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.66 HD13 HD12 ' A' ' 108' ' ' ILE . 7.0 tp -72.38 -23.13 61.07 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.679 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . 14.6 pt-20 -67.31 -59.23 3.58 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.492 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.544 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 11.4 mmm-85 -74.62 -53.84 8.58 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.79 -56.15 17.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 0.0 111.786 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.899 ' CD2' HG11 ' A' ' 6' ' ' VAL . 11.4 tp -66.02 -21.36 66.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.639 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.33 -34.83 73.14 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.34 -26.52 68.04 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.349 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.433 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.2 -15.95 59.28 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.649 0.261 . . . . 0.0 110.676 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.2 24.83 8.19 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 115.449 0.94 . . . . 0.0 115.449 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.679 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -121.37 165.2 15.88 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.75 1.275 . . . . 0.0 112.438 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.8 m -88.74 109.08 19.85 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.16 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.679 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -101.9 115.62 30.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.414 -178.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.942 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -133.62 132.19 40.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.828 HG21 ' HA ' ' A' ' 16' ' ' ARG . 59.2 p -105.87 164.14 12.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.489 0.661 . . . . 0.0 112.523 -178.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.104 ' HB2' HG13 ' A' ' 9' ' ' VAL . 4.2 m-85 -135.79 173.42 11.73 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.071 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.592 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 2.0 pp20? -61.53 -49.52 76.38 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.704 ' HB3' ' HB2' ' A' ' 57' ' ' MET . 19.6 m-20 -165.96 -35.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.564 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -172.79 -64.83 0.05 OUTLIER Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.992 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.14 -30.57 49.6 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.848 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 11.1 tt0 -56.14 -48.03 77.03 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.129 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.69 ' HA ' ' CE2' ' A' ' 33' ' ' PHE . 4.1 t -52.8 -40.65 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.313 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.63 HD11 HD12 ' A' ' 65' ' ' LEU . 44.9 mt -54.16 -42.12 69.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.727 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.0 -52.48 65.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.848 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.54 -27.94 64.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.812 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.812 HD21 ' HD2' ' A' ' 48' ' ' PRO . 11.9 mt -67.67 -28.53 67.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.579 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.17 -17.74 4.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.877 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.55 -0.02 8.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.554 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.82 164.38 23.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 111.363 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.481 HG23 HD13 ' A' ' 76' ' ' LEU . 88.9 m -138.97 113.35 8.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.562 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.812 ' HD2' HD21 ' A' ' 43' ' ' LEU . 46.3 Cg_endo -68.82 158.44 57.85 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.271 1.981 . . . . 0.0 111.54 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.498 ' OD2' HD12 ' A' ' 5' ' ' ILE . 8.2 m-20 -80.53 -25.94 38.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.47 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.938 HG21 HG23 ' A' ' 115' ' ' VAL . 7.6 p -147.93 97.88 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.684 0.278 . . . . 0.0 111.111 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.711 HD22 HD21 ' A' ' 76' ' ' LEU . 18.6 tp -86.83 152.87 22.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.999 0.428 . . . . 0.0 111.989 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 106' ' ' PHE . 1.1 tt -134.87 114.41 12.54 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.074 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 t -114.9 136.98 52.51 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.995 0.426 . . . . 0.0 111.919 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.414 ' C ' HG22 ' A' ' 55' ' ' ILE . 15.3 t70 -82.75 4.43 25.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.546 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.683 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 7.4 tt 41.84 82.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 12.2 ttp85 175.09 62.23 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.382 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.704 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 10.9 tpt -163.43 -61.13 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.801 ' HB2' ' HB3' ' A' ' 64' ' ' ALA . 17.9 Cg_endo -58.02 178.8 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.405 2.07 . . . . 0.0 112.616 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.77 -64.76 3.66 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.177 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.736 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 3.8 tpt -72.4 57.24 0.38 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.005 0.431 . . . . 0.0 110.099 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 0.4 OUTLIER 59.52 -81.8 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.237 -179.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -141.39 -31.29 0.15 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.566 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.662 HD11 ' O ' ' A' ' 84' ' ' HIS . 0.8 OUTLIER -60.27 -25.34 65.63 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.113 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.801 ' HB3' ' HB2' ' A' ' 58' ' ' PRO . . . -54.32 -34.17 60.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.926 0.393 . . . . 0.0 109.942 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.63 HD12 HD11 ' A' ' 40' ' ' LEU . 30.7 tp -56.82 -36.99 70.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.825 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.004 HD21 HD11 ' A' ' 80' ' ' ILE . 3.7 mm? -64.32 -44.53 91.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.848 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.776 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -57.21 -42.13 80.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.857 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.458 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 8.5 mm100 -65.18 -36.67 84.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.126 0.488 . . . . 0.0 110.487 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.786 HD12 ' HA ' ' A' ' 66' ' ' LEU . 59.2 mt -61.51 -39.75 84.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.083 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.776 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.64 -28.01 62.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.258 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -79.42 -39.36 32.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.567 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -96.66 -61.54 1.4 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.876 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.668 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 2.6 m-70 -82.25 157.88 67.51 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.495 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -68.3 -76.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.612 2.208 . . . . 0.0 112.966 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.658 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 31.1 mtm -145.26 56.1 1.23 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.027 0.441 . . . . 0.0 111.124 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.711 HD21 HD22 ' A' ' 51' ' ' LEU . 17.6 tp -67.05 112.66 10.43 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.145 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 42.1 Cg_endo -67.28 118.75 5.81 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.462 2.108 . . . . 0.0 111.632 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.73 HG21 HD13 ' A' ' 69' ' ' ILE . 11.5 t -120.63 148.93 23.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 111.651 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.736 HG21 ' CD2' ' A' ' 114' ' ' LEU . 2.7 mt -117.2 113.66 43.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.121 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.004 HD11 HD21 ' A' ' 66' ' ' LEU . 18.3 mm -93.5 135.54 27.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.111 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.888 ' HE3' ' HD2' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -73.09 -55.52 6.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.215 0.531 . . . . 0.0 110.7 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.547 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.5 m -106.39 157.62 17.49 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.218 -0.301 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.743 ' HB1' ' CD2' ' A' ' 87' ' ' LEU . . . -121.49 37.4 4.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.884 0.373 . . . . 0.0 110.695 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.662 ' O ' HD11 ' A' ' 63' ' ' LEU . 7.7 p80 -81.17 -172.81 3.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 74.91 -75.93 0.07 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.241 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.469 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -160.03 98.96 1.35 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.796 0.331 . . . . 0.0 111.45 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.833 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -47.81 -24.52 1.0 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.265 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.04 -42.11 27.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.889 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.413 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -72.25 -26.31 61.96 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.321 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.833 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.03 -45.79 72.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.45 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.59 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 15.0 t -67.6 -47.45 80.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 89' ' ' ALA . 2.7 p -63.34 -30.69 71.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.111 0.481 . . . . 0.0 110.16 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.792 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -59.04 -37.38 76.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.682 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.59 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 23.5 m-85 -59.04 -22.11 60.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.077 0.465 . . . . 0.0 110.014 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.63 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.3 -42.15 46.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.075 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.727 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp0? -76.13 -18.11 59.28 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.057 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 128.87 9.21 3.53 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.716 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.792 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -54.39 147.52 13.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 117.37 0.585 . . . . 0.0 111.433 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 56.2 t80 -86.68 -54.17 4.53 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.695 ' OD1' HG23 ' A' ' 79' ' ' ILE . 19.2 p30 171.51 -168.71 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.811 0.338 . . . . 0.0 111.273 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.57 ' CD2' ' HB ' ' A' ' 80' ' ' ILE . 11.3 m-85 -130.45 134.98 47.52 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.538 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.73 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -137.4 117.57 10.47 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.75 -0.205 . . . . 0.0 110.594 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 102' ' ' LEU . 58.8 Cg_exo -38.68 173.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.604 2.869 . . . . 0.0 114.501 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.888 ' HD2' ' HE3' ' A' ' 81' ' ' MET . 0.1 OUTLIER -36.91 -49.51 2.04 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.111 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.9 Cg_endo -47.8 123.81 8.94 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 N-CA-C 108.71 -1.304 . . . . 0.0 108.71 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.955 ' CZ ' HD21 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -156.89 -85.68 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.997 -177.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.9 p30 37.32 -162.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.857 0.361 . . . . 0.0 110.854 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.885 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -67.9 -52.52 38.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.587 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 32.1 m-20 -50.53 -56.63 10.76 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.549 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.658 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.6 mm-40 -78.27 -30.97 48.84 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.683 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.37 -54.31 4.87 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.755 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.885 HG21 HG23 ' A' ' 108' ' ' ILE . 32.2 t -55.07 -32.02 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.491 0.663 . . . . 0.0 110.156 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.34 -51.87 67.65 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.501 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.736 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.9 tp -75.3 -20.59 59.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.697 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.938 HG23 HG21 ' A' ' 50' ' ' VAL . 6.6 p -79.41 -50.0 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.092 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.496 ' N ' HG13 ' A' ' 115' ' ' VAL . 17.9 mt-10 -58.33 -43.97 88.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.666 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -24.33 67.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.96 0.409 . . . . 0.0 110.474 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.71 -59.05 2.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.979 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -64.95 -30.98 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.075 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 t -64.45 -37.18 86.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.076 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -78.7 -25.8 44.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.29 -52.2 29.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.01 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.23 176.36 7.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.93 179.893 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . 0.465 ' F1 ' ' HE1' ' A' ' 81' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.853 0.358 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 61.22 155.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.704 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.08 70.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.021 0.439 . . . . 0.0 111.198 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.477 ' C ' HD13 ' A' ' 5' ' ' ILE . . . -98.52 84.29 0.67 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.409 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.479 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 4.0 mm -107.03 112.4 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.678 0.275 . . . . 0.0 111.09 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.865 HG11 ' CD2' ' A' ' 23' ' ' LEU . 5.9 p -109.95 119.2 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.808 0.337 . . . . 0.0 110.563 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.936 ' CD1' HG22 ' A' ' 31' ' ' THR . 34.8 m0 -112.55 131.77 55.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.802 0.334 . . . . 0.0 110.566 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -122.77 145.6 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.167 0.508 . . . . 0.0 112.283 -177.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.011 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -131.26 107.91 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.15 178.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 31.6 t0 170.76 107.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.869 0.366 . . . . 0.0 111.674 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.56 -40.59 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.7 OUTLIER 69.23 -159.3 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t 30.96 -87.72 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.677 ' O ' HG23 ' A' ' 18' ' ' VAL . 9.6 t -56.09 -57.49 11.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 0.0 110.518 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.38 -22.46 27.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.098 0.475 . . . . 0.0 110.186 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.739 ' HA ' HG21 ' A' ' 32' ' ' THR . 5.2 ttp180 -77.42 -59.24 2.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.398 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.407 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 87.8 t90 -46.35 -38.86 9.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.811 HG12 HD13 ' A' ' 108' ' ' ILE . 1.6 t -72.2 -62.51 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.011 0.434 . . . . 0.0 111.911 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.674 HD13 HD12 ' A' ' 108' ' ' ILE . 3.6 mm? -65.37 -25.75 67.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.142 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.622 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 8.9 pt-20 -67.77 -59.3 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.611 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 6.6 mmm180 -71.75 -48.16 48.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.931 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -57.78 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.049 0.452 . . . . 0.0 111.345 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.865 ' CD2' HG11 ' A' ' 6' ' ' VAL . 4.8 tp -63.96 -22.98 67.16 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.348 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.32 -33.95 72.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.24 -22.33 74.45 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.282 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.487 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.72 -16.0 58.75 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.658 0.266 . . . . 0.0 110.997 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.7 25.54 6.52 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.218 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.685 HD12 ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -130.68 168.72 16.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.897 0.849 . . . . 0.0 111.725 179.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.8 m -98.79 105.85 18.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.874 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.69 ' HA ' HG13 ' A' ' 6' ' ' VAL . 33.6 t -104.38 112.87 26.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.936 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.0 t -120.53 154.63 35.07 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.755 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 16.2 p -125.26 164.87 19.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.543 0.687 . . . . 0.0 112.794 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.011 ' HB2' HG13 ' A' ' 9' ' ' VAL . 47.4 m-85 -135.97 173.78 11.34 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.517 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.742 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -61.94 -60.94 2.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -177.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.499 ' N ' HG12 ' A' ' 9' ' ' VAL . 7.4 t-20 -151.36 -24.73 0.2 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.688 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 167.91 -58.78 0.21 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.922 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.538 ' N ' HD22 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -52.62 -26.95 15.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.853 0.358 . . . . 0.0 110.685 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.799 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -59.38 -60.31 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.802 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.841 HG22 ' CD1' ' A' ' 33' ' ' PHE . 39.4 t -48.58 -34.48 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.834 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.472 ' CD1' ' HA ' ' A' ' 37' ' ' ASN . 19.2 mt -57.48 -43.52 84.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.59 -53.78 51.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.16 0.505 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.39 -31.24 71.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.905 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.746 ' HG ' HG12 ' A' ' 39' ' ' VAL . 12.2 mt -59.85 -29.84 68.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.9 -19.59 4.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.101 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 t -127.79 0.2 6.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -156.02 157.76 36.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.768 0.318 . . . . 0.0 110.78 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.463 HG23 HD13 ' A' ' 76' ' ' LEU . 85.8 m -138.82 114.79 8.65 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.223 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.588 ' HD2' HD21 ' A' ' 43' ' ' LEU . 61.1 Cg_endo -74.39 154.94 45.95 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.083 1.855 . . . . 0.0 111.716 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.21 -23.99 40.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.749 0.309 . . . . 0.0 111.08 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.916 HG23 HD11 ' A' ' 79' ' ' ILE . 3.3 p -145.8 92.31 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.56 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.685 HD11 HG21 ' A' ' 39' ' ' VAL . 63.2 tp -86.61 152.45 22.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.233 0.539 . . . . 0.0 111.929 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.966 ' O ' HG23 ' A' ' 9' ' ' VAL . 4.8 mt -138.2 123.26 19.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.557 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.578 ' HB3' HD13 ' A' ' 80' ' ' ILE . 7.3 t -111.05 144.76 39.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 50.0 t0 -75.47 -11.06 59.96 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.761 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 82' ' ' THR . 1.7 tt 44.35 78.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.563 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 9.2 tpt180 172.05 76.08 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.679 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.632 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.24 -61.78 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.672 ' HD3' HD21 ' A' ' 65' ' ' LEU . 73.7 Cg_endo -74.13 -170.08 0.66 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.134 1.889 . . . . 0.0 113.504 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.3 -59.68 10.27 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.845 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.672 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 10.4 tpp -72.92 52.91 0.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.911 0.386 . . . . 0.0 110.602 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.81 -76.75 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.287 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.75 -32.04 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.189 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.605 HD12 ' H ' ' A' ' 63' ' ' LEU . 4.0 mp -51.79 -29.56 19.57 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -55.66 -32.49 63.25 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.929 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.688 HD13 ' HA3' ' A' ' 36' ' ' GLY . 13.5 mt -56.2 -44.39 79.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.544 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.933 HD21 HD11 ' A' ' 80' ' ' ILE . 30.5 mt -60.57 -44.36 96.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.122 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.628 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 9.8 mttt -49.75 -40.8 42.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.212 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -70.37 -35.64 73.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.203 0.525 . . . . 0.0 110.321 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.847 HD12 ' HA ' ' A' ' 66' ' ' LEU . 69.9 mt -62.42 -40.62 88.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.09 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.628 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -76.23 -25.01 54.61 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.705 -179.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -36.21 25.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.649 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.0 mtp85 -92.77 -25.74 18.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.739 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.71 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 40.0 m-70 -124.25 152.72 68.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 120.862 0.363 . . . . 0.0 111.533 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.08 -83.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.083 2.522 . . . . 0.0 113.063 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.97 51.31 1.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.663 0.268 . . . . 0.0 111.073 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.518 HD21 HD22 ' A' ' 51' ' ' LEU . 55.3 tp -60.81 110.54 3.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.704 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.476 ' HD2' HD12 ' A' ' 76' ' ' LEU . 34.7 Cg_endo -64.84 115.7 3.4 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.103 1.868 . . . . 0.0 111.527 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.661 HG11 ' CD2' ' A' ' 66' ' ' LEU . 3.5 t -108.01 154.25 9.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.58 0.705 . . . . 0.0 111.525 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.916 HD11 HG23 ' A' ' 50' ' ' VAL . 3.5 mt -131.22 117.32 36.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.177 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.933 HD11 HD21 ' A' ' 66' ' ' LEU . 33.0 mm -93.42 143.51 11.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.997 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.733 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -94.3 -7.87 40.62 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.714 -179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.813 ' O ' HD13 ' A' ' 55' ' ' ILE . 3.0 m -147.52 129.11 15.05 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.93 0.395 . . . . 0.0 111.352 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB1' HD21 ' A' ' 87' ' ' LEU . . . -115.6 86.42 2.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -66.78 -159.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.935 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.7 34.15 0.53 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.673 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.468 ' HB2' HD13 ' A' ' 63' ' ' LEU . 1.3 m-20 -125.35 26.73 6.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.04 0.448 . . . . 0.0 110.333 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.633 HD13 ' CB ' ' A' ' 90' ' ' ALA . 1.1 mm? -44.54 -21.58 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.447 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -47.82 -47.26 31.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.521 0.2 . . . . 0.0 111.386 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.553 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -72.58 -22.45 60.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.856 0.36 . . . . 0.0 110.926 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.633 ' CB ' HD13 ' A' ' 87' ' ' LEU . . . -67.58 -49.02 65.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.374 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.595 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.4 t -57.71 -49.05 82.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.05 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -29.81 68.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.411 0.624 . . . . 0.0 109.901 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.602 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -58.53 -39.81 81.2 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.14 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 25.6 m-85 -61.31 -21.18 63.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.43 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.623 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.15 -42.59 55.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.706 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.623 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 1.2 pt20 -77.0 -15.1 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.817 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.32 13.44 4.81 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.626 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.602 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -55.52 143.77 28.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.146 0.473 . . . . 0.0 110.982 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.557 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 69.5 t80 -76.39 -53.96 7.41 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.222 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.4 t0 172.98 -166.1 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.947 0.403 . . . . 0.0 111.555 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.741 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.4 m-85 -129.05 118.97 23.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.347 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.465 HD23 ' HD1' ' A' ' 106' ' ' PHE . 5.9 tp -102.56 131.1 22.76 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.664 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.583 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 83.5 Cg_exo -47.48 168.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.551 2.168 . . . . 0.0 111.98 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.436 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -43.32 -46.36 15.7 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 88.1 Cg_exo -46.56 163.34 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 121.705 1.603 . . . . 0.0 110.763 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.744 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 5.0 t80 -169.39 -91.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.389 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.499 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.8 p-10 43.46 -174.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.73 0.3 . . . . 0.0 110.912 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.811 HD13 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.98 -48.14 76.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.225 0.536 . . . . 0.0 110.819 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 5.1 t70 -50.32 -57.18 8.47 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.082 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.681 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.5 mm-40 -79.25 -27.2 42.37 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.54 ' HB3' HD11 ' A' ' 19' ' ' LEU . . . -84.15 -53.43 5.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.578 ' HA ' HG12 ' A' ' 115' ' ' VAL . 42.3 t -59.17 -32.16 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.507 0.67 . . . . 0.0 110.17 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.89 -52.62 64.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.752 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.706 HD12 ' HD3' ' A' ' 117' ' ' ARG . 11.4 tp -75.67 -20.36 58.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.432 -1.258 . . . . 0.0 112.545 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 112' ' ' VAL . 3.6 p -78.28 -46.35 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.643 -0.423 . . . . 0.0 112.017 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.421 ' N ' HG13 ' A' ' 115' ' ' VAL . 43.6 mt-10 -61.95 -45.35 94.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.808 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.706 ' HD3' HD12 ' A' ' 114' ' ' LEU . 5.0 ptm180 -62.76 -25.7 68.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.671 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.557 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.93 -52.17 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.238 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.606 HD13 ' CD2' ' A' ' 28' ' ' LEU . 5.1 mt -68.31 -30.7 48.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.148 0.499 . . . . 0.0 110.738 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 m -65.28 -41.8 93.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.796 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -61.03 -31.26 70.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.734 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -88.13 -50.22 6.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.719 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 58.61 163.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.006 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.441 ' C ' ' H ' ' A' ' 3' ' ' ARG . 5.3 ttt . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 120.729 0.299 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 1' ' ' MET . 1.4 mt-30 71.27 -41.78 0.51 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.49 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.894 ' CG ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER 80.94 -55.71 0.31 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.361 0.601 . . . . 0.0 110.672 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.728 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 76.9 68.52 1.51 Allowed Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.814 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.894 HD11 ' CG ' ' A' ' 3' ' ' ARG . 1.5 mm -107.8 112.29 39.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.764 0.316 . . . . 0.0 110.763 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.951 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.1 p -113.91 124.56 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.526 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 1.005 ' CD1' HG22 ' A' ' 31' ' ' THR . 53.2 m0 -116.71 133.35 56.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.702 0.287 . . . . 0.0 110.394 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -119.13 128.99 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.924 HG23 ' HA ' ' A' ' 53' ' ' SER . 2.7 m -117.65 118.77 59.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 110.419 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.474 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 17.2 t0 -173.45 -146.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.872 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -65.24 -4.46 5.25 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.6 t0 58.56 -147.5 0.5 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 122.543 -0.098 . . . . 0.0 111.234 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t 34.31 -87.87 0.01 OUTLIER 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.852 ' O ' HG23 ' A' ' 18' ' ' VAL . 39.2 m -58.1 -57.31 13.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.76 0.314 . . . . 0.0 110.988 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.6 mm -60.58 -31.39 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.304 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.73 ' HA ' HG21 ' A' ' 32' ' ' THR . 15.4 ttp180 -72.37 -57.39 4.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.831 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.44 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 66.0 t90 -50.83 -42.4 58.45 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.852 HG23 ' O ' ' A' ' 14' ' ' SER . 0.9 OUTLIER -70.49 -58.77 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.184 0.516 . . . . 0.0 111.598 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.761 HD22 ' CD1' ' A' ' 108' ' ' ILE . 3.9 mm? -66.63 -26.99 67.34 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.67 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.589 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 12.2 pt-20 -66.87 -60.14 2.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.589 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.0 OUTLIER -72.35 -55.3 7.33 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.475 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -50.37 -57.25 8.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.0 111.815 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.951 ' CD2' HG11 ' A' ' 6' ' ' VAL . 4.6 tp -60.68 -25.24 66.22 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.438 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -68.76 -37.14 79.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.76 -23.69 70.91 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.513 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.414 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.69 -15.72 59.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.582 0.229 . . . . 0.0 110.977 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.14 25.04 6.58 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.39 -0.91 . . . . 0.0 114.29 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.666 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.24 170.06 15.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.78 0.79 . . . . 0.0 111.436 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.3 m -101.41 105.82 16.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.215 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.814 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 16.0 t -105.99 111.46 24.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.155 0.502 . . . . 0.0 111.952 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 1.005 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -121.26 155.64 34.2 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.73 HG21 ' HA ' ' A' ' 16' ' ' ARG . 32.6 p -126.02 159.99 31.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.559 0.695 . . . . 0.0 112.543 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.919 ' HB2' HG12 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -136.44 174.32 10.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.267 -179.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.641 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -63.04 -33.43 75.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.035 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.641 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 2.2 t30 -176.34 171.76 2.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.019 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.598 ' HA2' HG21 ' A' ' 9' ' ' VAL . . . -50.26 -25.27 7.93 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.144 -1.027 . . . . 0.0 111.907 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.504 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -58.58 -52.21 66.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.673 0.273 . . . . 0.0 110.63 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.6 tt0 -51.95 -51.54 56.44 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.669 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.734 HG21 HD11 ' A' ' 51' ' ' LEU . 52.2 t -50.72 -35.1 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.133 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.2 mt -54.98 -43.1 73.21 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.04 -47.79 64.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.879 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.99 80.39 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.91 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.679 HD21 ' HD2' ' A' ' 48' ' ' PRO . 14.7 mt -67.19 -25.0 65.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.239 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.23 -15.3 23.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.766 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.2 -4.97 8.39 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.646 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -167.07 165.96 15.41 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.932 0.396 . . . . 0.0 110.844 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.72 HG23 HD23 ' A' ' 76' ' ' LEU . 89.0 m -138.79 120.85 10.35 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.452 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.679 ' HD2' HD21 ' A' ' 43' ' ' LEU . 93.0 Cg_endo -80.61 162.11 21.8 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.087 1.858 . . . . 0.0 111.638 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -74.01 -27.9 61.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 0.0 110.849 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.789 HG21 HG23 ' A' ' 115' ' ' VAL . 3.3 p -145.14 154.95 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.734 HD11 HG21 ' A' ' 39' ' ' VAL . 9.5 tp -152.98 136.75 16.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 111.342 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.659 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -111.45 122.59 48.25 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.924 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -106.83 137.95 43.91 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.474 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 29.1 t0 -73.02 171.33 13.06 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.342 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.675 HG13 ' O ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -157.97 93.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.383 -178.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.83 44.12 2.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.579 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 8.1 ttp 59.89 46.14 1.26 Allowed Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 55.2 Cg_endo -71.1 -73.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.296 1.997 . . . . 0.0 112.188 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.412 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -112.15 -27.73 3.85 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.233 -0.508 . . . . 0.0 111.851 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.943 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 16.0 ttm -155.63 64.39 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.361 . . . . 0.0 110.456 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.675 ' O ' HG13 ' A' ' 55' ' ' ILE . 2.4 t70 71.87 -23.54 0.19 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.172 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.614 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 136.44 -29.55 2.78 Favored Glycine 0 CA--C 1.506 -0.505 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.874 ' HA ' HD23 ' A' ' 66' ' ' LEU . 2.2 mp -70.11 -19.85 63.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.891 -0.655 . . . . 0.0 110.296 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.943 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.64 -30.75 44.43 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.128 0.49 . . . . 0.0 109.819 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.554 HD11 ' C ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -59.63 -48.39 81.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.537 178.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.874 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.5 mm? -48.74 -41.72 33.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.018 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.713 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 16.9 tttp -58.78 -43.73 90.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.351 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -62.73 -38.83 92.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.221 0.534 . . . . 0.0 110.648 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 66' ' ' LEU . 73.5 mt -57.41 -40.22 73.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.814 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.713 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.34 -22.56 47.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.15 -43.5 86.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.862 0.363 . . . . 0.0 111.85 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -99.3 -31.97 11.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.037 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.546 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 1.9 m-70 -112.68 138.2 21.99 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.764 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.37 -68.15 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.261 1.974 . . . . 0.0 112.554 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mpp? -148.45 53.67 1.01 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 110.736 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.79 HD22 ' HD2' ' A' ' 77' ' ' PRO . 3.1 tm? -55.26 115.06 8.26 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.419 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.79 ' HD2' HD22 ' A' ' 76' ' ' LEU . 10.0 Cg_endo -53.5 121.51 9.62 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.615 2.21 . . . . 0.0 112.213 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.79 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.2 t -127.99 149.36 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.22 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.699 HG21 HD23 ' A' ' 114' ' ' LEU . 1.6 mp -137.4 116.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.586 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.752 HG22 ' H ' ' A' ' 82' ' ' THR . 25.3 mm -92.65 142.98 12.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.276 0.56 . . . . 0.0 111.944 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.524 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.87 -9.7 59.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.984 -178.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.752 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.4 m -147.6 152.45 37.94 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.611 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.804 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -161.66 73.51 0.43 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.494 ' CD2' ' H ' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -96.62 -21.12 17.83 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.29 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.3 m -159.84 175.76 12.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.049 0.452 . . . . 0.0 111.451 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.631 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER 54.42 29.25 10.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.411 -179.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.496 HD13 ' CB ' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -50.56 -21.06 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.546 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -47.81 -52.68 17.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.678 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -68.56 -19.77 64.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.109 -0.236 . . . . 0.0 111.315 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.66 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -66.75 -54.43 22.87 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.833 0.349 . . . . 0.0 111.011 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.647 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 4.1 t -62.23 -45.06 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 76.5 p -60.7 -27.05 67.58 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -59.09 -50.18 75.04 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.483 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.647 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -59.68 -33.63 71.82 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.901 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -39.72 69.48 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.449 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.58 ' HB2' ' CB ' ' A' ' 70' ' ' LYS . 7.6 pt20 -93.3 -7.42 44.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 132.02 82.36 0.22 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.766 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.79 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.46 139.18 2.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.559 0.218 . . . . 0.0 110.552 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 38.1 t80 -74.94 -53.76 8.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.347 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.701 ' OD2' HD11 ' A' ' 114' ' ' LEU . 38.5 p-10 177.71 -168.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.0 111.256 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.804 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 7.6 m-85 -123.1 152.76 40.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.802 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.669 HD12 ' O ' ' A' ' 103' ' ' PRO . 0.7 OUTLIER -143.02 142.79 22.72 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.759 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.669 ' O ' HD12 ' A' ' 102' ' ' LEU . 56.1 Cg_exo -51.68 165.44 0.73 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.382 2.054 . . . . 0.0 111.889 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -41.16 -51.05 8.07 Favored Pre-proline 0 N--CA 1.467 0.395 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 3.9 Cg_endo -47.62 164.1 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.868 1.712 . . . . 0.0 110.353 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.86 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 174.98 -85.59 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.174 -0.211 . . . . 0.0 111.089 -179.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 48.4 -174.16 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.761 ' CD1' HD22 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -57.7 -49.95 79.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.191 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.505 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.2 t70 -50.99 -58.89 4.91 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.154 -178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.86 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 7.6 mm-40 -81.18 -28.67 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.73 -47.74 10.86 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.951 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.686 HG21 HG23 ' A' ' 108' ' ' ILE . 59.5 t -62.09 -32.68 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.591 0.71 . . . . 0.0 109.733 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.64 -50.36 74.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.913 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.701 HD11 ' OD2' ' A' ' 100' ' ' ASP . 15.4 tp -75.69 -21.15 57.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.747 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.789 HG23 HG21 ' A' ' 50' ' ' VAL . 4.1 p -79.52 -48.14 21.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.836 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.439 ' N ' HG13 ' A' ' 115' ' ' VAL . 49.8 mt-10 -65.72 -39.95 91.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.918 0.389 . . . . 0.0 110.326 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.8 mtp85 -65.38 -23.88 67.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.763 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -75.01 -49.1 20.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.221 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.8 mt -68.0 -30.69 49.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.714 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.5 m -73.32 -40.0 64.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.877 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -77.9 -29.14 50.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.009 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -71.33 -51.85 22.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.853 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.27 170.9 15.16 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.986 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.885 0.374 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -161.22 -23.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.622 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.527 ' HG3' HG12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -74.39 50.32 0.4 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.859 0.362 . . . . 0.0 111.021 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.898 ' C ' HD13 ' A' ' 5' ' ' ILE . . . -68.05 89.77 0.21 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.898 HD13 ' C ' ' A' ' 4' ' ' GLY . 2.8 mm -124.42 118.85 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.056 HG23 HG13 ' A' ' 50' ' ' VAL . 9.0 p -105.68 122.85 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.952 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.911 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.2 m0 -107.87 137.41 45.93 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.674 -0.41 . . . . 0.0 109.975 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -131.06 144.45 37.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.331 -177.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.096 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -133.95 105.29 6.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.142 178.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 64.2 t0 166.9 118.3 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.292 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.442 ' CB ' HG12 ' A' ' 15' ' ' ILE . 2.4 t0 71.02 -16.36 0.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.1 t0 67.81 -139.63 0.11 Allowed 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.253 -0.279 . . . . 0.0 110.985 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 t -32.82 -43.17 0.09 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.505 ' O ' HG23 ' A' ' 18' ' ' VAL . 36.1 t -53.15 -69.65 0.11 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 25.9 mm -63.94 -20.79 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.638 ' HA ' HG21 ' A' ' 32' ' ' THR . 7.1 ttp180 -68.03 -58.48 4.43 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.027 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.495 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 77.3 t90 -51.13 -44.87 61.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.735 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.805 HG12 HD13 ' A' ' 108' ' ' ILE . 2.4 t -62.92 -61.04 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.13 0.49 . . . . 0.0 111.975 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.683 HD23 HG21 ' A' ' 8' ' ' VAL . 14.2 tp -72.28 -21.69 61.32 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 14.6 pt-20 -66.93 -56.06 11.86 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.408 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.533 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.8 OUTLIER -62.78 -56.93 13.09 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.459 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.82 -49.5 70.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 111.929 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.5 tm? -69.78 -24.07 63.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.181 0.515 . . . . 0.0 110.339 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.07 -32.74 70.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.4 -27.11 67.25 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.231 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.31 -15.38 59.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.767 0.318 . . . . 0.0 110.513 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.71 24.5 13.42 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.873 -0.68 . . . . 0.0 114.214 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.618 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -124.14 164.15 20.04 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 118.32 1.06 . . . . 0.0 112.438 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.659 ' HB ' HG23 ' A' ' 5' ' ' ILE . 99.7 m -84.66 136.79 33.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.926 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -127.57 111.53 13.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.715 -179.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.911 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -123.55 147.33 47.38 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 71.7 p -126.25 159.49 32.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.469 0.652 . . . . 0.0 112.658 -178.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.096 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.2 m-85 -136.13 174.12 10.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.987 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.562 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -54.52 -51.17 65.97 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -177.002 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.589 ' N ' HG12 ' A' ' 9' ' ' VAL . 11.3 m-20 -171.24 -20.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.648 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . 169.46 -45.61 0.21 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.732 -1.223 . . . . 0.0 114.13 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.555 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -61.04 -39.17 88.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.447 0.624 . . . . 0.0 111.415 -178.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.857 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -57.86 -54.17 49.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.493 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.736 HG21 ' CG2' ' A' ' 9' ' ' VAL . 2.6 t -51.53 -47.19 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.322 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.834 HD13 ' HB3' ' A' ' 68' ' ' GLN . 15.0 mt -48.01 -43.58 30.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.91 -48.67 65.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.903 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.91 -27.68 67.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.28 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.607 HD13 ' NE2' ' A' ' 73' ' ' HIS . 17.6 mt -73.01 -23.96 60.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.946 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.83 -19.62 6.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.475 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.19 3.16 5.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.52 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -153.99 154.52 33.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.897 0.38 . . . . 0.0 111.518 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.743 HG23 HD13 ' A' ' 76' ' ' LEU . 75.9 m -138.86 113.18 8.36 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.426 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.542 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 72.7 Cg_endo -74.17 165.58 31.59 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.324 2.016 . . . . 0.0 111.266 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.427 ' OD2' ' HA2' ' A' ' 4' ' ' GLY . 93.5 m-20 -77.53 -30.67 52.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.855 0.359 . . . . 0.0 110.894 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.056 HG13 HG23 ' A' ' 6' ' ' VAL . 7.6 p -146.52 102.04 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.486 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.682 ' HB2' HD21 ' A' ' 76' ' ' LEU . 61.3 tp -87.26 137.19 32.56 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.844 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.6 mt -119.14 122.46 42.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.31 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.66 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -119.16 148.35 43.18 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.588 ' O ' HD21 ' A' ' 65' ' ' LEU . 7.0 t0 -76.66 -167.0 0.74 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.558 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.806 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -165.4 72.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.832 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 29.2 ttt180 177.18 63.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.954 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.485 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 1.1 tmm? -163.27 -61.85 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.86 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.723 ' HB2' ' HB3' ' A' ' 64' ' ' ALA . 33.0 Cg_endo -61.82 -171.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.394 2.063 . . . . 0.0 112.689 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.11 -78.61 0.1 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.437 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.644 ' O ' ' N ' ' A' ' 62' ' ' GLY . 2.7 mtt -69.91 64.52 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.394 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.461 ' HB2' ' CE1' ' A' ' 84' ' ' HIS . 6.0 p-10 48.73 -66.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.543 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.806 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -143.51 -39.63 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.82 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.82 HD23 ' HB2' ' A' ' 90' ' ' ALA . 1.8 mp -51.65 -25.18 6.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.97 0.414 . . . . 0.0 110.291 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.723 ' HB3' ' HB2' ' A' ' 58' ' ' PRO . . . -55.55 -33.62 64.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.373 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.588 HD21 ' O ' ' A' ' 54' ' ' ASP . 3.5 pp -65.17 -25.68 67.84 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.847 ' HA ' HD12 ' A' ' 69' ' ' ILE . 6.2 mp -66.1 -41.55 90.45 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 22.1 mmtm -53.06 -50.93 63.35 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.784 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.834 ' HB3' HD13 ' A' ' 40' ' ' LEU . 1.8 mt-30 -53.36 -43.89 68.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.76 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.995 HG23 ' CE1' ' A' ' 73' ' ' HIS . 61.6 mt -55.68 -45.53 79.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.003 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.525 ' CB ' ' HG3' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -63.71 -28.21 69.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.121 0.486 . . . . 0.0 110.67 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.44 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 4.3 mt-30 -77.07 -41.14 43.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.236 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -93.57 -73.2 0.57 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.372 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.995 ' CE1' HG23 ' A' ' 69' ' ' ILE . 7.6 p80 -110.55 76.97 1.2 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.75 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.456 ' HB2' ' OE1' ' A' ' 96' ' ' GLN . 72.7 Cg_endo -77.25 29.44 0.42 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.963 2.442 . . . . 0.0 114.011 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.0 mtp -134.19 -32.07 1.08 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.855 0.36 . . . . 0.0 111.564 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.743 HD13 HG23 ' A' ' 47' ' ' THR . 5.6 tp -66.34 141.87 97.47 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.306 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.561 ' HD2' HD12 ' A' ' 76' ' ' LEU . 78.7 Cg_endo -76.87 131.43 12.18 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.819 2.346 . . . . 0.0 112.304 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.763 HG21 HD13 ' A' ' 69' ' ' ILE . 2.7 t -111.41 141.52 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.058 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.689 HG21 HD23 ' A' ' 114' ' ' LEU . 2.6 mt -130.28 115.93 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.434 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 66' ' ' LEU . 32.2 mm -93.64 145.82 7.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.042 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.687 ' HA ' HD23 ' A' ' 102' ' ' LEU . 0.0 OUTLIER -80.83 -24.64 38.32 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.347 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.624 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.0 m -148.03 149.44 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.755 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.771 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -126.93 68.23 1.26 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.754 0.311 . . . . 0.0 111.304 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.461 ' CE1' ' HB2' ' A' ' 61' ' ' ASP . 9.0 p80 -98.08 111.2 23.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.026 0.441 . . . . 0.0 111.569 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 t 54.39 168.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.022 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.553 ' HB2' HD13 ' A' ' 63' ' ' LEU . 0.8 OUTLIER 62.19 14.71 6.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.518 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.479 ' HA ' HD21 ' A' ' 63' ' ' LEU . 1.4 mt -46.38 -25.14 0.6 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -48.61 -41.12 29.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.865 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.494 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.93 -22.08 62.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.82 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -69.76 -34.51 73.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.942 0.401 . . . . 0.0 110.588 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.707 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.2 t -61.19 -45.15 99.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.141 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.591 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 20.6 m -57.99 -48.78 78.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.561 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.675 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -47.21 -43.67 21.75 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.154 0.502 . . . . 0.0 110.943 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.707 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 11.2 m-85 -54.89 -26.31 34.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.044 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.639 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -69.5 -48.07 61.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.341 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.639 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 26.7 mm-40 -72.5 -18.8 61.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.721 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.38 27.83 1.42 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.845 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.675 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -62.21 146.78 49.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.349 0.574 . . . . 0.0 110.295 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.584 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 45.4 t80 -74.18 -54.14 8.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.109 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 0.9 OUTLIER 166.99 -162.69 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.157 0.503 . . . . 0.0 111.445 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.771 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.4 m-85 -131.31 153.21 49.81 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.355 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.874 HD22 ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -141.53 149.89 55.66 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.963 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 29.0 Cg_endo -64.42 161.21 35.71 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.493 2.129 . . . . 0.0 111.426 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.586 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -33.58 -51.25 0.79 Allowed Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.1 Cg_endo -47.47 162.41 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.729 1.619 . . . . 0.0 110.345 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.874 ' CE1' HD22 ' A' ' 102' ' ' LEU . 0.1 OUTLIER 177.85 -79.45 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.064 -178.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 3.0 p30 42.54 -168.27 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.862 HG23 HG21 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -67.98 -47.19 79.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.825 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -51.95 -57.98 7.85 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.773 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.67 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 13.5 mm-40 -77.45 -31.88 54.12 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.699 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . . . -83.32 -49.93 8.88 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.537 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.862 HG21 HG23 ' A' ' 108' ' ' ILE . 44.4 t -59.47 -31.54 46.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.526 0.679 . . . . 0.0 109.758 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.84 -51.34 70.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.964 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.689 HD23 HG21 ' A' ' 79' ' ' ILE . 6.9 tp -75.86 -21.59 57.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.641 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.2 p -79.44 -48.15 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.023 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.435 ' N ' HG13 ' A' ' 115' ' ' VAL . 40.7 mt-10 -65.09 -40.52 94.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.699 0.285 . . . . 0.0 110.769 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.558 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 2.4 ptm85 -62.6 -25.07 67.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 0.0 110.394 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -70.61 -49.81 43.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.077 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.6 mt -66.38 -31.87 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -31.98 70.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.715 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.65 -24.98 63.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.956 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -66.32 -46.78 75.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.85 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.429 ' H ' ' HG2' ' A' ' 123' ' ' GLN . 3.9 pt20 -78.31 -55.33 5.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.16 0.505 . . . . 0.0 111.337 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 . . . . . 0 C--N 1.32 -0.705 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.085 -179.933 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.877 0.37 . . . . 0.0 111.494 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.4 mp0 -87.48 155.93 19.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.097 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.418 ' HD2' HG13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -75.85 2.9 11.15 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.24 82.36 0.34 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.356 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 1.4 mp -114.96 120.96 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.798 0.333 . . . . 0.0 111.211 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.98 HG23 HG13 ' A' ' 50' ' ' VAL . 7.5 p -114.23 120.77 64.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.321 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.943 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.8 m0 -111.04 136.46 50.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.744 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -122.12 137.89 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.888 -178.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -121.43 115.25 46.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.157 0.503 . . . . 0.0 110.068 178.138 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 7.5 t70 -168.35 -154.45 0.14 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.597 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -66.32 -3.17 5.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 65.56 -154.08 0.26 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.263 -0.273 . . . . 0.0 111.107 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.407 ' HB3' ' H ' ' A' ' 14' ' ' SER . 3.5 t 34.56 -89.12 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.792 ' O ' HG23 ' A' ' 18' ' ' VAL . 17.1 m -54.22 -58.81 5.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.724 0.297 . . . . 0.0 111.395 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.48 ' O ' HD23 ' A' ' 19' ' ' LEU . 26.4 mm -62.96 -30.53 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.937 0.398 . . . . 0.0 110.937 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.721 ' HA ' HG21 ' A' ' 32' ' ' THR . 22.5 ttt85 -72.36 -47.46 49.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.947 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.421 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 52.6 t90 -60.4 -40.92 92.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 14' ' ' SER . 1.7 t -74.24 -43.09 50.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.97 0.414 . . . . 0.0 111.557 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.693 HD22 ' CD1' ' A' ' 108' ' ' ILE . 3.9 mm? -77.02 -27.57 54.63 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.1 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.664 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 16.7 pt-20 -67.89 -59.77 3.03 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.925 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.513 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -68.58 -55.96 9.87 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.09 -51.39 58.0 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.91 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.5 tp -67.35 -23.3 65.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.413 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -68.22 -36.64 79.84 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.36 -24.44 65.63 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.203 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.672 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.43 -15.6 58.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.741 0.305 . . . . 0.0 110.91 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.61 26.14 9.41 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.988 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.738 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.66 170.37 11.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 117.759 0.78 . . . . 0.0 111.808 179.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.3 m -101.4 105.88 16.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.343 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.664 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 4.9 t -102.25 114.57 28.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.992 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.943 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -123.79 150.38 44.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.721 HG21 ' HA ' ' A' ' 16' ' ' ARG . 70.8 p -122.06 163.78 18.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.894 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.2 m-85 -136.4 175.43 9.62 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.755 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.621 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.9 pp20? -60.35 -55.69 30.52 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -177.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 5.6 m-80 -150.81 -43.89 0.12 Allowed 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.736 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 177.51 -46.03 0.1 OUTLIER Glycine 0 C--N 1.318 -0.454 0 C-N-CA 119.911 -1.138 . . . . 0.0 113.353 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.647 ' ND2' HD12 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -63.25 -27.73 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.796 0.332 . . . . 0.0 110.6 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -58.59 -55.45 34.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.712 179.392 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.83 HG21 HG22 ' A' ' 9' ' ' VAL . 3.4 t -50.53 -38.92 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.965 0.412 . . . . 0.0 111.123 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.647 HD12 ' ND2' ' A' ' 37' ' ' ASN . 13.3 mt -59.38 -44.07 92.82 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.847 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.52 -49.93 55.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.065 0.459 . . . . 0.0 111.108 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.09 -33.02 74.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.824 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.628 HD13 ' NE2' ' A' ' 73' ' ' HIS . 15.6 mt -62.15 -23.83 66.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.05 -20.42 16.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.791 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -116.56 -6.15 11.66 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -159.27 158.2 32.03 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.929 0.395 . . . . 0.0 111.012 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.9 m -138.71 114.93 8.76 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.954 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.597 ' CD ' HD21 ' A' ' 43' ' ' LEU . 91.0 Cg_endo -81.73 165.05 18.1 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.117 1.878 . . . . 0.0 111.53 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 5' ' ' ILE . 3.9 p30 -74.25 -59.81 2.56 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.123 0.487 . . . . 0.0 110.086 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.04 HG21 HG23 ' A' ' 115' ' ' VAL . 12.0 p -99.48 160.58 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.201 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 7' ' ' TRP . 32.1 tp -153.07 153.12 32.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.138 0.494 . . . . 0.0 111.676 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.955 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.2 mt -137.24 120.78 17.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.042 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.459 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -105.31 134.44 48.42 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.571 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 9.2 t70 -61.71 -28.43 69.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.636 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.937 HG21 HG22 ' A' ' 80' ' ' ILE . 0.3 OUTLIER 41.8 92.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.772 -179.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.547 ' O ' ' HG3' ' A' ' 57' ' ' MET . 0.0 OUTLIER -175.3 104.86 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.193 0.52 . . . . 0.0 112.124 179.237 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.547 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER 40.03 47.91 1.96 Allowed Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 178.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.634 ' HG3' ' HA2' ' A' ' 62' ' ' GLY . 98.6 Cg_endo -90.76 -53.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.511 2.141 . . . . 0.0 111.693 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.01 -21.9 0.12 Allowed Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.66 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.991 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 3.6 tpt -163.98 67.21 0.17 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.658 0.383 . . . . 0.0 110.071 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 71.95 -22.56 0.2 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.616 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.806 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 136.65 -27.68 2.93 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.74 ' HA ' HD23 ' A' ' 66' ' ' LEU . 5.1 mp -77.1 -19.97 56.29 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.991 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.77 -32.65 53.19 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.003 0.43 . . . . 0.0 110.455 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.548 HD13 ' HA3' ' A' ' 36' ' ' GLY . 14.7 mt -57.23 -44.42 83.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.538 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.029 HD11 HD11 ' A' ' 80' ' ' ILE . 3.5 mm? -55.02 -44.79 74.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.93 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.654 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -52.71 -45.06 66.76 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.17 179.591 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -67.45 -31.1 71.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.037 0.446 . . . . 0.0 110.601 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.835 HD12 ' HA ' ' A' ' 66' ' ' LEU . 94.5 mt -63.08 -41.06 91.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.755 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 3.4 pttp -74.76 -22.78 58.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.347 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.457 ' NE2' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -81.75 -31.95 31.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.395 -179.468 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.457 ' HG3' ' NE2' ' A' ' 71' ' ' GLN . 41.1 mtt180 -106.81 -59.48 1.8 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 112.191 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.628 ' NE2' HD13 ' A' ' 43' ' ' LEU . 2.2 m-70 -81.4 145.13 54.76 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.302 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -95.75 102.71 0.1 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.219 2.613 . . . . 0.0 113.14 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.577 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.6 mtt 54.26 35.97 24.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.809 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.564 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.1 tt -64.68 110.34 3.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.632 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.463 ' HG3' ' CZ ' ' A' ' 122' ' ' TYR . 51.1 Cg_exo -54.02 116.87 3.33 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.164 1.91 . . . . 0.0 111.713 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.685 HG21 HD13 ' A' ' 69' ' ' ILE . 2.4 t -122.1 146.07 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.321 0.581 . . . . 0.0 112.056 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.671 HG22 HD23 ' A' ' 102' ' ' LEU . 3.2 mt -122.07 116.94 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.957 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.029 HD11 HD11 ' A' ' 66' ' ' LEU . 9.3 mm -93.42 120.82 43.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.23 0.538 . . . . 0.0 112.315 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.508 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -74.35 -8.86 57.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.286 -179.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.574 ' H ' HG21 ' A' ' 55' ' ' ILE . 3.0 m -147.52 136.01 21.74 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.09 0.472 . . . . 0.0 111.948 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.811 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -134.03 84.41 2.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.137 0.494 . . . . 0.0 110.562 178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.423 ' CE1' HG21 ' A' ' 82' ' ' THR . 56.8 m-70 -66.78 -157.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.016 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -86.07 40.53 0.87 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.621 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -129.26 36.07 4.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.075 0.464 . . . . 0.0 109.98 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.705 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -45.42 -21.57 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.917 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.67 -55.12 10.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.492 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.53 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -69.42 -22.99 63.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.358 . . . . 0.0 110.654 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.705 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.69 -44.41 74.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.577 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 10.8 t -65.11 -42.66 94.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.804 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 77.6 p -67.12 -23.56 65.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.977 0.418 . . . . 0.0 109.932 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.691 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -65.99 -37.5 86.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.285 0.564 . . . . 0.0 109.835 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.618 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.9 m-85 -68.29 -23.9 64.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.282 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.41 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.1 OUTLIER -74.87 -29.55 61.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.272 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.691 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -92.19 -17.19 25.22 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.06 24.75 1.44 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.944 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.598 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -68.92 145.94 53.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.118 0.459 . . . . 0.0 110.584 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 22.9 t80 -79.45 -53.39 6.94 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.45 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t0 179.42 -164.99 0.05 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.945 0.403 . . . . 0.0 111.932 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.811 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 7.8 m-85 -137.56 122.52 18.96 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.537 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 106' ' ' PHE . 0.9 OUTLIER -123.0 142.87 39.24 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.898 -179.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.626 ' O ' HD12 ' A' ' 102' ' ' LEU . 50.9 Cg_exo -54.55 175.39 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.874 2.383 . . . . 0.0 113.07 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.593 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -43.5 -53.1 12.38 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.111 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 6.3 Cg_endo -48.73 163.42 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.832 1.688 . . . . 0.0 110.442 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.866 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 172.87 -81.23 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.539 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 45.65 -171.28 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.845 HG23 HG21 ' A' ' 112' ' ' VAL . 1.1 mp -60.13 -49.94 82.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.512 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 15.6 t0 -52.31 -58.57 6.25 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.866 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -80.35 -28.12 38.15 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.96 -52.16 6.56 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.589 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.845 HG21 HG23 ' A' ' 108' ' ' ILE . 40.1 t -57.75 -33.54 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.49 0.662 . . . . 0.0 110.082 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.0 -51.62 69.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.626 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.68 HD12 ' HD2' ' A' ' 117' ' ' ARG . 9.6 tp -75.53 -21.89 57.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.045 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 1.04 HG23 HG21 ' A' ' 50' ' ' VAL . 3.0 p -79.46 -52.16 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 115' ' ' VAL . 32.3 mt-10 -58.75 -40.14 82.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.648 0.261 . . . . 0.0 111.544 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.68 ' HD2' HD12 ' A' ' 114' ' ' LEU . 9.8 ptp180 -65.91 -23.73 66.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 0.0 110.774 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.494 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -71.71 -49.41 39.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.776 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.5 mt -71.05 -31.75 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.961 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.7 t -66.08 -34.64 78.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.721 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -78.21 -23.73 47.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.09 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.463 ' CZ ' ' HG3' ' A' ' 77' ' ' PRO . 0.3 OUTLIER -71.99 -59.19 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.98 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -76.41 173.05 11.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.85 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 N--CA 1.465 0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.564 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 ptm . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -96.58 -18.65 19.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 111.138 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.747 ' CG ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -66.34 -1.06 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.757 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.838 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 92.26 89.72 1.48 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.728 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.838 HD13 ' C ' ' A' ' 4' ' ' GLY . 3.9 mm -125.92 120.04 56.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.861 HG23 HG13 ' A' ' 50' ' ' VAL . 7.4 p -110.77 132.17 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.59 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.969 ' CD1' HG22 ' A' ' 31' ' ' THR . 35.0 m0 -119.58 127.44 52.97 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -124.2 122.05 63.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.882 HG23 ' HA ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -111.07 113.63 44.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.201 178.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.795 ' HB3' HG21 ' A' ' 15' ' ' ILE . 15.8 t0 -177.36 68.03 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.195 0.521 . . . . 0.0 111.464 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.8 t70 69.13 -2.14 1.9 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 14' ' ' SER . 6.6 p-10 43.25 -126.8 0.81 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.481 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.62 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 1.7 t 34.94 -82.59 0.0 OUTLIER 'General case' 0 C--N 1.343 0.304 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.755 ' O ' HG23 ' A' ' 18' ' ' VAL . 15.2 t -82.46 -48.4 11.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.655 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.795 HG21 ' HB3' ' A' ' 10' ' ' ASP . 46.6 mm -63.73 -22.4 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.745 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 0.0 OUTLIER -81.58 -55.54 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.358 . . . . 0.0 111.552 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.547 ' H ' ' HG3' ' A' ' 16' ' ' ARG . 85.1 t90 -48.78 -41.69 33.26 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -70.44 -61.43 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.432 . . . . 0.0 112.058 -178.63 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.54 HD23 HG11 ' A' ' 8' ' ' VAL . 8.3 tp -66.3 -27.36 67.86 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.659 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.504 ' HA ' ' HB2' ' A' ' 30' ' ' CYS . 12.4 pt-20 -67.7 -58.35 4.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.134 0.492 . . . . 0.0 111.446 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.491 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -54.39 -64.68 0.75 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.086 -179.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.34 -27.39 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.796 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.7 tm? -82.14 -29.85 31.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.383 0.611 . . . . 0.0 110.467 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.2 -32.44 73.51 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.55 -26.79 70.04 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.393 -0.908 . . . . 0.0 110.95 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.426 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.27 -15.52 58.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.97 24.54 11.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.051 0.78 . . . . 0.0 115.051 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.67 HD13 HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -126.18 164.15 21.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.611 1.205 . . . . 0.0 112.372 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.805 ' HB ' HG23 ' A' ' 5' ' ' ILE . 79.0 m -79.75 129.09 34.18 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.038 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 1.8 p -121.67 111.2 16.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.976 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.969 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -135.85 134.03 38.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.745 ' OG1' ' HB3' ' A' ' 16' ' ' ARG . 43.6 p -115.61 155.09 28.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.687 ' CE1' HG23 ' A' ' 31' ' ' THR . 0.0 OUTLIER -136.58 174.1 10.99 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.226 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.535 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -58.42 -108.9 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.686 ' O ' HG11 ' A' ' 9' ' ' VAL . 24.3 m-80 -85.86 -179.92 6.91 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.565 ' CA ' ' HG ' ' A' ' 65' ' ' LEU . . . -68.71 0.25 14.83 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.391 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.495 ' ND2' HD12 ' A' ' 40' ' ' LEU . 1.8 t-20 -81.28 -41.69 21.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.668 0.734 . . . . 0.0 109.507 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.535 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -51.92 -55.31 21.04 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.992 179.102 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.622 HG11 HD11 ' A' ' 51' ' ' LEU . 33.2 t -44.15 -35.07 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.151 0.501 . . . . 0.0 110.893 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.495 HD12 ' ND2' ' A' ' 37' ' ' ASN . 14.1 mt -61.84 -50.12 73.54 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.485 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.99 -48.26 82.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.324 0.583 . . . . 0.0 110.864 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.32 73.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.38 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.676 HD21 ' HD2' ' A' ' 48' ' ' PRO . 10.9 mt -66.62 -24.07 66.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.156 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.94 -18.4 60.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.669 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.55 -8.15 11.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -159.69 159.37 32.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 110.586 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.559 HG23 HD13 ' A' ' 76' ' ' LEU . 99.3 m -138.8 113.49 8.45 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.688 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.676 ' HD2' HD21 ' A' ' 43' ' ' LEU . 89.1 Cg_endo -80.0 165.34 21.89 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.215 1.944 . . . . 0.0 111.26 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.676 ' O ' ' HD2' ' A' ' 77' ' ' PRO . 3.3 p30 -74.38 -59.03 2.91 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.544 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.861 HG13 HG23 ' A' ' 6' ' ' VAL . 7.6 p -101.72 162.11 3.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.393 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.636 HD22 HD21 ' A' ' 76' ' ' LEU . 42.4 tp -152.86 152.25 31.33 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.013 0.435 . . . . 0.0 111.705 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -137.31 120.91 17.25 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.936 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.882 ' HA ' HG23 ' A' ' 9' ' ' VAL . 49.1 m -109.07 137.15 47.42 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 39.6 t0 -65.9 -20.59 66.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.694 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.686 HG21 ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER 47.22 79.71 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.154 0.502 . . . . 0.0 112.106 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 171.36 85.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.487 179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.651 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -163.3 -66.89 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.684 ' HG2' ' HB3' ' A' ' 64' ' ' ALA . 87.1 Cg_endo -77.4 -165.7 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.451 2.1 . . . . 0.0 113.677 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.98 -51.01 61.76 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.844 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.726 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -74.28 45.41 0.22 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.057 0.456 . . . . 0.0 110.563 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 55.81 -82.15 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.658 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -143.12 -31.92 0.1 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.926 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.668 HD12 ' H ' ' A' ' 63' ' ' LEU . 1.4 mp -49.92 -26.85 4.53 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.726 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -55.33 -30.98 61.3 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.997 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.565 ' HG ' ' CA ' ' A' ' 36' ' ' GLY . 2.3 mm? -60.94 -50.21 74.34 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.983 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.775 HD23 HD12 ' A' ' 69' ' ' ILE . 51.7 mt -49.65 -46.48 49.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.092 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -50.28 -46.59 55.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.211 0.529 . . . . 0.0 110.176 179.404 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -63.38 -38.63 91.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.525 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.775 HD12 HD23 ' A' ' 66' ' ' LEU . 75.2 mt -61.35 -40.85 87.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.521 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 44.5 pttt -72.24 -21.35 61.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.19 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.11 -31.8 62.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.586 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 mmt-85 -106.25 -24.0 12.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.031 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.553 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 40.8 m-70 -141.97 86.16 10.62 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.71 15.57 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.01 2.473 . . . . 0.0 113.127 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.572 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 11.9 mtt -145.36 4.83 1.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.636 HD21 HD22 ' A' ' 51' ' ' LEU . 15.9 tp -76.39 107.44 4.59 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 49' ' ' ASP . 39.3 Cg_exo -58.99 121.14 9.45 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.578 2.185 . . . . 0.0 111.732 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.687 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.3 t -120.64 150.52 23.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.488 0.661 . . . . 0.0 111.922 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.677 ' O ' HD23 ' A' ' 52' ' ' LEU . 3.7 mt -131.79 116.32 30.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.634 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.785 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 13.4 mm -93.43 137.92 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.635 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -85.41 -15.19 43.88 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.512 -179.199 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.686 ' O ' HG21 ' A' ' 55' ' ' ILE . 2.7 m -147.27 163.66 35.69 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.06 -47.62 3.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 110.973 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 44.56 59.37 3.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.978 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 52.37 -170.5 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.782 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.553 ' HB2' HD13 ' A' ' 63' ' ' LEU . 54.1 m-20 59.94 31.88 20.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.52 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.854 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -46.48 -24.25 0.49 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.723 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -47.81 -45.56 29.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.24 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.595 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.78 -23.07 62.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.675 0.274 . . . . 0.0 111.411 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.854 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -66.81 -46.39 75.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.742 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.7 t -61.3 -36.85 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.8 m -60.93 -41.23 95.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.213 0.53 . . . . 0.0 110.237 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.721 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -54.76 -49.06 71.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.117 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.618 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 8.7 m-85 -51.39 -27.76 10.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.596 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.574 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -70.4 -39.75 74.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.315 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.574 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 7.2 pt20 -77.97 -18.18 56.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.028 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.0 4.99 5.41 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.378 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.721 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -53.1 132.71 38.56 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.269 0.535 . . . . 0.0 110.751 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.792 ' CD2' ' HB2' ' A' ' 118' ' ' ALA . 8.6 t80 -64.14 -53.44 49.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.488 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 0.4 OUTLIER 175.75 -161.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.041 0.448 . . . . 0.0 111.904 -179.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.785 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.7 m-85 -132.57 135.86 46.2 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.136 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 103' ' ' PRO . 1.3 pp -126.59 136.49 28.77 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.842 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.814 ' O ' HD12 ' A' ' 102' ' ' LEU . 52.7 Cg_exo -51.68 172.13 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.271 1.98 . . . . 0.0 111.908 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.613 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -41.86 -49.8 10.52 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.649 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.9 Cg_endo -47.91 164.4 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 121.94 1.76 . . . . 0.0 110.704 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.815 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 173.86 -90.16 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.287 -0.165 . . . . 0.0 111.064 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.4 p30 50.98 -178.85 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.754 ' HA ' HG23 ' A' ' 112' ' ' VAL . 1.2 mp -54.46 -49.49 65.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.442 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 9.6 t0 -51.89 -58.79 5.45 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.815 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 4.8 mm-40 -82.41 -27.83 31.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . . . -84.1 -47.27 11.08 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.873 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.754 HG23 ' HA ' ' A' ' 108' ' ' ILE . 53.4 t -62.73 -32.03 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.493 0.663 . . . . 0.0 109.505 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.32 -49.89 75.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.144 178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.494 ' CD2' ' HB3' ' A' ' 102' ' ' LEU . 8.3 tp -75.64 -20.94 58.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.433 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.1 p -79.26 -49.41 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 115' ' ' VAL . 34.7 mt-10 -65.35 -44.24 88.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.631 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 117' ' ' ARG . 6.4 mmt180 -63.02 -23.88 67.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.408 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.792 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -73.18 -49.45 27.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.053 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.458 HG12 ' OD1' ' A' ' 49' ' ' ASP . 3.7 mt -67.02 -31.11 51.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.817 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 t -66.74 -43.11 85.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.752 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -68.46 -26.89 65.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.984 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -66.77 -53.23 35.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.534 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.35 -176.37 3.1 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.407 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--N 1.331 -0.239 0 CA-C-O 120.912 0.387 . . . . 0.0 110.83 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.891 0.377 . . . . 0.0 111.466 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.78 162.47 13.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.869 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.624 ' HD3' HD11 ' A' ' 5' ' ' ILE . 6.4 ttt180 -68.73 -52.28 32.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.09 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 67.36 85.85 0.09 OUTLIER Glycine 0 C--N 1.32 -0.33 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.854 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.624 HD11 ' HD3' ' A' ' 3' ' ' ARG . 3.4 mp -117.41 115.8 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 0.0 111.512 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.785 HG11 ' HG ' ' A' ' 23' ' ' LEU . 8.3 p -107.11 122.44 61.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.938 ' CD1' HG22 ' A' ' 31' ' ' THR . 35.2 m0 -112.42 137.92 49.91 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.587 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.709 HG13 ' HB2' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -126.55 147.92 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.095 -178.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -134.65 121.14 34.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.084 178.075 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.499 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 14.6 t0 -177.33 -147.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.905 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.53 -2.18 4.44 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 14' ' ' SER . 2.3 t70 55.49 -143.03 0.75 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.0 t 33.2 -90.22 0.01 OUTLIER 'General case' 0 C--N 1.342 0.274 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.837 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.8 m -57.8 -52.84 63.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.704 0.288 . . . . 0.0 111.357 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 14.6 mm -62.62 -36.28 74.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.943 0.401 . . . . 0.0 111.556 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.509 ' HA ' HG21 ' A' ' 32' ' ' THR . 11.4 ttt-85 -68.84 -41.92 77.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.313 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.483 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . 33.3 t90 -65.12 -58.7 5.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.306 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 14' ' ' SER . 1.4 t -57.35 -43.61 82.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.106 -178.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.684 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 4.4 mm? -76.85 -31.72 57.04 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.742 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 17.0 pt-20 -64.73 -61.92 1.89 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.687 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.729 ' HD2' ' H ' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -52.69 -63.87 1.0 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 0.0 112.095 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.16 -35.99 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.374 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.785 ' HG ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -73.87 -30.26 62.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.886 0.374 . . . . 0.0 110.331 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.08 -35.03 79.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.71 -25.76 69.28 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.129 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.39 -15.34 58.78 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.65 0.262 . . . . 0.0 111.03 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.64 26.03 10.25 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.73 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -137.44 176.0 9.1 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.46 0.63 . . . . 0.0 111.316 179.7 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.587 ' O ' HG12 ' A' ' 6' ' ' VAL . 22.2 m -105.87 131.51 53.1 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.432 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.742 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 2.0 t -119.71 114.31 21.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.86 0.362 . . . . 0.0 111.767 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.938 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -123.08 155.27 37.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 37.8 p -129.92 157.75 41.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.148 0.499 . . . . 0.0 112.167 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.805 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.5 m-85 -133.18 173.25 11.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.614 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.731 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -63.25 -47.21 83.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.199 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.614 ' O ' HG11 ' A' ' 9' ' ' VAL . 42.9 t30 -161.64 168.47 23.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.928 0.394 . . . . 0.0 110.666 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.701 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -49.75 -11.45 0.33 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.573 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -81.91 -45.36 15.56 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.603 0.701 . . . . 0.0 109.913 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.731 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 2.0 tt0 -55.28 -51.69 65.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.019 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.676 HG21 ' CG2' ' A' ' 9' ' ' VAL . 17.9 t -51.55 -33.13 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.035 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.385 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.627 HD13 ' HB3' ' A' ' 68' ' ' GLN . 17.3 mt -57.66 -51.68 68.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.011 0.434 . . . . 0.0 110.13 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.29 -47.45 85.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.746 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.74 -34.54 78.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.096 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.569 ' CD1' HG12 ' A' ' 39' ' ' VAL . 31.5 mt -68.24 -23.87 64.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.865 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.88 -15.33 29.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.329 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.24 -7.81 11.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -164.53 160.73 20.67 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 120.988 0.423 . . . . 0.0 111.46 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.3 m -138.8 112.76 8.34 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.262 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.934 ' HD2' HD11 ' A' ' 76' ' ' LEU . 6.5 Cg_exo -74.83 165.84 30.57 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.638 2.225 . . . . 0.0 111.487 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.11 -25.71 59.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.553 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.755 HG13 HG23 ' A' ' 6' ' ' VAL . 4.2 p -145.02 161.71 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.874 ' O ' HD12 ' A' ' 79' ' ' ILE . 33.1 tp -153.03 150.28 29.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.432 0.634 . . . . 0.0 112.362 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.857 ' O ' HG23 ' A' ' 9' ' ' VAL . 6.2 mt -128.28 115.91 19.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.971 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.627 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -107.95 135.45 49.31 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 24.0 t0 -75.89 170.96 15.22 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.599 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.661 HG13 ' HA3' ' A' ' 62' ' ' GLY . 1.3 tt -158.56 92.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.349 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.411 ' O ' ' CG ' ' A' ' 57' ' ' MET . 0.1 OUTLIER -124.65 56.91 1.28 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.954 0.407 . . . . 0.0 111.446 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.481 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 5.7 ptt? 47.97 41.75 1.02 Allowed Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 57' ' ' MET . 38.0 Cg_endo -65.44 -81.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 121.966 1.777 . . . . 0.0 111.319 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.39 -84.61 1.8 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 1.015 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -87.77 61.18 6.31 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.6 OUTLIER 67.11 -21.9 0.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.345 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.661 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 135.79 -33.02 2.45 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.583 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 4.8 mp -65.19 -21.67 66.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.015 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.39 -36.4 61.41 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.929 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.701 ' HB3' ' HA3' ' A' ' 36' ' ' GLY . 14.1 mt -56.58 -45.91 81.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.527 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.82 ' HA ' HD12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -58.43 -49.02 78.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.209 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.488 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 7.5 tttp -53.61 -42.3 67.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.217 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.627 ' HB3' HD13 ' A' ' 40' ' ' LEU . 21.8 mm100 -62.33 -40.04 95.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.696 0.284 . . . . 0.0 111.049 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.015 HG22 ' HD2' ' A' ' 73' ' ' HIS . 28.0 mt -56.41 -51.09 68.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.219 0.533 . . . . 0.0 111.187 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.704 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -59.07 -29.63 67.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.225 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.421 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 2.2 mt-30 -69.93 -23.71 63.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.992 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 -114.14 -15.05 12.29 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 1.015 ' HD2' HG22 ' A' ' 69' ' ' ILE . 1.7 p80 -106.73 166.34 11.31 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -87.12 -55.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.082 2.521 . . . . 0.0 112.278 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 19.6 mtp -157.38 43.3 0.34 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.619 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.934 HD11 ' HD2' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -72.0 113.32 19.29 Favored Pre-proline 0 N--CA 1.455 -0.188 0 C-N-CA 122.206 0.202 . . . . 0.0 111.407 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 39.9 Cg_endo -68.55 115.54 3.96 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 121.89 1.726 . . . . 0.0 111.945 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.598 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 6.1 t -98.82 150.36 5.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.082 0.467 . . . . 0.0 111.393 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.874 HD12 ' O ' ' A' ' 51' ' ' LEU . 2.1 mt -134.11 115.0 20.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.96 178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.689 HG22 ' H ' ' A' ' 82' ' ' THR . 27.6 mm -93.59 150.02 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.475 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -86.24 -20.05 29.05 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.432 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.714 HG21 ' CE1' ' A' ' 84' ' ' HIS . 3.1 m -141.17 142.25 34.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.215 0.531 . . . . 0.0 111.388 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.751 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -135.39 31.75 3.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.965 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.714 ' CE1' HG21 ' A' ' 82' ' ' THR . 1.1 p-80 -88.79 31.57 0.84 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.477 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.557 ' HB2' HD11 ' A' ' 63' ' ' LEU . 61.6 m -133.96 -161.94 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.713 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.406 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -56.34 86.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.589 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.801 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -51.2 -23.24 3.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 111.459 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.76 -44.9 39.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.958 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.583 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -66.92 -25.31 66.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.951 0.405 . . . . 0.0 111.21 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.801 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -72.57 -22.46 60.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.995 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.516 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 14.5 t -70.89 -41.39 77.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.059 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 32.8 m -65.79 -19.58 65.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.113 0.483 . . . . 0.0 109.935 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.618 ' CB ' HD22 ' A' ' 66' ' ' LEU . . . -64.52 -46.84 81.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.008 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.516 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.4 m-85 -63.93 -29.45 70.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.803 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.637 HE22 ' HD2' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -63.65 -45.52 89.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.897 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.68 ' HG2' ' HB3' ' A' ' 70' ' ' LYS . 1.4 pp0? -75.03 -18.51 60.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.628 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.64 21.16 4.39 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.533 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.652 ' HB2' ' NE2' ' A' ' 96' ' ' GLN . . . -59.18 157.04 11.13 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 117.082 0.441 . . . . 0.0 110.99 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 21.2 t80 -82.19 -53.38 6.12 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.543 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 169.86 -165.4 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.092 0.472 . . . . 0.0 111.531 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.751 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.2 m-85 -124.17 119.33 29.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.612 HD22 ' CE1' ' A' ' 106' ' ' PHE . 6.0 tp -102.51 134.95 19.65 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.77 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 11.3 Cg_endo -52.66 170.79 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.462 2.108 . . . . 0.0 111.674 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -43.63 -46.83 18.91 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.437 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.77 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 73.4 Cg_exo -48.11 163.36 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.682 1.588 . . . . 0.0 110.416 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.722 ' HD1' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -174.65 -86.66 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.694 -178.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.7 p30 43.42 -170.97 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.621 0.248 . . . . 0.0 110.445 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.845 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -67.91 -45.39 84.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.36 0.6 . . . . 0.0 111.429 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 12.9 t70 -52.8 -55.86 19.9 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.868 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.666 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.9 mm-40 -79.85 -27.98 40.1 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.722 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.28 -54.26 4.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.85 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.845 HG21 HG23 ' A' ' 108' ' ' ILE . 36.5 t -58.09 -33.58 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.439 0.637 . . . . 0.0 110.3 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.566 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.19 -51.61 68.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.9 0.857 . . . . 0.0 109.512 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.704 ' CD2' HG21 ' A' ' 79' ' ' ILE . 6.6 tp -76.24 -21.01 56.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.76 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.692 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.1 p -79.45 -50.28 18.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.164 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.471 ' N ' HG13 ' A' ' 115' ' ' VAL . 82.9 mt-10 -65.07 -45.13 86.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.649 0.262 . . . . 0.0 110.538 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -62.01 -26.31 68.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 0.0 110.419 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -72.48 -57.45 4.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.17 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.6 mt -68.43 -30.79 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.132 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.2 m -67.52 -45.12 76.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.026 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -66.7 -27.79 67.92 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.78 -57.62 3.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.986 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -75.6 179.19 5.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.844 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.894 0.378 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.98 -175.52 5.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.604 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -9.96 38.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.378 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 88.65 84.84 1.25 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.955 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.1 mp -104.23 113.28 40.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.729 0.3 . . . . 0.0 111.163 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.827 HG11 ' CD2' ' A' ' 23' ' ' LEU . 2.8 p -106.06 129.64 58.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.665 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.932 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.8 m0 -117.76 141.99 47.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.655 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -134.32 133.5 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.92 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -117.66 108.85 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.996 178.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 37.0 t0 166.84 120.1 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.246 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.436 ' HB3' HG12 ' A' ' 15' ' ' ILE . 1.1 t0 69.75 -45.2 0.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.133 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 16' ' ' ARG . 40.9 t0 75.15 -98.74 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.367 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' ASP . 5.7 p -26.67 -87.73 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.69 ' O ' HG23 ' A' ' 18' ' ' VAL . 35.3 m -54.98 -39.14 68.68 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG12 ' HB3' ' A' ' 11' ' ' ASP . 21.4 mm -68.47 -20.49 25.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.624 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -74.79 -58.54 3.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 111.236 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.437 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 49.9 t90 -49.96 -41.94 47.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.498 . . . . 0.0 112.237 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.792 HG12 HD13 ' A' ' 108' ' ' ILE . 1.6 t -70.44 -62.26 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.026 0.441 . . . . 0.0 111.734 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.61 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 3.8 mm? -63.7 -27.36 69.16 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.536 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.677 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 15.1 pt-20 -67.18 -61.06 2.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.654 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 1.1 mmm180 -67.51 -56.88 7.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.409 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -49.25 -59.58 3.55 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.931 0.396 . . . . 0.0 111.718 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.827 ' CD2' HG11 ' A' ' 6' ' ' VAL . 4.0 tp -61.4 -20.98 63.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.068 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -66.55 -38.5 87.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.97 -24.61 65.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.585 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.645 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.82 -15.59 58.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.664 0.269 . . . . 0.0 111.013 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.25 25.74 7.71 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.833 -0.698 . . . . 0.0 113.767 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.703 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.72 170.64 13.58 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 117.5 0.65 . . . . 0.0 111.609 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.0 m -107.26 105.47 15.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.086 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.746 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 2.1 t -98.94 118.1 34.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.177 0.513 . . . . 0.0 112.133 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.932 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -119.7 156.59 30.21 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 61.3 p -132.76 152.32 51.8 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.92 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -129.08 174.31 9.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.713 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -57.92 -108.46 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.501 -178.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -78.79 -68.44 0.65 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.115 0.484 . . . . 0.0 111.938 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.878 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -171.91 -33.67 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.046 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.819 HD22 HD12 ' A' ' 40' ' ' LEU . 6.0 m120 -62.14 -30.75 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.692 0.282 . . . . 0.0 110.733 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -54.22 -52.65 60.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.853 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.918 HG11 HD11 ' A' ' 51' ' ' LEU . 63.1 t -54.74 -47.14 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.048 0.451 . . . . 0.0 110.62 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.819 HD12 HD22 ' A' ' 37' ' ' ASN . 22.5 mt -50.9 -43.15 59.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.112 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.96 -47.71 67.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.274 0.559 . . . . 0.0 110.715 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.34 -31.81 73.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.5 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.632 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 10.6 mt -61.45 -26.3 67.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.111 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.73 -17.47 60.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.305 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.43 -6.21 11.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.72 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -161.88 162.21 29.16 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.828 0.347 . . . . 0.0 111.075 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.512 HG23 HD13 ' A' ' 76' ' ' LEU . 77.0 m -138.97 112.66 8.2 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.154 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.615 ' HD2' HD21 ' A' ' 43' ' ' LEU . 73.5 Cg_endo -76.58 164.31 30.65 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.899 1.733 . . . . 0.0 111.539 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.49 -23.54 58.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.809 0.338 . . . . 0.0 110.761 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.723 HG13 HG23 ' A' ' 6' ' ' VAL . 6.3 p -145.17 161.58 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.918 HD11 HG11 ' A' ' 39' ' ' VAL . 22.9 tp -151.45 148.42 28.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.524 0.678 . . . . 0.0 112.073 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.893 ' O ' HG23 ' A' ' 9' ' ' VAL . 3.1 mt -135.72 126.01 26.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.792 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.595 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -111.13 145.25 38.93 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -178.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 49.6 t0 -74.16 -19.4 60.57 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.27 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.778 HD13 ' O ' ' A' ' 82' ' ' THR . 7.0 tt 44.96 86.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.63 99.44 0.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.558 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 55.39 44.85 1.76 Allowed Pre-proline 0 N--CA 1.47 0.575 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 177.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.595 ' CD ' ' HA2' ' A' ' 62' ' ' GLY . 26.8 Cg_endo -91.9 -35.87 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.958 2.439 . . . . 0.0 112.422 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.06 -24.91 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.302 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.895 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 23.3 ttt -152.43 71.43 0.94 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.69 -35.45 0.24 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.1 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.641 ' C ' HG13 ' A' ' 55' ' ' ILE . . . 157.82 -34.54 0.53 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.577 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 5.3 mp -66.85 -25.05 66.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.768 0.318 . . . . 0.0 110.485 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.895 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.98 -26.02 23.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.656 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.565 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 76.2 mt -55.96 -40.27 73.0 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.151 0.5 . . . . 0.0 110.061 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.898 ' HA ' HD12 ' A' ' 69' ' ' ILE . 4.8 mp -70.33 -39.43 74.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.049 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.709 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.0 tmtt? -55.2 -42.99 74.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.299 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.651 ' HB2' HD13 ' A' ' 40' ' ' LEU . 12.1 mm100 -69.05 -37.5 78.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.735 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.898 HD12 ' HA ' ' A' ' 66' ' ' LEU . 13.2 mt -62.83 -23.1 32.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.803 0.335 . . . . 0.0 110.849 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.709 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 2.5 mtmp? -75.18 -50.72 15.33 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.105 0.955 . . . . 0.0 109.291 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -62.13 -33.21 74.04 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.337 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.516 ' NH1' ' HB3' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -94.13 -28.7 15.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.665 179.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.632 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 40.5 m-70 -153.54 82.4 4.69 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.653 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.709 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 55.5 Cg_endo -71.28 31.76 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.738 2.292 . . . . 0.0 113.172 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -143.78 -37.21 0.34 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.1 0.476 . . . . 0.0 111.238 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.558 HD23 ' CG2' ' A' ' 69' ' ' ILE . 6.7 tp -50.77 129.8 28.02 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.512 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.699 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 51.9 Cg_endo -73.24 122.98 8.44 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.729 2.286 . . . . 0.0 112.181 179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.731 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.3 t -110.28 142.78 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.125 0.488 . . . . 0.0 111.253 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.815 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.1 mt -133.89 113.52 18.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.383 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.822 ' CG1' HD21 ' A' ' 66' ' ' LEU . 18.9 mm -93.42 137.28 22.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.102 0.477 . . . . 0.0 112.127 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.682 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.84 -4.04 59.06 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.349 -179.168 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.778 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.5 m -148.03 144.19 27.75 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.584 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.775 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -143.78 61.41 1.37 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.336 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -98.93 -22.78 15.6 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.469 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -84.33 -166.49 1.46 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.169 0.509 . . . . 0.0 111.996 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -54.76 97.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.777 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.851 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -51.24 -21.68 2.24 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.3 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -48.59 -45.04 37.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.277 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.577 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.69 -20.61 66.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.804 0.335 . . . . 0.0 110.89 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.851 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -72.98 -32.2 65.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.711 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.562 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.9 t -65.71 -42.73 93.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 19.7 m -63.49 -19.91 65.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.382 . . . . 0.0 110.012 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.724 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -66.37 -44.95 81.72 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.451 0.643 . . . . 0.0 109.842 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.562 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 5.0 m-85 -65.88 -23.88 66.74 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.868 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.431 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -69.1 -36.39 77.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.307 179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.724 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 3.9 pp0? -86.68 -18.27 31.67 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.706 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.13 21.27 3.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.304 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.731 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -65.04 152.79 42.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.212 0.506 . . . . 0.0 110.182 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.547 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 38.6 t80 -81.96 -54.0 5.68 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.441 ' OD2' ' CD2' ' A' ' 99' ' ' PHE . 14.7 p30 174.77 -170.76 0.05 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.993 0.425 . . . . 0.0 111.685 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.775 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 5.1 m-85 -119.72 125.67 49.22 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.771 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.708 HD12 ' HD2' ' A' ' 103' ' ' PRO . 11.0 tp -102.87 139.33 20.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.458 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.714 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 20.9 Cg_endo -58.88 171.83 1.91 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.092 1.861 . . . . 0.0 111.096 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.493 ' HE3' ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -43.18 -45.88 13.98 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.714 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 87.3 Cg_exo -47.44 163.59 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 121.676 1.584 . . . . 0.0 110.843 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.802 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 3.2 t80 -167.56 -92.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.995 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 5.3 p-10 44.12 -173.79 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.654 0.264 . . . . 0.0 110.586 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.792 HD13 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.66 -47.14 81.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.386 0.612 . . . . 0.0 110.849 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.1 t70 -51.01 -58.12 6.88 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.212 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.668 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.7 mm-40 -79.13 -26.77 42.8 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.15 -53.16 5.71 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.138 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.628 HG21 HG23 ' A' ' 108' ' ' ILE . 43.9 t -59.97 -31.45 47.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.507 0.67 . . . . 0.0 110.084 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.23 -50.96 70.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.626 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.704 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 23.8 tp -75.46 -20.46 58.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.517 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.2 p -79.27 -48.03 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.055 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.447 ' N ' HG13 ' A' ' 115' ' ' VAL . 4.1 mt-10 -61.12 -45.66 93.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.726 0.298 . . . . 0.0 110.838 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.613 ' HD2' HD12 ' A' ' 114' ' ' LEU . 4.1 ptp180 -64.2 -23.73 67.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.897 0.379 . . . . 0.0 110.687 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.547 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.22 -49.46 35.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.938 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.1 mt -66.2 -30.89 51.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.6 m -68.37 -44.01 76.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -62.47 -31.13 71.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 77' ' ' PRO . 0.3 OUTLIER -85.11 -51.12 6.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.897 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 59.39 175.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.985 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mtt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.754 0.311 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.3 154.28 33.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.804 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 1.016 ' HG3' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -56.86 -34.28 67.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.053 0.454 . . . . 0.0 110.855 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.885 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 93.2 110.54 2.01 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.034 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.016 HD11 ' HG3' ' A' ' 3' ' ' ARG . 6.3 mm -129.39 113.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.849 HG23 HG13 ' A' ' 50' ' ' VAL . 9.2 p -105.56 127.69 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.838 ' CD1' HG22 ' A' ' 31' ' ' THR . 24.6 m0 -114.67 132.81 56.27 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -127.99 139.8 50.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.005 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -128.38 105.37 13.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.187 179.029 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 58.1 t0 166.72 119.45 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 O-C-N 123.424 0.453 . . . . 0.0 110.682 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.407 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 72.79 -28.11 0.19 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.16 0.429 . . . . 0.0 112.16 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 10' ' ' ASP . 7.9 t0 73.02 -133.38 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.978 -0.101 . . . . 0.0 110.943 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.1 t -30.71 -48.47 0.11 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.661 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.1 t -53.95 -68.18 0.2 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.654 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.588 ' CG2' HD12 ' A' ' 19' ' ' LEU . 24.8 mm -62.31 -20.76 25.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.55 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.628 ' HA ' HG21 ' A' ' 32' ' ' THR . 6.0 ttt180 -70.53 -60.57 2.19 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.651 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.519 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 57.1 t90 -49.98 -44.52 50.92 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.906 0.384 . . . . 0.0 111.912 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.731 HG12 HD13 ' A' ' 108' ' ' ILE . 1.3 t -64.97 -59.14 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.588 HD12 ' CG2' ' A' ' 15' ' ' ILE . 56.4 mt -70.75 -26.33 63.31 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.558 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 12.8 pt-20 -63.81 -57.88 8.54 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.769 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 2.4 mmp_? -63.75 -60.04 3.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.905 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.88 -56.17 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.977 0.417 . . . . 0.0 111.85 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.531 HD12 ' CG1' ' A' ' 6' ' ' VAL . 1.5 tm? -64.95 -23.75 67.32 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.015 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -71.28 -32.6 68.87 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.56 -26.49 66.65 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.385 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.558 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.31 -15.65 59.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.812 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.01 23.09 11.86 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.798 -0.715 . . . . 0.0 114.326 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.558 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -123.45 163.62 20.52 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.418 1.109 . . . . 0.0 112.167 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.592 ' HB ' HG23 ' A' ' 5' ' ' ILE . 89.9 m -84.53 136.35 33.84 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.626 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -127.97 108.51 10.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.645 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.838 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -121.68 147.59 45.69 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.9 p -125.59 161.44 27.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.63 0.728 . . . . 0.0 112.958 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.005 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.3 m-85 -136.12 173.86 11.25 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.108 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.475 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.6 pp20? -61.56 -60.51 3.58 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -152.97 -23.79 0.15 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.737 ' C ' HD21 ' A' ' 65' ' ' LEU . . . 166.44 -56.83 0.24 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.31 -0.947 . . . . 0.0 113.067 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.483 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -47.89 -37.5 14.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.014 -179.363 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.876 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 8.3 tt0 -58.42 -55.44 34.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.742 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.747 HG21 ' CG2' ' A' ' 9' ' ' VAL . 2.9 t -51.18 -46.48 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.107 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.627 HD21 ' CD1' ' A' ' 65' ' ' LEU . 31.7 mt -46.55 -45.57 18.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.21 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.07 -48.75 69.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.113 0.482 . . . . 0.0 111.326 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.79 -35.35 79.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.45 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.595 ' HG ' HG12 ' A' ' 39' ' ' VAL . 16.6 mt -63.38 -25.37 68.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.27 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -16.95 22.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.218 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.5 t -121.11 -5.39 9.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.472 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -156.53 160.04 39.13 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.91 0.386 . . . . 0.0 111.665 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.5 m -139.2 112.0 7.94 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.625 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD2' ' CD2' ' A' ' 43' ' ' LEU . 58.8 Cg_endo -69.47 166.43 27.28 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.717 2.278 . . . . 0.0 111.839 178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -81.86 -27.01 33.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.867 0.365 . . . . 0.0 110.475 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.849 HG13 HG23 ' A' ' 6' ' ' VAL . 4.8 p -147.95 101.17 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.425 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.881 ' O ' HD12 ' A' ' 79' ' ' ILE . 62.7 tp -87.15 141.74 28.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.409 0.623 . . . . 0.0 112.491 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.839 ' O ' HG23 ' A' ' 9' ' ' VAL . 5.3 mt -124.35 117.51 24.65 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -112.5 146.71 37.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.743 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 20.4 t0 -77.2 179.4 6.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.95 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.757 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.1 tt -156.23 78.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.798 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 50.7 ttp85 176.71 69.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.564 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.467 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -160.9 -67.09 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.879 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 57' ' ' MET . 35.6 Cg_endo -64.86 -176.06 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.536 2.158 . . . . 0.0 113.033 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.8 -54.34 38.14 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.486 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.587 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -78.14 49.23 0.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.733 0.301 . . . . 0.0 110.75 179.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.61 -72.13 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.721 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.757 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -149.47 -35.51 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.261 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.884 ' HA ' HD23 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -54.61 -21.42 10.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.11 179.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.527 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.75 -36.23 62.1 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.737 HD21 ' C ' ' A' ' 36' ' ' GLY . 1.1 tm? -59.97 -40.92 90.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.154 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.884 HD23 ' HA ' ' A' ' 63' ' ' LEU . 4.3 mm? -54.39 -43.94 71.87 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.17 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 53.9 tttm -56.9 -43.46 81.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.319 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.583 ' HB3' HD13 ' A' ' 40' ' ' LEU . 21.0 mm100 -60.93 -34.7 75.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.233 0.54 . . . . 0.0 110.147 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.983 HG23 ' CE1' ' A' ' 73' ' ' HIS . 92.5 mt -58.92 -39.84 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.527 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -69.61 -29.03 66.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.036 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.432 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -70.89 -35.36 72.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.986 -179.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.63 -71.64 0.71 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.527 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.983 ' CE1' HG23 ' A' ' 69' ' ' ILE . 4.6 p80 -112.22 71.96 1.15 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.458 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.542 ' O ' ' HG2' ' A' ' 75' ' ' MET . 62.4 Cg_endo -73.62 50.67 2.08 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.595 2.197 . . . . 0.0 113.675 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 8.8 mtm -156.64 -39.51 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.856 HD12 ' HD2' ' A' ' 77' ' ' PRO . 8.7 tp -59.57 130.33 87.8 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-O 120.945 0.403 . . . . 0.0 112.041 -178.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.856 ' HD2' HD12 ' A' ' 76' ' ' LEU . 47.3 Cg_endo -68.55 115.29 3.83 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.307 2.671 . . . . 0.0 113.871 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.95 HG21 HD13 ' A' ' 69' ' ' ILE . 3.2 t -98.38 151.79 4.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.407 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.881 HD12 ' O ' ' A' ' 51' ' ' LEU . 2.0 mt -136.57 114.56 14.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.064 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.617 HD11 HD21 ' A' ' 66' ' ' LEU . 17.9 mm -93.7 146.03 7.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.521 ' HE2' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.45 -14.53 56.94 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.602 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.8 m -148.43 161.96 40.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.1 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.701 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -145.24 64.04 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.856 0.36 . . . . 0.0 111.246 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.471 ' CD2' ' H ' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -98.89 111.86 24.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.987 0.422 . . . . 0.0 111.558 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.8 t 60.59 161.79 0.05 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.647 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.474 ' HB2' HD13 ' A' ' 63' ' ' LEU . 24.9 m-20 61.91 18.99 10.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.475 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.704 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -46.44 -22.68 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -48.06 -50.17 28.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.34 -20.01 65.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.689 0.281 . . . . 0.0 111.503 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.704 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -63.95 -57.17 10.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.809 0.338 . . . . 0.0 111.008 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.614 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.3 t -62.93 -43.47 99.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.5 m -58.8 -31.68 68.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.183 0.516 . . . . 0.0 110.458 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.689 ' HB1' HD12 ' A' ' 66' ' ' LEU . . . -63.65 -43.68 96.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.36 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.614 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 2.6 m-85 -59.59 -22.19 61.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.545 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.583 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.77 -37.99 54.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.099 -179.337 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.583 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 2.1 pp0? -100.04 -13.34 19.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.752 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 147.59 82.88 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.615 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.832 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.53 111.24 0.56 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.293 0.568 . . . . 0.0 111.611 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -55.22 -49.81 71.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.919 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.527 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER 173.92 -161.89 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.067 0.46 . . . . 0.0 111.918 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.701 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.9 m-85 -127.16 130.21 49.32 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.377 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.603 ' HB2' HD22 ' A' ' 114' ' ' LEU . 4.2 tp -108.27 142.43 25.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.11 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.677 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 17.8 Cg_endo -58.99 163.69 11.23 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.261 1.974 . . . . 0.0 111.372 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.421 ' HE2' ' OG1' ' A' ' 82' ' ' THR . 0.5 OUTLIER -36.25 -47.69 1.52 Allowed Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.613 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 84.2 Cg_exo -47.03 163.22 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.818 1.679 . . . . 0.0 110.756 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.669 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 3.6 t80 -165.55 -92.19 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.167 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.515 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.4 p-10 42.48 -173.69 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.874 0.369 . . . . 0.0 110.628 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.876 HG23 HG21 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -67.83 -47.49 79.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.285 0.564 . . . . 0.0 111.487 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 12.2 t70 -51.75 -57.58 8.86 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.713 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.669 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.5 mm-40 -78.45 -29.09 46.73 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.564 ' HB3' HD21 ' A' ' 19' ' ' LEU . . . -83.34 -54.55 4.91 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.061 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.876 HG21 HG23 ' A' ' 108' ' ' ILE . 39.6 t -57.2 -32.4 40.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.476 0.655 . . . . 0.0 110.162 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -58.84 -53.15 61.63 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.064 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.623 HD12 ' HD2' ' A' ' 117' ' ' ARG . 33.4 tp -74.62 -21.39 59.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.98 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.646 HG12 ' HA ' ' A' ' 112' ' ' VAL . 5.1 p -79.57 -50.16 18.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.161 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.457 ' N ' HG13 ' A' ' 115' ' ' VAL . 94.7 mt-10 -65.47 -40.07 92.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.78 0.324 . . . . 0.0 111.026 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.623 ' HD2' HD12 ' A' ' 114' ' ' LEU . 5.6 ptp180 -65.96 -27.52 68.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.461 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.19 -51.99 26.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.004 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.1 mt -65.29 -31.86 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.161 0.505 . . . . 0.0 111.033 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -43.58 76.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.52 -24.44 66.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -67.47 -43.75 80.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.982 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -75.53 170.25 16.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.986 179.806 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.957 0.408 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -162.78 173.68 13.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.785 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.43 -9.56 19.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.412 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 90.46 99.98 1.16 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.256 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 2.2 mp -124.2 113.49 36.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.478 0.656 . . . . 0.0 111.022 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.885 HG23 HG13 ' A' ' 50' ' ' VAL . 10.4 p -107.21 120.36 58.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.502 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.928 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.0 m0 -112.26 145.8 39.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.069 0.461 . . . . 0.0 110.222 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.949 ' CG1' HG22 ' A' ' 32' ' ' THR . 0.2 OUTLIER -137.29 149.67 25.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -176.145 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.98 HG13 ' HB2' ' A' ' 33' ' ' PHE . 1.4 t -133.28 105.17 7.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.787 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.58 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 44.1 t0 166.85 122.86 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.687 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.416 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER 72.04 -40.92 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.821 179.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 37.6 t0 75.28 -121.92 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.849 -0.159 . . . . 0.0 110.729 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.4 t -31.33 -47.54 0.11 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.515 ' O ' HG23 ' A' ' 18' ' ' VAL . 47.5 t -63.8 -63.32 1.2 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.342 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.961 HG22 HG21 ' A' ' 32' ' ' THR . 20.1 mm -63.21 -25.16 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.418 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.469 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 7.3 ttt180 -61.58 -58.05 9.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.02 0.438 . . . . 0.0 111.445 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.477 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 53.5 t90 -56.69 -46.28 81.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.649 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.708 HG12 HD13 ' A' ' 108' ' ' ILE . 2.0 t -65.47 -44.41 94.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.534 HD12 ' CD1' ' A' ' 108' ' ' ILE . 5.6 tp -83.06 -23.97 32.93 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -177.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.732 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 26.5 pt-20 -66.78 -56.19 11.56 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.729 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.3 mmm180 -65.51 -56.33 12.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.122 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.62 -45.65 73.73 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.811 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.3 tm? -69.21 -26.71 64.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.531 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.22 -32.44 73.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.14 -29.02 71.64 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.21 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.549 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.76 -15.37 59.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.78 0.324 . . . . 0.0 110.982 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.45 26.06 11.43 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.695 -0.765 . . . . 0.0 113.863 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.549 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -133.74 171.2 14.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.75 0.775 . . . . 0.0 111.903 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.647 ' O ' HG12 ' A' ' 6' ' ' VAL . 25.8 m -94.27 128.82 40.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.225 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.732 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 1.8 t -122.97 120.94 34.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.264 0.554 . . . . 0.0 111.865 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.928 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -134.3 132.32 39.43 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.961 HG21 HG22 ' A' ' 15' ' ' ILE . 76.5 p -107.97 159.28 16.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.484 0.659 . . . . 0.0 112.27 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.98 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.7 m-85 -131.96 174.2 10.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.12 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.498 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -63.36 -106.78 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.92 -178.425 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.433 ' O ' HD21 ' A' ' 65' ' ' LEU . 10.9 p30 -88.85 -49.56 6.74 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.87 ' HA3' HD23 ' A' ' 65' ' ' LEU . . . 173.83 -43.37 0.15 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.066 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.607 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 25.5 m120 -53.08 -24.72 10.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 111.2 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.6 OUTLIER -57.2 -60.02 4.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.43 179.419 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.722 HG21 HD11 ' A' ' 51' ' ' LEU . 72.7 t -58.65 -35.94 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.722 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.837 HD11 HE21 ' A' ' 68' ' ' GLN . 40.3 mt -47.17 -46.14 23.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 0.0 110.489 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.63 -45.95 34.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.972 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.56 -29.81 66.67 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.865 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.695 ' CD1' HG12 ' A' ' 39' ' ' VAL . 12.2 mt -72.05 -23.54 61.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.664 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.32 -17.71 13.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.606 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.55 -7.25 9.69 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.595 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -159.67 159.14 32.64 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.74 0.305 . . . . 0.0 111.397 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.593 HG23 HD13 ' A' ' 76' ' ' LEU . 93.5 m -138.75 114.33 8.63 Favored Pre-proline 0 N--CA 1.454 -0.263 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.713 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.686 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.9 Cg_endo -78.69 165.04 25.21 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.371 2.047 . . . . 0.0 111.331 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.03 -26.68 60.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.929 0.395 . . . . 0.0 110.451 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.885 HG13 HG23 ' A' ' 6' ' ' VAL . 10.0 p -145.11 161.09 13.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.722 HD11 HG21 ' A' ' 39' ' ' VAL . 13.5 tp -152.92 140.08 19.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.222 0.534 . . . . 0.0 112.3 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.88 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -104.55 137.6 42.16 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.489 179.436 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.661 ' OG ' HD22 ' A' ' 65' ' ' LEU . 26.2 t -127.72 133.98 49.55 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 32.0 t0 -83.08 172.87 12.26 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.242 0.544 . . . . 0.0 111.499 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.729 HG21 ' HB ' ' A' ' 82' ' ' THR . 0.6 OUTLIER -140.24 84.05 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.956 -179.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -111.49 36.28 3.3 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.744 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.694 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 52.87 53.28 11.81 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 178.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HG3' HD11 ' A' ' 65' ' ' LEU . 43.5 Cg_endo -75.02 -65.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.322 2.015 . . . . 0.0 111.831 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.44 -27.25 1.21 Allowed Glycine 0 CA--C 1.518 0.239 0 N-CA-C 111.824 -0.511 . . . . 0.0 111.824 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.726 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -155.09 63.09 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.694 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 4.3 p-10 54.12 -82.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.026 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.686 ' HA3' ' HB ' ' A' ' 55' ' ' ILE . . . -137.46 -24.24 0.43 Allowed Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.691 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.915 HD23 ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -77.51 -19.11 56.35 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.735 0.268 . . . . 0.0 111.106 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.726 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -55.14 -31.26 61.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.336 0.588 . . . . 0.0 109.897 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.87 HD23 ' HA3' ' A' ' 36' ' ' GLY . 6.6 mp -67.5 -36.27 80.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.425 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.796 HD13 ' HB2' ' A' ' 93' ' ' ALA . 14.1 mt -63.22 -42.64 99.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.912 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 50.4 tttm -55.01 -54.2 45.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.882 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.837 HE21 HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -54.75 -43.13 72.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.154 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.737 HD13 HG21 ' A' ' 78' ' ' VAL . 21.0 mt -59.17 -40.55 81.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.131 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -74.2 -23.07 59.15 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.981 -179.245 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -68.41 -51.21 46.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -93.48 -35.58 12.88 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.595 ' CD2' HD13 ' A' ' 43' ' ' LEU . 2.3 m-70 -99.65 144.04 27.57 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.603 -178.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 73' ' ' HIS . 27.9 Cg_exo -61.58 -70.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.623 2.215 . . . . 0.0 112.711 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 60.7 mtt -147.77 52.96 1.04 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.936 0.398 . . . . 0.0 111.516 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.593 HD13 HG23 ' A' ' 47' ' ' THR . 5.5 tp -72.34 113.8 24.03 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.639 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -53.49 132.73 50.2 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.191 1.928 . . . . 0.0 111.793 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.737 HG21 HD13 ' A' ' 69' ' ' ILE . 2.5 t -126.67 146.64 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.566 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.68 HG21 HD23 ' A' ' 114' ' ' LEU . 3.3 mt -126.88 116.39 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.955 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.822 HD13 ' CD1' ' A' ' 101' ' ' TYR . 1.4 mp -94.16 145.44 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.889 0.376 . . . . 0.0 111.306 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.708 ' HE1' HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -87.68 -22.21 24.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.248 -178.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.729 ' HB ' HG21 ' A' ' 55' ' ' ILE . 2.4 m -147.68 145.65 28.98 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.371 -0.206 . . . . 0.0 110.453 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.406 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -103.32 -29.28 11.34 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.73 0.3 . . . . 0.0 111.606 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.481 ' HB2' HD11 ' A' ' 55' ' ' ILE . 3.3 m-70 44.75 -92.67 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.448 ' O ' HD11 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -141.26 -172.84 3.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.942 0.401 . . . . 0.0 111.479 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 58.15 33.29 23.01 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.007 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.58 ' HA ' HD21 ' A' ' 63' ' ' LEU . 3.2 mt -48.82 -21.17 0.59 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.409 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -47.82 -44.55 28.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.636 0.255 . . . . 0.0 111.45 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -69.68 -21.61 63.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.577 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.915 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -68.11 -32.94 73.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.65 0.262 . . . . 0.0 111.026 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.533 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 9.8 t -71.27 -39.05 72.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.552 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 95.0 p -69.46 -20.23 63.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.805 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.796 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -66.84 -42.47 85.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.365 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.533 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 7.6 m-85 -64.6 -25.83 68.14 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.2 -38.51 51.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.62 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.687 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.7 pp0? -77.42 -18.45 57.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.295 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 131.11 -10.53 5.64 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.453 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.487 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -48.37 155.79 0.48 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.068 0.434 . . . . 0.0 111.329 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.65 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 18.7 t80 -86.41 -53.89 4.74 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.492 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER 169.23 -166.06 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.855 0.36 . . . . 0.0 111.337 -179.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.822 ' CD1' HD13 ' A' ' 80' ' ' ILE . 3.4 m-85 -121.46 133.83 55.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.287 0.565 . . . . 0.0 111.292 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.809 HD12 ' HD2' ' A' ' 103' ' ' PRO . 3.9 tp -120.76 141.63 32.8 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.905 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.809 ' HD2' HD12 ' A' ' 102' ' ' LEU . 19.5 Cg_endo -56.66 168.24 2.41 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.418 2.079 . . . . 0.0 111.815 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.572 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -43.09 -54.0 9.79 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.886 -0.143 . . . . 0.0 111.179 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 7.2 Cg_endo -48.43 163.88 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.878 1.719 . . . . 0.0 110.384 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.848 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER 173.81 -86.89 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.4 p30 50.12 -178.58 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.736 HG23 HG21 ' A' ' 112' ' ' VAL . 1.1 mp -55.83 -47.55 79.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.509 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 4.4 t70 -54.57 -58.63 6.72 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.822 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.848 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 5.5 mm-40 -81.93 -25.59 34.78 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.19 -51.16 7.73 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.518 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.736 HG21 HG23 ' A' ' 108' ' ' ILE . 46.5 t -61.24 -32.75 53.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.486 0.66 . . . . 0.0 110.099 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -58.98 -50.62 73.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.218 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.68 HD23 HG21 ' A' ' 79' ' ' ILE . 7.5 tp -77.1 -21.03 54.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.42 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 112' ' ' VAL . 3.0 p -78.18 -47.49 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.751 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.412 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 52.9 mt-10 -62.73 -42.4 99.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.83 0.348 . . . . 0.0 110.571 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -66.53 -24.48 66.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.612 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.65 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -73.23 -54.15 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.936 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -61.13 -31.44 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.981 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.0 t -70.06 -41.07 74.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.009 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.55 -42.56 98.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.053 0.454 . . . . 0.0 111.024 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -76.44 -52.76 9.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.023 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 59.51 177.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.809 0.337 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -68.32 143.69 55.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.825 ' HE ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -61.38 -20.56 63.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.118 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.95 93.37 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.544 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.825 HD11 ' HE ' ' A' ' 3' ' ' ARG . 3.4 mp -107.91 115.54 49.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.791 0.329 . . . . 0.0 110.853 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.8 HG11 ' CD2' ' A' ' 23' ' ' LEU . 3.0 p -107.01 126.69 63.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.937 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.777 ' CD1' HG22 ' A' ' 31' ' ' THR . 32.8 m0 -114.48 147.26 39.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.886 0.374 . . . . 0.0 110.643 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.968 HG21 HD23 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -137.28 145.75 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.924 0.392 . . . . 0.0 111.669 -178.526 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.899 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -129.28 112.14 24.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.231 178.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.697 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 7.5 t70 -165.21 -154.29 0.21 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.142 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.423 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -67.05 8.77 0.25 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.422 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 10' ' ' ASP . 2.9 p30 45.39 -143.84 0.21 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t 34.97 -91.78 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.817 ' O ' HG23 ' A' ' 18' ' ' VAL . 12.2 m -58.62 -52.33 66.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.703 0.287 . . . . 0.0 111.192 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.3 mm -62.69 -29.13 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 0.0 111.217 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.831 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.2 OUTLIER -72.79 -57.66 3.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.806 -179.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.412 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 77.1 t90 -50.2 -40.33 46.79 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 14' ' ' SER . 1.8 t -71.42 -56.41 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.968 HD23 HG21 ' A' ' 8' ' ' VAL . 6.0 tp -71.59 -23.02 61.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.685 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.79 -60.08 2.81 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.535 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.57 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 7.0 mmm180 -72.64 -52.86 13.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.866 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.465 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -50.62 -60.01 3.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.975 0.416 . . . . 0.0 111.598 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.8 ' CD2' HG11 ' A' ' 6' ' ' VAL . 4.5 tp -61.82 -22.7 65.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.288 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -67.56 -37.49 82.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.8 -24.31 68.12 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.571 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.48 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.11 -15.61 59.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.664 0.269 . . . . 0.0 110.924 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.57 24.06 7.61 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.963 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.636 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -130.37 172.14 12.18 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 117.686 0.743 . . . . 0.0 111.376 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.3 m -105.7 105.77 15.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.465 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.764 ' HA ' HG13 ' A' ' 6' ' ' VAL . 5.7 t -100.57 115.64 30.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.136 0.493 . . . . 0.0 112.235 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.777 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -117.82 156.33 28.54 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.831 HG21 ' HA ' ' A' ' 16' ' ' ARG . 29.8 p -130.12 161.05 31.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.229 0.537 . . . . 0.0 111.439 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.864 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.5 m-85 -133.57 174.46 10.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.42 -178.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.527 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.4 pp20? -59.04 -49.57 77.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -154.52 -51.43 0.09 Allowed 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.99 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.788 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -175.92 -44.38 0.06 OUTLIER Glycine 0 C--N 1.315 -0.597 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.967 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.635 HD22 HD12 ' A' ' 40' ' ' LEU . 4.2 m120 -62.49 -27.38 69.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.018 0.437 . . . . 0.0 110.648 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.674 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -59.65 -47.6 84.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.012 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.846 HG21 HG22 ' A' ' 9' ' ' VAL . 21.4 t -62.38 -42.07 94.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.977 0.418 . . . . 0.0 111.063 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.635 HD12 HD22 ' A' ' 37' ' ' ASN . 25.8 mt -52.07 -42.28 63.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.731 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.79 -48.35 38.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.199 0.523 . . . . 0.0 110.947 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.92 -32.15 72.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.009 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.696 ' CD1' HG12 ' A' ' 39' ' ' VAL . 12.9 mt -68.89 -21.32 64.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.609 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.19 -19.99 37.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.706 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.88 -1.15 6.61 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -153.69 153.27 31.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.942 0.401 . . . . 0.0 111.007 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.716 HG23 HD13 ' A' ' 76' ' ' LEU . 95.5 m -139.02 112.55 8.15 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.247 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.632 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.7 Cg_endo -77.42 164.2 28.96 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.944 1.763 . . . . 0.0 111.325 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.37 -25.6 59.6 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.693 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.596 HG13 HG23 ' A' ' 6' ' ' VAL . 4.8 p -145.07 159.68 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.005 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.535 HD11 HG11 ' A' ' 39' ' ' VAL . 14.9 tp -152.94 155.81 37.71 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.235 0.541 . . . . 0.0 112.179 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.899 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.7 mt -136.52 127.55 27.76 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.373 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.597 ' HB3' HD12 ' A' ' 80' ' ' ILE . 42.4 t -106.68 140.27 39.81 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.697 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 10.0 t0 -65.8 -35.87 81.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.697 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.866 HG21 HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER 45.12 90.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.971 0.415 . . . . 0.0 110.632 -179.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.91 90.31 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.595 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 53.6 44.99 2.14 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 178.457 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.626 ' HG3' ' HA2' ' A' ' 62' ' ' GLY . 90.0 Cg_endo -89.3 -54.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.574 2.183 . . . . 0.0 112.139 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.43 -19.42 0.09 OUTLIER Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.633 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.947 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 3.0 tpt -163.59 69.85 0.21 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.146 0.498 . . . . 0.0 110.132 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.54 -22.25 0.14 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.303 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.626 ' HA2' ' HG3' ' A' ' 58' ' ' PRO . . . 139.83 -34.86 1.98 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.236 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.776 HD13 ' HB3' ' A' ' 86' ' ' ASP . 4.9 mp -72.67 -16.32 61.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.509 -0.345 . . . . 0.0 111.047 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.947 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.68 -33.34 55.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.216 0.532 . . . . 0.0 110.191 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.564 HD13 ' HA3' ' A' ' 36' ' ' GLY . 49.6 mt -60.98 -35.62 77.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.561 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.906 HD11 HD11 ' A' ' 80' ' ' ILE . 3.6 mm? -61.28 -45.04 96.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.164 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.573 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 61.2 tttt -54.44 -41.48 69.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.62 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.604 ' CB ' HD13 ' A' ' 40' ' ' LEU . 11.6 mm100 -67.46 -33.41 75.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.627 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.634 HG23 ' HD2' ' A' ' 73' ' ' HIS . 92.8 mt -63.96 -38.37 82.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.829 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.36 -24.47 46.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.758 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.426 ' NE2' ' HG2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -86.09 -34.25 20.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.825 -178.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.426 ' HG2' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -94.86 -25.57 16.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.634 ' HD2' HG23 ' A' ' 69' ' ' ILE . 1.1 m-70 -126.36 163.4 40.55 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.795 0.331 . . . . 0.0 111.265 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 40.1 Cg_endo -72.07 -81.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.571 2.181 . . . . 0.0 112.857 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.629 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.0 mpt? -138.95 48.09 1.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 111.152 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.716 HD13 HG23 ' A' ' 47' ' ' THR . 4.7 tp -63.72 118.01 40.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.793 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.24 119.04 5.88 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.146 1.897 . . . . 0.0 111.87 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.554 HG21 HG21 ' A' ' 69' ' ' ILE . 2.3 t -117.11 139.71 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.271 0.558 . . . . 0.0 111.554 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.768 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.9 mt -123.7 115.47 45.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.445 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.906 HD11 HD11 ' A' ' 66' ' ' LEU . 4.8 mm -93.53 127.47 45.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.637 ' HA ' ' HG ' ' A' ' 102' ' ' LEU . 1.1 ptp -80.26 -2.09 43.6 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.625 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.807 ' HB ' HG23 ' A' ' 55' ' ' ILE . 2.7 m -147.87 142.87 26.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.73 0.3 . . . . 0.0 110.715 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.913 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -162.93 65.22 0.19 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.908 0.385 . . . . 0.0 111.004 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -98.26 -45.57 6.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.186 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.39 165.74 17.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 111.293 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.776 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.4 OUTLIER 59.91 24.08 13.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.429 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.606 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 4.7 mt -48.73 -21.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -48.01 -55.23 10.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.662 0.268 . . . . 0.0 111.58 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.475 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -60.0 -20.56 58.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.748 0.309 . . . . 0.0 111.095 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -66.96 -39.07 87.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.44 . . . . 0.0 110.419 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.601 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 16.2 t -64.99 -45.27 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.362 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 p -61.34 -32.39 72.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 110.403 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.679 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -58.83 -39.03 80.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.115 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.601 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 20.3 m-85 -61.76 -20.9 64.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.99 0.424 . . . . 0.0 110.164 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.648 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.49 -42.51 52.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.444 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.679 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -75.66 -16.56 60.17 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.029 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.23 24.43 2.22 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.297 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.553 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -65.85 140.13 58.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.819 0.31 . . . . 0.0 110.5 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 47.9 t80 -72.52 -53.67 11.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.198 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.623 ' OD2' HD11 ' A' ' 114' ' ' LEU . 47.4 p-10 178.26 -160.69 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.709 0.29 . . . . 0.0 111.38 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.913 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 8.1 m-85 -141.87 113.36 7.71 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.726 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.653 HD11 ' O ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -105.33 142.8 25.47 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.593 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.63 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 9.4 Cg_endo -51.01 166.97 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.002 2.468 . . . . 0.0 112.212 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.701 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -40.89 -42.94 4.04 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.701 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 3.6 Cg_endo -45.99 163.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.02 1.814 . . . . 0.0 110.328 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.831 ' HE2' HD22 ' A' ' 52' ' ' LEU . 43.6 t80 -169.93 -95.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.947 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.6 p30 44.27 -172.39 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.691 0.281 . . . . 0.0 110.551 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.786 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -67.71 -47.79 78.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.14 0.495 . . . . 0.0 112.069 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 37.3 m-20 -52.29 -54.53 30.28 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.716 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.687 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.4 mm-40 -80.24 -30.11 38.47 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.5 -51.0 7.72 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.2 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.734 ' HA ' HG12 ' A' ' 115' ' ' VAL . 40.6 t -61.47 -32.91 54.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.498 0.666 . . . . 0.0 110.241 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.34 -50.55 73.16 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.818 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.623 HD11 ' OD2' ' A' ' 100' ' ' ASP . 13.6 tp -77.65 -21.17 52.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.443 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.734 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.5 p -79.44 -50.74 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.494 ' N ' HG13 ' A' ' 115' ' ' VAL . 25.5 mt-10 -62.75 -42.45 99.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 110.843 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -63.28 -23.71 67.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.436 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.498 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -73.1 -55.98 5.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.067 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.9 mt -65.47 -31.6 54.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.13 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.5 t -66.77 -40.18 88.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.956 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -68.41 -24.88 64.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.176 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -72.05 -47.85 48.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.974 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -76.5 -55.28 5.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.213 0.53 . . . . 0.0 111.126 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.874 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.7 0.285 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.52 160.84 26.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.343 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.765 ' HE ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -75.35 0.32 17.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.492 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 85.69 92.92 0.83 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.866 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.765 HD11 ' HE ' ' A' ' 3' ' ' ARG . 2.3 mp -122.19 113.48 38.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.787 0.327 . . . . 0.0 111.357 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.798 HG23 HG13 ' A' ' 50' ' ' VAL . 11.8 p -105.45 131.51 54.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.365 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.824 ' CD1' HG22 ' A' ' 31' ' ' THR . 32.1 m0 -118.1 135.99 53.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.797 0.332 . . . . 0.0 110.764 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -127.19 138.21 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.9 -178.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.021 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -125.64 115.73 44.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.66 178.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.911 ' HB2' ' HE2' ' A' ' 81' ' ' MET . 12.5 t0 -170.95 -149.05 0.06 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.802 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -66.05 -3.04 4.69 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.443 ' OD1' ' HD3' ' A' ' 16' ' ' ARG . 2.4 t70 55.15 -141.24 0.87 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.304 0.113 . . . . 0.0 111.304 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 t 36.12 -92.25 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.811 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.2 t -60.47 -50.11 74.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.765 0.317 . . . . 0.0 111.044 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.86 -32.43 55.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 111.3 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.827 ' HA ' HG21 ' A' ' 32' ' ' THR . 11.8 ttt180 -70.98 -59.48 2.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.213 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.434 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 64.7 t90 -47.88 -44.47 29.51 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 14' ' ' SER . 1.9 t -67.59 -61.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.048 0.452 . . . . 0.0 111.932 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.573 ' HB3' ' SG ' ' A' ' 30' ' ' CYS . 37.1 mt -66.72 -25.63 66.62 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.615 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 19.8 pt-20 -66.05 -59.13 4.1 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.56 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.615 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.5 mmt180 -74.54 -59.94 2.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.133 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.01 -51.84 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.598 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.1 tm? -62.71 -31.99 73.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.173 0.511 . . . . 0.0 110.789 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 28' ' ' LEU . . . -65.32 -34.89 79.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.651 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.22 -24.49 67.34 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.452 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.91 -15.6 59.63 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.743 0.306 . . . . 0.0 111.153 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.79 14.0 16.76 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.809 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -127.12 172.51 10.47 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.85 0.825 . . . . 0.0 111.449 179.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 6' ' ' VAL . 57.2 m -105.56 113.95 27.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.309 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 35.8 t -107.62 114.43 28.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.172 0.51 . . . . 0.0 111.935 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.824 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -118.12 154.23 32.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.827 HG21 ' HA ' ' A' ' 16' ' ' ARG . 44.7 p -126.35 159.52 32.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.214 0.53 . . . . 0.0 112.12 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.021 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.8 m-85 -134.18 174.05 10.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.921 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -60.4 -53.55 56.23 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -176.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -156.88 -32.09 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.885 0.766 . . . . 0.0 112.844 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.739 ' HA3' ' HG ' ' A' ' 65' ' ' LEU . . . 167.79 -51.41 0.23 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.012 -1.089 . . . . 0.0 113.383 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.537 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -56.18 -29.87 61.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.864 0.364 . . . . 0.0 110.837 -179.206 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -62.46 -53.9 48.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.8 HG21 HG22 ' A' ' 9' ' ' VAL . 4.8 t -53.81 -37.59 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.382 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.769 HD21 ' CD1' ' A' ' 65' ' ' LEU . 17.7 mt -54.21 -43.05 70.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.04 0.448 . . . . 0.0 110.441 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.87 -47.15 66.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.993 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.02 -35.02 79.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.197 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' A' ' 73' ' ' HIS . 17.3 mt -66.52 -24.5 66.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.883 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.08 -19.06 17.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.961 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.13 -8.95 9.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -149.49 157.34 43.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.396 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.589 HG23 HD23 ' A' ' 76' ' ' LEU . 67.0 m -139.2 112.66 8.05 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.361 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.524 ' CD ' HD21 ' A' ' 43' ' ' LEU . 73.9 Cg_endo -75.56 165.43 30.5 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.143 1.896 . . . . 0.0 111.298 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.85 -25.09 59.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.019 0.437 . . . . 0.0 110.334 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.798 HG13 HG23 ' A' ' 6' ' ' VAL . 6.4 p -145.84 161.99 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.807 ' O ' HD12 ' A' ' 79' ' ' ILE . 19.3 tp -152.83 144.88 23.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.504 0.668 . . . . 0.0 111.623 -178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.904 HD22 ' CZ ' ' A' ' 106' ' ' PHE . 2.2 mt -127.92 115.26 18.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.687 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -106.87 143.68 34.61 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.561 ' HB2' ' HA ' ' A' ' 10' ' ' ASP . 15.6 t0 -73.5 176.84 5.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.734 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.887 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 6.6 tt -153.07 81.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.69 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 172.96 54.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.341 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.429 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.23 -62.5 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.454 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.606 ' HG2' ' HA2' ' A' ' 62' ' ' GLY . 18.9 Cg_endo -56.4 -177.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.672 2.248 . . . . 0.0 112.833 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -50.44 -75.53 0.21 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.59 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.777 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -71.26 59.88 0.28 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.844 0.354 . . . . 0.0 110.462 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.29 -73.57 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.312 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.887 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.77 -35.82 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.083 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.868 ' HA ' HD23 ' A' ' 66' ' ' LEU . 2.8 mp -55.24 -24.11 26.02 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.605 0.241 . . . . 0.0 111.032 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -55.4 -35.86 65.78 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.254 0.549 . . . . 0.0 109.996 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.769 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -58.46 -40.6 83.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.009 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.868 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.4 mm? -57.92 -43.23 86.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -55.25 -45.16 76.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.51 178.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -66.22 -34.27 77.65 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.932 0.396 . . . . 0.0 110.423 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.811 HD12 ' HA ' ' A' ' 66' ' ' LEU . 55.9 mt -60.18 -44.67 95.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.597 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -74.72 -21.4 59.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.601 -179.279 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 -35.02 26.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.625 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -100.45 -39.82 7.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.532 ' CD2' HD13 ' A' ' 43' ' ' LEU . 3.2 m-70 -102.12 151.79 38.12 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.696 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -96.37 102.3 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.252 2.635 . . . . 0.0 113.027 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.632 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 22.8 mtm 57.0 30.66 18.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.024 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.589 HD23 HG23 ' A' ' 47' ' ' THR . 2.2 tm? -64.99 111.4 5.8 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.527 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.432 ' HD2' HD22 ' A' ' 76' ' ' LEU . 43.8 Cg_exo -57.91 116.31 3.14 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.605 2.203 . . . . 0.0 112.531 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.875 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 1.6 t -116.4 151.01 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.646 0.736 . . . . 0.0 111.994 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.857 ' HB ' HD23 ' A' ' 52' ' ' LEU . 1.9 mp -139.67 119.26 13.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.759 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.63 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 21.8 mm -93.67 150.38 3.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.242 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.911 ' HE2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -82.35 -27.98 31.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.387 -177.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.66 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 18.0 m -133.98 157.35 46.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.567 0.222 . . . . 0.0 110.588 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.618 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -148.94 62.2 1.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.962 0.411 . . . . 0.0 111.326 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.59 ' CD2' ' H ' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -90.57 -93.98 0.12 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.706 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.46 160.35 22.71 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.078 0.466 . . . . 0.0 112.0 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.511 ' HB2' HD13 ' A' ' 63' ' ' LEU . 3.7 m-20 62.26 15.87 7.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.603 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.606 ' HA ' HD21 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -47.28 -23.46 0.56 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.31 -48.17 36.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.512 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -64.68 -20.52 66.35 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.582 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -58.72 -33.72 70.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.528 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.609 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.2 t -67.44 -36.92 77.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.582 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.527 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 16.5 m -63.31 -20.12 65.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.241 0.544 . . . . 0.0 109.706 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.751 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.65 -53.75 8.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.751 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.609 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.3 m-85 -59.31 -33.87 71.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.142 0.496 . . . . 0.0 110.675 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.2 pp0? -74.65 -38.02 62.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.051 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.751 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 2.9 pp0? -74.59 -18.31 60.59 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.897 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.0 -6.57 3.44 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.574 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.875 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -58.98 148.93 28.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.067 0.434 . . . . 0.0 111.62 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.509 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 40.8 t80 -78.07 -53.06 7.82 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.717 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.545 ' OD2' HD11 ' A' ' 114' ' ' LEU . 13.4 p30 -179.96 -166.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.328 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.618 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 3.0 m-85 -127.68 141.33 51.64 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.165 0.507 . . . . 0.0 111.402 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.63 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 4.5 tp -102.41 145.91 31.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.541 ' O ' HG23 ' A' ' 82' ' ' THR . 29.2 Cg_endo -68.89 -39.81 7.74 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.032 1.821 . . . . 0.0 112.36 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.686 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER 173.85 -48.77 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.773 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 5.4 Cg_endo -47.62 163.99 0.17 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.887 1.725 . . . . 0.0 109.78 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.904 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 2.5 t80 -166.09 -91.74 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.972 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.538 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.9 p-10 41.76 -174.94 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.997 0.427 . . . . 0.0 110.979 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.954 HG23 HG21 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -67.97 -49.55 67.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.392 0.615 . . . . 0.0 111.396 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.564 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -49.68 -57.77 6.59 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.974 -179.526 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.713 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.1 mm-40 -76.44 -29.97 57.18 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.569 ' HB3' HD21 ' A' ' 19' ' ' LEU . . . -83.19 -60.38 2.17 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.771 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.954 HG21 HG23 ' A' ' 108' ' ' ILE . 32.6 t -50.93 -33.74 12.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.45 0.643 . . . . 0.0 110.416 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.72 -51.05 71.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.379 178.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.831 HD23 HG21 ' A' ' 79' ' ' ILE . 9.3 tp -76.82 -20.31 56.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.814 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 112' ' ' VAL . 3.7 p -79.34 -48.77 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.443 -0.503 . . . . 0.0 112.151 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.463 ' N ' HG13 ' A' ' 115' ' ' VAL . 22.8 mt-10 -61.97 -46.75 87.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.853 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.56 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 4.5 ptm180 -64.0 -23.44 67.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.823 0.344 . . . . 0.0 110.701 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.509 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.65 -50.98 21.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.47 -30.93 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.262 0.553 . . . . 0.0 110.783 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.7 m -70.15 -40.85 74.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.838 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -76.77 -25.25 53.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.82 -24.48 24.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.234 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.88 158.95 38.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.971 0.415 . . . . 0.0 110.999 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.905 -179.897 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.6 mtp . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.78 0.324 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.557 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 0.9 OUTLIER -107.64 -40.33 5.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.48 179.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.794 ' HG2' HD11 ' A' ' 5' ' ' ILE . 1.6 ptp180 66.54 -25.74 0.11 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.514 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.761 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 101.91 93.29 2.2 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.242 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.794 HD11 ' HG2' ' A' ' 3' ' ' ARG . 5.3 mm -123.63 112.44 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.061 0.457 . . . . 0.0 111.578 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.12 HG11 HD13 ' A' ' 23' ' ' LEU . 2.8 p -115.78 120.89 66.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.86 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.94 ' CD1' HG22 ' A' ' 31' ' ' THR . 29.8 m0 -112.85 142.86 45.02 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.144 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.71 HG21 HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -132.69 144.77 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.261 -178.409 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.038 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -132.08 121.57 46.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.225 178.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.5 t0 -176.42 -148.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.284 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.27 -1.77 3.7 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.1 -146.72 0.5 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 121.288 -0.165 . . . . 0.0 110.843 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 14' ' ' SER . 85.5 p 34.06 -93.1 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.836 ' O ' HG23 ' A' ' 18' ' ' VAL . 49.7 p -52.88 -58.07 8.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.257 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.6 mm -60.61 -31.41 49.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.01 0.433 . . . . 0.0 111.253 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.695 ' HA ' HG21 ' A' ' 32' ' ' THR . 13.5 ttt85 -72.86 -59.51 2.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.82 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.466 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 16.9 t90 -46.99 -43.76 19.63 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -68.39 -62.85 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.806 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.738 ' HG ' HD12 ' A' ' 23' ' ' LEU . 6.1 tp -67.89 -21.77 65.13 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.724 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.0 pt-20 -67.54 -60.06 2.86 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.672 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.555 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -75.02 -47.3 29.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.521 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -54.89 -58.52 7.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.748 0.309 . . . . 0.0 111.772 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.12 HD13 HG11 ' A' ' 6' ' ' VAL . 2.8 mt -59.01 -28.24 66.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -61.77 -36.89 82.36 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.5 -24.99 71.25 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.457 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.652 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.67 -15.57 59.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 110.957 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.76 25.95 7.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.486 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.031 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.44 172.26 11.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.374 0.587 . . . . 0.0 111.401 179.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.2 m -104.1 109.46 21.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.22 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.724 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 7.6 t -106.65 110.51 22.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.198 0.523 . . . . 0.0 111.898 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.94 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.3 t -121.26 151.79 39.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.917 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.8 p -124.75 161.09 27.15 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.288 0.566 . . . . 0.0 112.108 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.038 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.3 m-85 -133.07 174.37 10.43 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.742 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.596 ' HG2' ' HG3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.66 -51.85 68.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -176.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -162.62 -24.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.7 0.682 . . . . 0.0 112.744 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.733 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . 163.79 -52.25 0.29 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.387 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -52.68 -33.69 48.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.724 0.297 . . . . 0.0 111.012 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.635 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -61.91 -54.32 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.731 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.859 HG21 ' CG2' ' A' ' 9' ' ' VAL . 2.9 t -54.58 -38.86 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.562 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.615 HD13 ' HB3' ' A' ' 68' ' ' GLN . 24.6 mt -52.26 -44.75 65.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.914 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.2 66.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.177 0.513 . . . . 0.0 111.048 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.46 94.18 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.547 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.622 ' HG ' HG12 ' A' ' 39' ' ' VAL . 21.7 mt -59.13 -26.48 64.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.473 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.48 -14.8 8.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.293 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.41 -9.51 10.34 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.98 165.16 32.54 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.087 0.47 . . . . 0.0 111.829 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.625 ' CG2' HD23 ' A' ' 76' ' ' LEU . 91.0 m -138.3 118.31 9.92 Favored Pre-proline 0 N--CA 1.452 -0.353 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.898 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.619 ' O ' HD21 ' A' ' 76' ' ' LEU . 73.6 Cg_endo -75.63 157.03 40.29 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.526 2.151 . . . . 0.0 111.991 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -73.76 -28.16 61.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 0.0 110.725 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.813 HG21 HG23 ' A' ' 115' ' ' VAL . 7.3 p -145.23 99.61 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.31 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.768 ' O ' HD12 ' A' ' 79' ' ' ILE . 63.7 tp -87.15 145.61 26.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.48 0.657 . . . . 0.0 112.184 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.858 HD23 ' HB ' ' A' ' 79' ' ' ILE . 5.1 mt -132.85 114.43 14.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.801 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -111.3 149.95 30.36 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -178.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 18.5 t0 -80.14 -178.18 6.42 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.695 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.808 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 2.6 tt -159.92 73.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.588 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 177.56 63.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.94 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.485 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 3.1 tpp -163.5 -62.36 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.596 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 19.6 Cg_endo -59.49 -178.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.544 2.162 . . . . 0.0 113.03 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.81 -66.25 2.89 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.54 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.3 OUTLIER -72.97 54.62 0.38 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.52 -75.8 0.01 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.838 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.808 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -145.12 -32.74 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.761 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.685 HD22 ' O ' ' A' ' 86' ' ' ASP . 1.4 mp -61.98 -16.46 51.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.503 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.526 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -54.59 -35.26 63.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.316 0.579 . . . . 0.0 109.72 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.733 HD13 ' HA3' ' A' ' 36' ' ' GLY . 7.7 mt -63.6 -38.78 92.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.745 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.867 ' HA ' HD12 ' A' ' 69' ' ' ILE . 7.4 mp -52.35 -47.47 66.07 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 1.5 ttmp? -51.79 -43.39 63.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.701 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.615 ' HB3' HD13 ' A' ' 40' ' ' LEU . 12.1 mm-40 -65.62 -35.75 81.72 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.613 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.921 HG23 ' CE1' ' A' ' 73' ' ' HIS . 82.3 mt -63.06 -44.95 99.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.188 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 74' ' ' PRO . 3.9 pttt -65.8 -23.67 66.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.187 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -28.32 41.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.297 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -112.31 -71.73 0.74 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.796 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.921 ' CE1' HG23 ' A' ' 69' ' ' ILE . 6.1 p80 -112.38 66.3 0.83 Allowed Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.494 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.572 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 25.8 Cg_endo -63.33 -31.99 72.88 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 113.576 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.538 ' HA ' ' HA3' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -88.89 -19.81 25.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.51 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.926 HD22 ' HD2' ' A' ' 77' ' ' PRO . 3.1 tm? -62.83 118.44 42.0 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.619 0.247 . . . . 0.0 111.42 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.926 ' HD2' HD22 ' A' ' 76' ' ' LEU . 52.7 Cg_exo -54.15 115.88 2.67 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.722 2.281 . . . . 0.0 113.087 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.789 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -113.98 142.39 26.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.015 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.858 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.1 mt -130.12 115.85 34.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.943 0.402 . . . . 0.0 110.55 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.687 HG22 ' H ' ' A' ' 82' ' ' THR . 25.1 mm -93.85 145.74 7.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.466 ' HE2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -78.72 -19.92 51.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.028 -179.11 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.687 ' H ' HG22 ' A' ' 80' ' ' ILE . 6.0 m -147.65 157.54 43.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.006 ' HB1' HD23 ' A' ' 87' ' ' LEU . . . -133.48 50.69 2.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.996 0.427 . . . . 0.0 111.166 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.56 -176.14 3.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.956 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.1 t 71.25 -76.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.423 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.685 ' O ' HD22 ' A' ' 63' ' ' LEU . 7.6 m-20 -139.08 77.52 1.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.841 0.353 . . . . 0.0 111.121 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 1.006 HD23 ' HB1' ' A' ' 83' ' ' ALA . 3.4 tm? -52.19 -21.8 3.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.62 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -49.06 -56.63 8.46 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.34 -24.26 67.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.7 ' HB3' HD22 ' A' ' 87' ' ' LEU . . . -57.84 -63.07 1.37 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.82 0.343 . . . . 0.0 111.825 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.404 HG13 ' HE2' ' A' ' 94' ' ' TYR . 11.6 t -56.57 -38.45 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.921 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.417 ' HA ' ' HB3' ' A' ' 95' ' ' GLN . 1.4 m -60.48 -33.53 72.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.744 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.734 ' HB2' HD23 ' A' ' 66' ' ' LEU . . . -68.12 -46.66 70.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.202 0.525 . . . . 0.0 111.118 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.633 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -75.83 -23.74 55.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.873 178.676 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -74.48 -33.67 62.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.939 178.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 93' ' ' ALA . 15.2 pt20 -82.56 -18.47 41.29 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.442 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 75' ' ' MET . . . 161.94 -25.39 0.24 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.292 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.789 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -60.42 162.67 5.96 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.679 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 100' ' ' ASP . 28.4 t80 -74.57 -54.04 8.25 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.4 t0 170.5 -157.48 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.831 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.0 m-85 -129.14 123.01 31.05 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.464 ' HB2' HD22 ' A' ' 114' ' ' LEU . 3.8 tp -104.45 137.79 19.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.144 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.454 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 69.5 Cg_exo -50.81 168.57 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.293 1.995 . . . . 0.0 111.847 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.672 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -44.07 -44.11 16.44 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.672 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 4.4 Cg_endo -47.4 163.48 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.645 1.563 . . . . 0.0 110.466 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.694 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 9.4 t80 -166.66 -94.36 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.679 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 43.01 -174.07 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.8 0.333 . . . . 0.0 110.918 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.796 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -67.55 -47.32 80.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.289 0.566 . . . . 0.0 111.557 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -51.98 -56.02 16.85 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.966 -178.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.7 mm-40 -79.49 -28.35 41.47 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.24 -53.8 5.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.018 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.713 ' HA ' HG12 ' A' ' 115' ' ' VAL . 42.8 t -58.63 -31.92 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 121.417 0.627 . . . . 0.0 110.221 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.17 -53.54 56.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.461 178.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.746 HD23 HG21 ' A' ' 79' ' ' ILE . 8.5 tp -75.19 -20.5 59.27 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.416 -1.265 . . . . 0.0 113.095 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.813 HG23 HG21 ' A' ' 50' ' ' VAL . 5.3 p -79.23 -49.76 19.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.504 ' N ' HG13 ' A' ' 115' ' ' VAL . 16.2 mt-10 -68.59 -38.87 81.0 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.944 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.614 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 4.4 ptp85 -66.15 -26.13 67.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.063 0.459 . . . . 0.0 110.649 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.451 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.49 -51.44 23.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.025 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -64.9 -31.48 54.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.146 0.498 . . . . 0.0 110.787 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.7 m -71.59 -42.56 67.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.746 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -30.37 69.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.788 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -74.08 -47.76 34.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.553 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -76.57 159.33 30.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.878 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.672 0.272 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 56.99 169.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.96 -179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.735 ' HB3' HD11 ' A' ' 5' ' ' ILE . 2.0 tpm_? -63.57 -22.1 66.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.798 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 56.78 76.29 0.21 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.818 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.735 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.4 mp -111.51 114.46 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.698 0.285 . . . . 0.0 110.985 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.996 HG11 HD13 ' A' ' 23' ' ' LEU . 7.7 p -105.53 116.11 48.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.248 179.314 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.838 ' CD1' HG22 ' A' ' 31' ' ' THR . 33.2 m0 -109.05 149.63 29.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.801 0.334 . . . . 0.0 111.35 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.679 HG21 HD23 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -139.5 148.51 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.548 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.9 HG22 HG21 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -134.18 118.37 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.139 177.435 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 12.3 t0 -173.64 -151.97 0.05 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.123 -179.356 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.34 -2.63 4.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 58.19 -137.73 0.88 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.009 178.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.9 p 34.74 -104.86 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.89 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -54.12 -42.73 69.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.567 0.223 . . . . 0.0 111.468 -179.178 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.8 mm -65.24 -36.26 77.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.063 0.458 . . . . 0.0 111.252 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.713 ' HA ' HG21 ' A' ' 32' ' ' THR . 26.4 ttt-85 -70.72 -56.31 6.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.829 -179.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.461 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 69.9 t90 -48.81 -43.87 38.65 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 14' ' ' SER . 1.6 t -67.2 -59.83 3.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.656 -0.417 . . . . 0.0 111.843 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.732 ' HG ' HD12 ' A' ' 23' ' ' LEU . 7.1 tp -70.93 -22.58 62.22 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.601 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 11.1 pt-20 -66.59 -60.12 3.0 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.435 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.588 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.6 mmt180 -74.9 -51.0 14.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.052 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.485 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -51.01 -58.7 5.39 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.032 HD22 HD13 ' A' ' 28' ' ' LEU . 1.8 mt -59.7 -28.93 67.74 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -61.33 -37.4 83.14 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.52 -24.91 69.77 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.672 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.79 -15.52 59.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.693 0.282 . . . . 0.0 111.0 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.1 24.02 7.83 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.503 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.032 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.29 169.77 13.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 111.371 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.2 m -104.52 105.68 15.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.086 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.758 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 18.0 t -101.69 112.75 25.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.198 0.523 . . . . 0.0 111.992 -179.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.838 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.1 t -122.13 152.95 39.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.18 178.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.713 HG21 ' HA ' ' A' ' 16' ' ' ARG . 38.1 p -126.74 152.5 46.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.267 0.556 . . . . 0.0 112.259 -179.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.883 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -129.21 174.04 9.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.54 -179.903 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.614 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -58.87 -104.65 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.025 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.412 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 13.8 m-20 -85.23 -70.76 0.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.751 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -167.26 -31.2 0.02 OUTLIER Glycine 0 C--N 1.318 -0.423 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.203 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.639 HD22 HD12 ' A' ' 40' ' ' LEU . 16.4 m120 -67.06 -31.3 71.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.506 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 1.7 tm-20 -52.99 -57.64 9.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.424 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.9 HG21 HG22 ' A' ' 9' ' ' VAL . 14.4 t -50.99 -42.71 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.297 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.639 HD12 HD22 ' A' ' 37' ' ' ASN . 26.1 mt -51.74 -44.58 63.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.96 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.07 -50.37 70.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.913 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.25 70.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.924 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.94 HD13 ' NE2' ' A' ' 73' ' ' HIS . 3.3 mt -67.61 -24.28 65.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.433 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.74 -17.12 3.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.34 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.71 -3.96 7.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -154.89 157.38 37.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.998 0.428 . . . . 0.0 111.372 -179.82 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.549 HG23 HD12 ' A' ' 76' ' ' LEU . 90.7 m -139.33 110.87 7.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.788 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.744 ' HD2' HD11 ' A' ' 76' ' ' LEU . 59.3 Cg_endo -71.73 156.76 56.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.429 2.086 . . . . 0.0 112.011 178.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -75.34 -24.27 57.32 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.304 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.898 HG11 ' CG2' ' A' ' 115' ' ' VAL . 6.7 p -145.02 95.3 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.441 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.72 ' O ' HD12 ' A' ' 79' ' ' ILE . 28.0 tp -86.86 138.29 31.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.264 0.554 . . . . 0.0 111.884 -179.136 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.796 HD23 ' HB ' ' A' ' 79' ' ' ILE . 4.4 mt -122.89 131.19 53.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.06 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.738 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -131.27 148.03 52.65 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.931 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 24.0 t0 -76.35 -164.47 0.4 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.315 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.77 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -170.66 77.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.276 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.408 ' HG2' ' F3 ' ' A' ' 125' ' ' BEF . 4.6 ptm180 179.38 56.41 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.86 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.619 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 12.7 tpt -157.7 -66.27 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.63 ' HG3' HD12 ' A' ' 65' ' ' LEU . 18.2 Cg_endo -58.06 -166.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.279 1.986 . . . . 0.0 112.877 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.84 -57.66 13.49 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.578 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.703 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -86.12 48.86 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.596 0.236 . . . . 0.0 110.831 179.808 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.521 ' HB3' HG13 ' A' ' 55' ' ' ILE . 0.3 OUTLIER 53.76 -83.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.991 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.77 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -138.84 -17.17 0.56 Allowed Glycine 0 CA--C 1.511 -0.161 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.032 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.914 HD13 ' OH ' ' A' ' 101' ' ' TYR . 1.8 tp -75.15 -12.89 60.4 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.192 0.52 . . . . 0.0 109.997 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.703 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -66.57 -64.87 0.76 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.5 178.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.883 HD22 ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -53.16 -22.94 7.18 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.856 179.834 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.883 ' N ' HD22 ' A' ' 65' ' ' LEU . 2.6 tp -62.19 -46.48 88.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.652 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 10.8 mtpp -55.62 -39.85 71.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.448 177.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.439 ' CG ' ' HA ' ' A' ' 65' ' ' LEU . 6.0 mm-40 -60.77 -33.23 72.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.038 178.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.008 HG23 ' ND1' ' A' ' 73' ' ' HIS . 96.3 mt -59.32 -48.09 88.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.873 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.652 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.25 -29.69 70.78 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.97 0.414 . . . . 0.0 110.749 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.482 ' HG3' ' HD2' ' A' ' 70' ' ' LYS . 7.8 mt-30 -80.87 -31.02 35.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.684 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.7 -56.82 3.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.619 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 1.008 ' ND1' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -91.04 157.3 43.25 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.385 -179.624 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.8 -59.14 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.446 2.097 . . . . 0.0 112.44 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.7 mtt -156.8 28.98 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.128 0.489 . . . . 0.0 110.428 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.744 HD11 ' HD2' ' A' ' 48' ' ' PRO . 1.8 tt -55.85 112.24 4.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.411 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 31.7 Cg_exo -62.63 114.54 2.43 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 121.836 1.691 . . . . 0.0 112.277 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.957 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -99.54 150.9 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.605 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.81 HG21 ' CD2' ' A' ' 114' ' ' LEU . 1.9 mp -133.74 115.44 21.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.82 0.343 . . . . 0.0 110.594 179.65 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.714 HG22 ' H ' ' A' ' 82' ' ' THR . 45.3 mm -97.25 149.32 5.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.223 0.535 . . . . 0.0 112.408 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.514 ' O ' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -82.07 -21.81 36.65 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.9 -178.746 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.737 ' O ' HG21 ' A' ' 55' ' ' ILE . 2.7 m -148.1 139.54 23.6 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.808 -0.558 . . . . 0.0 111.291 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.92 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -115.7 41.46 2.52 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.717 0.294 . . . . 0.0 111.583 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -81.18 54.47 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 0.0 110.831 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.9 p -159.19 -166.59 1.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.617 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.63 ' O ' HD23 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -61.35 85.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mt -49.13 -22.53 0.98 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.137 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -47.89 -45.93 31.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.984 0.421 . . . . 0.0 111.457 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.889 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . . . -72.05 -19.43 61.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.477 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' HA ' HD11 ' A' ' 63' ' ' LEU . . . -75.64 -46.18 32.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.341 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.768 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 12.1 t -68.19 -38.36 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.501 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.5 p -69.93 -23.4 63.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.977 178.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.611 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -63.86 -42.82 97.46 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.235 179.232 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.768 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 1.1 m-85 -63.75 -27.65 69.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.456 178.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.86 -34.85 62.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.381 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.635 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 1.1 pt20 -98.67 -5.22 32.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.608 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 130.89 80.24 0.21 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.135 -179.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.957 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.56 134.87 1.86 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.188 0.518 . . . . 0.0 111.384 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 32.7 t80 -75.79 -54.2 7.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.727 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER 171.99 -164.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.448 . . . . 0.0 111.449 -179.134 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.92 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 2.9 m-85 -125.89 119.92 29.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.989 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.643 HD23 ' CD2' ' A' ' 106' ' ' PHE . 4.3 tp -102.56 136.71 19.3 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.735 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 10.0 Cg_endo -49.22 167.88 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.664 2.243 . . . . 0.0 111.641 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -41.45 -49.93 9.2 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 111.369 0.137 . . . . 0.0 111.369 -178.747 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.735 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 71.0 Cg_exo -47.36 162.94 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.574 1.516 . . . . 0.0 110.028 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.74 ' HD1' ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -175.3 -85.54 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.39 -178.419 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.3 p30 42.66 -168.41 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.13 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.781 HD13 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.78 -47.24 80.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.268 0.556 . . . . 0.0 111.489 -179.887 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 5.0 t0 -51.75 -57.55 8.94 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.911 -179.321 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 17.8 mm-40 -78.98 -27.77 43.43 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.016 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.74 ' HB2' ' HD1' ' A' ' 106' ' ' PHE . . . -84.34 -54.76 4.56 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.826 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.751 HG21 HG23 ' A' ' 108' ' ' ILE . 39.2 t -56.49 -32.17 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.523 0.677 . . . . 0.0 110.023 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.55 -52.42 65.24 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.499 178.293 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.81 ' CD2' HG21 ' A' ' 79' ' ' ILE . 5.4 tp -74.51 -21.49 59.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.789 -178.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.898 ' CG2' HG11 ' A' ' 50' ' ' VAL . 7.2 p -79.27 -51.86 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 120.376 -0.529 . . . . 0.0 112.019 -179.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.544 ' N ' HG13 ' A' ' 115' ' ' VAL . 20.2 mt-10 -64.53 -46.34 83.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.527 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 mtt-85 -62.56 -27.65 69.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.85 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 114' ' ' LEU . . . -71.47 -54.66 9.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.219 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.62 -32.12 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.216 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 116' ' ' GLU . 0.4 OUTLIER -69.13 -40.52 78.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.829 179.861 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -57.83 -27.27 63.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.967 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -84.43 -52.7 5.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.736 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -76.57 173.16 11.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.757 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.841 0.353 . . . . 0.0 110.92 179.858 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . 0.408 ' F3 ' ' HG2' ' A' ' 56' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.645 0.259 . . . . 0.0 111.492 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -123.65 -18.51 6.09 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.421 ' O ' ' OD2' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -73.37 47.99 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.307 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.745 ' C ' HD13 ' A' ' 5' ' ' ILE . . . -68.62 81.59 0.22 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 178.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.745 HD13 ' C ' ' A' ' 4' ' ' GLY . 2.2 mm -114.54 117.84 56.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.078 0.466 . . . . 0.0 112.133 -178.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.058 HG11 HD13 ' A' ' 23' ' ' LEU . 2.6 p -106.11 123.94 61.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.698 177.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.972 ' CD1' HG22 ' A' ' 31' ' ' THR . 38.1 m0 -115.62 141.54 47.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.736 HG13 HD13 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -128.72 135.24 62.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.384 0.611 . . . . 0.0 111.934 -178.416 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.076 HG12 ' H ' ' A' ' 54' ' ' ASP . 1.5 t -123.53 108.17 20.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.06 179.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.548 ' HA ' ' HB2' ' A' ' 54' ' ' ASP . 14.0 t70 -161.66 -149.92 0.18 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.408 -179.071 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.518 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 2.8 m-20 -66.32 -3.08 5.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.574 0.226 . . . . 0.0 111.595 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.8 t70 61.29 -144.8 0.45 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.392 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t 32.74 -90.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.846 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.0 m -55.87 -52.36 64.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.749 0.309 . . . . 0.0 111.21 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.1 mm -63.79 -31.65 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 111.173 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.71 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.6 ttm180 -73.09 -54.59 8.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.677 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.539 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 44.4 t90 -51.3 -42.87 61.47 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.888 HG12 HD13 ' A' ' 108' ' ' ILE . 2.1 t -68.17 -63.11 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.058 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.744 ' HA ' HD11 ' A' ' 108' ' ' ILE . 9.1 mt -65.86 -22.05 66.51 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.659 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.51 -56.91 7.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.219 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.535 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.6 OUTLIER -77.87 -47.18 19.36 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.612 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.484 ' CB ' HG12 ' A' ' 108' ' ' ILE . . . -56.84 -58.07 9.72 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.752 0.311 . . . . 0.0 111.725 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.058 HD13 HG11 ' A' ' 6' ' ' VAL . 2.0 mt -61.29 -29.43 69.86 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -60.98 -34.15 74.32 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.59 -24.95 74.0 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.442 178.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.705 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.88 -15.56 59.66 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.726 179.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.82 25.15 7.73 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.817 179.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.011 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.21 170.4 11.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.267 0.534 . . . . 0.0 111.455 179.611 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.491 ' HB ' HG23 ' A' ' 5' ' ' ILE . 52.7 m -103.74 106.14 16.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.49 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.755 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.2 t -104.23 112.46 25.49 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.972 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -122.83 156.67 34.09 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.307 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 36.3 p -127.21 157.88 38.63 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.394 -0.522 . . . . 0.0 112.305 -178.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.847 ' HB2' HG22 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -135.92 171.49 14.38 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.81 -179.683 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.813 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -64.28 -49.68 70.87 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.017 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.813 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 2.1 t30 -162.79 167.06 23.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -178.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.679 ' N ' HG11 ' A' ' 9' ' ' VAL . . . -42.85 -27.79 0.61 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.382 -0.914 . . . . 0.0 112.735 -178.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.496 ' N ' HD12 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -64.09 -47.8 78.62 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.708 0.289 . . . . 0.0 110.753 179.371 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.671 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.8 OUTLIER -51.82 -52.19 51.04 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.046 179.527 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.841 HG23 HG21 ' A' ' 9' ' ' VAL . 32.0 t -48.69 -40.97 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.025 0.44 . . . . 0.0 110.935 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.667 HD13 ' HB3' ' A' ' 68' ' ' GLN . 17.7 mt -50.17 -48.22 54.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.61 -48.95 75.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.487 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.52 -41.08 96.61 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.906 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.637 HD21 ' CD ' ' A' ' 48' ' ' PRO . 29.4 mt -61.2 -20.82 63.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.02 -14.45 3.7 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.63 -179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.69 -6.89 6.82 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.547 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.604 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.19 166.89 20.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.883 0.373 . . . . 0.0 111.801 -179.46 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.522 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 57.6 m -139.02 122.1 10.73 Favored Pre-proline 0 N--CA 1.454 -0.228 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.436 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.682 ' HD2' HD11 ' A' ' 76' ' ' LEU . 98.4 Cg_endo -79.46 155.35 24.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.304 2.003 . . . . 0.0 111.491 178.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 3' ' ' ARG . 77.3 m-20 -75.34 -25.76 58.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.716 -179.32 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.911 HG11 ' CG2' ' A' ' 115' ' ' VAL . 3.8 p -145.69 91.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 39' ' ' VAL . 32.5 tp -87.12 144.49 26.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.228 -179.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.839 HD23 ' HB ' ' A' ' 79' ' ' ILE . 2.1 mt -125.95 137.5 53.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.934 178.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.712 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -133.57 135.61 44.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -178.197 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 1.076 ' H ' HG12 ' A' ' 9' ' ' VAL . 15.5 t0 -66.88 174.89 2.71 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.937 178.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.755 HG13 ' N ' ' A' ' 62' ' ' GLY . 6.8 tt -152.47 77.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.495 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER 176.67 65.7 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.188 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.634 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 1.6 ttt -158.46 -67.73 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 59.3 Cg_endo -70.18 -163.07 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.554 2.169 . . . . 0.0 113.035 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.62 -60.6 7.54 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.211 -179.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.905 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 1.8 mtp -84.39 45.36 1.11 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.839 0.32 . . . . 0.0 111.594 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.592 ' HB3' HG13 ' A' ' 55' ' ' ILE . 1.2 m-20 50.98 -75.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.366 179.154 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.755 ' N ' HG13 ' A' ' 55' ' ' ILE . . . -139.09 -33.17 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.386 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.761 HD22 ' O ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -56.75 -22.82 38.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.737 0.303 . . . . 0.0 110.324 -179.862 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.905 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -63.19 -39.25 94.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.217 0.532 . . . . 0.0 110.291 178.203 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.652 HD23 ' HA2' ' A' ' 62' ' ' GLY . 2.3 mm? -59.52 -37.44 78.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.39 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.826 ' HA ' HD12 ' A' ' 69' ' ' ILE . 3.0 mm? -59.75 -42.85 94.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.81 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.611 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 2.5 tttt -56.3 -44.45 79.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.655 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.667 ' HB3' HD13 ' A' ' 40' ' ' LEU . 3.0 mt-30 -63.52 -39.46 94.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.161 0.505 . . . . 0.0 111.142 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.826 HD12 ' HA ' ' A' ' 66' ' ' LEU . 58.4 mt -57.43 -51.43 69.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.679 -178.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.74 -23.6 67.3 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.401 -179.829 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -49.72 70.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.191 -178.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -99.35 -20.54 16.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.401 -178.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.521 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 4.2 m-70 -116.5 146.7 38.08 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.856 0.36 . . . . 0.0 111.152 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.85 -75.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.48 2.12 . . . . 0.0 112.74 -179.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 38.3 mtp -149.54 57.69 1.0 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.058 0.456 . . . . 0.0 111.072 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.682 HD11 ' HD2' ' A' ' 48' ' ' PRO . 2.0 tt -66.88 118.49 55.55 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.717 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.529 ' N ' HD23 ' A' ' 76' ' ' LEU . 32.3 Cg_exo -58.61 115.34 2.47 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.552 1.501 . . . . 0.0 111.929 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.012 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -111.27 150.09 13.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.143 179.522 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.839 ' HB ' HD23 ' A' ' 52' ' ' LEU . 2.8 mt -136.83 115.39 14.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.997 179.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 53' ' ' SER . 14.2 mm -93.09 150.91 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.98 0.419 . . . . 0.0 111.693 -178.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.738 ' HE3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -78.98 -27.01 43.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.195 -178.348 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 103' ' ' PRO . 2.8 m -143.29 170.7 15.27 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.883 ' HB1' HD21 ' A' ' 87' ' ' LEU . . . -127.61 45.57 2.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.675 ' O ' HD11 ' A' ' 63' ' ' LEU . 47.3 m-70 -69.34 -174.77 0.7 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.955 0.407 . . . . 0.0 111.135 179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 86' ' ' ASP . 48.1 t 50.67 -165.34 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.879 179.241 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.761 ' O ' HD22 ' A' ' 63' ' ' LEU . 19.3 p-10 -59.49 101.26 0.1 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.798 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.883 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -55.9 -21.87 22.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.082 178.971 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -48.14 -45.9 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.28 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.604 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.69 -19.27 65.15 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.461 -179.349 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.737 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -65.45 -53.99 34.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.086 0.469 . . . . 0.0 110.329 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.567 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.7 t -62.27 -39.83 85.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.561 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.648 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 83.5 p -63.55 -15.03 56.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.941 178.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -75.77 -57.76 3.69 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.187 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.701 ' N ' ' HB3' ' A' ' 98' ' ' ALA . 3.3 m-85 -52.48 -34.15 47.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.134 -179.276 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.648 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -75.61 -33.5 60.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.012 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.495 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 10.0 pt20 -99.01 3.13 46.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.38 179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.537 ' O ' HG23 ' A' ' 78' ' ' VAL . . . 125.08 81.9 0.48 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.575 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.012 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.54 132.85 1.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.153 0.501 . . . . 0.0 111.723 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.425 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 74.8 t80 -75.08 -53.52 8.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.531 -179.165 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.611 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -178.49 -166.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.143 0.497 . . . . 0.0 111.821 -179.556 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.511 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 2.4 m-85 -125.79 140.4 52.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.322 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.714 HD23 ' HD1' ' A' ' 106' ' ' PHE . 5.3 tp -101.89 150.43 37.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.778 ' O ' HG23 ' A' ' 82' ' ' THR . 16.5 Cg_exo -69.08 -43.15 3.42 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.302 2.001 . . . . 0.0 111.533 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.523 ' HE2' ' HB2' ' A' ' 81' ' ' MET . 0.0 OUTLIER 172.81 -46.96 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.479 178.963 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 104' ' ' LYS . 75.9 Cg_exo -47.72 164.59 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 121.905 1.737 . . . . 0.0 109.614 178.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.797 ' CE1' HD22 ' A' ' 52' ' ' LEU . 6.0 t80 -166.18 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.133 -177.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 3.7 p30 44.26 -172.08 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.881 0.372 . . . . 0.0 110.611 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.888 HD13 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -68.1 -50.63 56.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.155 0.502 . . . . 0.0 111.994 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.594 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -50.4 -54.35 22.47 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.943 -178.504 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.69 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 4.2 mm-40 -80.02 -30.62 39.56 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.228 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -83.85 -51.47 7.16 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.962 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.692 ' HA ' HG12 ' A' ' 115' ' ' VAL . 41.5 t -60.3 -31.97 49.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.388 0.613 . . . . 0.0 110.379 179.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.75 -51.82 68.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.742 0.782 . . . . 0.0 109.409 178.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.751 ' CD2' HG21 ' A' ' 79' ' ' ILE . 6.5 tp -75.26 -20.78 59.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.873 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.911 ' CG2' HG11 ' A' ' 50' ' ' VAL . 6.0 p -78.78 -51.64 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.217 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.546 ' N ' HG13 ' A' ' 115' ' ' VAL . 40.5 mt-10 -68.53 -40.88 80.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.783 0.325 . . . . 0.0 110.537 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -66.56 -26.83 67.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.528 179.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 114' ' ' LEU . . . -71.62 -55.04 8.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.956 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -66.43 -31.37 53.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.054 0.454 . . . . 0.0 110.79 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.3 t -67.78 -44.03 78.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.969 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.04 -24.28 65.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.11 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.48 -40.52 77.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.028 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -75.87 -174.57 2.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.793 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.783 0.325 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.655 ' O ' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -126.6 175.84 7.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.866 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 72.75 2.85 4.51 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.725 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.01 102.94 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.938 179.596 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.655 HD11 ' O ' ' A' ' 2' ' ' GLN . 3.1 mp -121.85 112.72 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.031 0.443 . . . . 0.0 110.898 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.121 HG11 HD13 ' A' ' 23' ' ' LEU . 8.9 p -113.73 126.05 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.886 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 1.096 ' CD1' HG22 ' A' ' 31' ' ' THR . 54.4 m0 -118.13 138.03 52.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.823 0.344 . . . . 0.0 110.801 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -123.61 119.21 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.895 -178.302 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.041 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -104.46 104.53 16.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.615 0.245 . . . . 0.0 110.357 179.212 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 63.9 t0 166.78 119.18 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.905 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.424 ' CB ' HG12 ' A' ' 15' ' ' ILE . 1.0 OUTLIER 73.84 -22.24 0.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 178.902 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 73.3 -140.97 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.532 -0.105 . . . . 0.0 110.966 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.0 t -31.69 -44.15 0.07 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.559 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -53.16 -69.56 0.11 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.695 -179.608 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 24.0 mm -60.4 -20.3 20.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.718 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 35.0 ttp180 -73.27 -61.81 1.69 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.781 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.58 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 80.5 t90 -47.64 -48.03 28.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.111 -178.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.604 HG12 HD13 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -64.6 -61.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.113 0.482 . . . . 0.0 111.971 -179.023 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.783 HD21 ' HB3' ' A' ' 111' ' ' ALA . 31.8 mt -68.65 -22.09 64.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.957 -177.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.609 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 17.8 pt-20 -66.57 -57.75 6.62 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.495 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -59.11 -51.15 71.28 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.664 -179.587 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.415 ' CB ' HG13 ' A' ' 108' ' ' ILE . . . -58.29 -51.96 67.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.841 0.353 . . . . 0.0 111.796 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.121 HD13 HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -67.24 -22.64 65.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.388 179.79 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.93 -34.84 78.65 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.027 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.65 -28.23 65.06 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.002 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.617 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.69 -15.48 59.78 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.895 0.378 . . . . 0.0 110.503 179.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.16 24.21 17.48 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.973 -0.632 . . . . 0.0 114.316 178.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.852 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -121.95 159.89 25.98 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 117.961 0.88 . . . . 0.0 112.751 -179.768 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.571 ' HB ' HG23 ' A' ' 5' ' ' ILE . 55.2 m -81.0 126.77 31.81 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.431 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.609 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -116.75 108.03 15.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.154 -178.482 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 1.096 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -130.29 141.84 50.58 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.151 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 65.0 p -115.86 162.53 17.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.574 0.702 . . . . 0.0 112.823 -178.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.041 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.6 m-85 -135.85 173.51 11.63 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.491 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.7 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.7 pp20? -62.91 -59.45 4.83 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -177.004 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.519 HD22 HD11 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -151.22 -60.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.08 -178.729 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.641 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . -152.44 -55.75 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.579 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.557 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -54.35 -29.59 48.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.991 0.395 . . . . 0.0 111.009 -179.216 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.846 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -62.19 -60.74 3.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.668 179.348 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.701 HG21 HG21 ' A' ' 9' ' ' VAL . 22.0 t -48.8 -42.65 13.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.272 179.311 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.63 HD13 ' HB3' ' A' ' 68' ' ' GLN . 38.6 mt -45.64 -46.58 14.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.033 0.444 . . . . 0.0 110.455 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.95 -47.39 80.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.537 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB2' ' HE2' ' A' ' 33' ' ' PHE . . . -67.83 -41.26 83.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.991 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.589 HD13 HG23 ' A' ' 69' ' ' ILE . 19.4 mt -66.32 -29.29 69.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.19 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.04 -19.99 55.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.201 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 t -123.42 0.62 8.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.638 ' CG ' ' HH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -164.65 165.62 20.81 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.116 0.484 . . . . 0.0 111.062 -179.916 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.948 HG23 HD23 ' A' ' 76' ' ' LEU . 54.1 m -138.5 114.52 8.85 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.498 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.582 ' O ' HD21 ' A' ' 76' ' ' LEU . 91.0 Cg_endo -77.58 164.54 28.22 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.1 1.866 . . . . 0.0 111.978 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.552 ' OD1' HD12 ' A' ' 5' ' ' ILE . 7.2 m-20 -78.01 -31.15 50.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.073 0.463 . . . . 0.0 110.401 179.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.646 HG13 HG23 ' A' ' 6' ' ' VAL . 3.4 p -145.22 149.05 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.855 HD12 ' HB2' ' A' ' 7' ' ' TRP . 0.6 OUTLIER -152.97 145.59 24.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.321 0.582 . . . . 0.0 112.31 -178.18 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.794 HD22 ' CZ ' ' A' ' 106' ' ' PHE . 1.2 mt -123.87 122.07 37.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.285 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -111.55 150.45 29.99 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.776 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.503 ' HA ' ' SD ' ' A' ' 81' ' ' MET . 15.8 t0 -77.48 169.72 17.82 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.465 179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.662 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 1.5 tt -144.02 165.94 13.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.369 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER 65.21 65.08 0.59 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.674 0.75 . . . . 0.0 111.297 -179.366 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.659 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -158.01 -63.02 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.685 179.293 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 68.7 Cg_endo -69.29 -157.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.505 2.136 . . . . 0.0 112.33 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.5 -72.94 0.6 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.069 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.799 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 1.5 ttt -71.22 57.51 0.23 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.916 0.388 . . . . 0.0 111.16 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.542 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 56.45 -77.58 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.537 -179.592 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.662 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.46 -31.27 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.389 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.86 ' HA ' HD23 ' A' ' 66' ' ' LEU . 1.7 mp -62.29 -17.1 57.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.745 0.307 . . . . 0.0 110.613 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.799 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -59.71 -37.98 80.38 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.014 0.435 . . . . 0.0 110.13 178.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.641 HD13 ' HA3' ' A' ' 36' ' ' GLY . 30.3 mt -61.26 -39.08 89.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.861 HD21 HD11 ' A' ' 80' ' ' ILE . 4.0 mm? -55.47 -43.51 75.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.142 179.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.656 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 23.6 ttmm -57.97 -42.51 85.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.768 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.63 ' HB3' HD13 ' A' ' 40' ' ' LEU . 3.2 mt-30 -65.51 -41.37 93.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.059 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.988 HG22 ' CD2' ' A' ' 73' ' ' HIS . 36.6 mt -57.25 -50.36 76.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.634 -179.141 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.27 -24.01 67.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.254 -179.532 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.7 -23.13 66.08 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.861 -0.335 . . . . 0.0 111.053 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -108.35 -20.18 13.22 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.988 ' CD2' HG22 ' A' ' 69' ' ' ILE . 6.2 p80 -113.64 166.99 10.11 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 112.106 -179.093 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 94.0 Cg_endo -88.27 -47.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.216 2.611 . . . . 0.0 111.837 178.641 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.613 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.2 mtt -157.45 54.37 0.49 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.948 HD23 HG23 ' A' ' 47' ' ' THR . 0.7 OUTLIER -76.61 112.6 22.83 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-O 120.62 0.247 . . . . 0.0 110.861 179.819 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.548 ' HD2' HD22 ' A' ' 76' ' ' LEU . 37.6 Cg_endo -66.81 115.47 3.6 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.158 1.906 . . . . 0.0 111.86 179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.842 HG13 HD23 ' A' ' 51' ' ' LEU . 2.4 t -109.11 152.34 11.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.878 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.735 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.2 mt -136.09 118.07 20.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.096 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.861 HD11 HD21 ' A' ' 66' ' ' LEU . 15.4 mm -93.61 144.25 9.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.387 0.613 . . . . 0.0 112.167 -179.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.732 ' HE3' ' CZ ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -77.21 -15.99 59.25 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.014 -179.369 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.669 ' H ' HG22 ' A' ' 80' ' ' ILE . 2.5 m -147.79 169.32 20.01 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.213 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -143.94 41.83 1.42 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.771 0.319 . . . . 0.0 111.488 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.527 ' CD2' HG21 ' A' ' 82' ' ' THR . 21.8 m-70 -68.62 113.74 6.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.963 0.411 . . . . 0.0 112.071 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 m 48.58 -177.52 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.925 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' HB2' HD13 ' A' ' 63' ' ' LEU . 6.5 m-20 52.24 26.22 3.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.155 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.795 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -56.14 -22.11 26.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.556 -179.919 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.32 -43.62 43.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.711 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.571 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.19 -23.42 62.96 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.323 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.795 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -64.7 -39.73 94.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.946 0.403 . . . . 0.0 110.492 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.593 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.1 t -69.88 -45.03 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.185 179.47 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.9 m -62.52 -28.89 70.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' A' ' 96' ' ' GLN . . . -62.13 -41.85 98.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.492 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.593 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.4 m-85 -61.43 -21.7 64.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.145 179.087 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.609 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -72.81 -42.18 64.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.772 -179.907 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.613 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.1 pt20 -77.55 -18.15 57.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.505 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.82 5.07 4.54 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.149 -1.024 . . . . 0.0 114.139 178.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -54.65 152.79 6.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.477 0.638 . . . . 0.0 111.311 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.472 ' HD2' HG12 ' A' ' 79' ' ' ILE . 39.3 t80 -85.7 -53.58 5.06 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.335 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.81 -163.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.18 0.514 . . . . 0.0 111.799 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.591 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.9 m-85 -131.66 122.11 25.42 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.624 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 103' ' ' PRO . 5.8 tp -103.69 141.03 21.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.728 -179.567 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 102' ' ' LEU . 19.6 Cg_endo -57.87 169.89 2.37 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.334 2.023 . . . . 0.0 111.591 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.661 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -44.22 -46.5 23.04 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -179.17 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 2.8 Cg_endo -46.49 163.62 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.826 1.684 . . . . 0.0 110.539 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.794 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 1.0 OUTLIER -166.41 -88.47 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.434 -177.812 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.546 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p-10 42.23 -175.48 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.959 0.409 . . . . 0.0 110.613 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.617 HD12 HD23 ' A' ' 19' ' ' LEU . 1.1 mp -68.01 -47.44 78.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.3 0.571 . . . . 0.0 111.652 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.643 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 68.1 m-20 -54.05 -54.96 32.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.831 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.746 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.9 mm-40 -77.65 -29.43 51.63 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.783 ' HB3' HD21 ' A' ' 19' ' ' LEU . . . -84.22 -57.34 3.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.015 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.601 HG21 HG23 ' A' ' 108' ' ' ILE . 43.9 t -54.67 -32.17 25.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.456 0.646 . . . . 0.0 110.142 179.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.85 -54.76 42.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.055 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.555 HD23 HG21 ' A' ' 79' ' ' ILE . 32.5 tp -73.33 -20.66 60.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.66 -179.138 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.734 HG21 HD11 ' A' ' 23' ' ' LEU . 2.4 p -79.06 -47.54 22.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.491 -0.484 . . . . 0.0 112.278 -178.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.08 -38.0 84.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.79 0.328 . . . . 0.0 110.462 179.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.2 mtt85 -65.04 -24.32 67.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.542 179.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.465 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.65 -52.55 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.066 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.7 mt -60.75 -31.49 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.107 0.479 . . . . 0.0 110.659 179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.5 m -70.56 -43.5 69.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.704 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -77.29 -28.92 53.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.859 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -75.64 -56.1 5.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.807 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 58.72 171.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.804 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mmt . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.872 0.368 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -152.31 139.55 19.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.504 ' CG ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -59.08 -21.05 58.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.045 179.696 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.554 ' HA3' HD23 ' A' ' 28' ' ' LEU . . . 81.63 106.41 0.37 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.538 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.567 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 2.2 mp -133.34 113.07 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.759 HG23 HG13 ' A' ' 50' ' ' VAL . 7.9 p -111.69 125.54 69.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.868 0.366 . . . . 0.0 111.433 179.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.841 ' CD1' HG22 ' A' ' 31' ' ' THR . 19.7 m0 -114.88 129.03 56.62 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.433 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.927 HG21 HD23 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -123.42 144.76 31.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -176.454 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.029 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -135.32 105.81 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.582 178.31 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.584 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 51.4 t0 167.49 120.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.637 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.431 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER 70.86 -32.15 0.24 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.216 179.567 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 13' ' ' SER . 5.0 t70 73.75 -134.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 12' ' ' ASP . 47.6 t -21.0 -58.17 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 18' ' ' VAL . 19.4 m -53.04 -69.52 0.11 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.259 -179.088 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 10' ' ' ASP . 26.7 mm -60.46 -20.38 20.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.737 ' HA ' HG21 ' A' ' 32' ' ' THR . 47.8 ttt180 -72.35 -61.45 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.861 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.42 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 75.9 t90 -47.46 -42.85 23.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.066 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.714 HG12 HD13 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -67.52 -62.16 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.736 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.927 HD23 HG21 ' A' ' 8' ' ' VAL . 8.6 tp -70.79 -21.6 62.47 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -177.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.573 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 22.7 pt-20 -67.47 -56.68 8.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.47 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.573 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 9.5 mmm-85 -68.51 -56.34 8.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.479 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.54 -36.94 64.82 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.693 ' HG ' HG11 ' A' ' 6' ' ' VAL . 1.1 tm? -73.7 -27.45 61.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.997 0.427 . . . . 0.0 110.687 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.42 -32.64 72.82 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.59 -25.71 71.66 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.432 178.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.567 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.77 -15.48 59.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.728 0.299 . . . . 0.0 111.135 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.64 25.34 8.69 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.487 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.567 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -134.98 178.27 7.16 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.632 0.716 . . . . 0.0 111.726 179.849 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' HG12 ' A' ' 6' ' ' VAL . 7.9 m -105.64 128.01 53.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.069 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HA ' HG13 ' A' ' 6' ' ' VAL . 42.6 t -123.11 113.01 18.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.134 0.492 . . . . 0.0 111.953 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.841 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.0 t -119.08 156.03 30.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.253 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.737 HG21 ' HA ' ' A' ' 16' ' ' ARG . 44.9 p -133.91 160.19 38.43 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.092 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.029 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.3 m-85 -135.86 174.16 10.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.421 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.55 ' CG ' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.89 -105.05 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.025 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.414 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -84.57 -61.52 1.77 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.033 0.444 . . . . 0.0 111.978 -178.154 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.805 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -176.64 -37.01 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.074 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.967 ' N ' HD21 ' A' ' 65' ' ' LEU . 3.0 m120 -60.18 -29.64 68.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.704 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -54.53 -54.8 36.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.424 179.791 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.637 HG21 ' CG2' ' A' ' 9' ' ' VAL . 6.6 t -49.39 -46.01 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.262 0.553 . . . . 0.0 110.907 179.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.713 HD13 ' HB3' ' A' ' 68' ' ' GLN . 30.3 mt -47.2 -43.46 21.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.306 -179.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.87 82.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.31 0.576 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.98 -36.22 77.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.1 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.853 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.3 mt -59.89 -24.46 64.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.201 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.84 -22.31 5.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.698 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.94 8.32 5.22 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.05 163.21 37.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.98 0.419 . . . . 0.0 111.198 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.86 HG23 HD23 ' A' ' 76' ' ' LEU . 77.7 m -138.39 118.56 9.91 Favored Pre-proline 0 N--CA 1.453 -0.315 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.009 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.658 ' CD ' HD21 ' A' ' 43' ' ' LEU . 56.0 Cg_endo -69.69 154.96 67.36 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.165 1.91 . . . . 0.0 112.292 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' HB3' ' O ' ' A' ' 5' ' ' ILE . 26.8 t0 -79.38 -32.66 43.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.611 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.759 HG13 HG23 ' A' ' 6' ' ' VAL . 7.3 p -150.47 94.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.625 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.573 HD23 HG22 ' A' ' 78' ' ' VAL . 28.5 tp -84.48 153.84 23.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.867 HD23 ' HB ' ' A' ' 79' ' ' ILE . 2.7 mt -136.74 114.76 11.45 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.802 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.546 ' HB3' ' CD1' ' A' ' 80' ' ' ILE . 4.9 t -108.95 149.4 29.25 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.655 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 25.9 t0 -82.99 166.84 18.49 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.381 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.79 HG23 ' HB ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -155.5 108.95 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.994 -179.914 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.47 40.22 0.76 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.375 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.502 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER 66.94 51.06 0.62 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.434 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 62.6 Cg_endo -78.96 -77.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.812 2.341 . . . . 0.0 112.159 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.402 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -109.27 -29.78 3.85 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.815 179.526 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.984 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -152.47 65.78 0.82 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.095 0.474 . . . . 0.0 110.279 179.362 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.536 ' O ' HG12 ' A' ' 55' ' ' ILE . 0.5 OUTLIER 68.74 -22.99 0.14 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.872 179.824 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.638 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 135.24 -31.49 2.68 Favored Glycine 0 CA--C 1.502 -0.757 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -179.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.833 ' HA ' HD23 ' A' ' 66' ' ' LEU . 4.7 mp -70.16 -15.47 62.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.984 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.89 -37.98 64.31 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.061 0.458 . . . . 0.0 110.447 178.448 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.967 HD21 ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -58.15 -36.61 73.25 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.926 179.511 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.855 ' HA ' HD12 ' A' ' 69' ' ' ILE . 4.0 mm? -59.34 -43.61 92.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.494 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.568 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 14.0 mttt -52.59 -47.25 67.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.09 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.713 ' HB3' HD13 ' A' ' 40' ' ' LEU . 2.0 mt-30 -61.09 -32.19 71.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.059 179.162 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.855 HD12 ' HA ' ' A' ' 66' ' ' LEU . 10.7 mt -67.97 -41.6 84.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.166 -178.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 9.9 pttt -77.63 -24.88 49.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.955 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -74.25 -43.43 57.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.883 0.373 . . . . 0.0 111.888 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -89.45 -54.59 4.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.132 -179.06 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.853 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -89.96 135.49 30.17 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.261 -178.858 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -56.74 -64.84 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.512 2.142 . . . . 0.0 112.667 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 96' ' ' GLN . 9.8 mtm -142.01 44.7 1.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.787 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.86 HD23 HG23 ' A' ' 47' ' ' THR . 2.9 tm? -63.01 111.17 4.39 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.037 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.619 ' HD2' HD22 ' A' ' 76' ' ' LEU . 38.7 Cg_exo -58.94 116.29 3.15 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.639 2.226 . . . . 0.0 113.013 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.966 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.7 t -118.55 153.29 20.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.68 179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.867 ' HB ' HD23 ' A' ' 52' ' ' LEU . 3.6 mt -134.14 117.6 25.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.017 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.754 HG22 ' H ' ' A' ' 82' ' ' THR . 26.6 mm -93.57 141.76 14.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.219 0.533 . . . . 0.0 112.06 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.656 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -84.72 -11.73 55.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.558 -179.147 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.79 ' HB ' HG23 ' A' ' 55' ' ' ILE . 15.3 m -147.47 133.0 18.71 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.576 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.814 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -125.63 -1.53 7.38 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 179.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.581 ' HD2' HG23 ' A' ' 82' ' ' THR . 9.1 m-70 -69.32 67.48 0.19 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 0.0 110.256 179.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.5 m -155.98 -79.09 0.09 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.35 -179.34 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.568 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -145.62 79.39 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.68 -179.609 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.648 HD23 ' HB3' ' A' ' 90' ' ' ALA . 4.5 mt -46.12 -21.46 0.15 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.281 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.76 -57.44 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.572 0.225 . . . . 0.0 110.96 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.45 -20.87 62.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 110.87 179.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.648 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -69.65 -60.88 2.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.517 ' HA ' ' HD2' ' A' ' 94' ' ' TYR . 21.6 t -60.75 -46.12 96.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.486 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.7 m -56.81 -49.12 76.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.003 0.43 . . . . 0.0 111.246 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.587 ' CB ' ' HB3' ' A' ' 66' ' ' LEU . . . -62.93 -40.3 97.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.143 -179.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 1.04 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -71.17 -20.71 62.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.218 179.918 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.587 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.56 -38.68 62.63 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.465 179.174 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.587 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 2.6 pt20 -100.23 -17.43 17.34 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.75 66.79 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.496 -1.335 . . . . 0.0 114.081 -179.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.04 ' HB3' ' HA ' ' A' ' 94' ' ' TYR . . . -170.48 132.91 1.0 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.592 0.234 . . . . 0.0 110.553 178.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 45.2 t80 -62.92 -53.14 58.7 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.504 -178.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 178.23 -161.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.788 0.327 . . . . 0.0 111.408 -179.306 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.814 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.2 m-85 -127.59 126.82 42.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.557 ' HB2' HD22 ' A' ' 114' ' ' LEU . 6.3 tp -108.03 135.38 19.88 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.81 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.425 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 77.3 Cg_exo -50.03 170.02 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.2 1.933 . . . . 0.0 111.453 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.659 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -44.6 -44.5 20.83 Favored Pre-proline 0 N--CA 1.464 0.252 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.296 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 4.8 Cg_endo -47.58 163.4 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.739 1.626 . . . . 0.0 110.942 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.785 ' CE1' HD22 ' A' ' 52' ' ' LEU . 9.8 t80 -165.68 -95.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.717 -178.4 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.2 p-10 44.18 -174.03 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.126 -0.359 . . . . 0.0 110.896 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.898 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -68.02 -47.72 77.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.197 0.523 . . . . 0.0 111.633 -179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 23.3 t70 -51.15 -57.47 8.65 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.714 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.687 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.3 mm-40 -78.22 -29.44 48.27 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.206 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -82.16 -57.71 3.27 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.772 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.898 HG21 HG23 ' A' ' 108' ' ' ILE . 38.5 t -54.06 -32.46 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.467 0.651 . . . . 0.0 110.159 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -59.46 -51.65 68.97 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.885 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.836 HD23 HG21 ' A' ' 79' ' ' ILE . 19.3 tp -77.42 -20.55 54.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.791 -178.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.609 ' CG2' HG11 ' A' ' 50' ' ' VAL . 4.2 p -76.43 -46.84 31.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.496 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.421 ' N ' HG13 ' A' ' 115' ' ' VAL . 29.1 mt-10 -63.62 -52.46 60.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.738 0.304 . . . . 0.0 110.537 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 -57.58 -25.89 60.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.05 0.452 . . . . 0.0 110.508 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.436 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.77 -53.87 8.37 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.488 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 115' ' ' VAL . 3.4 mt -68.83 -32.92 56.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.029 0.442 . . . . 0.0 111.112 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.59 -48.53 47.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.32 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -59.32 -25.24 64.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.369 . . . . 0.0 111.124 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -68.92 -50.3 50.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.678 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -76.36 165.44 24.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.835 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 -179.971 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 mtt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 120.994 0.426 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.94 154.07 23.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.1 -179.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -153.93 72.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.702 179.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.73 ' C ' HD13 ' A' ' 5' ' ' ILE . . . -99.84 99.56 2.08 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.762 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.73 HD13 ' C ' ' A' ' 4' ' ' GLY . 3.5 mm -119.41 112.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.655 0.264 . . . . 0.0 111.56 -179.205 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.85 HG11 ' HG ' ' A' ' 23' ' ' LEU . 8.6 p -106.31 118.04 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.291 178.438 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.826 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.4 m0 -111.92 123.8 51.02 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.685 HG21 HD23 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -117.27 136.19 55.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.301 -177.255 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.946 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -121.55 115.65 47.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.855 178.338 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.677 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 5.0 t70 -169.8 -152.62 0.1 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.113 -178.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.36 6.22 0.46 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 14' ' ' SER . 3.9 p30 47.05 -146.5 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t 35.49 -88.58 0.01 OUTLIER 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.803 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.7 m -59.93 -54.48 45.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.68 0.276 . . . . 0.0 111.116 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.9 mm -62.75 -31.75 53.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.486 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.767 ' HA ' HG21 ' A' ' 32' ' ' THR . 5.9 ttp180 -69.11 -48.96 61.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.564 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.659 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 14.9 t90 -61.63 -58.37 8.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.02 -179.24 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 14' ' ' SER . 1.4 t -55.62 -40.47 59.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.185 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.685 HD23 HG21 ' A' ' 8' ' ' VAL . 5.1 tp -84.32 -24.8 29.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -177.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.659 ' HG2' ' O ' ' A' ' 17' ' ' TRP . 19.7 pt-20 -67.63 -59.63 3.19 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.605 -178.702 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.8 ' HD3' ' H ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -59.35 -65.28 0.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.138 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.47 -30.64 5.35 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.956 -179.046 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.85 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.8 tm? -78.89 -32.44 45.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.25 0.548 . . . . 0.0 110.276 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.22 73.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.198 178.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.16 -26.67 71.65 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.602 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.85 -15.39 59.72 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.865 0.364 . . . . 0.0 110.684 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.38 25.69 10.78 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.827 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.696 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -131.09 169.07 16.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.621 0.71 . . . . 0.0 111.697 179.771 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.6 m -96.93 116.24 28.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.658 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.632 ' HA ' HG13 ' A' ' 6' ' ' VAL . 51.5 t -110.24 114.61 28.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.395 0.616 . . . . 0.0 111.883 -179.428 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.826 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.0 t -125.26 155.61 39.86 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.767 HG21 ' HA ' ' A' ' 16' ' ' ARG . 66.9 p -129.08 164.86 22.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.259 0.552 . . . . 0.0 112.116 -179.226 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.946 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.3 m-85 -136.43 174.57 10.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.799 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.618 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.1 pp20? -59.3 -55.68 31.73 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -177.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.431 ' O ' HD11 ' A' ' 65' ' ' LEU . 10.6 t-20 -153.15 -39.58 0.1 Allowed 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.759 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 175.82 -51.06 0.12 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.149 -1.024 . . . . 0.0 113.4 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.482 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -56.65 -27.5 58.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.729 0.3 . . . . 0.0 110.768 -179.513 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.763 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -61.16 -55.28 34.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.692 179.031 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.763 HG22 ' CD1' ' A' ' 33' ' ' PHE . 67.3 t -52.46 -43.16 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.971 0.415 . . . . 0.0 111.138 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' ' 68' ' ' GLN . 14.2 mt -52.76 -43.22 65.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.401 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.59 -49.4 68.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.201 0.524 . . . . 0.0 110.621 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.67 -30.36 71.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.571 179.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.641 HD21 ' HD2' ' A' ' 48' ' ' PRO . 10.0 mt -61.91 -22.15 65.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.362 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.18 -15.1 59.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.35 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 t -120.77 -5.2 9.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.459 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -161.51 165.54 28.44 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.907 0.384 . . . . 0.0 111.517 -179.968 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.7 m -138.27 115.75 9.28 Favored Pre-proline 0 N--CA 1.452 -0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.331 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.683 ' HD2' HD11 ' A' ' 76' ' ' LEU . 59.7 Cg_endo -72.73 147.23 44.57 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.495 2.13 . . . . 0.0 111.914 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 2.0 m-20 -77.71 -20.26 53.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.343 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.924 HG23 HD11 ' A' ' 79' ' ' ILE . 3.2 p -148.63 95.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.965 0.412 . . . . 0.0 110.168 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 79' ' ' ILE . 12.7 tp -86.74 151.75 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.293 -178.693 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.876 ' O ' HG23 ' A' ' 9' ' ' VAL . 15.5 mt -135.97 116.17 13.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.596 179.04 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.58 ' HB2' HD13 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -105.77 141.01 37.93 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -177.226 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.677 ' OD2' ' HA ' ' A' ' 10' ' ' ASP . 9.8 t70 -70.85 -28.36 64.53 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.957 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.689 HG13 ' C ' ' A' ' 62' ' ' GLY . 2.7 tt 45.98 83.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.556 0.217 . . . . 0.0 111.459 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.04 96.4 0.27 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.62 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 0.6 OUTLIER 58.04 46.37 1.78 Allowed Pre-proline 0 N--CA 1.466 0.352 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 178.352 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 57' ' ' MET . 87.9 Cg_endo -90.36 -55.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.987 2.458 . . . . 0.0 111.927 178.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.93 -18.59 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.422 179.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.975 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 10.2 tpt -158.75 71.54 0.55 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.18 0.514 . . . . 0.0 109.802 179.363 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.404 ' HB3' ' CB ' ' A' ' 85' ' ' SER . 0.4 OUTLIER 66.77 -31.27 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.9 179.832 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.689 ' C ' HG13 ' A' ' 55' ' ' ILE . . . 155.17 -34.07 0.66 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.823 -179.005 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' A' ' 90' ' ' ALA . 5.4 mp -72.47 -25.87 61.6 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.89 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.975 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.78 -30.34 44.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.283 0.563 . . . . 0.0 109.72 178.495 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.579 HD11 ' HA3' ' A' ' 36' ' ' GLY . 0.9 OUTLIER -47.94 -52.8 18.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.931 178.816 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.034 HD23 HD11 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -58.27 -53.07 62.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.245 179.127 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.746 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -43.24 -38.34 2.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.383 179.728 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.579 ' HB3' HD13 ' A' ' 40' ' ' LEU . 18.9 mm100 -71.39 -38.07 71.53 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.166 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.868 HD12 ' HA ' ' A' ' 66' ' ' LEU . 16.6 mt -64.33 -36.35 76.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.962 -179.202 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.746 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -73.44 -29.85 62.82 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.979 -179.907 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.66 -41.32 99.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.835 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -97.3 -23.09 16.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.782 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.46 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 56.2 m-70 -146.33 85.24 7.47 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.844 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.531 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 73.3 Cg_endo -75.53 13.11 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.948 2.432 . . . . 0.0 113.018 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.7 mtt -134.33 -0.62 2.96 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.61 0.243 . . . . 0.0 111.172 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.683 HD11 ' HD2' ' A' ' 48' ' ' PRO . 1.6 tt -76.54 113.16 26.54 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.487 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 45.5 Cg_endo -67.72 116.69 4.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.366 2.044 . . . . 0.0 111.81 178.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.763 ' HB ' HD21 ' A' ' 66' ' ' LEU . 3.1 t -115.47 151.22 17.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.539 0.685 . . . . 0.0 112.347 -178.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.924 HD11 HG23 ' A' ' 50' ' ' VAL . 1.1 mp -129.23 117.29 43.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.696 178.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.034 HD11 HD23 ' A' ' 66' ' ' LEU . 5.8 mm -93.52 133.15 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.594 -178.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.567 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -81.87 -1.88 49.19 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.488 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.588 ' HB ' HG23 ' A' ' 55' ' ' ILE . 2.4 m -148.0 158.92 44.31 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.091 -0.381 . . . . 0.0 110.069 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.736 ' HB2' ' HD2' ' A' ' 101' ' ' TYR . . . -163.19 57.59 0.19 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.866 0.365 . . . . 0.0 111.813 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -98.99 -20.39 16.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.695 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.412 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -84.48 -168.46 2.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.175 0.512 . . . . 0.0 112.339 -178.76 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.457 ' O ' HD22 ' A' ' 63' ' ' LEU . 4.5 m-20 -52.56 89.51 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.93 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.737 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -46.64 -22.96 0.34 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.555 179.042 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.98 -44.91 30.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.06 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . . . -65.82 -19.93 66.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.886 0.374 . . . . 0.0 111.363 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.737 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -75.78 -28.59 58.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.634 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.537 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.5 t -59.19 -38.84 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.536 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.6 m -65.35 -21.75 66.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.644 178.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.676 ' HB1' ' CB ' ' A' ' 98' ' ' ALA . . . -66.65 -47.65 71.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.857 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.537 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.4 m-85 -62.4 -24.32 67.32 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.076 179.34 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.61 -42.17 59.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.261 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.632 HE22 HG23 ' A' ' 78' ' ' VAL . 2.3 pp0? -77.73 -11.02 59.84 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.068 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.85 15.34 10.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.93 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.676 ' CB ' ' HB1' ' A' ' 93' ' ' ALA . . . -56.84 138.87 52.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.75 0.275 . . . . 0.0 110.499 179.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 17.1 t80 -69.14 -52.78 24.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.688 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.5 -161.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.766 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 6.6 m-85 -132.09 118.92 20.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.452 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.654 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 5.1 tp -102.44 140.89 21.53 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.332 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.707 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 22.1 Cg_endo -59.06 168.7 4.28 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.098 1.865 . . . . 0.0 111.047 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.607 ' HE3' ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -41.79 -43.35 6.34 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.329 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.707 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 80.4 Cg_exo -47.05 163.02 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.345 1.363 . . . . 0.0 110.317 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.714 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 2.9 t80 -166.44 -91.13 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.461 -177.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.543 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.7 p-10 43.42 -176.31 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.106 0 CA-C-O 120.854 0.359 . . . . 0.0 110.442 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.854 HG23 HG21 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -67.96 -45.23 84.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.303 0.573 . . . . 0.0 111.072 -179.837 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.6 t0 -52.15 -57.25 10.17 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.879 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.702 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.2 mm-40 -78.84 -29.34 44.57 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -84.2 -51.87 6.69 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.124 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.854 HG21 HG23 ' A' ' 108' ' ' ILE . 42.0 t -59.58 -32.3 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 121.589 0.709 . . . . 0.0 110.085 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -60.27 -50.94 71.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.362 178.386 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.654 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 12.5 tp -79.01 -20.5 48.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.56 -178.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 112' ' ' VAL . 5.4 p -74.94 -51.8 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.012 -179.182 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.527 ' N ' HG13 ' A' ' 115' ' ' VAL . 84.3 mt-10 -68.31 -37.87 81.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.877 0.37 . . . . 0.0 110.901 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -63.1 -23.99 67.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.457 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.436 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.94 -54.82 8.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -67.24 -30.71 50.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.111 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 m -66.96 -46.75 73.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -57.79 -26.55 62.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.163 -179.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -78.47 -57.48 3.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.969 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -75.62 -173.91 2.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.854 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mtp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.827 0.346 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.26 155.93 44.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.666 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -16.68 48.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.12 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.5 92.33 0.67 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.005 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.1 mp -111.08 112.99 42.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.962 0.41 . . . . 0.0 111.113 -179.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.9 HG11 ' CD2' ' A' ' 23' ' ' LEU . 5.8 p -108.15 128.94 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.715 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.869 ' CD1' HG22 ' A' ' 31' ' ' THR . 36.0 m0 -115.93 144.38 44.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.573 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.4 t -134.9 147.82 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.109 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.026 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -134.55 105.1 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.608 177.679 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.602 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 57.1 t0 166.85 123.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.804 0.335 . . . . 0.0 111.336 179.144 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.481 ' CB ' HG12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER 69.49 -21.78 0.16 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 178.849 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 10' ' ' ASP . 14.7 t70 70.56 -130.44 0.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 O-C-N 122.41 -0.181 . . . . 0.0 111.19 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 t -37.27 -45.36 0.65 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.044 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.652 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -53.94 -64.19 0.91 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.168 -179.639 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.663 HG23 HD23 ' A' ' 19' ' ' LEU . 32.1 mm -68.31 -20.63 25.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.696 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -68.84 -55.46 11.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.107 179.427 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.417 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 59.5 t90 -54.58 -43.96 72.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.795 0.331 . . . . 0.0 111.651 -179.776 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.714 HG12 HD13 ' A' ' 108' ' ' ILE . 1.4 t -68.46 -46.88 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.663 HD23 HG23 ' A' ' 15' ' ' ILE . 3.9 mm? -81.67 -23.85 36.64 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 14.0 pt-20 -67.66 -60.36 2.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.814 -179.151 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.6 mmt180 -63.92 -59.34 4.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.137 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.09 -54.24 21.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 111.932 -179.15 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.9 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.7 tp -65.26 -22.7 66.89 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.282 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -68.21 -36.79 80.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.25 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.26 -26.34 63.74 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.338 178.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.739 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.69 -15.47 59.14 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.703 0.287 . . . . 0.0 111.111 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.96 26.15 9.9 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.673 178.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.739 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -124.51 169.45 11.87 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.442 0.621 . . . . 0.0 111.224 179.53 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.2 m -104.17 106.46 16.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.166 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.685 ' HA ' HG13 ' A' ' 6' ' ' VAL . 11.4 t -101.76 115.06 29.69 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.058 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.869 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -118.94 156.63 29.22 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.696 HG21 ' HA ' ' A' ' 16' ' ' ARG . 18.3 p -129.84 162.79 27.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.658 0.742 . . . . 0.0 112.761 -179.283 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.026 ' HB2' HG13 ' A' ' 9' ' ' VAL . 20.0 m-85 -135.95 173.55 11.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.966 -179.078 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.662 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 1.5 pp20? -57.63 -59.52 5.07 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -177.319 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.493 ' HB2' ' HG3' ' A' ' 57' ' ' MET . 71.6 m-20 -152.54 -29.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.399 0.545 . . . . 0.0 112.466 -179.274 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.561 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 172.27 -59.19 0.16 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.892 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.423 ' N ' HD22 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -48.1 -31.35 5.45 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.852 0.358 . . . . 0.0 110.662 -179.701 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.843 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.3 OUTLIER -60.87 -56.41 21.48 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.491 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.778 HG22 ' CD1' ' A' ' 33' ' ' PHE . 5.0 t -53.86 -42.67 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.754 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.76 HD13 ' CB ' ' A' ' 68' ' ' GLN . 14.3 mt -53.95 -43.71 70.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.72 -50.67 68.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.55 68.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.51 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.679 HD21 ' HD2' ' A' ' 48' ' ' PRO . 9.0 mt -65.85 -25.15 67.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.062 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.45 -19.28 61.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.337 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 t -119.32 -1.78 10.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.903 -179.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -163.16 158.71 22.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.997 0.427 . . . . 0.0 111.1 -179.849 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.885 HG23 HD13 ' A' ' 76' ' ' LEU . 65.5 m -139.09 112.26 8.05 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.406 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.679 ' HD2' HD21 ' A' ' 43' ' ' LEU . 57.9 Cg_endo -71.36 164.35 36.03 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.921 1.747 . . . . 0.0 111.281 179.209 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.64 -24.1 58.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.907 0.384 . . . . 0.0 110.581 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.822 HG13 HG23 ' A' ' 6' ' ' VAL . 7.3 p -145.22 161.88 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.626 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.653 HD22 HD21 ' A' ' 76' ' ' LEU . 30.8 tp -152.83 155.88 37.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.214 0.53 . . . . 0.0 112.251 -178.605 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.88 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -138.01 121.08 16.73 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.831 -179.801 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.517 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -105.73 138.96 41.04 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.873 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.584 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 53.0 t0 -69.76 -19.3 63.53 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.995 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.624 HD11 ' CE1' ' A' ' 84' ' ' HIS . 5.2 tt 46.16 73.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.224 0.535 . . . . 0.0 111.604 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.17 75.52 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.489 179.754 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -163.13 -61.16 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.623 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.728 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 59.7 Cg_endo -70.38 -169.32 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.524 2.149 . . . . 0.0 113.656 -178.549 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.71 -58.29 15.36 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.51 179.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.768 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -73.72 51.79 0.38 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.145 0.497 . . . . 0.0 110.274 179.475 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.19 -80.11 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.329 -179.297 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.549 ' HA3' ' CA ' ' A' ' 55' ' ' ILE . . . -143.54 -31.98 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.368 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.733 ' HA ' HD13 ' A' ' 66' ' ' LEU . 3.8 mp -53.76 -24.11 14.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.768 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -61.29 -33.93 74.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.263 178.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.728 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 16.0 mt -60.41 -32.53 71.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.74 179.463 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.816 ' HA ' HD12 ' A' ' 69' ' ' ILE . 5.8 mp -67.22 -42.55 83.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.379 179.558 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.622 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 5.2 mttt -54.21 -41.47 68.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.657 178.742 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.76 ' CB ' HD13 ' A' ' 40' ' ' LEU . 80.2 mm-40 -63.28 -43.16 98.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.816 HD12 ' HA ' ' A' ' 66' ' ' LEU . 5.6 mt -66.47 -36.26 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.701 -178.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.622 ' HG2' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -73.66 -28.46 61.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.934 0.397 . . . . 0.0 110.92 179.853 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.427 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -72.94 -34.78 66.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.987 -179.823 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -93.48 -59.25 2.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.261 179.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.41 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 68.4 m-70 -111.83 85.15 6.03 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.355 179.463 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 56.2 Cg_endo -71.17 20.18 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.725 2.283 . . . . 0.0 113.282 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.504 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 29.1 mtm -144.15 0.93 1.08 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.885 HD13 HG23 ' A' ' 47' ' ' THR . 15.1 tp -76.17 114.87 41.72 Favored Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 179.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.31 120.64 8.16 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.471 2.114 . . . . 0.0 111.882 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.548 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.5 t -115.47 149.29 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.255 0.55 . . . . 0.0 111.885 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.699 HG21 HD23 ' A' ' 114' ' ' LEU . 3.6 mt -132.73 114.51 22.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.534 178.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.643 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 11.4 mm -93.78 138.28 20.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.19 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.626 ' HB3' ' HD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.15 -9.34 57.98 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.25 -179.338 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.64 ' H ' HG22 ' A' ' 80' ' ' ILE . 3.7 m -147.44 168.6 21.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.714 0.292 . . . . 0.0 110.671 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 84' ' ' HIS . . . -143.22 -18.89 0.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 179.646 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.624 ' CE1' HD11 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 23.14 -98.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.247 0.619 . . . . 0.0 112.372 -179.677 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 m -129.29 -176.91 4.03 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.92 0.391 . . . . 0.0 111.245 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.554 ' O ' HD22 ' A' ' 63' ' ' LEU . 5.6 t70 61.64 31.49 18.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.113 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mt -49.61 -21.64 1.07 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.768 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.92 -38.73 17.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.129 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.534 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -74.3 -20.39 60.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.123 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.668 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -71.08 -27.53 63.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.962 0.41 . . . . 0.0 110.109 178.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.573 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 11.4 t -69.08 -41.53 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.09 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.2 m -61.93 -26.46 68.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.054 0.454 . . . . 0.0 110.026 179.134 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -63.9 -46.01 86.75 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.929 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.573 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 10.2 m-85 -59.96 -23.78 63.86 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.555 179.199 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.8 -36.97 65.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.984 179.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.532 ' HB3' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -82.87 -3.5 56.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.733 -179.901 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.85 18.02 13.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.129 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.548 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -61.21 145.1 52.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.965 0.383 . . . . 0.0 110.164 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.532 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 36.9 t80 -72.87 -53.69 10.72 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.776 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.445 ' OD2' HD11 ' A' ' 114' ' ' LEU . 12.9 p30 172.61 -167.45 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.821 0.344 . . . . 0.0 111.287 -179.283 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.643 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.3 m-85 -125.6 117.44 23.55 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.064 0.459 . . . . 0.0 110.736 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.815 HD12 ' HD2' ' A' ' 103' ' ' PRO . 7.3 tp -103.01 134.16 19.94 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.577 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.815 ' HD2' HD12 ' A' ' 102' ' ' LEU . 19.3 Cg_endo -57.71 177.51 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.385 2.057 . . . . 0.0 111.562 179.264 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.621 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -40.02 -51.41 5.76 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.182 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 7.1 Cg_endo -48.13 163.88 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.304 2.003 . . . . 0.0 111.532 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.626 ' HD2' ' HB3' ' A' ' 81' ' ' MET . 0.0 OUTLIER 173.92 -88.7 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.132 -179.609 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.781 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 2.7 p30 47.77 -177.21 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.752 ' HA ' HG23 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -64.67 -49.03 82.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 C-N-CA 119.714 -0.795 . . . . 0.0 112.344 -178.727 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.649 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -53.89 -55.25 28.57 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.175 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.617 ' CG ' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -85.72 -28.16 24.82 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.704 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.781 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -82.81 -47.41 11.92 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.612 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.752 HG23 ' HA ' ' A' ' 108' ' ' ILE . 45.3 t -64.3 -32.9 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.474 0.654 . . . . 0.0 109.507 178.262 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -57.97 -47.95 81.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.172 178.5 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.699 HD23 HG21 ' A' ' 79' ' ' ILE . 6.3 tp -78.91 -22.39 45.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.981 -179.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 112' ' ' VAL . 2.3 p -79.37 -49.92 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.445 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 24.8 mt-10 -55.88 -48.46 75.54 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.626 0.25 . . . . 0.0 111.373 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.466 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -61.42 -23.25 65.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.867 0.365 . . . . 0.0 110.82 179.729 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.532 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.53 -48.2 42.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.92 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.2 mt -72.43 -30.76 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 121.198 0.523 . . . . 0.0 110.523 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.7 t -69.77 -45.12 68.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.013 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.69 -25.31 68.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.192 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -75.3 -56.21 4.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 -179.652 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -76.52 -173.63 2.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.818 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' BEF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_